<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>PA_2022_22007_PPO</title>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
<meta name="generator" content="pdftohtml 0.36"/>
<meta name="author" content="CQF"/>
<meta name="keywords" content="PDF/UA"/>
<meta name="date" content="2022-03-20T03:24:00+00:00"/>
<meta name="subject" content="Accessible PDF"/>
<style type="text/css">
<!--
.xflip {
    -moz-transform: scaleX(-1);
    -webkit-transform: scaleX(-1);
    -o-transform: scaleX(-1);
    transform: scaleX(-1);
    filter: fliph;
}
.yflip {
    -moz-transform: scaleY(-1);
    -webkit-transform: scaleY(-1);
    -o-transform: scaleY(-1);
    transform: scaleY(-1);
    filter: flipv;
}
.xyflip {
    -moz-transform: scaleX(-1) scaleY(-1);
    -webkit-transform: scaleX(-1) scaleY(-1);
    -o-transform: scaleX(-1) scaleY(-1);
    transform: scaleX(-1) scaleY(-1);
    filter: fliph + flipv;
}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<!-- Page 1 -->
<a name="1"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft10{font-size:18px;font-family:BCDEEE+TimesNewRomanPSMT;color:#000000;}
	.ft11{font-size:29px;font-family:BCDFEE+TimesNewRomanPS;color:#000000;}
	.ft12{font-size:20px;font-family:BCDFEE+TimesNewRomanPS;color:#000000;}
	.ft13{font-size:18px;font-family:BCDHEE+ArialMT;color:#000000;}
	.ft14{font-size:24px;font-family:BCDFEE+TimesNewRomanPS;color:#000000;}
	.ft15{font-size:18px;font-family:BCDGEE+SymbolMT;color:#000000;}
	.ft16{font-size:18px;font-family:Times;color:#000000;}
	.ft17{font-size:18px;line-height:23px;font-family:BCDEEE+TimesNewRomanPSMT;color:#000000;}
-->
</style>
<div id="page1-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2001.png" alt="background image"/>
<p style="position:absolute;top:55px;left:108px;white-space:nowrap" class="ft17">Aetna Medicare Advantra&#160;Central Value&#160;(PPO),&#160;Aetna Medicare Advantra Credit Value (PPO),&#160;<br/>Aetna Medicare Advantra&#160;Preferred&#160;Plan (PPO), Aetna Medicare Advantra&#160;Silver&#160;(PPO), Aetna&#160;<br/>Medicare&#160;Advantra Value (PPO), Aetna Medicare&#160;Choice&#160;II&#160;Plan (PPO), Aetna Medicare Choice&#160;<br/>Plan (PPO), Aetna Medicare Credit&#160;Plan (PPO), Aetna&#160;Medicare&#160;Discover&#160;Value Plan (PPO),&#160;<br/>Aetna Medicare DMG Prime (PPO), Aetna Medicare Elite&#160;(PPO), Aetna Medicare&#160;Elite Plan&#160;<br/>(PPO), Aetna Medicare Elite Plan 2 (PPO), Aetna Medicare&#160;Elite Plan 3 (PPO), Aetna Medicare&#160;<br/>Essential Elite Plan&#160;(PPO), Aetna Medicare&#160;Essential Plan (PPO), Aetna Medicare&#160;Explorer&#160;Elite&#160;<br/>(PPO), Aetna Medicare Explorer&#160;Plan (PPO), Aetna Medicare Explorer Premier&#160;(PPO), Aetna&#160;<br/>Medicare&#160;Explorer&#160;Premier 2 (PPO), Aetna Medicare Explorer&#160;Premier&#160;Plan (PPO), Aetna&#160;<br/>Medicare&#160;Explorer&#160;Premier Plus&#160;(PPO), Aetna Medicare&#160;Explorer&#160;Value (PPO), Aetna Medicare&#160;<br/>Freedom&#160;Core&#160;Plan (PPO), Aetna Medicare Freedom Plan (PPO), Aetna Medicare&#160;Freedom&#160;<br/>Preferred Plan (PPO), Aetna Medicare&#160;Gold Plan (PPO), Aetna Medicare Platinum Plan (PPO),&#160;<br/>Aetna Medicare Plus&#160;Plan (PPO), Aetna Medicare Preferred&#160;Premium Plan (PPO), Aetna&#160;<br/>Medicare&#160;Premier (PPO), Aetna&#160;Medicare Premier (Regional&#160;PPO), Aetna Medicare&#160;Premier&#160;1&#160;<br/>(PPO), Aetna Medicare Premier 2 (PPO), Aetna Medicare&#160;Premier Plan&#160;(PPO), Aetna Medicare&#160;<br/>Premier Plus (PPO),&#160;Aetna Medicare&#160;Premier Plus 2 (PPO), Aetna Medicare&#160;Premier Plus 2&#160;<br/>(Regional PPO), Aetna Medicare&#160;Premier Plus Plan (PPO), Aetna&#160;Medicare&#160;Prime&#160;(PPO), Aetna&#160;<br/>Medicare&#160;Prime 1&#160;(PPO), Aetna Medicare Prime&#160;Credit&#160;(PPO), Aetna Medicare Prime&#160;Premier&#160;<br/>(PPO), Aetna Medicare&#160;Select Plan (PPO), Aetna Medicare&#160;SNJ Prime Elite&#160;(PPO), Aetna&#160;<br/>Medicare&#160;The Valley Plan (PPO), Aetna Medicare&#160;Value&#160;(PPO), Aetna Medicare Value Plan&#160;<br/>(PPO), Aetna Medicare Value&#160;Plus&#160;Plan (PPO)&#160;<br/>Last Updated: 04/01/2022&#160;</p>
<p style="position:absolute;top:603px;left:108px;white-space:nowrap" class="ft11"><b>A</b></p>
<p style="position:absolute;top:608px;left:130px;white-space:nowrap" class="ft14"><b>BIRATERONE&#160;</b></p>
<p style="position:absolute;top:659px;left:116px;white-space:nowrap" class="ft12"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:683px;left:122px;white-space:nowrap" class="ft15">•</p>
<p style="position:absolute;top:682px;left:130px;white-space:nowrap" class="ft16">&#160;</p>
<p style="position:absolute;top:685px;left:149px;white-space:nowrap" class="ft10">Abiraterone&#160;Acetate&#160;</p>
<p style="position:absolute;top:705px;left:122px;white-space:nowrap" class="ft15">•</p>
<p style="position:absolute;top:704px;left:130px;white-space:nowrap" class="ft16">&#160;</p>
<p style="position:absolute;top:707px;left:149px;white-space:nowrap" class="ft10">Zytiga&#160;TABS&#160;500MG&#160;</p>
<p style="position:absolute;top:1018px;left:108px;white-space:nowrap" class="ft10">NR_0009_3741 09/2014</p>
<p style="position:absolute;top:1016px;left:287px;white-space:nowrap" class="ft16">&#160;</p>
<p style="position:absolute;top:1057px;left:108px;white-space:nowrap" class="ft10">Formulary ID: 22007: version 12&#160;</p>
<p style="position:absolute;top:1057px;left:801px;white-space:nowrap" class="ft10">1&#160;</p>
</div>
<!-- Page 2 -->
<a name="2"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft28{font-size:18px;font-family:BCDFEE+TimesNewRomanPS;color:#000000;}
	.ft29{font-size:18px;line-height:20px;font-family:BCDFEE+TimesNewRomanPS;color:#000000;}
	.ft210{font-size:18px;line-height:20px;font-family:BCDEEE+TimesNewRomanPSMT;color:#000000;}
-->
</style>
<div id="page2-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2002.png" alt="background image"/>
<p style="position:absolute;top:132px;left:126px;white-space:nowrap" class="ft22"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:132px;left:274px;white-space:nowrap" class="ft22"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:174px;left:126px;white-space:nowrap" class="ft28"><b>Indications&#160;</b></p>
<p style="position:absolute;top:174px;left:274px;white-space:nowrap" class="ft20">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:213px;left:126px;white-space:nowrap" class="ft28"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:213px;left:274px;white-space:nowrap" class="ft20">Node-positive (N1), non-metastatic (M0)&#160;prostate cancer&#160;</p>
<p style="position:absolute;top:252px;left:126px;white-space:nowrap" class="ft29"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:252px;left:274px;white-space:nowrap" class="ft20">N/A&#160;</p>
<p style="position:absolute;top:311px;left:126px;white-space:nowrap" class="ft29"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:311px;left:274px;white-space:nowrap" class="ft210">The requested&#160;drug will&#160;be used in combination with a gonadotropin-<br/>releasing hormone (GnRH) analog or&#160;after bilateral orchiectomy.&#160;</p>
<p style="position:absolute;top:391px;left:126px;white-space:nowrap" class="ft28"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:391px;left:274px;white-space:nowrap" class="ft20">N/A&#160;</p>
<p style="position:absolute;top:430px;left:126px;white-space:nowrap" class="ft29"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:430px;left:274px;white-space:nowrap" class="ft20">N/A&#160;</p>
<p style="position:absolute;top:489px;left:126px;white-space:nowrap" class="ft29"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:489px;left:274px;white-space:nowrap" class="ft20">Plan Year&#160;</p>
<p style="position:absolute;top:548px;left:126px;white-space:nowrap" class="ft28"><b>Other&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:548px;left:274px;white-space:nowrap" class="ft20">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:801px;white-space:nowrap" class="ft20">2&#160;</p>
</div>
<!-- Page 3 -->
<a name="3"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft311{font-size:18px;font-family:BCDFEE+TimesNewRomanPS;color:#7e7e7e;}
	.ft312{font-size:18px;font-family:BCDEEE+TimesNewRomanPSMT;color:#7e7e7e;}
	.ft313{font-size:24px;font-family:Times;color:#000000;}
-->
</style>
<div id="page3-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2003.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft31"><b>A</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft34"><b>CITRETIN</b></p>
<p style="position:absolute;top:119px;left:248px;white-space:nowrap" class="ft313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft32"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft35">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft36">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft30">Acitretin&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft32"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft32"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft38"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft30">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft38"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft310">Prevention of&#160;non-melanoma skin&#160;cancers in high risk individuals, Lichen&#160;<br/>planus, Keratosis&#160;follicularis (Darier&#160;Disease)&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft39"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft30">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft39"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft310">Psoriasis:&#160;The patient has experienced an inadequate&#160;treatment response,&#160;<br/>intolerance,&#160;or the patient has&#160;a contraindication&#160;to&#160;methotrexate&#160;or&#160;<br/>cyclosporine.&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft38"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft30">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft39"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft30">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft39"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft30">Plan Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft38"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft30">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:801px;white-space:nowrap" class="ft30">3&#160;</p>
</div>
<!-- Page 4 -->
<a name="4"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page4-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2004.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft41"><b>A</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft44"><b>CTIMMUNE</b></p>
<p style="position:absolute;top:119px;left:268px;white-space:nowrap" class="ft413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft42"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft45">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft46">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft40">Actimmune&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft42"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft42"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft48"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft40">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft48"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft40">Mycosis fungoides, Sezary syndrome.&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft49"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft40">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft49"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft40">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft48"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft40">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft49"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft40">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft49"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft40">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft48"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft40">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:801px;white-space:nowrap" class="ft40">4&#160;</p>
</div>
<!-- Page 5 -->
<a name="5"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page5-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2005.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft51"><b>A</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft54"><b>DEMPAS</b></p>
<p style="position:absolute;top:119px;left:231px;white-space:nowrap" class="ft513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft52"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft55">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft56">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft50">Adempas&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft52"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft52"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft58"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft50">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft58"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft50">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft59"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft50">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft59"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft510">For pulmonary&#160;arterial hypertension&#160;(PAH) (World Health Organization&#160;<br/>[WHO] Group 1): PAH was confirmed by right heart&#160;catheterization. For&#160;<br/>PAH new&#160;starts only:&#160;1)&#160;pretreatment mean pulmonary arterial pressure is&#160;<br/>greater than&#160;20 mmHg, AND&#160;2) pretreatment&#160;pulmonary capillary wedge&#160;<br/>pressure is less than or equal to 15&#160;mmHg, AND 3)&#160;pretreatment&#160;<br/>pulmonary vascular resistance&#160;is greater&#160;than or&#160;equal to 3 Wood units.&#160;<br/>For chronic thromboembolic pulmonary&#160;hypertension (CTEPH) (WHO&#160;<br/>Group 4):&#160;1) Patient has&#160;persistent or recurrent CTEPH&#160;after&#160;pulmonary&#160;<br/>endarterectomy (PEA), OR 2) Patient has&#160;inoperable CTEPH&#160;with the&#160;<br/>diagnosis confirmed by right&#160;heart&#160;catheterization&#160;AND by computed&#160;<br/>tomography&#160;(CT), magnetic&#160;resonance imaging (MRI), or&#160;pulmonary&#160;<br/>angiography.&#160;</p>
<p style="position:absolute;top:722px;left:126px;white-space:nowrap" class="ft58"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:722px;left:274px;white-space:nowrap" class="ft50">N/A&#160;</p>
<p style="position:absolute;top:760px;left:126px;white-space:nowrap" class="ft59"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:760px;left:274px;white-space:nowrap" class="ft50">N/A&#160;</p>
<p style="position:absolute;top:820px;left:126px;white-space:nowrap" class="ft59"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:820px;left:274px;white-space:nowrap" class="ft50">Plan Year&#160;</p>
<p style="position:absolute;top:879px;left:126px;white-space:nowrap" class="ft58"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:879px;left:274px;white-space:nowrap" class="ft50">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:801px;white-space:nowrap" class="ft50">5&#160;</p>
</div>
<!-- Page 6 -->
<a name="6"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page6-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2006.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft61"><b>A</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft64"><b>IMOVIG</b></p>
<p style="position:absolute;top:119px;left:226px;white-space:nowrap" class="ft613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft62"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft65">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft66">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft60">Aimovig&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft62"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft62"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft68"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft60">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft68"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft60">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft69"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft60">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft69"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft610">1)&#160;The patient received at least 3 months of treatment&#160;with the requested&#160;<br/>drug, and the patient had a reduction&#160;in migraine&#160;days per month from&#160;<br/>baseline, OR&#160;2) The patient experienced an inadequate&#160;treatment&#160;response&#160;<br/>with a&#160;4-week trial&#160;of any of the following: Antiepileptic drugs (AEDs),&#160;<br/>Beta-adrenergic blocking agents, Antidepressants, OR 3) The patient&#160;<br/>experienced&#160;an intolerance or&#160;has&#160;a contraindication that&#160;would prohibit a&#160;<br/>4-week trial&#160;of any of the&#160;following:&#160;Antiepileptic drugs (AEDs), Beta-<br/>adrenergic&#160;blocking agents, Antidepressants.&#160;</p>
<p style="position:absolute;top:639px;left:126px;white-space:nowrap" class="ft68"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:639px;left:274px;white-space:nowrap" class="ft60">N/A&#160;</p>
<p style="position:absolute;top:678px;left:126px;white-space:nowrap" class="ft69"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:678px;left:274px;white-space:nowrap" class="ft60">N/A&#160;</p>
<p style="position:absolute;top:737px;left:126px;white-space:nowrap" class="ft69"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:737px;left:274px;white-space:nowrap" class="ft60">Initial 3&#160;months,&#160;Reauthorization Plan Year&#160;</p>
<p style="position:absolute;top:796px;left:126px;white-space:nowrap" class="ft68"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:796px;left:274px;white-space:nowrap" class="ft60">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:801px;white-space:nowrap" class="ft60">6&#160;</p>
</div>
<!-- Page 7 -->
<a name="7"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page7-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2007.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft71"><b>A</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft74"><b>LECENSA</b></p>
<p style="position:absolute;top:119px;left:243px;white-space:nowrap" class="ft713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft72"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft75">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft76">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft70">Alecensa&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft72"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft72"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft78"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft70">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft78"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft710">Recurrent ALK-positive&#160;non-small cell&#160;lung cancer&#160;(NSCLC), brain&#160;<br/>metastases from&#160;ALK-positive NSCLC.&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft79"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft70">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft79"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft70">N/A&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft78"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft70">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft79"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft70">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft79"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft70">Plan Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft78"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft70">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:801px;white-space:nowrap" class="ft70">7&#160;</p>
</div>
<!-- Page 8 -->
<a name="8"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page8-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2008.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft81"><b>A</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft84"><b>LOSETRON</b></p>
<p style="position:absolute;top:119px;left:263px;white-space:nowrap" class="ft813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft82"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft85">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft86">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft80">Alosetron Hydrochloride&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft82"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft82"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft88"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft80">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft88"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft80">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft89"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft80">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft89"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft810">1)&#160;The requested drug&#160;is being prescribed for a biological female&#160;or a&#160;<br/>person that self-identifies as a female&#160;with a&#160;diagnosis of&#160;severe diarrhea-<br/>predominant irritable bowel syndrome (IBS) AND&#160;2) Chronic IBS&#160;<br/>symptoms lasting at least 6 months AND&#160;3) Gastrointestinal tract&#160;<br/>abnormalities have&#160;been&#160;ruled out AND&#160;4) Inadequate response to one&#160;<br/>conventional therapy (e.g., antispasmodics,&#160;antidepressants,&#160;<br/>antidiarrheals).&#160;</p>
<p style="position:absolute;top:618px;left:126px;white-space:nowrap" class="ft88"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:618px;left:274px;white-space:nowrap" class="ft80">N/A&#160;</p>
<p style="position:absolute;top:657px;left:126px;white-space:nowrap" class="ft89"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:657px;left:274px;white-space:nowrap" class="ft80">N/A&#160;</p>
<p style="position:absolute;top:716px;left:126px;white-space:nowrap" class="ft89"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:716px;left:274px;white-space:nowrap" class="ft80">Plan Year&#160;</p>
<p style="position:absolute;top:776px;left:126px;white-space:nowrap" class="ft88"><b>Other&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:776px;left:274px;white-space:nowrap" class="ft80">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:801px;white-space:nowrap" class="ft80">8&#160;</p>
</div>
<!-- Page 9 -->
<a name="9"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page9-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2009.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft91"><b>A</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft94"><b>LPHA</b></p>
<p style="position:absolute;top:118px;left:196px;white-space:nowrap" class="ft91"><b>1-</b></p>
<p style="position:absolute;top:123px;left:221px;white-space:nowrap" class="ft94"><b>PROTEINASE&#160;</b></p>
<p style="position:absolute;top:118px;left:383px;white-space:nowrap" class="ft91"><b>I</b></p>
<p style="position:absolute;top:123px;left:395px;white-space:nowrap" class="ft94"><b>NHIBITOR</b></p>
<p style="position:absolute;top:119px;left:518px;white-space:nowrap" class="ft913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft92"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft95">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft96">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft90">Prolastin-c&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft92"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft92"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft98"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft90">All&#160;FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft98"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft90">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft99"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft90">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft99"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft910">For alpha1-proteinase&#160;inhibitor deficiency: Patient must have 1)&#160;clinically&#160;<br/>evident&#160;emphysema and&#160;2) pretreatment serum alpha1-proteinase inhibitor&#160;<br/>level&#160;less&#160;than 11 micromol/L&#160;(80 mg/dL by radial&#160;immunodiffusion or 50&#160;<br/>mg/dL by nephelometry).&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft98"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft90">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft99"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft90">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft99"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft90">Plan Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft98"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft90">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:801px;white-space:nowrap" class="ft90">9&#160;</p>
</div>
<!-- Page 10 -->
<a name="10"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page10-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2010.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft101"><b>A</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft104"><b>LUNBRIG</b></p>
<p style="position:absolute;top:119px;left:242px;white-space:nowrap" class="ft1013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft102"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft105">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft106">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft100">Alunbrig&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft102"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft102"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft108"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft100">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft108"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1010">Recurrent ALK-positive&#160;non-small cell&#160;lung cancer&#160;(NSCLC), brain&#160;<br/>metastases from&#160;ALK-positive NSCLC.&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft109"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft100">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft109"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft100">N/A&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft108"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft100">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft109"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft100">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft109"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft100">Plan Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft108"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft100">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft100">10&#160;</p>
</div>
<!-- Page 11 -->
<a name="11"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page11-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2011.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft111"><b>A</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft114"><b>MBRISENTAN</b></p>
<p style="position:absolute;top:119px;left:292px;white-space:nowrap" class="ft1113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft112"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft115">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft116">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft110">Ambrisentan&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft112"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft112"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft118"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft110">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft118"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft110">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft119"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft110">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft119"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft1110">Pulmonary&#160;arterial&#160;hypertension&#160;(PAH) (World&#160;Health Organization&#160;<br/>[WHO] Group 1): Diagnosis was confirmed by right heart catheterization.&#160;<br/>For PAH&#160;new starts only: 1)&#160;Pretreatment mean&#160;pulmonary arterial&#160;<br/>pressure is greater than 20 mmHg, 2)&#160;Pretreatment pulmonary capillary&#160;<br/>wedge pressure is&#160;less&#160;than or&#160;equal to 15 mmHg, and 3)&#160;Pretreatment&#160;<br/>pulmonary vascular resistance&#160;is greater&#160;than or&#160;equal to 3 Wood units.&#160;</p>
<p style="position:absolute;top:598px;left:126px;white-space:nowrap" class="ft118"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:598px;left:274px;white-space:nowrap" class="ft110">N/A&#160;</p>
<p style="position:absolute;top:636px;left:126px;white-space:nowrap" class="ft119"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:636px;left:274px;white-space:nowrap" class="ft110">N/A&#160;</p>
<p style="position:absolute;top:696px;left:126px;white-space:nowrap" class="ft119"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:696px;left:274px;white-space:nowrap" class="ft110">Plan Year&#160;</p>
<p style="position:absolute;top:755px;left:126px;white-space:nowrap" class="ft118"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:755px;left:274px;white-space:nowrap" class="ft110">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft110">11&#160;</p>
</div>
<!-- Page 12 -->
<a name="12"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page12-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2012.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft121"><b>A</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft124"><b>RCALYST</b></p>
<p style="position:absolute;top:119px;left:244px;white-space:nowrap" class="ft1213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft122"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft125">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft126">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft120">Arcalyst&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft122"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft122"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft128"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft120">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft128"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1210">Prevention of&#160;gout flares&#160;in patients initiating or continuing urate-<br/>lowering&#160;therapy.&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft129"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft120">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft129"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft1210">For prevention&#160;of gout&#160;flares in patients initiating&#160;or continuing urate-<br/>lowering&#160;therapy (e.g.,&#160;allopurinol)&#160;(new&#160;starts):&#160;1) two or more gout&#160;<br/>flares within&#160;the previous 12 months,&#160;AND 2) inadequate&#160;response,&#160;<br/>intolerance&#160;or contraindication to&#160;maximum tolerated doses&#160;of a&#160;non-<br/>steroidal&#160;anti-inflammatory drug (NSAID) and colchicine, AND&#160;3)&#160;<br/>concurrent use with urate-lowering&#160;therapy. For prevention of&#160;gout flares&#160;<br/>in patients initiating or continuing urate-lowering&#160;therapy&#160;(e.g.,&#160;<br/>allopurinol)&#160;(continuation): 1)&#160;patient must have&#160;achieved or&#160;maintained&#160;a&#160;<br/>clinical benefit&#160;(i.e.,&#160;a fewer number&#160;of gout&#160;attacks or&#160;fewer&#160;flare&#160;days)&#160;<br/>compared to&#160;baseline, AND 2) continued use&#160;of urate-lowering therapy&#160;<br/>concurrently&#160;with the&#160;requested drug.&#160;</p>
<p style="position:absolute;top:722px;left:126px;white-space:nowrap" class="ft128"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:722px;left:274px;white-space:nowrap" class="ft120">N/A&#160;</p>
<p style="position:absolute;top:760px;left:126px;white-space:nowrap" class="ft129"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:760px;left:274px;white-space:nowrap" class="ft120">N/A&#160;</p>
<p style="position:absolute;top:820px;left:126px;white-space:nowrap" class="ft129"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:820px;left:274px;white-space:nowrap" class="ft120">For prevention&#160;of gout&#160;flares: 4 months. Other: Plan Year&#160;</p>
<p style="position:absolute;top:879px;left:126px;white-space:nowrap" class="ft128"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:879px;left:274px;white-space:nowrap" class="ft120">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft120">12&#160;</p>
</div>
<!-- Page 13 -->
<a name="13"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page13-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2013.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft131"><b>A</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft134"><b>RMODAFINIL</b></p>
<p style="position:absolute;top:119px;left:290px;white-space:nowrap" class="ft1313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft132"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft135">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft136">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft130">Armodafinil&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft132"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft132"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft138"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft130">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft138"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft130">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft139"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft130">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft139"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft1310">1)&#160;The patient has&#160;a diagnosis of&#160;narcolepsy and&#160;the diagnosis is&#160;<br/>confirmed by sleep&#160;lab evaluation OR&#160;2) The patient has a diagnosis of&#160;<br/>Shift Work&#160;Disorder&#160;(SWD) OR 3) The patient&#160;has a&#160;diagnosis of&#160;<br/>obstructive&#160;sleep apnea (OSA) and the&#160;diagnosis is confirmed&#160;by&#160;<br/>polysomnography.&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft138"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft130">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft139"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft130">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft139"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft130">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft138"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft130">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft130">13&#160;</p>
</div>
<!-- Page 14 -->
<a name="14"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page14-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2014.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft141"><b>A</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft144"><b>SPARLAS</b></p>
<p style="position:absolute;top:119px;left:239px;white-space:nowrap" class="ft1413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft142"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft145">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft146">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft140">Asparlas&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft142"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft142"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft148"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft140">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft148"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft140">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft149"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft140">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft149"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft140">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft148"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft140">Patient age&#160;21 years or&#160;less&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft149"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft140">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft149"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft140">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft148"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft140">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft140">14&#160;</p>
</div>
<!-- Page 15 -->
<a name="15"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page15-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2015.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft151"><b>A</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft154"><b>USTEDO</b></p>
<p style="position:absolute;top:119px;left:228px;white-space:nowrap" class="ft1513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft152"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft155">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft156">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft150">Austedo&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft152"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft152"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft158"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft150">All FDA-approved Indications, Some&#160;Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft158"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft150">Tourette's syndrome&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft159"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft150">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft159"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft150">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft158"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft150">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft159"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft150">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft159"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft150">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft158"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft150">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft150">15&#160;</p>
</div>
<!-- Page 16 -->
<a name="16"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page16-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2016.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft161"><b>A</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft164"><b>VONEX</b></p>
<p style="position:absolute;top:119px;left:216px;white-space:nowrap" class="ft1613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft162"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft165">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft166">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft160">Avonex&#160;INJ 30MCG/0.5ML&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft165">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft166">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft160">Avonex Pen&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft162"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft162"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft168"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft160">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft168"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft160">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft169"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft160">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft169"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft160">N/A&#160;</p>
<p style="position:absolute;top:557px;left:126px;white-space:nowrap" class="ft168"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:557px;left:274px;white-space:nowrap" class="ft160">N/A&#160;</p>
<p style="position:absolute;top:596px;left:126px;white-space:nowrap" class="ft169"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:596px;left:274px;white-space:nowrap" class="ft160">N/A&#160;</p>
<p style="position:absolute;top:656px;left:126px;white-space:nowrap" class="ft169"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:656px;left:274px;white-space:nowrap" class="ft160">Plan Year&#160;</p>
<p style="position:absolute;top:715px;left:126px;white-space:nowrap" class="ft168"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:715px;left:274px;white-space:nowrap" class="ft160">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft160">16&#160;</p>
</div>
<!-- Page 17 -->
<a name="17"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page17-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2017.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft171"><b>A</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft174"><b>YVAKIT</b></p>
<p style="position:absolute;top:119px;left:226px;white-space:nowrap" class="ft1713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft172"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft175">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft176">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft170">Ayvakit&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft172"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft172"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft178"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft170">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft178"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1710">Myeloid&#160;and&#160;lymphoid neoplasms with eosinophilia, gastrointestinal&#160;<br/>stromal tumor (GIST) for unresectable, recurrent,&#160;or metastatic disease&#160;<br/>without&#160;platelet-derived&#160;growth factor receptor&#160;alpha (PDGFRA) exon 18&#160;<br/>mutation&#160;</p>
<p style="position:absolute;top:458px;left:126px;white-space:nowrap" class="ft179"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:458px;left:274px;white-space:nowrap" class="ft170">N/A&#160;</p>
<p style="position:absolute;top:518px;left:126px;white-space:nowrap" class="ft179"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:518px;left:274px;white-space:nowrap" class="ft1710">For myeloid&#160;and lymphoid neoplasms with eosinophilia, the&#160;patient meets&#160;<br/>all&#160;of the&#160;following criteria: 1)&#160;the disease is FIP1L1-&#160;PDGFRA&#160;<br/>rearrangement-positive,&#160;AND 2) The&#160;disease harbors&#160;a PDGFRA D842A&#160;<br/>mutation, AND&#160;3) The disease is resistant&#160;to imatinib. For GIST, the&#160;<br/>patient meets either&#160;of the following&#160;criteria:&#160;1) The disease harbors&#160;<br/>PDGFRA exon 18 mutation, including PDGFRA D842V mutations, OR&#160;<br/>2) The requested drug will be used after failure on at least&#160;two Food and&#160;<br/>Drug&#160;Administration (FDA)-approved therapies&#160;in unresectable,&#160;<br/>recurrent, or&#160;metastatic&#160;disease without PDGFRA exon 18 mutation. For&#160;<br/>advanced systemic mastocytosis (AdvSM):&#160;1) the&#160;patient has&#160;a diagnosis&#160;<br/>of advanced systemic mastocytosis&#160;including aggressive systemic&#160;<br/>mastocytosis (ASM), systemic mastocytosis with associated&#160;<br/>hematological neoplasm&#160;(SM-AHN), and mast cell leukemia&#160;(MCL) AND&#160;<br/>2) the patient has&#160;a platelet count of greater than or equal to 50,000/mcL.&#160;</p>
<p style="position:absolute;top:825px;left:126px;white-space:nowrap" class="ft178"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:825px;left:274px;white-space:nowrap" class="ft170">N/A&#160;</p>
<p style="position:absolute;top:864px;left:126px;white-space:nowrap" class="ft179"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:864px;left:274px;white-space:nowrap" class="ft170">N/A&#160;</p>
<p style="position:absolute;top:923px;left:126px;white-space:nowrap" class="ft179"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:923px;left:274px;white-space:nowrap" class="ft170">Plan Year&#160;</p>
<p style="position:absolute;top:983px;left:126px;white-space:nowrap" class="ft178"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:983px;left:274px;white-space:nowrap" class="ft170">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft170">17&#160;</p>
</div>
<!-- Page 18 -->
<a name="18"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page18-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2018.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft181"><b>B</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft184"><b>ALVERSA</b></p>
<p style="position:absolute;top:119px;left:243px;white-space:nowrap" class="ft1813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft182"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft185">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft186">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft180">Balversa&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft182"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft182"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft188"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft180">All&#160;FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft188"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft180">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft189"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft180">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft189"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft180">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft188"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft180">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft189"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft180">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft189"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft180">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft188"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft180">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft180">18&#160;</p>
</div>
<!-- Page 19 -->
<a name="19"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page19-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2019.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft191"><b>B</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft194"><b>ANZEL</b></p>
<p style="position:absolute;top:119px;left:211px;white-space:nowrap" class="ft1913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft192"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft195">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft196">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft190">Banzel&#160;TABS&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft195">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft196">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft190">Rufinamide&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft192"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft192"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft198"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft190">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft198"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft190">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft199"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft190">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft199"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft190">N/A&#160;</p>
<p style="position:absolute;top:557px;left:126px;white-space:nowrap" class="ft198"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:557px;left:274px;white-space:nowrap" class="ft190">1 year&#160;of age or&#160;older&#160;</p>
<p style="position:absolute;top:596px;left:126px;white-space:nowrap" class="ft199"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:596px;left:274px;white-space:nowrap" class="ft190">N/A&#160;</p>
<p style="position:absolute;top:656px;left:126px;white-space:nowrap" class="ft199"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:656px;left:274px;white-space:nowrap" class="ft190">Plan Year&#160;</p>
<p style="position:absolute;top:715px;left:126px;white-space:nowrap" class="ft198"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:715px;left:274px;white-space:nowrap" class="ft190">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft190">19&#160;</p>
</div>
<!-- Page 20 -->
<a name="20"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page20-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2020.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft201"><b>B</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft204"><b>ELEODAQ</b></p>
<p style="position:absolute;top:119px;left:248px;white-space:nowrap" class="ft2013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft202"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft205">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft206">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft200">Beleodaq&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft202"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft202"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft208"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft200">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft208"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2010">Adult T-cell&#160;leukemia/lymphoma,&#160;mycosis fungoides/Sezary&#160;syndrome,&#160;<br/>extranodal NK/T-cell&#160;lymphoma&#160;(nasal&#160;type), hepatosplenic&#160;gamma-delta&#160;<br/>T-cell lymphoma, and primary&#160;cutaneous anaplastic&#160;large&#160;cell&#160;lymphoma&#160;</p>
<p style="position:absolute;top:437px;left:126px;white-space:nowrap" class="ft209"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:437px;left:274px;white-space:nowrap" class="ft200">N/A&#160;</p>
<p style="position:absolute;top:497px;left:126px;white-space:nowrap" class="ft209"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:497px;left:274px;white-space:nowrap" class="ft200">N/A&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft208"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft200">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft209"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft200">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft209"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft200">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft208"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft200">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft200">20&#160;</p>
</div>
<!-- Page 21 -->
<a name="21"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page21-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2021.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft211"><b>B</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft214"><b>ENLYSTA</b></p>
<p style="position:absolute;top:119px;left:241px;white-space:nowrap" class="ft2113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft212"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft215">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft216">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft210">Benlysta&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft212"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft212"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft218"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft210">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft218"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft210">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft219"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft210">For patients&#160;new to therapy: severe active&#160;central nervous system&#160;lupus.&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft219"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2110">For systemic&#160;lupus&#160;erythematosus (SLE):&#160;1) Patient&#160;is currently receiving&#160;<br/>a stable standard therapy&#160;regimen (e.g., corticosteroid or antimalarial)&#160;for&#160;<br/>SLE&#160;OR&#160;2)&#160;patient is not currently receiving stable standard&#160;therapy&#160;<br/>regimen for&#160;SLE&#160;because patient tried and had an&#160;inadequate response&#160;or&#160;<br/>intolerance to stable standard therapy&#160;regimen. For lupus nephritis: 1)&#160;<br/>Patient is currently receiving a&#160;stable&#160;standard&#160;therapy regimen (e.g.,&#160;<br/>corticosteroid) for&#160;lupus&#160;nephritis OR 2) patient&#160;is not&#160;currently receiving&#160;<br/>a stable standard therapy&#160;regimen for lupus nephritis because&#160;patient tried&#160;<br/>and had an&#160;inadequate&#160;response or&#160;intolerance to a&#160;stable standard&#160;therapy&#160;<br/>regimen.&#160;</p>
<p style="position:absolute;top:680px;left:126px;white-space:nowrap" class="ft218"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:680px;left:274px;white-space:nowrap" class="ft210">N/A&#160;</p>
<p style="position:absolute;top:719px;left:126px;white-space:nowrap" class="ft219"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:719px;left:274px;white-space:nowrap" class="ft210">N/A&#160;</p>
<p style="position:absolute;top:778px;left:126px;white-space:nowrap" class="ft219"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:778px;left:274px;white-space:nowrap" class="ft210">Plan Year&#160;</p>
<p style="position:absolute;top:838px;left:126px;white-space:nowrap" class="ft218"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:838px;left:274px;white-space:nowrap" class="ft210">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft210">21&#160;</p>
</div>
<!-- Page 22 -->
<a name="22"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page22-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2022.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft221"><b>B</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft224"><b>ESREMI</b></p>
<p style="position:absolute;top:119px;left:223px;white-space:nowrap" class="ft2213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft222"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft225">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft226">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft220">Besremi&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft222"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft222"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft228"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft220">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft228"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft220">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft229"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft220">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft229"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft220">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft228"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft220">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft229"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft220">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft229"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft220">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft228"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft220">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft220">22&#160;</p>
</div>
<!-- Page 23 -->
<a name="23"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page23-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2023.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft231"><b>B</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft234"><b>ETASERON</b></p>
<p style="position:absolute;top:119px;left:260px;white-space:nowrap" class="ft2313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft232"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft235">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft236">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft230">Betaseron&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft232"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft232"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft238"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft230">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft238"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft230">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft239"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft230">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft239"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft230">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft238"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft230">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft239"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft230">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft239"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft230">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft238"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft230">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft230">23&#160;</p>
</div>
<!-- Page 24 -->
<a name="24"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page24-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2024.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft241"><b>B</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft244"><b>EVACIZUMAB</b></p>
<p style="position:absolute;top:119px;left:295px;white-space:nowrap" class="ft2413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft242"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft245">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft246">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft240">Zirabev&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft240">24&#160;</p>
</div>
<!-- Page 25 -->
<a name="25"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page25-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2025.png" alt="background image"/>
<p style="position:absolute;top:132px;left:126px;white-space:nowrap" class="ft252"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:132px;left:274px;white-space:nowrap" class="ft252"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:174px;left:126px;white-space:nowrap" class="ft258"><b>Indications&#160;</b></p>
<p style="position:absolute;top:174px;left:274px;white-space:nowrap" class="ft250">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:213px;left:126px;white-space:nowrap" class="ft258"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:213px;left:274px;white-space:nowrap" class="ft2510">Breast&#160;cancer, central&#160;nervous system&#160;(CNS) tumor types: adult low-grade&#160;<br/>(WHO&#160;Grade II)&#160;infiltrative supratentorial&#160;<br/>astrocytoma/oligodendroglioma, adult intracranial&#160;and spinal&#160;<br/>ependymoma, anaplastic&#160;gliomas, adult medulloblastoma, primary central&#160;<br/>nervous system lymphoma, meningiomas, limited and extensive brain&#160;<br/>metastases,&#160;and metastatic spine tumors, malignant pleural&#160;mesothelioma,&#160;<br/>ovarian cancer/fallopian&#160;tube cancer/primary peritoneal&#160;cancer types:&#160;<br/>carcinosarcoma (malignant mixed Mullerian&#160;tumors), clear cell&#160;<br/>carcinoma,&#160;mucinous&#160;carcinoma, grade 1 endometrioid carcinoma, low-<br/>grade serous&#160;carcinoma,&#160;ovarian borderline&#160;epithelial tumors&#160;(low&#160;<br/>malignant&#160;potential) with invasive implants, and&#160;malignant sex cord-<br/>stromal tumors, soft tissue sarcoma types: angiosarcoma and&#160;solitary&#160;<br/>fibrous&#160;tumor/hemangiopericytoma,&#160;uterine neoplasms, endometrial&#160;<br/>cancer, vulvar&#160;squamous&#160;cell&#160;carcinoma, and ophthalmic-related&#160;<br/>disorders: diabetic macular edema, neovascular (wet)&#160;age-related macular&#160;<br/>degeneration including&#160;polypoidal choroidopathy and retinal angiomatous&#160;<br/>proliferation&#160;subtypes, macular edema following&#160;retinal vein&#160;occlusion,&#160;<br/>proliferative&#160;diabetic retinopathy, choroidal neovascularization,&#160;<br/>neovascular glaucoma and retinopathy of prematurity, small bowel&#160;<br/>adenocarcinoma.&#160;</p>
<p style="position:absolute;top:645px;left:126px;white-space:nowrap" class="ft259"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:645px;left:274px;white-space:nowrap" class="ft250">N/A&#160;</p>
<p style="position:absolute;top:704px;left:126px;white-space:nowrap" class="ft259"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:704px;left:274px;white-space:nowrap" class="ft250">N/A&#160;</p>
<p style="position:absolute;top:784px;left:126px;white-space:nowrap" class="ft258"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:784px;left:274px;white-space:nowrap" class="ft250">N/A&#160;</p>
<p style="position:absolute;top:823px;left:126px;white-space:nowrap" class="ft259"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:823px;left:274px;white-space:nowrap" class="ft250">N/A&#160;</p>
<p style="position:absolute;top:882px;left:126px;white-space:nowrap" class="ft259"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:882px;left:274px;white-space:nowrap" class="ft250">Plan Year&#160;</p>
<p style="position:absolute;top:942px;left:126px;white-space:nowrap" class="ft258"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:942px;left:274px;white-space:nowrap" class="ft2510">Coverage&#160;under&#160;Part&#160;D will be denied&#160;if&#160;coverage&#160;is available under Part&#160;<br/>A or Part&#160;B as the&#160;medication&#160;is prescribed&#160;and dispensed or&#160;administered&#160;<br/>for&#160;the individual.&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft250">25&#160;</p>
</div>
<!-- Page 26 -->
<a name="26"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page26-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2026.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft261"><b>B</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft264"><b>EXAROTENE</b></p>
<p style="position:absolute;top:119px;left:280px;white-space:nowrap" class="ft2613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft262"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft265">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft266">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft260">Bexarotene&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft262"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft262"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft268"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft260">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft268"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2610">Mycosis fungoides, Sezary syndrome, CD30-positive primary cutaneous&#160;<br/>anaplastic&#160;large cell lymphoma, CD30-positive&#160;lymphomatoid&#160;papulosis.&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft269"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft260">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft269"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft260">N/A&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft268"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft260">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft269"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft260">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft269"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft260">Plan Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft268"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft260">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft260">26&#160;</p>
</div>
<!-- Page 27 -->
<a name="27"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page27-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2027.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft271"><b>B</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft274"><b>LENREP</b></p>
<p style="position:absolute;top:119px;left:225px;white-space:nowrap" class="ft2713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft272"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft275">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft276">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft270">Blenrep&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft272"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft272"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft278"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft270">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft278"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft270">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft279"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft270">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft279"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft270">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft278"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft270">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft279"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft270">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft279"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft270">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft278"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft270">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft270">27&#160;</p>
</div>
<!-- Page 28 -->
<a name="28"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page28-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2028.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft281"><b>B</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft284"><b>OSENTAN</b></p>
<p style="position:absolute;top:119px;left:244px;white-space:nowrap" class="ft2813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft282"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft285">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft286">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft280">Bosentan&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft285">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft286">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft280">Tracleer&#160;TBSO&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft282"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft282"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft288"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft280">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft288"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft280">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft289"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft280">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft289"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft2810">For&#160;pulmonary&#160;arterial hypertension&#160;(PAH) (World Health Organization&#160;<br/>[WHO] Group 1): Diagnosis was confirmed by right heart catheterization.&#160;<br/>For PAH&#160;new starts only: 1)&#160;Pretreatment mean&#160;pulmonary arterial&#160;<br/>pressure is greater than 20 mmHg, 2)&#160;Pretreatment pulmonary capillary&#160;<br/>wedge pressure&#160;is less than or&#160;equal to 15 mmHg, and 3)&#160;Pretreatment&#160;<br/>pulmonary vascular resistance&#160;is greater&#160;than or&#160;equal to 3 Wood units.&#160;</p>
<p style="position:absolute;top:620px;left:126px;white-space:nowrap" class="ft288"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:620px;left:274px;white-space:nowrap" class="ft280">N/A&#160;</p>
<p style="position:absolute;top:658px;left:126px;white-space:nowrap" class="ft289"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:658px;left:274px;white-space:nowrap" class="ft280">N/A&#160;</p>
<p style="position:absolute;top:718px;left:126px;white-space:nowrap" class="ft289"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:718px;left:274px;white-space:nowrap" class="ft280">Plan Year&#160;</p>
<p style="position:absolute;top:777px;left:126px;white-space:nowrap" class="ft288"><b>Other&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:777px;left:274px;white-space:nowrap" class="ft280">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft280">28&#160;</p>
</div>
<!-- Page 29 -->
<a name="29"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page29-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2029.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft291"><b>B</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft294"><b>OSULIF</b></p>
<p style="position:absolute;top:119px;left:217px;white-space:nowrap" class="ft2913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft292"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft295">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft296">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft290">Bosulif&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft292"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft292"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft298"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft290">All FDA-approved Indications, Some Medically&#160;accepted&#160;Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft298"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2910">Philadelphia&#160;chromosome&#160;positive acute lymphoblastic leukemia&#160;(Ph+&#160;<br/>ALL)&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft299"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft290">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft299"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft2910">For chronic&#160;myeloid leukemia&#160;(CML) or&#160;acute lymphoblastic leukemia&#160;<br/>(ALL): Diagnosis was confirmed by&#160;detection of&#160;the Philadelphia&#160;<br/>chromosome or&#160;BCR-ABL gene. For CML, including patients newly&#160;<br/>diagnosed with CML and patients who have received a&#160;hematopoietic&#160;<br/>stem&#160;cell transplant: patient has experienced resistance or intolerance to&#160;<br/>imatinib or&#160;dasatinib. If&#160;patient experienced resistance to an alternative&#160;<br/>tyrosine kinase inhibitor for CML, patient is negative&#160;for&#160;all&#160;of the&#160;<br/>following&#160;mutations:&#160;T315I, G250E, V299L, and F317L.&#160;</p>
<p style="position:absolute;top:660px;left:126px;white-space:nowrap" class="ft298"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:660px;left:274px;white-space:nowrap" class="ft290">N/A&#160;</p>
<p style="position:absolute;top:698px;left:126px;white-space:nowrap" class="ft299"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:698px;left:274px;white-space:nowrap" class="ft290">N/A&#160;</p>
<p style="position:absolute;top:758px;left:126px;white-space:nowrap" class="ft299"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:758px;left:274px;white-space:nowrap" class="ft290">Plan Year&#160;</p>
<p style="position:absolute;top:817px;left:126px;white-space:nowrap" class="ft298"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:817px;left:274px;white-space:nowrap" class="ft290">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft290">29&#160;</p>
</div>
<!-- Page 30 -->
<a name="30"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page30-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2030.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft301"><b>B</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft304"><b>RAFTOVI</b></p>
<p style="position:absolute;top:119px;left:239px;white-space:nowrap" class="ft3013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft302"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft305">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft306">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft300">Braftovi&#160;CAPS 75MG&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft302"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft302"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft308"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft300">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft308"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft300">Adjuvant systemic&#160;therapy for&#160;cutaneous melanoma&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft309"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft300">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft309"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft3010">For colorectal&#160;cancer: The patient must meet both of the following&#160;<br/>criteria:&#160;1) Tumor&#160;is positive&#160;for&#160;BRAF&#160;V600E&#160;mutation, 2)&#160;The&#160;<br/>requested drug will&#160;be used for either of&#160;the following: a) as&#160;subsequent&#160;<br/>therapy&#160;for&#160;advanced or&#160;metastatic&#160;disease, or&#160;b)&#160;as primary&#160;treatment for&#160;<br/>unresectable&#160;metachronous metastases. For cutaneous melanoma:&#160;The&#160;<br/>patient must&#160;meet&#160;all&#160;of the following&#160;criteria: 1)&#160;Tumor&#160;is positive for&#160;<br/>BRAF&#160;V600 activating&#160;mutation (e.g., V600E&#160;or V600K), 2) The&#160;<br/>requested drug will&#160;be used in combination with&#160;binimetinib,&#160;and 3)&#160;The&#160;<br/>requested drug will&#160;be used for either of&#160;the following: a) unresectable or&#160;<br/>metastatic&#160;disease, or&#160;b)&#160;adjuvant&#160;systemic therapy.&#160;</p>
<p style="position:absolute;top:680px;left:126px;white-space:nowrap" class="ft308"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:680px;left:274px;white-space:nowrap" class="ft300">N/A&#160;</p>
<p style="position:absolute;top:719px;left:126px;white-space:nowrap" class="ft309"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:719px;left:274px;white-space:nowrap" class="ft300">N/A&#160;</p>
<p style="position:absolute;top:778px;left:126px;white-space:nowrap" class="ft309"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:778px;left:274px;white-space:nowrap" class="ft300">Plan Year&#160;</p>
<p style="position:absolute;top:838px;left:126px;white-space:nowrap" class="ft308"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:838px;left:274px;white-space:nowrap" class="ft300">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft300">30&#160;</p>
</div>
<!-- Page 31 -->
<a name="31"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page31-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2031.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft311"><b>B</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft314"><b>RIVIACT</b></p>
<p style="position:absolute;top:119px;left:232px;white-space:nowrap" class="ft3113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft312"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft315">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft316">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft310">Briviact&#160;ORAL&#160;SOLN&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft315">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft316">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft310">Briviact&#160;TABS&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft312"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft312"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft318"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft310">All FDA-approved&#160;Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft318"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft310">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft319"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft310">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft319"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft3110">1)&#160;The patient has&#160;experienced an inadequate&#160;treatment response,&#160;<br/>intolerance,&#160;or contraindication to a&#160;generic anticonvulsant&#160;AND 2) If&#160;the&#160;<br/>patient is 4&#160;years of&#160;age&#160;or older,&#160;the patient has&#160;experienced an&#160;<br/>inadequate treatment response, intolerance, or contraindication to any of&#160;<br/>the following: Aptiom,&#160;Vimpat, Xcopri, Spritam.&#160;</p>
<p style="position:absolute;top:599px;left:126px;white-space:nowrap" class="ft318"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:599px;left:274px;white-space:nowrap" class="ft310">1 month&#160;of age or&#160;older&#160;</p>
<p style="position:absolute;top:638px;left:126px;white-space:nowrap" class="ft319"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:638px;left:274px;white-space:nowrap" class="ft310">N/A&#160;</p>
<p style="position:absolute;top:697px;left:126px;white-space:nowrap" class="ft319"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:697px;left:274px;white-space:nowrap" class="ft310">Plan Year&#160;</p>
<p style="position:absolute;top:756px;left:126px;white-space:nowrap" class="ft318"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:756px;left:274px;white-space:nowrap" class="ft310">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft310">31&#160;</p>
</div>
<!-- Page 32 -->
<a name="32"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page32-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2032.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft321"><b>B</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft324"><b>RIVIACT&#160;</b></p>
<p style="position:absolute;top:118px;left:238px;white-space:nowrap" class="ft321"><b>I</b></p>
<p style="position:absolute;top:123px;left:250px;white-space:nowrap" class="ft324"><b>NJ</b></p>
<p style="position:absolute;top:119px;left:279px;white-space:nowrap" class="ft3213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft322"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft325">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft326">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft320">Briviact&#160;INJ&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft322"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft322"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft328"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft320">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft328"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft320">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft329"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft320">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft329"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft3210">1)&#160;The patient has&#160;experienced an inadequate&#160;treatment response,&#160;<br/>intolerance,&#160;or contraindication to a&#160;generic anticonvulsant&#160;AND 2) If&#160;the&#160;<br/>patient is 4&#160;years of&#160;age&#160;or older,&#160;the patient has&#160;experienced an&#160;<br/>inadequate treatment response, intolerance, or contraindication to any of&#160;<br/>the following: Aptiom,&#160;Vimpat, Xcopri, Spritam.&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft328"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft320">1 month&#160;of age or&#160;older&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft329"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft320">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft329"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft320">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft328"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft320">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft320">32&#160;</p>
</div>
<!-- Page 33 -->
<a name="33"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page33-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2033.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft331"><b>B</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft334"><b>RUKINSA</b></p>
<p style="position:absolute;top:119px;left:239px;white-space:nowrap" class="ft3313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft332"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft335">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft336">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft330">Brukinsa&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft332"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft332"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft338"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft330">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft338"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft330">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft339"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft330">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft339"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft330">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft338"><b>Age&#160;Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft330">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft339"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft330">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft339"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft330">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft338"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft330">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft330">33&#160;</p>
</div>
<!-- Page 34 -->
<a name="34"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page34-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2034.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft341"><b>B</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft344"><b>UPRENORPHINE</b></p>
<p style="position:absolute;top:119px;left:323px;white-space:nowrap" class="ft3413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft342"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft345">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft346">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft340">Buprenorphine Hcl&#160;SUBL&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft342"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft342"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft348"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft340">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft348"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft340">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft349"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft340">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft349"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft3410">The requested&#160;drug is being prescribed for the treatment&#160;of&#160;opioid use&#160;<br/>disorder AND&#160;patient meets one of the following: 1)&#160;The patient is&#160;<br/>pregnant or&#160;breastfeeding, and the&#160;requested drug is being prescribed for&#160;<br/>induction therapy and/or subsequent&#160;maintenance&#160;therapy&#160;for treatment of&#160;<br/>opioid use disorder OR 2) The requested drug&#160;is being prescribed for&#160;<br/>induction therapy for transition&#160;from&#160;opioid use&#160;to&#160;treatment&#160;of opioid use&#160;<br/>disorder OR 3) The requested drug&#160;is being prescribed for maintenance&#160;<br/>therapy&#160;for&#160;treatment of&#160;opioid use disorder in a&#160;patient who is&#160;intolerant&#160;<br/>to naloxone.&#160;</p>
<p style="position:absolute;top:660px;left:126px;white-space:nowrap" class="ft348"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:660px;left:274px;white-space:nowrap" class="ft340">N/A&#160;</p>
<p style="position:absolute;top:698px;left:126px;white-space:nowrap" class="ft349"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:698px;left:274px;white-space:nowrap" class="ft340">N/A&#160;</p>
<p style="position:absolute;top:758px;left:126px;white-space:nowrap" class="ft349"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:758px;left:274px;white-space:nowrap" class="ft340">12 months&#160;</p>
<p style="position:absolute;top:817px;left:126px;white-space:nowrap" class="ft348"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:817px;left:274px;white-space:nowrap" class="ft340">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft340">34&#160;</p>
</div>
<!-- Page 35 -->
<a name="35"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page35-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2035.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft351"><b>B</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft354"><b>UPRENORPHINE&#160;</b></p>
<p style="position:absolute;top:118px;left:329px;white-space:nowrap" class="ft351"><b>P</b></p>
<p style="position:absolute;top:123px;left:347px;white-space:nowrap" class="ft354"><b>ATCH</b></p>
<p style="position:absolute;top:119px;left:416px;white-space:nowrap" class="ft3513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft352"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft355">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft356">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft350">Buprenorphine&#160;PTWK&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft352"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft352"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft358"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft350">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft358"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft350">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft359"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft350">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft359"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft3510">1)&#160;The requested drug&#160;is being prescribed for pain&#160;associated&#160;with cancer,&#160;<br/>sickle cell disease, a&#160;terminal condition, or pain&#160;being managed through&#160;<br/>palliative&#160;care&#160;OR&#160;2) The requested&#160;drug is being prescribed&#160;for&#160;pain&#160;<br/>severe&#160;enough to require&#160;daily, around-the-clock,&#160;long-term&#160;treatment in&#160;a&#160;<br/>patient who has been taking an opioid&#160;AND 3) The patient can safely take&#160;<br/>the requested dose based&#160;on their history of&#160;opioid use [Note: This drug&#160;<br/>should be prescribed only by healthcare&#160;professionals&#160;who are&#160;<br/>knowledgeable in&#160;the use of potent opioids for the management of chronic&#160;<br/>pain.]&#160;AND 4) The patient has&#160;been&#160;evaluated and the patient&#160;will&#160;be&#160;<br/>monitored&#160;for the development of opioid use disorder&#160;AND 5) This&#160;<br/>request&#160;is for continuation of therapy&#160;for&#160;a patient&#160;who has been receiving&#160;<br/>an extended-release&#160;opioid agent&#160;for at least&#160;30 days OR the patient has&#160;<br/>taken an&#160;immediate-release opioid for at&#160;least one week.&#160;</p>
<p style="position:absolute;top:742px;left:126px;white-space:nowrap" class="ft358"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:742px;left:274px;white-space:nowrap" class="ft350">N/A&#160;</p>
<p style="position:absolute;top:781px;left:126px;white-space:nowrap" class="ft359"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:781px;left:274px;white-space:nowrap" class="ft350">N/A&#160;</p>
<p style="position:absolute;top:841px;left:126px;white-space:nowrap" class="ft359"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:841px;left:274px;white-space:nowrap" class="ft350">Plan Year&#160;</p>
<p style="position:absolute;top:900px;left:126px;white-space:nowrap" class="ft358"><b>Other&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:900px;left:274px;white-space:nowrap" class="ft350">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft350">35&#160;</p>
</div>
<!-- Page 36 -->
<a name="36"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page36-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2036.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft361"><b>C</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft364"><b>ABOMETYX</b></p>
<p style="position:absolute;top:119px;left:271px;white-space:nowrap" class="ft3613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft362"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft365">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft366">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft360">Cabometyx&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft362"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft362"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft368"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft360">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft368"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft360">Non-small cell&#160;lung cancer&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft369"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft360">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft369"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft3610">For renal&#160;cell carcinoma: The disease&#160;is advanced, relapsed, or stage&#160;IV.&#160;<br/>For non-small cell&#160;lung cancer: 1) The disease is&#160;rearranged during&#160;<br/>transfection (RET) positive AND 2) the disease is recurrent,&#160;advanced, or&#160;<br/>metastatic. For hepatocellular carcinoma:&#160;the requested drug will be used&#160;<br/>as subsequent treatment.&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft368"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft360">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft369"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft360">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft369"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft360">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft368"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft360">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft360">36&#160;</p>
</div>
<!-- Page 37 -->
<a name="37"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page37-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2037.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft371"><b>C</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft374"><b>ALCIPOTRIENE</b></p>
<p style="position:absolute;top:119px;left:315px;white-space:nowrap" class="ft3713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft372"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft375">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft376">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft370">Calcipotriene&#160;CREA&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft375">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft376">&#160;&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft370">Calcipotriene&#160;OINT&#160;</p>
<p style="position:absolute;top:242px;left:122px;white-space:nowrap" class="ft375">•</p>
<p style="position:absolute;top:241px;left:130px;white-space:nowrap" class="ft376">&#160;&#160;</p>
<p style="position:absolute;top:244px;left:149px;white-space:nowrap" class="ft370">Calcipotriene&#160;SOLN&#160;</p>
<p style="position:absolute;top:264px;left:122px;white-space:nowrap" class="ft375">•</p>
<p style="position:absolute;top:263px;left:130px;white-space:nowrap" class="ft376">&#160;&#160;</p>
<p style="position:absolute;top:266px;left:149px;white-space:nowrap" class="ft3710">Calcipotriene/betamethasone&#160;<br/>Dipropionate&#160;OINT&#160;</p>
<p style="position:absolute;top:306px;left:122px;white-space:nowrap" class="ft375">•</p>
<p style="position:absolute;top:306px;left:130px;white-space:nowrap" class="ft376">&#160;&#160;</p>
<p style="position:absolute;top:308px;left:149px;white-space:nowrap" class="ft370">Calcitriol&#160;OINT&#160;</p>
<p style="position:absolute;top:328px;left:122px;white-space:nowrap" class="ft375">•</p>
<p style="position:absolute;top:328px;left:130px;white-space:nowrap" class="ft376">&#160;&#160;</p>
<p style="position:absolute;top:330px;left:149px;white-space:nowrap" class="ft370">Enstilar&#160;</p>
<p style="position:absolute;top:407px;left:126px;white-space:nowrap" class="ft372"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:407px;left:274px;white-space:nowrap" class="ft372"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:449px;left:126px;white-space:nowrap" class="ft378"><b>Indications&#160;</b></p>
<p style="position:absolute;top:449px;left:274px;white-space:nowrap" class="ft370">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:488px;left:126px;white-space:nowrap" class="ft378"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:488px;left:274px;white-space:nowrap" class="ft370">N/A&#160;</p>
<p style="position:absolute;top:527px;left:126px;white-space:nowrap" class="ft379"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:527px;left:274px;white-space:nowrap" class="ft370">N/A&#160;</p>
<p style="position:absolute;top:586px;left:126px;white-space:nowrap" class="ft379"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:586px;left:274px;white-space:nowrap" class="ft3710">1)&#160;The requested drug&#160;is being prescribed for the&#160;treatment of&#160;psoriasis&#160;<br/>AND 2) The&#160;patient experienced an inadequate&#160;treatment response,&#160;<br/>intolerance,&#160;or the patient has&#160;a contraindication&#160;to&#160;a topical steroid.&#160;</p>
<p style="position:absolute;top:666px;left:126px;white-space:nowrap" class="ft378"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:666px;left:274px;white-space:nowrap" class="ft370">N/A&#160;</p>
<p style="position:absolute;top:705px;left:126px;white-space:nowrap" class="ft379"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:705px;left:274px;white-space:nowrap" class="ft370">N/A&#160;</p>
<p style="position:absolute;top:764px;left:126px;white-space:nowrap" class="ft379"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:764px;left:274px;white-space:nowrap" class="ft370">Plan Year&#160;</p>
<p style="position:absolute;top:824px;left:126px;white-space:nowrap" class="ft378"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:824px;left:274px;white-space:nowrap" class="ft370">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft370">37&#160;</p>
</div>
<!-- Page 38 -->
<a name="38"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page38-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2038.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft381"><b>C</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft384"><b>ALQUENCE</b></p>
<p style="position:absolute;top:119px;left:266px;white-space:nowrap" class="ft3813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft382"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft385">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft386">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft380">Calquence&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft382"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft382"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft388"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft380">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft388"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft380">Waldenstrom macroglobulinemia/lymphoplasmacytic&#160;lymphoma&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft389"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft380">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft389"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft3810">For chronic&#160;lymphocytic&#160;leukemia or small lymphocytic&#160;lymphoma:&#160;the&#160;<br/>patient has&#160;experienced an intolerable adverse&#160;event with ibrutinib.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft388"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft380">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft389"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft380">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft389"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft380">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft388"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft380">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft380">38&#160;</p>
</div>
<!-- Page 39 -->
<a name="39"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page39-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2039.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft391"><b>C</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft394"><b>APLYTA</b></p>
<p style="position:absolute;top:119px;left:228px;white-space:nowrap" class="ft3913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft392"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft395">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft396">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft390">Caplyta&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft392"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft392"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft398"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft390">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft398"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft390">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft399"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft390">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft399"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft3910">The patient&#160;experienced&#160;an inadequate treatment response, intolerance, or&#160;<br/>contraindication to one of the following generic products: A)&#160;aripiprazole,&#160;<br/>B) asenapine, C) olanzapine, D) quetiapine, E)&#160;risperidone, F) ziprasidone&#160;<br/>AND the patient&#160;experienced an inadequate&#160;treatment&#160;response,&#160;<br/>intolerance,&#160;or contraindication to one of&#160;the following brand&#160;products: A)&#160;<br/>Latuda, B) Rexulti, C)&#160;Secuado.&#160;</p>
<p style="position:absolute;top:598px;left:126px;white-space:nowrap" class="ft398"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:598px;left:274px;white-space:nowrap" class="ft390">N/A&#160;</p>
<p style="position:absolute;top:636px;left:126px;white-space:nowrap" class="ft399"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:636px;left:274px;white-space:nowrap" class="ft390">N/A&#160;</p>
<p style="position:absolute;top:696px;left:126px;white-space:nowrap" class="ft399"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:696px;left:274px;white-space:nowrap" class="ft390">Plan Year&#160;</p>
<p style="position:absolute;top:755px;left:126px;white-space:nowrap" class="ft398"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:755px;left:274px;white-space:nowrap" class="ft390">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft390">39&#160;</p>
</div>
<!-- Page 40 -->
<a name="40"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page40-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2040.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft401"><b>C</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft404"><b>APRELSA</b></p>
<p style="position:absolute;top:119px;left:242px;white-space:nowrap" class="ft4013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft402"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft405">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft406">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft400">Caprelsa&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft402"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft402"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft408"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft400">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft408"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft400">Differentiated thyroid&#160;carcinoma: papillary, follicular, and Hurthle cell.&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft409"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft400">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft409"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft400">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft408"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft400">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft409"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft400">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft409"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft400">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft408"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft400">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft400">40&#160;</p>
</div>
<!-- Page 41 -->
<a name="41"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page41-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2041.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft411"><b>C</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft414"><b>ARAC</b></p>
<p style="position:absolute;top:119px;left:199px;white-space:nowrap" class="ft4113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft412"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft415">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft416">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft410">Fluorouracil&#160;CREA&#160;0.5%&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft412"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft412"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft418"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft410">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft418"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft410">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft419"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft4110">Patients who&#160;are&#160;pregnant or&#160;may become&#160;pregnant. Patients with&#160;<br/>dihydropyrimidine dehydrogenase (DPD) enzyme deficiency.&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft419"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft4110">If&#160;being&#160;used as part&#160;of&#160;a compounded product, all active ingredients in&#160;<br/>the compounded product are FDA&#160;approved for topical use.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft418"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft410">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft419"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft410">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft419"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft410">3 months&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft418"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft410">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft410">41&#160;</p>
</div>
<!-- Page 42 -->
<a name="42"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page42-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2042.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft421"><b>C</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft424"><b>ARBAGLU</b></p>
<p style="position:absolute;top:119px;left:250px;white-space:nowrap" class="ft4213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft422"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft425">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft426">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft420">Carbaglu&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft422"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft422"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft428"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft420">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft428"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft420">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft429"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft420">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft429"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft4210">For N-acetylglutamate&#160;synthase (NAGS) deficiency: Diagnosis of NAGS&#160;<br/>deficiency&#160;was confirmed by enzymatic or genetic testing.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft428"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft420">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft429"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft420">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft429"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft420">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft428"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft420">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft420">42&#160;</p>
</div>
<!-- Page 43 -->
<a name="43"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page43-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2043.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft431"><b>C</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft434"><b>AYSTON</b></p>
<p style="position:absolute;top:119px;left:230px;white-space:nowrap" class="ft4313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft432"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft435">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft436">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft430">Cayston&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft432"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft432"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft438"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft430">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft438"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft430">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft439"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft430">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft439"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft4310">For&#160;treatment&#160;of respiratory symptoms in cystic&#160;fibrosis patients: 1)&#160;<br/>Pseudomonas aeruginosa&#160;is present in&#160;the patient's&#160;airway cultures&#160;OR&#160;2)&#160;<br/>The patient&#160;has a&#160;history&#160;of pseudomonas aeruginosa infection or&#160;<br/>colonization&#160;in the airways.&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft438"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft430">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft439"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft430">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft439"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft430">Plan Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft438"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft430">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft430">43&#160;</p>
</div>
<!-- Page 44 -->
<a name="44"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page44-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2044.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft441"><b>C</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft444"><b>ERDELGA</b></p>
<p style="position:absolute;top:119px;left:248px;white-space:nowrap" class="ft4413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft442"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft445">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft446">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft440">Cerdelga&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft442"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft442"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft448"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft440">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft448"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft440">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft449"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft440">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft449"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft4410">For Gaucher&#160;disease, the&#160;diagnosis was confirmed by an enzyme assay&#160;<br/>demonstrating a deficiency of&#160;beta-glucocerebrosidase&#160;enzyme activity&#160;or&#160;<br/>by genetic testing. The patient's CYP2D6 metabolizer status has been&#160;<br/>established&#160;using&#160;an FDA-cleared&#160;test. The patient is a CYP2D6 extensive&#160;<br/>metabolizer, an intermediate&#160;metabolizer, or a&#160;poor metabolizer.&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft448"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft440">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft449"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft440">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft449"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft440">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft448"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft440">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft440">44&#160;</p>
</div>
<!-- Page 45 -->
<a name="45"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page45-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2045.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft451"><b>C</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft454"><b>HANTIX</b></p>
<p style="position:absolute;top:119px;left:226px;white-space:nowrap" class="ft4513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft452"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft455">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft456">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft450">Apo-varenicline&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft455">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft456">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft450">Chantix&#160;TABS&#160;0.5MG,&#160;1MG&#160;</p>
<p style="position:absolute;top:242px;left:122px;white-space:nowrap" class="ft455">•</p>
<p style="position:absolute;top:241px;left:130px;white-space:nowrap" class="ft456">&#160;</p>
<p style="position:absolute;top:244px;left:149px;white-space:nowrap" class="ft450">Chantix Continuing Month Pak&#160;</p>
<p style="position:absolute;top:264px;left:122px;white-space:nowrap" class="ft455">•</p>
<p style="position:absolute;top:263px;left:130px;white-space:nowrap" class="ft456">&#160;</p>
<p style="position:absolute;top:266px;left:149px;white-space:nowrap" class="ft450">Chantix Starting Month&#160;Pak&#160;</p>
<p style="position:absolute;top:286px;left:122px;white-space:nowrap" class="ft455">•</p>
<p style="position:absolute;top:285px;left:130px;white-space:nowrap" class="ft456">&#160;</p>
<p style="position:absolute;top:288px;left:149px;white-space:nowrap" class="ft450">Varenicline&#160;Tartrate&#160;</p>
<p style="position:absolute;top:365px;left:126px;white-space:nowrap" class="ft452"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:365px;left:274px;white-space:nowrap" class="ft452"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:407px;left:126px;white-space:nowrap" class="ft458"><b>Indications&#160;</b></p>
<p style="position:absolute;top:407px;left:274px;white-space:nowrap" class="ft450">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:445px;left:126px;white-space:nowrap" class="ft458"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:445px;left:274px;white-space:nowrap" class="ft450">N/A&#160;</p>
<p style="position:absolute;top:484px;left:126px;white-space:nowrap" class="ft459"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:484px;left:274px;white-space:nowrap" class="ft450">N/A&#160;</p>
<p style="position:absolute;top:543px;left:126px;white-space:nowrap" class="ft459"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:543px;left:274px;white-space:nowrap" class="ft450">N/A&#160;</p>
<p style="position:absolute;top:623px;left:126px;white-space:nowrap" class="ft458"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:623px;left:274px;white-space:nowrap" class="ft450">N/A&#160;</p>
<p style="position:absolute;top:662px;left:126px;white-space:nowrap" class="ft459"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:662px;left:274px;white-space:nowrap" class="ft450">N/A&#160;</p>
<p style="position:absolute;top:722px;left:126px;white-space:nowrap" class="ft459"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:722px;left:274px;white-space:nowrap" class="ft450">6 months&#160;</p>
<p style="position:absolute;top:781px;left:126px;white-space:nowrap" class="ft458"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:781px;left:274px;white-space:nowrap" class="ft4510">This Prior&#160;Authorization&#160;requirement&#160;applies after the member has&#160;<br/>received a&#160;cumulative 24 weeks of therapy in a&#160;Plan Year.&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft450">45&#160;</p>
</div>
<!-- Page 46 -->
<a name="46"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft4614{font-size:29px;font-family:Times;color:#000000;}
-->
</style>
<div id="page46-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2046.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft461"><b>C</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft464"><b>HLORDIAZEPOXIDE&#160;</b></p>
<p style="position:absolute;top:118px;left:376px;white-space:nowrap" class="ft461"><b>-&#160;65</b></p>
<p style="position:absolute;top:113px;left:422px;white-space:nowrap" class="ft4614">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft462"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft465">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft466">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft4610">Chlordiazepoxide Hcl&#160;CAPS 10MG,&#160;<br/>5MG&#160;</p>
<p style="position:absolute;top:240px;left:122px;white-space:nowrap" class="ft465">•</p>
<p style="position:absolute;top:240px;left:130px;white-space:nowrap" class="ft466">&#160;&#160;</p>
<p style="position:absolute;top:242px;left:149px;white-space:nowrap" class="ft460">Chlordiazepoxide Hydrochloride</p>
<p style="position:absolute;top:240px;left:386px;white-space:nowrap" class="ft466">&#160;</p>
<p style="position:absolute;top:263px;left:149px;white-space:nowrap" class="ft460">CAPS 25MG</p>
<p style="position:absolute;top:260px;left:245px;white-space:nowrap" class="ft466">&#160;</p>
<p style="position:absolute;top:340px;left:126px;white-space:nowrap" class="ft462"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:340px;left:274px;white-space:nowrap" class="ft462"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:382px;left:126px;white-space:nowrap" class="ft468"><b>Indications&#160;</b></p>
<p style="position:absolute;top:382px;left:274px;white-space:nowrap" class="ft460">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:421px;left:126px;white-space:nowrap" class="ft468"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:421px;left:274px;white-space:nowrap" class="ft460">N/A&#160;</p>
<p style="position:absolute;top:459px;left:126px;white-space:nowrap" class="ft469"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:459px;left:274px;white-space:nowrap" class="ft460">N/A&#160;</p>
<p style="position:absolute;top:519px;left:126px;white-space:nowrap" class="ft469"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:519px;left:274px;white-space:nowrap" class="ft4610">For all&#160;indications: the prescriber must acknowledge the benefit&#160;of&#160;<br/>therapy with&#160;the prescribed medication outweighs the potential risks for&#160;<br/>the patient. &#160;(Note: The&#160;American Geriatrics&#160;Society&#160;identifies the&#160;use of&#160;<br/>this medication as potentially inappropriate in&#160;older&#160;adults, meaning it is&#160;<br/>best&#160;avoided, prescribed&#160;at reduced dosage, or used with caution or&#160;<br/>carefully&#160;monitored.) &#160;For the&#160;management of anxiety disorders: 1) the&#160;<br/>requested drug is&#160;being used concurrently with a selective&#160;serotonin&#160;<br/>reuptake inhibitor&#160;(SSRI) or&#160;serotonin-norepinephrine reuptake inhibitor&#160;<br/>(SNRI)&#160;until&#160;SSRI/SNRI&#160;is effective&#160;for&#160;the symptoms of&#160;anxiety, OR 2)&#160;<br/>the patient has experienced an inadequate treatment response,&#160;intolerance,&#160;<br/>or has a contraindication&#160;to AT LEAST TWO&#160;agents from the&#160;following&#160;<br/>classes: a) selective&#160;serotonin reuptake inhibitors&#160;(SSRIs), OR&#160;b)&#160;<br/>serotonin-norepinephrine reuptake inhibitors&#160;(SNRIs).&#160;</p>
<p style="position:absolute;top:806px;left:126px;white-space:nowrap" class="ft468"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:806px;left:274px;white-space:nowrap" class="ft460">N/A&#160;</p>
<p style="position:absolute;top:845px;left:126px;white-space:nowrap" class="ft469"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:845px;left:274px;white-space:nowrap" class="ft460">N/A&#160;</p>
<p style="position:absolute;top:904px;left:126px;white-space:nowrap" class="ft469"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:904px;left:274px;white-space:nowrap" class="ft4610">Short-term relief&#160;anxiety-preop apprehens and anx-1 mo, Anxiety&#160;<br/>Disorder-4&#160;mo, Alc&#160;Withdrawal-PlanYR&#160;</p>
<p style="position:absolute;top:963px;left:126px;white-space:nowrap" class="ft468"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:963px;left:274px;white-space:nowrap" class="ft4610">This Prior&#160;Authorization&#160;requirement&#160;only applies&#160;to patients 65 years of&#160;<br/>age or&#160;older.&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft460">46&#160;</p>
</div>
<!-- Page 47 -->
<a name="47"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page47-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2047.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft471"><b>C</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft474"><b>LOBAZAM</b></p>
<p style="position:absolute;top:119px;left:254px;white-space:nowrap" class="ft4713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft472"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft475">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft476">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft470">Clobazam&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft472"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft472"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft478"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft470">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft478"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft470">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft479"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft470">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft479"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft470">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft478"><b>Age&#160;Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft470">2 years&#160;of age or&#160;older&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft479"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft470">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft479"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft470">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft478"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft470">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft470">47&#160;</p>
</div>
<!-- Page 48 -->
<a name="48"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page48-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2048.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft481"><b>C</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft484"><b>LOMIPRAMINE</b></p>
<p style="position:absolute;top:119px;left:311px;white-space:nowrap" class="ft4813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft482"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft485">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft486">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft480">Clomipramine Hcl&#160;CAPS&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft482"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft482"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft488"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft480">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft488"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft480">Depression,&#160;Panic Disorder&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft489"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft480">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft489"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft4810">1)&#160;The requested drug&#160;is being prescribed for one&#160;of the following:&#160;<br/>Obsessive-Compulsive&#160;Disorder&#160;(OCD) or&#160;Panic&#160;Disorder&#160;AND 2) The&#160;<br/>patient has&#160;experienced an inadequate treatment response, intolerance, or&#160;<br/>the patient has a contraindication to&#160;any of the following: a serotonin&#160;and&#160;<br/>norepinephrine reuptake&#160;inhibitor&#160;(SNRI)&#160;or a&#160;selective serotonin&#160;<br/>reuptake inhibitor (SSRI) OR 3) The requested drug is&#160;being prescribed&#160;<br/>for&#160;Depression AND 4)&#160;The patient&#160;has experienced an inadequate&#160;<br/>treatment response, intolerance, or the patient has&#160;a contraindication&#160;to&#160;<br/>two of the following:&#160;serotonin&#160;and&#160;norepinephrine reuptake&#160;inhibitors&#160;<br/>(SNRIs), selective serotonin reuptake inhibitors&#160;(SSRIs), mirtazapine,&#160;<br/>bupropion.&#160;</p>
<p style="position:absolute;top:701px;left:126px;white-space:nowrap" class="ft488"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:701px;left:274px;white-space:nowrap" class="ft480">N/A&#160;</p>
<p style="position:absolute;top:740px;left:126px;white-space:nowrap" class="ft489"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:740px;left:274px;white-space:nowrap" class="ft480">N/A&#160;</p>
<p style="position:absolute;top:799px;left:126px;white-space:nowrap" class="ft489"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:799px;left:274px;white-space:nowrap" class="ft480">Plan Year&#160;</p>
<p style="position:absolute;top:859px;left:126px;white-space:nowrap" class="ft488"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:859px;left:274px;white-space:nowrap" class="ft480">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft480">48&#160;</p>
</div>
<!-- Page 49 -->
<a name="49"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page49-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2049.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft491"><b>C</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft494"><b>LORAZEPATE</b></p>
<p style="position:absolute;top:119px;left:295px;white-space:nowrap" class="ft4913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft492"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft495">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft496">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft490">Clorazepate&#160;Dipotassium&#160;TABS&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft492"><b>PA&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft492"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft498"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft490">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft498"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft490">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft499"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft490">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft499"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft4910">For all&#160;indications: the prescriber must acknowledge the benefit&#160;of&#160;<br/>therapy with&#160;the requested drug outweighs the potential risks&#160;for the&#160;<br/>patient. (Note: The&#160;American Geriatrics Society identifies&#160;the use of this&#160;<br/>medication&#160;as potentially inappropriate&#160;in older&#160;adults,&#160;meaning it&#160;is best&#160;<br/>avoided, prescribed at&#160;reduced dosage, or&#160;used with caution or carefully&#160;<br/>monitored.) For the management of&#160;anxiety disorders: 1)&#160;the&#160;requested&#160;<br/>drug is being used concurrently with a selective&#160;serotonin reuptake&#160;<br/>inhibitor&#160;(SSRI) or&#160;serotonin-norepinephrine reuptake&#160;inhibitor (SNRI)&#160;<br/>until&#160;the SSRI/SNRI becomes effective for the symptoms of&#160;anxiety OR&#160;<br/>2) the patient has&#160;experienced an inadequate&#160;treatment&#160;response,&#160;<br/>intolerance,&#160;or has a contraindication&#160;to AT LEAST TWO&#160;agents from the&#160;<br/>following&#160;classes:&#160;a)&#160;selective serotonin reuptake inhibitors&#160;(SSRIs) OR&#160;<br/>b) serotonin-norepinephrine reuptake inhibitors (SNRIs).&#160;</p>
<p style="position:absolute;top:742px;left:126px;white-space:nowrap" class="ft498"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:742px;left:274px;white-space:nowrap" class="ft490">N/A&#160;</p>
<p style="position:absolute;top:781px;left:126px;white-space:nowrap" class="ft499"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:781px;left:274px;white-space:nowrap" class="ft490">N/A&#160;</p>
<p style="position:absolute;top:841px;left:126px;white-space:nowrap" class="ft499"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:841px;left:274px;white-space:nowrap" class="ft4910">Short-term relief&#160;anxiety-1 month, Anxiety Disorders-4&#160;months, All other&#160;<br/>Diagnoses-Plan Year&#160;</p>
<p style="position:absolute;top:900px;left:126px;white-space:nowrap" class="ft498"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:900px;left:274px;white-space:nowrap" class="ft4910">This Prior&#160;Authorization&#160;requirement&#160;only applies&#160;to patients 65 years of&#160;<br/>age or&#160;older.&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft490">49&#160;</p>
</div>
<!-- Page 50 -->
<a name="50"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page50-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2050.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft501"><b>C</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft504"><b>LOZAPINE&#160;</b></p>
<p style="position:absolute;top:118px;left:261px;white-space:nowrap" class="ft501"><b>O</b></p>
<p style="position:absolute;top:123px;left:284px;white-space:nowrap" class="ft504"><b>DT</b></p>
<p style="position:absolute;top:119px;left:318px;white-space:nowrap" class="ft5013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft502"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft505">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft506">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft500">Clozapine Odt&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft502"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft502"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft508"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft500">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft508"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft500">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft509"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft500">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft509"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft500">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft508"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft500">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft509"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft500">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft509"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft500">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft508"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft500">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft500">50&#160;</p>
</div>
<!-- Page 51 -->
<a name="51"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page51-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2051.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft511"><b>C</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft514"><b>OLY</b></p>
<p style="position:absolute;top:118px;left:182px;white-space:nowrap" class="ft511"><b>-</b></p>
<p style="position:absolute;top:123px;left:192px;white-space:nowrap" class="ft514"><b>MYCIN</b></p>
<p style="position:absolute;top:119px;left:276px;white-space:nowrap" class="ft5113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft512"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft515">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft516">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft510">Colistimethate Sodium&#160;INJ&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft512"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft512"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft518"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft510">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft518"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft510">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft519"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft510">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft519"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft5110">Intravenous&#160;(IV) or&#160;intramuscular&#160;(IM) use only. Administration will not&#160;<br/>be via&#160;nebulizer.&#160;(Note:&#160;CMS endorsed compendia do not support&#160;<br/>inhalation/nebulization&#160;of colistimethate.). The&#160;infection is proven or&#160;<br/>strongly&#160;suspected&#160;to be caused by susceptible bacteria based&#160;on: 1)&#160;<br/>culture&#160;and susceptibility&#160;information&#160;OR&#160;2) local epidemiology and&#160;<br/>susceptibility patterns.&#160;</p>
<p style="position:absolute;top:598px;left:126px;white-space:nowrap" class="ft518"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:598px;left:274px;white-space:nowrap" class="ft510">N/A&#160;</p>
<p style="position:absolute;top:636px;left:126px;white-space:nowrap" class="ft519"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:636px;left:274px;white-space:nowrap" class="ft510">Prescribed by&#160;or in consultation with an infectious disease specialist&#160;</p>
<p style="position:absolute;top:696px;left:126px;white-space:nowrap" class="ft519"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:696px;left:274px;white-space:nowrap" class="ft510">Initial&#160;approval:&#160;3&#160;months, Renewal:&#160;Plan Year&#160;</p>
<p style="position:absolute;top:755px;left:126px;white-space:nowrap" class="ft518"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:755px;left:274px;white-space:nowrap" class="ft510">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft510">51&#160;</p>
</div>
<!-- Page 52 -->
<a name="52"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page52-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2052.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft521"><b>C</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft524"><b>OMETRIQ</b></p>
<p style="position:absolute;top:119px;left:248px;white-space:nowrap" class="ft5213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft522"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft525">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft526">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft520">Cometriq&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft522"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft522"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft528"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft520">All&#160;FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft528"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft5210">Non-small cell&#160;lung cancer&#160;(NSCLC), differentiated thyroid carcinoma:&#160;<br/>papillary, follicular, and&#160;Hurthle cell.&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft529"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft520">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft529"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft5210">For NSCLC: The requested medication is used for NSCLC when the&#160;<br/>patient's disease expresses rearranged during transfection (RET) gene&#160;<br/>rearrangements.&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft528"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft520">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft529"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft520">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft529"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft520">Plan Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft528"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft520">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft520">52&#160;</p>
</div>
<!-- Page 53 -->
<a name="53"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page53-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2053.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft531"><b>C</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft534"><b>OPIKTRA</b></p>
<p style="position:absolute;top:119px;left:242px;white-space:nowrap" class="ft5313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft532"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft535">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft536">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft530">Copiktra&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft532"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft532"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft538"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft530">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft538"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft5310">Gastric MALT&#160;lymphoma, non-gastric MALT lymphoma, nodal marginal&#160;<br/>zone lymphoma, splenic marginal&#160;zone lymphoma&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft539"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft530">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft539"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft5310">For follicular&#160;lymphoma, gastric MALT lymphoma, non-gastric MALT&#160;<br/>lymphoma,&#160;nodal marginal zone&#160;lymphoma, and splenic marginal zone&#160;<br/>lymphoma: the requested&#160;drug will be&#160;used as subsequent therapy after at&#160;<br/>least 2 prior&#160;therapies.&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft538"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft530">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft539"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft530">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft539"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft530">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft538"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft530">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft530">53&#160;</p>
</div>
<!-- Page 54 -->
<a name="54"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page54-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2054.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft541"><b>C</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft544"><b>OTELLIC</b></p>
<p style="position:absolute;top:119px;left:239px;white-space:nowrap" class="ft5413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft542"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft545">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft546">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft540">Cotellic&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft542"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft542"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft548"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft540">All&#160;FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft548"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft5410">Central nervous&#160;system (CNS) cancer&#160;(i.e., glioma, meningioma,&#160;<br/>astrocytoma)&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft549"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft540">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft549"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft5410">For adjuvant&#160;treatment of melanoma, and central&#160;nervous system (CNS)&#160;<br/>cancer&#160;(i.e.,&#160;glioma, meningioma, astrocytoma):&#160;The patient&#160;must&#160;meet&#160;<br/>both of&#160;the following criteria: 1) The&#160;tumor is positive for BRAF V600&#160;<br/>activating&#160;mutation (e.g.,&#160;V600E&#160;or V600K), and 2)&#160;The requested drug&#160;<br/>will&#160;be used&#160;in combination with vemurafenib. For&#160;unresectable or&#160;<br/>metastatic&#160;melanoma: The patient must meet both&#160;of the following&#160;<br/>criteria:&#160;1) The tumor is&#160;positive for&#160;BRAF&#160;V600 activating&#160;mutation&#160;<br/>(e.g., V600E&#160;or V600K), and 2)&#160;The requested&#160;drug will be used in&#160;<br/>combination&#160;with vemurafenib&#160;(with&#160;or without&#160;atezolizumab).&#160;</p>
<p style="position:absolute;top:680px;left:126px;white-space:nowrap" class="ft548"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:680px;left:274px;white-space:nowrap" class="ft540">N/A&#160;</p>
<p style="position:absolute;top:719px;left:126px;white-space:nowrap" class="ft549"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:719px;left:274px;white-space:nowrap" class="ft540">N/A&#160;</p>
<p style="position:absolute;top:778px;left:126px;white-space:nowrap" class="ft549"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:778px;left:274px;white-space:nowrap" class="ft540">Plan Year&#160;</p>
<p style="position:absolute;top:838px;left:126px;white-space:nowrap" class="ft548"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:838px;left:274px;white-space:nowrap" class="ft540">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft540">54&#160;</p>
</div>
<!-- Page 55 -->
<a name="55"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page55-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2055.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft551"><b>C</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft554"><b>YSTAGON</b></p>
<p style="position:absolute;top:119px;left:248px;white-space:nowrap" class="ft5513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft552"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft555">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft556">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft550">Cystagon&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft552"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft552"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft558"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft550">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft558"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft550">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft559"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft550">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft559"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft5510">For&#160;nephropathic&#160;cystinosis: Diagnosis of&#160;nephropathic&#160;cystinosis&#160;was&#160;<br/>confirmed by the presence of&#160;increased cystine&#160;concentration&#160;in&#160;<br/>leukocytes or by genetic&#160;testing.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft558"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft550">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft559"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft550">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft559"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft550">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft558"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft550">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft550">55&#160;</p>
</div>
<!-- Page 56 -->
<a name="56"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page56-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2056.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft561"><b>C</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft564"><b>YSTARAN</b></p>
<p style="position:absolute;top:119px;left:246px;white-space:nowrap" class="ft5613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft562"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft565">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft566">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft560">Cystaran&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft562"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft562"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft568"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft560">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft568"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft560">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft569"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft560">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft569"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft5610">For cystinosis: 1)&#160;Diagnosis&#160;of cystinosis was confirmed by the presence&#160;<br/>of increased&#160;cystine concentration&#160;in leukocytes or by genetic testing,&#160;and&#160;<br/>2) Patient has corneal cystine&#160;crystal&#160;accumulation.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft568"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft560">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft569"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft560">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft569"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft560">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft568"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft560">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft560">56&#160;</p>
</div>
<!-- Page 57 -->
<a name="57"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page57-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2057.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft571"><b>D</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft574"><b>ALFAMPRIDINE</b></p>
<p style="position:absolute;top:119px;left:319px;white-space:nowrap" class="ft5713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft572"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft575">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft576">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft570">Dalfampridine Er&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft572"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft572"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft578"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft570">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft578"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft570">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft579"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft570">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft579"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft5710">For multiple&#160;sclerosis, patient must&#160;meet&#160;the following: For&#160;new starts,&#160;<br/>prior to initiating&#160;therapy, patient meets&#160;the following: patient&#160;<br/>demonstrates sustained walking impairment. For continuation of therapy,&#160;<br/>patient meets the following: patient&#160;must&#160;have experienced an&#160;<br/>improvement in walking&#160;speed OR other&#160;objective measure&#160;of walking&#160;<br/>ability since&#160;starting&#160;the requested drug.&#160;</p>
<p style="position:absolute;top:598px;left:126px;white-space:nowrap" class="ft578"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:598px;left:274px;white-space:nowrap" class="ft570">N/A&#160;</p>
<p style="position:absolute;top:636px;left:126px;white-space:nowrap" class="ft579"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:636px;left:274px;white-space:nowrap" class="ft570">N/A&#160;</p>
<p style="position:absolute;top:696px;left:126px;white-space:nowrap" class="ft579"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:696px;left:274px;white-space:nowrap" class="ft570">Plan Year&#160;</p>
<p style="position:absolute;top:755px;left:126px;white-space:nowrap" class="ft578"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:755px;left:274px;white-space:nowrap" class="ft570">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft570">57&#160;</p>
</div>
<!-- Page 58 -->
<a name="58"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page58-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2058.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft581"><b>D</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft584"><b>AURISMO</b></p>
<p style="position:absolute;top:119px;left:246px;white-space:nowrap" class="ft5813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft582"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft585">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft586">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft580">Daurismo&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft582"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft582"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft588"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft580">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft588"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft5810">Post&#160;induction&#160;therapy&#160;following response to previous therapy with the&#160;<br/>same regimen for acute myeloid leukemia&#160;(AML). Relapsed/refractory&#160;<br/>AML as a component of&#160;repeating the initial successful&#160;induction&#160;<br/>regimen.&#160;</p>
<p style="position:absolute;top:458px;left:126px;white-space:nowrap" class="ft589"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:458px;left:274px;white-space:nowrap" class="ft580">N/A&#160;</p>
<p style="position:absolute;top:518px;left:126px;white-space:nowrap" class="ft589"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:518px;left:274px;white-space:nowrap" class="ft5810">For acute&#160;myeloid&#160;leukemia: 1)&#160;the requested&#160;medication must be used&#160;in&#160;<br/>combination&#160;with cytarabine, 2)&#160;the patient is 75&#160;years of&#160;age&#160;or older&#160;OR&#160;<br/>has comorbidities that preclude&#160;intensive&#160;chemotherapy, and&#160;3) the&#160;<br/>requested medication will&#160;be used as&#160;treatment for induction therapy,&#160;<br/>post-induction therapy,&#160;or relapsed&#160;or refractory&#160;disease.&#160;</p>
<p style="position:absolute;top:639px;left:126px;white-space:nowrap" class="ft588"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:639px;left:274px;white-space:nowrap" class="ft580">N/A&#160;</p>
<p style="position:absolute;top:678px;left:126px;white-space:nowrap" class="ft589"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:678px;left:274px;white-space:nowrap" class="ft580">N/A&#160;</p>
<p style="position:absolute;top:737px;left:126px;white-space:nowrap" class="ft589"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:737px;left:274px;white-space:nowrap" class="ft580">Plan Year&#160;</p>
<p style="position:absolute;top:796px;left:126px;white-space:nowrap" class="ft588"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:796px;left:274px;white-space:nowrap" class="ft580">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft580">58&#160;</p>
</div>
<!-- Page 59 -->
<a name="59"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page59-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2059.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft591"><b>D</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft594"><b>EFERASIROX</b></p>
<p style="position:absolute;top:119px;left:287px;white-space:nowrap" class="ft5913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft592"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft595">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft596">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft590">Deferasirox&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft592"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft592"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft598"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft590">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft598"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft590">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft599"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft590">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft599"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft5910">For chronic&#160;iron overload due to blood transfusions: pretreatment serum&#160;<br/>ferritin level is greater than 1000 mcg/L.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft598"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft590">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft599"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft590">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft599"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft590">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft598"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft590">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft590">59&#160;</p>
</div>
<!-- Page 60 -->
<a name="60"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page60-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2060.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft601"><b>D</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft604"><b>EMSER</b></p>
<p style="position:absolute;top:119px;left:215px;white-space:nowrap" class="ft6013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft602"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft605">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft606">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft600">Metyrosine&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft602"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft602"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft608"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft600">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft608"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft600">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft609"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft600">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft609"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft600">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft608"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft600">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft609"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft600">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft609"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft600">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft608"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft600">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft600">60&#160;</p>
</div>
<!-- Page 61 -->
<a name="61"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page61-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2061.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft611"><b>D</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft614"><b>ESVENLAFAXINE</b></p>
<p style="position:absolute;top:119px;left:335px;white-space:nowrap" class="ft6113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft612"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft615">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft616">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft610">Desvenlafaxine Er&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft612"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft612"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft618"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft610">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft618"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft610">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft619"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft610">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft619"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft6110">Patient has&#160;experienced an inadequate treatment response, intolerance, or&#160;<br/>the patient has a contraindication to TWO of the following:&#160;serotonin&#160;and&#160;<br/>norepinephrine reuptake&#160;inhibitors&#160;(SNRIs), selective serotonin&#160;reuptake&#160;<br/>inhibitors&#160;(SSRIs), mirtazapine, bupropion.&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft618"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft610">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft619"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft610">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft619"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft610">Plan Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft618"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft610">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft610">61&#160;</p>
</div>
<!-- Page 62 -->
<a name="62"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page62-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2062.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft621"><b>D</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft624"><b>HE&#160;</b></p>
<p style="position:absolute;top:118px;left:170px;white-space:nowrap" class="ft621"><b>N</b></p>
<p style="position:absolute;top:123px;left:192px;white-space:nowrap" class="ft624"><b>ASAL</b></p>
<p style="position:absolute;top:119px;left:256px;white-space:nowrap" class="ft6213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft622"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft625">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft626">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft6210">Dihydroergotamine Mesylate&#160;<br/>NASAL&#160;SOLN&#160;</p>
<p style="position:absolute;top:297px;left:126px;white-space:nowrap" class="ft622"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:297px;left:274px;white-space:nowrap" class="ft622"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:339px;left:126px;white-space:nowrap" class="ft628"><b>Indications&#160;</b></p>
<p style="position:absolute;top:339px;left:274px;white-space:nowrap" class="ft620">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:378px;left:126px;white-space:nowrap" class="ft628"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:378px;left:274px;white-space:nowrap" class="ft620">N/A&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft629"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft620">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft629"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft6210">1)&#160;The patient has&#160;experienced an inadequate&#160;treatment response to one&#160;<br/>triptan 5-HT1 receptor&#160;agonist OR 2) The patient has experienced an&#160;<br/>intolerance to one triptan 5-HT1 receptor&#160;agonist&#160;OR&#160;3) The patient has&#160;a&#160;<br/>contraindication that would prohibit&#160;a trial of triptan 5-HT1 receptor&#160;<br/>agonists.&#160;</p>
<p style="position:absolute;top:598px;left:126px;white-space:nowrap" class="ft628"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:598px;left:274px;white-space:nowrap" class="ft620">N/A&#160;</p>
<p style="position:absolute;top:636px;left:126px;white-space:nowrap" class="ft629"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:636px;left:274px;white-space:nowrap" class="ft620">N/A&#160;</p>
<p style="position:absolute;top:696px;left:126px;white-space:nowrap" class="ft629"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:696px;left:274px;white-space:nowrap" class="ft620">Plan Year&#160;</p>
<p style="position:absolute;top:755px;left:126px;white-space:nowrap" class="ft628"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:755px;left:274px;white-space:nowrap" class="ft620">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft620">62&#160;</p>
</div>
<!-- Page 63 -->
<a name="63"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page63-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2063.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft631"><b>D</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft634"><b>IACOMIT</b></p>
<p style="position:absolute;top:119px;left:240px;white-space:nowrap" class="ft6313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft632"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft635">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft636">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft630">Diacomit&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft632"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft632"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft638"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft630">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft638"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft630">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft639"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft630">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft639"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft630">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft638"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft630">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft639"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft630">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft639"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft630">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft638"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft630">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft630">63&#160;</p>
</div>
<!-- Page 64 -->
<a name="64"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page64-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2064.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft641"><b>D</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft644"><b>IAZEPAM</b></p>
<p style="position:absolute;top:119px;left:243px;white-space:nowrap" class="ft6413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft642"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft645">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft646">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft640">Diazepam&#160;CONC&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft645">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft646">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft640">Diazepam&#160;INJ 5MG/ML&#160;</p>
<p style="position:absolute;top:242px;left:122px;white-space:nowrap" class="ft645">•</p>
<p style="position:absolute;top:241px;left:130px;white-space:nowrap" class="ft646">&#160;</p>
<p style="position:absolute;top:244px;left:149px;white-space:nowrap" class="ft640">Diazepam&#160;ORAL SOLN 5MG/5ML&#160;</p>
<p style="position:absolute;top:264px;left:122px;white-space:nowrap" class="ft645">•</p>
<p style="position:absolute;top:263px;left:130px;white-space:nowrap" class="ft646">&#160;</p>
<p style="position:absolute;top:266px;left:149px;white-space:nowrap" class="ft640">Diazepam&#160;TABS&#160;</p>
<p style="position:absolute;top:343px;left:126px;white-space:nowrap" class="ft642"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:343px;left:274px;white-space:nowrap" class="ft642"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:385px;left:126px;white-space:nowrap" class="ft648"><b>Indications&#160;</b></p>
<p style="position:absolute;top:385px;left:274px;white-space:nowrap" class="ft640">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:423px;left:126px;white-space:nowrap" class="ft648"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:423px;left:274px;white-space:nowrap" class="ft640">N/A&#160;</p>
<p style="position:absolute;top:462px;left:126px;white-space:nowrap" class="ft649"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:462px;left:274px;white-space:nowrap" class="ft640">N/A&#160;</p>
<p style="position:absolute;top:521px;left:126px;white-space:nowrap" class="ft649"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:521px;left:274px;white-space:nowrap" class="ft6410">For all&#160;indications: the prescriber must acknowledge the benefit&#160;of&#160;<br/>therapy with&#160;the requested drug outweighs the potential risks&#160;for the&#160;<br/>patient. (Note: The&#160;American Geriatrics Society identifies&#160;the use of this&#160;<br/>medication&#160;as potentially inappropriate&#160;in older&#160;adults,&#160;meaning it&#160;is best&#160;<br/>avoided, prescribed at&#160;reduced dosage, or&#160;used with caution or carefully&#160;<br/>monitored.) For the management of&#160;anxiety disorders: 1)&#160;the&#160;requested&#160;<br/>drug is being used concurrently with a selective&#160;serotonin reuptake&#160;<br/>inhibitor&#160;(SSRI) or&#160;serotonin-norepinephrine reuptake&#160;inhibitor (SNRI)&#160;<br/>until&#160;the SSRI/SNRI becomes effective for the symptoms of&#160;anxiety, OR&#160;<br/>2) The patient has&#160;experienced an inadequate&#160;treatment response,&#160;<br/>intolerance,&#160;or has a contraindication&#160;to AT LEAST TWO&#160;agents from the&#160;<br/>following&#160;classes:&#160;a)&#160;selective serotonin reuptake inhibitors&#160;(SSRIs), b)&#160;<br/>serotonin-norepinephrine reuptake inhibitors&#160;(SNRIs).&#160;</p>
<p style="position:absolute;top:808px;left:126px;white-space:nowrap" class="ft648"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:808px;left:274px;white-space:nowrap" class="ft640">N/A&#160;</p>
<p style="position:absolute;top:847px;left:126px;white-space:nowrap" class="ft649"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:847px;left:274px;white-space:nowrap" class="ft640">N/A&#160;</p>
<p style="position:absolute;top:907px;left:126px;white-space:nowrap" class="ft649"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:907px;left:274px;white-space:nowrap" class="ft6410">Short-term relief&#160;anx-1&#160;mo, skeletal&#160;muscle spasm-3 mo, Anx Disorders-4&#160;<br/>mo, Other Diagnoses-PlanYR&#160;</p>
<p style="position:absolute;top:966px;left:126px;white-space:nowrap" class="ft648"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:966px;left:274px;white-space:nowrap" class="ft6410">This Prior&#160;Authorization&#160;requirement&#160;only applies&#160;to patients 65 years of&#160;<br/>age or&#160;older.&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft640">64&#160;</p>
</div>
<!-- Page 65 -->
<a name="65"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page65-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2065.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft651"><b>D</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft654"><b>ICLOFENAC&#160;</b></p>
<p style="position:absolute;top:118px;left:280px;white-space:nowrap" class="ft651"><b>G</b></p>
<p style="position:absolute;top:123px;left:303px;white-space:nowrap" class="ft654"><b>EL&#160;</b></p>
<p style="position:absolute;top:118px;left:341px;white-space:nowrap" class="ft651"><b>1%</b></p>
<p style="position:absolute;top:113px;left:386px;white-space:nowrap" class="ft6514">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft652"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft655">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft656">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft650">Diclofenac&#160;Sodium&#160;GEL 1%&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft652"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft652"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft658"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft650">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft658"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft650">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft659"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft650">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft659"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft6510">The patient&#160;has osteoarthritis pain in joints&#160;susceptible to topical treatment&#160;<br/>such as feet, ankles, knees, hands, wrists, or elbows.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft658"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft650">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft659"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft650">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft659"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft650">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft658"><b>Other&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft650">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft650">65&#160;</p>
</div>
<!-- Page 66 -->
<a name="66"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page66-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2066.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft661"><b>D</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft664"><b>ICLOFENAC&#160;</b></p>
<p style="position:absolute;top:118px;left:280px;white-space:nowrap" class="ft661"><b>S</b></p>
<p style="position:absolute;top:123px;left:296px;white-space:nowrap" class="ft664"><b>OLN</b></p>
<p style="position:absolute;top:119px;left:348px;white-space:nowrap" class="ft6613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft662"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft665">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft666">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft660">Pennsaid&#160;SOLN 2%&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft662"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft662"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft668"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft660">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft668"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft660">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft669"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft660">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft669"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft660">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft668"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft660">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft669"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft660">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft669"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft660">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft668"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft660">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft660">66&#160;</p>
</div>
<!-- Page 67 -->
<a name="67"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page67-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2067.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft671"><b>D</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft674"><b>OPTELET</b></p>
<p style="position:absolute;top:119px;left:243px;white-space:nowrap" class="ft6713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft672"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft675">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft676">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft670">Doptelet&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft672"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft672"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft678"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft670">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft678"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft670">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft679"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft670">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft679"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft6710">For&#160;thrombocytopenia&#160;associated with chronic&#160;liver&#160;disease: Baseline&#160;<br/>platelet&#160;count prior to a&#160;scheduled procedure&#160;is less than 50,000/mcL. For&#160;<br/>chronic immune thrombocytopenia (ITP): 1)&#160;For&#160;new starts: a) Patient has&#160;<br/>had an inadequate&#160;response or&#160;is intolerant&#160;to a prior therapy such as&#160;<br/>corticosteroids or immunoglobulins,&#160;AND b) Untransfused platelet count&#160;<br/>at any point&#160;prior to the&#160;initiation of the requested&#160;medication&#160;is less than&#160;<br/>30,000/mcL&#160;OR&#160;30,000 to 50,000/mcL&#160;with symptomatic bleeding or risk&#160;<br/>factor(s)&#160;for&#160;bleeding&#160;(e.g., undergoing a medical or dental procedure&#160;<br/>where blood&#160;loss&#160;is anticipated,&#160;comorbidities such as peptic ulcer&#160;disease&#160;<br/>and hypertension, anticoagulation therapy, profession or&#160;lifestyle&#160;that&#160;<br/>predisposes&#160;patient to&#160;trauma). 2) For continuation of therapy,&#160;platelet&#160;<br/>count response to the requested drug: a)&#160;Current platelet&#160;count is less than&#160;<br/>or equal to 200,000/mcL&#160;OR&#160;b) Current platelet count is greater than&#160;<br/>200,000/mcL and less&#160;than or&#160;equal to 400,000/mcL and dosing will be&#160;<br/>adjusted to a&#160;platelet&#160;count sufficient&#160;to avoid clinically important&#160;<br/>bleeding.&#160;</p>
<p style="position:absolute;top:805px;left:126px;white-space:nowrap" class="ft678"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:805px;left:274px;white-space:nowrap" class="ft670">18 years&#160;of age or older&#160;</p>
<p style="position:absolute;top:843px;left:126px;white-space:nowrap" class="ft679"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:843px;left:274px;white-space:nowrap" class="ft670">N/A&#160;</p>
<p style="position:absolute;top:903px;left:126px;white-space:nowrap" class="ft679"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:903px;left:274px;white-space:nowrap" class="ft6710">Chronic&#160;liver&#160;disease:&#160;1&#160;month, ITP initial:&#160;6&#160;months, ITP reauthorization:&#160;<br/>Plan Year&#160;</p>
<p style="position:absolute;top:962px;left:126px;white-space:nowrap" class="ft678"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:962px;left:274px;white-space:nowrap" class="ft670">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft670">67&#160;</p>
</div>
<!-- Page 68 -->
<a name="68"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page68-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2068.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft681"><b>D</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft684"><b>RIZALMA</b></p>
<p style="position:absolute;top:119px;left:246px;white-space:nowrap" class="ft6813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft682"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft685">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft686">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft680">Drizalma Sprinkle&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft682"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft682"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft688"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft680">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft688"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft680">Cancer&#160;pain,&#160;chemotherapy-induced&#160;neuropathic&#160;pain&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft689"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft680">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft689"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft6810">1)&#160;The patient has&#160;tried&#160;duloxetine capsules OR 2) The patient is unable to&#160;<br/>take&#160;duloxetine capsules&#160;for&#160;any reason (e.g., difficulty swallowing&#160;<br/>capsules,&#160;requires nasogastric administration).&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft688"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft680">Generalized&#160;Anxiety&#160;Disorder&#160;-&#160;7 years&#160;of age or&#160;older&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft689"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft680">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft689"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft680">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft688"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft680">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft680">68&#160;</p>
</div>
<!-- Page 69 -->
<a name="69"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page69-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2069.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft691"><b>D</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft694"><b>RONABINOL</b></p>
<p style="position:absolute;top:119px;left:278px;white-space:nowrap" class="ft6913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft692"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft695">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft696">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft690">Dronabinol&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft692"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft692"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft698"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft690">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft698"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft690">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft699"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft690">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft699"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft6910">For chemotherapy-induced&#160;nausea and vomiting (CINV):&#160;The patient is&#160;<br/>receiving cancer&#160;chemotherapy AND&#160;has experienced an inadequate&#160;<br/>treatment response, intolerance, or contraindication to one oral 5-HT3&#160;<br/>receptor&#160;antagonist.&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft698"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft690">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft699"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft690">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft699"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft690">6 months&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft698"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft6910">Coverage&#160;under&#160;Part&#160;D will be denied&#160;if&#160;coverage&#160;is available under Part&#160;<br/>A or Part&#160;B as the&#160;medication&#160;is prescribed&#160;and dispensed or&#160;administered&#160;<br/>for&#160;the individual.&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft690">69&#160;</p>
</div>
<!-- Page 70 -->
<a name="70"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page70-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2070.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft701"><b>D</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft704"><b>UEXIS</b></p>
<p style="position:absolute;top:119px;left:203px;white-space:nowrap" class="ft7013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft702"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft705">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft706">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft700">Duexis&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft705">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft706">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft700">Ibuprofen/famotidine&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft702"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft702"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft708"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft700">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft708"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft700">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft709"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft700">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft709"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft7010">The patient&#160;has tried two different regimens containing any combination&#160;<br/>of a&#160;nonsteroidal anti-inflammatory&#160;drug (NSAID) and an acid blocker&#160;<br/>from any of&#160;the following drug classes:&#160;H2-receptor&#160;antagonist&#160;(H2RA),&#160;<br/>proton pump inhibitor&#160;(PPI).&#160;</p>
<p style="position:absolute;top:578px;left:126px;white-space:nowrap" class="ft708"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:578px;left:274px;white-space:nowrap" class="ft700">N/A&#160;</p>
<p style="position:absolute;top:617px;left:126px;white-space:nowrap" class="ft709"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:617px;left:274px;white-space:nowrap" class="ft700">N/A&#160;</p>
<p style="position:absolute;top:676px;left:126px;white-space:nowrap" class="ft709"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:676px;left:274px;white-space:nowrap" class="ft700">Plan Year&#160;</p>
<p style="position:absolute;top:736px;left:126px;white-space:nowrap" class="ft708"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:736px;left:274px;white-space:nowrap" class="ft700">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft700">70&#160;</p>
</div>
<!-- Page 71 -->
<a name="71"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page71-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2071.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft711"><b>E</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft714"><b>MSAM</b></p>
<p style="position:absolute;top:119px;left:204px;white-space:nowrap" class="ft7113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft712"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft715">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft716">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft710">Emsam&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft712"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft712"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft718"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft710">All&#160;FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft718"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft710">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft719"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft710">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft719"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft7110">1)&#160;Patient has experienced an inadequate treatment response, intolerance,&#160;<br/>or the patient has&#160;a contraindication&#160;to&#160;TWO of the&#160;following: serotonin&#160;<br/>and norepinephrine&#160;reuptake&#160;inhibitors&#160;(SNRIs), selective&#160;serotonin&#160;<br/>reuptake inhibitors&#160;(SSRIs), mirtazapine, bupropion OR&#160;2) Patient is&#160;<br/>unable&#160;to&#160;swallow oral formulations.&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft718"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft710">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft719"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft710">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft719"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft710">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft718"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft710">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft710">71&#160;</p>
</div>
<!-- Page 72 -->
<a name="72"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page72-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2072.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft721"><b>E</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft724"><b>NBREL</b></p>
<p style="position:absolute;top:119px;left:211px;white-space:nowrap" class="ft7213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft722"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft725">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft726">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft720">Enbrel&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft725">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft726">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft720">Enbrel&#160;Mini&#160;</p>
<p style="position:absolute;top:242px;left:122px;white-space:nowrap" class="ft725">•</p>
<p style="position:absolute;top:241px;left:130px;white-space:nowrap" class="ft726">&#160;</p>
<p style="position:absolute;top:244px;left:149px;white-space:nowrap" class="ft720">Enbrel&#160;Sureclick&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft720">72&#160;</p>
</div>
<!-- Page 73 -->
<a name="73"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page73-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2073.png" alt="background image"/>
<p style="position:absolute;top:132px;left:126px;white-space:nowrap" class="ft732"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:132px;left:274px;white-space:nowrap" class="ft732"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:174px;left:126px;white-space:nowrap" class="ft738"><b>Indications&#160;</b></p>
<p style="position:absolute;top:174px;left:274px;white-space:nowrap" class="ft730">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:213px;left:126px;white-space:nowrap" class="ft738"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:213px;left:274px;white-space:nowrap" class="ft730">Hidradenitis suppurativa&#160;</p>
<p style="position:absolute;top:252px;left:126px;white-space:nowrap" class="ft739"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:252px;left:274px;white-space:nowrap" class="ft730">N/A&#160;</p>
<p style="position:absolute;top:311px;left:126px;white-space:nowrap" class="ft739"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:311px;left:274px;white-space:nowrap" class="ft7310">For moderately&#160;to severely active rheumatoid arthritis (new&#160;starts&#160;only):&#160;<br/>1) Inadequate response,&#160;intolerance or contraindication to methotrexate&#160;<br/>(MTX) OR 2) Inadequate response&#160;or intolerance to a prior biologic&#160;<br/>disease-modifying&#160;antirheumatic drug (DMARD) or&#160;a targeted synthetic&#160;<br/>DMARD. For&#160;active ankylosing spondylitis (new starts only):&#160;1)&#160;<br/>Inadequate response&#160;to a non-steroidal anti-inflammatory drug (NSAID)&#160;<br/>trial, OR&#160;2) Intolerance&#160;or contraindication to NSAIDs. For moderate to&#160;<br/>severe plaque psoriasis&#160;(new&#160;starts only): 1) At least&#160;3% of body surface&#160;<br/>area&#160;(BSA) is affected OR crucial body areas&#160;(e.g., feet, hands, face, neck,&#160;<br/>groin, intertriginous&#160;areas) are affected at&#160;the time of&#160;diagnosis, AND&#160;2)&#160;<br/>Patient meets any of the&#160;following: a) Patient has&#160;experienced&#160;an&#160;<br/>inadequate response&#160;or intolerance&#160;to&#160;either phototherapy&#160;(e.g., UVB,&#160;<br/>PUVA)&#160;or pharmacologic treatment with methotrexate, cyclosporine, or&#160;<br/>acitretin, OR b) Pharmacologic treatment&#160;with methotrexate,&#160;<br/>cyclosporine, or acitretin is contraindicated, OR c)&#160;Patient has&#160;severe&#160;<br/>psoriasis that warrants a&#160;biologic DMARD as first-line therapy (i.e. at&#160;<br/>least 10%&#160;of the BSA&#160;or crucial body&#160;areas&#160;(e.g.,&#160;hands, feet,&#160;face, neck,&#160;<br/>scalp, genitals/groin, intertriginous&#160;areas)&#160;are&#160;affected). For&#160;hidradenitis&#160;<br/>suppurativa&#160;(new starts only): patient has severe, refractory disease.&#160;</p>
<p style="position:absolute;top:722px;left:126px;white-space:nowrap" class="ft738"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:722px;left:274px;white-space:nowrap" class="ft730">N/A&#160;</p>
<p style="position:absolute;top:761px;left:126px;white-space:nowrap" class="ft739"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:761px;left:274px;white-space:nowrap" class="ft730">N/A&#160;</p>
<p style="position:absolute;top:820px;left:126px;white-space:nowrap" class="ft739"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:820px;left:274px;white-space:nowrap" class="ft730">Plan Year&#160;</p>
<p style="position:absolute;top:880px;left:126px;white-space:nowrap" class="ft738"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:880px;left:274px;white-space:nowrap" class="ft730">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft730">73&#160;</p>
</div>
<!-- Page 74 -->
<a name="74"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page74-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2074.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft741"><b>E</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft744"><b>NHERTU</b></p>
<p style="position:absolute;top:119px;left:231px;white-space:nowrap" class="ft7413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft742"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft745">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft746">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft740">Enhertu&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft742"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft742"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft748"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft740">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft748"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft7410">Non-small cell&#160;lung cancer&#160;with human epidermal growth factor receptor&#160;<br/>2 (HER2) mutations, HER2-amplified and RAS and BRAF&#160;wild-type&#160;<br/>colorectal cancer.&#160;</p>
<p style="position:absolute;top:437px;left:126px;white-space:nowrap" class="ft749"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:437px;left:274px;white-space:nowrap" class="ft740">N/A&#160;</p>
<p style="position:absolute;top:497px;left:126px;white-space:nowrap" class="ft749"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:497px;left:274px;white-space:nowrap" class="ft740">N/A&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft748"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft740">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft749"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft740">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft749"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft740">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft748"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft7410">Coverage&#160;under&#160;Part&#160;D will be denied&#160;if&#160;coverage&#160;is available under Part&#160;<br/>A or Part&#160;B as the&#160;medication&#160;is prescribed&#160;and dispensed or&#160;administered&#160;<br/>for&#160;the individual.&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft740">74&#160;</p>
</div>
<!-- Page 75 -->
<a name="75"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page75-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2075.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft751"><b>E</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft754"><b>PCLUSA</b></p>
<p style="position:absolute;top:119px;left:224px;white-space:nowrap" class="ft7513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft752"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft755">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft756">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft750">Epclusa&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft752"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft752"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft758"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft750">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft758"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft750">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft759"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft750">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft759"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft7510">For hepatitis&#160;C virus&#160;(HCV):&#160;Infection confirmed by presence of HCV&#160;<br/>RNA in the&#160;serum prior&#160;to starting treatment. Planned treatment regimen,&#160;<br/>genotype, prior treatment history, presence&#160;or absence of&#160;cirrhosis&#160;<br/>(compensated or decompensated&#160;[Child Turcotte Pugh class&#160;B or C]),&#160;<br/>presence or&#160;absence of human immunodeficiency virus (HIV) coinfection,&#160;<br/>presence or&#160;absence of resistance-associated substitutions where&#160;<br/>applicable,&#160;liver and kidney transplantation status if&#160;applicable. Coverage&#160;<br/>conditions&#160;and specific durations of approval&#160;will&#160;be based on&#160;current&#160;<br/>AASLD treatment guidelines.&#160;</p>
<p style="position:absolute;top:660px;left:126px;white-space:nowrap" class="ft758"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:660px;left:274px;white-space:nowrap" class="ft750">N/A&#160;</p>
<p style="position:absolute;top:698px;left:126px;white-space:nowrap" class="ft759"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:698px;left:274px;white-space:nowrap" class="ft750">N/A&#160;</p>
<p style="position:absolute;top:758px;left:126px;white-space:nowrap" class="ft759"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:758px;left:274px;white-space:nowrap" class="ft750">Criteria will&#160;be applied consistent with current AASLD-IDSA guidance.&#160;</p>
<p style="position:absolute;top:817px;left:126px;white-space:nowrap" class="ft758"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:817px;left:274px;white-space:nowrap" class="ft750">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft750">75&#160;</p>
</div>
<!-- Page 76 -->
<a name="76"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page76-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2076.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft761"><b>E</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft764"><b>PIDIOLEX</b></p>
<p style="position:absolute;top:119px;left:247px;white-space:nowrap" class="ft7613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft762"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft765">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft766">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft760">Epidiolex&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft762"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft762"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft768"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft760">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft768"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft760">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft769"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft760">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft769"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft760">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft768"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft760">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft769"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft760">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft769"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft760">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft768"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft760">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft760">76&#160;</p>
</div>
<!-- Page 77 -->
<a name="77"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page77-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2077.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft771"><b>E</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft774"><b>PO</b></p>
<p style="position:absolute;top:119px;left:161px;white-space:nowrap" class="ft7713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft772"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft775">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft776">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft770">Procrit&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft770">77&#160;</p>
</div>
<!-- Page 78 -->
<a name="78"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page78-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2078.png" alt="background image"/>
<p style="position:absolute;top:132px;left:126px;white-space:nowrap" class="ft782"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:132px;left:274px;white-space:nowrap" class="ft782"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:174px;left:126px;white-space:nowrap" class="ft788"><b>Indications&#160;</b></p>
<p style="position:absolute;top:174px;left:274px;white-space:nowrap" class="ft780">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:213px;left:126px;white-space:nowrap" class="ft788"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:213px;left:274px;white-space:nowrap" class="ft7810">Anemia&#160;due&#160;to myelodysplastic syndromes (MDS), anemia in congestive&#160;<br/>heart&#160;failure&#160;(CHF), anemia in rheumatoid arthritis&#160;(RA), anemia due to&#160;<br/>hepatitis C treatment&#160;(ribavirin in combination with either interferon alfa&#160;<br/>or peginterferon alfa)&#160;</p>
<p style="position:absolute;top:314px;left:126px;white-space:nowrap" class="ft789"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:314px;left:274px;white-space:nowrap" class="ft7810">Patients receiving&#160;chemotherapy with&#160;curative intent. Patients with&#160;<br/>myeloid cancer.&#160;</p>
<p style="position:absolute;top:373px;left:126px;white-space:nowrap" class="ft789"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:373px;left:274px;white-space:nowrap" class="ft7810">Requirements regarding&#160;hemoglobin&#160;(Hgb) values exclude values&#160;due&#160;to a&#160;<br/>recent transfusion. For initial approval: 1)&#160;for&#160;all&#160;uses except anemia&#160;due&#160;<br/>to chemotherapy or myelodysplastic&#160;syndrome (MDS): patient has&#160;<br/>adequate&#160;iron stores&#160;(defined as a transferrin saturation [TSAT] greater&#160;<br/>than or&#160;equal to 20%) AND&#160;2) for all uses except surgery: pretreatment&#160;<br/>(no erythropoietin treatment in previous month)&#160;Hgb is&#160;less than 10 g/dL&#160;<br/>(less than 9&#160;g/dL for anemia&#160;in congestive heart&#160;failure), AND&#160;3) for&#160;<br/>MDS: pretreatment serum erythropoietin level is&#160;500 international units/L&#160;<br/>or less. For reauthorizations (patient&#160;received erythropoietin&#160;treatment in&#160;<br/>previous&#160;month)&#160;in&#160;all&#160;uses except surgery: 1) patient&#160;has received at&#160;least&#160;<br/>12 weeks of&#160;erythropoietin therapy,&#160;AND 2) patient&#160;responded to&#160;<br/>erythropoietin therapy,&#160;AND 3) current Hgb is&#160;less than 12 g/dL, AND&#160;4)&#160;<br/>for&#160;all uses&#160;except&#160;anemia due to chemotherapy or MDS: patient has&#160;<br/>adequate&#160;iron stores&#160;(defined as a&#160;TSAT&#160;greater&#160;than or&#160;equal&#160;to 20%).&#160;</p>
<p style="position:absolute;top:681px;left:126px;white-space:nowrap" class="ft788"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:681px;left:274px;white-space:nowrap" class="ft780">N/A&#160;</p>
<p style="position:absolute;top:720px;left:126px;white-space:nowrap" class="ft789"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:720px;left:274px;white-space:nowrap" class="ft780">N/A&#160;</p>
<p style="position:absolute;top:779px;left:126px;white-space:nowrap" class="ft789"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:779px;left:274px;white-space:nowrap" class="ft780">16 weeks&#160;</p>
<p style="position:absolute;top:838px;left:126px;white-space:nowrap" class="ft788"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:838px;left:274px;white-space:nowrap" class="ft7810">Coverage&#160;includes&#160;use&#160;in&#160;anemia in&#160;patients whose religious&#160;beliefs&#160;forbid&#160;<br/>blood transfusions. Coverage under&#160;Part&#160;D will&#160;be denied&#160;if&#160;coverage&#160;is&#160;<br/>available under&#160;Part&#160;A or Part B as&#160;the medication is&#160;prescribed and&#160;<br/>dispensed or administered for&#160;the individual (e.g.,&#160;used for treatment of&#160;<br/>anemia for&#160;a&#160;patient with&#160;chronic renal failure&#160;who is undergoing dialysis,&#160;<br/>or furnished&#160;from physician's supply incident&#160;to a physician service).&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft780">78&#160;</p>
</div>
<!-- Page 79 -->
<a name="79"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page79-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2079.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft791"><b>E</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft794"><b>RIVEDGE</b></p>
<p style="position:absolute;top:119px;left:240px;white-space:nowrap" class="ft7913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft792"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft795">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft796">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft790">Erivedge&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft792"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft792"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft798"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft790">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft798"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft790">Adult medulloblastoma&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft799"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft790">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft799"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft7910">For adult&#160;medulloblastoma:&#160;patient&#160;has received&#160;chemotherapy previously&#160;<br/>AND has tumor(s) with&#160;mutations&#160;in&#160;the sonic hedgehog pathway&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft798"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft790">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft799"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft790">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft799"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft790">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft798"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft790">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft790">79&#160;</p>
</div>
<!-- Page 80 -->
<a name="80"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page80-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2080.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft801"><b>E</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft804"><b>RLEADA</b></p>
<p style="position:absolute;top:119px;left:229px;white-space:nowrap" class="ft8013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft802"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft805">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft806">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft800">Erleada&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft802"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft802"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft808"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft800">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft808"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft800">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft809"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft800">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft809"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft8010">The requested&#160;drug will&#160;be used in combination with a gonadotropin-<br/>releasing hormone (GnRH) analog or&#160;after bilateral orchiectomy.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft808"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft800">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft809"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft800">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft809"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft800">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft808"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft800">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft800">80&#160;</p>
</div>
<!-- Page 81 -->
<a name="81"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page81-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2081.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft811"><b>E</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft814"><b>RLOTINIB</b></p>
<p style="position:absolute;top:119px;left:248px;white-space:nowrap" class="ft8113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft812"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft815">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft816">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft810">Erlotinib Hydrochloride&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft812"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft812"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft818"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft810">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft818"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft8110">Recurrent or&#160;advanced non-small cell lung cancer (NSCLC), recurrent&#160;<br/>chordoma, relapsed or stage IV renal&#160;cell&#160;carcinoma (RCC), brain&#160;<br/>metastases from&#160;NSCLC.&#160;</p>
<p style="position:absolute;top:437px;left:126px;white-space:nowrap" class="ft819"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:437px;left:274px;white-space:nowrap" class="ft810">N/A&#160;</p>
<p style="position:absolute;top:497px;left:126px;white-space:nowrap" class="ft819"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:497px;left:274px;white-space:nowrap" class="ft8110">For NSCLC&#160;(including brain&#160;metastases from NSCLC): 1)&#160;the disease&#160;is&#160;<br/>recurrent,&#160;advanced, or&#160;metastatic&#160;and 2) the patient has sensitizing EGFR&#160;<br/>mutation-positive disease. For pancreatic cancer: the disease&#160;is locally&#160;<br/>advanced, unresectable,&#160;or&#160;metastatic.&#160;</p>
<p style="position:absolute;top:598px;left:126px;white-space:nowrap" class="ft818"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:598px;left:274px;white-space:nowrap" class="ft810">N/A&#160;</p>
<p style="position:absolute;top:636px;left:126px;white-space:nowrap" class="ft819"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:636px;left:274px;white-space:nowrap" class="ft810">N/A&#160;</p>
<p style="position:absolute;top:696px;left:126px;white-space:nowrap" class="ft819"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:696px;left:274px;white-space:nowrap" class="ft810">Plan Year&#160;</p>
<p style="position:absolute;top:755px;left:126px;white-space:nowrap" class="ft818"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:755px;left:274px;white-space:nowrap" class="ft810">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft810">81&#160;</p>
</div>
<!-- Page 82 -->
<a name="82"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page82-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2082.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft821"><b>E</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft824"><b>SBRIET</b></p>
<p style="position:absolute;top:119px;left:216px;white-space:nowrap" class="ft8213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft822"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft825">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft826">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft820">Esbriet&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft822"><b>PA&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft822"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft828"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft820">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft828"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft820">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft829"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft820">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft829"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft8210">For idiopathic&#160;pulmonary fibrosis (Initial Review Only): 1)&#160;a high-<br/>resolution computed&#160;tomography (HRCT) study of the chest or&#160;a&#160;lung&#160;<br/>biopsy reveals the usual interstitial pneumonia&#160;(UIP) pattern,&#160;OR&#160;2)&#160;<br/>HRCT study&#160;of the chest&#160;reveals a&#160;result&#160;other&#160;than the UIP pattern&#160;(e.g.,&#160;<br/>probable UIP, indeterminate&#160;for UIP)&#160;and the&#160;diagnosis is&#160;supported either&#160;<br/>by a lung biopsy or by a&#160;multidisciplinary discussion between at least&#160;a&#160;<br/>radiologist and pulmonologist&#160;who are experienced in idiopathic&#160;<br/>pulmonary fibrosis if&#160;a lung biopsy&#160;has not&#160;been&#160;conducted.&#160;</p>
<p style="position:absolute;top:639px;left:126px;white-space:nowrap" class="ft828"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:639px;left:274px;white-space:nowrap" class="ft820">N/A&#160;</p>
<p style="position:absolute;top:678px;left:126px;white-space:nowrap" class="ft829"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:678px;left:274px;white-space:nowrap" class="ft820">N/A&#160;</p>
<p style="position:absolute;top:737px;left:126px;white-space:nowrap" class="ft829"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:737px;left:274px;white-space:nowrap" class="ft820">Plan Year&#160;</p>
<p style="position:absolute;top:796px;left:126px;white-space:nowrap" class="ft828"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:796px;left:274px;white-space:nowrap" class="ft820">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft820">82&#160;</p>
</div>
<!-- Page 83 -->
<a name="83"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page83-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2083.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft831"><b>E</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft834"><b>VEROLIMUS</b></p>
<p style="position:absolute;top:119px;left:276px;white-space:nowrap" class="ft8313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft832"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft835">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft836">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft830">Afinitor&#160;TABS&#160;10MG&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft835">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft836">&#160;&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft830">Afinitor Disperz&#160;</p>
<p style="position:absolute;top:242px;left:122px;white-space:nowrap" class="ft835">•</p>
<p style="position:absolute;top:241px;left:130px;white-space:nowrap" class="ft836">&#160;&#160;</p>
<p style="position:absolute;top:244px;left:149px;white-space:nowrap" class="ft8310">Everolimus&#160;TABS&#160;10MG, 2.5MG,&#160;<br/>5MG, 7.5MG&#160;</p>
<p style="position:absolute;top:284px;left:122px;white-space:nowrap" class="ft835">•</p>
<p style="position:absolute;top:284px;left:130px;white-space:nowrap" class="ft836">&#160;&#160;</p>
<p style="position:absolute;top:286px;left:149px;white-space:nowrap" class="ft830">Everolimus&#160;TBSO&#160;</p>
<p style="position:absolute;top:363px;left:126px;white-space:nowrap" class="ft832"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:363px;left:274px;white-space:nowrap" class="ft832"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:405px;left:126px;white-space:nowrap" class="ft838"><b>Indications&#160;</b></p>
<p style="position:absolute;top:405px;left:274px;white-space:nowrap" class="ft830">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:444px;left:126px;white-space:nowrap" class="ft838"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:444px;left:274px;white-space:nowrap" class="ft8310">Classic Hodgkin&#160;lymphoma, thymomas and thymic carcinomas,&#160;<br/>Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphoma, soft&#160;<br/>tissue sarcoma (perivascular&#160;epithelioid cell&#160;tumors (PEComa)&#160;and&#160;<br/>lymphangioleiomyomatosis&#160;subtypes), gastrointestinal stromal tumors,&#160;<br/>neuroendocrine tumors&#160;of the&#160;thymus, thyroid&#160;carcinoma&#160;(papillary,&#160;<br/>Hurthle cell,&#160;and follicular), endometrial carcinoma.&#160;</p>
<p style="position:absolute;top:586px;left:126px;white-space:nowrap" class="ft839"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:586px;left:274px;white-space:nowrap" class="ft830">N/A&#160;</p>
<p style="position:absolute;top:646px;left:126px;white-space:nowrap" class="ft839"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:646px;left:274px;white-space:nowrap" class="ft8310">For breast&#160;cancer: 1)&#160;The disease is&#160;recurrent or metastatic&#160;hormone&#160;<br/>receptor&#160;(HR)-positive,&#160;human epidermal growth factor receptor&#160;2&#160;<br/>(HER2)-negative, AND&#160;2) The requested medication is prescribed in&#160;<br/>combination&#160;with exemestane, fulvestrant, or&#160;tamoxifen, AND&#160;3) The&#160;<br/>requested medication is&#160;used for subsequent&#160;treatment. For&#160;renal cell&#160;<br/>carcinoma:&#160;The disease&#160;is relapsed,&#160;advanced, or&#160;stage IV. For&#160;<br/>subependymal giant cell astrocytoma&#160;(SEGA):&#160;The requested drug is&#160;<br/>given as adjuvant treatment.&#160;</p>
<p style="position:absolute;top:829px;left:126px;white-space:nowrap" class="ft838"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:829px;left:274px;white-space:nowrap" class="ft830">N/A&#160;</p>
<p style="position:absolute;top:868px;left:126px;white-space:nowrap" class="ft839"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:868px;left:274px;white-space:nowrap" class="ft830">N/A&#160;</p>
<p style="position:absolute;top:927px;left:126px;white-space:nowrap" class="ft839"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:927px;left:274px;white-space:nowrap" class="ft830">Plan Year&#160;</p>
<p style="position:absolute;top:987px;left:126px;white-space:nowrap" class="ft838"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:987px;left:274px;white-space:nowrap" class="ft830">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft830">83&#160;</p>
</div>
<!-- Page 84 -->
<a name="84"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page84-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2084.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft841"><b>E</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft844"><b>XKIVITY</b></p>
<p style="position:absolute;top:119px;left:233px;white-space:nowrap" class="ft8413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft842"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft845">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft846">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft840">Exkivity&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft842"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft842"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft848"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft840">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft848"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft840">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft849"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft840">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft849"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft840">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft848"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft840">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft849"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft840">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft849"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft840">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft848"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft840">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft840">84&#160;</p>
</div>
<!-- Page 85 -->
<a name="85"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page85-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2085.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft851"><b>F</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft854"><b>ANAPT</b></p>
<p style="position:absolute;top:119px;left:209px;white-space:nowrap" class="ft8513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft852"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft855">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft856">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft850">Fanapt&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft855">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft856">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft850">Fanapt Titration Pack&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft852"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft852"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft858"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft850">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft858"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft850">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft859"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft850">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft859"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft8510">The patient&#160;experienced&#160;an inadequate treatment response, intolerance, or&#160;<br/>contraindication to one of the following generic products: A)&#160;aripiprazole,&#160;<br/>B) asenapine, C) olanzapine, D) quetiapine, E)&#160;risperidone, F) ziprasidone&#160;<br/>AND the patient&#160;experienced an inadequate&#160;treatment&#160;response,&#160;<br/>intolerance,&#160;or contraindication to one of&#160;the following brand&#160;products: A)&#160;<br/>Latuda, B) Rexulti, C)&#160;Secuado.&#160;</p>
<p style="position:absolute;top:620px;left:126px;white-space:nowrap" class="ft858"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:620px;left:274px;white-space:nowrap" class="ft850">N/A&#160;</p>
<p style="position:absolute;top:658px;left:126px;white-space:nowrap" class="ft859"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:658px;left:274px;white-space:nowrap" class="ft850">N/A&#160;</p>
<p style="position:absolute;top:718px;left:126px;white-space:nowrap" class="ft859"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:718px;left:274px;white-space:nowrap" class="ft850">Plan Year&#160;</p>
<p style="position:absolute;top:777px;left:126px;white-space:nowrap" class="ft858"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:777px;left:274px;white-space:nowrap" class="ft850">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft850">85&#160;</p>
</div>
<!-- Page 86 -->
<a name="86"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page86-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2086.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft861"><b>F</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft864"><b>ARYDAK</b></p>
<p style="position:absolute;top:119px;left:232px;white-space:nowrap" class="ft8613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft862"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft865">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft866">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft860">Farydak&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft862"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft862"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft868"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft860">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft868"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft860">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft869"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft860">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft869"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft860">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft868"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft860">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft869"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft860">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft869"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft860">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft868"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft860">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft860">86&#160;</p>
</div>
<!-- Page 87 -->
<a name="87"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page87-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2087.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft871"><b>F</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft874"><b>ASENRA</b></p>
<p style="position:absolute;top:119px;left:225px;white-space:nowrap" class="ft8713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft872"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft875">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft876">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft870">Fasenra&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft875">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft876">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft870">Fasenra Pen&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft872"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft872"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft878"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft870">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft878"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft870">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft879"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft870">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft879"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft8710">For severe&#160;asthma: For&#160;initial therapy: 1)&#160;Either&#160;a)&#160;Patient&#160;has baseline&#160;<br/>blood eosinophil count&#160;of at&#160;least 150 cells per&#160;microliter OR b) Patient&#160;is&#160;<br/>dependent&#160;on systemic corticosteroids, and 2)&#160;Patient&#160;has a history of&#160;<br/>severe&#160;asthma despite current treatment&#160;with&#160;both of&#160;the following&#160;<br/>medications&#160;at optimized&#160;doses: a) inhaled corticosteroid and&#160;b) additional&#160;<br/>controller (long-acting beta2-agonist, leukotriene&#160;modifier, or sustained-<br/>release theophylline).&#160;For continuation of therapy: Asthma control has&#160;<br/>improved on&#160;treatment with the requested drug, as&#160;demonstrated by a&#160;<br/>reduction in&#160;the frequency and/or&#160;severity of&#160;symptoms and&#160;exacerbations&#160;<br/>or a&#160;reduction in the daily maintenance oral corticosteroid dose.&#160;</p>
<p style="position:absolute;top:702px;left:126px;white-space:nowrap" class="ft878"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:702px;left:274px;white-space:nowrap" class="ft870">12 years&#160;of age or older&#160;</p>
<p style="position:absolute;top:741px;left:126px;white-space:nowrap" class="ft879"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:741px;left:274px;white-space:nowrap" class="ft870">N/A&#160;</p>
<p style="position:absolute;top:801px;left:126px;white-space:nowrap" class="ft879"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:801px;left:274px;white-space:nowrap" class="ft870">Plan Year&#160;</p>
<p style="position:absolute;top:860px;left:126px;white-space:nowrap" class="ft878"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:860px;left:274px;white-space:nowrap" class="ft870">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft870">87&#160;</p>
</div>
<!-- Page 88 -->
<a name="88"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page88-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2088.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft881"><b>F</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft884"><b>ENTANYL&#160;</b></p>
<p style="position:absolute;top:118px;left:250px;white-space:nowrap" class="ft881"><b>P</b></p>
<p style="position:absolute;top:123px;left:268px;white-space:nowrap" class="ft884"><b>ATCH</b></p>
<p style="position:absolute;top:119px;left:337px;white-space:nowrap" class="ft8813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft882"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft885">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft886">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft880">Fentanyl&#160;PT72&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft882"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft882"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft888"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft880">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft888"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft880">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft889"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft880">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft889"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft8810">1)&#160;The requested drug&#160;is being prescribed for pain&#160;associated&#160;with cancer,&#160;<br/>sickle cell disease, a&#160;terminal condition, or pain&#160;being managed through&#160;<br/>palliative&#160;care&#160;OR&#160;2) The requested&#160;drug is being prescribed&#160;for&#160;pain&#160;<br/>severe&#160;enough to require&#160;daily, around-the-clock,&#160;long-term&#160;treatment in&#160;a&#160;<br/>patient who has been taking an opioid&#160;AND 3) The patient can safely take&#160;<br/>the requested dose based&#160;on their history of&#160;opioid use [Note: This drug&#160;<br/>should be prescribed only by healthcare&#160;professionals&#160;who are&#160;<br/>knowledgeable&#160;in&#160;the use of potent opioids for the management of chronic&#160;<br/>pain.]&#160;AND 4) The patient has&#160;been&#160;evaluated and the patient&#160;will&#160;be&#160;<br/>monitored&#160;for the development of opioid use disorder&#160;AND 5) This&#160;<br/>request&#160;is for continuation of therapy&#160;for&#160;a patient&#160;who has been receiving&#160;<br/>an extended-release&#160;opioid agent&#160;for at least&#160;30 days OR the patient has&#160;<br/>taken an&#160;immediate-release opioid for at&#160;least one week.&#160;</p>
<p style="position:absolute;top:742px;left:126px;white-space:nowrap" class="ft888"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:742px;left:274px;white-space:nowrap" class="ft880">N/A&#160;</p>
<p style="position:absolute;top:781px;left:126px;white-space:nowrap" class="ft889"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:781px;left:274px;white-space:nowrap" class="ft880">N/A&#160;</p>
<p style="position:absolute;top:841px;left:126px;white-space:nowrap" class="ft889"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:841px;left:274px;white-space:nowrap" class="ft880">Plan Year&#160;</p>
<p style="position:absolute;top:900px;left:126px;white-space:nowrap" class="ft888"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:900px;left:274px;white-space:nowrap" class="ft880">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft880">88&#160;</p>
</div>
<!-- Page 89 -->
<a name="89"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page89-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2089.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft891"><b>F</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft894"><b>ETZIMA</b></p>
<p style="position:absolute;top:119px;left:224px;white-space:nowrap" class="ft8913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft892"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft895">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft896">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft890">Fetzima&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft895">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft896">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft890">Fetzima Titration Pack&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft892"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft892"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft898"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft890">All FDA-approved&#160;Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft898"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft890">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft899"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft890">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft899"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft8910">The patient&#160;has experienced an inadequate&#160;treatment response,&#160;<br/>intolerance,&#160;or the patient has&#160;a contraindication&#160;to&#160;TWO of the&#160;following:&#160;<br/>serotonin and norepinephrine reuptake inhibitors&#160;(SNRIs), selective&#160;<br/>serotonin reuptake&#160;inhibitors&#160;(SSRIs), mirtazapine, bupropion.&#160;</p>
<p style="position:absolute;top:578px;left:126px;white-space:nowrap" class="ft898"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:578px;left:274px;white-space:nowrap" class="ft890">N/A&#160;</p>
<p style="position:absolute;top:617px;left:126px;white-space:nowrap" class="ft899"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:617px;left:274px;white-space:nowrap" class="ft890">N/A&#160;</p>
<p style="position:absolute;top:676px;left:126px;white-space:nowrap" class="ft899"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:676px;left:274px;white-space:nowrap" class="ft890">Plan Year&#160;</p>
<p style="position:absolute;top:736px;left:126px;white-space:nowrap" class="ft898"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:736px;left:274px;white-space:nowrap" class="ft890">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft890">89&#160;</p>
</div>
<!-- Page 90 -->
<a name="90"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page90-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2090.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft901"><b>F</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft904"><b>INTEPLA</b></p>
<p style="position:absolute;top:119px;left:233px;white-space:nowrap" class="ft9013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft902"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft905">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft906">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft900">Fintepla&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft902"><b>PA&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft902"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft908"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft900">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft908"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft900">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft909"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft900">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft909"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft900">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft908"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft900">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft909"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft900">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft909"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft900">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft908"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft900">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft900">90&#160;</p>
</div>
<!-- Page 91 -->
<a name="91"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page91-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2091.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft911"><b>F</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft914"><b>LUOROURACIL</b></p>
<p style="position:absolute;top:119px;left:309px;white-space:nowrap" class="ft9113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft912"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft915">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft916">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft910">Fluoroplex&#160;CREA&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft915">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft916">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft910">Fluorouracil&#160;CREA&#160;5%&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft912"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft912"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft918"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft910">All&#160;FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft918"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft910">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft919"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft9110">Patients who&#160;are&#160;pregnant or&#160;may become&#160;pregnant. Fluorouracil cream&#160;5&#160;<br/>percent only: Patients with dihydropyrimidine dehydrogenase (DPD)&#160;<br/>enzyme deficiency.&#160;</p>
<p style="position:absolute;top:498px;left:126px;white-space:nowrap" class="ft919"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:498px;left:274px;white-space:nowrap" class="ft9110">Applies to&#160;new starts only. If&#160;being used as part of a&#160;compounded product,&#160;<br/>all&#160;active ingredients in&#160;the compounded product are FDA&#160;approved for&#160;<br/>topical use.&#160;</p>
<p style="position:absolute;top:578px;left:126px;white-space:nowrap" class="ft918"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:578px;left:274px;white-space:nowrap" class="ft910">N/A&#160;</p>
<p style="position:absolute;top:617px;left:126px;white-space:nowrap" class="ft919"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:617px;left:274px;white-space:nowrap" class="ft910">N/A&#160;</p>
<p style="position:absolute;top:676px;left:126px;white-space:nowrap" class="ft919"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:676px;left:274px;white-space:nowrap" class="ft910">3 months&#160;</p>
<p style="position:absolute;top:736px;left:126px;white-space:nowrap" class="ft918"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:736px;left:274px;white-space:nowrap" class="ft910">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft910">91&#160;</p>
</div>
<!-- Page 92 -->
<a name="92"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page92-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2092.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft921"><b>F</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft924"><b>ORTAMET</b></p>
<p style="position:absolute;top:118px;left:250px;white-space:nowrap" class="ft921"><b>/</b></p>
<p style="position:absolute;top:123px;left:259px;white-space:nowrap" class="ft924"><b>GLUMETZA</b></p>
<p style="position:absolute;top:119px;left:399px;white-space:nowrap" class="ft9213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft922"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft925">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft926">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft9210">Metformin&#160;Hydrochloride Er&#160;TB24&#160;<br/>500MG&#160;</p>
<p style="position:absolute;top:297px;left:126px;white-space:nowrap" class="ft922"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:297px;left:274px;white-space:nowrap" class="ft922"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:339px;left:126px;white-space:nowrap" class="ft928"><b>Indications&#160;</b></p>
<p style="position:absolute;top:339px;left:274px;white-space:nowrap" class="ft920">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:378px;left:126px;white-space:nowrap" class="ft928"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:378px;left:274px;white-space:nowrap" class="ft920">N/A&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft929"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft920">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft929"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft920">The patient&#160;has experienced an intolerance&#160;to generic&#160;Glucophage XR.&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft928"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft920">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft929"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft920">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft929"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft920">Plan Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft928"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft920">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft920">92&#160;</p>
</div>
<!-- Page 93 -->
<a name="93"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page93-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2093.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft931"><b>F</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft934"><b>ORTEO</b></p>
<p style="position:absolute;top:119px;left:213px;white-space:nowrap" class="ft9313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft932"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft935">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft936">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft930">Forteo&#160;INJ 620MCG/2.48ML&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft930">93&#160;</p>
</div>
<!-- Page 94 -->
<a name="94"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page94-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2094.png" alt="background image"/>
<p style="position:absolute;top:132px;left:126px;white-space:nowrap" class="ft942"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:132px;left:274px;white-space:nowrap" class="ft942"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:174px;left:126px;white-space:nowrap" class="ft948"><b>Indications&#160;</b></p>
<p style="position:absolute;top:174px;left:274px;white-space:nowrap" class="ft940">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:213px;left:126px;white-space:nowrap" class="ft948"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:213px;left:274px;white-space:nowrap" class="ft940">N/A&#160;</p>
<p style="position:absolute;top:252px;left:126px;white-space:nowrap" class="ft949"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:252px;left:274px;white-space:nowrap" class="ft940">N/A&#160;</p>
<p style="position:absolute;top:311px;left:126px;white-space:nowrap" class="ft949"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:311px;left:274px;white-space:nowrap" class="ft9410">For postmenopausal&#160;osteoporosis: patient has&#160;ONE of the following (1 or&#160;<br/>2):&#160;1) a&#160;history of&#160;fragility fracture, OR 2) A pre-treatment T-score of&#160;less&#160;<br/>than or&#160;equal to&#160;-2.5 or pre-treatment&#160;T-score greater&#160;than&#160;-2.5 and less&#160;<br/>than -1 with&#160;a high pre-treatment Fracture Risk Assessment Tool (FRAX)&#160;<br/>fracture probability AND&#160;patient has ANY of the following:&#160;a)&#160;indicators&#160;<br/>for&#160;higher fracture risk (e.g., advanced age, frailty, glucocorticoid therapy,&#160;<br/>very low T-scores, or&#160;increased&#160;fall&#160;risk), OR&#160;b) patient has&#160;failed prior&#160;<br/>treatment with or&#160;is intolerant&#160;to a previous&#160;injectable&#160;osteoporosis&#160;<br/>therapy OR&#160;c)&#160;patient has had an oral&#160;bisphosphonate&#160;trial of&#160;at least&#160;1-<br/>year&#160;duration or there is&#160;a clinical reason to avoid treatment with an oral&#160;<br/>bisphosphonate. For primary or hypogonadal&#160;osteoporosis&#160;in&#160;men:&#160;patient&#160;<br/>has one&#160;of the following: 1)&#160;a history of osteoporotic vertebral or hip&#160;<br/>fracture, OR&#160;2) pre-treatment T-score of less than or equal&#160;to&#160;-2.5, OR&#160;3)&#160;<br/>pre-treatment T-score greater&#160;than&#160;-2.5 and less&#160;than&#160;-1 with a&#160;high pre-<br/>treatment FRAX fracture probability. For glucocorticoid-induced&#160;<br/>osteoporosis: Patient has&#160;had an oral&#160;bisphosphonate&#160;trial of&#160;at&#160;least 1-<br/>year&#160;duration unless patient has a contraindication or intolerance to an&#160;<br/>oral bisphosphonate, AND patient&#160;meets ANY of the following: 1)&#160;patient&#160;<br/>has a&#160;history&#160;of fragility&#160;fracture, OR&#160;2) a&#160;pre-treatment T-score&#160;of less&#160;<br/>than or&#160;equal to&#160;-2.5, OR&#160;3) pre-treatment T-score greater&#160;than -2.5 and&#160;<br/>less than -1&#160;with a&#160;high&#160;pre-treatment FRAX&#160;fracture&#160;probability.&#160;</p>
<p style="position:absolute;top:764px;left:126px;white-space:nowrap" class="ft948"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:764px;left:274px;white-space:nowrap" class="ft940">N/A&#160;</p>
<p style="position:absolute;top:802px;left:126px;white-space:nowrap" class="ft949"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:802px;left:274px;white-space:nowrap" class="ft940">N/A&#160;</p>
<p style="position:absolute;top:862px;left:126px;white-space:nowrap" class="ft949"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:862px;left:274px;white-space:nowrap" class="ft9410">24 months&#160;total&#160;unless&#160;the patient remains&#160;at high risk for fracture&#160;and&#160;<br/>benefit outweighs&#160;risk&#160;</p>
<p style="position:absolute;top:921px;left:126px;white-space:nowrap" class="ft948"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:921px;left:274px;white-space:nowrap" class="ft9410">Patient has&#160;high FRAX fracture probability if the&#160;10 year&#160;probability is&#160;<br/>either greater than or&#160;equal to 20 percent for any&#160;major osteoporotic&#160;<br/>fracture or greater than or equal to 3&#160;percent for hip fracture. If&#160;<br/>glucocorticoid treatment&#160;is greater than 7.5 mg (prednisone&#160;equivalent)&#160;<br/>per&#160;day, the&#160;estimated risk score generated with FRAX should&#160;be&#160;<br/>multiplied by 1.15 for major&#160;osteoporotic fracture and 1.2 for&#160;hip fracture.&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft940">94&#160;</p>
</div>
<!-- Page 95 -->
<a name="95"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page95-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2095.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft951"><b>F</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft954"><b>OTIVDA</b></p>
<p style="position:absolute;top:119px;left:222px;white-space:nowrap" class="ft9513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft952"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft955">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft956">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft950">Fotivda&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft952"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft952"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft958"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft950">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft958"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft950">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft959"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft950">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft959"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft9510">For advanced&#160;renal cell&#160;carcinoma:&#160;The following criteria must be met:&#160;1)&#160;<br/>The disease&#160;is relapsed or refractory,&#160;2) The requested medication must&#160;be&#160;<br/>used after at&#160;least two prior&#160;systemic therapies, and 3) The patient has&#160;<br/>experienced&#160;disease progression or an&#160;intolerable adverse&#160;event with a&#160;<br/>trial of&#160;cabozantinib.&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft958"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft950">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft959"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft950">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft959"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft950">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft958"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft950">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft950">95&#160;</p>
</div>
<!-- Page 96 -->
<a name="96"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page96-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2096.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft961"><b>F</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft964"><b>YCOMPA</b></p>
<p style="position:absolute;top:119px;left:234px;white-space:nowrap" class="ft9613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft962"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft965">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft966">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft960">Fycompa&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft962"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft962"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft968"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft960">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft968"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft960">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft969"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft960">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft969"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft9610">For treatment&#160;of partial-onset&#160;seizures:&#160;1) The patient experienced an&#160;<br/>inadequate treatment response, intolerance, or contraindication to a&#160;<br/>generic anticonvulsant&#160;AND 2) The&#160;patient has&#160;experienced&#160;an inadequate&#160;<br/>treatment response, intolerance, or contraindication to any of&#160;the&#160;<br/>following:&#160;Aptiom, Vimpat, Xcopri, Spritam. For adjunctive treatment&#160;of&#160;<br/>primary&#160;generalized&#160;tonic-clonic seizures: 1) The&#160;patient experienced an&#160;<br/>inadequate treatment response, intolerance, or contraindication to a&#160;<br/>generic anticonvulsant&#160;AND 2) The&#160;patient experienced an inadequate&#160;<br/>treatment response, intolerance, or contraindication to one of&#160;the&#160;<br/>following:&#160;Vimpat, Spritam.&#160;</p>
<p style="position:absolute;top:680px;left:126px;white-space:nowrap" class="ft968"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:680px;left:274px;white-space:nowrap" class="ft9610">Partial-onset seizures: 4&#160;years of&#160;age&#160;or older. Primary generalized&#160;tonic-<br/>clonic&#160;seizures: 12 years&#160;of&#160;age or&#160;older&#160;</p>
<p style="position:absolute;top:740px;left:126px;white-space:nowrap" class="ft969"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:740px;left:274px;white-space:nowrap" class="ft960">N/A&#160;</p>
<p style="position:absolute;top:799px;left:126px;white-space:nowrap" class="ft969"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:799px;left:274px;white-space:nowrap" class="ft960">Plan Year&#160;</p>
<p style="position:absolute;top:859px;left:126px;white-space:nowrap" class="ft968"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:859px;left:274px;white-space:nowrap" class="ft960">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft960">96&#160;</p>
</div>
<!-- Page 97 -->
<a name="97"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page97-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2097.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft971"><b>G</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft974"><b>ATTEX</b></p>
<p style="position:absolute;top:119px;left:214px;white-space:nowrap" class="ft9713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft972"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft975">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft976">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft970">Gattex&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft972"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft972"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft978"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft970">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft978"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft970">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft979"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft970">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft979"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft9710">For short&#160;bowel syndrome (SBS) initial therapy:&#160;Adult patients were&#160;<br/>dependent&#160;on parenteral&#160;support for at least 12&#160;months. For SBS&#160;<br/>continuation: Requirement for parenteral support&#160;has decreased from&#160;<br/>baseline&#160;while on therapy with the requested&#160;medication.&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft978"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft970">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft979"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft970">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft979"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft970">Plan Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft978"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft970">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft970">97&#160;</p>
</div>
<!-- Page 98 -->
<a name="98"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page98-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2098.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft981"><b>G</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft984"><b>AVRETO</b></p>
<p style="position:absolute;top:119px;left:234px;white-space:nowrap" class="ft9813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft982"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft985">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft986">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft980">Gavreto&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft982"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft982"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft988"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft980">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft988"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft9810">Recurrent or&#160;advanced rearranged during transfection (RET)&#160;<br/>rearrangement-positive non-small cell lung cancer&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft989"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft980">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft989"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft9810">For non-small&#160;cell&#160;lung cancer, patient must meet&#160;all&#160;of the&#160;following:&#160;1)&#160;<br/>The disease&#160;is recurrent,&#160;advanced, or metastatic,&#160;and 2)&#160;The tumor&#160;is&#160;<br/>rearranged during transfection&#160;(RET) fusion-positive or&#160;RET&#160;<br/>rearrangement-positive.&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft988"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft9810">Non-small cell&#160;lung cancer:&#160;18 years&#160;of age or&#160;older.&#160;Medullary thyroid&#160;<br/>cancer&#160;and thyroid cancer:&#160;12 years&#160;of age or&#160;older.&#160;</p>
<p style="position:absolute;top:636px;left:126px;white-space:nowrap" class="ft989"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:636px;left:274px;white-space:nowrap" class="ft980">N/A&#160;</p>
<p style="position:absolute;top:696px;left:126px;white-space:nowrap" class="ft989"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:696px;left:274px;white-space:nowrap" class="ft980">Plan Year&#160;</p>
<p style="position:absolute;top:755px;left:126px;white-space:nowrap" class="ft988"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:755px;left:274px;white-space:nowrap" class="ft980">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft980">98&#160;</p>
</div>
<!-- Page 99 -->
<a name="99"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page99-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2099.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft991"><b>G</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft994"><b>ILENYA</b></p>
<p style="position:absolute;top:119px;left:225px;white-space:nowrap" class="ft9913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft992"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft995">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft996">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft990">Gilenya&#160;CAPS 0.5MG&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft992"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft992"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft998"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft990">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft998"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft990">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft999"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft990">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft999"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft990">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft998"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft990">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft999"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft990">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft999"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft990">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft998"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft990">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:792px;white-space:nowrap" class="ft990">99&#160;</p>
</div>
<!-- Page 100 -->
<a name="100"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page100-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2100.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1001"><b>G</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1004"><b>ILOTRIF</b></p>
<p style="position:absolute;top:119px;left:233px;white-space:nowrap" class="ft10013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1002"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1005">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1006">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1000">Gilotrif&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1002"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1002"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1008"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1000">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1008"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1000">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1009"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1000">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1009"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft10010">For non-small&#160;cell&#160;lung cancer (NSCLC): Patient&#160;meets either of the&#160;<br/>following:&#160;<br/>1) Patient has metastatic&#160;squamous NSCLC that progressed after&#160;<br/>platinum-based chemotherapy, OR&#160;2) Patient has&#160;sensitizing&#160;EGFR&#160;<br/>mutation-positive disease.&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft1008"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft1000">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft1009"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft1000">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft1009"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft1000">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft1008"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft1000">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1000">100&#160;</p>
</div>
<!-- Page 101 -->
<a name="101"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page101-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2101.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1011"><b>G</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1014"><b>LATIRAMER</b></p>
<p style="position:absolute;top:119px;left:281px;white-space:nowrap" class="ft10113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1012"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1015">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1016">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1010">Copaxone&#160;INJ 20MG/ML, 40MG/ML&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1012"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1012"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1018"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1010">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1018"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1010">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1019"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1010">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1019"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft1010">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft1018"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft1010">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft1019"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft1010">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft1019"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft1010">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft1018"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft1010">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1010">101&#160;</p>
</div>
<!-- Page 102 -->
<a name="102"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page102-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2102.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1021"><b>G</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1024"><b>ROWTH&#160;</b></p>
<p style="position:absolute;top:118px;left:232px;white-space:nowrap" class="ft1021"><b>H</b></p>
<p style="position:absolute;top:123px;left:255px;white-space:nowrap" class="ft1024"><b>ORMONE</b></p>
<p style="position:absolute;top:119px;left:366px;white-space:nowrap" class="ft10213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1022"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1025">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1026">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1020">Genotropin&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft1025">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft1026">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft1020">Genotropin&#160;Miniquick&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1020">102&#160;</p>
</div>
<!-- Page 103 -->
<a name="103"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page103-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2103.png" alt="background image"/>
<p style="position:absolute;top:132px;left:126px;white-space:nowrap" class="ft1032"><b>PA&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:132px;left:274px;white-space:nowrap" class="ft1032"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:174px;left:126px;white-space:nowrap" class="ft1038"><b>Indications&#160;</b></p>
<p style="position:absolute;top:174px;left:274px;white-space:nowrap" class="ft1030">All Medically-accepted Indications.&#160;</p>
<p style="position:absolute;top:213px;left:126px;white-space:nowrap" class="ft1038"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:213px;left:274px;white-space:nowrap" class="ft1030">N/A&#160;</p>
<p style="position:absolute;top:252px;left:126px;white-space:nowrap" class="ft1039"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:252px;left:274px;white-space:nowrap" class="ft1030">Pediatric patients&#160;with closed epiphyses (except in patients with PWS).&#160;</p>
<p style="position:absolute;top:311px;left:126px;white-space:nowrap" class="ft1039"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:311px;left:274px;white-space:nowrap" class="ft10310">Pediatric growth&#160;hormone deficiency (GHD):&#160;Patient (pt) meets&#160;any of&#160;the&#160;<br/>following: 1) younger than 2.5 years&#160;old (yo) with pre-treatment (pre-tx)&#160;<br/>height&#160;(ht)&#160;more&#160;than 2 standard deviations&#160;(SD)&#160;below mean&#160;and slow&#160;<br/>growth velocity OR&#160;2) 2.5 yo or older AND&#160;one&#160;of the following: a) pre-<br/>tx 1-year ht&#160;velocity more than 2 SD below mean OR b) pre-tx&#160;ht more&#160;<br/>than 2 SD below mean and 1-year&#160;ht&#160;velocity more than 1 SD below&#160;<br/>mean, AND patient meets any of the&#160;following: 1) failed 2 pre-tx growth&#160;<br/>hormone (GH) stimulation tests (peak below 10 ng/mL), OR&#160;2)&#160;<br/>pituitary/central nervous&#160;system (CNS) disorder (e.g., genetic defects,&#160;<br/>CNS tumors, congenital&#160;structural abnormalities)&#160;and pre-tx insulin-like&#160;<br/>growth factor-1 (IGF-1) more&#160;than 2 SD below mean, OR&#160;3) pt&#160;is a&#160;<br/>neonate or&#160;was diagnosed with GHD&#160;as a neonate. Turner syndrome: 1)&#160;<br/>Confirmed by karyotyping AND 2) pre-tx ht is&#160;less than the 5th percentile&#160;<br/>for&#160;age. Small&#160;for gestational age&#160;(GA): 1)&#160;Birth&#160;weight (wt) less than&#160;<br/>2500g at GA greater than 37 weeks, OR birth wt or length below&#160;3rd&#160;<br/>percentile for GA or at&#160;least 2 SD below mean for GA, AND&#160;2) did not&#160;<br/>manifest&#160;catch-up growth by age 2.&#160;</p>
<p style="position:absolute;top:681px;left:126px;white-space:nowrap" class="ft1038"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:681px;left:274px;white-space:nowrap" class="ft1030">SGA:&#160;2 years of&#160;age or&#160;older&#160;</p>
<p style="position:absolute;top:720px;left:126px;white-space:nowrap" class="ft1039"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:720px;left:274px;white-space:nowrap" class="ft10310">Endocrinologist,&#160;pediatric endocrinologist, pediatric nephrologist,&#160;<br/>infectious disease specialist, gastroenterologist/nutritional support&#160;<br/>specialist, geneticist.&#160;</p>
<p style="position:absolute;top:800px;left:126px;white-space:nowrap" class="ft1039"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:800px;left:274px;white-space:nowrap" class="ft1030">Plan Year&#160;</p>
<p style="position:absolute;top:859px;left:126px;white-space:nowrap" class="ft1038"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:859px;left:274px;white-space:nowrap" class="ft10310">Adult GHD: Pt&#160;meets any of the following: 1) failed 2 pre-tx&#160;GH&#160;<br/>stimulation tests, OR&#160;2) pre-tx&#160;IGF-1&#160;more&#160;than 2 SD below mean AND&#160;<br/>failed 1 pre-tx GH stimulation test. (Note:&#160;Stimulation tests include: a)&#160;<br/>insulin&#160;tolerance test [ITT] [peak GH less&#160;than or&#160;equal&#160;to 5 ng/ml], or b)&#160;<br/>Macrelin-stimulation test [peak GH level&#160;less than 2.8ng/ml],&#160;or c)&#160;<br/>glucagon-stimulation test [GST] [peak GH&#160;level less than or equal to 3&#160;<br/>ng/ml] for pt with a body&#160;mass index&#160;[BMI] 25-30 kg/m2 and&#160;high pretest&#160;<br/>probability&#160;of GHD&#160;[e.g., acquired structural abnormalities] or BMI&#160;less&#160;<br/>than 25 kg/m2, or d)&#160;GST [peak GH level&#160;less than or equal to 1 ng/ml] in&#160;<br/>pt with BMI&#160;25-30 kg/m2 and low pretest probability of GHD or BMI&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1030">103&#160;</p>
</div>
<!-- Page 104 -->
<a name="104"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page104-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2104.png" alt="background image"/>
<p style="position:absolute;top:127px;left:274px;white-space:nowrap" class="ft10410">greater than&#160;30 kg/m2), OR 3) organic hypothalamic-pituitary disease&#160;<br/>(e.g., suprasellar mass with previous&#160;surgery and&#160;cranial irradiation)&#160;with&#160;<br/>3 or more&#160;pituitary hormone deficiencies AND pre-tx IGF-1&#160;more&#160;than 2&#160;<br/>SD&#160;below mean, OR&#160;4) genetic or structural hypothalamic-pituitary&#160;<br/>defects, OR 5) childhood-onset&#160;GHD with congenital (genetic&#160;or&#160;<br/>structural)&#160;abnormality&#160;of the hypothalamus/pituitary/CNS. Renewal for&#160;<br/>pediatric GHD, TS, SGA, and adult GHD: Patient is experiencing&#160;<br/>improvement.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1040">104&#160;</p>
</div>
<!-- Page 105 -->
<a name="105"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page105-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2105.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1051"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1054"><b>AEGARDA</b></p>
<p style="position:absolute;top:119px;left:253px;white-space:nowrap" class="ft10513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1052"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1055">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1056">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1050">Haegarda&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1052"><b>PA&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1052"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1058"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1050">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1058"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1050">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1059"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1050">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1059"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft10510">The requested&#160;drug is being used for the prevention of&#160;acute angioedema&#160;<br/>attacks. Patient has hereditary angioedema&#160;(HAE) with C1 inhibitor&#160;<br/>deficiency or dysfunction confirmed by laboratory testing OR&#160;patient has&#160;<br/>hereditary angioedema&#160;with normal C1 inhibitor&#160;confirmed&#160;by laboratory&#160;<br/>testing. For&#160;patients with HAE with&#160;normal C1 inhibitor, EITHER 1)&#160;<br/>Patient tested positive for an F12, angiopoietin-1, plasminogen, or&#160;<br/>kininogen-1&#160;(KNG1) gene mutation&#160;OR&#160;2) Patient has a&#160;family history of&#160;<br/>angioedema and the angioedema was&#160;refractory to a trial of an&#160;<br/>antihistamine for at least one month.&#160;</p>
<p style="position:absolute;top:660px;left:126px;white-space:nowrap" class="ft1058"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:660px;left:274px;white-space:nowrap" class="ft1050">N/A&#160;</p>
<p style="position:absolute;top:698px;left:126px;white-space:nowrap" class="ft1059"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:698px;left:274px;white-space:nowrap" class="ft1050">Immunologist,&#160;allergist,&#160;rheumatologist&#160;</p>
<p style="position:absolute;top:758px;left:126px;white-space:nowrap" class="ft1059"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:758px;left:274px;white-space:nowrap" class="ft1050">Plan Year&#160;</p>
<p style="position:absolute;top:817px;left:126px;white-space:nowrap" class="ft1058"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:817px;left:274px;white-space:nowrap" class="ft1050">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1050">105&#160;</p>
</div>
<!-- Page 106 -->
<a name="106"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page106-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2106.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1061"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1064"><b>ARVONI</b></p>
<p style="position:absolute;top:119px;left:229px;white-space:nowrap" class="ft10613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1062"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1065">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1066">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1060">Harvoni&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1062"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1062"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1068"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1060">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1068"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1060">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1069"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1060">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1069"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft10610">For&#160;hepatitis&#160;C virus&#160;(HCV):&#160;Infection confirmed by presence of HCV&#160;<br/>RNA in the&#160;serum prior&#160;to starting treatment. Planned treatment regimen,&#160;<br/>genotype, prior treatment history, presence&#160;or absence of&#160;cirrhosis&#160;<br/>(compensated or decompensated&#160;[Child Turcotte&#160;Pugh&#160;class&#160;B or C]),&#160;<br/>presence or&#160;absence of human immunodeficiency virus (HIV) coinfection,&#160;<br/>presence or&#160;absence of resistance-associated substitutions where&#160;<br/>applicable,&#160;liver and kidney transplantation status if&#160;applicable. Coverage&#160;<br/>conditions&#160;and specific durations of approval&#160;will&#160;be based on&#160;current&#160;<br/>AASLD treatment guidelines.&#160;</p>
<p style="position:absolute;top:660px;left:126px;white-space:nowrap" class="ft1068"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:660px;left:274px;white-space:nowrap" class="ft1060">N/A&#160;</p>
<p style="position:absolute;top:698px;left:126px;white-space:nowrap" class="ft1069"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:698px;left:274px;white-space:nowrap" class="ft1060">N/A&#160;</p>
<p style="position:absolute;top:758px;left:126px;white-space:nowrap" class="ft1069"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:758px;left:274px;white-space:nowrap" class="ft10610">Criteria applied&#160;consistent w/ current AASLD-IDSA&#160;guidance. Reminder&#160;<br/>for&#160;8wk option if appropriate.&#160;</p>
<p style="position:absolute;top:817px;left:126px;white-space:nowrap" class="ft1068"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:817px;left:274px;white-space:nowrap" class="ft1060">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1060">106&#160;</p>
</div>
<!-- Page 107 -->
<a name="107"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page107-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2107.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1071"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1074"><b>ERCEPTIN&#160;</b></p>
<p style="position:absolute;top:118px;left:261px;white-space:nowrap" class="ft1071"><b>H</b></p>
<p style="position:absolute;top:123px;left:285px;white-space:nowrap" class="ft1074"><b>YLECTA</b></p>
<p style="position:absolute;top:119px;left:385px;white-space:nowrap" class="ft10713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1072"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1075">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1076">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1070">Herceptin Hylecta&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1072"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1072"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1078"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1070">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1078"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft10710">Neoadjuvant&#160;treatment&#160;for human epidermal growth factor&#160;receptor&#160;2&#160;<br/>(HER2)-positive breast cancer,&#160;recurrent or&#160;advanced unresectable HER2-<br/>positive breast&#160;cancer.&#160;</p>
<p style="position:absolute;top:437px;left:126px;white-space:nowrap" class="ft1079"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:437px;left:274px;white-space:nowrap" class="ft1070">N/A&#160;</p>
<p style="position:absolute;top:497px;left:126px;white-space:nowrap" class="ft1079"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:497px;left:274px;white-space:nowrap" class="ft1070">N/A&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft1078"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft1070">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft1079"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft1070">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft1079"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft1070">Neoadjuvant&#160;therapy&#160;for&#160;breast&#160;cancer: 6 months, Other: Plan&#160;Year.&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft1078"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft10710">Coverage&#160;under&#160;Part&#160;D will be denied&#160;if&#160;coverage&#160;is available under Part&#160;<br/>A or Part&#160;B as the&#160;medication&#160;is prescribed&#160;and dispensed or&#160;administered&#160;<br/>for&#160;the individual.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1070">107&#160;</p>
</div>
<!-- Page 108 -->
<a name="108"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page108-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2108.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1081"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1084"><b>ETLIOZ</b></p>
<p style="position:absolute;top:119px;left:223px;white-space:nowrap" class="ft10813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1082"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1085">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1086">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1080">Hetlioz&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1082"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1082"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1088"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1080">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1088"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1080">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1089"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1080">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1089"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft10810">For Non-24-Hour&#160;Sleep-Wake&#160;Disorder: 1)&#160;for&#160;initial therapy&#160;and&#160;<br/>continuation&#160;of therapy:&#160;a)&#160;diagnosis&#160;of total blindness in both eyes (e.g.,&#160;<br/>nonfunctioning retinas)&#160;and b) unable to perceive&#160;light&#160;in either eye, AND&#160;<br/>2) if currently on therapy&#160;with the&#160;requested drug,&#160;patient must meet at&#160;<br/>least one of&#160;the following: a)&#160;increased total nighttime sleep or b)&#160;<br/>decreased daytime nap&#160;duration. For nighttime sleep disturbances&#160;in&#160;<br/>Smith-Magenis Syndrome (SMS): 1)&#160;for&#160;initial&#160;therapy and continuation&#160;<br/>therapy,&#160;the patient has&#160;a&#160;confirmed diagnosis of&#160;SMS AND&#160;2) if&#160;<br/>currently on&#160;therapy with&#160;the requested drug, the patient experiences&#160;<br/>improvement in the quality of&#160;sleep since starting&#160;therapy.&#160;</p>
<p style="position:absolute;top:680px;left:126px;white-space:nowrap" class="ft1088"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:680px;left:274px;white-space:nowrap" class="ft1080">Non-24:&#160;18 years of&#160;age&#160;or older. SMS: 16 years&#160;of age or&#160;older&#160;</p>
<p style="position:absolute;top:719px;left:126px;white-space:nowrap" class="ft1089"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:719px;left:274px;white-space:nowrap" class="ft1080">Sleep disorder&#160;specialist&#160;or neurologist&#160;</p>
<p style="position:absolute;top:778px;left:126px;white-space:nowrap" class="ft1089"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:778px;left:274px;white-space:nowrap" class="ft1080">Initiation:&#160;6&#160;Months, Renewal:&#160;Plan&#160;Year&#160;</p>
<p style="position:absolute;top:838px;left:126px;white-space:nowrap" class="ft1088"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:838px;left:274px;white-space:nowrap" class="ft1080">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1080">108&#160;</p>
</div>
<!-- Page 109 -->
<a name="109"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page109-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2109.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1091"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1094"><b>ETLIOZ&#160;</b></p>
<p style="position:absolute;top:118px;left:230px;white-space:nowrap" class="ft1091"><b>L</b></p>
<p style="position:absolute;top:123px;left:250px;white-space:nowrap" class="ft1094"><b>Q</b></p>
<p style="position:absolute;top:119px;left:268px;white-space:nowrap" class="ft10913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1092"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1095">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1096">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1090">Hetlioz Lq&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1092"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1092"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1098"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1090">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1098"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1090">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1099"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1090">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1099"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft10910">For&#160;nighttime&#160;sleep disturbances in Smith-Magenis Syndrome (SMS):&#160;1)&#160;<br/>for&#160;initial&#160;therapy and continuation therapy, the patient has&#160;a&#160;confirmed&#160;<br/>diagnosis of&#160;SMS AND&#160;2) if currently on therapy&#160;with the&#160;requested drug,&#160;<br/>the patient&#160;experiences improvement in the&#160;quality of sleep&#160;since starting&#160;<br/>therapy.&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft1098"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft1090">3 to&#160;15 years of age&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft1099"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft1090">Sleep disorder&#160;specialist&#160;or neurologist&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft1099"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft1090">Initiation:&#160;6&#160;Months, Renewal:&#160;Plan&#160;Year.&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft1098"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft1090">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1090">109&#160;</p>
</div>
<!-- Page 110 -->
<a name="110"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page110-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2110.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1101"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1104"><b>IGH&#160;</b></p>
<p style="position:absolute;top:118px;left:184px;white-space:nowrap" class="ft1101"><b>R</b></p>
<p style="position:absolute;top:123px;left:206px;white-space:nowrap" class="ft1104"><b>ISK&#160;</b></p>
<p style="position:absolute;top:118px;left:253px;white-space:nowrap" class="ft1101"><b>M</b></p>
<p style="position:absolute;top:123px;left:281px;white-space:nowrap" class="ft1104"><b>EDICATION&#160;</b></p>
<p style="position:absolute;top:118px;left:426px;white-space:nowrap" class="ft1101"><b>-&#160;65</b></p>
<p style="position:absolute;top:113px;left:472px;white-space:nowrap" class="ft11014">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1102"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1105">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1106">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1100">Chlordiazepoxide/amitriptyline&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft1105">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft1106">&#160;&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft1100">Dicyclomine Hcl&#160;SOLN&#160;</p>
<p style="position:absolute;top:242px;left:122px;white-space:nowrap" class="ft1105">•</p>
<p style="position:absolute;top:241px;left:130px;white-space:nowrap" class="ft1106">&#160;&#160;</p>
<p style="position:absolute;top:244px;left:149px;white-space:nowrap" class="ft1100">Dicyclomine&#160;Hydrochloride&#160;CAPS&#160;</p>
<p style="position:absolute;top:264px;left:122px;white-space:nowrap" class="ft1105">•</p>
<p style="position:absolute;top:263px;left:130px;white-space:nowrap" class="ft1106">&#160;&#160;</p>
<p style="position:absolute;top:266px;left:149px;white-space:nowrap" class="ft1100">Dicyclomine Hydrochloride&#160;INJ&#160;</p>
<p style="position:absolute;top:286px;left:122px;white-space:nowrap" class="ft1105">•</p>
<p style="position:absolute;top:285px;left:130px;white-space:nowrap" class="ft1106">&#160;&#160;</p>
<p style="position:absolute;top:288px;left:149px;white-space:nowrap" class="ft1100">Dicyclomine Hydrochloride&#160;TABS&#160;</p>
<p style="position:absolute;top:308px;left:122px;white-space:nowrap" class="ft1105">•</p>
<p style="position:absolute;top:307px;left:130px;white-space:nowrap" class="ft1106">&#160;&#160;</p>
<p style="position:absolute;top:310px;left:149px;white-space:nowrap" class="ft1100">Dihydroergotamine Mesylate&#160;INJ&#160;</p>
<p style="position:absolute;top:330px;left:122px;white-space:nowrap" class="ft1105">•</p>
<p style="position:absolute;top:329px;left:130px;white-space:nowrap" class="ft1106">&#160;&#160;</p>
<p style="position:absolute;top:332px;left:149px;white-space:nowrap" class="ft1100">Diphenhydramine&#160;Hcl&#160;INJ 50MG/ML&#160;</p>
<p style="position:absolute;top:352px;left:122px;white-space:nowrap" class="ft1105">•</p>
<p style="position:absolute;top:351px;left:130px;white-space:nowrap" class="ft1106">&#160;&#160;</p>
<p style="position:absolute;top:354px;left:149px;white-space:nowrap" class="ft1100">Dipyridamole&#160;TABS&#160;</p>
<p style="position:absolute;top:374px;left:122px;white-space:nowrap" class="ft1105">•</p>
<p style="position:absolute;top:373px;left:130px;white-space:nowrap" class="ft1106">&#160;&#160;</p>
<p style="position:absolute;top:376px;left:149px;white-space:nowrap" class="ft1100">Disopyramide Phosphate&#160;CAPS&#160;</p>
<p style="position:absolute;top:396px;left:122px;white-space:nowrap" class="ft1105">•</p>
<p style="position:absolute;top:395px;left:130px;white-space:nowrap" class="ft1106">&#160;&#160;</p>
<p style="position:absolute;top:398px;left:149px;white-space:nowrap" class="ft11010">Guanfacine Er&#160;TB24 1MG, 2MG,&#160;<br/>4MG&#160;</p>
<p style="position:absolute;top:438px;left:122px;white-space:nowrap" class="ft1105">•</p>
<p style="position:absolute;top:438px;left:130px;white-space:nowrap" class="ft1106">&#160;&#160;</p>
<p style="position:absolute;top:440px;left:149px;white-space:nowrap" class="ft1100">Guanfacine Hcl&#160;</p>
<p style="position:absolute;top:460px;left:122px;white-space:nowrap" class="ft1105">•</p>
<p style="position:absolute;top:459px;left:130px;white-space:nowrap" class="ft1106">&#160;&#160;</p>
<p style="position:absolute;top:462px;left:149px;white-space:nowrap" class="ft11010">Guanfacine Hydrochloride&#160;TB24&#160;<br/>3MG&#160;</p>
<p style="position:absolute;top:503px;left:122px;white-space:nowrap" class="ft1105">•</p>
<p style="position:absolute;top:502px;left:130px;white-space:nowrap" class="ft1106">&#160;&#160;</p>
<p style="position:absolute;top:505px;left:149px;white-space:nowrap" class="ft11010">Ketorolac Tromethamine&#160;INJ&#160;<br/>15MG/ML, 30MG/ML&#160;</p>
<p style="position:absolute;top:546px;left:122px;white-space:nowrap" class="ft1105">•</p>
<p style="position:absolute;top:545px;left:130px;white-space:nowrap" class="ft1106">&#160;&#160;</p>
<p style="position:absolute;top:548px;left:149px;white-space:nowrap" class="ft1100">Ketorolac Tromethamine&#160;TABS&#160;</p>
<p style="position:absolute;top:568px;left:122px;white-space:nowrap" class="ft1105">•</p>
<p style="position:absolute;top:567px;left:130px;white-space:nowrap" class="ft1106">&#160;&#160;</p>
<p style="position:absolute;top:570px;left:149px;white-space:nowrap" class="ft1100">Meprobamate&#160;</p>
<p style="position:absolute;top:590px;left:122px;white-space:nowrap" class="ft1105">•</p>
<p style="position:absolute;top:589px;left:130px;white-space:nowrap" class="ft1106">&#160;&#160;</p>
<p style="position:absolute;top:592px;left:149px;white-space:nowrap" class="ft1100">Methscopolamine&#160;Bromide&#160;TABS&#160;</p>
<p style="position:absolute;top:612px;left:122px;white-space:nowrap" class="ft1105">•</p>
<p style="position:absolute;top:611px;left:130px;white-space:nowrap" class="ft1106">&#160;&#160;</p>
<p style="position:absolute;top:614px;left:149px;white-space:nowrap" class="ft1100">Methyldopa&#160;TABS&#160;250MG, 500MG&#160;</p>
<p style="position:absolute;top:634px;left:122px;white-space:nowrap" class="ft1105">•</p>
<p style="position:absolute;top:633px;left:130px;white-space:nowrap" class="ft1106">&#160;&#160;</p>
<p style="position:absolute;top:636px;left:149px;white-space:nowrap" class="ft1100">Perphenazine/amitriptyline&#160;</p>
<p style="position:absolute;top:656px;left:122px;white-space:nowrap" class="ft1105">•</p>
<p style="position:absolute;top:655px;left:130px;white-space:nowrap" class="ft1106">&#160;&#160;</p>
<p style="position:absolute;top:658px;left:149px;white-space:nowrap" class="ft11010">Thioridazine Hcl&#160;TABS&#160;100MG,&#160;<br/>10MG, 25MG, 50MG&#160;</p>
<p style="position:absolute;top:698px;left:122px;white-space:nowrap" class="ft1105">•</p>
<p style="position:absolute;top:698px;left:130px;white-space:nowrap" class="ft1106">&#160;&#160;</p>
<p style="position:absolute;top:700px;left:149px;white-space:nowrap" class="ft1100">Trimethobenzamide Hydrochloride&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1100">110&#160;</p>
</div>
<!-- Page 111 -->
<a name="111"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page111-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2111.png" alt="background image"/>
<p style="position:absolute;top:132px;left:126px;white-space:nowrap" class="ft1112"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:132px;left:274px;white-space:nowrap" class="ft1112"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:174px;left:126px;white-space:nowrap" class="ft1118"><b>Indications&#160;</b></p>
<p style="position:absolute;top:174px;left:274px;white-space:nowrap" class="ft1110">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:213px;left:126px;white-space:nowrap" class="ft1118"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:213px;left:274px;white-space:nowrap" class="ft1110">N/A&#160;</p>
<p style="position:absolute;top:252px;left:126px;white-space:nowrap" class="ft1119"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:252px;left:274px;white-space:nowrap" class="ft1110">N/A&#160;</p>
<p style="position:absolute;top:311px;left:126px;white-space:nowrap" class="ft1119"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:311px;left:274px;white-space:nowrap" class="ft1110">N/A&#160;</p>
<p style="position:absolute;top:391px;left:126px;white-space:nowrap" class="ft1118"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:391px;left:274px;white-space:nowrap" class="ft1110">N/A&#160;</p>
<p style="position:absolute;top:430px;left:126px;white-space:nowrap" class="ft1119"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:430px;left:274px;white-space:nowrap" class="ft1110">N/A&#160;</p>
<p style="position:absolute;top:489px;left:126px;white-space:nowrap" class="ft1119"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:489px;left:274px;white-space:nowrap" class="ft1110">Plan Year&#160;</p>
<p style="position:absolute;top:548px;left:126px;white-space:nowrap" class="ft1118"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:548px;left:274px;white-space:nowrap" class="ft11110">This Prior&#160;Authorization&#160;requirement&#160;only applies&#160;to patients 65 years of&#160;<br/>age or&#160;older. (The American Geriatrics Society identifies&#160;the use of this&#160;<br/>medication&#160;as potentially inappropriate&#160;in older&#160;adults,&#160;meaning&#160;it&#160;is best&#160;<br/>avoided, prescribed at&#160;reduced dosage, or&#160;used with caution or carefully&#160;<br/>monitored.)&#160;<br/>Prescriber must acknowledge that the&#160;benefit of&#160;therapy with&#160;this&#160;<br/>prescribed&#160;medication&#160;outweighs&#160;the potential&#160;risks&#160;for&#160;this patient.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1110">111&#160;</p>
</div>
<!-- Page 112 -->
<a name="112"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page112-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2112.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1121"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1124"><b>RM&#160;</b></p>
<p style="position:absolute;top:118px;left:177px;white-space:nowrap" class="ft1121"><b>-&#160;A</b></p>
<p style="position:absolute;top:123px;left:215px;white-space:nowrap" class="ft1124"><b>NTICONVULSANTS&#160;</b></p>
<p style="position:absolute;top:118px;left:445px;white-space:nowrap" class="ft1121"><b>-&#160;65</b></p>
<p style="position:absolute;top:113px;left:491px;white-space:nowrap" class="ft11214">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1122"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1125">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1126">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1120">Phenobarbital&#160;ELIX 20MG/5ML&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft1125">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft1126">&#160;&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft11210">Phenobarbital&#160;TABS&#160;100MG, 15MG,&#160;<br/>16.2MG, 30MG, 32.4MG, 60MG,&#160;<br/>64.8MG, 97.2MG&#160;</p>
<p style="position:absolute;top:283px;left:122px;white-space:nowrap" class="ft1125">•</p>
<p style="position:absolute;top:282px;left:130px;white-space:nowrap" class="ft1126">&#160;&#160;</p>
<p style="position:absolute;top:285px;left:149px;white-space:nowrap" class="ft1120">Phenobarbital Sodium&#160;INJ&#160;</p>
<p style="position:absolute;top:282px;left:344px;white-space:nowrap" class="ft1126"></p>
<p style="position:absolute;top:306px;left:149px;white-space:nowrap" class="ft1120">130MG/ML, 65MG/ML</p>
<p style="position:absolute;top:303px;left:325px;white-space:nowrap" class="ft1126">&#160;</p>
<p style="position:absolute;top:383px;left:126px;white-space:nowrap" class="ft1122"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:383px;left:274px;white-space:nowrap" class="ft1122"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:425px;left:126px;white-space:nowrap" class="ft1128"><b>Indications&#160;</b></p>
<p style="position:absolute;top:425px;left:274px;white-space:nowrap" class="ft1120">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:463px;left:126px;white-space:nowrap" class="ft1128"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:463px;left:274px;white-space:nowrap" class="ft1120">Epilepsy&#160;</p>
<p style="position:absolute;top:502px;left:126px;white-space:nowrap" class="ft1129"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:502px;left:274px;white-space:nowrap" class="ft1120">N/A&#160;</p>
<p style="position:absolute;top:561px;left:126px;white-space:nowrap" class="ft1129"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:561px;left:274px;white-space:nowrap" class="ft1120">N/A&#160;</p>
<p style="position:absolute;top:642px;left:126px;white-space:nowrap" class="ft1128"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:642px;left:274px;white-space:nowrap" class="ft1120">N/A&#160;</p>
<p style="position:absolute;top:680px;left:126px;white-space:nowrap" class="ft1129"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:680px;left:274px;white-space:nowrap" class="ft1120">N/A&#160;</p>
<p style="position:absolute;top:740px;left:126px;white-space:nowrap" class="ft1129"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:740px;left:274px;white-space:nowrap" class="ft1120">Plan Year&#160;</p>
<p style="position:absolute;top:799px;left:126px;white-space:nowrap" class="ft1128"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:799px;left:274px;white-space:nowrap" class="ft11210">This Prior&#160;Authorization&#160;requirement&#160;only applies&#160;to patients 65 years of&#160;<br/>age or&#160;older. (The American Geriatrics Society identifies&#160;the use of this&#160;<br/>medication&#160;as potentially inappropriate&#160;in older&#160;adults,&#160;meaning it&#160;is best&#160;<br/>avoided, prescribed at&#160;reduced dosage, or&#160;used with caution or carefully&#160;<br/>monitored.)&#160;<br/>Prescriber must acknowledge that the&#160;benefit of&#160;therapy with&#160;this&#160;<br/>prescribed&#160;medication&#160;outweighs&#160;the potential&#160;risks&#160;for&#160;this patient.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1120">112&#160;</p>
</div>
<!-- Page 113 -->
<a name="113"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page113-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2113.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1131"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1134"><b>RM&#160;</b></p>
<p style="position:absolute;top:118px;left:177px;white-space:nowrap" class="ft1131"><b>-&#160;H</b></p>
<p style="position:absolute;top:123px;left:217px;white-space:nowrap" class="ft1134"><b>YPNOTICS&#160;</b></p>
<p style="position:absolute;top:118px;left:347px;white-space:nowrap" class="ft1131"><b>-&#160;65</b></p>
<p style="position:absolute;top:113px;left:393px;white-space:nowrap" class="ft11314">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1132"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1135">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1136">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1130">Eszopiclone&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft1135">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft1136">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft1130">Zaleplon&#160;</p>
<p style="position:absolute;top:242px;left:122px;white-space:nowrap" class="ft1135">•</p>
<p style="position:absolute;top:241px;left:130px;white-space:nowrap" class="ft1136">&#160;</p>
<p style="position:absolute;top:244px;left:149px;white-space:nowrap" class="ft1130">Zolpidem Tartrate&#160;TABS&#160;</p>
<p style="position:absolute;top:321px;left:126px;white-space:nowrap" class="ft1132"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:321px;left:274px;white-space:nowrap" class="ft1132"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:363px;left:126px;white-space:nowrap" class="ft1138"><b>Indications&#160;</b></p>
<p style="position:absolute;top:363px;left:274px;white-space:nowrap" class="ft1130">All FDA-approved&#160;Indications.&#160;</p>
<p style="position:absolute;top:401px;left:126px;white-space:nowrap" class="ft1138"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:401px;left:274px;white-space:nowrap" class="ft1130">N/A&#160;</p>
<p style="position:absolute;top:440px;left:126px;white-space:nowrap" class="ft1139"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:440px;left:274px;white-space:nowrap" class="ft1130">N/A&#160;</p>
<p style="position:absolute;top:499px;left:126px;white-space:nowrap" class="ft1139"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:499px;left:274px;white-space:nowrap" class="ft11310">1)&#160;The patient has&#160;a contraindication&#160;to the non-HRM (non-High Risk&#160;<br/>Medication) alternative&#160;drug doxepin (3 mg or 6&#160;mg)&#160;OR&#160;2) The non-<br/>HRM (non-High Risk Medication)&#160;alternative&#160;drug doxepin (3 mg or 6&#160;<br/>mg)&#160;has been tried AND 3)&#160;The patient experienced an inadequate&#160;<br/>treatment response&#160;OR&#160;intolerance to the non-HRM (non-High Risk&#160;<br/>Medication) alternative&#160;drug doxepin (3 mg or 6&#160;mg)&#160;AND 4) If&#160;the&#160;<br/>patient is using two or more&#160;additional central nervous system (CNS)&#160;<br/>active medications&#160;(e.g.,&#160;lorazepam,&#160;quetiapine, sertraline, clonazepam,&#160;<br/>escitalopram, alprazolam) with the requested drug, the prescriber has&#160;<br/>determined&#160;that taking multiple central nervous&#160;system&#160;(CNS) active&#160;<br/>medications&#160;is medically necessary for the patient&#160;[Note: Use of multiple&#160;<br/>central nervous system&#160;(CNS) active&#160;medications&#160;in older adults is&#160;<br/>associated with an&#160;increased risk of falls.].&#160;</p>
<p style="position:absolute;top:786px;left:126px;white-space:nowrap" class="ft1138"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:786px;left:274px;white-space:nowrap" class="ft1130">N/A&#160;</p>
<p style="position:absolute;top:825px;left:126px;white-space:nowrap" class="ft1139"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:825px;left:274px;white-space:nowrap" class="ft1130">N/A&#160;</p>
<p style="position:absolute;top:885px;left:126px;white-space:nowrap" class="ft1139"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:885px;left:274px;white-space:nowrap" class="ft1130">Plan Year&#160;</p>
<p style="position:absolute;top:944px;left:126px;white-space:nowrap" class="ft1138"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:944px;left:274px;white-space:nowrap" class="ft11310">This Prior&#160;Authorization&#160;requirement&#160;only applies&#160;to patients 65 years of&#160;<br/>age or&#160;older. (The American Geriatrics Society identifies&#160;the use of this&#160;<br/>medication&#160;as potentially inappropriate&#160;in older&#160;adults,&#160;meaning it&#160;is best&#160;<br/>avoided, prescribed at&#160;reduced dosage, or&#160;used with caution or carefully&#160;<br/>monitored.) Prescriber must acknowledge that the&#160;benefit of&#160;therapy with&#160;<br/>this prescribed medication outweighs the potential risks for this patient.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1130">113&#160;</p>
</div>
<!-- Page 114 -->
<a name="114"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page114-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2114.png" alt="background image"/>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1140">114</p>
<p style="position:absolute;top:1093px;left:810px;white-space:nowrap" class="ft1146">&#160;</p>
</div>
<!-- Page 115 -->
<a name="115"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page115-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2115.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1151"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1154"><b>RM&#160;</b></p>
<p style="position:absolute;top:118px;left:177px;white-space:nowrap" class="ft1151"><b>-&#160;S</b></p>
<p style="position:absolute;top:123px;left:210px;white-space:nowrap" class="ft1154"><b>COPOLAMINE&#160;</b></p>
<p style="position:absolute;top:118px;left:384px;white-space:nowrap" class="ft1151"><b>-&#160;65</b></p>
<p style="position:absolute;top:113px;left:430px;white-space:nowrap" class="ft11514">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1152"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1155">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1156">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1150">Scopolamine&#160;PT72 1MG/3DAYS&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1152"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1152"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1158"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1150">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1158"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1150">Excessive salivation&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1159"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1150">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1159"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft1150">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft1158"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft1150">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft1159"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft1150">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft1159"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft1150">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft1158"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft11510">This Prior&#160;Authorization&#160;requirement&#160;only applies&#160;to patients 65 years of&#160;<br/>age or&#160;older. (The American Geriatrics Society identifies&#160;the use of this&#160;<br/>medication&#160;as potentially inappropriate&#160;in older&#160;adults,&#160;meaning it&#160;is best&#160;<br/>avoided, prescribed at&#160;reduced dosage, or&#160;used with caution or carefully&#160;<br/>monitored.)&#160;<br/>Prescriber must acknowledge that the&#160;benefit of&#160;therapy with&#160;this&#160;<br/>prescribed&#160;medication&#160;outweighs&#160;the potential&#160;risks&#160;for&#160;this patient.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1150">115&#160;</p>
</div>
<!-- Page 116 -->
<a name="116"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page116-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2116.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1161"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1164"><b>RM</b></p>
<p style="position:absolute;top:118px;left:171px;white-space:nowrap" class="ft1161"><b>-</b></p>
<p style="position:absolute;top:123px;left:181px;white-space:nowrap" class="ft1164"><b>ANTIPARKINSON&#160;</b></p>
<p style="position:absolute;top:118px;left:391px;white-space:nowrap" class="ft1161"><b>-&#160;65</b></p>
<p style="position:absolute;top:113px;left:437px;white-space:nowrap" class="ft11614">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1162"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1165">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1166">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1160">Benztropine&#160;Mesylate&#160;INJ&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft1165">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft1166">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft1160">Benztropine&#160;Mesylate&#160;TABS&#160;</p>
<p style="position:absolute;top:242px;left:122px;white-space:nowrap" class="ft1165">•</p>
<p style="position:absolute;top:241px;left:130px;white-space:nowrap" class="ft1166">&#160;</p>
<p style="position:absolute;top:244px;left:149px;white-space:nowrap" class="ft1160">Trihexyphenidyl&#160;Hcl&#160;SOLN&#160;</p>
<p style="position:absolute;top:264px;left:122px;white-space:nowrap" class="ft1165">•</p>
<p style="position:absolute;top:263px;left:130px;white-space:nowrap" class="ft1166">&#160;</p>
<p style="position:absolute;top:266px;left:149px;white-space:nowrap" class="ft1160">Trihexyphenidyl&#160;Hydrochloride&#160;</p>
<p style="position:absolute;top:343px;left:126px;white-space:nowrap" class="ft1162"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:343px;left:274px;white-space:nowrap" class="ft1162"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:385px;left:126px;white-space:nowrap" class="ft1168"><b>Indications&#160;</b></p>
<p style="position:absolute;top:385px;left:274px;white-space:nowrap" class="ft1160">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:423px;left:126px;white-space:nowrap" class="ft1168"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:423px;left:274px;white-space:nowrap" class="ft1160">N/A&#160;</p>
<p style="position:absolute;top:462px;left:126px;white-space:nowrap" class="ft1169"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:462px;left:274px;white-space:nowrap" class="ft1160">N/A&#160;</p>
<p style="position:absolute;top:521px;left:126px;white-space:nowrap" class="ft1169"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:521px;left:274px;white-space:nowrap" class="ft11610">EPS&#160;(extrapyramidal&#160;symptoms): 1)&#160;The patient&#160;has not&#160;tried&#160;the non-<br/>HRM alternative drug amantadine AND&#160;2) The&#160;patient has&#160;a&#160;<br/>contraindication to&#160;the non-HRM alternative drug amantadine OR 3) The&#160;<br/>patient has&#160;tried&#160;the non-HRM alternative drug amantadine AND&#160;4) The&#160;<br/>patient experienced an inadequate&#160;treatment response OR intolerance to&#160;<br/>the non-HRM alternative drug amantadine. Parkinson's:&#160;1) The patient has&#160;<br/>tried two of&#160;the following non-HRM alternative drugs: amantadine,&#160;<br/>carbidopa/levodopa, pramipexole, or ropinirole. AND&#160;2) The&#160;patient&#160;<br/>experienced&#160;an inadequate treatment response OR intolerance to two of&#160;<br/>the following non-HRM alternative drugs: amantadine,&#160;<br/>carbidopa/levodopa, pramipexole, or ropinirole.&#160;</p>
<p style="position:absolute;top:767px;left:126px;white-space:nowrap" class="ft1168"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:767px;left:274px;white-space:nowrap" class="ft1160">N/A&#160;</p>
<p style="position:absolute;top:806px;left:126px;white-space:nowrap" class="ft1169"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:806px;left:274px;white-space:nowrap" class="ft1160">N/A&#160;</p>
<p style="position:absolute;top:865px;left:126px;white-space:nowrap" class="ft1169"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:865px;left:274px;white-space:nowrap" class="ft1160">Plan Year&#160;</p>
<p style="position:absolute;top:925px;left:126px;white-space:nowrap" class="ft1168"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:925px;left:274px;white-space:nowrap" class="ft11610">This Prior&#160;Authorization&#160;requirement&#160;only applies&#160;to patients 65 years of&#160;<br/>age or&#160;older. (The American Geriatrics Society identifies&#160;the use of this&#160;<br/>medication&#160;as potentially inappropriate&#160;in older&#160;adults,&#160;meaning&#160;it&#160;is best&#160;<br/>avoided, prescribed at&#160;reduced dosage, or&#160;used with caution or carefully&#160;<br/>monitored.)&#160;<br/>Prescriber must acknowledge that the&#160;benefit of&#160;therapy with&#160;this&#160;<br/>prescribed&#160;medication&#160;outweighs&#160;the potential&#160;risks&#160;for&#160;this patient.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1160">116&#160;</p>
</div>
<!-- Page 117 -->
<a name="117"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page117-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2117.png" alt="background image"/>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1170">117</p>
<p style="position:absolute;top:1093px;left:810px;white-space:nowrap" class="ft1176">&#160;</p>
</div>
<!-- Page 118 -->
<a name="118"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page118-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2118.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1181"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1184"><b>RM</b></p>
<p style="position:absolute;top:118px;left:171px;white-space:nowrap" class="ft1181"><b>-</b></p>
<p style="position:absolute;top:123px;left:181px;white-space:nowrap" class="ft1184"><b>CYPROHEPTADINE&#160;</b></p>
<p style="position:absolute;top:118px;left:415px;white-space:nowrap" class="ft1181"><b>-&#160;65</b></p>
<p style="position:absolute;top:113px;left:461px;white-space:nowrap" class="ft11814">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1182"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1185">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1186">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1180">Cyproheptadine Hcl&#160;SYRP&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft1185">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft1186">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft1180">Cyproheptadine Hydrochloride&#160;TABS&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft1182"><b>PA&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft1182"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft1188"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft1180">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft1188"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft1180">Pruritus,&#160;spasticity due&#160;to&#160;spinal cord injury&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft1189"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft1180">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft1189"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft11810">For rhinitis:&#160;1) The patient has&#160;tried&#160;two of the following non-HRM&#160;<br/>alternative drugs: levocetirizine, azelastine nasal,&#160;fluticasone&#160;nasal, or&#160;<br/>flunisolide nasal&#160;AND 2) The patient&#160;experienced&#160;an inadequate treatment&#160;<br/>response OR intolerance to two of&#160;the following non-HRM alternative&#160;<br/>drugs: levocetirizine, azelastine nasal, fluticasone&#160;nasal, or&#160;flunisolide&#160;<br/>nasal.&#160;</p>
<p style="position:absolute;top:620px;left:126px;white-space:nowrap" class="ft1188"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:620px;left:274px;white-space:nowrap" class="ft1180">N/A&#160;</p>
<p style="position:absolute;top:658px;left:126px;white-space:nowrap" class="ft1189"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:658px;left:274px;white-space:nowrap" class="ft1180">N/A&#160;</p>
<p style="position:absolute;top:718px;left:126px;white-space:nowrap" class="ft1189"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:718px;left:274px;white-space:nowrap" class="ft1180">Plan Year&#160;</p>
<p style="position:absolute;top:777px;left:126px;white-space:nowrap" class="ft1188"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:777px;left:274px;white-space:nowrap" class="ft11810">This Prior&#160;Authorization&#160;requirement&#160;only applies&#160;to patients 65 years of&#160;<br/>age or&#160;older. (The American Geriatrics Society identifies&#160;the use of this&#160;<br/>medication&#160;as potentially inappropriate&#160;in older&#160;adults,&#160;meaning it&#160;is best&#160;<br/>avoided, prescribed at&#160;reduced dosage, or&#160;used with caution or carefully&#160;<br/>monitored.)&#160;<br/>The prescriber&#160;must acknowledge that the benefit&#160;of therapy with this&#160;<br/>prescribed&#160;medication&#160;outweighs&#160;the potential&#160;risks&#160;for&#160;this patient.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1180">118&#160;</p>
</div>
<!-- Page 119 -->
<a name="119"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page119-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2119.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1191"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1194"><b>RM</b></p>
<p style="position:absolute;top:118px;left:171px;white-space:nowrap" class="ft1191"><b>-</b></p>
<p style="position:absolute;top:123px;left:181px;white-space:nowrap" class="ft1194"><b>DOXEPIN&#160;</b></p>
<p style="position:absolute;top:118px;left:298px;white-space:nowrap" class="ft1191"><b>-&#160;65</b></p>
<p style="position:absolute;top:113px;left:344px;white-space:nowrap" class="ft11914">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1192"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1195">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1196">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1190">Doxepin Hcl&#160;CAPS 150MG, 75MG&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft1195">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft1196">&#160;&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft1190">Doxepin Hcl&#160;CONC&#160;</p>
<p style="position:absolute;top:242px;left:122px;white-space:nowrap" class="ft1195">•</p>
<p style="position:absolute;top:241px;left:130px;white-space:nowrap" class="ft1196">&#160;&#160;</p>
<p style="position:absolute;top:244px;left:149px;white-space:nowrap" class="ft1190">Doxepin Hydrochloride&#160;CAPS&#160;</p>
<p style="position:absolute;top:241px;left:374px;white-space:nowrap" class="ft1196"></p>
<p style="position:absolute;top:264px;left:149px;white-space:nowrap" class="ft1190">100MG, 10MG, 25MG, 50MG</p>
<p style="position:absolute;top:262px;left:372px;white-space:nowrap" class="ft1196">&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1190">119&#160;</p>
</div>
<!-- Page 120 -->
<a name="120"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page120-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2120.png" alt="background image"/>
<p style="position:absolute;top:132px;left:126px;white-space:nowrap" class="ft1202"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:132px;left:274px;white-space:nowrap" class="ft1202"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:174px;left:126px;white-space:nowrap" class="ft1208"><b>Indications&#160;</b></p>
<p style="position:absolute;top:174px;left:274px;white-space:nowrap" class="ft1200">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:213px;left:126px;white-space:nowrap" class="ft1208"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:213px;left:274px;white-space:nowrap" class="ft1200">N/A&#160;</p>
<p style="position:absolute;top:252px;left:126px;white-space:nowrap" class="ft1209"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:252px;left:274px;white-space:nowrap" class="ft1200">N/A&#160;</p>
<p style="position:absolute;top:311px;left:126px;white-space:nowrap" class="ft1209"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:311px;left:274px;white-space:nowrap" class="ft12010">For depression: 1)&#160;The patient tried&#160;two of the following alternative&#160;drugs:&#160;<br/>SSRIs&#160;(selective serotonin&#160;reuptake inhibitors), SNRIs&#160;(serotonin-<br/>norepinephrine reuptake&#160;inhibitors), bupropion,&#160;mirtazapine, or trazodone&#160;<br/>AND 2) The&#160;patient experienced an inadequate&#160;treatment response OR&#160;<br/>intolerance to two of the following&#160;alternative drugs: SSRIs&#160;(selective&#160;<br/>serotonin reuptake&#160;inhibitors), SNRIs (serotonin-norepinephrine reuptake&#160;<br/>inhibitors), bupropion,&#160;mirtazapine, or trazodone. For anxiety: 1)&#160;The&#160;<br/>patient has&#160;tried&#160;two of the following alternative&#160;drugs: buspirone,&#160;<br/>duloxetine,&#160;escitalopram, sertraline, or venlafaxine extended-release&#160;AND&#160;<br/>2) The patient experienced an inadequate&#160;treatment response&#160;OR&#160;<br/>intolerance to two of the following&#160;alternative drugs: buspirone,&#160;<br/>duloxetine,&#160;escitalopram, sertraline, or venlafaxine extended-release.&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft1208"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft1200">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft1209"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft1200">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft1209"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft1200">Plan Year&#160;</p>
<p style="position:absolute;top:735px;left:126px;white-space:nowrap" class="ft1208"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:735px;left:274px;white-space:nowrap" class="ft12010">This Prior&#160;Authorization&#160;requirement&#160;only applies&#160;to patients 65 years of&#160;<br/>age or&#160;older. (The American Geriatrics Society identifies&#160;the use of this&#160;<br/>medication&#160;as potentially inappropriate&#160;in older&#160;adults,&#160;meaning it&#160;is best&#160;<br/>avoided, prescribed at&#160;reduced dosage, or&#160;used with caution or carefully&#160;<br/>monitored.)&#160;<br/>Prescriber must acknowledge that the&#160;benefit of&#160;therapy with&#160;this&#160;<br/>prescribed&#160;medication&#160;outweighs&#160;the potential&#160;risks&#160;for&#160;this patient.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1200">120&#160;</p>
</div>
<!-- Page 121 -->
<a name="121"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page121-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2121.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1211"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1214"><b>RM</b></p>
<p style="position:absolute;top:118px;left:171px;white-space:nowrap" class="ft1211"><b>-</b></p>
<p style="position:absolute;top:123px;left:181px;white-space:nowrap" class="ft1214"><b>HYDROXYZINE&#160;</b></p>
<p style="position:absolute;top:118px;left:370px;white-space:nowrap" class="ft1211"><b>-&#160;65</b></p>
<p style="position:absolute;top:113px;left:416px;white-space:nowrap" class="ft12114">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1212"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1215">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1216">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1210">Hydroxyzine Hcl&#160;SYRP&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft1215">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft1216">&#160;&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft1210">Hydroxyzine Hcl&#160;TABS 50MG&#160;</p>
<p style="position:absolute;top:242px;left:122px;white-space:nowrap" class="ft1215">•</p>
<p style="position:absolute;top:241px;left:130px;white-space:nowrap" class="ft1216">&#160;&#160;</p>
<p style="position:absolute;top:244px;left:149px;white-space:nowrap" class="ft12110">Hydroxyzine Hydrochloride&#160;TABS&#160;<br/>10MG, 25MG&#160;</p>
<p style="position:absolute;top:284px;left:122px;white-space:nowrap" class="ft1215">•</p>
<p style="position:absolute;top:284px;left:130px;white-space:nowrap" class="ft1216">&#160;&#160;</p>
<p style="position:absolute;top:286px;left:149px;white-space:nowrap" class="ft1210">Hydroxyzine Pamoate&#160;CAPS&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1210">121&#160;</p>
</div>
<!-- Page 122 -->
<a name="122"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page122-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2122.png" alt="background image"/>
<p style="position:absolute;top:132px;left:126px;white-space:nowrap" class="ft1222"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:132px;left:274px;white-space:nowrap" class="ft1222"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:174px;left:126px;white-space:nowrap" class="ft1228"><b>Indications&#160;</b></p>
<p style="position:absolute;top:174px;left:274px;white-space:nowrap" class="ft1220">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:213px;left:126px;white-space:nowrap" class="ft1228"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:213px;left:274px;white-space:nowrap" class="ft1220">N/A&#160;</p>
<p style="position:absolute;top:252px;left:126px;white-space:nowrap" class="ft1229"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:252px;left:274px;white-space:nowrap" class="ft1220">N/A&#160;</p>
<p style="position:absolute;top:311px;left:126px;white-space:nowrap" class="ft1229"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:311px;left:274px;white-space:nowrap" class="ft12210">For anxiety:&#160;1) The patient has&#160;tried&#160;two of the&#160;following alternative&#160;<br/>drugs: buspirone, duloxetine, escitalopram, sertraline, or&#160;venlafaxine&#160;<br/>extended-release AND 2) The patient experienced&#160;an inadequate&#160;<br/>treatment response&#160;OR&#160;intolerance to two of the&#160;following&#160;alternative&#160;<br/>drugs: buspirone, duloxetine, escitalopram, sertraline, or&#160;venlafaxine&#160;<br/>extended-release OR&#160;3) The patient&#160;has not&#160;tried&#160;two of the following&#160;<br/>alternative drugs: buspirone, duloxetine, escitalopram, sertraline or&#160;<br/>venlafaxine&#160;extended-release AND 4) The patient has acute anxiety.&#160;If&#160;the&#160;<br/>patient is&#160;taking one or more&#160;additional anticholinergic medications&#160;(e.g.,&#160;<br/>oxybutynin,&#160;meclizine, paroxetine, amitriptyline,&#160;dicyclomine,&#160;<br/>cyclobenzaprine)&#160;with the requested&#160;drug, the prescriber has determined&#160;<br/>that&#160;taking&#160;multiple&#160;anticholinergic&#160;medications&#160;is medically necessary&#160;<br/>for&#160;the patient [Note: Use of multiple anticholinergic medications in older&#160;<br/>adults&#160;is associated with&#160;an increased risk of&#160;cognitive decline.].&#160;</p>
<p style="position:absolute;top:619px;left:126px;white-space:nowrap" class="ft1228"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:619px;left:274px;white-space:nowrap" class="ft1220">N/A&#160;</p>
<p style="position:absolute;top:657px;left:126px;white-space:nowrap" class="ft1229"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:657px;left:274px;white-space:nowrap" class="ft1220">N/A&#160;</p>
<p style="position:absolute;top:717px;left:126px;white-space:nowrap" class="ft1229"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:717px;left:274px;white-space:nowrap" class="ft1220">Plan Year&#160;</p>
<p style="position:absolute;top:776px;left:126px;white-space:nowrap" class="ft1228"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:776px;left:274px;white-space:nowrap" class="ft12210">This Prior&#160;Authorization&#160;requirement&#160;only applies&#160;to patients 65 years of&#160;<br/>age or&#160;older. (The American Geriatrics Society identifies&#160;the use of this&#160;<br/>medication&#160;as potentially inappropriate&#160;in older&#160;adults,&#160;meaning it&#160;is best&#160;<br/>avoided, prescribed&#160;at reduced dosage, or&#160;used with caution or carefully&#160;<br/>monitored.)&#160;<br/>Prescriber must acknowledge that the&#160;benefit of&#160;therapy with&#160;this&#160;<br/>prescribed&#160;medication&#160;outweighs&#160;the potential&#160;risks&#160;for&#160;this patient.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1220">122&#160;</p>
</div>
<!-- Page 123 -->
<a name="123"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page123-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2123.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1231"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1234"><b>RM</b></p>
<p style="position:absolute;top:118px;left:171px;white-space:nowrap" class="ft1231"><b>-</b></p>
<p style="position:absolute;top:123px;left:181px;white-space:nowrap" class="ft1234"><b>HYDROXYZINE&#160;</b></p>
<p style="position:absolute;top:118px;left:370px;white-space:nowrap" class="ft1231"><b>I</b></p>
<p style="position:absolute;top:123px;left:382px;white-space:nowrap" class="ft1234"><b>NJ&#160;</b></p>
<p style="position:absolute;top:118px;left:417px;white-space:nowrap" class="ft1231"><b>-&#160;65</b></p>
<p style="position:absolute;top:113px;left:463px;white-space:nowrap" class="ft12314">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1232"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1235">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1236">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1230">Hydroxyzine Hcl&#160;INJ 25MG/ML&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft1235">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft1236">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft1230">Hydroxyzine Hydrochloride&#160;INJ&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1230">123&#160;</p>
</div>
<!-- Page 124 -->
<a name="124"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page124-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2124.png" alt="background image"/>
<p style="position:absolute;top:132px;left:126px;white-space:nowrap" class="ft1242"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:132px;left:274px;white-space:nowrap" class="ft1242"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:174px;left:126px;white-space:nowrap" class="ft1248"><b>Indications&#160;</b></p>
<p style="position:absolute;top:174px;left:274px;white-space:nowrap" class="ft1240">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:213px;left:126px;white-space:nowrap" class="ft1248"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:213px;left:274px;white-space:nowrap" class="ft1240">N/A&#160;</p>
<p style="position:absolute;top:252px;left:126px;white-space:nowrap" class="ft1249"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:252px;left:274px;white-space:nowrap" class="ft1240">N/A&#160;</p>
<p style="position:absolute;top:311px;left:126px;white-space:nowrap" class="ft1249"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:311px;left:274px;white-space:nowrap" class="ft12410">Alcohol Withdrawal&#160;Syndrome: 1)&#160;The patient has not&#160;tried one of&#160;the&#160;<br/>following&#160;alternative drugs: clorazepate&#160;or lorazepam AND&#160;2) The patient&#160;<br/>has a&#160;contraindication to&#160;one of&#160;the following alternative&#160;drugs:&#160;<br/>clorazepate&#160;or lorazepam OR 3) The patient has&#160;tried one of&#160;the following&#160;<br/>alternative drugs: clorazepate or lorazepam&#160;AND 4) The patient&#160;<br/>experienced&#160;an inadequate treatment response OR intolerance to one of&#160;<br/>the following alternative&#160;drugs: clorazepate&#160;or lorazepam. Anxiety: 1)&#160;The&#160;<br/>patient has&#160;tried&#160;two of the following&#160;alternative&#160;drugs: buspirone,&#160;<br/>duloxetine,&#160;escitalopram, sertraline or venlafaxine extended-release AND&#160;<br/>2) The patient experienced an inadequate&#160;treatment response&#160;OR&#160;<br/>intolerance to two of the following&#160;alternative drugs: buspirone,&#160;<br/>duloxetine,&#160;escitalopram,&#160;sertraline or venlafaxine extended-release OR 3)&#160;<br/>The patient&#160;has not&#160;tried&#160;two of the following alternative drugs:&#160;<br/>buspirone, duloxetine, escitalopram,&#160;sertraline or&#160;venlafaxine&#160;extended-<br/>release AND&#160;4) The patient has acute anxiety.&#160;</p>
<p style="position:absolute;top:639px;left:126px;white-space:nowrap" class="ft1248"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:639px;left:274px;white-space:nowrap" class="ft1240">N/A&#160;</p>
<p style="position:absolute;top:678px;left:126px;white-space:nowrap" class="ft1249"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:678px;left:274px;white-space:nowrap" class="ft1240">N/A&#160;</p>
<p style="position:absolute;top:738px;left:126px;white-space:nowrap" class="ft1249"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:738px;left:274px;white-space:nowrap" class="ft1240">Plan Year&#160;</p>
<p style="position:absolute;top:797px;left:126px;white-space:nowrap" class="ft1248"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:797px;left:274px;white-space:nowrap" class="ft12410">This Prior&#160;Authorization&#160;requirement&#160;only applies&#160;to patients 65 years of&#160;<br/>age or&#160;older. (The American Geriatrics Society identifies&#160;the use of this&#160;<br/>medication&#160;as potentially inappropriate&#160;in older&#160;adults,&#160;meaning it&#160;is best&#160;<br/>avoided, prescribed at&#160;reduced dosage, or&#160;used with caution or carefully&#160;<br/>monitored.)&#160;<br/>Prescriber must acknowledge that the&#160;benefit of&#160;therapy with&#160;this&#160;<br/>prescribed&#160;medication&#160;outweighs&#160;the potential&#160;risks&#160;for&#160;this patient.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1240">124&#160;</p>
</div>
<!-- Page 125 -->
<a name="125"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page125-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2125.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1251"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1254"><b>RM</b></p>
<p style="position:absolute;top:118px;left:171px;white-space:nowrap" class="ft1251"><b>-</b></p>
<p style="position:absolute;top:123px;left:181px;white-space:nowrap" class="ft1254"><b>PROMETHAZINE&#160;</b></p>
<p style="position:absolute;top:118px;left:387px;white-space:nowrap" class="ft1251"><b>-&#160;65</b></p>
<p style="position:absolute;top:113px;left:433px;white-space:nowrap" class="ft12514">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1252"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1255">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1256">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1250">Promethazine Hcl&#160;INJ&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft1255">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft1256">&#160;&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft1250">Promethazine Hcl&#160;SUPP&#160;12.5MG,&#160;</p>
<p style="position:absolute;top:219px;left:400px;white-space:nowrap" class="ft1256"></p>
<p style="position:absolute;top:242px;left:149px;white-space:nowrap" class="ft1250">25MG</p>
<p style="position:absolute;top:240px;left:195px;white-space:nowrap" class="ft1256">&#160;</p>
<p style="position:absolute;top:262px;left:122px;white-space:nowrap" class="ft1255">•</p>
<p style="position:absolute;top:262px;left:130px;white-space:nowrap" class="ft1256">&#160;&#160;</p>
<p style="position:absolute;top:264px;left:149px;white-space:nowrap" class="ft1250">Promethazine Hcl&#160;TABS 12.5MG&#160;</p>
<p style="position:absolute;top:284px;left:122px;white-space:nowrap" class="ft1255">•</p>
<p style="position:absolute;top:284px;left:130px;white-space:nowrap" class="ft1256">&#160;&#160;</p>
<p style="position:absolute;top:286px;left:149px;white-space:nowrap" class="ft1250">Promethazine Hcl Plain&#160;</p>
<p style="position:absolute;top:306px;left:122px;white-space:nowrap" class="ft1255">•</p>
<p style="position:absolute;top:306px;left:130px;white-space:nowrap" class="ft1256">&#160;&#160;</p>
<p style="position:absolute;top:308px;left:149px;white-space:nowrap" class="ft12510">Promethazine Hydrochloride&#160;TABS&#160;<br/>25MG, 50MG&#160;</p>
<p style="position:absolute;top:349px;left:122px;white-space:nowrap" class="ft1255">•</p>
<p style="position:absolute;top:348px;left:130px;white-space:nowrap" class="ft1256">&#160;&#160;</p>
<p style="position:absolute;top:351px;left:149px;white-space:nowrap" class="ft1250">Promethegan&#160;</p>
<p style="position:absolute;top:428px;left:126px;white-space:nowrap" class="ft1252"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:428px;left:274px;white-space:nowrap" class="ft1252"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:470px;left:126px;white-space:nowrap" class="ft1258"><b>Indications&#160;</b></p>
<p style="position:absolute;top:470px;left:274px;white-space:nowrap" class="ft1250">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:509px;left:126px;white-space:nowrap" class="ft1258"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:509px;left:274px;white-space:nowrap" class="ft1250">N/A&#160;</p>
<p style="position:absolute;top:547px;left:126px;white-space:nowrap" class="ft1259"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:547px;left:274px;white-space:nowrap" class="ft1250">N/A&#160;</p>
<p style="position:absolute;top:607px;left:126px;white-space:nowrap" class="ft1259"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:607px;left:274px;white-space:nowrap" class="ft12510">Rhinitis:&#160;1) The patient&#160;has tried two of the following non-HRM&#160;<br/>alternative drugs: levocetirizine, azelastine nasal,&#160;fluticasone&#160;nasal, or&#160;<br/>flunisolide nasal&#160;AND 2) The patient&#160;experienced&#160;an inadequate treatment&#160;<br/>response OR intolerance to two of&#160;the following non-HRM alternative&#160;<br/>drugs: levocetirizine, azelastine nasal, fluticasone&#160;nasal, or&#160;flunisolide&#160;<br/>nasal.&#160;</p>
<p style="position:absolute;top:749px;left:126px;white-space:nowrap" class="ft1258"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:749px;left:274px;white-space:nowrap" class="ft1250">N/A&#160;</p>
<p style="position:absolute;top:788px;left:126px;white-space:nowrap" class="ft1259"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:788px;left:274px;white-space:nowrap" class="ft1250">N/A&#160;</p>
<p style="position:absolute;top:847px;left:126px;white-space:nowrap" class="ft1259"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:847px;left:274px;white-space:nowrap" class="ft1250">Plan Year&#160;</p>
<p style="position:absolute;top:906px;left:126px;white-space:nowrap" class="ft1258"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:906px;left:274px;white-space:nowrap" class="ft12510">This Prior&#160;Authorization&#160;requirement&#160;only applies&#160;to patients 65 years of&#160;<br/>age or&#160;older. (The American Geriatrics Society identifies&#160;the use of this&#160;<br/>medication&#160;as potentially inappropriate&#160;in older&#160;adults,&#160;meaning it&#160;is best&#160;<br/>avoided, prescribed at&#160;reduced dosage, or&#160;used with caution or carefully&#160;<br/>monitored.)&#160;<br/>Prescriber must acknowledge that the&#160;benefit of&#160;therapy with&#160;this&#160;<br/>prescribed&#160;medication&#160;outweighs&#160;the potential&#160;risks&#160;for&#160;this patient.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1250">125&#160;</p>
</div>
<!-- Page 126 -->
<a name="126"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page126-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2126.png" alt="background image"/>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1260">126</p>
<p style="position:absolute;top:1093px;left:810px;white-space:nowrap" class="ft1266">&#160;</p>
</div>
<!-- Page 127 -->
<a name="127"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page127-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2127.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1271"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1274"><b>RMS&#160;</b></p>
<p style="position:absolute;top:118px;left:191px;white-space:nowrap" class="ft1271"><b>-&#160;A</b></p>
<p style="position:absolute;top:123px;left:228px;white-space:nowrap" class="ft1274"><b>NTIDEPRESSANTS</b></p>
<p style="position:absolute;top:119px;left:443px;white-space:nowrap" class="ft12713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1272"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1275">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1276">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1270">Amitriptyline Hcl&#160;TABS 100MG,&#160;</p>
<p style="position:absolute;top:197px;left:397px;white-space:nowrap" class="ft1276"></p>
<p style="position:absolute;top:221px;left:149px;white-space:nowrap" class="ft1270">150MG, 75MG</p>
<p style="position:absolute;top:218px;left:260px;white-space:nowrap" class="ft1276">&#160;</p>
<p style="position:absolute;top:240px;left:122px;white-space:nowrap" class="ft1275">•</p>
<p style="position:absolute;top:240px;left:130px;white-space:nowrap" class="ft1276">&#160;&#160;</p>
<p style="position:absolute;top:242px;left:149px;white-space:nowrap" class="ft1270">Amitriptyline Hydrochloride&#160;TABS</p>
<p style="position:absolute;top:240px;left:407px;white-space:nowrap" class="ft1276">&#160;</p>
<p style="position:absolute;top:263px;left:149px;white-space:nowrap" class="ft1270">10MG, 25MG, 50MG</p>
<p style="position:absolute;top:260px;left:307px;white-space:nowrap" class="ft1276">&#160;</p>
<p style="position:absolute;top:283px;left:122px;white-space:nowrap" class="ft1275">•</p>
<p style="position:absolute;top:282px;left:130px;white-space:nowrap" class="ft1276">&#160;&#160;</p>
<p style="position:absolute;top:285px;left:149px;white-space:nowrap" class="ft1270">Desipramine&#160;Hydrochloride&#160;</p>
<p style="position:absolute;top:305px;left:122px;white-space:nowrap" class="ft1275">•</p>
<p style="position:absolute;top:304px;left:130px;white-space:nowrap" class="ft1276">&#160;&#160;</p>
<p style="position:absolute;top:307px;left:149px;white-space:nowrap" class="ft1270">Imipramine Hcl&#160;TABS&#160;25MG, 50MG&#160;</p>
<p style="position:absolute;top:327px;left:122px;white-space:nowrap" class="ft1275">•</p>
<p style="position:absolute;top:326px;left:130px;white-space:nowrap" class="ft1276">&#160;&#160;</p>
<p style="position:absolute;top:329px;left:149px;white-space:nowrap" class="ft1270">Imipramine Hydrochloride&#160;TABS</p>
<p style="position:absolute;top:326px;left:392px;white-space:nowrap" class="ft1276">&#160;</p>
<p style="position:absolute;top:350px;left:149px;white-space:nowrap" class="ft1270">10MG</p>
<p style="position:absolute;top:347px;left:195px;white-space:nowrap" class="ft1276">&#160;</p>
<p style="position:absolute;top:370px;left:122px;white-space:nowrap" class="ft1275">•</p>
<p style="position:absolute;top:369px;left:130px;white-space:nowrap" class="ft1276">&#160;&#160;</p>
<p style="position:absolute;top:372px;left:149px;white-space:nowrap" class="ft1270">Imipramine Pamoate&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1270">127&#160;</p>
</div>
<!-- Page 128 -->
<a name="128"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page128-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2128.png" alt="background image"/>
<p style="position:absolute;top:132px;left:126px;white-space:nowrap" class="ft1282"><b>PA&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:132px;left:274px;white-space:nowrap" class="ft1282"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:174px;left:126px;white-space:nowrap" class="ft1288"><b>Indications&#160;</b></p>
<p style="position:absolute;top:174px;left:274px;white-space:nowrap" class="ft1280">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:213px;left:126px;white-space:nowrap" class="ft1288"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:213px;left:274px;white-space:nowrap" class="ft1280">Neuropathic&#160;pain&#160;</p>
<p style="position:absolute;top:252px;left:126px;white-space:nowrap" class="ft1289"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:252px;left:274px;white-space:nowrap" class="ft1280">N/A&#160;</p>
<p style="position:absolute;top:311px;left:126px;white-space:nowrap" class="ft1289"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:311px;left:274px;white-space:nowrap" class="ft12810">If&#160;the&#160;requested drug&#160;is being prescribed for the treatment&#160;of&#160;depression:&#160;<br/>1) The patient tried two&#160;of the following alternative&#160;drugs: SSRIs&#160;<br/>(selective serotonin&#160;reuptake&#160;inhibitors), SNRIs&#160;(serotonin-norepinephrine&#160;<br/>reuptake inhibitors), bupropion, mirtazapine,&#160;or trazodone AND&#160;2) The&#160;<br/>patient experienced an inadequate&#160;treatment response OR intolerance to&#160;<br/>two of the following alternative drugs: SSRIs (selective&#160;serotonin&#160;<br/>reuptake inhibitors), SNRIs (serotonin-norepinephrine reuptake&#160;<br/>inhibitors), bupropion,&#160;mirtazapine, or trazodone.&#160;</p>
<p style="position:absolute;top:494px;left:126px;white-space:nowrap" class="ft1288"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:494px;left:274px;white-space:nowrap" class="ft1280">N/A&#160;</p>
<p style="position:absolute;top:533px;left:126px;white-space:nowrap" class="ft1289"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:533px;left:274px;white-space:nowrap" class="ft1280">N/A&#160;</p>
<p style="position:absolute;top:593px;left:126px;white-space:nowrap" class="ft1289"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:593px;left:274px;white-space:nowrap" class="ft1280">Plan Year&#160;</p>
<p style="position:absolute;top:652px;left:126px;white-space:nowrap" class="ft1288"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:652px;left:274px;white-space:nowrap" class="ft12810">This Prior&#160;Authorization&#160;requirement&#160;only applies&#160;to patients 65 years of&#160;<br/>age or&#160;older. (The American Geriatrics Society identifies&#160;the use of this&#160;<br/>medication&#160;as potentially inappropriate&#160;in older&#160;adults,&#160;meaning it&#160;is best&#160;<br/>avoided, prescribed at&#160;reduced dosage, or&#160;used with caution or carefully&#160;<br/>monitored.)&#160;<br/>Prescriber must acknowledge that the&#160;benefit of&#160;therapy with&#160;this&#160;<br/>prescribed&#160;medication&#160;outweighs&#160;the potential&#160;risks&#160;for&#160;this patient.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1280">128&#160;</p>
</div>
<!-- Page 129 -->
<a name="129"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page129-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2129.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1291"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1294"><b>RMS&#160;</b></p>
<p style="position:absolute;top:118px;left:191px;white-space:nowrap" class="ft1291"><b>-&#160;C</b></p>
<p style="position:absolute;top:123px;left:228px;white-space:nowrap" class="ft1294"><b>ARBINOXAMINE</b></p>
<p style="position:absolute;top:119px;left:424px;white-space:nowrap" class="ft12913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1292"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1295">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1296">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1290">Carbinoxamine Maleate&#160;SOLN&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft1295">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft1296">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft1290">Carbinoxamine Maleate&#160;TABS&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft1292"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft1292"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft1298"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft1290">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft1298"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft1290">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft1299"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft1290">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft1299"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft12910">Rhinitis:&#160;1) The patient&#160;has tried two of the following non-HRM&#160;<br/>alternative drugs: levocetirizine, azelastine nasal,&#160;fluticasone&#160;nasal, or&#160;<br/>flunisolide nasal&#160;AND 2) The patient&#160;experienced&#160;an inadequate treatment&#160;<br/>response OR intolerance to two of&#160;the following non-HRM alternative&#160;<br/>drugs: levocetirizine, azelastine nasal, fluticasone&#160;nasal, or&#160;flunisolide&#160;<br/>nasal.&#160;</p>
<p style="position:absolute;top:620px;left:126px;white-space:nowrap" class="ft1298"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:620px;left:274px;white-space:nowrap" class="ft1290">N/A&#160;</p>
<p style="position:absolute;top:658px;left:126px;white-space:nowrap" class="ft1299"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:658px;left:274px;white-space:nowrap" class="ft1290">N/A&#160;</p>
<p style="position:absolute;top:718px;left:126px;white-space:nowrap" class="ft1299"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:718px;left:274px;white-space:nowrap" class="ft1290">Plan Year&#160;</p>
<p style="position:absolute;top:777px;left:126px;white-space:nowrap" class="ft1298"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:777px;left:274px;white-space:nowrap" class="ft12910">This Prior&#160;Authorization&#160;requirement&#160;only applies&#160;to patients 65 years of&#160;<br/>age or&#160;older. (The American Geriatrics Society identifies&#160;the use of this&#160;<br/>medication&#160;as potentially inappropriate&#160;in older&#160;adults,&#160;meaning it&#160;is best&#160;<br/>avoided, prescribed at&#160;reduced dosage, or&#160;used with caution or carefully&#160;<br/>monitored.)&#160;<br/>Prescriber must acknowledge that the&#160;benefit of&#160;therapy with&#160;this&#160;<br/>prescribed&#160;medication&#160;outweighs&#160;the potential&#160;risks&#160;for&#160;this patient.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1290">129&#160;</p>
</div>
<!-- Page 130 -->
<a name="130"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page130-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2130.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1301"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1304"><b>RMS&#160;</b></p>
<p style="position:absolute;top:118px;left:191px;white-space:nowrap" class="ft1301"><b>-&#160;C</b></p>
<p style="position:absolute;top:123px;left:228px;white-space:nowrap" class="ft1304"><b>LEMASTINE</b></p>
<p style="position:absolute;top:118px;left:372px;white-space:nowrap" class="ft1301"><b>-&#160;65</b></p>
<p style="position:absolute;top:113px;left:418px;white-space:nowrap" class="ft13014">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1302"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1305">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1306">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1300">Clemastine&#160;Fumarate&#160;TABS 2.68MG&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1302"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1302"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1308"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1300">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1308"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1300">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1309"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1300">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1309"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft13010">Rhinitis:&#160;1) The patient&#160;has tried two of the following non-HRM&#160;<br/>alternative drugs: levocetirizine, azelastine nasal,&#160;fluticasone&#160;nasal, or&#160;<br/>flunisolide nasal&#160;AND 2) The patient&#160;experienced&#160;an inadequate treatment&#160;<br/>response OR intolerance to two of&#160;the following non-HRM alternative&#160;<br/>drugs: levocetirizine, azelastine nasal, fluticasone&#160;nasal, or&#160;flunisolide&#160;<br/>nasal.&#160;</p>
<p style="position:absolute;top:598px;left:126px;white-space:nowrap" class="ft1308"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:598px;left:274px;white-space:nowrap" class="ft1300">N/A&#160;</p>
<p style="position:absolute;top:636px;left:126px;white-space:nowrap" class="ft1309"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:636px;left:274px;white-space:nowrap" class="ft1300">N/A&#160;</p>
<p style="position:absolute;top:696px;left:126px;white-space:nowrap" class="ft1309"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:696px;left:274px;white-space:nowrap" class="ft1300">Plan Year&#160;</p>
<p style="position:absolute;top:755px;left:126px;white-space:nowrap" class="ft1308"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:755px;left:274px;white-space:nowrap" class="ft13010">This Prior&#160;Authorization&#160;requirement&#160;only applies&#160;to patients 65 years of&#160;<br/>age or&#160;older. (The American Geriatrics Society identifies&#160;the use of this&#160;<br/>medication&#160;as potentially inappropriate&#160;in older&#160;adults,&#160;meaning it&#160;is best&#160;<br/>avoided, prescribed at&#160;reduced dosage, or&#160;used with caution or carefully&#160;<br/>monitored.)&#160;<br/>Prescriber must acknowledge that the&#160;benefit of&#160;therapy with&#160;this&#160;<br/>prescribed&#160;medication&#160;outweighs&#160;the potential&#160;risks&#160;for&#160;this patient.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1300">130&#160;</p>
</div>
<!-- Page 131 -->
<a name="131"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page131-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2131.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1311"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1314"><b>RMS&#160;</b></p>
<p style="position:absolute;top:118px;left:191px;white-space:nowrap" class="ft1311"><b>-&#160;M</b></p>
<p style="position:absolute;top:123px;left:235px;white-space:nowrap" class="ft1314"><b>ECLIZINE&#160;</b></p>
<p style="position:absolute;top:118px;left:358px;white-space:nowrap" class="ft1311"><b>-&#160;65</b></p>
<p style="position:absolute;top:113px;left:404px;white-space:nowrap" class="ft13114">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1312"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1315">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1316">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1310">Meclizine Hcl&#160;TABS&#160;12.5MG&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft1315">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft1316">&#160;&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft13110">Meclizine Hydrochloride&#160;TABS&#160;<br/>25MG&#160;</p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1312"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1312"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:361px;left:126px;white-space:nowrap" class="ft1318"><b>Indications&#160;</b></p>
<p style="position:absolute;top:361px;left:274px;white-space:nowrap" class="ft1310">All&#160;Medically-accepted Indications.&#160;</p>
<p style="position:absolute;top:400px;left:126px;white-space:nowrap" class="ft1318"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:400px;left:274px;white-space:nowrap" class="ft1310">N/A&#160;</p>
<p style="position:absolute;top:439px;left:126px;white-space:nowrap" class="ft1319"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:439px;left:274px;white-space:nowrap" class="ft1310">N/A&#160;</p>
<p style="position:absolute;top:498px;left:126px;white-space:nowrap" class="ft1319"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:498px;left:274px;white-space:nowrap" class="ft1310">N/A&#160;</p>
<p style="position:absolute;top:578px;left:126px;white-space:nowrap" class="ft1318"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:578px;left:274px;white-space:nowrap" class="ft1310">N/A&#160;</p>
<p style="position:absolute;top:617px;left:126px;white-space:nowrap" class="ft1319"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:617px;left:274px;white-space:nowrap" class="ft1310">N/A&#160;</p>
<p style="position:absolute;top:676px;left:126px;white-space:nowrap" class="ft1319"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:676px;left:274px;white-space:nowrap" class="ft1310">Plan Year&#160;</p>
<p style="position:absolute;top:736px;left:126px;white-space:nowrap" class="ft1318"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:736px;left:274px;white-space:nowrap" class="ft13110">This Prior&#160;Authorization&#160;requirement&#160;only applies&#160;to patients 65 years of&#160;<br/>age or&#160;older. (The American Geriatrics Society identifies&#160;the use of this&#160;<br/>medication&#160;as potentially inappropriate&#160;in older&#160;adults,&#160;meaning it&#160;is best&#160;<br/>avoided, prescribed at&#160;reduced dosage, or&#160;used with caution or carefully&#160;<br/>monitored.)&#160;<br/>Prescriber must acknowledge that the&#160;benefit of&#160;therapy with&#160;this&#160;<br/>prescribed&#160;medication&#160;outweighs&#160;the potential&#160;risks&#160;for&#160;this patient.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1310">131&#160;</p>
</div>
<!-- Page 132 -->
<a name="132"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page132-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2132.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1321"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1324"><b>RMS&#160;</b></p>
<p style="position:absolute;top:118px;left:191px;white-space:nowrap" class="ft1321"><b>-&#160;T</b></p>
<p style="position:absolute;top:123px;left:227px;white-space:nowrap" class="ft1324"><b>CAS</b></p>
<p style="position:absolute;top:119px;left:275px;white-space:nowrap" class="ft13213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1322"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1325">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1326">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1320">Protriptyline&#160;Hcl&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft1325">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft1326">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft1320">Trimipramine Maleate&#160;CAPS&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft1322"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft1322"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft1328"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft1320">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft1328"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft1320">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft1329"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft1320">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft1329"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft13210">1)&#160;The patient tried two&#160;of the following alternative&#160;drugs: SSRIs&#160;<br/>(selective serotonin&#160;reuptake&#160;inhibitors), SNRIs&#160;(serotonin-norepinephrine&#160;<br/>reuptake inhibitors),&#160;bupropion, mirtazapine, or trazodone AND&#160;2) The&#160;<br/>patient experienced an inadequate&#160;treatment response OR intolerance to&#160;<br/>two of the following alternative drugs: SSRIs (selective&#160;serotonin&#160;<br/>reuptake inhibitors), SNRIs (serotonin-norepinephrine reuptake&#160;<br/>inhibitors),&#160;bupropion,&#160;mirtazapine, or trazodone.&#160;</p>
<p style="position:absolute;top:640px;left:126px;white-space:nowrap" class="ft1328"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:640px;left:274px;white-space:nowrap" class="ft1320">N/A&#160;</p>
<p style="position:absolute;top:679px;left:126px;white-space:nowrap" class="ft1329"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:679px;left:274px;white-space:nowrap" class="ft1320">N/A&#160;</p>
<p style="position:absolute;top:738px;left:126px;white-space:nowrap" class="ft1329"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:738px;left:274px;white-space:nowrap" class="ft1320">Plan Year&#160;</p>
<p style="position:absolute;top:798px;left:126px;white-space:nowrap" class="ft1328"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:798px;left:274px;white-space:nowrap" class="ft13210">This Prior&#160;Authorization&#160;requirement&#160;only applies&#160;to patients 65 years of&#160;<br/>age or&#160;older. (The American Geriatrics Society identifies&#160;the use of this&#160;<br/>medication&#160;as potentially inappropriate&#160;in older&#160;adults,&#160;meaning it&#160;is best&#160;<br/>avoided, prescribed at&#160;reduced dosage, or&#160;used with caution or carefully&#160;<br/>monitored.)&#160;<br/>Prescriber must acknowledge that the&#160;benefit of&#160;therapy with&#160;this&#160;<br/>prescribed&#160;medication&#160;outweighs&#160;the potential&#160;risks&#160;for&#160;this patient.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1320">132&#160;</p>
</div>
<!-- Page 133 -->
<a name="133"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page133-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2133.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1331"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1334"><b>RM</b></p>
<p style="position:absolute;top:118px;left:171px;white-space:nowrap" class="ft1331"><b>-</b></p>
<p style="position:absolute;top:123px;left:181px;white-space:nowrap" class="ft1334"><b>SKELETAL&#160;</b></p>
<p style="position:absolute;top:118px;left:317px;white-space:nowrap" class="ft1331"><b>M</b></p>
<p style="position:absolute;top:123px;left:345px;white-space:nowrap" class="ft1334"><b>USCLE&#160;</b></p>
<p style="position:absolute;top:118px;left:431px;white-space:nowrap" class="ft1331"><b>R</b></p>
<p style="position:absolute;top:123px;left:453px;white-space:nowrap" class="ft1334"><b>ELAXANTS&#160;</b></p>
<p style="position:absolute;top:118px;left:589px;white-space:nowrap" class="ft1331"><b>-&#160;65</b></p>
<p style="position:absolute;top:113px;left:635px;white-space:nowrap" class="ft13314">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1332"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1335">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1336">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1330">Chlorzoxazone&#160;TABS&#160;500MG&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft1335">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft1336">&#160;&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft13310">Cyclobenzaprine Hydrochloride&#160;<br/>TABS&#160;10MG, 5MG&#160;</p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1332"><b>PA&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1332"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:361px;left:126px;white-space:nowrap" class="ft1338"><b>Indications&#160;</b></p>
<p style="position:absolute;top:361px;left:274px;white-space:nowrap" class="ft1330">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:400px;left:126px;white-space:nowrap" class="ft1338"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:400px;left:274px;white-space:nowrap" class="ft1330">N/A&#160;</p>
<p style="position:absolute;top:439px;left:126px;white-space:nowrap" class="ft1339"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:439px;left:274px;white-space:nowrap" class="ft1330">N/A&#160;</p>
<p style="position:absolute;top:498px;left:126px;white-space:nowrap" class="ft1339"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:498px;left:274px;white-space:nowrap" class="ft13310">If&#160;the&#160;patient is using one&#160;or more&#160;additional anticholinergic&#160;medications&#160;<br/>(e.g., oxybutynin, meclizine, paroxetine, amitriptyline, dicyclomine,&#160;<br/>hydroxyzine) with the requested drug, the prescriber has determined that&#160;<br/>taking&#160;multiple anticholinergic medications&#160;is medically necessary for the&#160;<br/>patient [Note: Use&#160;of multiple anticholinergic&#160;medications&#160;in&#160;older&#160;adults&#160;<br/>is associated with an increased risk of cognitive decline.].&#160;</p>
<p style="position:absolute;top:640px;left:126px;white-space:nowrap" class="ft1338"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:640px;left:274px;white-space:nowrap" class="ft1330">N/A&#160;</p>
<p style="position:absolute;top:679px;left:126px;white-space:nowrap" class="ft1339"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:679px;left:274px;white-space:nowrap" class="ft1330">N/A&#160;</p>
<p style="position:absolute;top:738px;left:126px;white-space:nowrap" class="ft1339"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:738px;left:274px;white-space:nowrap" class="ft1330">3 months&#160;</p>
<p style="position:absolute;top:798px;left:126px;white-space:nowrap" class="ft1338"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:798px;left:274px;white-space:nowrap" class="ft13310">This Prior&#160;Authorization&#160;requirement&#160;only applies&#160;to patients 65 years of&#160;<br/>age or&#160;older. (The American Geriatrics Society identifies&#160;the use of this&#160;<br/>medication&#160;as potentially inappropriate&#160;in older&#160;adults,&#160;meaning it&#160;is best&#160;<br/>avoided, prescribed&#160;at reduced dosage, or&#160;used with caution or carefully&#160;<br/>monitored.)&#160;<br/>Prescriber must acknowledge that the&#160;benefit of&#160;therapy with&#160;this&#160;<br/>prescribed&#160;medication&#160;outweighs&#160;the potential&#160;risks&#160;for&#160;this patient.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1330">133&#160;</p>
</div>
<!-- Page 134 -->
<a name="134"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page134-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2134.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1341"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1344"><b>UMIRA</b></p>
<p style="position:absolute;top:119px;left:215px;white-space:nowrap" class="ft13413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1342"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1345">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1346">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1340">Humira&#160;INJ&#160;10MG/0.1ML,&#160;</p>
<p style="position:absolute;top:197px;left:349px;white-space:nowrap" class="ft1346"></p>
<p style="position:absolute;top:221px;left:149px;white-space:nowrap" class="ft1340">20MG/0.2ML, 40MG/0.4ML,&#160;</p>
<p style="position:absolute;top:218px;left:370px;white-space:nowrap" class="ft1346"></p>
<p style="position:absolute;top:241px;left:149px;white-space:nowrap" class="ft1340">40MG/0.8ML</p>
<p style="position:absolute;top:238px;left:250px;white-space:nowrap" class="ft1346">&#160;</p>
<p style="position:absolute;top:261px;left:122px;white-space:nowrap" class="ft1345">•</p>
<p style="position:absolute;top:260px;left:130px;white-space:nowrap" class="ft1346">&#160;&#160;</p>
<p style="position:absolute;top:263px;left:149px;white-space:nowrap" class="ft1340">Humira Pediatric Crohns&#160;Disease&#160;</p>
<p style="position:absolute;top:260px;left:393px;white-space:nowrap" class="ft1346"></p>
<p style="position:absolute;top:284px;left:149px;white-space:nowrap" class="ft1340">Starter Pack&#160;INJ 0, 80MG/0.8ML</p>
<p style="position:absolute;top:281px;left:391px;white-space:nowrap" class="ft1346">&#160;</p>
<p style="position:absolute;top:304px;left:122px;white-space:nowrap" class="ft1345">•</p>
<p style="position:absolute;top:303px;left:130px;white-space:nowrap" class="ft1346">&#160;&#160;</p>
<p style="position:absolute;top:306px;left:149px;white-space:nowrap" class="ft1340">Humira Pen&#160;</p>
<p style="position:absolute;top:326px;left:122px;white-space:nowrap" class="ft1345">•</p>
<p style="position:absolute;top:325px;left:130px;white-space:nowrap" class="ft1346">&#160;&#160;</p>
<p style="position:absolute;top:328px;left:149px;white-space:nowrap" class="ft1340">Humira Pen-cd/uc/hs Starter&#160;</p>
<p style="position:absolute;top:348px;left:122px;white-space:nowrap" class="ft1345">•</p>
<p style="position:absolute;top:347px;left:130px;white-space:nowrap" class="ft1346">&#160;&#160;</p>
<p style="position:absolute;top:350px;left:149px;white-space:nowrap" class="ft1340">Humira Pen-pediatric Uc Starter&#160;Pack&#160;</p>
<p style="position:absolute;top:370px;left:122px;white-space:nowrap" class="ft1345">•</p>
<p style="position:absolute;top:369px;left:130px;white-space:nowrap" class="ft1346">&#160;&#160;</p>
<p style="position:absolute;top:372px;left:149px;white-space:nowrap" class="ft1340">Humira Pen-ps/uv&#160;Starter&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1340">134&#160;</p>
</div>
<!-- Page 135 -->
<a name="135"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page135-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2135.png" alt="background image"/>
<p style="position:absolute;top:132px;left:126px;white-space:nowrap" class="ft1352"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:132px;left:274px;white-space:nowrap" class="ft1352"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:174px;left:126px;white-space:nowrap" class="ft1358"><b>Indications&#160;</b></p>
<p style="position:absolute;top:174px;left:274px;white-space:nowrap" class="ft1350">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:213px;left:126px;white-space:nowrap" class="ft1358"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:213px;left:274px;white-space:nowrap" class="ft1350">Axial spondyloarthritis,&#160;Behcet's syndrome&#160;</p>
<p style="position:absolute;top:252px;left:126px;white-space:nowrap" class="ft1359"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:252px;left:274px;white-space:nowrap" class="ft1350">N/A&#160;</p>
<p style="position:absolute;top:311px;left:126px;white-space:nowrap" class="ft1359"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:311px;left:274px;white-space:nowrap" class="ft13510">For&#160;moderately&#160;to severely active rheumatoid arthritis (new&#160;starts&#160;only):&#160;<br/>1) Inadequate response,&#160;intolerance or contraindication to methotrexate&#160;<br/>(MTX) OR 2) Inadequate response or intolerance to a prior biologic&#160;<br/>disease-modifying&#160;antirheumatic drug (DMARD) or&#160;a targeted synthetic&#160;<br/>DMARD. For&#160;active ankylosing spondylitis and&#160;axial&#160;spondyloarthritis&#160;<br/>(new starts only): 1) Inadequate&#160;response to a non-steroidal anti-<br/>inflammatory drug (NSAID) trial OR&#160;2) Intolerance or contraindication&#160;to&#160;<br/>NSAIDs. For&#160;moderate&#160;to&#160;severe plaque psoriasis (new starts&#160;only): 1) At&#160;<br/>least 3%&#160;of body surface area&#160;(BSA) is affected&#160;OR&#160;crucial body areas&#160;<br/>(e.g., feet, hands, face, neck, groin,&#160;intertriginous areas) are affected at the&#160;<br/>time of&#160;diagnosis, AND 2) Patient meets any of the following: a)&#160;Patient&#160;<br/>has experienced an inadequate&#160;response or&#160;intolerance to either&#160;<br/>phototherapy (e.g., UVB, PUVA) or&#160;pharmacologic treatment with&#160;<br/>methotrexate, cyclosporine, or&#160;acitretin, OR b) Pharmacologic&#160;treatment&#160;<br/>with methotrexate, cyclosporine, or acitretin is contraindicated, OR c)&#160;<br/>Patient has&#160;severe psoriasis&#160;that warrants a biologic DMARD as first-line&#160;<br/>therapy&#160;(i.e.&#160;at least&#160;10%&#160;of the BSA&#160;or crucial&#160;body areas&#160;(e.g., hands,&#160;<br/>feet,&#160;face, neck, scalp, genitals/groin,&#160;intertriginous areas) are&#160;affected).&#160;<br/>For moderately to severely active Crohn's disease (new starts&#160;only): 1)&#160;<br/>Inadequate response&#160;to at least one&#160;conventional&#160;therapy&#160;(e.g.,&#160;<br/>corticosteroids), OR 2) Intolerance or contraindication to conventional&#160;<br/>therapy. For&#160;moderately to severely active ulcerative colitis (new starts&#160;<br/>only): 1) Inadequate&#160;response to at least&#160;one conventional therapy (e.g.,&#160;<br/>corticosteroids), OR 2) Intolerance or contraindication to conventional&#160;<br/>therapy.&#160;</p>
<p style="position:absolute;top:846px;left:126px;white-space:nowrap" class="ft1358"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:846px;left:274px;white-space:nowrap" class="ft1350">N/A&#160;</p>
<p style="position:absolute;top:885px;left:126px;white-space:nowrap" class="ft1359"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:885px;left:274px;white-space:nowrap" class="ft1350">N/A&#160;</p>
<p style="position:absolute;top:945px;left:126px;white-space:nowrap" class="ft1359"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:945px;left:274px;white-space:nowrap" class="ft1350">Plan Year&#160;</p>
<p style="position:absolute;top:1004px;left:126px;white-space:nowrap" class="ft1358"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:1004px;left:274px;white-space:nowrap" class="ft1350">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1350">135&#160;</p>
</div>
<!-- Page 136 -->
<a name="136"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page136-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2136.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1361"><b>H</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1364"><b>YPNOTIC</b></p>
<p style="position:absolute;top:118px;left:242px;white-space:nowrap" class="ft1361"><b>-</b></p>
<p style="position:absolute;top:123px;left:252px;white-space:nowrap" class="ft1364"><b>BENZODIAZEPINES&#160;</b></p>
<p style="position:absolute;top:118px;left:489px;white-space:nowrap" class="ft1361"><b>-&#160;65</b></p>
<p style="position:absolute;top:113px;left:535px;white-space:nowrap" class="ft13614">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1362"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1365">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1366">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft13610">Temazepam&#160;CAPS 15MG, 22.5MG,&#160;<br/>7.5MG&#160;</p>
<p style="position:absolute;top:240px;left:122px;white-space:nowrap" class="ft1365">•</p>
<p style="position:absolute;top:240px;left:130px;white-space:nowrap" class="ft1366">&#160;&#160;</p>
<p style="position:absolute;top:242px;left:149px;white-space:nowrap" class="ft1360">Triazolam&#160;</p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1362"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1362"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:361px;left:126px;white-space:nowrap" class="ft1368"><b>Indications&#160;</b></p>
<p style="position:absolute;top:361px;left:274px;white-space:nowrap" class="ft1360">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:400px;left:126px;white-space:nowrap" class="ft1368"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:400px;left:274px;white-space:nowrap" class="ft1360">N/A&#160;</p>
<p style="position:absolute;top:439px;left:126px;white-space:nowrap" class="ft1369"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:439px;left:274px;white-space:nowrap" class="ft1360">N/A&#160;</p>
<p style="position:absolute;top:498px;left:126px;white-space:nowrap" class="ft1369"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:498px;left:274px;white-space:nowrap" class="ft13610">Prescriber must&#160;acknowledge the benefit of&#160;therapy with the requested&#160;<br/>drug outweighs the potential risks for the patient.&#160; (Note:&#160;The&#160;American&#160;<br/>Geriatrics Society identifies&#160;the use&#160;of this medication as potentially&#160;<br/>inappropriate in older adults, meaning it&#160;is best&#160;avoided, prescribed&#160;at&#160;<br/>reduced dosage, or used&#160;with caution&#160;or carefully&#160;monitored.) &#160;The patient&#160;<br/>has experienced an inadequate&#160;treatment response, intolerance, or has a&#160;<br/>contraindication to doxepin (3 mg or&#160;6 mg).&#160;</p>
<p style="position:absolute;top:661px;left:126px;white-space:nowrap" class="ft1368"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:661px;left:274px;white-space:nowrap" class="ft1360">N/A&#160;</p>
<p style="position:absolute;top:700px;left:126px;white-space:nowrap" class="ft1369"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:700px;left:274px;white-space:nowrap" class="ft1360">N/A&#160;</p>
<p style="position:absolute;top:759px;left:126px;white-space:nowrap" class="ft1369"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:759px;left:274px;white-space:nowrap" class="ft1360">Plan Year&#160;</p>
<p style="position:absolute;top:819px;left:126px;white-space:nowrap" class="ft1368"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:819px;left:274px;white-space:nowrap" class="ft13610">This Prior&#160;Authorization&#160;requirement&#160;only applies&#160;to patients 65 years of&#160;<br/>age or&#160;older.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1360">136&#160;</p>
</div>
<!-- Page 137 -->
<a name="137"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page137-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2137.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1371"><b>I</b></p>
<p style="position:absolute;top:123px;left:120px;white-space:nowrap" class="ft1374"><b>BRANCE</b></p>
<p style="position:absolute;top:119px;left:221px;white-space:nowrap" class="ft13713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1372"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1375">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1376">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1370">Ibrance&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1372"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1372"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1378"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1370">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1378"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft13710">Unresectable well-differentiated/dedifferentiated liposarcoma of&#160;the&#160;<br/>retroperitoneum.&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft1379"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft1370">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft1379"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft1370">N/A&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft1378"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft1370">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft1379"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft1370">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft1379"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft1370">Plan Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft1378"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft1370">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1370">137&#160;</p>
</div>
<!-- Page 138 -->
<a name="138"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page138-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2138.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1381"><b>I</b></p>
<p style="position:absolute;top:123px;left:120px;white-space:nowrap" class="ft1384"><b>CATIBANT</b></p>
<p style="position:absolute;top:119px;left:246px;white-space:nowrap" class="ft13813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1382"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1385">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1386">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1380">Icatibant Acetate&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft1385">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft1386">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft1380">Sajazir&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft1382"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft1382"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft1388"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft1380">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft1388"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft1380">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft1389"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft1380">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft1389"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft13810">For hereditary&#160;angioedema (HAE):&#160;The requested drug is being used for&#160;<br/>the treatment of&#160;acute angioedema attacks. Patient has&#160;HAE with C1&#160;<br/>inhibitor&#160;deficiency or dysfunction confirmed by&#160;laboratory&#160;testing OR&#160;<br/>patient has&#160;HAE with normal C1 inhibitor confirmed by&#160;laboratory&#160;<br/>testing. For&#160;patients with HAE with&#160;normal C1 inhibitor, EITHER 1)&#160;<br/>Patient tested positive for an F12, angiopoietin-1, plasminogen, or&#160;<br/>kininogen-1&#160;(KNG1) gene mutation&#160;OR&#160;2) Patient has a&#160;family history of&#160;<br/>angioedema and the angioedema was&#160;refractory to&#160;a trial of an&#160;<br/>antihistamine for at least one month.&#160;</p>
<p style="position:absolute;top:682px;left:126px;white-space:nowrap" class="ft1388"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:682px;left:274px;white-space:nowrap" class="ft1380">18 years&#160;of age or older&#160;</p>
<p style="position:absolute;top:720px;left:126px;white-space:nowrap" class="ft1389"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:720px;left:274px;white-space:nowrap" class="ft1380">Immunologist,&#160;allergist,&#160;rheumatologist&#160;</p>
<p style="position:absolute;top:780px;left:126px;white-space:nowrap" class="ft1389"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:780px;left:274px;white-space:nowrap" class="ft1380">Plan Year&#160;</p>
<p style="position:absolute;top:839px;left:126px;white-space:nowrap" class="ft1388"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:839px;left:274px;white-space:nowrap" class="ft1380">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1380">138&#160;</p>
</div>
<!-- Page 139 -->
<a name="139"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page139-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2139.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1391"><b>I</b></p>
<p style="position:absolute;top:123px;left:120px;white-space:nowrap" class="ft1394"><b>CLUSIG</b></p>
<p style="position:absolute;top:119px;left:212px;white-space:nowrap" class="ft13913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1392"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1395">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1396">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1390">Iclusig&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1392"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1392"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1398"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1390">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1398"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft13910">Therapy after&#160;hematopoietic&#160;stem cell transplant (HSCT) for chronic&#160;<br/>myeloid leukemia&#160;(CML) and acute&#160;lymphoblastic&#160;leukemia (ALL)&#160;<br/>patients&#160;</p>
<p style="position:absolute;top:437px;left:126px;white-space:nowrap" class="ft1399"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:437px;left:274px;white-space:nowrap" class="ft1390">N/A&#160;</p>
<p style="position:absolute;top:497px;left:126px;white-space:nowrap" class="ft1399"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:497px;left:274px;white-space:nowrap" class="ft13910">For chronic&#160;myeloid leukemia&#160;(CML) or&#160;acute lymphoblastic leukemia&#160;<br/>(ALL): diagnosis was confirmed by&#160;detection of&#160;the Philadelphia&#160;<br/>chromosome or&#160;BCR-ABL gene. For CML, including patients who have&#160;<br/>received a&#160;hematopoietic stem cell transplant:&#160;1) patient has&#160;accelerated or&#160;<br/>blast phase CML and no other kinase inhibitor is&#160;indicated,&#160;OR 2) patient&#160;<br/>has chronic&#160;phase&#160;CML and has experienced resistance&#160;or intolerance to&#160;<br/>at least&#160;2 prior kinase inhibitors&#160;AND at least one of&#160;those&#160;was imatinib&#160;or&#160;<br/>dasatinib, OR 3) patient&#160;is positive&#160;for the T315I mutation.&#160;</p>
<p style="position:absolute;top:680px;left:126px;white-space:nowrap" class="ft1398"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:680px;left:274px;white-space:nowrap" class="ft1390">N/A&#160;</p>
<p style="position:absolute;top:719px;left:126px;white-space:nowrap" class="ft1399"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:719px;left:274px;white-space:nowrap" class="ft1390">N/A&#160;</p>
<p style="position:absolute;top:778px;left:126px;white-space:nowrap" class="ft1399"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:778px;left:274px;white-space:nowrap" class="ft1390">Plan Year&#160;</p>
<p style="position:absolute;top:838px;left:126px;white-space:nowrap" class="ft1398"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:838px;left:274px;white-space:nowrap" class="ft1390">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1390">139&#160;</p>
</div>
<!-- Page 140 -->
<a name="140"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page140-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2140.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1401"><b>I</b></p>
<p style="position:absolute;top:123px;left:120px;white-space:nowrap" class="ft1404"><b>DHIFA</b></p>
<p style="position:absolute;top:119px;left:197px;white-space:nowrap" class="ft14013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1402"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1405">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1406">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1400">Idhifa&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1402"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1402"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1408"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1400">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1408"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1400">Newly-diagnosed acute&#160;myeloid leukemia&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1409"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1400">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1409"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft14010">For acute&#160;myeloid&#160;leukemia&#160;(AML) with an isocitrate dehydrogenase-2&#160;<br/>(IDH2) mutation: 1)&#160;patient has a physiologic age of&#160;60 years or older&#160;<br/>with newly-diagnosed AML and meets one&#160;of the&#160;following: a) patient&#160;is&#160;<br/>not a candidate&#160;for intensive induction therapy,&#160;or b)&#160;patient&#160;declines&#160;<br/>intensive induction chemotherapy,&#160;OR&#160;2) patient has&#160;a physiologic age of&#160;<br/>60 years or&#160;older&#160;and&#160;the requested&#160;drug will be&#160;used as post-induction&#160;<br/>therapy&#160;following response to induction therapy&#160;with the&#160;requested drug&#160;<br/>OR&#160;3) patient has&#160;relapsed or&#160;refractory AML.&#160;</p>
<p style="position:absolute;top:639px;left:126px;white-space:nowrap" class="ft1408"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:639px;left:274px;white-space:nowrap" class="ft1400">N/A&#160;</p>
<p style="position:absolute;top:678px;left:126px;white-space:nowrap" class="ft1409"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:678px;left:274px;white-space:nowrap" class="ft1400">N/A&#160;</p>
<p style="position:absolute;top:737px;left:126px;white-space:nowrap" class="ft1409"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:737px;left:274px;white-space:nowrap" class="ft1400">Plan Year&#160;</p>
<p style="position:absolute;top:796px;left:126px;white-space:nowrap" class="ft1408"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:796px;left:274px;white-space:nowrap" class="ft1400">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1400">140&#160;</p>
</div>
<!-- Page 141 -->
<a name="141"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page141-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2141.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1411"><b>I</b></p>
<p style="position:absolute;top:123px;left:120px;white-space:nowrap" class="ft1414"><b>MATINIB</b></p>
<p style="position:absolute;top:119px;left:228px;white-space:nowrap" class="ft14113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1412"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1415">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1416">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1410">Imatinib&#160;Mesylate&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1412"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1412"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1418"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1410">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1418"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft14110">Desmoid tumors, pigmented villonodular synovitis/tenosynovial&#160;giant&#160;cell&#160;<br/>tumor (PVNS/TGCT), recurrent chordoma, melanoma, AIDS-related&#160;<br/>Kaposi sarcoma, chronic myelomonocytic&#160;leukemia, chronic&#160;graft&#160;versus&#160;<br/>host&#160;disease&#160;(cGVHD), T-cell acute lymphoblastic leukemia,&#160;aggressive&#160;<br/>systemic&#160;mastocytosis when eosinophilia is present with FIP1L1-<br/>PDGFRA fusion gene&#160;</p>
<p style="position:absolute;top:500px;left:126px;white-space:nowrap" class="ft1419"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:500px;left:274px;white-space:nowrap" class="ft1410">N/A&#160;</p>
<p style="position:absolute;top:559px;left:126px;white-space:nowrap" class="ft1419"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:559px;left:274px;white-space:nowrap" class="ft14110">For chronic&#160;myeloid leukemia&#160;(CML) or&#160;Philadelphia&#160;chromosome&#160;<br/>positive acute lymphoblastic&#160;leukemia (Ph+ ALL):&#160;diagnosis&#160;was&#160;<br/>confirmed by detection&#160;of the Philadelphia&#160;chromosome or&#160;BCR-ABL&#160;<br/>gene. For&#160;CML: patient&#160;did not&#160;fail&#160;(excluding&#160;failure due to&#160;intolerance)&#160;<br/>prior therapy with a&#160;tyrosine kinase inhibitor. For melanoma:&#160;c-Kit&#160;<br/>mutation is&#160;positive.&#160;</p>
<p style="position:absolute;top:701px;left:126px;white-space:nowrap" class="ft1418"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:701px;left:274px;white-space:nowrap" class="ft1410">N/A&#160;</p>
<p style="position:absolute;top:740px;left:126px;white-space:nowrap" class="ft1419"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:740px;left:274px;white-space:nowrap" class="ft1410">N/A&#160;</p>
<p style="position:absolute;top:799px;left:126px;white-space:nowrap" class="ft1419"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:799px;left:274px;white-space:nowrap" class="ft1410">Plan Year&#160;</p>
<p style="position:absolute;top:859px;left:126px;white-space:nowrap" class="ft1418"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:859px;left:274px;white-space:nowrap" class="ft1410">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1410">141&#160;</p>
</div>
<!-- Page 142 -->
<a name="142"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page142-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2142.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1421"><b>I</b></p>
<p style="position:absolute;top:123px;left:120px;white-space:nowrap" class="ft1424"><b>MBRUVICA</b></p>
<p style="position:absolute;top:119px;left:254px;white-space:nowrap" class="ft14213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1422"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1425">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1426">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1420">Imbruvica&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1420">142&#160;</p>
</div>
<!-- Page 143 -->
<a name="143"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page143-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2143.png" alt="background image"/>
<p style="position:absolute;top:132px;left:126px;white-space:nowrap" class="ft1432"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:132px;left:274px;white-space:nowrap" class="ft1432"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:174px;left:126px;white-space:nowrap" class="ft1438"><b>Indications&#160;</b></p>
<p style="position:absolute;top:174px;left:274px;white-space:nowrap" class="ft1430">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:213px;left:126px;white-space:nowrap" class="ft1438"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:213px;left:274px;white-space:nowrap" class="ft14310">Hairy cell&#160;leukemia,&#160;lymphoplasmacytic&#160;lymphoma, follicular lymphoma,&#160;<br/>primary&#160;central nervous system&#160;lymphoma, AIDS-related B-cell&#160;<br/>lymphoma,&#160;histologic transformation of nodal&#160;marginal zone&#160;lymphoma&#160;<br/>to diffuse&#160;large B-cell lymphoma, diffuse large B-cell lymphoma, post-<br/>transplant&#160;lymphoproliferative&#160;disorders, high-grade B-cell lymphoma.&#160;</p>
<p style="position:absolute;top:334px;left:126px;white-space:nowrap" class="ft1439"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:334px;left:274px;white-space:nowrap" class="ft1430">N/A&#160;</p>
<p style="position:absolute;top:394px;left:126px;white-space:nowrap" class="ft1439"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:394px;left:274px;white-space:nowrap" class="ft14310">For mantle&#160;cell&#160;lymphoma: 1)&#160;the requested drug&#160;will&#160;be used&#160;in a patient&#160;<br/>who has received at least one prior&#160;therapy, OR&#160;2) the requested drug will&#160;<br/>be used in combination with rituximab as pretreatment to induction&#160;<br/>therapy with&#160;RHyperCVAD&#160;(rituximab, cyclophosphamide, vincristine,&#160;<br/>doxorubicin,&#160;and dexamethasone)&#160;regimen. For&#160;marginal zone&#160;lymphoma&#160;<br/>(including gastric mucosa-associated&#160;lymphoid&#160;tissue [MALT]&#160;<br/>lymphoma,&#160;non-gastric&#160;MALT&#160;lymphoma, nodal marginal&#160;zone&#160;<br/>lymphoma,&#160;and splenic marginal&#160;zone lymphoma):&#160;the patient has&#160;<br/>received at&#160;least one prior therapy. For hairy cell&#160;leukemia:&#160;the requested&#160;<br/>drug will be&#160;used as a single agent for disease&#160;progression. For primary&#160;<br/>central nervous system lymphoma: 1) the disease&#160;is relapsed&#160;or refractory&#160;<br/>OR&#160;2) the requested drug&#160;is used for induction therapy as&#160;a single agent.&#160;<br/>For histologic transformation of nodal marginal&#160;zone lymphoma to diffuse&#160;<br/>large B-cell&#160;lymphoma: the requested&#160;drug will be&#160;used in patients&#160;who&#160;<br/>have received prior chemoimmunotherapy. For diffuse large B-cell&#160;<br/>lymphoma: the requested&#160;drug will be&#160;used as second-line or&#160;subsequent&#160;<br/>therapy. For&#160;AIDS-related B-cell lymphoma: the requested&#160;drug will be&#160;<br/>used as a single agent and as second-line or subsequent therapy for&#160;<br/>relapsed disease. For post-transplant lymphoproliferative disorders: the&#160;<br/>requested drug will&#160;be used in patients who have received prior&#160;<br/>chemoimmunotherapy. For high-grade B-cell lymphoma:&#160;the requested&#160;<br/>drug will be&#160;used as second-line or&#160;subsequent&#160;therapy. For follicular&#160;<br/>lymphoma: the requested&#160;drug will&#160;be&#160;used as a single agent.&#160;</p>
<p style="position:absolute;top:888px;left:126px;white-space:nowrap" class="ft1438"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:888px;left:274px;white-space:nowrap" class="ft1430">N/A&#160;</p>
<p style="position:absolute;top:927px;left:126px;white-space:nowrap" class="ft1439"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:927px;left:274px;white-space:nowrap" class="ft1430">N/A&#160;</p>
<p style="position:absolute;top:986px;left:126px;white-space:nowrap" class="ft1439"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:986px;left:274px;white-space:nowrap" class="ft1430">Plan Year&#160;</p>
<p style="position:absolute;top:1045px;left:126px;white-space:nowrap" class="ft1438"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:1045px;left:274px;white-space:nowrap" class="ft1430">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1430">143&#160;</p>
</div>
<!-- Page 144 -->
<a name="144"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page144-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2144.png" alt="background image"/>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1440">144</p>
<p style="position:absolute;top:1093px;left:810px;white-space:nowrap" class="ft1446">&#160;</p>
</div>
<!-- Page 145 -->
<a name="145"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page145-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2145.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1451"><b>I</b></p>
<p style="position:absolute;top:123px;left:120px;white-space:nowrap" class="ft1454"><b>MLYGIC</b></p>
<p style="position:absolute;top:119px;left:221px;white-space:nowrap" class="ft14513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1452"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1455">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1456">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1450">Imlygic&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1452"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1452"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1458"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1450">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1458"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1450">Limited resectable&#160;or incompletely&#160;resectable melanoma&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1459"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1450">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1459"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft14510">For melanoma: The&#160;requested drug&#160;will&#160;be used&#160;for&#160;the treatment&#160;of&#160;<br/>unresectable, limited&#160;resectable, or&#160;incompletely&#160;resectable cutaneous,&#160;<br/>subcutaneous, and nodal&#160;lesions.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft1458"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft1450">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft1459"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft1450">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft1459"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft1450">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft1458"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft1450">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1450">145&#160;</p>
</div>
<!-- Page 146 -->
<a name="146"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page146-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2146.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1461"><b>I</b></p>
<p style="position:absolute;top:123px;left:120px;white-space:nowrap" class="ft1464"><b>NCRELEX</b></p>
<p style="position:absolute;top:119px;left:237px;white-space:nowrap" class="ft14613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1462"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1465">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1466">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1460">Increlex&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1462"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1462"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1468"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1460">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1468"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1460">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1469"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1460">Pediatric patients&#160;with closed epiphyses&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1469"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft14610">For growth&#160;failure&#160;due to severe&#160;primary&#160;insulin-like growth factor-1&#160;<br/>(IGF-1) deficiency or growth hormone gene deletion in patients who have&#160;<br/>developed neutralizing antibodies to&#160;growth hormone, must&#160;meet&#160;all&#160;of&#160;<br/>the following prior to beginning therapy with the requested drug (new&#160;<br/>starts only):&#160;1) height 3 or more&#160;standard&#160;deviations (SD) below the mean&#160;<br/>for&#160;children&#160;of the same&#160;age and gender&#160;AND 2) basal&#160;IGF-1&#160;level 3 or&#160;<br/>more SD below the mean&#160;for&#160;children&#160;of the same&#160;age and gender&#160;AND 3)&#160;<br/>provocative&#160;growth hormone&#160;test showing a normal or elevated growth&#160;<br/>hormone&#160;level. For renewal, patient&#160;is experiencing improvement.&#160;</p>
<p style="position:absolute;top:660px;left:126px;white-space:nowrap" class="ft1468"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:660px;left:274px;white-space:nowrap" class="ft1460">N/A&#160;</p>
<p style="position:absolute;top:698px;left:126px;white-space:nowrap" class="ft1469"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:698px;left:274px;white-space:nowrap" class="ft1460">N/A&#160;</p>
<p style="position:absolute;top:758px;left:126px;white-space:nowrap" class="ft1469"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:758px;left:274px;white-space:nowrap" class="ft1460">Plan Year&#160;</p>
<p style="position:absolute;top:817px;left:126px;white-space:nowrap" class="ft1468"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:817px;left:274px;white-space:nowrap" class="ft1460">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1460">146&#160;</p>
</div>
<!-- Page 147 -->
<a name="147"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page147-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2147.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1471"><b>I</b></p>
<p style="position:absolute;top:123px;left:120px;white-space:nowrap" class="ft1474"><b>NLYTA</b></p>
<p style="position:absolute;top:119px;left:204px;white-space:nowrap" class="ft14713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1472"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1475">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1476">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1470">Inlyta&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1472"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1472"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1478"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1470">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1478"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1470">Thyroid carcinoma&#160;(papillary, Hurthle cell, or follicular).&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1479"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1470">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1479"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft1470">For renal&#160;cell carcinoma: the disease&#160;is advanced,&#160;relapsed, or&#160;stage IV.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft1478"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft1470">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft1479"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft1470">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft1479"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft1470">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft1478"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft1470">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1470">147&#160;</p>
</div>
<!-- Page 148 -->
<a name="148"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page148-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2148.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1481"><b>I</b></p>
<p style="position:absolute;top:123px;left:120px;white-space:nowrap" class="ft1484"><b>NQOVI</b></p>
<p style="position:absolute;top:119px;left:201px;white-space:nowrap" class="ft14813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1482"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1485">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1486">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1480">Inqovi&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1482"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1482"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1488"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1480">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1488"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1480">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1489"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1480">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1489"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft1480">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft1488"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft1480">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft1489"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft1480">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft1489"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft1480">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft1488"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft1480">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1480">148&#160;</p>
</div>
<!-- Page 149 -->
<a name="149"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page149-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2149.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1491"><b>I</b></p>
<p style="position:absolute;top:123px;left:120px;white-space:nowrap" class="ft1494"><b>NREBIC</b></p>
<p style="position:absolute;top:119px;left:213px;white-space:nowrap" class="ft14913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1492"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1495">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1496">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1490">Inrebic&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1492"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1492"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1498"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1490">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1498"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft14910">Myeloid,&#160;lymphoid, or&#160;mixed&#160;lineage neoplasms with eosinophilia and&#160;<br/>janus&#160;kinase 2 (JAK2) rearrangement&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft1499"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft1490">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft1499"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft14910">For myeloid, lymphoid,&#160;or mixed lineage neoplasms&#160;with eosinophilia and&#160;<br/>JAK2 rearrangement: the disease is&#160;in&#160;chronic or&#160;blast phase.&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft1498"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft1490">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft1499"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft1490">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft1499"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft1490">Plan Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft1498"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft1490">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1490">149&#160;</p>
</div>
<!-- Page 150 -->
<a name="150"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page150-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2150.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1501"><b>I</b></p>
<p style="position:absolute;top:123px;left:120px;white-space:nowrap" class="ft1504"><b>R&#160;</b></p>
<p style="position:absolute;top:118px;left:143px;white-space:nowrap" class="ft1501"><b>B</b></p>
<p style="position:absolute;top:123px;left:163px;white-space:nowrap" class="ft1504"><b>EFORE&#160;</b></p>
<p style="position:absolute;top:118px;left:252px;white-space:nowrap" class="ft1501"><b>E</b></p>
<p style="position:absolute;top:123px;left:272px;white-space:nowrap" class="ft1504"><b>R</b></p>
<p style="position:absolute;top:119px;left:289px;white-space:nowrap" class="ft15013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1502"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1505">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1506">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1500">Hydrocodone&#160;Bitartrate Er&#160;T24A&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft1505">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft1506">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft1500">Hysingla Er&#160;</p>
<p style="position:absolute;top:242px;left:122px;white-space:nowrap" class="ft1505">•</p>
<p style="position:absolute;top:241px;left:130px;white-space:nowrap" class="ft1506">&#160;</p>
<p style="position:absolute;top:244px;left:149px;white-space:nowrap" class="ft1500">Methadone&#160;Hcl&#160;INJ&#160;</p>
<p style="position:absolute;top:264px;left:122px;white-space:nowrap" class="ft1505">•</p>
<p style="position:absolute;top:263px;left:130px;white-space:nowrap" class="ft1506">&#160;</p>
<p style="position:absolute;top:266px;left:149px;white-space:nowrap" class="ft1500">Methadone&#160;Hcl&#160;ORAL&#160;SOLN&#160;</p>
<p style="position:absolute;top:286px;left:122px;white-space:nowrap" class="ft1505">•</p>
<p style="position:absolute;top:285px;left:130px;white-space:nowrap" class="ft1506">&#160;</p>
<p style="position:absolute;top:288px;left:149px;white-space:nowrap" class="ft1500">Methadone&#160;Hcl&#160;TABS&#160;</p>
<p style="position:absolute;top:308px;left:122px;white-space:nowrap" class="ft1505">•</p>
<p style="position:absolute;top:307px;left:130px;white-space:nowrap" class="ft1506">&#160;</p>
<p style="position:absolute;top:310px;left:149px;white-space:nowrap" class="ft1500">Methadone&#160;Hydrochloride&#160;CONC&#160;</p>
<p style="position:absolute;top:330px;left:122px;white-space:nowrap" class="ft1505">•</p>
<p style="position:absolute;top:329px;left:130px;white-space:nowrap" class="ft1506">&#160;</p>
<p style="position:absolute;top:332px;left:149px;white-space:nowrap" class="ft1500">Morphine Sulfate Er&#160;CP24&#160;</p>
<p style="position:absolute;top:352px;left:122px;white-space:nowrap" class="ft1505">•</p>
<p style="position:absolute;top:351px;left:130px;white-space:nowrap" class="ft1506">&#160;</p>
<p style="position:absolute;top:354px;left:149px;white-space:nowrap" class="ft1500">Morphine Sulfate Er&#160;TBCR&#160;</p>
<p style="position:absolute;top:374px;left:122px;white-space:nowrap" class="ft1505">•</p>
<p style="position:absolute;top:373px;left:130px;white-space:nowrap" class="ft1506">&#160;</p>
<p style="position:absolute;top:376px;left:149px;white-space:nowrap" class="ft1500">Tramadol Hcl Er&#160;TB24&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1500">150&#160;</p>
</div>
<!-- Page 151 -->
<a name="151"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page151-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2151.png" alt="background image"/>
<p style="position:absolute;top:132px;left:126px;white-space:nowrap" class="ft1512"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:132px;left:274px;white-space:nowrap" class="ft1512"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:174px;left:126px;white-space:nowrap" class="ft1518"><b>Indications&#160;</b></p>
<p style="position:absolute;top:174px;left:274px;white-space:nowrap" class="ft1510">All&#160;FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:213px;left:126px;white-space:nowrap" class="ft1518"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:213px;left:274px;white-space:nowrap" class="ft1510">N/A&#160;</p>
<p style="position:absolute;top:252px;left:126px;white-space:nowrap" class="ft1519"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:252px;left:274px;white-space:nowrap" class="ft1510">N/A&#160;</p>
<p style="position:absolute;top:311px;left:126px;white-space:nowrap" class="ft1519"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:311px;left:274px;white-space:nowrap" class="ft15110">1)&#160;The requested drug&#160;is being prescribed for pain&#160;associated&#160;with cancer,&#160;<br/>sickle cell disease, a&#160;terminal condition, or pain&#160;being managed through&#160;<br/>palliative&#160;care&#160;OR&#160;2) The requested&#160;drug is being prescribed&#160;for&#160;pain&#160;<br/>severe&#160;enough to require&#160;daily, around-the-clock,&#160;long-term&#160;treatment in&#160;a&#160;<br/>patient who has been taking an opioid&#160;AND 3) The patient can safely take&#160;<br/>the requested dose based&#160;on their history of&#160;opioid use [Note: This drug&#160;<br/>should be prescribed only by healthcare&#160;professionals&#160;who are&#160;<br/>knowledgeable in&#160;the use of potent opioids for the management of chronic&#160;<br/>pain.]&#160;AND 4) The patient has&#160;been&#160;evaluated and the patient&#160;will&#160;be&#160;<br/>monitored&#160;for the&#160;development of opioid use disorder&#160;AND 5) This&#160;<br/>request&#160;is for continuation of therapy&#160;for&#160;a patient&#160;who has been receiving&#160;<br/>an extended-release&#160;opioid agent&#160;for at least&#160;30 days OR the patient has&#160;<br/>taken an&#160;immediate-release opioid for at&#160;least one week.&#160;</p>
<p style="position:absolute;top:598px;left:126px;white-space:nowrap" class="ft1518"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:598px;left:274px;white-space:nowrap" class="ft1510">N/A&#160;</p>
<p style="position:absolute;top:637px;left:126px;white-space:nowrap" class="ft1519"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:637px;left:274px;white-space:nowrap" class="ft1510">N/A&#160;</p>
<p style="position:absolute;top:696px;left:126px;white-space:nowrap" class="ft1519"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:696px;left:274px;white-space:nowrap" class="ft1510">Plan Year&#160;</p>
<p style="position:absolute;top:756px;left:126px;white-space:nowrap" class="ft1518"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:756px;left:274px;white-space:nowrap" class="ft1510">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1510">151&#160;</p>
</div>
<!-- Page 152 -->
<a name="152"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page152-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2152.png" alt="background image"/>
</div>
<!-- Page 153 -->
<a name="153"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page153-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2153.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1531"><b>I</b></p>
<p style="position:absolute;top:123px;left:120px;white-space:nowrap" class="ft1534"><b>SOTRETINOIN</b></p>
<p style="position:absolute;top:128px;left:289px;white-space:nowrap" class="ft15313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1532"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1535">•</p>
<p style="position:absolute;top:203px;left:130px;white-space:nowrap" class="ft1536">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1530">Accutane&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft1535">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft1536">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft1530">Amnesteem&#160;</p>
<p style="position:absolute;top:242px;left:122px;white-space:nowrap" class="ft1535">•</p>
<p style="position:absolute;top:241px;left:130px;white-space:nowrap" class="ft1536">&#160;</p>
<p style="position:absolute;top:244px;left:149px;white-space:nowrap" class="ft1530">Claravis&#160;</p>
<p style="position:absolute;top:264px;left:122px;white-space:nowrap" class="ft1535">•</p>
<p style="position:absolute;top:263px;left:130px;white-space:nowrap" class="ft1536">&#160;</p>
<p style="position:absolute;top:266px;left:149px;white-space:nowrap" class="ft1530">Isotretinoin&#160;CAPS&#160;</p>
<p style="position:absolute;top:286px;left:122px;white-space:nowrap" class="ft1535">•</p>
<p style="position:absolute;top:285px;left:130px;white-space:nowrap" class="ft1536">&#160;</p>
<p style="position:absolute;top:288px;left:149px;white-space:nowrap" class="ft1530">Myorisan&#160;</p>
<p style="position:absolute;top:308px;left:122px;white-space:nowrap" class="ft1535">•</p>
<p style="position:absolute;top:307px;left:130px;white-space:nowrap" class="ft1536">&#160;</p>
<p style="position:absolute;top:310px;left:149px;white-space:nowrap" class="ft1530">Zenatane&#160;</p>
<p style="position:absolute;top:387px;left:126px;white-space:nowrap" class="ft1532"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:387px;left:274px;white-space:nowrap" class="ft1532"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:429px;left:126px;white-space:nowrap" class="ft1538"><b>Indications&#160;</b></p>
<p style="position:absolute;top:429px;left:274px;white-space:nowrap" class="ft1530">All FDA-approved&#160;Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:467px;left:126px;white-space:nowrap" class="ft1538"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:467px;left:274px;white-space:nowrap" class="ft15310">Refractory acne&#160;vulgaris, severe&#160;refractory rosacea, neuroblastoma,&#160;<br/>cutaneous T-cell lymphoma (CTCL) (e.g., mycosis fungoides,&#160;Sezary&#160;<br/>syndrome),&#160;high risk for&#160;developing&#160;skin cancer&#160;(squamous cell&#160;cancers),&#160;<br/>transient&#160;acantholytic dermatosis (Grover's Disease), keratosis&#160;follicularis&#160;<br/>(Darier Disease), lamellar ichthyosis, pityriasis rubra pilaris.&#160;</p>
<p style="position:absolute;top:589px;left:126px;white-space:nowrap" class="ft1539"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:589px;left:274px;white-space:nowrap" class="ft1530">N/A&#160;</p>
<p style="position:absolute;top:648px;left:126px;white-space:nowrap" class="ft1539"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:648px;left:274px;white-space:nowrap" class="ft1530">N/A&#160;</p>
<p style="position:absolute;top:728px;left:126px;white-space:nowrap" class="ft1538"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:728px;left:274px;white-space:nowrap" class="ft1530">N/A&#160;</p>
<p style="position:absolute;top:767px;left:126px;white-space:nowrap" class="ft1539"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:767px;left:274px;white-space:nowrap" class="ft1530">N/A&#160;</p>
<p style="position:absolute;top:826px;left:126px;white-space:nowrap" class="ft1539"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:826px;left:274px;white-space:nowrap" class="ft1530">Plan Year&#160;</p>
<p style="position:absolute;top:886px;left:126px;white-space:nowrap" class="ft1538"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:886px;left:274px;white-space:nowrap" class="ft1530">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1530">153&#160;</p>
</div>
<!-- Page 154 -->
<a name="154"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page154-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2154.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1541"><b>I</b></p>
<p style="position:absolute;top:123px;left:120px;white-space:nowrap" class="ft1544"><b>TRACONAZOLE</b></p>
<p style="position:absolute;top:119px;left:308px;white-space:nowrap" class="ft15413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1542"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1545">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1546">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1540">Itraconazole&#160;CAPS&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1542"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1542"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1548"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1540">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1548"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft15410">Coccidioidomycosis,&#160;Coccidioidomycosis prophylaxis&#160;in HIV infection,&#160;<br/>Cryptococcosis, Histoplasmosis prophylaxis&#160;in HIV infection,&#160;invasive&#160;<br/>fungal&#160;infection prophylaxis in liver transplant patients, Microsporidiosis,&#160;<br/>Talaromycosis (formerly&#160;Penicilliosis), Pityriasis versicolor/Tinea&#160;<br/>versicolor, Sporotrichosis, Tinea&#160;corporis, Tinea&#160;cruris, Tinea capitis,&#160;<br/>Tinea&#160;manuum, Tinea&#160;pedis&#160;</p>
<p style="position:absolute;top:500px;left:126px;white-space:nowrap" class="ft1549"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:500px;left:274px;white-space:nowrap" class="ft1540">N/A&#160;</p>
<p style="position:absolute;top:559px;left:126px;white-space:nowrap" class="ft1549"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:559px;left:274px;white-space:nowrap" class="ft15410">If&#160;for&#160;the treatment of&#160;onychomycosis due to dermatophytes&#160;(Tinea&#160;<br/>unguium), the diagnosis has been confirmed by a&#160;fungal diagnostic&#160;test&#160;<br/>(e.g., potassium hydroxide [KOH] preparation, fungal culture,&#160;or nail&#160;<br/>biopsy).&#160;</p>
<p style="position:absolute;top:660px;left:126px;white-space:nowrap" class="ft1548"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:660px;left:274px;white-space:nowrap" class="ft1540">N/A&#160;</p>
<p style="position:absolute;top:698px;left:126px;white-space:nowrap" class="ft1549"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:698px;left:274px;white-space:nowrap" class="ft1540">N/A&#160;</p>
<p style="position:absolute;top:758px;left:126px;white-space:nowrap" class="ft1549"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:758px;left:274px;white-space:nowrap" class="ft15410">Disseminated/CNS&#160;histoplasmosis,&#160;Histoplasmosis/Coccidioidomycosis&#160;<br/>ppx: 12 mths. Others: 6 mths&#160;</p>
<p style="position:absolute;top:817px;left:126px;white-space:nowrap" class="ft1548"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:817px;left:274px;white-space:nowrap" class="ft1540">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1540">154&#160;</p>
</div>
<!-- Page 155 -->
<a name="155"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page155-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2155.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1551"><b>I</b></p>
<p style="position:absolute;top:123px;left:120px;white-space:nowrap" class="ft1554"><b>VERMECTIN&#160;</b></p>
<p style="position:absolute;top:118px;left:275px;white-space:nowrap" class="ft1551"><b>T</b></p>
<p style="position:absolute;top:123px;left:295px;white-space:nowrap" class="ft1554"><b>AB</b></p>
<p style="position:absolute;top:119px;left:328px;white-space:nowrap" class="ft15513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1552"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1555">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1556">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1550">Ivermectin&#160;TABS&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1552"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1552"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1558"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1550">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1558"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft15510">Ascariasis,&#160;Cutaneous larva&#160;migrans, Mansonelliasis, Scabies,&#160;<br/>Gnathostomiasis, Pediculosis&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft1559"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft1550">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft1559"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft15510">The requested&#160;drug is not being prescribed&#160;for&#160;the prevention or treatment&#160;<br/>of coronavirus disease 2019 (COVID-19).&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft1558"><b>Age&#160;Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft1550">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft1559"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft1550">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft1559"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft1550">1 month&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft1558"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft1550">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1550">155&#160;</p>
</div>
<!-- Page 156 -->
<a name="156"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page156-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2156.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1561"><b>I</b></p>
<p style="position:absolute;top:123px;left:120px;white-space:nowrap" class="ft1564"><b>VIG</b></p>
<p style="position:absolute;top:119px;left:165px;white-space:nowrap" class="ft15613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1562"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1565">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1566">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1560">Bivigam&#160;INJ 10%, 5GM/50ML&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft1565">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft1566">&#160;&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft1560">Flebogamma Dif&#160;</p>
<p style="position:absolute;top:242px;left:122px;white-space:nowrap" class="ft1565">•</p>
<p style="position:absolute;top:241px;left:130px;white-space:nowrap" class="ft1566">&#160;&#160;</p>
<p style="position:absolute;top:244px;left:149px;white-space:nowrap" class="ft1560">Gammagard Liquid&#160;</p>
<p style="position:absolute;top:264px;left:122px;white-space:nowrap" class="ft1565">•</p>
<p style="position:absolute;top:263px;left:130px;white-space:nowrap" class="ft1566">&#160;&#160;</p>
<p style="position:absolute;top:266px;left:149px;white-space:nowrap" class="ft15610">Gammagard S/d Iga Less Than&#160;<br/>1mcg/ml&#160;</p>
<p style="position:absolute;top:306px;left:122px;white-space:nowrap" class="ft1565">•</p>
<p style="position:absolute;top:306px;left:130px;white-space:nowrap" class="ft1566">&#160;&#160;</p>
<p style="position:absolute;top:308px;left:149px;white-space:nowrap" class="ft15610">Gammaked&#160;INJ 10GM/100ML,&#160;<br/>1GM/10ML, 20GM/200ML,&#160;<br/>5GM/50ML&#160;</p>
<p style="position:absolute;top:370px;left:122px;white-space:nowrap" class="ft1565">•</p>
<p style="position:absolute;top:369px;left:130px;white-space:nowrap" class="ft1566">&#160;&#160;</p>
<p style="position:absolute;top:372px;left:149px;white-space:nowrap" class="ft15610">Gammaplex&#160;INJ 10GM/100ML,&#160;<br/>10GM/200ML, 20GM/200ML,&#160;<br/>20GM/400ML, 5GM/100ML,&#160;<br/>5GM/50ML&#160;</p>
<p style="position:absolute;top:454px;left:122px;white-space:nowrap" class="ft1565">•</p>
<p style="position:absolute;top:453px;left:130px;white-space:nowrap" class="ft1566">&#160;&#160;</p>
<p style="position:absolute;top:456px;left:149px;white-space:nowrap" class="ft1560">Gamunex-c&#160;</p>
<p style="position:absolute;top:476px;left:122px;white-space:nowrap" class="ft1565">•</p>
<p style="position:absolute;top:475px;left:130px;white-space:nowrap" class="ft1566">&#160;&#160;</p>
<p style="position:absolute;top:478px;left:149px;white-space:nowrap" class="ft15610">Octagam&#160;INJ 10GM/100ML,&#160;<br/>10GM/200ML, 2.5GM/50ML,&#160;<br/>20GM/200ML, 25GM/500ML,&#160;<br/>2GM/20ML, 30GM/300ML,&#160;<br/>5GM/100ML, 5GM/50ML&#160;</p>
<p style="position:absolute;top:581px;left:122px;white-space:nowrap" class="ft1565">•</p>
<p style="position:absolute;top:580px;left:130px;white-space:nowrap" class="ft1566">&#160;&#160;</p>
<p style="position:absolute;top:583px;left:149px;white-space:nowrap" class="ft1560">Panzyga&#160;</p>
<p style="position:absolute;top:603px;left:122px;white-space:nowrap" class="ft1565">•</p>
<p style="position:absolute;top:602px;left:130px;white-space:nowrap" class="ft1566">&#160;&#160;</p>
<p style="position:absolute;top:605px;left:149px;white-space:nowrap" class="ft1560">Privigen&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1560">156&#160;</p>
</div>
<!-- Page 157 -->
<a name="157"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page157-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2157.png" alt="background image"/>
<p style="position:absolute;top:132px;left:126px;white-space:nowrap" class="ft1572"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:132px;left:274px;white-space:nowrap" class="ft1572"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:174px;left:126px;white-space:nowrap" class="ft1578"><b>Indications&#160;</b></p>
<p style="position:absolute;top:174px;left:274px;white-space:nowrap" class="ft1570">All Medically-accepted Indications.&#160;</p>
<p style="position:absolute;top:213px;left:126px;white-space:nowrap" class="ft1578"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:213px;left:274px;white-space:nowrap" class="ft1570">N/A&#160;</p>
<p style="position:absolute;top:252px;left:126px;white-space:nowrap" class="ft1579"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:252px;left:274px;white-space:nowrap" class="ft1570">N/A&#160;</p>
<p style="position:absolute;top:311px;left:126px;white-space:nowrap" class="ft1579"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:311px;left:274px;white-space:nowrap" class="ft15710">For B-cell&#160;chronic&#160;lymphocytic&#160;leukemia&#160;(CLL):&#160;1) serum IgG less&#160;than&#160;<br/>500 mg/dL&#160;OR&#160;2) a&#160;history of&#160;recurrent bacterial infections.&#160;For bone&#160;<br/>marrow transplant/hematopoietic stem cell transplant&#160;(BMT/HSCT):&#160;1)&#160;<br/>IVIG is requested within&#160;the first 100&#160;days post-transplant OR 2) serum&#160;<br/>IgG less than 400 mg/dL. For pediatric human&#160;immunodeficiency virus&#160;<br/>(HIV) infection:&#160;1) serum IgG less&#160;than 400 mg/dL, OR 2) history of&#160;<br/>recurrent bacterial&#160;infections. For dermatomyositis and polymyositis: 1) at&#160;<br/>least one standard first-line&#160;treatment (corticosteroid or&#160;<br/>immunosuppressant) has been tried&#160;but was unsuccessful or&#160;not tolerated&#160;<br/>OR&#160;2) patient is unable to receive&#160;standard therapy because&#160;of a&#160;<br/>contraindication or other clinical&#160;reason. For pure&#160;red cell&#160;aplasia&#160;<br/>(PRCA): PRCA&#160;is secondary to parvovirus B19 infection.&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft1578"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft1570">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft1579"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft1570">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft1579"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft1570">Plan Year&#160;</p>
<p style="position:absolute;top:735px;left:126px;white-space:nowrap" class="ft1578"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:735px;left:274px;white-space:nowrap" class="ft15710">Coverage&#160;under&#160;Part&#160;D will be denied&#160;if&#160;coverage&#160;is available under Part&#160;<br/>A or Part&#160;B as the&#160;medication&#160;is prescribed&#160;and dispensed or&#160;administered&#160;<br/>for&#160;the individual.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1570">157&#160;</p>
</div>
<!-- Page 158 -->
<a name="158"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page158-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2158.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1581"><b>J</b></p>
<p style="position:absolute;top:123px;left:123px;white-space:nowrap" class="ft1584"><b>AKAFI</b></p>
<p style="position:absolute;top:119px;left:200px;white-space:nowrap" class="ft15813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1582"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1585">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1586">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1580">Jakafi&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1582"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1582"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1588"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1580">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1588"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft15810">Lower-risk&#160;myelofibrosis, accelerated phase myelofibrosis, blast&#160;phase&#160;<br/>myelofibrosis/acute myeloid leukemia, acute&#160;lymphoblastic&#160;leukemia&#160;<br/>(ALL), chronic myelomonocytic&#160;leukemia&#160;(CMML)-2, BCR-ABL&#160;<br/>negative atypical&#160;chronic myeloid leukemia&#160;(aCML), essential&#160;<br/>thrombocythemia,&#160;and myeloid,&#160;lymphoid or&#160;mixed lineage neoplasms&#160;<br/>with eosinophilia and JAK2 rearrangement&#160;</p>
<p style="position:absolute;top:500px;left:126px;white-space:nowrap" class="ft1589"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:500px;left:274px;white-space:nowrap" class="ft1580">N/A&#160;</p>
<p style="position:absolute;top:559px;left:126px;white-space:nowrap" class="ft1589"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:559px;left:274px;white-space:nowrap" class="ft15810">For polycythemia&#160;vera:&#160;patient had an inadequate&#160;response&#160;or&#160;intolerance&#160;<br/>to interferon therapy or hydroxyurea.&#160;For acute lymphoblastic&#160;leukemia:&#160;<br/>patient has&#160;a&#160;cytokine&#160;receptor-like factor 2 (CRLF2) mutation or a&#160;<br/>mutation associated with&#160;activation of the Janus kinase/signal&#160;transducers&#160;<br/>and activators&#160;of transcription (JAK/STAT) pathway. For CMML-2: the&#160;<br/>requested drug is&#160;used in&#160;combination with a&#160;hypomethylating agent. For&#160;<br/>BCR-ABL negative aCML: the&#160;requested drug&#160;is used as a&#160;single&#160;agent&#160;or&#160;<br/>in combination with a&#160;hypomethylating agent. For essential&#160;<br/>thrombocythemia: patient had an inadequate&#160;response or&#160;loss&#160;of response&#160;<br/>to hydroxyurea, interferon therapy,&#160;or anagrelide. For myeloid, lymphoid,&#160;<br/>or mixed lineage neoplasms&#160;with eosinophilia and JAK2 rearrangement:&#160;<br/>the disease&#160;is in chronic or blast phase.&#160;</p>
<p style="position:absolute;top:825px;left:126px;white-space:nowrap" class="ft1588"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:825px;left:274px;white-space:nowrap" class="ft1580">N/A&#160;</p>
<p style="position:absolute;top:864px;left:126px;white-space:nowrap" class="ft1589"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:864px;left:274px;white-space:nowrap" class="ft1580">N/A&#160;</p>
<p style="position:absolute;top:923px;left:126px;white-space:nowrap" class="ft1589"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:923px;left:274px;white-space:nowrap" class="ft1580">Plan Year&#160;</p>
<p style="position:absolute;top:983px;left:126px;white-space:nowrap" class="ft1588"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:983px;left:274px;white-space:nowrap" class="ft1580">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1580">158&#160;</p>
</div>
<!-- Page 159 -->
<a name="159"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page159-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2159.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1591"><b>K</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1594"><b>ALYDECO</b></p>
<p style="position:absolute;top:119px;left:251px;white-space:nowrap" class="ft15913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1592"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1595">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1596">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1590">Kalydeco&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1592"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1592"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1598"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1590">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1598"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1590">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1599"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1590">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1599"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft15910">For cystic&#160;fibrosis (CF):&#160;The requested medication will&#160;not be used in&#160;<br/>combination&#160;with other&#160;medications&#160;containing ivacaftor.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft1598"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft1590">4 months&#160;of age or older&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft1599"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft1590">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft1599"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft1590">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft1598"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft1590">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1590">159&#160;</p>
</div>
<!-- Page 160 -->
<a name="160"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page160-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2160.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1601"><b>K</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1604"><b>ESIMPTA</b></p>
<p style="position:absolute;top:119px;left:241px;white-space:nowrap" class="ft16013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1602"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1605">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1606">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1600">Kesimpta&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1602"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1602"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1608"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1600">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1608"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1600">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1609"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1600">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1609"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft1600">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft1608"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft1600">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft1609"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft1600">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft1609"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft1600">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft1608"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft1600">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1600">160&#160;</p>
</div>
<!-- Page 161 -->
<a name="161"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page161-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2161.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1611"><b>K</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1614"><b>ETOCONAZOLE</b></p>
<p style="position:absolute;top:119px;left:319px;white-space:nowrap" class="ft16113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1612"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1615">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1616">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1610">Ketoconazole&#160;TABS&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1612"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1612"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1618"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1610">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1618"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1610">Cushing's syndrome&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1619"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft16110">Acute or&#160;chronic liver disease. Concurrent use with drugs&#160;that are&#160;<br/>contraindicated with ketoconazole&#160;tablets: dofetilide, quinidine, pimozide,&#160;<br/>cisapride,&#160;methadone, disopyramide,&#160;dronedarone, ranolazine, ergot&#160;<br/>alkaloids, irinotecan,&#160;lurasidone, oral&#160;midazolam,&#160;alprazolam,&#160;triazolam,&#160;<br/>felodipine, nisoldipine, tolvaptan,&#160;eplerenone, lovastatin, simvastatin, or&#160;<br/>colchicine.&#160;</p>
<p style="position:absolute;top:538px;left:126px;white-space:nowrap" class="ft1619"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:538px;left:274px;white-space:nowrap" class="ft16110">The potential&#160;benefits&#160;outweigh the&#160;risks of&#160;treatment with oral&#160;<br/>ketoconazole. For systemic&#160;fungal&#160;infections, the patient has&#160;any of&#160;the&#160;<br/>following diagnoses: blastomycosis, coccidioidomycosis, histoplasmosis,&#160;<br/>chromomycosis, or&#160;paracoccidioidomycosis. For Cushing's&#160;syndrome: the&#160;<br/>requested drug is&#160;being prescribed&#160;for a patient&#160;who cannot tolerate&#160;<br/>surgery or where surgery&#160;has not&#160;been curative.&#160;</p>
<p style="position:absolute;top:680px;left:126px;white-space:nowrap" class="ft1618"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:680px;left:274px;white-space:nowrap" class="ft1610">N/A&#160;</p>
<p style="position:absolute;top:719px;left:126px;white-space:nowrap" class="ft1619"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:719px;left:274px;white-space:nowrap" class="ft1610">N/A&#160;</p>
<p style="position:absolute;top:778px;left:126px;white-space:nowrap" class="ft1619"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:778px;left:274px;white-space:nowrap" class="ft1610">6 months&#160;</p>
<p style="position:absolute;top:838px;left:126px;white-space:nowrap" class="ft1618"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:838px;left:274px;white-space:nowrap" class="ft1610">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1610">161&#160;</p>
</div>
<!-- Page 162 -->
<a name="162"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page162-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2162.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1621"><b>K</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1624"><b>EYTRUDA</b></p>
<p style="position:absolute;top:119px;left:250px;white-space:nowrap" class="ft16213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1622"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1625">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1626">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1620">Keytruda&#160;INJ 100MG/4ML&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1622"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1622"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1628"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1620">All Medically-accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1628"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1620">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1629"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1620">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1629"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft1620">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft1628"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft1620">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft1629"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft1620">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft1629"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft1620">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft1628"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft1620">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1620">162&#160;</p>
</div>
<!-- Page 163 -->
<a name="163"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page163-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2163.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1631"><b>K</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1634"><b>ISQALI</b></p>
<p style="position:absolute;top:119px;left:215px;white-space:nowrap" class="ft16313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1632"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1635">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1636">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1630">Kisqali&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft1635">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft1636">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft1630">Kisqali Femara&#160;200 Dose&#160;</p>
<p style="position:absolute;top:242px;left:122px;white-space:nowrap" class="ft1635">•</p>
<p style="position:absolute;top:241px;left:130px;white-space:nowrap" class="ft1636">&#160;</p>
<p style="position:absolute;top:244px;left:149px;white-space:nowrap" class="ft1630">Kisqali Femara&#160;400 Dose&#160;</p>
<p style="position:absolute;top:264px;left:122px;white-space:nowrap" class="ft1635">•</p>
<p style="position:absolute;top:263px;left:130px;white-space:nowrap" class="ft1636">&#160;</p>
<p style="position:absolute;top:266px;left:149px;white-space:nowrap" class="ft1630">Kisqali Femara&#160;600 Dose&#160;</p>
<p style="position:absolute;top:343px;left:126px;white-space:nowrap" class="ft1632"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:343px;left:274px;white-space:nowrap" class="ft1632"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:385px;left:126px;white-space:nowrap" class="ft1638"><b>Indications&#160;</b></p>
<p style="position:absolute;top:385px;left:274px;white-space:nowrap" class="ft1630">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:423px;left:126px;white-space:nowrap" class="ft1638"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:423px;left:274px;white-space:nowrap" class="ft1630">N/A&#160;</p>
<p style="position:absolute;top:462px;left:126px;white-space:nowrap" class="ft1639"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:462px;left:274px;white-space:nowrap" class="ft1630">N/A&#160;</p>
<p style="position:absolute;top:521px;left:126px;white-space:nowrap" class="ft1639"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:521px;left:274px;white-space:nowrap" class="ft1630">N/A&#160;</p>
<p style="position:absolute;top:601px;left:126px;white-space:nowrap" class="ft1638"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:601px;left:274px;white-space:nowrap" class="ft1630">N/A&#160;</p>
<p style="position:absolute;top:640px;left:126px;white-space:nowrap" class="ft1639"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:640px;left:274px;white-space:nowrap" class="ft1630">N/A&#160;</p>
<p style="position:absolute;top:700px;left:126px;white-space:nowrap" class="ft1639"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:700px;left:274px;white-space:nowrap" class="ft1630">Plan Year&#160;</p>
<p style="position:absolute;top:759px;left:126px;white-space:nowrap" class="ft1638"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:759px;left:274px;white-space:nowrap" class="ft16310">For treatment&#160;of breast&#160;cancer using&#160;Kisqali&#160;(ribociclib)&#160;in combination&#160;<br/>with an aromatase inhibitor or Kisqali Femara&#160;Co-Pack (ribociclib and&#160;<br/>letrozole) as&#160;initial&#160;endocrine-based therapy: if the patient is&#160;<br/>postmenopausal&#160;OR&#160;male, the&#160;patient has&#160;experienced an intolerable&#160;<br/>adverse&#160;event to Ibrance (palbociclib) AND&#160;Verzenio (abemaciclib)&#160;or&#160;<br/>has a&#160;contraindication to&#160;Ibrance (palbociclib) AND&#160;Verzenio&#160;<br/>(abemaciclib). For&#160;treatment of breast cancer&#160;with Kisqali&#160;(ribociclib)&#160;in&#160;<br/>combination&#160;with fulvestrant, one of the following&#160;criteria must met: 1)&#160;<br/>the requested drug is being used with&#160;fulvestrant&#160;as initial endocrine-<br/>based therapy in a postmenopausal patient or&#160;in a male, OR&#160;2) the&#160;<br/>requested drug is&#160;being used following disease progression on endocrine&#160;<br/>therapy&#160;in a postmenopausal&#160;patient&#160;or in a&#160;male&#160;and the&#160;patient has&#160;<br/>experienced&#160;an intolerable adverse event to&#160;Ibrance (palbociclib) AND&#160;<br/>Verzenio&#160;(abemaciclib) OR has a contraindication to Ibrance&#160;(palbociclib)&#160;<br/>AND Verzenio (abemaciclib).&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1630">163&#160;</p>
</div>
<!-- Page 164 -->
<a name="164"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page164-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2164.png" alt="background image"/>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1640">164</p>
<p style="position:absolute;top:1093px;left:810px;white-space:nowrap" class="ft1646">&#160;</p>
</div>
<!-- Page 165 -->
<a name="165"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page165-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2165.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1651"><b>K</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1654"><b>ORLYM</b></p>
<p style="position:absolute;top:119px;left:223px;white-space:nowrap" class="ft16513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1652"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1655">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1656">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1650">Korlym&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1652"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1652"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1658"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1650">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1658"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1650">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1659"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1650">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1659"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft1650">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft1658"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft1650">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft1659"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft1650">Endocrinologist&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft1659"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft1650">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft1658"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft1650">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1650">165&#160;</p>
</div>
<!-- Page 166 -->
<a name="166"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page166-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2166.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1661"><b>K</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1664"><b>RISTALOSE</b></p>
<p style="position:absolute;top:119px;left:269px;white-space:nowrap" class="ft16613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1662"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1665">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1666">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1660">Kristalose&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1662"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1662"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1668"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1660">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1668"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1660">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1669"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1660">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1669"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft16610">1)&#160;The patient has&#160;experienced an inadequate&#160;treatment response to a one&#160;<br/>month trial&#160;of generic lactulose solution OR&#160;2) The patient has&#160;<br/>experienced&#160;an intolerance that would prohibit a&#160;one month&#160;trial&#160;of&#160;<br/>generic lactulose&#160;solution.&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft1668"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft1660">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft1669"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft1660">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft1669"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft1660">Plan Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft1668"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft1660">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1660">166&#160;</p>
</div>
<!-- Page 167 -->
<a name="167"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page167-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2167.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1671"><b>K</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1674"><b>UVAN</b></p>
<p style="position:absolute;top:119px;left:201px;white-space:nowrap" class="ft16713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1672"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1675">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1676">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1670">Sapropterin&#160;Dihydrochloride&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1672"><b>PA&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1672"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1678"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1670">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1678"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1670">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1679"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1670">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1679"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft16710">For phenylketonuria: For patients&#160;who have not&#160;yet received&#160;a therapeutic&#160;<br/>trial of&#160;the requested drug, the patient's pretreatment, including before&#160;<br/>dietary management, phenylalanine&#160;level&#160;is greater than 6&#160;mg/dL (360&#160;<br/>micromol/L). For patients who completed a&#160;therapeutic&#160;trial of the&#160;<br/>requested drug, the&#160;patient must have&#160;experienced&#160;improvement (for&#160;<br/>example, reduction&#160;in blood phenylalanine&#160;levels, improvement in&#160;<br/>neuropsychiatric symptoms).&#160;</p>
<p style="position:absolute;top:618px;left:126px;white-space:nowrap" class="ft1678"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:618px;left:274px;white-space:nowrap" class="ft1670">N/A&#160;</p>
<p style="position:absolute;top:657px;left:126px;white-space:nowrap" class="ft1679"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:657px;left:274px;white-space:nowrap" class="ft1670">N/A&#160;</p>
<p style="position:absolute;top:716px;left:126px;white-space:nowrap" class="ft1679"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:716px;left:274px;white-space:nowrap" class="ft1670">Initial:&#160;2 months. All others: Plan Year.&#160;</p>
<p style="position:absolute;top:776px;left:126px;white-space:nowrap" class="ft1678"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:776px;left:274px;white-space:nowrap" class="ft1670">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1670">167&#160;</p>
</div>
<!-- Page 168 -->
<a name="168"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page168-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2168.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1681"><b>K</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft1684"><b>YNMOBI</b></p>
<p style="position:absolute;top:119px;left:233px;white-space:nowrap" class="ft16813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1682"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1685">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1686">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1680">Kynmobi&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1682"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1682"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1688"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1680">All FDA-approved&#160;Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1688"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1680">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1689"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1680">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1689"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft16810">For continuation&#160;treatment of&#160;off episodes in Parkinson's&#160;disease:&#160;The&#160;<br/>patient is&#160;experiencing improvement on the requested drug.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft1688"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft1680">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft1689"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft1680">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft1689"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft1680">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft1688"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft1680">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1680">168&#160;</p>
</div>
<!-- Page 169 -->
<a name="169"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page169-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2169.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1691"><b>L</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft1694"><b>APATINIB</b></p>
<p style="position:absolute;top:119px;left:245px;white-space:nowrap" class="ft16913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1692"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1695">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1696">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1690">Lapatinib Ditosylate&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1692"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1692"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1698"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1690">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1698"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft16910">Brain metastases&#160;from human epidermal&#160;growth&#160;factor receptor 2&#160;<br/>(HER2)-positive breast cancer,&#160;recurrent epidermal growth factor&#160;receptor&#160;<br/>(EGFR)-positive chordoma, HER2-amplified&#160;and&#160;RAS and BRAF wild-<br/>type colorectal&#160;cancer&#160;in&#160;combination with trastuzumab.&#160;</p>
<p style="position:absolute;top:458px;left:126px;white-space:nowrap" class="ft1699"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:458px;left:274px;white-space:nowrap" class="ft1690">N/A&#160;</p>
<p style="position:absolute;top:518px;left:126px;white-space:nowrap" class="ft1699"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:518px;left:274px;white-space:nowrap" class="ft16910">For HER2-positive&#160;breast cancer, the&#160;requested drug will&#160;be used in&#160;<br/>combination&#160;with any of&#160;the following: 1)&#160;aromatase inhibitor, 2)&#160;<br/>capecitabine, OR&#160;3) trastuzumab.&#160;</p>
<p style="position:absolute;top:598px;left:126px;white-space:nowrap" class="ft1698"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:598px;left:274px;white-space:nowrap" class="ft1690">N/A&#160;</p>
<p style="position:absolute;top:636px;left:126px;white-space:nowrap" class="ft1699"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:636px;left:274px;white-space:nowrap" class="ft1690">N/A&#160;</p>
<p style="position:absolute;top:696px;left:126px;white-space:nowrap" class="ft1699"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:696px;left:274px;white-space:nowrap" class="ft1690">Plan Year&#160;</p>
<p style="position:absolute;top:755px;left:126px;white-space:nowrap" class="ft1698"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:755px;left:274px;white-space:nowrap" class="ft1690">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1690">169&#160;</p>
</div>
<!-- Page 170 -->
<a name="170"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page170-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2170.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1701"><b>L</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft1704"><b>ENVIMA</b></p>
<p style="position:absolute;top:119px;left:228px;white-space:nowrap" class="ft17013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1702"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1705">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1706">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1700">Lenvima 10&#160;Mg Daily Dose&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft1705">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft1706">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft1700">Lenvima 12mg Daily Dose&#160;</p>
<p style="position:absolute;top:242px;left:122px;white-space:nowrap" class="ft1705">•</p>
<p style="position:absolute;top:241px;left:130px;white-space:nowrap" class="ft1706">&#160;</p>
<p style="position:absolute;top:244px;left:149px;white-space:nowrap" class="ft1700">Lenvima 14&#160;Mg Daily Dose&#160;</p>
<p style="position:absolute;top:264px;left:122px;white-space:nowrap" class="ft1705">•</p>
<p style="position:absolute;top:263px;left:130px;white-space:nowrap" class="ft1706">&#160;</p>
<p style="position:absolute;top:266px;left:149px;white-space:nowrap" class="ft1700">Lenvima 18&#160;Mg Daily Dose&#160;</p>
<p style="position:absolute;top:286px;left:122px;white-space:nowrap" class="ft1705">•</p>
<p style="position:absolute;top:285px;left:130px;white-space:nowrap" class="ft1706">&#160;</p>
<p style="position:absolute;top:288px;left:149px;white-space:nowrap" class="ft1700">Lenvima 20&#160;Mg Daily Dose&#160;</p>
<p style="position:absolute;top:308px;left:122px;white-space:nowrap" class="ft1705">•</p>
<p style="position:absolute;top:307px;left:130px;white-space:nowrap" class="ft1706">&#160;</p>
<p style="position:absolute;top:310px;left:149px;white-space:nowrap" class="ft1700">Lenvima 24&#160;Mg Daily Dose&#160;</p>
<p style="position:absolute;top:330px;left:122px;white-space:nowrap" class="ft1705">•</p>
<p style="position:absolute;top:329px;left:130px;white-space:nowrap" class="ft1706">&#160;</p>
<p style="position:absolute;top:332px;left:149px;white-space:nowrap" class="ft1700">Lenvima 4&#160;Mg Daily Dose&#160;</p>
<p style="position:absolute;top:352px;left:122px;white-space:nowrap" class="ft1705">•</p>
<p style="position:absolute;top:351px;left:130px;white-space:nowrap" class="ft1706">&#160;</p>
<p style="position:absolute;top:354px;left:149px;white-space:nowrap" class="ft1700">Lenvima 8&#160;Mg Daily Dose&#160;</p>
<p style="position:absolute;top:431px;left:126px;white-space:nowrap" class="ft1702"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:431px;left:274px;white-space:nowrap" class="ft1702"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:473px;left:126px;white-space:nowrap" class="ft1708"><b>Indications&#160;</b></p>
<p style="position:absolute;top:473px;left:274px;white-space:nowrap" class="ft1700">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:511px;left:126px;white-space:nowrap" class="ft1708"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:511px;left:274px;white-space:nowrap" class="ft1700">Medullary thyroid&#160;carcinoma, recurrent endometrial carcinoma&#160;</p>
<p style="position:absolute;top:550px;left:126px;white-space:nowrap" class="ft1709"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:550px;left:274px;white-space:nowrap" class="ft1700">N/A&#160;</p>
<p style="position:absolute;top:609px;left:126px;white-space:nowrap" class="ft1709"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:609px;left:274px;white-space:nowrap" class="ft17010">For differentiated&#160;thyroid&#160;cancer&#160;(follicular, papillary, or Hurthle cell):&#160;<br/>disease is not amenable&#160;to&#160;radioactive iodine&#160;therapy and unresectable,&#160;<br/>locally recurrent, persistent, or&#160;metastatic. For hepatocellular&#160;carcinoma:&#160;<br/>disease is unresectable or inoperable, local,&#160;metastatic or with&#160;extensive&#160;<br/>liver tumor&#160;burden. For&#160;renal cell carcinoma:&#160;disease is&#160;advanced,&#160;<br/>relapsed, or&#160;stage IV. For endometrial carcinoma,&#160;the patient&#160;meets ALL&#160;<br/>of the following: 1)&#160;The disease is&#160;advanced or recurrent, 2) The disease&#160;<br/>is not&#160;microsatellite instability-high&#160;(MSI-H) or&#160;mismatch&#160;repair deficient&#160;<br/>(dMMR), 3)&#160;The patient&#160;experienced&#160;disease progression following prior&#160;<br/>systemic&#160;therapy, AND 4)&#160;The patient is not&#160;a candidate&#160;for&#160;curative&#160;<br/>surgery or radiation.&#160;</p>
<p style="position:absolute;top:855px;left:126px;white-space:nowrap" class="ft1708"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:855px;left:274px;white-space:nowrap" class="ft1700">N/A&#160;</p>
<p style="position:absolute;top:894px;left:126px;white-space:nowrap" class="ft1709"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:894px;left:274px;white-space:nowrap" class="ft1700">N/A&#160;</p>
<p style="position:absolute;top:953px;left:126px;white-space:nowrap" class="ft1709"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:953px;left:274px;white-space:nowrap" class="ft1700">Plan Year&#160;</p>
<p style="position:absolute;top:1013px;left:126px;white-space:nowrap" class="ft1708"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:1013px;left:274px;white-space:nowrap" class="ft1700">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1700">170&#160;</p>
</div>
<!-- Page 171 -->
<a name="171"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page171-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2171.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1711"><b>L</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft1714"><b>EUPROLIDE</b></p>
<p style="position:absolute;top:119px;left:271px;white-space:nowrap" class="ft17113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1712"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1715">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1716">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1710">Leuprolide&#160;Acetate&#160;INJ&#160;1MG/0.2ML&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1712"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1712"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1718"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1710">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1718"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft17110">Use in&#160;combination with growth hormone for children with growth failure&#160;<br/>and advancing puberty,&#160;recurrent&#160;androgen receptor&#160;positive&#160;salivary&#160;<br/>gland tumors.&#160;</p>
<p style="position:absolute;top:437px;left:126px;white-space:nowrap" class="ft1719"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:437px;left:274px;white-space:nowrap" class="ft1710">N/A&#160;</p>
<p style="position:absolute;top:497px;left:126px;white-space:nowrap" class="ft1719"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:497px;left:274px;white-space:nowrap" class="ft1710">N/A&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft1718"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft1710">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft1719"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft1710">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft1719"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft1710">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft1718"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft1710">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1710">171&#160;</p>
</div>
<!-- Page 172 -->
<a name="172"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page172-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2172.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1721"><b>L</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft1724"><b>IBTAYO</b></p>
<p style="position:absolute;top:119px;left:223px;white-space:nowrap" class="ft17213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1722"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1725">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1726">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1720">Libtayo&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1722"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1722"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1728"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1720">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1728"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1720">Inoperable or&#160;incompletely resected&#160;cutaneous squamous cell carcinoma&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1729"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1720">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1729"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft17210">For cutaneous&#160;squamous cell carcinoma:&#160;patient&#160;meets both&#160;of the&#160;<br/>following: 1) disease is one of the&#160;following:&#160;a) metastatic, b) locally&#160;<br/>advanced, or&#160;c)&#160;regional and inoperable or&#160;incompletely resected, and 2)&#160;<br/>patient is not a candidate&#160;for&#160;curative surgery or curative radiation.&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft1728"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft1720">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft1729"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft1720">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft1729"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft1720">Plan Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft1728"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft1720">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1720">172&#160;</p>
</div>
<!-- Page 173 -->
<a name="173"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page173-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2173.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1731"><b>L</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft1734"><b>IDOCAINE&#160;</b></p>
<p style="position:absolute;top:118px;left:257px;white-space:nowrap" class="ft1731"><b>P</b></p>
<p style="position:absolute;top:123px;left:275px;white-space:nowrap" class="ft1734"><b>ATCHES</b></p>
<p style="position:absolute;top:119px;left:374px;white-space:nowrap" class="ft17313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1732"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1735">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1736">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1730">Lidocaine&#160;PTCH&#160;5%&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1732"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1732"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1738"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1730">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1738"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft17310">Pain associated&#160;with diabetic neuropathy, pain&#160;associated with cancer-<br/>related neuropathy (including treatment-related neuropathy&#160;[e.g.,&#160;<br/>neuropathy associated with radiation&#160;treatment or&#160;chemotherapy]).&#160;</p>
<p style="position:absolute;top:437px;left:126px;white-space:nowrap" class="ft1739"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:437px;left:274px;white-space:nowrap" class="ft1730">N/A&#160;</p>
<p style="position:absolute;top:497px;left:126px;white-space:nowrap" class="ft1739"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:497px;left:274px;white-space:nowrap" class="ft1730">N/A&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft1738"><b>Age&#160;Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft1730">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft1739"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft1730">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft1739"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft1730">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft1738"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft1730">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1730">173&#160;</p>
</div>
<!-- Page 174 -->
<a name="174"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page174-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2174.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1741"><b>L</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft1744"><b>INEZOLID</b></p>
<p style="position:absolute;top:119px;left:248px;white-space:nowrap" class="ft17413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1742"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1745">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1746">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1740">Linezolid&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1742"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1742"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1748"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1740">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1748"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1740">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1749"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1740">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1749"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft17410">The infection&#160;is proven&#160;or strongly suspected&#160;to&#160;be caused by susceptible&#160;<br/>bacteria. The patient will be using&#160;the requested&#160;drug orally&#160;or&#160;<br/>intravenously.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft1748"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft1740">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft1749"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft17410">Prescribed or&#160;directed by&#160;an Infectious Disease specialist when being&#160;<br/>converted from intravenous (IV) linezolid&#160;(Zyvox)&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft1749"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft1740">28 days&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft1748"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft1740">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1740">174&#160;</p>
</div>
<!-- Page 175 -->
<a name="175"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page175-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2175.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1751"><b>L</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft1754"><b>ONSURF</b></p>
<p style="position:absolute;top:119px;left:227px;white-space:nowrap" class="ft17513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1752"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1755">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1756">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1750">Lonsurf&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1752"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1752"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1758"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1750">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1758"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1750">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1759"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1750">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1759"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft17510">For colorectal&#160;cancer: The disease is&#160;advanced or metastatic.&#160;For gastric&#160;<br/>or gastroesophageal&#160;junction adenocarcinoma, all&#160;of the following criteria&#160;<br/>must&#160;be&#160;met: 1)&#160;The disease is unresectable locally advanced,&#160;recurrent, or&#160;<br/>metastatic,&#160;and 2) The patient has&#160;been previously&#160;treated with&#160;at least&#160;<br/>two prior lines of&#160;chemotherapy.&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft1758"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft1750">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft1759"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft1750">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft1759"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft1750">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft1758"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft1750">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1750">175&#160;</p>
</div>
<!-- Page 176 -->
<a name="176"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page176-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2176.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1761"><b>L</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft1764"><b>ORBRENA</b></p>
<p style="position:absolute;top:119px;left:248px;white-space:nowrap" class="ft17613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1762"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1765">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1766">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1760">Lorbrena&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1762"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1762"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1768"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1760">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1768"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft17610">Anaplastic lymphoma&#160;kinase (ALK)-positive recurrent or advanced non-<br/>small cell&#160;lung cancer&#160;(NSCLC). Repressor of silencing (ROS)-1&#160;<br/>rearrangement-positive recurrent, advanced, or&#160;metastatic&#160;NSCLC&#160;<br/>following progression on&#160;crizotinib, entrectinib, or ceritinib.&#160;</p>
<p style="position:absolute;top:458px;left:126px;white-space:nowrap" class="ft1769"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:458px;left:274px;white-space:nowrap" class="ft1760">N/A&#160;</p>
<p style="position:absolute;top:518px;left:126px;white-space:nowrap" class="ft1769"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:518px;left:274px;white-space:nowrap" class="ft1760">N/A&#160;</p>
<p style="position:absolute;top:598px;left:126px;white-space:nowrap" class="ft1768"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:598px;left:274px;white-space:nowrap" class="ft1760">N/A&#160;</p>
<p style="position:absolute;top:636px;left:126px;white-space:nowrap" class="ft1769"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:636px;left:274px;white-space:nowrap" class="ft1760">N/A&#160;</p>
<p style="position:absolute;top:696px;left:126px;white-space:nowrap" class="ft1769"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:696px;left:274px;white-space:nowrap" class="ft1760">Plan Year&#160;</p>
<p style="position:absolute;top:755px;left:126px;white-space:nowrap" class="ft1768"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:755px;left:274px;white-space:nowrap" class="ft1760">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1760">176&#160;</p>
</div>
<!-- Page 177 -->
<a name="177"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page177-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2177.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1771"><b>L</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft1774"><b>UMAKRAS</b></p>
<p style="position:absolute;top:119px;left:252px;white-space:nowrap" class="ft17713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1772"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1775">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1776">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1770">Lumakras&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1772"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1772"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1778"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1770">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1778"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1770">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1779"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1770">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1779"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft1770">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft1778"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft1770">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft1779"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft1770">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft1779"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft1770">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft1778"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft1770">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1770">177&#160;</p>
</div>
<!-- Page 178 -->
<a name="178"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page178-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2178.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1781"><b>L</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft1784"><b>UMOXITI</b></p>
<p style="position:absolute;top:119px;left:239px;white-space:nowrap" class="ft17813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1782"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1785">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1786">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1780">Lumoxiti&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1782"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1782"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1788"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1780">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1788"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1780">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1789"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1780">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1789"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft17810">For hairy&#160;cell leukemia,&#160;the patient will not receive more&#160;than 6 cycles of&#160;<br/>treatment with the&#160;requested drug.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft1788"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft1780">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft1789"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft1780">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft1789"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft1780">6 months&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft1788"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft1780">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1780">178&#160;</p>
</div>
<!-- Page 179 -->
<a name="179"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page179-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2179.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1791"><b>L</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft1794"><b>UPRON&#160;</b></p>
<p style="position:absolute;top:118px;left:219px;white-space:nowrap" class="ft1791"><b>P</b></p>
<p style="position:absolute;top:123px;left:238px;white-space:nowrap" class="ft1794"><b>ED</b></p>
<p style="position:absolute;top:119px;left:271px;white-space:nowrap" class="ft17913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1792"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1795">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1796">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1790">Lupron Depot-ped (1-month)&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft1795">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft1796">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft1790">Lupron Depot-ped (3-month)&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft1792"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft1792"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft1798"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft1790">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft1798"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft1790">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft1799"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft1790">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft1799"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft17910">For central&#160;precocious puberty (CPP),&#160;patients not currently&#160;receiving&#160;<br/>therapy&#160;must meet all of&#160;the following criteria: 1)&#160;Diagnosis of CPP was&#160;<br/>confirmed by a pubertal&#160;response&#160;to&#160;a gonadotropin releasing hormone&#160;<br/>(GnRH) agonist test&#160;OR&#160;a pubertal level of&#160;a&#160;third generation luteinizing&#160;<br/>hormone (LH) assay, 2)&#160;Assessment&#160;of bone&#160;age&#160;versus chronological age&#160;<br/>supports the&#160;diagnosis of&#160;CPP, and 3) The onset of secondary sexual&#160;<br/>characteristics occurred&#160;prior to 8 years&#160;of age for female patients&#160;OR&#160;<br/>prior to 9 years&#160;of age for male patients.&#160;</p>
<p style="position:absolute;top:661px;left:126px;white-space:nowrap" class="ft1798"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:661px;left:274px;white-space:nowrap" class="ft17910">CPP:&#160;Patient must&#160;be&#160;less than 12 years&#160;old&#160;if&#160;female&#160;and less than 13&#160;<br/>years old&#160;if&#160;male.&#160;</p>
<p style="position:absolute;top:720px;left:126px;white-space:nowrap" class="ft1799"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:720px;left:274px;white-space:nowrap" class="ft1790">N/A&#160;</p>
<p style="position:absolute;top:780px;left:126px;white-space:nowrap" class="ft1799"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:780px;left:274px;white-space:nowrap" class="ft1790">Plan Year&#160;</p>
<p style="position:absolute;top:839px;left:126px;white-space:nowrap" class="ft1798"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:839px;left:274px;white-space:nowrap" class="ft1790">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1790">179&#160;</p>
</div>
<!-- Page 180 -->
<a name="180"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page180-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2180.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1801"><b>L</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft1804"><b>UPRON</b></p>
<p style="position:absolute;top:118px;left:213px;white-space:nowrap" class="ft1801"><b>-</b></p>
<p style="position:absolute;top:123px;left:223px;white-space:nowrap" class="ft1804"><b>ENDOMETRIOSIS</b></p>
<p style="position:absolute;top:119px;left:429px;white-space:nowrap" class="ft18013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1802"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1805">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1806">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft18010">Lupron Depot (1-month)&#160;INJ&#160;<br/>3.75MG&#160;</p>
<p style="position:absolute;top:240px;left:122px;white-space:nowrap" class="ft1805">•</p>
<p style="position:absolute;top:240px;left:130px;white-space:nowrap" class="ft1806">&#160;&#160;</p>
<p style="position:absolute;top:242px;left:149px;white-space:nowrap" class="ft18010">Lupron Depot (3-month)&#160;INJ&#160;<br/>11.25MG&#160;</p>
<p style="position:absolute;top:340px;left:126px;white-space:nowrap" class="ft1802"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:340px;left:274px;white-space:nowrap" class="ft1802"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:382px;left:126px;white-space:nowrap" class="ft1808"><b>Indications&#160;</b></p>
<p style="position:absolute;top:382px;left:274px;white-space:nowrap" class="ft1800">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:421px;left:126px;white-space:nowrap" class="ft1808"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:421px;left:274px;white-space:nowrap" class="ft18010">Breast&#160;cancer, malignant&#160;sex cord-stromal&#160;tumors, epithelial ovarian&#160;<br/>cancer/fallopian tube&#160;cancer/primary peritoneal&#160;cancer&#160;</p>
<p style="position:absolute;top:480px;left:126px;white-space:nowrap" class="ft1809"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:480px;left:274px;white-space:nowrap" class="ft1800">N/A&#160;</p>
<p style="position:absolute;top:539px;left:126px;white-space:nowrap" class="ft1809"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:539px;left:274px;white-space:nowrap" class="ft18010">For uterine&#160;fibroids, patient must meet one&#160;of the&#160;following:&#160;1) Diagnosis&#160;<br/>of anemia (e.g., hematocrit&#160;less&#160;than or equal&#160;to 30 percent and/or&#160;<br/>hemoglobin&#160;less than or&#160;equal&#160;to 10g/dL), OR&#160;2) the requested medication&#160;<br/>will&#160;be used&#160;prior to surgery&#160;for&#160;uterine fibroids.&#160;</p>
<p style="position:absolute;top:640px;left:126px;white-space:nowrap" class="ft1808"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:640px;left:274px;white-space:nowrap" class="ft1800">N/A&#160;</p>
<p style="position:absolute;top:679px;left:126px;white-space:nowrap" class="ft1809"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:679px;left:274px;white-space:nowrap" class="ft1800">N/A&#160;</p>
<p style="position:absolute;top:738px;left:126px;white-space:nowrap" class="ft1809"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:738px;left:274px;white-space:nowrap" class="ft18010">Fibroids:&#160;3&#160;months (mo), max 6&#160;mo&#160;total. Endometriosis:&#160;6&#160;mo, max 12&#160;<br/>mo total. Others:&#160;Plan Year&#160;</p>
<p style="position:absolute;top:798px;left:126px;white-space:nowrap" class="ft1808"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:798px;left:274px;white-space:nowrap" class="ft1800">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1800">180&#160;</p>
</div>
<!-- Page 181 -->
<a name="181"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page181-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2181.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1811"><b>L</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft1814"><b>YNPARZA</b></p>
<p style="position:absolute;top:119px;left:245px;white-space:nowrap" class="ft18113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1812"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1815">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1816">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1810">Lynparza&#160;TABS&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1812"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1812"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1818"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1810">All FDA-approved Indications, Some Medically&#160;accepted&#160;Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1818"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft18110">Recurrent HER2-negative,&#160;BRCA&#160;1/2-germline&#160;mutated breast&#160;cancer,&#160;<br/>recurrent or&#160;metastatic&#160;HER2-positive, BRCA&#160;1/2-germline&#160;mutated&#160;<br/>breast&#160;cancer&#160;</p>
<p style="position:absolute;top:437px;left:126px;white-space:nowrap" class="ft1819"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:437px;left:274px;white-space:nowrap" class="ft1810">N/A&#160;</p>
<p style="position:absolute;top:497px;left:126px;white-space:nowrap" class="ft1819"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:497px;left:274px;white-space:nowrap" class="ft18110">For breast&#160;cancer&#160;the disease must be: 1)&#160;BRCA&#160;1/2-germline&#160;mutated,&#160;<br/>and 2)&#160;recurrent or&#160;metastatic. For prostate cancer: The patient has&#160;<br/>progressed on prior treatment with an androgen receptor-directed therapy.&#160;<br/>For epithelial ovarian, fallopian&#160;tube, or primary peritoneal cancer: 1) The&#160;<br/>requested drug is&#160;used for maintenance therapy for stage&#160;II-IV&#160;or&#160;<br/>recurrent disease who are in complete or&#160;partial response to chemotherapy&#160;<br/>OR&#160;2) The patient has&#160;deleterious or&#160;suspected deleterious germline&#160;<br/>BRCA-mutated advanced, recurrent,&#160;or persistent&#160;disease after two or&#160;<br/>more prior&#160;chemotherapy regimens.&#160;</p>
<p style="position:absolute;top:701px;left:126px;white-space:nowrap" class="ft1818"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:701px;left:274px;white-space:nowrap" class="ft1810">N/A&#160;</p>
<p style="position:absolute;top:740px;left:126px;white-space:nowrap" class="ft1819"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:740px;left:274px;white-space:nowrap" class="ft1810">N/A&#160;</p>
<p style="position:absolute;top:799px;left:126px;white-space:nowrap" class="ft1819"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:799px;left:274px;white-space:nowrap" class="ft1810">Plan Year&#160;</p>
<p style="position:absolute;top:859px;left:126px;white-space:nowrap" class="ft1818"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:859px;left:274px;white-space:nowrap" class="ft1810">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1810">181&#160;</p>
</div>
<!-- Page 182 -->
<a name="182"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page182-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2182.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1821"><b>L</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft1824"><b>YRICA&#160;</b></p>
<p style="position:absolute;top:118px;left:213px;white-space:nowrap" class="ft1821"><b>C</b></p>
<p style="position:absolute;top:123px;left:234px;white-space:nowrap" class="ft1824"><b>R</b></p>
<p style="position:absolute;top:119px;left:252px;white-space:nowrap" class="ft18213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1822"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1825">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1826">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1820">Pregabalin&#160;Er&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1822"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1822"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1828"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1820">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1828"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1820">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1829"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1820">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1829"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft18210">The patient&#160;has experienced an inadequate&#160;treatment response&#160;to&#160;<br/>gabapentin,&#160;or the patient has&#160;experienced an intolerance to gabapentin, or&#160;<br/>the patient has a contraindication to gabapentin.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft1828"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft1820">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft1829"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft1820">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft1829"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft1820">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft1828"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft1820">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1820">182&#160;</p>
</div>
<!-- Page 183 -->
<a name="183"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page183-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2183.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1831"><b>M</b></p>
<p style="position:absolute;top:123px;left:136px;white-space:nowrap" class="ft1834"><b>AVYRET</b></p>
<p style="position:absolute;top:119px;left:238px;white-space:nowrap" class="ft18313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1832"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1835">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1836">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1830">Mavyret&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1832"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1832"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1838"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1830">All&#160;FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1838"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1830">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1839"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft18310">Decompensated cirrhosis/moderate&#160;or severe hepatic&#160;impairment&#160;(Child&#160;<br/>Turcotte Pugh [CTP] class B or C).&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1839"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft18310">For hepatitis&#160;C virus&#160;(HCV):&#160;Infection confirmed by presence of HCV&#160;<br/>RNA in the&#160;serum prior&#160;to starting treatment. Planned treatment regimen,&#160;<br/>genotype, prior treatment history, presence&#160;or absence of&#160;cirrhosis&#160;<br/>(compensated or decompensated&#160;[CTP class B or&#160;C]), presence&#160;or absence&#160;<br/>of human&#160;immunodeficiency virus&#160;(HIV) coinfection, presence or&#160;absence&#160;<br/>of resistance-associated substitutions&#160;where applicable, liver&#160;and kidney&#160;<br/>transplantation status&#160;if&#160;applicable. Coverage conditions&#160;and specific&#160;<br/>durations of approval&#160;will be&#160;based on current American Association for&#160;<br/>the Study of&#160;Liver&#160;Diseases (AASLD) treatment&#160;guidelines.&#160;</p>
<p style="position:absolute;top:660px;left:126px;white-space:nowrap" class="ft1838"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:660px;left:274px;white-space:nowrap" class="ft1830">N/A&#160;</p>
<p style="position:absolute;top:698px;left:126px;white-space:nowrap" class="ft1839"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:698px;left:274px;white-space:nowrap" class="ft1830">N/A&#160;</p>
<p style="position:absolute;top:758px;left:126px;white-space:nowrap" class="ft1839"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:758px;left:274px;white-space:nowrap" class="ft1830">Criteria will&#160;be applied consistent with current AASLD-IDSA guidance&#160;</p>
<p style="position:absolute;top:817px;left:126px;white-space:nowrap" class="ft1838"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:817px;left:274px;white-space:nowrap" class="ft1830">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1830">183&#160;</p>
</div>
<!-- Page 184 -->
<a name="184"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page184-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2184.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1841"><b>M</b></p>
<p style="position:absolute;top:123px;left:136px;white-space:nowrap" class="ft1844"><b>EKINIST</b></p>
<p style="position:absolute;top:119px;left:236px;white-space:nowrap" class="ft18413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1842"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1845">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1846">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1840">Mekinist&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1842"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1842"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1848"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1840">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1848"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft18410">Brain metastases&#160;from melanoma, uveal&#160;melanoma, central&#160;nervous&#160;<br/>system (CNS) cancer (i.e., glioma, meningioma, astrocytoma), low grade&#160;<br/>serous ovarian cancer.&#160;</p>
<p style="position:absolute;top:437px;left:126px;white-space:nowrap" class="ft1849"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:437px;left:274px;white-space:nowrap" class="ft1840">N/A&#160;</p>
<p style="position:absolute;top:497px;left:126px;white-space:nowrap" class="ft1849"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:497px;left:274px;white-space:nowrap" class="ft18410">For brain&#160;metastasis from melanoma, adjuvant treatment of&#160;melanoma,&#160;<br/>and central&#160;nervous system (CNS) cancer&#160;(i.e., glioma, meningioma,&#160;<br/>astrocytoma):&#160;1) The&#160;tumor&#160;is positive for&#160;a BRAF&#160;V600 activating&#160;<br/>mutation (e.g., V600E&#160;or V600K), and 2)&#160;The requested drug will&#160;be used&#160;<br/>in combination with dabrafenib. For&#160;unresectable&#160;or metastatic melanoma:&#160;<br/>1) The tumor is positive&#160;for&#160;a BRAF&#160;V600 activating mutation (e.g.,&#160;<br/>V600E&#160;or V600K), and 2) The&#160;requested drug will be used as&#160;a single&#160;<br/>agent&#160;or in combination&#160;with dabrafenib. For non-small cell&#160;lung cancer,&#160;<br/>and anaplastic thyroid cancer: 1) The&#160;tumor is positive for a&#160;BRAF&#160;<br/>V600E&#160;mutation, and 2)&#160;The requested drug will&#160;be used in combination&#160;<br/>with dabrafenib. For&#160;uveal melanoma, the&#160;requested drug will be used as&#160;a&#160;<br/>single&#160;agent.&#160;For low grade serous&#160;ovarian&#160;cancer: The requested drug&#160;<br/>will&#160;be used&#160;to treat persistent&#160;or recurrent disease.&#160;</p>
<p style="position:absolute;top:784px;left:126px;white-space:nowrap" class="ft1848"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:784px;left:274px;white-space:nowrap" class="ft1840">N/A&#160;</p>
<p style="position:absolute;top:823px;left:126px;white-space:nowrap" class="ft1849"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:823px;left:274px;white-space:nowrap" class="ft1840">N/A&#160;</p>
<p style="position:absolute;top:882px;left:126px;white-space:nowrap" class="ft1849"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:882px;left:274px;white-space:nowrap" class="ft1840">Plan Year&#160;</p>
<p style="position:absolute;top:941px;left:126px;white-space:nowrap" class="ft1848"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:941px;left:274px;white-space:nowrap" class="ft1840">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1840">184&#160;</p>
</div>
<!-- Page 185 -->
<a name="185"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page185-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2185.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1851"><b>M</b></p>
<p style="position:absolute;top:123px;left:136px;white-space:nowrap" class="ft1854"><b>EKTOVI</b></p>
<p style="position:absolute;top:119px;left:232px;white-space:nowrap" class="ft18513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1852"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1855">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1856">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1850">Mektovi&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1852"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1852"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1858"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1850">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1858"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1850">Adjuvant systemic&#160;therapy for&#160;cutaneous melanoma&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1859"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1850">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1859"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft18510">For cutaneous&#160;melanoma: The patient must meet all of&#160;the following&#160;<br/>criteria:&#160;1) Tumor&#160;is positive&#160;for&#160;BRAF&#160;V600 activating mutation&#160;(e.g.,&#160;<br/>V600E&#160;or V600K), 2) The requested&#160;drug will be&#160;used in combination&#160;<br/>with encorafenib, and 3)&#160;The requested drug will&#160;be used for&#160;either of&#160;the&#160;<br/>following: a) unresectable or&#160;metastatic&#160;disease,&#160;or b)&#160;adjuvant systemic&#160;<br/>therapy.&#160;</p>
<p style="position:absolute;top:598px;left:126px;white-space:nowrap" class="ft1858"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:598px;left:274px;white-space:nowrap" class="ft1850">N/A&#160;</p>
<p style="position:absolute;top:636px;left:126px;white-space:nowrap" class="ft1859"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:636px;left:274px;white-space:nowrap" class="ft1850">N/A&#160;</p>
<p style="position:absolute;top:696px;left:126px;white-space:nowrap" class="ft1859"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:696px;left:274px;white-space:nowrap" class="ft1850">Plan Year&#160;</p>
<p style="position:absolute;top:755px;left:126px;white-space:nowrap" class="ft1858"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:755px;left:274px;white-space:nowrap" class="ft1850">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1850">185&#160;</p>
</div>
<!-- Page 186 -->
<a name="186"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page186-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2186.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1861"><b>M</b></p>
<p style="position:absolute;top:123px;left:136px;white-space:nowrap" class="ft1864"><b>EMANTINE</b></p>
<p style="position:absolute;top:119px;left:268px;white-space:nowrap" class="ft18613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1862"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1865">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1866">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1860">Memantine&#160;Hcl Titration Pak&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft1865">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft1866">&#160;&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft18610">Memantine&#160;Hydrochloride&#160;SOLN&#160;<br/>2MG/ML&#160;</p>
<p style="position:absolute;top:262px;left:122px;white-space:nowrap" class="ft1865">•</p>
<p style="position:absolute;top:262px;left:130px;white-space:nowrap" class="ft1866">&#160;&#160;</p>
<p style="position:absolute;top:264px;left:149px;white-space:nowrap" class="ft1860">Memantine&#160;Hydrochloride&#160;TABS&#160;</p>
<p style="position:absolute;top:284px;left:122px;white-space:nowrap" class="ft1865">•</p>
<p style="position:absolute;top:284px;left:130px;white-space:nowrap" class="ft1866">&#160;&#160;</p>
<p style="position:absolute;top:286px;left:149px;white-space:nowrap" class="ft1860">Memantine&#160;Hydrochloride Er&#160;</p>
<p style="position:absolute;top:363px;left:126px;white-space:nowrap" class="ft1862"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:363px;left:274px;white-space:nowrap" class="ft1862"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:405px;left:126px;white-space:nowrap" class="ft1868"><b>Indications&#160;</b></p>
<p style="position:absolute;top:405px;left:274px;white-space:nowrap" class="ft1860">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:444px;left:126px;white-space:nowrap" class="ft1868"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:444px;left:274px;white-space:nowrap" class="ft1860">N/A&#160;</p>
<p style="position:absolute;top:483px;left:126px;white-space:nowrap" class="ft1869"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:483px;left:274px;white-space:nowrap" class="ft1860">N/A&#160;</p>
<p style="position:absolute;top:542px;left:126px;white-space:nowrap" class="ft1869"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:542px;left:274px;white-space:nowrap" class="ft1860">N/A&#160;</p>
<p style="position:absolute;top:622px;left:126px;white-space:nowrap" class="ft1868"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:622px;left:274px;white-space:nowrap" class="ft1860">N/A&#160;</p>
<p style="position:absolute;top:661px;left:126px;white-space:nowrap" class="ft1869"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:661px;left:274px;white-space:nowrap" class="ft1860">N/A&#160;</p>
<p style="position:absolute;top:720px;left:126px;white-space:nowrap" class="ft1869"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:720px;left:274px;white-space:nowrap" class="ft1860">Plan Year&#160;</p>
<p style="position:absolute;top:780px;left:126px;white-space:nowrap" class="ft1868"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:780px;left:274px;white-space:nowrap" class="ft1860">This edit&#160;only applies to patients less than 30 years of&#160;age.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1860">186&#160;</p>
</div>
<!-- Page 187 -->
<a name="187"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page187-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2187.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1871"><b>M</b></p>
<p style="position:absolute;top:123px;left:136px;white-space:nowrap" class="ft1874"><b>EPRON</b></p>
<p style="position:absolute;top:119px;left:220px;white-space:nowrap" class="ft18713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1872"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1875">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1876">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1870">Atovaquone&#160;SUSP&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1872"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1872"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1878"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1870">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1878"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft18710">Babesiosis,&#160;Toxoplasmosis, Pneumocystis&#160;jirovecii&#160;pneumonia&#160;<br/>prophylaxis in pediatric&#160;patients, mild-to-moderate Pneumocystis&#160;jirovecii&#160;<br/>pneumonia&#160;treatment in&#160;pediatric patients.&#160;</p>
<p style="position:absolute;top:437px;left:126px;white-space:nowrap" class="ft1879"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:437px;left:274px;white-space:nowrap" class="ft1870">N/A&#160;</p>
<p style="position:absolute;top:497px;left:126px;white-space:nowrap" class="ft1879"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:497px;left:274px;white-space:nowrap" class="ft18710">For the&#160;treatment of mild-to-moderate Pneumocystis&#160;jiroveci pneumonia&#160;<br/>(PCP): the patient had an&#160;intolerance&#160;or has a contraindication&#160;to&#160;<br/>sulfamethoxazole/trimethoprim&#160;(SMX-TMP). For the prevention of&#160;PCP&#160;<br/>and primary&#160;toxoplasmosis prophylaxis indications: A)&#160;the patient had&#160;an&#160;<br/>intolerance&#160;or has a contraindication&#160;to SMX-TMP, AND B) the patient&#160;<br/>has had a CD4 cell count of less than&#160;200 cells per cubic millimeter&#160;<br/>within the past&#160;3 months. For secondary&#160;toxoplasmosis prophylaxis: the&#160;<br/>patient has&#160;had a CD4 cell&#160;count&#160;of less than 200&#160;cells per cubic&#160;<br/>millimeter within the past&#160;6 months. &#160;For babesiosis treatment: the&#160;<br/>requested drug is&#160;used concurrently&#160;with azithromycin OR&#160;clindamycin.&#160;</p>
<p style="position:absolute;top:722px;left:126px;white-space:nowrap" class="ft1878"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:722px;left:274px;white-space:nowrap" class="ft1870">N/A&#160;</p>
<p style="position:absolute;top:760px;left:126px;white-space:nowrap" class="ft1879"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:760px;left:274px;white-space:nowrap" class="ft1870">N/A&#160;</p>
<p style="position:absolute;top:820px;left:126px;white-space:nowrap" class="ft1879"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:820px;left:274px;white-space:nowrap" class="ft18710">Secondary toxoplasmosis&#160;prophylaxis: 6 months,&#160;All other indications: 3&#160;<br/>months&#160;</p>
<p style="position:absolute;top:879px;left:126px;white-space:nowrap" class="ft1878"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:879px;left:274px;white-space:nowrap" class="ft1870">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1870">187&#160;</p>
</div>
<!-- Page 188 -->
<a name="188"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page188-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2188.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1881"><b>M</b></p>
<p style="position:absolute;top:123px;left:136px;white-space:nowrap" class="ft1884"><b>ODAFINIL</b></p>
<p style="position:absolute;top:119px;left:256px;white-space:nowrap" class="ft18813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1882"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1885">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1886">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1880">Modafinil&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1882"><b>PA&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1882"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1888"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1880">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1888"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1880">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1889"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1880">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1889"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft18810">1)&#160;The patient has&#160;a diagnosis of&#160;narcolepsy and&#160;the diagnosis is&#160;<br/>confirmed by sleep&#160;lab evaluation OR&#160;2) The patient has a diagnosis of&#160;<br/>Shift Work&#160;Disorder&#160;(SWD) OR 3) The patient&#160;has a&#160;diagnosis of&#160;<br/>obstructive&#160;sleep apnea (OSA) and the&#160;diagnosis is confirmed&#160;by&#160;<br/>polysomnography.&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft1888"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft1880">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft1889"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft1880">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft1889"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft1880">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft1888"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft1880">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1880">188&#160;</p>
</div>
<!-- Page 189 -->
<a name="189"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page189-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2189.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1891"><b>M</b></p>
<p style="position:absolute;top:123px;left:136px;white-space:nowrap" class="ft1894"><b>ONJUVI</b></p>
<p style="position:absolute;top:119px;left:228px;white-space:nowrap" class="ft18913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1892"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1895">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1896">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1890">Monjuvi&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1892"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1892"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1898"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1890">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1898"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1890">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1899"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1890">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1899"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft1890">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft1898"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft1890">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft1899"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft1890">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft1899"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft1890">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft1898"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft1890">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1890">189&#160;</p>
</div>
<!-- Page 190 -->
<a name="190"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page190-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2190.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1901"><b>M</b></p>
<p style="position:absolute;top:123px;left:136px;white-space:nowrap" class="ft1904"><b>YLOTARG</b></p>
<p style="position:absolute;top:119px;left:258px;white-space:nowrap" class="ft19013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1902"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1905">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1906">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1900">Mylotarg&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1902"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1902"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1908"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1900">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1908"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1900">Acute promyelocytic&#160;leukemia&#160;(APL)&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1909"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1900">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1909"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft1900">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft1908"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft1900">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft1909"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft1900">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft1909"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft1900">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft1908"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft1900">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1900">190&#160;</p>
</div>
<!-- Page 191 -->
<a name="191"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page191-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2191.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1911"><b>N</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft1914"><b>APROXEN</b></p>
<p style="position:absolute;top:118px;left:248px;white-space:nowrap" class="ft1911"><b>-</b></p>
<p style="position:absolute;top:123px;left:258px;white-space:nowrap" class="ft1914"><b>ESOMEPRAZOLE</b></p>
<p style="position:absolute;top:119px;left:461px;white-space:nowrap" class="ft19113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1912"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1915">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1916">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1910">Naproxen/esomeprazole&#160;Magnesium&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1912"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1912"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1918"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1910">All&#160;FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1918"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1910">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1919"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1910">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1919"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft19110">The patient&#160;has tried two different regimens containing any combination&#160;<br/>of a&#160;nonsteroidal anti-inflammatory&#160;drug (NSAID) and an acid blocker&#160;<br/>from any of&#160;the following drug classes:&#160;H2-receptor&#160;antagonist&#160;(H2RA),&#160;<br/>proton pump inhibitor&#160;(PPI).&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft1918"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft1910">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft1919"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft1910">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft1919"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft1910">Plan Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft1918"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft1910">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1910">191&#160;</p>
</div>
<!-- Page 192 -->
<a name="192"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page192-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2192.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1921"><b>N</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft1924"><b>ATPARA</b></p>
<p style="position:absolute;top:119px;left:230px;white-space:nowrap" class="ft19213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1922"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1925">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1926">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1920">Natpara&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1922"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1922"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1928"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1920">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1928"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1920">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1929"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft19210">Acute postsurgical&#160;hypoparathyroidism (within 6&#160;months of&#160;surgery)&#160;and&#160;<br/>expected&#160;recovery from&#160;hypoparathyroidism.&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1929"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft1920">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft1928"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft1920">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft1929"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft1920">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft1929"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft1920">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft1928"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft1920">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1920">192&#160;</p>
</div>
<!-- Page 193 -->
<a name="193"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page193-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2193.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1931"><b>N</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft1934"><b>AYZILAM</b></p>
<p style="position:absolute;top:119px;left:246px;white-space:nowrap" class="ft19313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1932"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1935">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1936">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1930">Nayzilam&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1932"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1932"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1938"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1930">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1938"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1930">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1939"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1930">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1939"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft1930">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft1938"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft1930">12 years&#160;of age or older&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft1939"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft1930">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft1939"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft1930">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft1938"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft1930">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1930">193&#160;</p>
</div>
<!-- Page 194 -->
<a name="194"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page194-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2194.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1941"><b>N</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft1944"><b>ERLYNX</b></p>
<p style="position:absolute;top:119px;left:231px;white-space:nowrap" class="ft19413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1942"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1945">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1946">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1940">Nerlynx&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1942"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1942"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1948"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1940">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1948"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft19410">Recurrent human&#160;epidermal&#160;growth&#160;factor receptor 2 (HER2)-positive&#160;<br/>breast&#160;cancer, Brain&#160;metastases from&#160;HER2-positive breast&#160;cancer.&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft1949"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft1940">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft1949"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft1940">N/A&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft1948"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft1940">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft1949"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft1940">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft1949"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft1940">Plan&#160;Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft1948"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft1940">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1940">194&#160;</p>
</div>
<!-- Page 195 -->
<a name="195"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page195-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2195.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1951"><b>N</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft1954"><b>EXAVAR</b></p>
<p style="position:absolute;top:119px;left:232px;white-space:nowrap" class="ft19513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1952"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1955">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1956">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1950">Nexavar&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1952"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1952"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1958"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1950">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1958"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft19510">Acute myeloid&#160;leukemia, soft&#160;tissue&#160;sarcoma (angiosarcoma,&#160;desmoid&#160;<br/>tumors/aggressive fibromatosis, and&#160;solitary&#160;fibrous tumor&#160;subtypes),&#160;<br/>gastrointestinal&#160;stromal tumor, medullary&#160;thyroid&#160;carcinoma,&#160;<br/>osteosarcoma, recurrent&#160;chordoma, epithelial ovarian cancer,&#160;fallopian&#160;<br/>tube cancer,&#160;primary&#160;peritoneal&#160;cancer.&#160;</p>
<p style="position:absolute;top:479px;left:126px;white-space:nowrap" class="ft1959"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:479px;left:274px;white-space:nowrap" class="ft1950">N/A&#160;</p>
<p style="position:absolute;top:538px;left:126px;white-space:nowrap" class="ft1959"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:538px;left:274px;white-space:nowrap" class="ft19510">For thyroid&#160;carcinoma:&#160;Histology&#160;is follicular, papillary, Hurthle cell or&#160;<br/>medullary. For acute myeloid&#160;leukemia, any of the following&#160;criteria must&#160;<br/>be met: 1) The requested&#160;drug is used&#160;in combination with azacitidine or&#160;<br/>decitabine&#160;for low-intensity treatment induction&#160;or post-induction&#160;therapy&#160;<br/>AND the patient&#160;is 60&#160;years&#160;of age or older&#160;with&#160;FLT3-ITD mutation, OR&#160;<br/>2) The disease is relapsed/refractory&#160;AND the requested drug is a&#160;<br/>component&#160;of repeating&#160;the initial successful induction&#160;if&#160;late relapse&#160;<br/>(greater&#160;than or&#160;equal&#160;to&#160;12 months),&#160;OR&#160;3) The disease&#160;is&#160;<br/>relapsed/refractory AND&#160;the requested drug is used in combination with&#160;<br/>azacitidine or decitabine&#160;if&#160;the patient is FLT3-ITD mutation&#160;positive. For&#160;<br/>renal cell carcinoma, the&#160;patient meets ALL of the following:&#160;1) The&#160;<br/>disease is advanced, AND&#160;2) The patient has experienced disease&#160;<br/>progression&#160;or an intolerable adverse&#160;event&#160;with&#160;a trial of cabozantinib or&#160;<br/>axitinib.&#160;</p>
<p style="position:absolute;top:846px;left:126px;white-space:nowrap" class="ft1958"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:846px;left:274px;white-space:nowrap" class="ft1950">N/A&#160;</p>
<p style="position:absolute;top:885px;left:126px;white-space:nowrap" class="ft1959"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:885px;left:274px;white-space:nowrap" class="ft1950">N/A&#160;</p>
<p style="position:absolute;top:944px;left:126px;white-space:nowrap" class="ft1959"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:944px;left:274px;white-space:nowrap" class="ft1950">Plan Year&#160;</p>
<p style="position:absolute;top:1003px;left:126px;white-space:nowrap" class="ft1958"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:1003px;left:274px;white-space:nowrap" class="ft1950">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1950">195&#160;</p>
</div>
<!-- Page 196 -->
<a name="196"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page196-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2196.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1961"><b>N</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft1964"><b>INLARO</b></p>
<p style="position:absolute;top:119px;left:226px;white-space:nowrap" class="ft19613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1962"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1965">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1966">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1960">Ninlaro&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1962"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1962"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1968"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1960">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1968"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft19610">Systemic light&#160;chain&#160;amyloidosis, Waldenstrom&#160;<br/>macroglobulinemia/lymphoplasmacytic lymphoma&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft1969"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft1960">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft1969"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft19610">For multiple&#160;myeloma:&#160;The requested&#160;drug will be&#160;used in combination&#160;<br/>with lenalidomide and dexamethasone OR&#160;pomalidomide and&#160;<br/>dexamethasone OR&#160;dexamethasone&#160;OR&#160;cyclophosphamide and&#160;<br/>dexamethasone OR&#160;as a single&#160;agent.&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft1968"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft1960">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft1969"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft1960">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft1969"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft1960">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft1968"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft1960">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1960">196&#160;</p>
</div>
<!-- Page 197 -->
<a name="197"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page197-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2197.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1971"><b>N</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft1974"><b>ITISINONE</b></p>
<p style="position:absolute;top:119px;left:256px;white-space:nowrap" class="ft19713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1972"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1975">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1976">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1970">Nitisinone&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1972"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1972"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1978"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1970">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1978"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1970">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1979"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1970">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1979"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft19710">For hereditary&#160;tyrosinemia type 1: Diagnosis of&#160;hereditary&#160;tyrosinemia&#160;<br/>type 1 is&#160;confirmed by one of&#160;the following:&#160;1) biochemical testing&#160;(e.g.,&#160;<br/>detection of&#160;succinylacetone in urine) or 2)&#160;DNA testing&#160;(mutation&#160;<br/>analysis).&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft1978"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft1970">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft1979"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft1970">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft1979"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft1970">Plan Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft1978"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft1970">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1970">197&#160;</p>
</div>
<!-- Page 198 -->
<a name="198"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page198-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2198.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1981"><b>N</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft1984"><b>ORTHERA</b></p>
<p style="position:absolute;top:119px;left:251px;white-space:nowrap" class="ft19813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1982"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1985">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1986">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1980">Droxidopa&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1982"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1982"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1988"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1980">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1988"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1980">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1989"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1980">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1989"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft19810">For neurogenic&#160;orthostatic hypotension (nOH):&#160;Prior to initial&#160;therapy,&#160;<br/>patient has&#160;a&#160;persistent, consistent decrease in systolic blood pressure of at&#160;<br/>least 20 mmHg OR decrease in diastolic blood pressure of at&#160;least 10&#160;<br/>mmHg within 3 minutes&#160;of standing&#160;or head-up&#160;tilt&#160;test. For&#160;continuation&#160;<br/>of therapy for nOH, patient experienced benefit&#160;from therapy&#160;(e.g., a&#160;<br/>sustained decrease in dizziness,&#160;lightheadedness,&#160;or feeling&#160;faint). For&#160;<br/>both initial and continuation of&#160;therapy for&#160;nOH, the requested&#160;drug will&#160;<br/>be used for&#160;patients with neurogenic orthostatic&#160;hypotension associated&#160;<br/>with one&#160;of the following diagnoses:&#160;1) Primary autonomic failure due&#160;to&#160;<br/>Parkinson's&#160;disease, multiple system&#160;atrophy, or&#160;pure&#160;autonomic failure,&#160;<br/>OR&#160;2) Dopamine beta-hydroxylase deficiency,&#160;OR&#160;3) Non-diabetic&#160;<br/>autonomic neuropathy.&#160;</p>
<p style="position:absolute;top:722px;left:126px;white-space:nowrap" class="ft1988"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:722px;left:274px;white-space:nowrap" class="ft1980">N/A&#160;</p>
<p style="position:absolute;top:760px;left:126px;white-space:nowrap" class="ft1989"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:760px;left:274px;white-space:nowrap" class="ft1980">N/A&#160;</p>
<p style="position:absolute;top:820px;left:126px;white-space:nowrap" class="ft1989"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:820px;left:274px;white-space:nowrap" class="ft1980">3 months&#160;</p>
<p style="position:absolute;top:879px;left:126px;white-space:nowrap" class="ft1988"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:879px;left:274px;white-space:nowrap" class="ft1980">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1980">198&#160;</p>
</div>
<!-- Page 199 -->
<a name="199"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page199-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2199.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft1991"><b>N</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft1994"><b>UBEQA</b></p>
<p style="position:absolute;top:119px;left:215px;white-space:nowrap" class="ft19913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft1992"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft1995">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft1996">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft1990">Nubeqa&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft1992"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft1992"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft1998"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft1990">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft1998"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft1990">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft1999"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft1990">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft1999"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft19910">The requested&#160;drug will&#160;be used in combination with a gonadotropin-<br/>releasing hormone (GnRH) analog or&#160;after bilateral orchiectomy.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft1998"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft1990">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft1999"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft1990">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft1999"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft1990">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft1998"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft1990">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft1990">199&#160;</p>
</div>
<!-- Page 200 -->
<a name="200"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page200-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2200.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2001"><b>N</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft2004"><b>UEDEXTA</b></p>
<p style="position:absolute;top:119px;left:247px;white-space:nowrap" class="ft20013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2002"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2005">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2006">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2000">Nuedexta&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2002"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2002"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2008"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2000">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2008"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2000">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2009"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2000">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2009"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2000">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2008"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2000">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2009"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2000">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2009"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2000">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2008"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2000">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2000">200&#160;</p>
</div>
<!-- Page 201 -->
<a name="201"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page201-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2201.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2011"><b>N</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft2014"><b>UPLAZID</b></p>
<p style="position:absolute;top:119px;left:238px;white-space:nowrap" class="ft20113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2012"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2015">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2016">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2010">Nuplazid&#160;CAPS&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft2015">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft2016">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft2010">Nuplazid&#160;TABS 10MG&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft2012"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft2012"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft2018"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft2010">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft2018"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft2010">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft2019"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft2010">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft2019"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft20110">For hallucinations&#160;and delusions associated with&#160;Parkinson's&#160;disease&#160;<br/>psychosis, the diagnosis of Parkinson's disease&#160;must&#160;be&#160;made prior to the&#160;<br/>onset&#160;of psychotic&#160;symptoms.&#160;</p>
<p style="position:absolute;top:557px;left:126px;white-space:nowrap" class="ft2018"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:557px;left:274px;white-space:nowrap" class="ft2010">N/A&#160;</p>
<p style="position:absolute;top:596px;left:126px;white-space:nowrap" class="ft2019"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:596px;left:274px;white-space:nowrap" class="ft2010">N/A&#160;</p>
<p style="position:absolute;top:656px;left:126px;white-space:nowrap" class="ft2019"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:656px;left:274px;white-space:nowrap" class="ft2010">Plan Year&#160;</p>
<p style="position:absolute;top:715px;left:126px;white-space:nowrap" class="ft2018"><b>Other&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:715px;left:274px;white-space:nowrap" class="ft2010">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2010">201&#160;</p>
</div>
<!-- Page 202 -->
<a name="202"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page202-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2202.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2021"><b>O</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft2024"><b>CTREOTIDE</b></p>
<p style="position:absolute;top:119px;left:275px;white-space:nowrap" class="ft20213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2022"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2025">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2026">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft20210">Octreotide&#160;Acetate&#160;INJ&#160;<br/>1000MCG/ML, 100MCG/ML,&#160;<br/>200MCG/ML, 500MCG/ML,&#160;<br/>50MCG/ML&#160;</p>
<p style="position:absolute;top:339px;left:126px;white-space:nowrap" class="ft2022"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:339px;left:274px;white-space:nowrap" class="ft2022"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:381px;left:126px;white-space:nowrap" class="ft2028"><b>Indications&#160;</b></p>
<p style="position:absolute;top:381px;left:274px;white-space:nowrap" class="ft2020">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:419px;left:126px;white-space:nowrap" class="ft2028"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:419px;left:274px;white-space:nowrap" class="ft2020">Tumor&#160;control&#160;of thymomas&#160;and&#160;thymic carcinomas.&#160;</p>
<p style="position:absolute;top:458px;left:126px;white-space:nowrap" class="ft2029"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:458px;left:274px;white-space:nowrap" class="ft2020">N/A&#160;</p>
<p style="position:absolute;top:518px;left:126px;white-space:nowrap" class="ft2029"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:518px;left:274px;white-space:nowrap" class="ft20210">For acromegaly&#160;(initial):&#160;1) patient has a high pretreatment insulin-like&#160;<br/>growth factor-1 (IGF-1) level for age&#160;and/or&#160;gender&#160;based on the&#160;<br/>laboratory&#160;reference range, and 2)&#160;patient had an&#160;inadequate or partial&#160;<br/>response&#160;to&#160;surgery or radiotherapy&#160;OR&#160;there is&#160;a clinical&#160;reason for why&#160;<br/>the patient has not had surgery or&#160;radiotherapy.&#160;For acromegaly&#160;<br/>(continuation of therapy):&#160;patient's IGF-1 level has decreased&#160;or&#160;<br/>normalized&#160;since&#160;initiation of therapy. For tumor control of&#160;thymomas&#160;and&#160;<br/>thymic carcinomas, the requested drug&#160;will&#160;be used as second-line&#160;<br/>systemic&#160;therapy in patients with unresectable or&#160;extrathoracic metastatic&#160;<br/>disease.&#160;</p>
<p style="position:absolute;top:742px;left:126px;white-space:nowrap" class="ft2028"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:742px;left:274px;white-space:nowrap" class="ft2020">N/A&#160;</p>
<p style="position:absolute;top:781px;left:126px;white-space:nowrap" class="ft2029"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:781px;left:274px;white-space:nowrap" class="ft2020">N/A&#160;</p>
<p style="position:absolute;top:841px;left:126px;white-space:nowrap" class="ft2029"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:841px;left:274px;white-space:nowrap" class="ft2020">Plan Year&#160;</p>
<p style="position:absolute;top:900px;left:126px;white-space:nowrap" class="ft2028"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:900px;left:274px;white-space:nowrap" class="ft2020">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2020">202&#160;</p>
</div>
<!-- Page 203 -->
<a name="203"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page203-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2203.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2031"><b>O</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft2034"><b>DOMZO</b></p>
<p style="position:absolute;top:119px;left:225px;white-space:nowrap" class="ft20313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2032"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2035">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2036">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2030">Odomzo&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2032"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2032"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2038"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2030">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2038"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2030">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2039"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2030">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2039"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2030">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2038"><b>Age&#160;Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2030">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2039"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2030">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2039"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2030">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2038"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2030">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2030">203&#160;</p>
</div>
<!-- Page 204 -->
<a name="204"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page204-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2204.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2041"><b>O</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft2044"><b>FEV</b></p>
<p style="position:absolute;top:119px;left:179px;white-space:nowrap" class="ft20413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2042"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2045">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2046">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2040">Ofev&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2042"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2042"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2048"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2040">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2048"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2040">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2049"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2040">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2049"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2040">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2048"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2040">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2049"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2040">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2049"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2040">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2048"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2040">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2040">204&#160;</p>
</div>
<!-- Page 205 -->
<a name="205"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page205-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2205.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2051"><b>O</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft2054"><b>NCASPAR</b></p>
<p style="position:absolute;top:119px;left:246px;white-space:nowrap" class="ft20513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2052"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2055">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2056">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2050">Oncaspar&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2052"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2052"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2058"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2050">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2058"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft20510">Extranodal&#160;natural&#160;killer/T-cell&#160;lymphoma (nasal type), hepatosplenic&#160;<br/>gamma-delta T-cell lymphoma&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft2059"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft2050">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft2059"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft20510">For extranodal&#160;natural killer/T-cell&#160;lymphoma&#160;(nasal&#160;type), acute&#160;<br/>lymphoblastic leukemia,&#160;and hepatosplenic gamma-delta T-cell&#160;<br/>lymphoma: the requested&#160;drug must be used in conjunction with multi-<br/>agent&#160;chemotherapy.&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft2058"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft2050">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft2059"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft2050">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft2059"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft2050">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft2058"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft2050">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2050">205&#160;</p>
</div>
<!-- Page 206 -->
<a name="206"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page206-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2206.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2061"><b>O</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft2064"><b>NUREG</b></p>
<p style="position:absolute;top:119px;left:218px;white-space:nowrap" class="ft20613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2062"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2065">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2066">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2060">Onureg&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2062"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2062"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2068"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2060">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2068"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2060">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2069"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2060">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2069"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2060">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2068"><b>Age&#160;Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2060">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2069"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2060">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2069"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2060">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2068"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2060">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2060">206&#160;</p>
</div>
<!-- Page 207 -->
<a name="207"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page207-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2207.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2071"><b>O</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft2074"><b>PSUMIT</b></p>
<p style="position:absolute;top:119px;left:225px;white-space:nowrap" class="ft20713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2072"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2075">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2076">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2070">Opsumit&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2072"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2072"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2078"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2070">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2078"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2070">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2079"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2070">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2079"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft20710">For pulmonary&#160;arterial hypertension&#160;(PAH) (World Health Organization&#160;<br/>[WHO] Group 1): Diagnosis was confirmed by right heart catheterization.&#160;<br/>For PAH&#160;new starts only: 1)&#160;Pretreatment mean&#160;pulmonary arterial&#160;<br/>pressure is greater than 20 mmHg, 2)&#160;Pretreatment pulmonary capillary&#160;<br/>wedge pressure&#160;is less than or&#160;equal to 15 mmHg, and 3)&#160;Pretreatment&#160;<br/>pulmonary vascular resistance&#160;is greater&#160;than or&#160;equal to 3 Wood units.&#160;</p>
<p style="position:absolute;top:598px;left:126px;white-space:nowrap" class="ft2078"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:598px;left:274px;white-space:nowrap" class="ft2070">N/A&#160;</p>
<p style="position:absolute;top:636px;left:126px;white-space:nowrap" class="ft2079"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:636px;left:274px;white-space:nowrap" class="ft2070">N/A&#160;</p>
<p style="position:absolute;top:696px;left:126px;white-space:nowrap" class="ft2079"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:696px;left:274px;white-space:nowrap" class="ft2070">Plan Year&#160;</p>
<p style="position:absolute;top:755px;left:126px;white-space:nowrap" class="ft2078"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:755px;left:274px;white-space:nowrap" class="ft2070">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2070">207&#160;</p>
</div>
<!-- Page 208 -->
<a name="208"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page208-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2208.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2081"><b>O</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft2084"><b>RACEA</b></p>
<p style="position:absolute;top:119px;left:217px;white-space:nowrap" class="ft20813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2082"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2085">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2086">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2080">Doxycycline&#160;CPDR&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft2085">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft2086">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft2080">Oracea&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft2082"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft2082"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft2088"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft2080">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft2088"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft2080">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft2089"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft2080">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft2089"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft20810">Patient must&#160;have experienced an inadequate&#160;treatment response,&#160;<br/>intolerance,&#160;or has a contraindication&#160;to formulary&#160;generic topical&#160;<br/>metronidazole.&#160;</p>
<p style="position:absolute;top:557px;left:126px;white-space:nowrap" class="ft2088"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:557px;left:274px;white-space:nowrap" class="ft2080">N/A&#160;</p>
<p style="position:absolute;top:596px;left:126px;white-space:nowrap" class="ft2089"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:596px;left:274px;white-space:nowrap" class="ft2080">N/A&#160;</p>
<p style="position:absolute;top:656px;left:126px;white-space:nowrap" class="ft2089"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:656px;left:274px;white-space:nowrap" class="ft2080">Plan Year&#160;</p>
<p style="position:absolute;top:715px;left:126px;white-space:nowrap" class="ft2088"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:715px;left:274px;white-space:nowrap" class="ft2080">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2080">208&#160;</p>
</div>
<!-- Page 209 -->
<a name="209"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page209-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2209.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2091"><b>O</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft2094"><b>RAL</b></p>
<p style="position:absolute;top:118px;left:182px;white-space:nowrap" class="ft2091"><b>-</b></p>
<p style="position:absolute;top:123px;left:192px;white-space:nowrap" class="ft2094"><b>INTRANASAL&#160;</b></p>
<p style="position:absolute;top:118px;left:357px;white-space:nowrap" class="ft2091"><b>F</b></p>
<p style="position:absolute;top:123px;left:375px;white-space:nowrap" class="ft2094"><b>ENTANYL</b></p>
<p style="position:absolute;top:119px;left:492px;white-space:nowrap" class="ft20913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2092"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2095">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2096">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2090">Fentanyl&#160;Citrate Oral Transmucosal&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2092"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2092"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2098"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2090">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2098"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2090">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2099"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2090">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2099"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft20910">1)&#160;The requested drug&#160;is indicated for the treatment of&#160;breakthrough&#160;<br/>CANCER-related pain only. The requested drug&#160;is being prescribed&#160;for&#160;<br/>the management&#160;of breakthrough pain&#160;in a CANCER patient&#160;with&#160;<br/>underlying&#160;CANCER pain AND&#160;2) The International&#160;Classification of&#160;<br/>Diseases (ICD) diagnosis code provided supports the CANCER-<br/>RELATED diagnosis.&#160;[Note:&#160;For drug coverage&#160;approval, ICD&#160;diagnosis&#160;<br/>code provided MUST support the CANCER-RELATED diagnosis.]&#160;AND&#160;<br/>3) The patient is currently receiving,&#160;and will continue&#160;to receive, around-<br/>the-clock opioid therapy&#160;for&#160;underlying CANCER pain AND 4)&#160;The&#160;<br/>requested drug is&#160;intended only for use in opioid tolerant patients. The&#160;<br/>patient can safely&#160;take&#160;the requested&#160;dose based on their current opioid&#160;<br/>use history.&#160;[Note: Patients considered opioid&#160;tolerant&#160;are&#160;those who are&#160;<br/>taking around-the-clock&#160;medicine consisting of at least 60 mg of oral&#160;<br/>morphine per day, at least 25 mcg per hour of&#160;transdermal fentanyl, at&#160;<br/>least 30 mg&#160;of oral oxycodone per&#160;day, at&#160;least 60 mg of&#160;oral&#160;hydrocodone&#160;<br/>per&#160;day, at least&#160;8&#160;mg of oral&#160;hydromorphone per&#160;day, at least 25&#160;mg of&#160;<br/>oral oxymorphone per&#160;day, or&#160;an equianalgesic&#160;dose of&#160;another opioid&#160;<br/>medication&#160;daily&#160;for&#160;one&#160;week or longer.].&#160;</p>
<p style="position:absolute;top:846px;left:126px;white-space:nowrap" class="ft2098"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:846px;left:274px;white-space:nowrap" class="ft2090">N/A&#160;</p>
<p style="position:absolute;top:885px;left:126px;white-space:nowrap" class="ft2099"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:885px;left:274px;white-space:nowrap" class="ft2090">N/A&#160;</p>
<p style="position:absolute;top:944px;left:126px;white-space:nowrap" class="ft2099"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:944px;left:274px;white-space:nowrap" class="ft2090">Plan Year&#160;</p>
<p style="position:absolute;top:1003px;left:126px;white-space:nowrap" class="ft2098"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:1003px;left:274px;white-space:nowrap" class="ft2090">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2090">209&#160;</p>
</div>
<!-- Page 210 -->
<a name="210"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page210-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2210.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2101"><b>O</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft2104"><b>RGOVYX</b></p>
<p style="position:absolute;top:119px;left:238px;white-space:nowrap" class="ft21013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2102"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2105">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2106">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2100">Orgovyx&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2102"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2102"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2108"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2100">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2108"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2100">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2109"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2100">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2109"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2100">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2108"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2100">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2109"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2100">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2109"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2100">Plan year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2108"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2100">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2100">210&#160;</p>
</div>
<!-- Page 211 -->
<a name="211"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page211-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2211.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2111"><b>O</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft2114"><b>RKAMBI</b></p>
<p style="position:absolute;top:119px;left:233px;white-space:nowrap" class="ft21113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2112"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2115">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2116">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2110">Orkambi&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2112"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2112"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2118"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2110">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2118"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2110">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2119"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2110">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2119"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft21110">For cystic&#160;fibrosis (CF):&#160;The requested medication will&#160;not be used in&#160;<br/>combination&#160;with other&#160;medications&#160;containing ivacaftor.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2118"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2110">2 years&#160;of age or&#160;older&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2119"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2110">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2119"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2110">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2118"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2110">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2110">211&#160;</p>
</div>
<!-- Page 212 -->
<a name="212"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page212-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2212.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2121"><b>O</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft2124"><b>XANDROLONE</b></p>
<p style="position:absolute;top:119px;left:305px;white-space:nowrap" class="ft21213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2122"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2125">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2126">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2120">Oxandrolone&#160;TABS&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2122"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2122"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2128"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2120">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2128"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft21210">Cachexia&#160;associated&#160;with AIDS (HIV&#160;wasting), To enhance&#160;growth in&#160;<br/>patients with Turners Syndrome&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft2129"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft2120">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft2129"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft2120">N/A&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft2128"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft2120">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft2129"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft2120">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft2129"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft2120">Turners Syndrome: Plan&#160;Year, All&#160;other&#160;diagnoses: 6 months&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft2128"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft21210">Coverage&#160;will&#160;be denied if request&#160;is for an indication excluded from&#160;<br/>Medicare&#160;Part&#160;D.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2120">212&#160;</p>
</div>
<!-- Page 213 -->
<a name="213"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page213-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2213.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2131"><b>O</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft2134"><b>XAZEPAM&#160;</b></p>
<p style="position:absolute;top:118px;left:259px;white-space:nowrap" class="ft2131"><b>-&#160;65</b></p>
<p style="position:absolute;top:113px;left:305px;white-space:nowrap" class="ft21314">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2132"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2135">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2136">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2130">Oxazepam&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2132"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2132"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2138"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2130">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2138"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2130">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2139"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2130">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2139"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft21310">For all&#160;indications: the prescriber must acknowledge the benefit&#160;of&#160;<br/>therapy with&#160;the requested drug outweighs the potential risks&#160;for the&#160;<br/>patient. &#160;(Note:&#160;The American Geriatrics&#160;Society identifies&#160;the use of this&#160;<br/>medication&#160;as potentially inappropriate&#160;in older&#160;adults,&#160;meaning it&#160;is best&#160;<br/>avoided, prescribed at&#160;reduced dosage, or&#160;used with caution or carefully&#160;<br/>monitored.) &#160;For the management of&#160;anxiety disorders, anxiety associated&#160;<br/>with depression, and the&#160;management of anxiety, tension, agitation and&#160;<br/>irritability&#160;in&#160;older&#160;patients:&#160;1) the&#160;requested drug&#160;is being used&#160;<br/>concurrently&#160;with a&#160;selective&#160;serotonin&#160;reuptake inhibitor (SSRI) or&#160;<br/>serotonin-norepinephrine reuptake inhibitor (SNRI) until the SSRI/SNRI&#160;<br/>becomes&#160;effective for the symptoms of anxiety,&#160;OR&#160;2) the patient has&#160;<br/>experienced&#160;an inadequate treatment response, intolerance, or&#160;a has a&#160;<br/>contraindication to AT LEAST TWO&#160;agents from&#160;the following classes:&#160;<br/>a)&#160;selective&#160;serotonin reuptake&#160;inhibitors&#160;(SSRIs), b)&#160;serotonin-<br/>norepinephrine reuptake&#160;inhibitors&#160;(SNRIs).&#160;</p>
<p style="position:absolute;top:784px;left:126px;white-space:nowrap" class="ft2138"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:784px;left:274px;white-space:nowrap" class="ft2130">N/A&#160;</p>
<p style="position:absolute;top:823px;left:126px;white-space:nowrap" class="ft2139"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:823px;left:274px;white-space:nowrap" class="ft2130">N/A&#160;</p>
<p style="position:absolute;top:882px;left:126px;white-space:nowrap" class="ft2139"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:882px;left:274px;white-space:nowrap" class="ft21310">Short-term relief&#160;anxiety-1 month, Anxiety Disorders-4&#160;months, Alcohol&#160;<br/>Withdrawal-Plan Year&#160;</p>
<p style="position:absolute;top:941px;left:126px;white-space:nowrap" class="ft2138"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:941px;left:274px;white-space:nowrap" class="ft21310">This Prior&#160;Authorization&#160;requirement&#160;only applies&#160;to patients 65 years of&#160;<br/>age&#160;or older.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2130">213&#160;</p>
</div>
<!-- Page 214 -->
<a name="214"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page214-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2214.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2141"><b>P</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft2144"><b>ADCEV</b></p>
<p style="position:absolute;top:119px;left:212px;white-space:nowrap" class="ft21413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2142"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2145">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2146">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2140">Padcev&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2142"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2142"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2148"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2140">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2148"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft21410">Recurrent primary&#160;carcinoma of&#160;the urethra, recurrent or&#160;persistent&#160;<br/>urothelial carcinoma of&#160;the bladder.&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft2149"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft2140">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft2149"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft21410">For urothelial&#160;carcinoma, the&#160;requested drug will be used as&#160;subsequent&#160;<br/>therapy&#160;for&#160;any of the following: a) locally&#160;advanced or metastatic&#160;<br/>urothelial carcinoma, b)&#160;urothelial carcinoma of&#160;the bladder&#160;with muscle&#160;<br/>invasive local recurrence or&#160;persistent disease in&#160;a preserved&#160;bladder, c)&#160;<br/>urothelial carcinoma of&#160;the bladder&#160;with metastatic or local recurrence&#160;<br/>post&#160;cystectomy, or d)&#160;recurrent primary carcinoma of&#160;the urethra.&#160;</p>
<p style="position:absolute;top:618px;left:126px;white-space:nowrap" class="ft2148"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:618px;left:274px;white-space:nowrap" class="ft2140">N/A&#160;</p>
<p style="position:absolute;top:657px;left:126px;white-space:nowrap" class="ft2149"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:657px;left:274px;white-space:nowrap" class="ft2140">N/A&#160;</p>
<p style="position:absolute;top:716px;left:126px;white-space:nowrap" class="ft2149"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:716px;left:274px;white-space:nowrap" class="ft2140">Plan Year&#160;</p>
<p style="position:absolute;top:776px;left:126px;white-space:nowrap" class="ft2148"><b>Other&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:776px;left:274px;white-space:nowrap" class="ft2140">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2140">214&#160;</p>
</div>
<!-- Page 215 -->
<a name="215"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page215-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2215.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2151"><b>P</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft2154"><b>EGASYS</b></p>
<p style="position:absolute;top:119px;left:222px;white-space:nowrap" class="ft21513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2152"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2155">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2156">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2150">Pegasys&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2152"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2152"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2158"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2150">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2158"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft21510">Myeloproliferative neoplasm&#160;(essential&#160;thrombocythemia, polycythemia&#160;<br/>vera, symptomatic low risk myelofibrosis), systemic&#160;mastocytosis, adult&#160;<br/>T-cell leukemia/lymphoma, mycosis&#160;fungoides/Sezary syndrome,&#160;primary&#160;<br/>cutaneous CD30+ T-cell&#160;lymphoproliferative disorders.&#160;</p>
<p style="position:absolute;top:458px;left:126px;white-space:nowrap" class="ft2159"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:458px;left:274px;white-space:nowrap" class="ft2150">N/A&#160;</p>
<p style="position:absolute;top:518px;left:126px;white-space:nowrap" class="ft2159"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:518px;left:274px;white-space:nowrap" class="ft21510">For chronic&#160;hepatitis C:&#160;Hepatitis C&#160;virus (HCV)&#160;confirmed by presence&#160;<br/>of hepatitis C&#160;virus HCV RNA in serum prior&#160;to&#160;starting&#160;treatment and the&#160;<br/>planned treatment regimen.&#160;</p>
<p style="position:absolute;top:598px;left:126px;white-space:nowrap" class="ft2158"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:598px;left:274px;white-space:nowrap" class="ft2150">N/A&#160;</p>
<p style="position:absolute;top:636px;left:126px;white-space:nowrap" class="ft2159"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:636px;left:274px;white-space:nowrap" class="ft2150">N/A&#160;</p>
<p style="position:absolute;top:696px;left:126px;white-space:nowrap" class="ft2159"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:696px;left:274px;white-space:nowrap" class="ft21510">HCV:&#160;12-48 weeks&#160;depending on regimen. HBV: 48 weeks. All&#160;Other:&#160;<br/>Plan Year.&#160;</p>
<p style="position:absolute;top:755px;left:126px;white-space:nowrap" class="ft2158"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:755px;left:274px;white-space:nowrap" class="ft2150">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2150">215&#160;</p>
</div>
<!-- Page 216 -->
<a name="216"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page216-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2216.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2161"><b>P</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft2164"><b>EMAZYRE</b></p>
<p style="position:absolute;top:119px;left:249px;white-space:nowrap" class="ft21613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2162"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2165">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2166">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2160">Pemazyre&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2162"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2162"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2168"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2160">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2168"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2160">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2169"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2160">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2169"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2160">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2168"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2160">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2169"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2160">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2169"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2160">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2168"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2160">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2160">216&#160;</p>
</div>
<!-- Page 217 -->
<a name="217"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page217-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2217.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2171"><b>P</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft2174"><b>EPAXTO</b></p>
<p style="position:absolute;top:119px;left:226px;white-space:nowrap" class="ft21713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2172"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2175">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2176">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2170">Pepaxto&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2172"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2172"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2178"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2170">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2178"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2170">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2179"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2170">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2179"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2170">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2178"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2170">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2179"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2170">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2179"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2170">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2178"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2170">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2170">217&#160;</p>
</div>
<!-- Page 218 -->
<a name="218"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page218-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2218.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2181"><b>P</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft2184"><b>HENYLBUTYRATE</b></p>
<p style="position:absolute;top:119px;left:345px;white-space:nowrap" class="ft21813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2182"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2185">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2186">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft21810">Sodium&#160;Phenylbutyrate&#160;POWD&#160;<br/>3GM/TSP&#160;</p>
<p style="position:absolute;top:240px;left:122px;white-space:nowrap" class="ft2185">•</p>
<p style="position:absolute;top:240px;left:130px;white-space:nowrap" class="ft2186">&#160;&#160;</p>
<p style="position:absolute;top:242px;left:149px;white-space:nowrap" class="ft2180">Sodium&#160;Phenylbutyrate&#160;TABS&#160;</p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2182"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2182"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:361px;left:126px;white-space:nowrap" class="ft2188"><b>Indications&#160;</b></p>
<p style="position:absolute;top:361px;left:274px;white-space:nowrap" class="ft2180">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:400px;left:126px;white-space:nowrap" class="ft2188"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:400px;left:274px;white-space:nowrap" class="ft2180">N/A&#160;</p>
<p style="position:absolute;top:439px;left:126px;white-space:nowrap" class="ft2189"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:439px;left:274px;white-space:nowrap" class="ft2180">N/A&#160;</p>
<p style="position:absolute;top:498px;left:126px;white-space:nowrap" class="ft2189"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:498px;left:274px;white-space:nowrap" class="ft21810">For urea&#160;cycle disorder:&#160;Diagnosis of urea cycle disorder (UCD) was&#160;<br/>confirmed by enzymatic,&#160;biochemical or&#160;genetic&#160;testing.&#160;</p>
<p style="position:absolute;top:578px;left:126px;white-space:nowrap" class="ft2188"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:578px;left:274px;white-space:nowrap" class="ft2180">N/A&#160;</p>
<p style="position:absolute;top:617px;left:126px;white-space:nowrap" class="ft2189"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:617px;left:274px;white-space:nowrap" class="ft2180">N/A&#160;</p>
<p style="position:absolute;top:676px;left:126px;white-space:nowrap" class="ft2189"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:676px;left:274px;white-space:nowrap" class="ft2180">Plan Year&#160;</p>
<p style="position:absolute;top:736px;left:126px;white-space:nowrap" class="ft2188"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:736px;left:274px;white-space:nowrap" class="ft2180">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2180">218&#160;</p>
</div>
<!-- Page 219 -->
<a name="219"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page219-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2219.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2191"><b>P</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft2194"><b>HESGO</b></p>
<p style="position:absolute;top:119px;left:212px;white-space:nowrap" class="ft21913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2192"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2195">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2196">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2190">Phesgo&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2192"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2192"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2198"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2190">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2198"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft21910">Recurrent human&#160;epidermal&#160;growth&#160;factor receptor 2 (HER2)-positive&#160;<br/>breast&#160;cancer&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft2199"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft2190">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft2199"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft2190">N/A&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft2198"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft2190">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft2199"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft2190">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft2199"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft2190">Neoadjuvant&#160;therapy&#160;for&#160;breast&#160;cancer: 6 months. Other: Plan&#160;Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft2198"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft2190">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2190">219&#160;</p>
</div>
<!-- Page 220 -->
<a name="220"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page220-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2220.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2201"><b>P</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft2204"><b>IQRAY</b></p>
<p style="position:absolute;top:119px;left:206px;white-space:nowrap" class="ft22013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2202"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2205">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2206">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2200">Piqray 200mg Daily Dose&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft2205">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft2206">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft2200">Piqray 250mg Daily Dose&#160;</p>
<p style="position:absolute;top:242px;left:122px;white-space:nowrap" class="ft2205">•</p>
<p style="position:absolute;top:241px;left:130px;white-space:nowrap" class="ft2206">&#160;</p>
<p style="position:absolute;top:244px;left:149px;white-space:nowrap" class="ft2200">Piqray 300mg Daily Dose&#160;</p>
<p style="position:absolute;top:321px;left:126px;white-space:nowrap" class="ft2202"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:321px;left:274px;white-space:nowrap" class="ft2202"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:363px;left:126px;white-space:nowrap" class="ft2208"><b>Indications&#160;</b></p>
<p style="position:absolute;top:363px;left:274px;white-space:nowrap" class="ft2200">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:401px;left:126px;white-space:nowrap" class="ft2208"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:401px;left:274px;white-space:nowrap" class="ft22010">Recurrent hormone&#160;receptor&#160;(HR)-positive, human epidermal growth&#160;<br/>factor receptor 2 (HER2)-negative, PIK3CA-mutated breast cancer&#160;in&#160;<br/>combination&#160;with fulvestrant.&#160;</p>
<p style="position:absolute;top:481px;left:126px;white-space:nowrap" class="ft2209"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:481px;left:274px;white-space:nowrap" class="ft2200">N/A&#160;</p>
<p style="position:absolute;top:541px;left:126px;white-space:nowrap" class="ft2209"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:541px;left:274px;white-space:nowrap" class="ft2200">N/A&#160;</p>
<p style="position:absolute;top:621px;left:126px;white-space:nowrap" class="ft2208"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:621px;left:274px;white-space:nowrap" class="ft2200">N/A&#160;</p>
<p style="position:absolute;top:660px;left:126px;white-space:nowrap" class="ft2209"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:660px;left:274px;white-space:nowrap" class="ft2200">N/A&#160;</p>
<p style="position:absolute;top:719px;left:126px;white-space:nowrap" class="ft2209"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:719px;left:274px;white-space:nowrap" class="ft2200">Plan Year&#160;</p>
<p style="position:absolute;top:778px;left:126px;white-space:nowrap" class="ft2208"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:778px;left:274px;white-space:nowrap" class="ft2200">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2200">220&#160;</p>
</div>
<!-- Page 221 -->
<a name="221"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page221-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2221.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2211"><b>P</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft2214"><b>OLIVY</b></p>
<p style="position:absolute;top:119px;left:205px;white-space:nowrap" class="ft22113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2212"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2215">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2216">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2210">Polivy&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2212"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2212"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2218"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2210">All&#160;FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2218"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft22110">High-grade&#160;B-cell&#160;lymphomas, histologic&#160;transformation of&#160;follicular to&#160;<br/>diffuse large B-cell&#160;lymphoma without translocations of MYC and BCL2&#160;<br/>and/or&#160;BCL6, monomorphic post-transplant&#160;lymphoproliferative disorders&#160;<br/>(B-cell type), acquired immunodeficiency syndrome (AIDS)-related B-<br/>cell&#160;lymphomas&#160;(AIDS-related diffuse large B-cell&#160;lymphoma, primary&#160;<br/>effusion lymphoma, and&#160;human herpesvirus-8 (HHV8)-positive diffuse&#160;<br/>large B-cell&#160;lymphoma),&#160;histologic transformation of nodal&#160;marginal zone&#160;<br/>lymphoma to diffuse large B-cell lymphoma, follicular&#160;lymphoma.&#160;</p>
<p style="position:absolute;top:541px;left:126px;white-space:nowrap" class="ft2219"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:541px;left:274px;white-space:nowrap" class="ft2210">N/A&#160;</p>
<p style="position:absolute;top:600px;left:126px;white-space:nowrap" class="ft2219"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:600px;left:274px;white-space:nowrap" class="ft22110">For diffuse&#160;large B-cell&#160;lymphomas&#160;and high-grade B-cell lymphomas: 1)&#160;<br/>The requested drug is used as a single agent or in&#160;combination with&#160;<br/>bendamustine with or&#160;without a rituximab product,&#160;AND 2) Patient has&#160;<br/>received at&#160;least&#160;two prior therapies.&#160;</p>
<p style="position:absolute;top:701px;left:126px;white-space:nowrap" class="ft2218"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:701px;left:274px;white-space:nowrap" class="ft2210">N/A&#160;</p>
<p style="position:absolute;top:740px;left:126px;white-space:nowrap" class="ft2219"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:740px;left:274px;white-space:nowrap" class="ft2210">N/A&#160;</p>
<p style="position:absolute;top:799px;left:126px;white-space:nowrap" class="ft2219"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:799px;left:274px;white-space:nowrap" class="ft2210">Plan Year&#160;</p>
<p style="position:absolute;top:859px;left:126px;white-space:nowrap" class="ft2218"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:859px;left:274px;white-space:nowrap" class="ft2210">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2210">221&#160;</p>
</div>
<!-- Page 222 -->
<a name="222"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page222-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2222.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2221"><b>P</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft2224"><b>OMALYST</b></p>
<p style="position:absolute;top:119px;left:248px;white-space:nowrap" class="ft22213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2222"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2225">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2226">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2220">Pomalyst&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2222"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2222"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2228"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2220">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2228"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft22210">Systemic light&#160;chain&#160;amyloidosis, primary central nervous system&#160;(CNS)&#160;<br/>lymphoma,&#160;POEMS syndrome.&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft2229"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft2220">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft2229"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft22210">For multiple&#160;myeloma:&#160;The patient has previously&#160;received at&#160;least&#160;two&#160;<br/>prior therapies for multiple myeloma,&#160;including&#160;an immunomodulatory&#160;<br/>agent&#160;AND a proteasome inhibitor. For Kaposi&#160;sarcoma, patient meets&#160;<br/>one of&#160;the following: 1)&#160;patient has&#160;acquired&#160;immunodeficiency syndrome&#160;<br/>(AIDS), or 2) patient&#160;is negative for human immunodeficiency virus&#160;<br/>(HIV).&#160;</p>
<p style="position:absolute;top:618px;left:126px;white-space:nowrap" class="ft2228"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:618px;left:274px;white-space:nowrap" class="ft2220">N/A&#160;</p>
<p style="position:absolute;top:657px;left:126px;white-space:nowrap" class="ft2229"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:657px;left:274px;white-space:nowrap" class="ft2220">N/A&#160;</p>
<p style="position:absolute;top:716px;left:126px;white-space:nowrap" class="ft2229"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:716px;left:274px;white-space:nowrap" class="ft2220">Plan Year&#160;</p>
<p style="position:absolute;top:776px;left:126px;white-space:nowrap" class="ft2228"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:776px;left:274px;white-space:nowrap" class="ft2220">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2220">222&#160;</p>
</div>
<!-- Page 223 -->
<a name="223"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page223-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2223.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2231"><b>P</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft2234"><b>OTELIGEO</b></p>
<p style="position:absolute;top:119px;left:256px;white-space:nowrap" class="ft22313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2232"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2235">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2236">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2230">Poteligeo&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2232"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2232"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2238"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2230">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2238"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2230">Adult T-cell&#160;leukemia/lymphoma&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2239"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2230">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2239"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2230">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2238"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2230">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2239"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2230">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2239"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2230">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2238"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2230">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2230">223&#160;</p>
</div>
<!-- Page 224 -->
<a name="224"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page224-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2224.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2241"><b>P</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft2244"><b>RALUENT</b></p>
<p style="position:absolute;top:119px;left:244px;white-space:nowrap" class="ft22413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2242"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2245">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2246">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2240">Praluent&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2242"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2242"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2248"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2240">All FDA-approved&#160;Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2248"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2240">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2249"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2240">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2249"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2240">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2248"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2240">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2249"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2240">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2249"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2240">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2248"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2240">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2240">224&#160;</p>
</div>
<!-- Page 225 -->
<a name="225"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page225-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2225.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2251"><b>P</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft2254"><b>REGABALIN</b></p>
<p style="position:absolute;top:119px;left:272px;white-space:nowrap" class="ft22513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2252"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2255">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2256">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2250">Pregabalin&#160;CAPS&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft2255">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft2256">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft2250">Pregabalin&#160;SOLN&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft2252"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft2252"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft2258"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft2250">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft2258"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft22510">Cancer-Related Neuropathic&#160;Pain, Cancer&#160;Treatment-Related Neuropathic&#160;<br/>Pain&#160;</p>
<p style="position:absolute;top:439px;left:126px;white-space:nowrap" class="ft2259"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:439px;left:274px;white-space:nowrap" class="ft2250">N/A&#160;</p>
<p style="position:absolute;top:498px;left:126px;white-space:nowrap" class="ft2259"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:498px;left:274px;white-space:nowrap" class="ft22510">1)&#160;The requested drug&#160;is being prescribed for the&#160;management of&#160;<br/>postherpetic&#160;neuralgia, the management of&#160;neuropathic&#160;pain associated&#160;<br/>with diabetic peripheral&#160;neuropathy, cancer-related neuropathic pain, or&#160;<br/>cancer&#160;treatment-related&#160;neuropathic&#160;pain AND&#160;2) The&#160;patient has&#160;<br/>experienced&#160;an inadequate treatment response, intolerance, or&#160;<br/>contraindication to gabapentin OR&#160;3) The requested drug&#160;is being&#160;<br/>prescribed as adjunctive&#160;therapy&#160;for&#160;the treatment of partial onset&#160;seizures&#160;<br/>OR&#160;4) The requested drug is being prescribed for&#160;the management&#160;of&#160;<br/>fibromyalgia or the management of&#160;neuropathic&#160;pain associated with&#160;<br/>spinal&#160;cord injury.&#160;</p>
<p style="position:absolute;top:723px;left:126px;white-space:nowrap" class="ft2258"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:723px;left:274px;white-space:nowrap" class="ft2250">N/A&#160;</p>
<p style="position:absolute;top:762px;left:126px;white-space:nowrap" class="ft2259"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:762px;left:274px;white-space:nowrap" class="ft2250">N/A&#160;</p>
<p style="position:absolute;top:821px;left:126px;white-space:nowrap" class="ft2259"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:821px;left:274px;white-space:nowrap" class="ft2250">Plan Year&#160;</p>
<p style="position:absolute;top:881px;left:126px;white-space:nowrap" class="ft2258"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:881px;left:274px;white-space:nowrap" class="ft2250">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2250">225&#160;</p>
</div>
<!-- Page 226 -->
<a name="226"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page226-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2226.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2261"><b>P</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft2264"><b>RETOMANID</b></p>
<p style="position:absolute;top:119px;left:278px;white-space:nowrap" class="ft22613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2262"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2265">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2266">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2260">Pretomanid&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2262"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2262"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2268"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2260">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2268"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2260">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2269"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2260">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2269"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2260">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2268"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2260">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2269"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2260">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2269"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2260">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2268"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2260">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2260">226&#160;</p>
</div>
<!-- Page 227 -->
<a name="227"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page227-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2227.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2271"><b>P</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft2274"><b>ROMACTA</b></p>
<p style="position:absolute;top:119px;left:253px;white-space:nowrap" class="ft22713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2272"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2275">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2276">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2270">Promacta&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2270">227&#160;</p>
</div>
<!-- Page 228 -->
<a name="228"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page228-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2228.png" alt="background image"/>
<p style="position:absolute;top:132px;left:126px;white-space:nowrap" class="ft2282"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:132px;left:274px;white-space:nowrap" class="ft2282"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:174px;left:126px;white-space:nowrap" class="ft2288"><b>Indications&#160;</b></p>
<p style="position:absolute;top:174px;left:274px;white-space:nowrap" class="ft2280">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:213px;left:126px;white-space:nowrap" class="ft2288"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:213px;left:274px;white-space:nowrap" class="ft2280">N/A&#160;</p>
<p style="position:absolute;top:252px;left:126px;white-space:nowrap" class="ft2289"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:252px;left:274px;white-space:nowrap" class="ft2280">N/A&#160;</p>
<p style="position:absolute;top:311px;left:126px;white-space:nowrap" class="ft2289"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:311px;left:274px;white-space:nowrap" class="ft22810">For chronic&#160;or persistent&#160;immune thrombocytopenia (ITP): 1)&#160;For new&#160;<br/>starts:&#160;a)&#160;Patient&#160;has had&#160;an inadequate response&#160;or is intolerant to a prior&#160;<br/>therapy such&#160;as corticosteroids or immunoglobulins, b)&#160;Untransfused&#160;<br/>platelet&#160;(plt) count at&#160;any point&#160;prior&#160;to the&#160;initiation of the requested&#160;<br/>medication&#160;is less than 30,000/mcL&#160;OR&#160;30,000-50,000/mcL&#160;with&#160;<br/>symptomatic bleeding or risk&#160;factor(s)&#160;for&#160;bleeding (e.g., undergoing a&#160;<br/>medical or&#160;dental procedure&#160;where blood loss is&#160;anticipated,&#160;comorbidities&#160;<br/>such as peptic ulcer&#160;disease and hypertension, anticoagulation therapy,&#160;<br/>profession or lifestyle&#160;that predisposes patient&#160;to&#160;trauma)&#160;AND c) For&#160;<br/>chronic ITP only: patient&#160;has had an inadequate&#160;response or&#160;intolerance to&#160;<br/>avatrombopag. 2)&#160;For continuation of therapy, plt count&#160;response&#160;to the&#160;<br/>requested drug: a)&#160;Current plt&#160;count is less than or equal to 200,000/mcL&#160;<br/>OR&#160;b) Current plt&#160;count is greater&#160;than 200,000/mcL to less than or&#160;equal&#160;<br/>to 400,000/mcL and dosing will&#160;be&#160;adjusted to a&#160;plt&#160;count sufficient to&#160;<br/>avoid clinically&#160;important bleeding.&#160;For thrombocytopenia associated&#160;<br/>with chronic&#160;hepatitis C:&#160;1) For&#160;new starts:&#160;the requested drug&#160;is used for&#160;<br/>initiation and maintenance of&#160;interferon-based therapy. 2) For&#160;<br/>continuation&#160;of therapy:&#160;patient is&#160;receiving&#160;interferon-based therapy. For&#160;<br/>severe&#160;aplastic anemia (AA): For&#160;continuation of therapy following the&#160;<br/>initial 6&#160;month approval for severe aplastic anemia: The patient&#160;must&#160;meet&#160;<br/>one of&#160;the following: 1)&#160;Current plt&#160;count is 50,000-200,000/mcL OR&#160;2)&#160;<br/>Current plt&#160;count is less&#160;than 50,000/mcL and patient&#160;has not&#160;received&#160;<br/>appropriately titrated therapy for at&#160;least 16 weeks, OR&#160;3) Current plt&#160;<br/>count is&#160;less&#160;than 50,000/mcL and patient is&#160;transfusion-independent, OR&#160;<br/>4) Current plt count is greater than 200,000/mcL&#160;to less than&#160;or equal to&#160;<br/>400,000/mcL and dosing will be adjusted to&#160;achieve and maintain an&#160;<br/>appropriate&#160;target&#160;plt&#160;count.&#160;</p>
<p style="position:absolute;top:888px;left:126px;white-space:nowrap" class="ft2288"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:888px;left:274px;white-space:nowrap" class="ft2280">N/A&#160;</p>
<p style="position:absolute;top:927px;left:126px;white-space:nowrap" class="ft2289"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:927px;left:274px;white-space:nowrap" class="ft2280">N/A&#160;</p>
<p style="position:absolute;top:986px;left:126px;white-space:nowrap" class="ft2289"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:986px;left:274px;white-space:nowrap" class="ft22810">HCV:&#160;6mo, ITP/AA&#160;initial:&#160;6mo, ITP&#160;reauth: Plan Year, AA&#160;reauth:&#160;APR-<br/>Plan Year, IPR-16 wks&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2280">228&#160;</p>
</div>
<!-- Page 229 -->
<a name="229"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page229-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2229.png" alt="background image"/>
<p style="position:absolute;top:127px;left:126px;white-space:nowrap" class="ft2298"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:127px;left:274px;white-space:nowrap" class="ft22910">APR:&#160;adequate platelet&#160;response (greater&#160;than 50,000/mcL),&#160;IPR:&#160;<br/>inadequate platelet&#160;response (less than 50,000/mcL).&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2290">229&#160;</p>
</div>
<!-- Page 230 -->
<a name="230"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page230-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2230.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2301"><b>P</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft2304"><b>ULMOZYME</b></p>
<p style="position:absolute;top:119px;left:273px;white-space:nowrap" class="ft23013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2302"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2305">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2306">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2300">Pulmozyme&#160;SOLN&#160;2.5MG/2.5ML&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2302"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2302"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2308"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2300">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2308"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2300">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2309"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2300">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2309"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft23010">For cystic&#160;fibrosis: Diagnosis of&#160;cystic fibrosis was confirmed by&#160;<br/>appropriate&#160;diagnostic or genetic testing.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2308"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2300">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2309"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2300">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2309"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2300">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2308"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft23010">Coverage&#160;under&#160;Part&#160;D will be denied&#160;if&#160;coverage&#160;is available&#160;under&#160;Part&#160;<br/>A or Part&#160;B as the&#160;medication&#160;is prescribed&#160;and dispensed or&#160;administered&#160;<br/>for&#160;the individual.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2300">230&#160;</p>
</div>
<!-- Page 231 -->
<a name="231"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page231-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2231.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2311"><b>Q</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft2314"><b>INLOCK</b></p>
<p style="position:absolute;top:119px;left:229px;white-space:nowrap" class="ft23113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2312"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2315">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2316">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2310">Qinlock&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2312"><b>PA&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2312"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2318"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2310">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2318"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2310">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2319"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2310">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2319"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2310">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2318"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2310">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2319"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2310">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2319"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2310">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2318"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2310">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2310">231&#160;</p>
</div>
<!-- Page 232 -->
<a name="232"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page232-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2232.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2321"><b>Q</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft2324"><b>UETIAPINE&#160;</b></p>
<p style="position:absolute;top:118px;left:271px;white-space:nowrap" class="ft2321"><b>X</b></p>
<p style="position:absolute;top:123px;left:292px;white-space:nowrap" class="ft2324"><b>R</b></p>
<p style="position:absolute;top:119px;left:310px;white-space:nowrap" class="ft23213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2322"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2325">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2326">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2320">Quetiapine&#160;Fumarate Er&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2322"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2322"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2328"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2320">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2328"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft23210">Maintenance monotherapy&#160;treatment&#160;in bipolar&#160;I&#160;disorder, monotherapy&#160;<br/>treatment of&#160;generalized&#160;anxiety disorder, monotherapy treatment of&#160;<br/>major depressive&#160;disorder&#160;</p>
<p style="position:absolute;top:437px;left:126px;white-space:nowrap" class="ft2329"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:437px;left:274px;white-space:nowrap" class="ft2320">N/A&#160;</p>
<p style="position:absolute;top:497px;left:126px;white-space:nowrap" class="ft2329"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:497px;left:274px;white-space:nowrap" class="ft23210">For schizophrenia,&#160;acute&#160;treatment of manic or mixed episodes associated&#160;<br/>with bipolar I disorder, both as&#160;monotherapy&#160;and&#160;as an adjunct to lithium&#160;<br/>or divalproex, the acute treatment of&#160;depressive episodes associated with&#160;<br/>bipolar disorder, maintenance treatment of&#160;bipolar I disorder,&#160;as an&#160;<br/>adjunct&#160;to lithium or&#160;divalproex, adjunctive&#160;treatment of major depressive&#160;<br/>disorder, or&#160;maintenance&#160;monotherapy treatment in bipolar I disorder: The&#160;<br/>patient experienced an inadequate&#160;treatment&#160;response, intolerance, or&#160;<br/>contraindication to one of the following generic products: A)&#160;aripiprazole,&#160;<br/>B) asenapine, C) olanzapine, D) quetiapine immediate-release, E)&#160;<br/>risperidone,&#160;F) ziprasidone. For all indications:&#160;If&#160;the patient&#160;is 65 years of&#160;<br/>age or&#160;older AND&#160;is using two or more&#160;additional&#160;central nervous system&#160;<br/>(CNS) active medications (e.g., lorazepam, sertraline,&#160;clonazepam,&#160;<br/>escitalopram, alprazolam, zolpidem)&#160;with the&#160;requested drug,&#160;the&#160;<br/>prescriber determined&#160;that taking multiple central&#160;nervous system&#160;(CNS)&#160;<br/>active medications&#160;is medically necessary. [Note:&#160;Use of multiple central&#160;<br/>nervous system (CNS) active&#160;medications in older adults is&#160;associated&#160;<br/>with an increased risk of falls.].&#160;</p>
<p style="position:absolute;top:867px;left:126px;white-space:nowrap" class="ft2328"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:867px;left:274px;white-space:nowrap" class="ft2320">N/A&#160;</p>
<p style="position:absolute;top:905px;left:126px;white-space:nowrap" class="ft2329"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:905px;left:274px;white-space:nowrap" class="ft2320">N/A&#160;</p>
<p style="position:absolute;top:965px;left:126px;white-space:nowrap" class="ft2329"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:965px;left:274px;white-space:nowrap" class="ft2320">Plan Year&#160;</p>
<p style="position:absolute;top:1024px;left:126px;white-space:nowrap" class="ft2328"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:1024px;left:274px;white-space:nowrap" class="ft2320">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2320">232&#160;</p>
</div>
<!-- Page 233 -->
<a name="233"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page233-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2233.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2331"><b>Q</b></p>
<p style="position:absolute;top:123px;left:131px;white-space:nowrap" class="ft2334"><b>UININE&#160;</b></p>
<p style="position:absolute;top:118px;left:224px;white-space:nowrap" class="ft2331"><b>S</b></p>
<p style="position:absolute;top:123px;left:241px;white-space:nowrap" class="ft2334"><b>ULFATE</b></p>
<p style="position:absolute;top:119px;left:338px;white-space:nowrap" class="ft23313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2332"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2335">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2336">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2330">Quinine&#160;Sulfate&#160;CAPS 324MG&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2332"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2332"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2338"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2330">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2338"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2330">Babesiosis,&#160;uncomplicated Plasmodium vivax&#160;malaria&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2339"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2330">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2339"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2330">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2338"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2330">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2339"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2330">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2339"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2330">1 month&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2338"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2330">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2330">233&#160;</p>
</div>
<!-- Page 234 -->
<a name="234"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page234-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2234.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2341"><b>R</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft2344"><b>EGRANEX</b></p>
<p style="position:absolute;top:119px;left:250px;white-space:nowrap" class="ft23413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2342"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2345">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2346">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2340">Regranex&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2342"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2342"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2348"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2340">All&#160;FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2348"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2340">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2349"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2340">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2349"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft23410">For the&#160;treatment of lower&#160;extremity diabetic neuropathic ulcers&#160;that&#160;<br/>extend into the subcutaneous tissue or beyond and have an&#160;adequate blood&#160;<br/>supply.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2348"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2340">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2349"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2340">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2349"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2340">20 weeks&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2348"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2340">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2340">234&#160;</p>
</div>
<!-- Page 235 -->
<a name="235"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page235-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2235.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2351"><b>R</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft2354"><b>ETEVMO</b></p>
<p style="position:absolute;top:119px;left:236px;white-space:nowrap" class="ft23513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2352"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2355">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2356">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2350">Retevmo&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2352"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2352"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2358"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2350">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2358"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft23510">Recurrent or&#160;advanced rearranged during transfection (RET)-<br/>rearrangement positive non-small cell lung cancer&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft2359"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft2350">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft2359"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft23510">For non-small&#160;cell&#160;lung cancer, patient must meet&#160;all&#160;of the&#160;following:&#160;1)&#160;<br/>The disease&#160;is recurrent,&#160;advanced or metastatic,&#160;and 2) Tumor is RET&#160;<br/>fusion-positive or&#160;RET&#160;rearrangement-positive.&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft2358"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft23510">Non-small cell&#160;lung cancer:&#160;18 years&#160;of age or&#160;older.&#160;Medullary thyroid&#160;<br/>cancer&#160;and thyroid cancer:&#160;12 years&#160;of age or&#160;older.&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft2359"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft2350">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft2359"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft2350">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft2358"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft2350">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2350">235&#160;</p>
</div>
<!-- Page 236 -->
<a name="236"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page236-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2236.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2361"><b>R</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft2364"><b>EVLIMID</b></p>
<p style="position:absolute;top:119px;left:238px;white-space:nowrap" class="ft23613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2362"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2365">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2366">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2360">Revlimid&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2360">236&#160;</p>
</div>
<!-- Page 237 -->
<a name="237"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page237-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2237.png" alt="background image"/>
<p style="position:absolute;top:132px;left:126px;white-space:nowrap" class="ft2372"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:132px;left:274px;white-space:nowrap" class="ft2372"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:174px;left:126px;white-space:nowrap" class="ft2378"><b>Indications&#160;</b></p>
<p style="position:absolute;top:174px;left:274px;white-space:nowrap" class="ft2370">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:213px;left:126px;white-space:nowrap" class="ft2378"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:213px;left:274px;white-space:nowrap" class="ft23710">Systemic light&#160;chain&#160;amyloidosis, classical Hodgkin lymphoma,&#160;<br/>myelodysplastic&#160;syndrome without the 5q deletion cytogenetic&#160;<br/>abnormality,&#160;myelofibrosis-associated anemia, POEMS syndrome,&#160;<br/>myeloproliferative neoplasms, non-Hodgkin's lymphoma with&#160;the&#160;<br/>following subtypes:&#160;acquired&#160;immunodeficiency&#160;syndrome (AIDS)-<br/>related non-germinal&#160;center&#160;diffuse large B-cell&#160;lymphoma, primary&#160;<br/>central nervous system (CNS) lymphoma, monomorphic post-transplant&#160;<br/>lymphoproliferative disorder, chronic&#160;lymphocytic leukemia&#160;(CLL)/small&#160;<br/>lymphocytic&#160;lymphoma (SLL), diffuse large B-cell lymphoma,&#160;<br/>multicentric&#160;Castleman's&#160;disease, adult T-cell&#160;leukemia/lymphoma,&#160;<br/>mycosis fungoides&#160;(MF)/Sezary syndrome (SS),&#160;angioimmunoblastic T-<br/>cell&#160;lymphoma (AITL),&#160;peripheral T-cell lymphoma not&#160;otherwise&#160;<br/>specified&#160;(PTCL NOS), enteropathy-associated T-cell lymphoma,&#160;<br/>monomorphic epitheliotropic intestinal T-cell&#160;lymphoma, nodal peripheral&#160;<br/>T-cell lymphoma, primary cutaneous&#160;anaplastic&#160;large cell&#160;lymphoma&#160;<br/>(ALCL), hepatosplenic&#160;T-cell lymphoma, high-grade B-cell lymphomas,&#160;<br/>histologic transformation of nodal&#160;marginal zone&#160;lymphoma to diffuse&#160;<br/>large B-cell&#160;lymphoma,&#160;histologic transformation of follicular lymphoma&#160;<br/>to diffuse&#160;large B-cell lymphoma, AIDS-related&#160;Kaposi sarcoma,&#160;<br/>smoldering&#160;myeloma&#160;</p>
<p style="position:absolute;top:645px;left:126px;white-space:nowrap" class="ft2379"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:645px;left:274px;white-space:nowrap" class="ft2370">N/A&#160;</p>
<p style="position:absolute;top:704px;left:126px;white-space:nowrap" class="ft2379"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:704px;left:274px;white-space:nowrap" class="ft23710">For myelodysplastic&#160;syndrome (MDS):&#160;Lower&#160;risk MDS with&#160;<br/>symptomatic anemia per the Revised International Prognostic&#160;Scoring&#160;<br/>System (IPSS-R), International Prognostic Scoring System (IPSS), or&#160;<br/>World Health organization (WHO) classification-based Prognostic&#160;<br/>Scoring System (WPSS).&#160;</p>
<p style="position:absolute;top:826px;left:126px;white-space:nowrap" class="ft2378"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:826px;left:274px;white-space:nowrap" class="ft2370">N/A&#160;</p>
<p style="position:absolute;top:864px;left:126px;white-space:nowrap" class="ft2379"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:864px;left:274px;white-space:nowrap" class="ft2370">N/A&#160;</p>
<p style="position:absolute;top:924px;left:126px;white-space:nowrap" class="ft2379"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:924px;left:274px;white-space:nowrap" class="ft2370">Plan Year&#160;</p>
<p style="position:absolute;top:983px;left:126px;white-space:nowrap" class="ft2378"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:983px;left:274px;white-space:nowrap" class="ft2370">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2370">237&#160;</p>
</div>
<!-- Page 238 -->
<a name="238"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page238-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2238.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2381"><b>R</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft2384"><b>EZUROCK</b></p>
<p style="position:absolute;top:119px;left:251px;white-space:nowrap" class="ft23813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2382"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2385">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2386">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2380">Rezurock&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2382"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2382"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2388"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2380">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2388"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2380">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2389"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2380">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2389"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2380">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2388"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2380">12 years&#160;of age or older&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2389"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2380">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2389"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2380">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2388"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2380">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2380">238&#160;</p>
</div>
<!-- Page 239 -->
<a name="239"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page239-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2239.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2391"><b>R</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft2394"><b>INVOQ</b></p>
<p style="position:absolute;top:119px;left:211px;white-space:nowrap" class="ft23913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2392"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2395">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2396">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2390">Rinvoq&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2392"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2392"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2398"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2390">All&#160;FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2398"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2390">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2399"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2390">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2399"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft23910">For moderately&#160;to severely active rheumatoid arthritis (new&#160;starts&#160;only):&#160;<br/>1) inadequate response,&#160;intolerance or contraindication to methotrexate&#160;<br/>(MTX) OR 2) inadequate response or intolerance to a prior biologic&#160;<br/>disease-modifying&#160;antirheumatic drug (DMARD) or&#160;a targeted synthetic&#160;<br/>DMARD.&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft2398"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft2390">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft2399"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft2390">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft2399"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft2390">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft2398"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft2390">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2390">239&#160;</p>
</div>
<!-- Page 240 -->
<a name="240"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page240-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2240.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2401"><b>R</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft2404"><b>ITUXAN&#160;</b></p>
<p style="position:absolute;top:118px;left:230px;white-space:nowrap" class="ft2401"><b>H</b></p>
<p style="position:absolute;top:123px;left:254px;white-space:nowrap" class="ft2404"><b>YCELA</b></p>
<p style="position:absolute;top:119px;left:338px;white-space:nowrap" class="ft24013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2402"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2405">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2406">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2400">Rituxan Hycela&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2402"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2402"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2408"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2400">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2408"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft24010">Castleman's&#160;disease&#160;(CD), high-grade B-cell lymphoma, histologic&#160;<br/>transformation of nodal&#160;marginal&#160;zone lymphoma to diffuse&#160;large B-cell&#160;<br/>lymphoma,&#160;marginal&#160;zone lymphomas (nodal marginal zone&#160;lymphoma,&#160;<br/>gastric mucosa-associated lymphoid&#160;tissue (MALT) lymphoma,&#160;<br/>nongastric&#160;MALT&#160;lymphoma, and&#160;splenic marginal&#160;zone lymphoma),&#160;<br/>mantle&#160;cell&#160;lymphoma, post-transplant lymphoproliferative disorder&#160;<br/>(PTLD), primary cutaneous B-cell lymphoma (e.g., cutaneous marginal&#160;<br/>zone lymphoma or cutaneous follicle center lymphomas), hairy cell&#160;<br/>leukemia, small lymphocytic&#160;lymphoma (SLL).&#160;</p>
<p style="position:absolute;top:562px;left:126px;white-space:nowrap" class="ft2409"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:562px;left:274px;white-space:nowrap" class="ft2400">N/A&#160;</p>
<p style="position:absolute;top:621px;left:126px;white-space:nowrap" class="ft2409"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:621px;left:274px;white-space:nowrap" class="ft24010">Malignancies must&#160;be CD20 positive. Patient must receive&#160;at least one&#160;<br/>full dose of&#160;a rituximab&#160;product by&#160;intravenous infusion without&#160;<br/>experiencing severe adverse reactions.&#160;</p>
<p style="position:absolute;top:701px;left:126px;white-space:nowrap" class="ft2408"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:701px;left:274px;white-space:nowrap" class="ft2400">N/A&#160;</p>
<p style="position:absolute;top:740px;left:126px;white-space:nowrap" class="ft2409"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:740px;left:274px;white-space:nowrap" class="ft2400">N/A&#160;</p>
<p style="position:absolute;top:799px;left:126px;white-space:nowrap" class="ft2409"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:799px;left:274px;white-space:nowrap" class="ft2400">Plan Year&#160;</p>
<p style="position:absolute;top:859px;left:126px;white-space:nowrap" class="ft2408"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:859px;left:274px;white-space:nowrap" class="ft2400">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2400">240&#160;</p>
</div>
<!-- Page 241 -->
<a name="241"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page241-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2241.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2411"><b>R</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft2414"><b>ITUXIMAB</b></p>
<p style="position:absolute;top:119px;left:255px;white-space:nowrap" class="ft24113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2412"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2415">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2416">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2410">Rituxan&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft2415">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft2416">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft2410">Ruxience&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2410">241&#160;</p>
</div>
<!-- Page 242 -->
<a name="242"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page242-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2242.png" alt="background image"/>
<p style="position:absolute;top:132px;left:126px;white-space:nowrap" class="ft2422"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:132px;left:274px;white-space:nowrap" class="ft2422"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:174px;left:126px;white-space:nowrap" class="ft2428"><b>Indications&#160;</b></p>
<p style="position:absolute;top:174px;left:274px;white-space:nowrap" class="ft2420">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:213px;left:126px;white-space:nowrap" class="ft2428"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:213px;left:274px;white-space:nowrap" class="ft24210">Non-Hodgkin's lymphoma&#160;subtypes&#160;[small&#160;lymphocytic&#160;lymphoma&#160;<br/>(SLL), mantle cell lymphoma, marginal zone&#160;lymphomas&#160;(nodal, splenic,&#160;<br/>gastric mucosa-associated lymphoid&#160;tissue [MALT], nongastric MALT),&#160;<br/>Burkitt&#160;lymphoma, primary cutaneous B-cell lymphoma, high-grade B-<br/>cell&#160;lymphoma&#160;with&#160;translocations of MYC and BCL2 and/or BCL6&#160;<br/>(double/triple hit&#160;lymphoma), high-grade B-cell lymphoma not&#160;otherwise&#160;<br/>specified, histological&#160;transformation from&#160;follicular&#160;lymphoma to diffuse&#160;<br/>large B-cell&#160;lymphoma,&#160;histological&#160;transformation from nodal&#160;marginal&#160;<br/>zone lymphoma to diffuse large B-cell&#160;lymphoma, Castleman's disease,&#160;<br/>acquired immunodeficiency syndrome (AIDS)-related B-cell&#160;lymphoma,&#160;<br/>hairy cell&#160;leukemia, post-transplant lymphoproliferative disorder&#160;(PTLD),&#160;<br/>B-cell&#160;lymphoblastic lymphoma], refractory&#160;immune or&#160;idiopathic&#160;<br/>thrombocytopenic&#160;purpura (ITP), autoimmune hemolytic anemia,&#160;<br/>Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphoma,&#160;<br/>chronic graft-versus-host disease (GVHD), Sjogren&#160;syndrome, thrombotic&#160;<br/>thrombocytopenic&#160;purpura, refractory&#160;myasthenia&#160;gravis, Hodgkin's&#160;<br/>lymphoma (nodular&#160;lymphocyte-predominant), primary&#160;central nervous&#160;<br/>system (CNS) lymphoma, leptomeningeal&#160;metastases from lymphomas,&#160;<br/>acute&#160;lymphoblastic leukemia, prevention of Epstein-Barr&#160;virus (EBV)-<br/>related PTLD, multiple sclerosis, and immune checkpoint&#160;inhibitor-<br/>related toxicities&#160;</p>
<p style="position:absolute;top:666px;left:126px;white-space:nowrap" class="ft2429"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:666px;left:274px;white-space:nowrap" class="ft2420">N/A&#160;</p>
<p style="position:absolute;top:725px;left:126px;white-space:nowrap" class="ft2429"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:725px;left:274px;white-space:nowrap" class="ft24210">For moderately&#160;to severely active rheumatoid arthritis (new&#160;starts&#160;only):&#160;<br/>1) patient&#160;meets ANY of the following: a)&#160;requested drug will&#160;be used&#160;in&#160;<br/>combination&#160;with methotrexate (MTX) OR&#160;b) patient has&#160;intolerance or&#160;<br/>contraindication to MTX, AND 2) patient meets ANY&#160;of the following: a)&#160;<br/>inadequate response, intolerance, or&#160;contraindication to MTX&#160;OR&#160;b)&#160;<br/>inadequate response&#160;or intolerance&#160;to&#160;a prior&#160;biologic disease-modifying&#160;<br/>antirheumatic drug (DMARD) or a targeted synthetic DMARD.&#160;<br/>Hematologic malignancies&#160;must be&#160;CD20-positive. For multiple sclerosis:&#160;<br/>1) patient has a diagnosis of relapsing&#160;remitting multiple sclerosis&#160;and 2)&#160;<br/>patient has&#160;had an inadequate&#160;response to two or&#160;more disease-modifying&#160;<br/>drugs&#160;indicated for multiple sclerosis despite adequate duration of&#160;<br/>treatment.&#160;</p>
<p style="position:absolute;top:991px;left:126px;white-space:nowrap" class="ft2428"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:991px;left:274px;white-space:nowrap" class="ft2420">N/A&#160;</p>
<p style="position:absolute;top:1030px;left:126px;white-space:nowrap" class="ft2429"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:1030px;left:274px;white-space:nowrap" class="ft2420">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2420">242&#160;</p>
</div>
<!-- Page 243 -->
<a name="243"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page243-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2243.png" alt="background image"/>
<p style="position:absolute;top:127px;left:126px;white-space:nowrap" class="ft2439"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:127px;left:274px;white-space:nowrap" class="ft24310">Immune checkpoint&#160;inhibitor-related&#160;toxicities: 3&#160;months, All&#160;other: Plan&#160;<br/>Year&#160;</p>
<p style="position:absolute;top:186px;left:126px;white-space:nowrap" class="ft2438"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:186px;left:274px;white-space:nowrap" class="ft2430">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2430">243&#160;</p>
</div>
<!-- Page 244 -->
<a name="244"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page244-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2244.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2441"><b>R</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft2444"><b>OZLYTREK</b></p>
<p style="position:absolute;top:119px;left:266px;white-space:nowrap" class="ft24413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2442"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2445">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2446">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2440">Rozlytrek&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2442"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2442"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2448"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2440">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2448"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft24410">Recurrent or&#160;advanced ROS1-positive non-small cell&#160;lung cancer&#160;<br/>(NSCLC), advanced, recurrent, or persistent&#160;neurotrophic tyrosine&#160;<br/>receptor&#160;kinase (NTRK) gene fusion-positive solid tumors, first-line&#160;<br/>treatment of&#160;NTRK&#160;gene&#160;fusion-positive solid&#160;tumors.&#160;</p>
<p style="position:absolute;top:458px;left:126px;white-space:nowrap" class="ft2449"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:458px;left:274px;white-space:nowrap" class="ft2440">N/A&#160;</p>
<p style="position:absolute;top:518px;left:126px;white-space:nowrap" class="ft2449"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:518px;left:274px;white-space:nowrap" class="ft24410">For all&#160;neurotrophic tyrosine&#160;receptor kinase&#160;(NTRK) gene fusion-<br/>positive solid tumors,&#160;the disease is&#160;without&#160;a known acquired resistance&#160;<br/>mutation.&#160;</p>
<p style="position:absolute;top:598px;left:126px;white-space:nowrap" class="ft2448"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:598px;left:274px;white-space:nowrap" class="ft2440">N/A&#160;</p>
<p style="position:absolute;top:636px;left:126px;white-space:nowrap" class="ft2449"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:636px;left:274px;white-space:nowrap" class="ft2440">N/A&#160;</p>
<p style="position:absolute;top:696px;left:126px;white-space:nowrap" class="ft2449"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:696px;left:274px;white-space:nowrap" class="ft2440">Plan Year&#160;</p>
<p style="position:absolute;top:755px;left:126px;white-space:nowrap" class="ft2448"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:755px;left:274px;white-space:nowrap" class="ft2440">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2440">244&#160;</p>
</div>
<!-- Page 245 -->
<a name="245"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page245-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2245.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2451"><b>R</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft2454"><b>UBRACA</b></p>
<p style="position:absolute;top:119px;left:232px;white-space:nowrap" class="ft24513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2452"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2455">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2456">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2450">Rubraca&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2452"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2452"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2458"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2450">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2458"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2450">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2459"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2450">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2459"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft24510">For metastatic&#160;castration-resistant prostate cancer with a deleterious breast&#160;<br/>cancer&#160;susceptibility gene (BRCA) mutation (germline and/or somatic): 1)&#160;<br/>patient has&#160;been treated&#160;with androgen receptor-directed therapy, 2)&#160;<br/>patient&#160;has been treated&#160;with a&#160;taxane-based chemotherapy or the patient&#160;<br/>is not&#160;fit&#160;for&#160;chemotherapy, 3) the requested drug will&#160;be used in&#160;<br/>combination&#160;with a&#160;gonadotropin-releasing hormone (GnRH) analog or&#160;<br/>after bilateral orchiectomy, and 4)&#160;patient experienced&#160;an unacceptable&#160;<br/>toxicity with a trial&#160;of Lynparza&#160;(olaparib). For maintenance treatment of&#160;<br/>patients with recurrent&#160;epithelial ovarian, fallopian tube, or primary&#160;<br/>peritoneal cancer&#160;who are&#160;in a complete or partial response to&#160;platinum-<br/>based chemotherapy, patient experienced an unacceptable toxicity with a&#160;<br/>trial of Lynparza&#160;(olaparib). For treatment&#160;of patients&#160;with&#160;a deleterious&#160;<br/>breast&#160;cancer susceptibility gene&#160;(BRCA) mutation (germline&#160;and/or&#160;<br/>somatic)-associated epithelial ovarian, fallopian tube, or&#160;primary&#160;<br/>peritoneal cancer&#160;who have been treated with&#160;two or more&#160;<br/>chemotherapies:&#160;if&#160;prescribed for deleterious germline BRCA-mutated&#160;<br/>advanced ovarian&#160;cancer&#160;treated with&#160;two or more prior&#160;chemotherapies,&#160;<br/>the patient&#160;experienced an unacceptable toxicity&#160;with a&#160;trial of Lynparza&#160;<br/>(olaparib).&#160;</p>
<p style="position:absolute;top:867px;left:126px;white-space:nowrap" class="ft2458"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:867px;left:274px;white-space:nowrap" class="ft2450">N/A&#160;</p>
<p style="position:absolute;top:905px;left:126px;white-space:nowrap" class="ft2459"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:905px;left:274px;white-space:nowrap" class="ft2450">N/A&#160;</p>
<p style="position:absolute;top:965px;left:126px;white-space:nowrap" class="ft2459"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:965px;left:274px;white-space:nowrap" class="ft2450">Plan Year&#160;</p>
<p style="position:absolute;top:1024px;left:126px;white-space:nowrap" class="ft2458"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:1024px;left:274px;white-space:nowrap" class="ft2450">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2450">245&#160;</p>
</div>
<!-- Page 246 -->
<a name="246"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page246-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2246.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2461"><b>R</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft2464"><b>YDAPT</b></p>
<p style="position:absolute;top:119px;left:212px;white-space:nowrap" class="ft24613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2462"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2465">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2466">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2460">Rydapt&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2462"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2462"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2468"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2460">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2468"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft24610">Relapsed or&#160;refractory acute myeloid&#160;leukemia (AML), myeloid,&#160;<br/>lymphoid, or mixed lineage neoplasms with eosinophilia and&#160;FGFR1 or&#160;<br/>FLT3 rearrangements, post-remission maintenance therapy for acute&#160;<br/>myeloid leukemia&#160;(AML), re-induction in residual disease&#160;for acute&#160;<br/>myeloid leukemia&#160;(AML)&#160;</p>
<p style="position:absolute;top:479px;left:126px;white-space:nowrap" class="ft2469"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:479px;left:274px;white-space:nowrap" class="ft2460">N/A&#160;</p>
<p style="position:absolute;top:538px;left:126px;white-space:nowrap" class="ft2469"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:538px;left:274px;white-space:nowrap" class="ft24610">For acute&#160;myeloid&#160;leukemia&#160;(AML): AML must&#160;be FLT3 mutation-<br/>positive. For&#160;myeloid, lymphoid, or&#160;mixed&#160;lineage neoplasms with&#160;<br/>eosinophilia and FGFR1&#160;or FLT3 rearrangements: the disease&#160;is in&#160;<br/>chronic or blast&#160;phase.&#160;</p>
<p style="position:absolute;top:639px;left:126px;white-space:nowrap" class="ft2468"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:639px;left:274px;white-space:nowrap" class="ft2460">N/A&#160;</p>
<p style="position:absolute;top:678px;left:126px;white-space:nowrap" class="ft2469"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:678px;left:274px;white-space:nowrap" class="ft2460">N/A&#160;</p>
<p style="position:absolute;top:737px;left:126px;white-space:nowrap" class="ft2469"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:737px;left:274px;white-space:nowrap" class="ft2460">Plan Year&#160;</p>
<p style="position:absolute;top:796px;left:126px;white-space:nowrap" class="ft2468"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:796px;left:274px;white-space:nowrap" class="ft2460">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2460">246&#160;</p>
</div>
<!-- Page 247 -->
<a name="247"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page247-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2247.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2471"><b>S</b></p>
<p style="position:absolute;top:123px;left:125px;white-space:nowrap" class="ft2474"><b>ANDOSTATIN&#160;</b></p>
<p style="position:absolute;top:118px;left:291px;white-space:nowrap" class="ft2471"><b>L</b></p>
<p style="position:absolute;top:123px;left:311px;white-space:nowrap" class="ft2474"><b>AR</b></p>
<p style="position:absolute;top:119px;left:346px;white-space:nowrap" class="ft24713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2472"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2475">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2476">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2470">Sandostatin&#160;Lar Depot&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2470">247&#160;</p>
</div>
<!-- Page 248 -->
<a name="248"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page248-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2248.png" alt="background image"/>
<p style="position:absolute;top:132px;left:126px;white-space:nowrap" class="ft2482"><b>PA&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:132px;left:274px;white-space:nowrap" class="ft2482"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:174px;left:126px;white-space:nowrap" class="ft2488"><b>Indications&#160;</b></p>
<p style="position:absolute;top:174px;left:274px;white-space:nowrap" class="ft2480">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:213px;left:126px;white-space:nowrap" class="ft2488"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:213px;left:274px;white-space:nowrap" class="ft24810">Tumor&#160;control&#160;of thymomas&#160;and&#160;thymic carcinomas, neuroendocrine&#160;<br/>tumors&#160;(NETs) of the gastrointestinal (GI)&#160;tract, lung, thymus&#160;(carcinoid&#160;<br/>tumors), unresected primary&#160;gastrinoma, NETs of&#160;the pancreas, and&#160;<br/>pheochromocytoma/paraganglioma.&#160;</p>
<p style="position:absolute;top:314px;left:126px;white-space:nowrap" class="ft2489"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:314px;left:274px;white-space:nowrap" class="ft2480">N/A&#160;</p>
<p style="position:absolute;top:373px;left:126px;white-space:nowrap" class="ft2489"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:373px;left:274px;white-space:nowrap" class="ft24810">For acromegaly&#160;(initial):&#160;1) patient has a high pretreatment insulin-like&#160;<br/>growth factor-1 (IGF-1) level for age&#160;and/or&#160;gender&#160;based on the&#160;<br/>laboratory&#160;reference range, and 2)&#160;patient had an&#160;inadequate or partial&#160;<br/>response&#160;to&#160;surgery or radiotherapy&#160;OR&#160;there is&#160;a clinical reason for why&#160;<br/>the patient has not had surgery or&#160;radiotherapy.&#160;For acromegaly&#160;<br/>(continuation of therapy):&#160;patient's IGF-1 level has decreased&#160;or&#160;<br/>normalized&#160;since&#160;initiation of therapy. For tumor control, the&#160;requested&#160;<br/>drug will&#160;be&#160;used for any&#160;of the following: 1)&#160;neuroendocrine&#160;tumors&#160;of&#160;<br/>the gastrointestinal tract&#160;or pancreas in patients with locoregional&#160;<br/>advanced disease and/or distant metastatic disease, OR 2) neuroendocrine&#160;<br/>tumors&#160;of the thymus or&#160;lung in patients with&#160;locoregional unresectable&#160;<br/>disease and/or distant&#160;metastatic disease, OR&#160;3) unresected primary&#160;<br/>gastrinoma,&#160;OR&#160;4) thymomas and thymic carcinomas&#160;as second-line&#160;<br/>systemic&#160;therapy in patients with unresectable or&#160;extrathoracic metastatic&#160;<br/>disease, OR&#160;5) pheochromocytomas&#160;and paragangliomas, used for&#160;either&#160;<br/>of the following: a) symptomatic locally unresectable disease with&#160;<br/>somatostatin&#160;receptor&#160;positive imaging, OR b) secreting tumors&#160;in&#160;<br/>metastatic&#160;disease.&#160;</p>
<p style="position:absolute;top:764px;left:126px;white-space:nowrap" class="ft2488"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:764px;left:274px;white-space:nowrap" class="ft2480">N/A&#160;</p>
<p style="position:absolute;top:802px;left:126px;white-space:nowrap" class="ft2489"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:802px;left:274px;white-space:nowrap" class="ft2480">N/A&#160;</p>
<p style="position:absolute;top:862px;left:126px;white-space:nowrap" class="ft2489"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:862px;left:274px;white-space:nowrap" class="ft2480">Plan Year&#160;</p>
<p style="position:absolute;top:921px;left:126px;white-space:nowrap" class="ft2488"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:921px;left:274px;white-space:nowrap" class="ft2480">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2480">248&#160;</p>
</div>
<!-- Page 249 -->
<a name="249"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page249-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2249.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2491"><b>S</b></p>
<p style="position:absolute;top:123px;left:125px;white-space:nowrap" class="ft2494"><b>ARCLISA</b></p>
<p style="position:absolute;top:119px;left:233px;white-space:nowrap" class="ft24913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2492"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2495">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2496">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2490">Sarclisa&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2492"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2492"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2498"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2490">All&#160;FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2498"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2490">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2499"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2490">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2499"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2490">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2498"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2490">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2499"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2490">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2499"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2490">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2498"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2490">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2490">249&#160;</p>
</div>
<!-- Page 250 -->
<a name="250"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page250-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2250.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2501"><b>S</b></p>
<p style="position:absolute;top:123px;left:125px;white-space:nowrap" class="ft2504"><b>CEMBLIX</b></p>
<p style="position:absolute;top:119px;left:239px;white-space:nowrap" class="ft25013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2502"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2505">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2506">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2500">Scemblix&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2502"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2502"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2508"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2500">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2508"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2500">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2509"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2500">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2509"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft25010">For&#160;chronic&#160;myeloid leukemia&#160;(CML) in the chronic phase:&#160;1) the&#160;<br/>diagnosis was confirmed by detection of the Philadelphia&#160;chromosome&#160;or&#160;<br/>BCR-ABL gene AND&#160;the patient meets&#160;either of&#160;the following: A) the&#160;<br/>patient has&#160;previously been treated with 2 or&#160;more tyrosine kinase&#160;<br/>inhibitors&#160;(TKIs)&#160;AND at least one&#160;of those was&#160;imatinib or dasatinib, OR&#160;<br/>B) the&#160;patient is positive for the T315I mutation.&#160;</p>
<p style="position:absolute;top:598px;left:126px;white-space:nowrap" class="ft2508"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:598px;left:274px;white-space:nowrap" class="ft2500">N/A&#160;</p>
<p style="position:absolute;top:636px;left:126px;white-space:nowrap" class="ft2509"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:636px;left:274px;white-space:nowrap" class="ft2500">N/A&#160;</p>
<p style="position:absolute;top:696px;left:126px;white-space:nowrap" class="ft2509"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:696px;left:274px;white-space:nowrap" class="ft2500">Plan Year&#160;</p>
<p style="position:absolute;top:755px;left:126px;white-space:nowrap" class="ft2508"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:755px;left:274px;white-space:nowrap" class="ft2500">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2500">250&#160;</p>
</div>
<!-- Page 251 -->
<a name="251"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page251-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2251.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2511"><b>S</b></p>
<p style="position:absolute;top:123px;left:125px;white-space:nowrap" class="ft2514"><b>IGNIFOR</b></p>
<p style="position:absolute;top:119px;left:230px;white-space:nowrap" class="ft25113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2512"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2515">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2516">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2510">Signifor&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2512"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2512"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2518"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2510">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2518"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2510">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2519"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2510">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2519"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2510">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2518"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2510">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2519"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2510">Endocrinologist&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2519"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2510">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2518"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2510">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2510">251&#160;</p>
</div>
<!-- Page 252 -->
<a name="252"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page252-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2252.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2521"><b>S</b></p>
<p style="position:absolute;top:123px;left:125px;white-space:nowrap" class="ft2524"><b>ILDENAFIL</b></p>
<p style="position:absolute;top:119px;left:258px;white-space:nowrap" class="ft25213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2522"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2525">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2526">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2520">Sildenafil&#160;INJ&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft2525">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft2526">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft2520">Sildenafil Citrate&#160;TABS&#160;20MG&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft2522"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft2522"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft2528"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft2520">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft2528"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft2520">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft2529"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft2520">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft2529"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft25210">For pulmonary&#160;arterial hypertension&#160;(PAH) (World Health Organization&#160;<br/>[WHO] Group 1): Diagnosis was confirmed by right heart catheterization.&#160;<br/>For PAH&#160;new starts only: 1)&#160;Pretreatment mean&#160;pulmonary arterial&#160;<br/>pressure is greater than 20 mmHg, 2)&#160;Pretreatment pulmonary capillary&#160;<br/>wedge pressure&#160;is less than or&#160;equal to 15 mmHg, and 3)&#160;Pretreatment&#160;<br/>pulmonary vascular resistance&#160;is greater&#160;than or&#160;equal to 3 Wood units.&#160;</p>
<p style="position:absolute;top:620px;left:126px;white-space:nowrap" class="ft2528"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:620px;left:274px;white-space:nowrap" class="ft2520">N/A&#160;</p>
<p style="position:absolute;top:658px;left:126px;white-space:nowrap" class="ft2529"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:658px;left:274px;white-space:nowrap" class="ft2520">N/A&#160;</p>
<p style="position:absolute;top:718px;left:126px;white-space:nowrap" class="ft2529"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:718px;left:274px;white-space:nowrap" class="ft2520">Plan Year&#160;</p>
<p style="position:absolute;top:777px;left:126px;white-space:nowrap" class="ft2528"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:777px;left:274px;white-space:nowrap" class="ft2520">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2520">252&#160;</p>
</div>
<!-- Page 253 -->
<a name="253"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page253-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2253.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2531"><b>S</b></p>
<p style="position:absolute;top:123px;left:125px;white-space:nowrap" class="ft2534"><b>IRTURO</b></p>
<p style="position:absolute;top:119px;left:221px;white-space:nowrap" class="ft25313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2532"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2535">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2536">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2530">Sirturo&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2532"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2532"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2538"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2530">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2538"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2530">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2539"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2530">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2539"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2530">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2538"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2530">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2539"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2530">Prescribed by&#160;or in consultation with an infectious disease specialist.&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2539"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2530">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2538"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2530">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2530">253&#160;</p>
</div>
<!-- Page 254 -->
<a name="254"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page254-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2254.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2541"><b>S</b></p>
<p style="position:absolute;top:123px;left:125px;white-space:nowrap" class="ft2544"><b>KYRIZI</b></p>
<p style="position:absolute;top:119px;left:213px;white-space:nowrap" class="ft25413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2542"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2545">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2546">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2540">Skyrizi&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft2545">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft2546">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft2540">Skyrizi Pen&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft2542"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft2542"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft2548"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft2540">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft2548"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft2540">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft2549"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft2540">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft2549"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft25410">For moderate&#160;to severe&#160;plaque&#160;psoriasis&#160;(new starts only): 1)&#160;at least 3%&#160;<br/>of body surface area (BSA) is affected OR crucial body areas&#160;(e.g., feet,&#160;<br/>hands, face,&#160;neck, groin,&#160;intertriginous areas) are&#160;affected at the time of&#160;<br/>diagnosis, AND&#160;2) patient meets any&#160;of the following: a) patient has&#160;<br/>experienced&#160;an inadequate response&#160;or intolerance to either&#160;phototherapy&#160;<br/>(e.g., UVB,&#160;PUVA)&#160;or pharmacologic treatment with methotrexate,&#160;<br/>cyclosporine, or acitretin, or b) pharmacologic treatment with&#160;<br/>methotrexate, cyclosporine, or&#160;acitretin is contraindicated, or&#160;c)&#160;patient&#160;<br/>has severe psoriasis that warrants&#160;a biologic disease-modifying&#160;<br/>antirheumatic drug (DMARD) as first-line therapy (i.e. at least 10%&#160;of the&#160;<br/>body surface area or crucial&#160;body&#160;areas [e.g., hands, feet,&#160;face, neck,&#160;<br/>scalp, genitals/groin, intertriginous&#160;areas]&#160;are&#160;affected).&#160;</p>
<p style="position:absolute;top:744px;left:126px;white-space:nowrap" class="ft2548"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:744px;left:274px;white-space:nowrap" class="ft2540">N/A&#160;</p>
<p style="position:absolute;top:783px;left:126px;white-space:nowrap" class="ft2549"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:783px;left:274px;white-space:nowrap" class="ft2540">N/A&#160;</p>
<p style="position:absolute;top:842px;left:126px;white-space:nowrap" class="ft2549"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:842px;left:274px;white-space:nowrap" class="ft2540">Plan Year&#160;</p>
<p style="position:absolute;top:901px;left:126px;white-space:nowrap" class="ft2548"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:901px;left:274px;white-space:nowrap" class="ft2540">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2540">254&#160;</p>
</div>
<!-- Page 255 -->
<a name="255"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page255-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2255.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2551"><b>S</b></p>
<p style="position:absolute;top:123px;left:125px;white-space:nowrap" class="ft2554"><b>OMATULINE&#160;</b></p>
<p style="position:absolute;top:118px;left:281px;white-space:nowrap" class="ft2551"><b>D</b></p>
<p style="position:absolute;top:123px;left:303px;white-space:nowrap" class="ft2554"><b>EPOT</b></p>
<p style="position:absolute;top:119px;left:368px;white-space:nowrap" class="ft25513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2552"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2555">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2556">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2550">Somatuline Depot&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2552"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2552"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2558"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2550">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2558"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft25510">Tumor&#160;control&#160;of neuroendocrine tumors (NETs) of&#160;the lung, thymus&#160;<br/>(carcinoid&#160;tumors)&#160;or unresected primary&#160;gastrinoma, and&#160;<br/>pheochromocytoma/paraganglioma.&#160;</p>
<p style="position:absolute;top:437px;left:126px;white-space:nowrap" class="ft2559"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:437px;left:274px;white-space:nowrap" class="ft2550">N/A&#160;</p>
<p style="position:absolute;top:497px;left:126px;white-space:nowrap" class="ft2559"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:497px;left:274px;white-space:nowrap" class="ft25510">For acromegaly&#160;(initial):&#160;1) patient has a high pretreatment insulin-like&#160;<br/>growth factor-1 (IGF-1) level for age&#160;and/or&#160;gender&#160;based on the&#160;<br/>laboratory&#160;reference range, and 2)&#160;patient had an&#160;inadequate or partial&#160;<br/>response&#160;to&#160;surgery or radiotherapy&#160;OR&#160;there is&#160;a clinical&#160;reason for why&#160;<br/>the patient has not had surgery or&#160;radiotherapy.&#160;For acromegaly&#160;<br/>continuation&#160;of therapy:&#160;patient's IGF-1 level has decreased&#160;or normalized&#160;<br/>since&#160;initiation of therapy. For tumor control, the&#160;requested drug will&#160;be&#160;<br/>used for any&#160;of the following: 1)&#160;neuroendocrine&#160;tumor of the thymus or&#160;<br/>lung in patients with locoregional unresectable disease and/or distant&#160;<br/>metastatic&#160;disease, OR 2)&#160;unresected&#160;primary&#160;carcinoma, OR 3)&#160;<br/>pheochromocytomas and&#160;paragangliomas, used&#160;for either&#160;of the&#160;<br/>following: a) symptomatic locally unresectable disease with&#160;somatostatin&#160;<br/>receptor&#160;positive imaging OR b) secreting&#160;tumor in metastatic&#160;disease.&#160;</p>
<p style="position:absolute;top:784px;left:126px;white-space:nowrap" class="ft2558"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:784px;left:274px;white-space:nowrap" class="ft2550">N/A&#160;</p>
<p style="position:absolute;top:823px;left:126px;white-space:nowrap" class="ft2559"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:823px;left:274px;white-space:nowrap" class="ft2550">N/A&#160;</p>
<p style="position:absolute;top:882px;left:126px;white-space:nowrap" class="ft2559"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:882px;left:274px;white-space:nowrap" class="ft2550">Plan Year&#160;</p>
<p style="position:absolute;top:941px;left:126px;white-space:nowrap" class="ft2558"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:941px;left:274px;white-space:nowrap" class="ft2550">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2550">255&#160;</p>
</div>
<!-- Page 256 -->
<a name="256"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page256-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2256.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2561"><b>S</b></p>
<p style="position:absolute;top:123px;left:125px;white-space:nowrap" class="ft2564"><b>OMAVERT</b></p>
<p style="position:absolute;top:119px;left:250px;white-space:nowrap" class="ft25613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2562"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2565">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2566">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2560">Somavert&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2562"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2562"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2568"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2560">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2568"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2560">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2569"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2560">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2569"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft25610">For acromegaly&#160;(initial):&#160;1) patient has a high pretreatment insulin-like&#160;<br/>growth factor-1 (IGF-1) level for age&#160;and/or&#160;gender&#160;based on the&#160;<br/>laboratory&#160;reference range, and 2)&#160;patient had an&#160;inadequate or partial&#160;<br/>response&#160;to&#160;surgery or radiotherapy&#160;OR&#160;there is&#160;a clinical reason for why&#160;<br/>the patient has not had surgery or&#160;radiotherapy.&#160;For acromegaly&#160;<br/>continuation&#160;of therapy:&#160;patient's IGF-1 level has decreased&#160;or normalized&#160;<br/>since&#160;initiation of therapy.&#160;</p>
<p style="position:absolute;top:618px;left:126px;white-space:nowrap" class="ft2568"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:618px;left:274px;white-space:nowrap" class="ft2560">N/A&#160;</p>
<p style="position:absolute;top:657px;left:126px;white-space:nowrap" class="ft2569"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:657px;left:274px;white-space:nowrap" class="ft2560">N/A&#160;</p>
<p style="position:absolute;top:716px;left:126px;white-space:nowrap" class="ft2569"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:716px;left:274px;white-space:nowrap" class="ft2560">Plan Year&#160;</p>
<p style="position:absolute;top:776px;left:126px;white-space:nowrap" class="ft2568"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:776px;left:274px;white-space:nowrap" class="ft2560">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2560">256&#160;</p>
</div>
<!-- Page 257 -->
<a name="257"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page257-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2257.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2571"><b>S</b></p>
<p style="position:absolute;top:123px;left:125px;white-space:nowrap" class="ft2574"><b>PRITAM</b></p>
<p style="position:absolute;top:119px;left:222px;white-space:nowrap" class="ft25713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2572"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2575">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2576">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2570">Spritam&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2572"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2572"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2578"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2570">All&#160;FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2578"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2570">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2579"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2570">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2579"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2570">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2578"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft25710">Partial-Onset Seizures: 4&#160;years of&#160;age&#160;or older.&#160;Myoclonic Seizures:&#160;12&#160;<br/>years of&#160;age&#160;or older. Primary Generalized&#160;Tonic-Clonic&#160;Seizures:&#160;6 years&#160;<br/>of age or&#160;older.&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft2579"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft2570">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft2579"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft2570">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft2578"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft2570">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2570">257&#160;</p>
</div>
<!-- Page 258 -->
<a name="258"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page258-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2258.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2581"><b>S</b></p>
<p style="position:absolute;top:123px;left:125px;white-space:nowrap" class="ft2584"><b>PRYCEL</b></p>
<p style="position:absolute;top:119px;left:223px;white-space:nowrap" class="ft25813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2582"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2585">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2586">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2580">Sprycel&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2582"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2582"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2588"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2580">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2588"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft25810">Gastrointestinal stromal&#160;tumor&#160;(GIST), metastatic&#160;chondrosarcoma,&#160;<br/>recurrent&#160;chordoma, T-cell&#160;acute&#160;lymphoblastic&#160;leukemia (ALL),&#160;<br/>Philadelphia&#160;(Ph)-like B-ALL&#160;</p>
<p style="position:absolute;top:437px;left:126px;white-space:nowrap" class="ft2589"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:437px;left:274px;white-space:nowrap" class="ft2580">N/A&#160;</p>
<p style="position:absolute;top:497px;left:126px;white-space:nowrap" class="ft2589"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:497px;left:274px;white-space:nowrap" class="ft25810">For chronic&#160;myeloid leukemia&#160;(CML), including patients who have&#160;<br/>received a&#160;hematopoietic stem cell transplant:&#160;diagnosis was&#160;confirmed by&#160;<br/>detection of&#160;the Philadelphia (Ph) chromosome or BCR-ABL&#160;gene. If&#160;<br/>patient experienced resistance to an alternative tyrosine&#160;kinase inhibitor&#160;<br/>for&#160;CML, patient is negative for T315I/A, F317L/V/I/C, and&#160;V299L&#160;<br/>mutations. For acute lymphoblastic leukemia&#160;(ALL), the&#160;patient has&#160;a&#160;<br/>diagnosis of&#160;one of&#160;the following: 1)&#160;Philadelphia&#160;chromosome positive&#160;<br/>ALL that&#160;has been confirmed by detection of the Ph chromosome or&#160;<br/>BCR-ABL gene, OR 2) Ph-like B-ALL with ABL-class kinase fusion, OR&#160;<br/>3) relapsed&#160;or refractory&#160;T-cell ALL with ABL-class translocation. For&#160;<br/>GIST, patient must have&#160;progressed&#160;on imatinib,&#160;sunitinib, and&#160;<br/>regorafenib.&#160;</p>
<p style="position:absolute;top:763px;left:126px;white-space:nowrap" class="ft2588"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:763px;left:274px;white-space:nowrap" class="ft2580">N/A&#160;</p>
<p style="position:absolute;top:802px;left:126px;white-space:nowrap" class="ft2589"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:802px;left:274px;white-space:nowrap" class="ft2580">N/A&#160;</p>
<p style="position:absolute;top:861px;left:126px;white-space:nowrap" class="ft2589"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:861px;left:274px;white-space:nowrap" class="ft2580">Plan Year&#160;</p>
<p style="position:absolute;top:921px;left:126px;white-space:nowrap" class="ft2588"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:921px;left:274px;white-space:nowrap" class="ft2580">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2580">258&#160;</p>
</div>
<!-- Page 259 -->
<a name="259"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page259-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2259.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2591"><b>S</b></p>
<p style="position:absolute;top:123px;left:125px;white-space:nowrap" class="ft2594"><b>TELARA</b></p>
<p style="position:absolute;top:119px;left:225px;white-space:nowrap" class="ft25913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2592"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2595">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2596">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2590">Stelara&#160;INJ&#160;45MG/0.5ML, 90MG/ML&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2592"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2592"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2598"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2590">All&#160;FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2598"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2590">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2599"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2590">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2599"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft25910">For moderate&#160;to severe&#160;plaque&#160;psoriasis&#160;(new starts only): 1)&#160;At least 3%&#160;<br/>of body surface area (BSA) is affected OR crucial body areas&#160;(e.g., feet,&#160;<br/>hands, face,&#160;neck, groin,&#160;intertriginous areas) are&#160;affected at the time of&#160;<br/>diagnosis and 2) Patient&#160;had an inadequate&#160;response, intolerance, or&#160;<br/>contraindication to&#160;two of the following products:&#160;Enbrel&#160;(etanercept),&#160;<br/>Humira (adalimumab), Skyrizi (risankizumab-rzaa).&#160;For active psoriatic&#160;<br/>arthritis (PsA) (new starts): patient had an inadequate&#160;response,&#160;<br/>intolerance,&#160;or contraindication to&#160;two of the following products: Enbrel&#160;<br/>(etanercept),&#160;Humira (adalimumab), Skyrizi (risankizumab-rzaa), Xeljanz&#160;<br/>(tofacitinib)/Xeljanz XR (tofacitinib&#160;extended-release).&#160;For&#160;moderately to&#160;<br/>severely active Crohn's&#160;disease (new&#160;starts): patient had&#160;an inadequate&#160;<br/>response,&#160;intolerance, or&#160;contraindication to Humira&#160;(adalimumab). For&#160;<br/>moderately&#160;to&#160;severely active ulcerative colitis (new starts): patient had an&#160;<br/>inadequate response, intolerance, or&#160;contraindication to Humira&#160;<br/>(adalimumab).&#160;</p>
<p style="position:absolute;top:784px;left:126px;white-space:nowrap" class="ft2598"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:784px;left:274px;white-space:nowrap" class="ft2590">N/A&#160;</p>
<p style="position:absolute;top:823px;left:126px;white-space:nowrap" class="ft2599"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:823px;left:274px;white-space:nowrap" class="ft2590">N/A&#160;</p>
<p style="position:absolute;top:882px;left:126px;white-space:nowrap" class="ft2599"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:882px;left:274px;white-space:nowrap" class="ft2590">Plan Year&#160;</p>
<p style="position:absolute;top:941px;left:126px;white-space:nowrap" class="ft2598"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:941px;left:274px;white-space:nowrap" class="ft2590">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2590">259&#160;</p>
</div>
<!-- Page 260 -->
<a name="260"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page260-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2260.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2601"><b>S</b></p>
<p style="position:absolute;top:123px;left:125px;white-space:nowrap" class="ft2604"><b>TIVARGA</b></p>
<p style="position:absolute;top:119px;left:238px;white-space:nowrap" class="ft26013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2602"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2605">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2606">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2600">Stivarga&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2602"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2602"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2608"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2600">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2608"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft26010">Progressive&#160;gastrointestinal&#160;stromal tumors (GIST), osteosarcoma,&#160;<br/>glioblastoma, angiosarcoma, retroperitoneal/intra-abdominal soft tissue&#160;<br/>sarcoma, rhabdomyosarcoma, solitary fibrous&#160;tumor, and soft tissue&#160;<br/>sarcomas of&#160;the extremities, body wall, head and neck, advanced&#160;<br/>colorectal cancer.&#160;</p>
<p style="position:absolute;top:479px;left:126px;white-space:nowrap" class="ft2609"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:479px;left:274px;white-space:nowrap" class="ft2600">N/A&#160;</p>
<p style="position:absolute;top:538px;left:126px;white-space:nowrap" class="ft2609"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:538px;left:274px;white-space:nowrap" class="ft26010">For gastrointestinal&#160;stromal&#160;tumors:&#160;The disease&#160;is progressive, locally&#160;<br/>advanced, unresectable,&#160;or metastatic.&#160;</p>
<p style="position:absolute;top:618px;left:126px;white-space:nowrap" class="ft2608"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:618px;left:274px;white-space:nowrap" class="ft2600">N/A&#160;</p>
<p style="position:absolute;top:657px;left:126px;white-space:nowrap" class="ft2609"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:657px;left:274px;white-space:nowrap" class="ft2600">N/A&#160;</p>
<p style="position:absolute;top:716px;left:126px;white-space:nowrap" class="ft2609"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:716px;left:274px;white-space:nowrap" class="ft2600">Plan Year&#160;</p>
<p style="position:absolute;top:776px;left:126px;white-space:nowrap" class="ft2608"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:776px;left:274px;white-space:nowrap" class="ft2600">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2600">260&#160;</p>
</div>
<!-- Page 261 -->
<a name="261"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page261-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2261.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2611"><b>S</b></p>
<p style="position:absolute;top:123px;left:125px;white-space:nowrap" class="ft2614"><b>UTENT</b></p>
<p style="position:absolute;top:119px;left:207px;white-space:nowrap" class="ft26113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2612"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2615">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2616">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2610">Sunitinib Malate&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft2615">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft2616">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft2610">Sutent&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft2612"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft2612"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft2618"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft2610">All&#160;FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft2618"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft26110">Thyroid carcinoma&#160;(follicular, medullary, papillary, and Hurthle cell), soft&#160;<br/>tissue sarcoma (angiosarcoma, solitary&#160;fibrous&#160;tumor, and alveolar soft&#160;<br/>part sarcoma subtypes), recurrent&#160;chordoma,&#160;thymic carcinoma.&#160;</p>
<p style="position:absolute;top:459px;left:126px;white-space:nowrap" class="ft2619"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:459px;left:274px;white-space:nowrap" class="ft2610">N/A&#160;</p>
<p style="position:absolute;top:519px;left:126px;white-space:nowrap" class="ft2619"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:519px;left:274px;white-space:nowrap" class="ft2610">For renal&#160;cell carcinoma,&#160;the disease&#160;is relapsed,&#160;advanced, or&#160;stage IV.&#160;</p>
<p style="position:absolute;top:599px;left:126px;white-space:nowrap" class="ft2618"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:599px;left:274px;white-space:nowrap" class="ft2610">N/A&#160;</p>
<p style="position:absolute;top:638px;left:126px;white-space:nowrap" class="ft2619"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:638px;left:274px;white-space:nowrap" class="ft2610">N/A&#160;</p>
<p style="position:absolute;top:697px;left:126px;white-space:nowrap" class="ft2619"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:697px;left:274px;white-space:nowrap" class="ft2610">Plan Year&#160;</p>
<p style="position:absolute;top:756px;left:126px;white-space:nowrap" class="ft2618"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:756px;left:274px;white-space:nowrap" class="ft2610">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2610">261&#160;</p>
</div>
<!-- Page 262 -->
<a name="262"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page262-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2262.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2621"><b>S</b></p>
<p style="position:absolute;top:123px;left:125px;white-space:nowrap" class="ft2624"><b>YMLIN</b></p>
<p style="position:absolute;top:119px;left:207px;white-space:nowrap" class="ft26213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2622"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2625">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2626">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2620">Symlinpen 120&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft2625">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft2626">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft2620">Symlinpen 60&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft2622"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft2622"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft2628"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft2620">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft2628"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft2620">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft2629"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft2620">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft2629"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft2620">N/A&#160;</p>
<p style="position:absolute;top:557px;left:126px;white-space:nowrap" class="ft2628"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:557px;left:274px;white-space:nowrap" class="ft2620">N/A&#160;</p>
<p style="position:absolute;top:596px;left:126px;white-space:nowrap" class="ft2629"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:596px;left:274px;white-space:nowrap" class="ft2620">N/A&#160;</p>
<p style="position:absolute;top:656px;left:126px;white-space:nowrap" class="ft2629"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:656px;left:274px;white-space:nowrap" class="ft2620">Plan Year&#160;</p>
<p style="position:absolute;top:715px;left:126px;white-space:nowrap" class="ft2628"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:715px;left:274px;white-space:nowrap" class="ft2620">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2620">262&#160;</p>
</div>
<!-- Page 263 -->
<a name="263"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page263-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2263.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2631"><b>S</b></p>
<p style="position:absolute;top:123px;left:125px;white-space:nowrap" class="ft2634"><b>YMPAZAN</b></p>
<p style="position:absolute;top:119px;left:247px;white-space:nowrap" class="ft26313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2632"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2635">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2636">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2630">Sympazan&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2632"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2632"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2638"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2630">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2638"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2630">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2639"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2630">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2639"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2630">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2638"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2630">2 years&#160;of age or&#160;older&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2639"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2630">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2639"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2630">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2638"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2630">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2630">263&#160;</p>
</div>
<!-- Page 264 -->
<a name="264"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page264-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2264.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2641"><b>S</b></p>
<p style="position:absolute;top:123px;left:125px;white-space:nowrap" class="ft2644"><b>YNRIBO</b></p>
<p style="position:absolute;top:119px;left:221px;white-space:nowrap" class="ft26413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2642"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2645">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2646">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2640">Synribo&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2642"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2642"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2648"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2640">All FDA-approved Indications, Some Medically&#160;accepted&#160;Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2648"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft26410">Follow-up therapy&#160;for chronic&#160;myeloid leukemia (CML) patients&#160;after&#160;<br/>hematopoietic stem cell&#160;transplant (HSCT)&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft2649"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft2640">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft2649"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft2640">N/A&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft2648"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft2640">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft2649"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft2640">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft2649"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft2640">Plan Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft2648"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft2640">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2640">264&#160;</p>
</div>
<!-- Page 265 -->
<a name="265"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page265-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2265.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2651"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2654"><b>ABRECTA</b></p>
<p style="position:absolute;top:119px;left:245px;white-space:nowrap" class="ft26513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2652"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2655">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2656">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2650">Tabrecta&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2652"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2652"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2658"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2650">All FDA-approved&#160;Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2658"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2650">Treatment&#160;of&#160;recurrent or advanced non-small cell lung cancer (NSCLC).&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2659"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2650">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2659"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft26510">For recurrent, advanced,&#160;or metastatic NSCLC: Tumor&#160;is&#160;positive for&#160;<br/>mesenchymal-epithelial&#160;transition (MET) exon 14 skipping&#160;mutation.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2658"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2650">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2659"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2650">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2659"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2650">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2658"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2650">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2650">265&#160;</p>
</div>
<!-- Page 266 -->
<a name="266"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page266-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2266.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2661"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2664"><b>ADALAFIL&#160;</b></p>
<p style="position:absolute;top:118px;left:260px;white-space:nowrap" class="ft2661"><b>(</b></p>
<p style="position:absolute;top:123px;left:269px;white-space:nowrap" class="ft2664"><b>PAH</b></p>
<p style="position:absolute;top:118px;left:320px;white-space:nowrap" class="ft2661"><b>)</b></p>
<p style="position:absolute;top:113px;left:330px;white-space:nowrap" class="ft26614">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2662"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2665">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2666">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2660">Alyq&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft2665">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft2666">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft2660">Tadalafil&#160;TABS 20MG&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft2662"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft2662"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft2668"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft2660">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft2668"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft2660">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft2669"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft2660">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft2669"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft26610">For pulmonary&#160;arterial hypertension&#160;(PAH) (World Health Organization&#160;<br/>[WHO] Group 1): Diagnosis was confirmed by right heart catheterization.&#160;<br/>For PAH&#160;new starts only: 1)&#160;Pretreatment mean&#160;pulmonary arterial&#160;<br/>pressure is greater than 20 mmHg, 2)&#160;Pretreatment pulmonary capillary&#160;<br/>wedge pressure&#160;is less than or&#160;equal to 15 mmHg, and 3)&#160;Pretreatment&#160;<br/>pulmonary vascular resistance&#160;is greater&#160;than or&#160;equal to 3 Wood units.&#160;</p>
<p style="position:absolute;top:620px;left:126px;white-space:nowrap" class="ft2668"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:620px;left:274px;white-space:nowrap" class="ft2660">N/A&#160;</p>
<p style="position:absolute;top:658px;left:126px;white-space:nowrap" class="ft2669"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:658px;left:274px;white-space:nowrap" class="ft2660">N/A&#160;</p>
<p style="position:absolute;top:718px;left:126px;white-space:nowrap" class="ft2669"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:718px;left:274px;white-space:nowrap" class="ft2660">Plan Year&#160;</p>
<p style="position:absolute;top:777px;left:126px;white-space:nowrap" class="ft2668"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:777px;left:274px;white-space:nowrap" class="ft2660">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2660">266&#160;</p>
</div>
<!-- Page 267 -->
<a name="267"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page267-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2267.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2671"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2674"><b>AFINLAR</b></p>
<p style="position:absolute;top:119px;left:237px;white-space:nowrap" class="ft26713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2672"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2675">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2676">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2670">Tafinlar&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2672"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2672"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2678"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2670">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2678"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft26710">Brain metastases&#160;from melanoma, thyroid carcinoma (papillary&#160;<br/>carcinoma,&#160;follicular carcinoma,&#160;and&#160;Hurthle cell carcinoma),&#160;central&#160;<br/>nervous system (CNS) cancer&#160;(i.e., glioma, meningioma, astrocytoma)&#160;</p>
<p style="position:absolute;top:437px;left:126px;white-space:nowrap" class="ft2679"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:437px;left:274px;white-space:nowrap" class="ft2670">N/A&#160;</p>
<p style="position:absolute;top:497px;left:126px;white-space:nowrap" class="ft2679"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:497px;left:274px;white-space:nowrap" class="ft26710">For brain&#160;metastases&#160;from melanoma, adjuvant treatment of&#160;melanoma,&#160;<br/>and central&#160;nervous system (CNS) cancer&#160;(i.e., glioma, meningioma,&#160;<br/>astrocytoma):&#160;1) The&#160;tumor&#160;is positive for&#160;a BRAF&#160;V600 activating&#160;<br/>mutation (e.g., V600E&#160;or V600K), and 2)&#160;The&#160;requested drug will&#160;be used&#160;<br/>in combination with trametinib. For&#160;unresectable&#160;or metastatic melanoma:&#160;<br/>1) The tumor is positive&#160;for&#160;a BRAF&#160;V600 activating mutation (e.g.,&#160;<br/>V600E&#160;or V600K), and 2) The&#160;requested drug will be used as&#160;a single&#160;<br/>agent&#160;or in combination&#160;with trametinib. For non-small cell&#160;lung cancer:&#160;<br/>1) The tumor is positive&#160;for&#160;a BRAF&#160;V600E&#160;mutation, and 2)&#160;The&#160;<br/>requested drug will&#160;be used in combination with trametinib. For&#160;thyroid&#160;<br/>carcinoma&#160;with papillary, follicular,&#160;or Hurthle histology: The tumor is&#160;<br/>positive for&#160;BRAF&#160;activating&#160;mutation (e.g., V600E or V600K).&#160;</p>
<p style="position:absolute;top:763px;left:126px;white-space:nowrap" class="ft2678"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:763px;left:274px;white-space:nowrap" class="ft2670">N/A&#160;</p>
<p style="position:absolute;top:802px;left:126px;white-space:nowrap" class="ft2679"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:802px;left:274px;white-space:nowrap" class="ft2670">N/A&#160;</p>
<p style="position:absolute;top:861px;left:126px;white-space:nowrap" class="ft2679"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:861px;left:274px;white-space:nowrap" class="ft2670">Plan Year&#160;</p>
<p style="position:absolute;top:921px;left:126px;white-space:nowrap" class="ft2678"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:921px;left:274px;white-space:nowrap" class="ft2670">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2670">267&#160;</p>
</div>
<!-- Page 268 -->
<a name="268"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page268-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2268.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2681"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2684"><b>AGRISSO</b></p>
<p style="position:absolute;top:119px;left:236px;white-space:nowrap" class="ft26813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2682"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2685">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2686">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2680">Tagrisso&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2682"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2682"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2688"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2680">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2688"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft26810">Sensitizing&#160;epidermal&#160;growth factor&#160;receptor&#160;(EGFR) mutation-positive&#160;<br/>recurrent or&#160;advanced non-small cell&#160;lung cancer&#160;(NSCLC), brain&#160;<br/>metastases from&#160;sensitizing EGFR&#160;mutation-positive NSCLC,&#160;<br/>leptomeningeal&#160;metastases from EGFR&#160;mutation-positive NSCLC&#160;</p>
<p style="position:absolute;top:458px;left:126px;white-space:nowrap" class="ft2689"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:458px;left:274px;white-space:nowrap" class="ft2680">N/A&#160;</p>
<p style="position:absolute;top:518px;left:126px;white-space:nowrap" class="ft2689"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:518px;left:274px;white-space:nowrap" class="ft26810">For NSCLC,&#160;the requested drug is used in any of the following settings:&#160;<br/>1) The patient meets both of the following: a)&#160;patient has&#160;metastatic,&#160;<br/>advanced, or&#160;recurrent NSCLC (including brain and/or leptomeningeal&#160;<br/>metastases from&#160;NSCLC) and b) patient has a&#160;sensitizing EGFR&#160;mutation&#160;<br/>OR&#160;2) Patient meets both of the following: a)&#160;request&#160;is for&#160;adjuvant&#160;<br/>treatment of&#160;NSCLC following tumor resection and b) patient has EGFR&#160;<br/>mutation-positive disease.&#160;</p>
<p style="position:absolute;top:680px;left:126px;white-space:nowrap" class="ft2688"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:680px;left:274px;white-space:nowrap" class="ft2680">N/A&#160;</p>
<p style="position:absolute;top:719px;left:126px;white-space:nowrap" class="ft2689"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:719px;left:274px;white-space:nowrap" class="ft2680">N/A&#160;</p>
<p style="position:absolute;top:778px;left:126px;white-space:nowrap" class="ft2689"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:778px;left:274px;white-space:nowrap" class="ft2680">Plan Year&#160;</p>
<p style="position:absolute;top:838px;left:126px;white-space:nowrap" class="ft2688"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:838px;left:274px;white-space:nowrap" class="ft2680">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2680">268&#160;</p>
</div>
<!-- Page 269 -->
<a name="269"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page269-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2269.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2691"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2694"><b>ALTZ</b></p>
<p style="position:absolute;top:119px;left:193px;white-space:nowrap" class="ft26913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2692"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2695">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2696">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2690">Taltz&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2692"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2692"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2698"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2690">All&#160;FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2698"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2690">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2699"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2690">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2699"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft26910">For moderate&#160;to severe&#160;plaque&#160;psoriasis&#160;(new starts only): 1)&#160;At least 3%&#160;<br/>of body surface area (BSA) is affected OR crucial body areas&#160;(e.g., feet,&#160;<br/>hands, face,&#160;neck, groin,&#160;intertriginous areas) are&#160;affected at the time of&#160;<br/>diagnosis AND&#160;2) the patient had an&#160;inadequate response,&#160;intolerance, or&#160;<br/>contraindication to one of the following products:&#160;Enbrel&#160;(etanercept),&#160;<br/>Humira (adalimumab), Skyrizi (risankizumab-rzaa).&#160;For active ankylosing&#160;<br/>spondylitis&#160;(new&#160;starts only):&#160;the patient had an&#160;inadequate&#160;response,&#160;<br/>intolerance,&#160;or contraindication to either Enbrel (etanercept)&#160;or Humira&#160;<br/>(adalimumab). For&#160;active psoriatic arthritis (PsA) (new starts only):&#160;the&#160;<br/>patient had an inadequate&#160;response,&#160;intolerance, or contraindication&#160;to one&#160;<br/>of the following products:&#160;Enbrel (etanercept), Humira&#160;(adalimumab),&#160;<br/>Skyrizi (risankizumab-rzaa), Xeljanz (tofacitinib)/Xeljanz XR (tofacitinib&#160;<br/>extended-release).&#160;For&#160;active axial&#160;spondyloarthritis&#160;(new&#160;starts only):&#160;<br/>Patient meets any of the&#160;following: 1) has had an&#160;inadequate response&#160;to a&#160;<br/>non-steroidal anti-inflammatory drug&#160;(NSAID) trial or&#160;2) has&#160;an&#160;<br/>intolerance&#160;or contraindication to NSAIDs.&#160;</p>
<p style="position:absolute;top:805px;left:126px;white-space:nowrap" class="ft2698"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:805px;left:274px;white-space:nowrap" class="ft2690">N/A&#160;</p>
<p style="position:absolute;top:843px;left:126px;white-space:nowrap" class="ft2699"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:843px;left:274px;white-space:nowrap" class="ft2690">N/A&#160;</p>
<p style="position:absolute;top:903px;left:126px;white-space:nowrap" class="ft2699"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:903px;left:274px;white-space:nowrap" class="ft2690">Plan Year&#160;</p>
<p style="position:absolute;top:962px;left:126px;white-space:nowrap" class="ft2698"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:962px;left:274px;white-space:nowrap" class="ft2690">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2690">269&#160;</p>
</div>
<!-- Page 270 -->
<a name="270"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page270-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2270.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2701"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2704"><b>ALZENNA</b></p>
<p style="position:absolute;top:119px;left:245px;white-space:nowrap" class="ft27013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2702"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2705">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2706">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2700">Talzenna&#160;CAPS 0.25MG, 1MG&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2702"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2702"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2708"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2700">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2708"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft27010">Recurrent&#160;germline&#160;breast cancer&#160;susceptibility gene (BRCA)-mutated&#160;<br/>breast&#160;cancer&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft2709"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft2700">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft2709"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft27010">For germline&#160;BRCA-mutated&#160;(gBRCAm) metastatic or recurrent breast&#160;<br/>cancer, the patient experienced an unacceptable&#160;toxicity with&#160;a trial of&#160;<br/>Lynparza (olaparib).&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft2708"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft2700">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft2709"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft2700">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft2709"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft2700">Plan Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft2708"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft2700">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2700">270&#160;</p>
</div>
<!-- Page 271 -->
<a name="271"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page271-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2271.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2711"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2714"><b>ARGRETIN&#160;</b></p>
<p style="position:absolute;top:118px;left:263px;white-space:nowrap" class="ft2711"><b>T</b></p>
<p style="position:absolute;top:123px;left:283px;white-space:nowrap" class="ft2714"><b>OPICAL</b></p>
<p style="position:absolute;top:119px;left:377px;white-space:nowrap" class="ft27113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2712"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2715">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2716">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2710">Targretin&#160;GEL&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2712"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2712"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2718"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2710">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2718"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft27110">Mycosis fungoides, chronic or&#160;smoldering adult&#160;T-cell&#160;<br/>leukemia/lymphoma, primary cutaneous marginal zone&#160;lymphoma,&#160;<br/>primary&#160;cutaneous follicle center lymphoma.&#160;</p>
<p style="position:absolute;top:437px;left:126px;white-space:nowrap" class="ft2719"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:437px;left:274px;white-space:nowrap" class="ft2710">N/A&#160;</p>
<p style="position:absolute;top:497px;left:126px;white-space:nowrap" class="ft2719"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:497px;left:274px;white-space:nowrap" class="ft2710">N/A&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft2718"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft2710">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft2719"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft2710">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft2719"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft2710">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft2718"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft2710">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2710">271&#160;</p>
</div>
<!-- Page 272 -->
<a name="272"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page272-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2272.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2721"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2724"><b>ASIGNA</b></p>
<p style="position:absolute;top:119px;left:221px;white-space:nowrap" class="ft27213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2722"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2725">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2726">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2720">Tasigna&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2722"><b>PA&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2722"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2728"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2720">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2728"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft27210">Philadelphia&#160;chromosome&#160;positive acute lymphoblastic leukemia&#160;(Ph+&#160;<br/>ALL), gastrointestinal stromal tumor (GIST)&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft2729"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft2720">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft2729"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft27210">For chronic&#160;myeloid leukemia&#160;(CML) or&#160;acute lymphoblastic leukemia&#160;<br/>(ALL), diagnosis was confirmed by&#160;detection of&#160;the Philadelphia&#160;<br/>chromosome or&#160;BCR-ABL gene. For CML, including patients newly&#160;<br/>diagnosed with CML and patients who have received a&#160;hematopoietic&#160;<br/>stem&#160;cell transplant: patient has experienced resistance or intolerance to&#160;<br/>imatinib or&#160;dasatinib. If&#160;patient experienced resistance to an alternative&#160;<br/>tyrosine kinase inhibitor for CML, patient is negative&#160;for&#160;T315I, Y253H,&#160;<br/>E255K/V, and F359V/C/I&#160;mutations.&#160;For GIST, patient must&#160;have&#160;<br/>progressed on imatinib,&#160;sunitinib, and regorafenib.&#160;</p>
<p style="position:absolute;top:680px;left:126px;white-space:nowrap" class="ft2728"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:680px;left:274px;white-space:nowrap" class="ft2720">N/A&#160;</p>
<p style="position:absolute;top:719px;left:126px;white-space:nowrap" class="ft2729"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:719px;left:274px;white-space:nowrap" class="ft2720">N/A&#160;</p>
<p style="position:absolute;top:778px;left:126px;white-space:nowrap" class="ft2729"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:778px;left:274px;white-space:nowrap" class="ft2720">Plan Year&#160;</p>
<p style="position:absolute;top:838px;left:126px;white-space:nowrap" class="ft2728"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:838px;left:274px;white-space:nowrap" class="ft2720">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2720">272&#160;</p>
</div>
<!-- Page 273 -->
<a name="273"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page273-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2273.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2731"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2734"><b>AZAROTENE</b></p>
<p style="position:absolute;top:119px;left:280px;white-space:nowrap" class="ft27313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2732"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2735">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2736">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2730">Tazarotene&#160;CREA&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft2735">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft2736">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft2730">Tazorac&#160;CREA&#160;0.05%&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft2732"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft2732"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft2738"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft2730">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft2738"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft2730">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft2739"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft2730">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft2739"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft27310">For plaque&#160;psoriasis:&#160;1)&#160;The requested drug is being prescribed to treat&#160;<br/>less than 20&#160;percent of&#160;the patient's body surface&#160;area AND 2) The patient&#160;<br/>experienced&#160;an inadequate treatment response or&#160;intolerance&#160;to&#160;at least&#160;<br/>one topical corticosteroid&#160;OR&#160;has a&#160;contraindication that&#160;would&#160;prohibit a&#160;<br/>trial of&#160;topical corticosteroids.&#160;</p>
<p style="position:absolute;top:599px;left:126px;white-space:nowrap" class="ft2738"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:599px;left:274px;white-space:nowrap" class="ft2730">N/A&#160;</p>
<p style="position:absolute;top:638px;left:126px;white-space:nowrap" class="ft2739"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:638px;left:274px;white-space:nowrap" class="ft2730">N/A&#160;</p>
<p style="position:absolute;top:697px;left:126px;white-space:nowrap" class="ft2739"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:697px;left:274px;white-space:nowrap" class="ft2730">Plan Year&#160;</p>
<p style="position:absolute;top:756px;left:126px;white-space:nowrap" class="ft2738"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:756px;left:274px;white-space:nowrap" class="ft2730">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2730">273&#160;</p>
</div>
<!-- Page 274 -->
<a name="274"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page274-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2274.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2741"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2744"><b>AZVERIK</b></p>
<p style="position:absolute;top:119px;left:240px;white-space:nowrap" class="ft27413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2742"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2745">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2746">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2740">Tazverik&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2742"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2742"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2748"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2740">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2748"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2740">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2749"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2740">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2749"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2740">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2748"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft27410">Epithelioid sarcoma: 16&#160;years of&#160;age&#160;or older, Follicular&#160;lymphoma:&#160;18&#160;<br/>years of&#160;age&#160;or older&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft2749"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft2740">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft2749"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft2740">Plan Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft2748"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft2740">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2740">274&#160;</p>
</div>
<!-- Page 275 -->
<a name="275"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page275-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2275.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2751"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2754"><b>ECENTRIQ</b></p>
<p style="position:absolute;top:119px;left:256px;white-space:nowrap" class="ft27513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2752"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2755">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2756">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2750">Tecentriq&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2750">275&#160;</p>
</div>
<!-- Page 276 -->
<a name="276"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page276-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2276.png" alt="background image"/>
<p style="position:absolute;top:132px;left:126px;white-space:nowrap" class="ft2762"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:132px;left:274px;white-space:nowrap" class="ft2762"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:174px;left:126px;white-space:nowrap" class="ft2768"><b>Indications&#160;</b></p>
<p style="position:absolute;top:174px;left:274px;white-space:nowrap" class="ft2760">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:213px;left:126px;white-space:nowrap" class="ft2768"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:213px;left:274px;white-space:nowrap" class="ft27610">Recurrent or&#160;advanced non-small cell lung cancer, PD-L1 positive triple&#160;<br/>negative recurrent breast cancer&#160;in combination with paclitaxel protein-<br/>bound&#160;</p>
<p style="position:absolute;top:293px;left:126px;white-space:nowrap" class="ft2769"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:293px;left:274px;white-space:nowrap" class="ft2760">N/A&#160;</p>
<p style="position:absolute;top:352px;left:126px;white-space:nowrap" class="ft2769"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:352px;left:274px;white-space:nowrap" class="ft27610">For urothelial&#160;carcinoma, patient meets one of the following&#160;criteria: 1)&#160;<br/>Patient is&#160;ineligible&#160;for&#160;cisplatin&#160;therapy and tumors&#160;express&#160;PD-L1&#160;<br/>(defined as PD-L1 stained tumor-infiltrating immune cells&#160;[IC] covering&#160;<br/>greater than&#160;or equal to 5&#160;percent of&#160;the tumor area) OR 2) Patient is&#160;<br/>ineligible for any platinum containing chemotherapy. For non-small cell&#160;<br/>lung cancer&#160;(NSCLC): 1)&#160;the patient&#160;has recurrent, advanced&#160;or metastatic&#160;<br/>disease AND the requested drug will be used as&#160;any of the following: a)&#160;<br/>first-line&#160;treatment of&#160;tumors with high PD-L1 expression (defined&#160;as PD-<br/>L1 stained greater than or equal to 50&#160;percent of&#160;tumor&#160;cells or PD-L1&#160;<br/>stained tumor-infiltrating immune cells&#160;[IC] covering greater&#160;than or&#160;<br/>equal&#160;to 10&#160;percent of&#160;the tumor area) and no EGFR&#160;or ALK&#160;genomic&#160;<br/>tumor aberrations, b) used in combination with&#160;carboplatin,&#160;paclitaxel,&#160;<br/>and bevacizumab, or&#160;in&#160;combination&#160;with carboplatin and albumin-bound&#160;<br/>paclitaxel for nonsquamous NSCLC, or&#160;c)&#160;the requested drug&#160;will&#160;be used&#160;<br/>as subsequent therapy or continuation maintenance therapy,&#160;OR&#160;2) the&#160;<br/>patient has&#160;stage&#160;II to&#160;IIIA&#160;disease AND&#160;the requested drug will be used&#160;<br/>as adjuvant treatment&#160;following resection and platinum-based&#160;<br/>chemotherapy for&#160;tumors with PD-L1 expression&#160;on greater than or equal&#160;<br/>to 1 percent&#160;of tumor&#160;cells. For hepatocellular&#160;carcinoma,&#160;the requested&#160;<br/>drug will be&#160;used as initial treatment&#160;in combination with bevacizumab.&#160;</p>
<p style="position:absolute;top:784px;left:126px;white-space:nowrap" class="ft2768"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:784px;left:274px;white-space:nowrap" class="ft2760">N/A&#160;</p>
<p style="position:absolute;top:823px;left:126px;white-space:nowrap" class="ft2769"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:823px;left:274px;white-space:nowrap" class="ft2760">N/A&#160;</p>
<p style="position:absolute;top:882px;left:126px;white-space:nowrap" class="ft2769"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:882px;left:274px;white-space:nowrap" class="ft2760">Plan Year&#160;</p>
<p style="position:absolute;top:942px;left:126px;white-space:nowrap" class="ft2768"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:942px;left:274px;white-space:nowrap" class="ft2760">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2760">276&#160;</p>
</div>
<!-- Page 277 -->
<a name="277"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page277-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2277.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2771"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2774"><b>ECFIDERA</b></p>
<p style="position:absolute;top:119px;left:253px;white-space:nowrap" class="ft27713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2772"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2775">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2776">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2770">Tecfidera&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft2775">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft2776">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft2770">Tecfidera&#160;Starter Pack&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft2772"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft2772"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft2778"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft2770">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft2778"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft2770">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft2779"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft2770">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft2779"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft2770">N/A&#160;</p>
<p style="position:absolute;top:557px;left:126px;white-space:nowrap" class="ft2778"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:557px;left:274px;white-space:nowrap" class="ft2770">N/A&#160;</p>
<p style="position:absolute;top:596px;left:126px;white-space:nowrap" class="ft2779"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:596px;left:274px;white-space:nowrap" class="ft2770">N/A&#160;</p>
<p style="position:absolute;top:656px;left:126px;white-space:nowrap" class="ft2779"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:656px;left:274px;white-space:nowrap" class="ft2770">Plan Year&#160;</p>
<p style="position:absolute;top:715px;left:126px;white-space:nowrap" class="ft2778"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:715px;left:274px;white-space:nowrap" class="ft2770">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2770">277&#160;</p>
</div>
<!-- Page 278 -->
<a name="278"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page278-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2278.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2781"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2784"><b>EMAZEPAM&#160;</b></p>
<p style="position:absolute;top:118px;left:277px;white-space:nowrap" class="ft2781"><b>30</b></p>
<p style="position:absolute;top:123px;left:307px;white-space:nowrap" class="ft2784"><b>MG&#160;</b></p>
<p style="position:absolute;top:118px;left:354px;white-space:nowrap" class="ft2781"><b>-&#160;65</b></p>
<p style="position:absolute;top:113px;left:400px;white-space:nowrap" class="ft27814">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2782"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2785">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2786">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2780">Temazepam&#160;CAPS 30MG&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2782"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2782"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2788"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2780">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2788"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2780">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2789"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2780">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2789"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft27810">Prescriber must&#160;acknowledge that the&#160;benefit of&#160;therapy with&#160;the&#160;<br/>requested drug outweighs the potential risks for the patient. (Note:&#160;The&#160;<br/>American Geriatrics&#160;Society&#160;identifies the&#160;use of this medication as&#160;<br/>potentially inappropriate in older adults, meaning&#160;it&#160;is best&#160;avoided,&#160;<br/>prescribed at reduced dosage, or&#160;used with caution or carefully&#160;<br/>monitored.) The patient&#160;has experienced an inadequate&#160;treatment&#160;<br/>response,&#160;intolerance, or&#160;has a&#160;contraindication to&#160;doxepin (3&#160;mg or&#160;6&#160;<br/>mg).&#160;</p>
<p style="position:absolute;top:639px;left:126px;white-space:nowrap" class="ft2788"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:639px;left:274px;white-space:nowrap" class="ft2780">N/A&#160;</p>
<p style="position:absolute;top:678px;left:126px;white-space:nowrap" class="ft2789"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:678px;left:274px;white-space:nowrap" class="ft2780">N/A&#160;</p>
<p style="position:absolute;top:737px;left:126px;white-space:nowrap" class="ft2789"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:737px;left:274px;white-space:nowrap" class="ft2780">Plan Year&#160;</p>
<p style="position:absolute;top:796px;left:126px;white-space:nowrap" class="ft2788"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:796px;left:274px;white-space:nowrap" class="ft27810">This Prior&#160;Authorization&#160;requirement&#160;only applies&#160;to patients 65 years of&#160;<br/>age or&#160;older.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2780">278&#160;</p>
</div>
<!-- Page 279 -->
<a name="279"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page279-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2279.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2791"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2794"><b>EPMETKO</b></p>
<p style="position:absolute;top:119px;left:251px;white-space:nowrap" class="ft27913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2792"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2795">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2796">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2790">Tepmetko&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2792"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2792"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2798"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2790">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2798"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2790">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2799"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2790">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2799"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2790">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2798"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2790">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2799"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2790">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2799"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2790">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2798"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2790">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2790">279&#160;</p>
</div>
<!-- Page 280 -->
<a name="280"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page280-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2280.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2801"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2804"><b>ESTOSTERONE&#160;</b></p>
<p style="position:absolute;top:118px;left:313px;white-space:nowrap" class="ft2801"><b>C</b></p>
<p style="position:absolute;top:123px;left:334px;white-space:nowrap" class="ft2804"><b>YPIONATE&#160;</b></p>
<p style="position:absolute;top:118px;left:467px;white-space:nowrap" class="ft2801"><b>I</b></p>
<p style="position:absolute;top:123px;left:479px;white-space:nowrap" class="ft2804"><b>NJ</b></p>
<p style="position:absolute;top:119px;left:508px;white-space:nowrap" class="ft28013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2802"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2805">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2806">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft28010">Testosterone&#160;Cypionate&#160;INJ&#160;<br/>100MG/ML, 200MG/ML&#160;</p>
<p style="position:absolute;top:297px;left:126px;white-space:nowrap" class="ft2802"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:297px;left:274px;white-space:nowrap" class="ft2802"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:339px;left:126px;white-space:nowrap" class="ft2808"><b>Indications&#160;</b></p>
<p style="position:absolute;top:339px;left:274px;white-space:nowrap" class="ft2800">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:378px;left:126px;white-space:nowrap" class="ft2808"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:378px;left:274px;white-space:nowrap" class="ft2800">Gender Dysphoria&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft2809"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft2800">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft2809"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft28010">Primary or&#160;hypogonadotropic hypogonadism: 1)&#160;Request&#160;is for&#160;<br/>continuation&#160;of testosterone therapy&#160;and the&#160;patient had a&#160;confirmed low&#160;<br/>morning&#160;testosterone&#160;level according&#160;to current practice guidelines or&#160;<br/>your standard lab reference values before starting&#160;testosterone&#160;therapy&#160;<br/>[Note: Safety and efficacy of&#160;testosterone products&#160;in patients with &#34;age-<br/>related hypogonadism&#34; (also referred to as &#34;late-onset&#160;hypogonadism&#34;)&#160;<br/>have not&#160;been established.] OR 2) Request&#160;is not for&#160;continuation of&#160;<br/>testosterone&#160;therapy&#160;and&#160;the patient has at least two confirmed low&#160;<br/>morning&#160;testosterone&#160;levels according to current&#160;practice guidelines or&#160;<br/>your standard lab reference values [Note:&#160;Safety and efficacy&#160;of&#160;<br/>testosterone&#160;products in&#160;patients with &#34;age-related hypogonadism&#34;&#160;(also&#160;<br/>referred to as &#34;late-onset hypogonadism&#34;) have not been established.].&#160;<br/>Gender dysphoria: The patient is&#160;able to make&#160;an&#160;informed decision&#160;to&#160;<br/>engage in hormone&#160;therapy.&#160;</p>
<p style="position:absolute;top:784px;left:126px;white-space:nowrap" class="ft2808"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:784px;left:274px;white-space:nowrap" class="ft2800">N/A&#160;</p>
<p style="position:absolute;top:823px;left:126px;white-space:nowrap" class="ft2809"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:823px;left:274px;white-space:nowrap" class="ft2800">N/A&#160;</p>
<p style="position:absolute;top:882px;left:126px;white-space:nowrap" class="ft2809"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:882px;left:274px;white-space:nowrap" class="ft2800">Plan Year&#160;</p>
<p style="position:absolute;top:941px;left:126px;white-space:nowrap" class="ft2808"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:941px;left:274px;white-space:nowrap" class="ft2800">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2800">280&#160;</p>
</div>
<!-- Page 281 -->
<a name="281"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page281-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2281.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2811"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2814"><b>ESTOSTERONE&#160;</b></p>
<p style="position:absolute;top:118px;left:313px;white-space:nowrap" class="ft2811"><b>E</b></p>
<p style="position:absolute;top:123px;left:333px;white-space:nowrap" class="ft2814"><b>NANTHATE&#160;</b></p>
<p style="position:absolute;top:118px;left:475px;white-space:nowrap" class="ft2811"><b>I</b></p>
<p style="position:absolute;top:123px;left:487px;white-space:nowrap" class="ft2814"><b>NJ</b></p>
<p style="position:absolute;top:119px;left:516px;white-space:nowrap" class="ft28113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2812"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2815">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2816">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2810">Testosterone&#160;Enanthate&#160;INJ&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2812"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2812"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2818"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2810">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2818"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2810">Gender Dysphoria&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2819"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2810">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2819"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft28110">Primary or&#160;hypogonadotropic hypogonadism: 1)&#160;Request&#160;is for&#160;<br/>continuation&#160;of testosterone therapy&#160;and the&#160;patient had a&#160;confirmed low&#160;<br/>morning&#160;testosterone&#160;level according&#160;to current practice guidelines or&#160;<br/>your standard lab reference values before starting&#160;testosterone&#160;therapy&#160;<br/>[Note: Safety and efficacy of&#160;testosterone products&#160;in patients with &#34;age-<br/>related hypogonadism&#34; (also referred to as &#34;late-onset&#160;hypogonadism&#34;)&#160;<br/>have not&#160;been established.] OR 2) Request&#160;is not for&#160;continuation of&#160;<br/>testosterone&#160;therapy&#160;and&#160;the patient has at least two confirmed low&#160;<br/>morning&#160;testosterone&#160;levels according to current&#160;practice guidelines or&#160;<br/>your standard lab reference values [Note:&#160;Safety and efficacy&#160;of&#160;<br/>testosterone&#160;products in&#160;patients with &#34;age-related hypogonadism&#34;&#160;(also&#160;<br/>referred&#160;to&#160;as &#34;late-onset hypogonadism&#34;) have not been established.].&#160;<br/>Gender dysphoria: The patient is&#160;able to make&#160;an&#160;informed decision&#160;to&#160;<br/>engage in hormone&#160;therapy.&#160;</p>
<p style="position:absolute;top:763px;left:126px;white-space:nowrap" class="ft2818"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:763px;left:274px;white-space:nowrap" class="ft2810">N/A&#160;</p>
<p style="position:absolute;top:802px;left:126px;white-space:nowrap" class="ft2819"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:802px;left:274px;white-space:nowrap" class="ft2810">N/A&#160;</p>
<p style="position:absolute;top:861px;left:126px;white-space:nowrap" class="ft2819"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:861px;left:274px;white-space:nowrap" class="ft2810">Plan Year&#160;</p>
<p style="position:absolute;top:921px;left:126px;white-space:nowrap" class="ft2818"><b>Other&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:921px;left:274px;white-space:nowrap" class="ft2810">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2810">281&#160;</p>
</div>
<!-- Page 282 -->
<a name="282"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page282-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2282.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2821"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2824"><b>ETRABENAZINE</b></p>
<p style="position:absolute;top:119px;left:320px;white-space:nowrap" class="ft28213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2822"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2825">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2826">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2820">Tetrabenazine&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2822"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2822"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2828"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2820">All FDA-approved Indications, Some&#160;Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2828"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft28210">Tic disorders, tardive dyskinesia, hemiballismus, chorea not&#160;associated&#160;<br/>with Huntington's&#160;disease.&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft2829"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft2820">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft2829"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft28210">For treatment&#160;of chorea&#160;associated with Huntington's disease:&#160;The patient&#160;<br/>must&#160;have a&#160;prior inadequate&#160;response or&#160;intolerable adverse&#160;event&#160;with&#160;<br/>deutetrabenazine&#160;therapy. For treatment of tardive dyskinesia: The patient&#160;<br/>must&#160;have a&#160;prior inadequate&#160;response or&#160;intolerable adverse&#160;event&#160;with&#160;<br/>deutetrabenazine&#160;or valbenazine&#160;therapy.&#160;</p>
<p style="position:absolute;top:598px;left:126px;white-space:nowrap" class="ft2828"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:598px;left:274px;white-space:nowrap" class="ft2820">N/A&#160;</p>
<p style="position:absolute;top:636px;left:126px;white-space:nowrap" class="ft2829"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:636px;left:274px;white-space:nowrap" class="ft2820">N/A&#160;</p>
<p style="position:absolute;top:696px;left:126px;white-space:nowrap" class="ft2829"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:696px;left:274px;white-space:nowrap" class="ft2820">Plan Year&#160;</p>
<p style="position:absolute;top:755px;left:126px;white-space:nowrap" class="ft2828"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:755px;left:274px;white-space:nowrap" class="ft2820">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2820">282&#160;</p>
</div>
<!-- Page 283 -->
<a name="283"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page283-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2283.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2831"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2834"><b>HALOMID</b></p>
<p style="position:absolute;top:119px;left:248px;white-space:nowrap" class="ft28313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2832"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2835">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2836">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2830">Thalomid&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2832"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2832"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2838"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2830">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2838"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft28310">Myelofibrosis-related anemia,&#160;recurrent aphthous&#160;stomatitis, recurrent&#160;<br/>human immunodeficiency virus&#160;(HIV)-associated aphthous&#160;ulcers,&#160;<br/>cachexia, HIV-associated diarrhea, acquired&#160;immunodeficiency syndrome&#160;<br/>(AIDS)-related Kaposi's&#160;sarcoma, Behcet's syndrome, chronic graft-<br/>versus-host disease, Crohn's disease,&#160;multicentric&#160;Castleman's disease.&#160;</p>
<p style="position:absolute;top:479px;left:126px;white-space:nowrap" class="ft2839"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:479px;left:274px;white-space:nowrap" class="ft2830">N/A&#160;</p>
<p style="position:absolute;top:538px;left:126px;white-space:nowrap" class="ft2839"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:538px;left:274px;white-space:nowrap" class="ft2830">For cachexia: Cachexia&#160;must&#160;be due&#160;to cancer or&#160;HIV infection.&#160;</p>
<p style="position:absolute;top:618px;left:126px;white-space:nowrap" class="ft2838"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:618px;left:274px;white-space:nowrap" class="ft2830">N/A&#160;</p>
<p style="position:absolute;top:657px;left:126px;white-space:nowrap" class="ft2839"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:657px;left:274px;white-space:nowrap" class="ft2830">N/A&#160;</p>
<p style="position:absolute;top:716px;left:126px;white-space:nowrap" class="ft2839"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:716px;left:274px;white-space:nowrap" class="ft2830">Plan Year&#160;</p>
<p style="position:absolute;top:776px;left:126px;white-space:nowrap" class="ft2838"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:776px;left:274px;white-space:nowrap" class="ft2830">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2830">283&#160;</p>
</div>
<!-- Page 284 -->
<a name="284"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page284-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2284.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2841"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2844"><b>IBSOVO</b></p>
<p style="position:absolute;top:119px;left:221px;white-space:nowrap" class="ft28413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2842"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2845">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2846">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2840">Tibsovo&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2842"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2842"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2848"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2840">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2848"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2840">Conventional (grades 1-3) or&#160;dedifferentiated chondrosarcoma&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2849"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2840">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2849"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft28410">Patient has&#160;disease with a&#160;susceptible&#160;isocitrate dehydrogenase-1 (IDH1)&#160;<br/>mutation. For acute myeloid leukemia (AML):&#160;1) patient has&#160;newly-<br/>diagnosed AML and meets one&#160;of the&#160;following: a) 75 years&#160;of age or&#160;<br/>older, b) patient has comorbidities that preclude&#160;use of&#160;intensive induction&#160;<br/>chemotherapy, or c)&#160;patient is 60 physiologic years&#160;of age or older&#160;and&#160;<br/>declines intensive induction chemotherapy, OR&#160;2) patient&#160;is 60&#160;<br/>physiologic years&#160;of age&#160;or older&#160;and&#160;the requested drug will&#160;be used as&#160;<br/>post-induction therapy&#160;following&#160;response to induction&#160;therapy with the&#160;<br/>requested drug, OR&#160;3) patient has&#160;relapsed or refractory AML. For&#160;<br/>unresectable&#160;or metastatic cholangiocarcinoma:&#160;the requested&#160;drug will be&#160;<br/>used as subsequent treatment&#160;for&#160;progression on&#160;or after systemic&#160;<br/>treatment.&#160;</p>
<p style="position:absolute;top:722px;left:126px;white-space:nowrap" class="ft2848"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:722px;left:274px;white-space:nowrap" class="ft2840">N/A&#160;</p>
<p style="position:absolute;top:760px;left:126px;white-space:nowrap" class="ft2849"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:760px;left:274px;white-space:nowrap" class="ft2840">N/A&#160;</p>
<p style="position:absolute;top:820px;left:126px;white-space:nowrap" class="ft2849"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:820px;left:274px;white-space:nowrap" class="ft2840">Plan Year&#160;</p>
<p style="position:absolute;top:879px;left:126px;white-space:nowrap" class="ft2848"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:879px;left:274px;white-space:nowrap" class="ft2840">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2840">284&#160;</p>
</div>
<!-- Page 285 -->
<a name="285"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page285-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2285.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2851"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2854"><b>OBRAMYCIN</b></p>
<p style="position:absolute;top:119px;left:281px;white-space:nowrap" class="ft28513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2852"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2855">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2856">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2850">Tobramycin&#160;NEBU&#160;300MG/5ML&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2852"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2852"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2858"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2850">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2858"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2850">Non-cystic fibrosis&#160;bronchiectasis&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2859"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2850">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2859"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft28510">For&#160;cystic&#160;fibrosis and non-cystic fibrosis bronchiectasis,&#160;the patient must&#160;<br/>meet one of&#160;the following: 1)&#160;Pseudomonas&#160;aeruginosa is&#160;present in&#160;the&#160;<br/>patient's airway cultures, OR&#160;2) the patient has a history of Pseudomonas&#160;<br/>aeruginosa infection or colonization&#160;in the airways.&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft2858"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft2850">N/A&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft2859"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft2850">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft2859"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft2850">Plan Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft2858"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft28510">Coverage&#160;under&#160;Part&#160;D will be denied&#160;if&#160;coverage&#160;is available under Part&#160;<br/>A or Part&#160;B as the&#160;medication&#160;is prescribed&#160;and dispensed or&#160;administered&#160;<br/>for&#160;the individual.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2850">285&#160;</p>
</div>
<!-- Page 286 -->
<a name="286"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page286-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2286.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2861"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2864"><b>OPICAL&#160;</b></p>
<p style="position:absolute;top:118px;left:227px;white-space:nowrap" class="ft2861"><b>D</b></p>
<p style="position:absolute;top:123px;left:249px;white-space:nowrap" class="ft2864"><b>OXEPIN</b></p>
<p style="position:absolute;top:119px;left:343px;white-space:nowrap" class="ft28613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2862"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2865">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2866">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2860">Doxepin Hydrochloride&#160;CREA&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2862"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2862"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2868"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2860">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2868"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2860">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2869"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2860">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2869"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft28610">The patient&#160;has experienced an inadequate&#160;response to a&#160;topical&#160;<br/>corticosteroid or a topical calcineurin&#160;inhibitor&#160;(e.g., tacrolimus).&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2868"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2860">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2869"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2860">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2869"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2860">1 month&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2868"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2860">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2860">286&#160;</p>
</div>
<!-- Page 287 -->
<a name="287"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page287-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2287.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2871"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2874"><b>OPICAL&#160;</b></p>
<p style="position:absolute;top:118px;left:227px;white-space:nowrap" class="ft2871"><b>L</b></p>
<p style="position:absolute;top:123px;left:247px;white-space:nowrap" class="ft2874"><b>IDOCAINE</b></p>
<p style="position:absolute;top:119px;left:370px;white-space:nowrap" class="ft28713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2872"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2875">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2876">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2870">Lidocaine&#160;OINT 5%&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft2875">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft2876">&#160;&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft28710">Lidocaine Hcl&#160;EXTERNAL SOLN&#160;<br/>4%&#160;</p>
<p style="position:absolute;top:262px;left:122px;white-space:nowrap" class="ft2875">•</p>
<p style="position:absolute;top:262px;left:130px;white-space:nowrap" class="ft2876">&#160;&#160;</p>
<p style="position:absolute;top:264px;left:149px;white-space:nowrap" class="ft2870">Lidocaine/prilocaine&#160;CREA&#160;</p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft2872"><b>PA&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft2872"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:383px;left:126px;white-space:nowrap" class="ft2878"><b>Indications&#160;</b></p>
<p style="position:absolute;top:383px;left:274px;white-space:nowrap" class="ft2870">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:422px;left:126px;white-space:nowrap" class="ft2878"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:422px;left:274px;white-space:nowrap" class="ft2870">N/A&#160;</p>
<p style="position:absolute;top:461px;left:126px;white-space:nowrap" class="ft2879"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:461px;left:274px;white-space:nowrap" class="ft2870">N/A&#160;</p>
<p style="position:absolute;top:520px;left:126px;white-space:nowrap" class="ft2879"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:520px;left:274px;white-space:nowrap" class="ft28710">1)&#160;The requested drug&#160;is being used for topical&#160;anesthesia, AND&#160;2) If the&#160;<br/>requested drug will&#160;be used as part&#160;of a&#160;compounded product,&#160;then all the&#160;<br/>active ingredients&#160;in the&#160;compounded product&#160;are Food and Drug&#160;<br/>Administration (FDA) approved for&#160;topical use.&#160;</p>
<p style="position:absolute;top:621px;left:126px;white-space:nowrap" class="ft2878"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:621px;left:274px;white-space:nowrap" class="ft2870">N/A&#160;</p>
<p style="position:absolute;top:660px;left:126px;white-space:nowrap" class="ft2879"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:660px;left:274px;white-space:nowrap" class="ft2870">N/A&#160;</p>
<p style="position:absolute;top:719px;left:126px;white-space:nowrap" class="ft2879"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:719px;left:274px;white-space:nowrap" class="ft2870">3 months&#160;</p>
<p style="position:absolute;top:778px;left:126px;white-space:nowrap" class="ft2878"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:778px;left:274px;white-space:nowrap" class="ft28710">Coverage&#160;under&#160;Part&#160;D will be denied&#160;if&#160;coverage&#160;is available under Part&#160;<br/>A or Part&#160;B as the&#160;medication&#160;is prescribed&#160;and dispensed or&#160;administered&#160;<br/>for&#160;the individual.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2870">287&#160;</p>
</div>
<!-- Page 288 -->
<a name="288"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page288-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2288.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2881"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2884"><b>OPICAL&#160;</b></p>
<p style="position:absolute;top:118px;left:227px;white-space:nowrap" class="ft2881"><b>T</b></p>
<p style="position:absolute;top:123px;left:247px;white-space:nowrap" class="ft2884"><b>ESTOSTERONES</b></p>
<p style="position:absolute;top:119px;left:440px;white-space:nowrap" class="ft28813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2882"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2885">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2886">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft28810">Androderm&#160;PT24 2MG/24HR,&#160;<br/>4MG/24HR&#160;</p>
<p style="position:absolute;top:240px;left:122px;white-space:nowrap" class="ft2885">•</p>
<p style="position:absolute;top:240px;left:130px;white-space:nowrap" class="ft2886">&#160;&#160;</p>
<p style="position:absolute;top:242px;left:149px;white-space:nowrap" class="ft28810">Testosterone&#160;GEL 10MG/ACT,&#160;<br/>25MG/2.5GM, 50MG/5GM&#160;</p>
<p style="position:absolute;top:283px;left:122px;white-space:nowrap" class="ft2885">•</p>
<p style="position:absolute;top:282px;left:130px;white-space:nowrap" class="ft2886">&#160;&#160;</p>
<p style="position:absolute;top:285px;left:149px;white-space:nowrap" class="ft2880">Testosterone&#160;Pump&#160;GEL&#160;1%&#160;</p>
<p style="position:absolute;top:305px;left:122px;white-space:nowrap" class="ft2885">•</p>
<p style="position:absolute;top:304px;left:130px;white-space:nowrap" class="ft2886">&#160;&#160;</p>
<p style="position:absolute;top:307px;left:149px;white-space:nowrap" class="ft2880">Testosterone&#160;Topical&#160;Solution&#160;</p>
<p style="position:absolute;top:384px;left:126px;white-space:nowrap" class="ft2882"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:384px;left:274px;white-space:nowrap" class="ft2882"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:426px;left:126px;white-space:nowrap" class="ft2888"><b>Indications&#160;</b></p>
<p style="position:absolute;top:426px;left:274px;white-space:nowrap" class="ft2880">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:465px;left:126px;white-space:nowrap" class="ft2888"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:465px;left:274px;white-space:nowrap" class="ft2880">Gender Dysphoria&#160;</p>
<p style="position:absolute;top:503px;left:126px;white-space:nowrap" class="ft2889"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:503px;left:274px;white-space:nowrap" class="ft2880">N/A&#160;</p>
<p style="position:absolute;top:563px;left:126px;white-space:nowrap" class="ft2889"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:563px;left:274px;white-space:nowrap" class="ft28810">Primary or&#160;hypogonadotropic hypogonadism: 1)&#160;Request&#160;is for&#160;<br/>continuation&#160;of testosterone therapy&#160;and the&#160;patient had a&#160;confirmed low&#160;<br/>morning&#160;testosterone&#160;level according&#160;to current practice guidelines or&#160;<br/>your standard lab reference values before starting&#160;testosterone&#160;therapy&#160;<br/>[Note: Safety and efficacy of&#160;testosterone products&#160;in patients with &#34;age-<br/>related hypogonadism&#34; (also referred to as &#34;late-onset&#160;hypogonadism&#34;)&#160;<br/>have not&#160;been established.] OR 2) Request&#160;is not for&#160;continuation of&#160;<br/>testosterone&#160;therapy&#160;and&#160;the patient has at least two confirmed low&#160;<br/>morning&#160;testosterone&#160;levels according to current&#160;practice guidelines or&#160;<br/>your standard lab reference values [Note:&#160;Safety and efficacy&#160;of&#160;<br/>testosterone&#160;products in&#160;patients with &#34;age-related hypogonadism&#34;&#160;(also&#160;<br/>referred&#160;to&#160;as &#34;late-onset hypogonadism&#34;) have not been established.].&#160;<br/>Gender dysphoria: The patient is&#160;able to make&#160;an&#160;informed decision&#160;to&#160;<br/>engage in hormone&#160;therapy.&#160;</p>
<p style="position:absolute;top:871px;left:126px;white-space:nowrap" class="ft2888"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:871px;left:274px;white-space:nowrap" class="ft2880">N/A&#160;</p>
<p style="position:absolute;top:909px;left:126px;white-space:nowrap" class="ft2889"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:909px;left:274px;white-space:nowrap" class="ft2880">N/A&#160;</p>
<p style="position:absolute;top:969px;left:126px;white-space:nowrap" class="ft2889"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:969px;left:274px;white-space:nowrap" class="ft2880">Plan Year&#160;</p>
<p style="position:absolute;top:1028px;left:126px;white-space:nowrap" class="ft2888"><b>Other&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:1028px;left:274px;white-space:nowrap" class="ft2880">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2880">288&#160;</p>
</div>
<!-- Page 289 -->
<a name="289"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page289-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2289.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2891"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2894"><b>OPICAL&#160;</b></p>
<p style="position:absolute;top:118px;left:227px;white-space:nowrap" class="ft2891"><b>T</b></p>
<p style="position:absolute;top:123px;left:247px;white-space:nowrap" class="ft2894"><b>RETINOIN</b></p>
<p style="position:absolute;top:119px;left:369px;white-space:nowrap" class="ft28913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2892"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2895">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2896">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2890">Tretinoin&#160;CREA&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft2895">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft2896">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft2890">Tretinoin&#160;GEL&#160;</p>
<p style="position:absolute;top:242px;left:122px;white-space:nowrap" class="ft2895">•</p>
<p style="position:absolute;top:241px;left:130px;white-space:nowrap" class="ft2896">&#160;</p>
<p style="position:absolute;top:244px;left:149px;white-space:nowrap" class="ft2890">Tretinoin Microsphere&#160;</p>
<p style="position:absolute;top:264px;left:122px;white-space:nowrap" class="ft2895">•</p>
<p style="position:absolute;top:263px;left:130px;white-space:nowrap" class="ft2896">&#160;</p>
<p style="position:absolute;top:266px;left:149px;white-space:nowrap" class="ft2890">Tretinoin Microsphere&#160;Pump&#160;</p>
<p style="position:absolute;top:343px;left:126px;white-space:nowrap" class="ft2892"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:343px;left:274px;white-space:nowrap" class="ft2892"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:385px;left:126px;white-space:nowrap" class="ft2898"><b>Indications&#160;</b></p>
<p style="position:absolute;top:385px;left:274px;white-space:nowrap" class="ft2890">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:423px;left:126px;white-space:nowrap" class="ft2898"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:423px;left:274px;white-space:nowrap" class="ft2890">N/A&#160;</p>
<p style="position:absolute;top:462px;left:126px;white-space:nowrap" class="ft2899"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:462px;left:274px;white-space:nowrap" class="ft2890">N/A&#160;</p>
<p style="position:absolute;top:521px;left:126px;white-space:nowrap" class="ft2899"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:521px;left:274px;white-space:nowrap" class="ft2890">N/A&#160;</p>
<p style="position:absolute;top:601px;left:126px;white-space:nowrap" class="ft2898"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:601px;left:274px;white-space:nowrap" class="ft2890">N/A&#160;</p>
<p style="position:absolute;top:640px;left:126px;white-space:nowrap" class="ft2899"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:640px;left:274px;white-space:nowrap" class="ft2890">N/A&#160;</p>
<p style="position:absolute;top:700px;left:126px;white-space:nowrap" class="ft2899"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:700px;left:274px;white-space:nowrap" class="ft2890">Plan Year&#160;</p>
<p style="position:absolute;top:759px;left:126px;white-space:nowrap" class="ft2898"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:759px;left:274px;white-space:nowrap" class="ft2890">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2890">289&#160;</p>
</div>
<!-- Page 290 -->
<a name="290"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page290-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2290.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2901"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2904"><b>OREMIFENE</b></p>
<p style="position:absolute;top:119px;left:276px;white-space:nowrap" class="ft29013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2902"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2905">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2906">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2900">Toremifene&#160;Citrate&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2902"><b>PA&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2902"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2908"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2900">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2908"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2900">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2909"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft29010">Congenital/acquired&#160;QT&#160;prolongation&#160;(long QT&#160;syndrome), uncorrected&#160;<br/>hypokalemia, or uncorrected hypomagnesemia.&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2909"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2900">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2908"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2900">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2909"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2900">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2909"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2900">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2908"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2900">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2900">290&#160;</p>
</div>
<!-- Page 291 -->
<a name="291"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page291-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2291.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2911"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2914"><b>RELSTAR</b></p>
<p style="position:absolute;top:119px;left:241px;white-space:nowrap" class="ft29113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2912"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2915">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2916">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft29110">Trelstar&#160;Mixject&#160;INJ 11.25MG,&#160;<br/>3.75MG&#160;</p>
<p style="position:absolute;top:297px;left:126px;white-space:nowrap" class="ft2912"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:297px;left:274px;white-space:nowrap" class="ft2912"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:339px;left:126px;white-space:nowrap" class="ft2918"><b>Indications&#160;</b></p>
<p style="position:absolute;top:339px;left:274px;white-space:nowrap" class="ft2910">All FDA-approved Indications, Some Medically&#160;accepted&#160;Indications.&#160;</p>
<p style="position:absolute;top:378px;left:126px;white-space:nowrap" class="ft2918"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:378px;left:274px;white-space:nowrap" class="ft2910">Gender dysphoria&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft2919"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft2910">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft2919"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft29110">For gender&#160;dysphoria, patient meets either of the following (1&#160;or 2): 1) the&#160;<br/>requested drug is&#160;used to&#160;suppress puberty and&#160;the patient is at Tanner&#160;<br/>stage 2 or&#160;greater, OR 2) patient is&#160;undergoing gender transition, and the&#160;<br/>patient will receive&#160;the requested drug concomitantly with gender-<br/>affirming hormones.&#160;</p>
<p style="position:absolute;top:598px;left:126px;white-space:nowrap" class="ft2918"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:598px;left:274px;white-space:nowrap" class="ft2910">N/A&#160;</p>
<p style="position:absolute;top:636px;left:126px;white-space:nowrap" class="ft2919"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:636px;left:274px;white-space:nowrap" class="ft2910">N/A&#160;</p>
<p style="position:absolute;top:696px;left:126px;white-space:nowrap" class="ft2919"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:696px;left:274px;white-space:nowrap" class="ft2910">Plan Year&#160;</p>
<p style="position:absolute;top:755px;left:126px;white-space:nowrap" class="ft2918"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:755px;left:274px;white-space:nowrap" class="ft2910">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2910">291&#160;</p>
</div>
<!-- Page 292 -->
<a name="292"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page292-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2292.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2921"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2924"><b>REPROSTINIL&#160;</b></p>
<p style="position:absolute;top:118px;left:299px;white-space:nowrap" class="ft2921"><b>I</b></p>
<p style="position:absolute;top:123px;left:311px;white-space:nowrap" class="ft2924"><b>NJ</b></p>
<p style="position:absolute;top:119px;left:340px;white-space:nowrap" class="ft29213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2922"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2925">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2926">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2920">Treprostinil&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2922"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2922"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2928"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2920">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2928"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2920">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2929"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2920">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2929"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft29210">For pulmonary&#160;arterial hypertension&#160;(World Health Organization [WHO]&#160;<br/>Group 1), the diagnosis was confirmed by right heart&#160;catheterization. For&#160;<br/>new starts only:&#160;1) pretreatment mean pulmonary arterial pressure is&#160;<br/>greater than&#160;20 mmHg, 2) pretreatment pulmonary capillary&#160;wedge&#160;<br/>pressure is less than or equal to 15&#160;mmHg, AND 3)&#160;pretreatment&#160;<br/>pulmonary vascular resistance&#160;is greater&#160;than or&#160;equal to 3 Wood units.&#160;</p>
<p style="position:absolute;top:598px;left:126px;white-space:nowrap" class="ft2928"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:598px;left:274px;white-space:nowrap" class="ft2920">N/A&#160;</p>
<p style="position:absolute;top:636px;left:126px;white-space:nowrap" class="ft2929"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:636px;left:274px;white-space:nowrap" class="ft2920">N/A&#160;</p>
<p style="position:absolute;top:696px;left:126px;white-space:nowrap" class="ft2929"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:696px;left:274px;white-space:nowrap" class="ft2920">Plan Year&#160;</p>
<p style="position:absolute;top:755px;left:126px;white-space:nowrap" class="ft2928"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:755px;left:274px;white-space:nowrap" class="ft29210">Coverage&#160;under&#160;Part D will be denied&#160;if&#160;coverage&#160;is available under Part&#160;<br/>A or Part&#160;B as the&#160;medication&#160;is prescribed&#160;and dispensed or&#160;administered&#160;<br/>for&#160;the individual.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2920">292&#160;</p>
</div>
<!-- Page 293 -->
<a name="293"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page293-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2293.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2931"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2934"><b>RIENTINE</b></p>
<p style="position:absolute;top:119px;left:247px;white-space:nowrap" class="ft29313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2932"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2935">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2936">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2930">Trientine Hydrochloride&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2932"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2932"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2938"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2930">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2938"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2930">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2939"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2930">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2939"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2930">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2938"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2930">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2939"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2930">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2939"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2930">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2938"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2930">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2930">293&#160;</p>
</div>
<!-- Page 294 -->
<a name="294"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page294-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2294.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2941"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2944"><b>RIKAFTA</b></p>
<p style="position:absolute;top:119px;left:239px;white-space:nowrap" class="ft29413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2942"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2945">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2946">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2940">Trikafta&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2942"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2942"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2948"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2940">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2948"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2940">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2949"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2940">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2949"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft29410">The requested&#160;medication will&#160;not be used in combination with other&#160;<br/>medications&#160;containing ivacaftor.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2948"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2940">6 years&#160;of age or&#160;older&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2949"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2940">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2949"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2940">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2948"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2940">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2940">294&#160;</p>
</div>
<!-- Page 295 -->
<a name="295"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page295-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2295.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2951"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2954"><b>RODELVY</b></p>
<p style="position:absolute;top:119px;left:248px;white-space:nowrap" class="ft29513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2952"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2955">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2956">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2950">Trodelvy&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2952"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2952"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2958"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2950">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2958"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2950">Recurrent&#160;triple-negative&#160;breast&#160;cancer&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2959"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2950">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2959"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2950">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2958"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2950">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2959"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2950">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2959"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2950">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2958"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2950">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2950">295&#160;</p>
</div>
<!-- Page 296 -->
<a name="296"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page296-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2296.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2961"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2964"><b>RUSELTIQ</b></p>
<p style="position:absolute;top:119px;left:252px;white-space:nowrap" class="ft29613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2962"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2965">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2966">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2960">Truseltiq&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2962"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2962"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2968"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2960">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2968"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2960">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2969"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2960">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2969"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2960">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2968"><b>Age&#160;Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2960">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2969"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2960">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2969"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2960">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2968"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2960">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2960">296&#160;</p>
</div>
<!-- Page 297 -->
<a name="297"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page297-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2297.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2971"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2974"><b>UKYSA</b></p>
<p style="position:absolute;top:119px;left:212px;white-space:nowrap" class="ft29713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2972"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2975">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2976">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2970">Tukysa&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2972"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2972"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2978"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2970">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2978"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft29710">Recurrent human&#160;epidermal&#160;growth&#160;factor receptor 2 (HER2)-positive&#160;<br/>breast&#160;cancer, including&#160;patients with brain&#160;metastases, who&#160;have received&#160;<br/>one or&#160;more&#160;lines of prior HER2-targeted therapy&#160;in the&#160;metastatic setting.&#160;</p>
<p style="position:absolute;top:437px;left:126px;white-space:nowrap" class="ft2979"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:437px;left:274px;white-space:nowrap" class="ft2970">N/A&#160;</p>
<p style="position:absolute;top:497px;left:126px;white-space:nowrap" class="ft2979"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:497px;left:274px;white-space:nowrap" class="ft2970">N/A&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft2978"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft2970">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft2979"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft2970">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft2979"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft2970">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft2978"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft2970">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2970">297&#160;</p>
</div>
<!-- Page 298 -->
<a name="298"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page298-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2298.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2981"><b>T</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft2984"><b>URALIO</b></p>
<p style="position:absolute;top:119px;left:224px;white-space:nowrap" class="ft29813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2982"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2985">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2986">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2980">Turalio&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2982"><b>PA&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2982"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2988"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2980">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2988"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2980">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2989"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2980">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2989"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft2980">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2988"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2980">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2989"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2980">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2989"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2980">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2988"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2980">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2980">298&#160;</p>
</div>
<!-- Page 299 -->
<a name="299"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page299-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2299.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft2991"><b>U</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft2994"><b>BRELVY</b></p>
<p style="position:absolute;top:119px;left:230px;white-space:nowrap" class="ft29913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft2992"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft2995">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft2996">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft2990">Ubrelvy&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft2992"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft2992"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft2998"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft2990">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft2998"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft2990">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft2999"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft2990">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft2999"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft29910">The patient&#160;has experienced an inadequate&#160;treatment response,&#160;<br/>intolerance,&#160;or the patient has&#160;a contraindication&#160;to&#160;one triptan&#160;5-HT1&#160;<br/>receptor&#160;agonist.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft2998"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft2990">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft2999"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft2990">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft2999"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft2990">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft2998"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft2990">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft2990">299&#160;</p>
</div>
<!-- Page 300 -->
<a name="300"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page300-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2300.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3001"><b>U</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3004"><b>KONIQ</b></p>
<p style="position:absolute;top:119px;left:212px;white-space:nowrap" class="ft30013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3002"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3005">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3006">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3000">Ukoniq&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3002"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3002"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3008"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3000">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3008"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft3000">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft3009"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft3000">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft3009"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft3000">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft3008"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft3000">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft3009"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft3000">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft3009"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft3000">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft3008"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft3000">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3000">300&#160;</p>
</div>
<!-- Page 301 -->
<a name="301"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page301-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2301.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3011"><b>V</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3014"><b>ALCHLOR</b></p>
<p style="position:absolute;top:119px;left:251px;white-space:nowrap" class="ft30113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3012"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3015">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3016">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3010">Valchlor&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3012"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3012"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3018"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3010">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3018"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft30110">Chronic&#160;or&#160;smoldering adult&#160;T-cell&#160;leukemia/lymphoma, Stage 2 or&#160;higher&#160;<br/>mycosis fungoides/Sezary syndrome,&#160;primary&#160;cutaneous marginal&#160;zone&#160;<br/>lymphoma,&#160;primary&#160;cutaneous follicle center lymphoma, lymphomatoid&#160;<br/>papulosis.&#160;</p>
<p style="position:absolute;top:458px;left:126px;white-space:nowrap" class="ft3019"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:458px;left:274px;white-space:nowrap" class="ft3010">N/A&#160;</p>
<p style="position:absolute;top:518px;left:126px;white-space:nowrap" class="ft3019"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:518px;left:274px;white-space:nowrap" class="ft3010">N/A&#160;</p>
<p style="position:absolute;top:598px;left:126px;white-space:nowrap" class="ft3018"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:598px;left:274px;white-space:nowrap" class="ft3010">N/A&#160;</p>
<p style="position:absolute;top:636px;left:126px;white-space:nowrap" class="ft3019"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:636px;left:274px;white-space:nowrap" class="ft3010">N/A&#160;</p>
<p style="position:absolute;top:696px;left:126px;white-space:nowrap" class="ft3019"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:696px;left:274px;white-space:nowrap" class="ft3010">Plan Year&#160;</p>
<p style="position:absolute;top:755px;left:126px;white-space:nowrap" class="ft3018"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:755px;left:274px;white-space:nowrap" class="ft3010">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3010">301&#160;</p>
</div>
<!-- Page 302 -->
<a name="302"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page302-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2302.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3021"><b>V</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3024"><b>ALTOCO</b></p>
<p style="position:absolute;top:119px;left:234px;white-space:nowrap" class="ft30213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3022"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3025">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3026">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3020">Valtoco&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3022"><b>PA&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3022"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3028"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3020">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3028"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft3020">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft3029"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft3020">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft3029"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft3020">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft3028"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft3020">6 years&#160;of age or&#160;older&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft3029"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft3020">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft3029"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft3020">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft3028"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft3020">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3020">302&#160;</p>
</div>
<!-- Page 303 -->
<a name="303"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page303-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2303.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3031"><b>V</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3034"><b>ELCADE</b></p>
<p style="position:absolute;top:119px;left:230px;white-space:nowrap" class="ft30313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3032"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3035">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3036">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3030">Bortezomib&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft3035">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft3036">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft3030">Velcade&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft3032"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft3032"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft3038"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft3030">All FDA-approved&#160;Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft3038"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft30310">Systemic light&#160;chain&#160;amyloidosis, Waldenstrom's&#160;<br/>macroglobulinemia/lymphoplasmacytic lymphoma, multicentric&#160;<br/>Castleman's&#160;disease, adult T-cell&#160;leukemia/lymphoma, acute&#160;<br/>lymphoblastic leukemia,&#160;AIDS-related Kaposi's&#160;sarcoma, Hodgkin&#160;<br/>lymphoma,&#160;POEMS syndrome&#160;</p>
<p style="position:absolute;top:501px;left:126px;white-space:nowrap" class="ft3039"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:501px;left:274px;white-space:nowrap" class="ft3030">N/A&#160;</p>
<p style="position:absolute;top:560px;left:126px;white-space:nowrap" class="ft3039"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:560px;left:274px;white-space:nowrap" class="ft3030">N/A&#160;</p>
<p style="position:absolute;top:640px;left:126px;white-space:nowrap" class="ft3038"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:640px;left:274px;white-space:nowrap" class="ft3030">N/A&#160;</p>
<p style="position:absolute;top:679px;left:126px;white-space:nowrap" class="ft3039"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:679px;left:274px;white-space:nowrap" class="ft3030">N/A&#160;</p>
<p style="position:absolute;top:738px;left:126px;white-space:nowrap" class="ft3039"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:738px;left:274px;white-space:nowrap" class="ft3030">Plan Year&#160;</p>
<p style="position:absolute;top:798px;left:126px;white-space:nowrap" class="ft3038"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:798px;left:274px;white-space:nowrap" class="ft30310">Coverage&#160;under&#160;Part&#160;D will be denied&#160;if&#160;coverage&#160;is available under Part&#160;<br/>A or Part&#160;B as the&#160;medication&#160;is prescribed&#160;and dispensed or&#160;administered&#160;<br/>for&#160;the individual.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3030">303&#160;</p>
</div>
<!-- Page 304 -->
<a name="304"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page304-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2304.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3041"><b>V</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3044"><b>ELTASSA</b></p>
<p style="position:absolute;top:119px;left:239px;white-space:nowrap" class="ft30413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3042"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3045">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3046">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3040">Veltassa&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3042"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3042"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3048"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3040">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3048"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft3040">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft3049"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft3040">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft3049"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft30410">The patient&#160;has experienced an inadequate&#160;treatment response,&#160;<br/>intolerance,&#160;or has a contraindication&#160;to Lokelma.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft3048"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft3040">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft3049"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft3040">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft3049"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft3040">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft3048"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft3040">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3040">304&#160;</p>
</div>
<!-- Page 305 -->
<a name="305"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page305-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2305.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3051"><b>V</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3054"><b>ENCLEXTA</b></p>
<p style="position:absolute;top:119px;left:263px;white-space:nowrap" class="ft30513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3052"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3055">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3056">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3050">Venclexta&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft3055">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft3056">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft3050">Venclexta Starting Pack&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft3052"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft3052"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft3058"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft3050">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft3058"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft30510">Mantle cell&#160;lymphoma, blastic plasmacytoid dendritic cell&#160;neoplasm&#160;<br/>(BPDCN),&#160;multiple&#160;myeloma,&#160;relapsed or&#160;refractory acute myeloid&#160;<br/>leukemia (AML), AML in patients 60 physiologic years&#160;of age&#160;or older.&#160;</p>
<p style="position:absolute;top:459px;left:126px;white-space:nowrap" class="ft3059"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:459px;left:274px;white-space:nowrap" class="ft3050">N/A&#160;</p>
<p style="position:absolute;top:519px;left:126px;white-space:nowrap" class="ft3059"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:519px;left:274px;white-space:nowrap" class="ft30510">For acute&#160;myeloid&#160;leukemia&#160;(AML), any of the&#160;following criteria must be&#160;<br/>met: 1)&#160;the patient's physiologic age is 60 years&#160;of age or older OR 2) the&#160;<br/>requested drug will&#160;be used as a component of&#160;repeating&#160;the initial&#160;<br/>successful&#160;induction&#160;regimen&#160;if&#160;late&#160;relapse OR&#160;3) the patient has&#160;<br/>comorbidities that preclude use&#160;of intensive&#160;induction chemotherapy OR&#160;<br/>4) the requested drug will be used for relapsed or refractory disease. For&#160;<br/>blastic plasmacytoid dendritic cell&#160;neoplasm (BPDCN), any&#160;of the&#160;<br/>following&#160;criteria must be met: 1)&#160;patient has systemic disease&#160;treated&#160;<br/>with palliative intent OR 2) patient&#160;has relapsed&#160;or refractory&#160;disease. For&#160;<br/>multiple&#160;myeloma,&#160;all&#160;of the following must be met:&#160;1) the disease is&#160;<br/>relapsed or&#160;progressive&#160;AND 2) the requested drug will be used in&#160;<br/>combination&#160;with dexamethasone AND&#160;3) patient has&#160;t(11:14)&#160;<br/>translocation.&#160;</p>
<p style="position:absolute;top:806px;left:126px;white-space:nowrap" class="ft3058"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:806px;left:274px;white-space:nowrap" class="ft3050">N/A&#160;</p>
<p style="position:absolute;top:845px;left:126px;white-space:nowrap" class="ft3059"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:845px;left:274px;white-space:nowrap" class="ft3050">N/A&#160;</p>
<p style="position:absolute;top:904px;left:126px;white-space:nowrap" class="ft3059"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:904px;left:274px;white-space:nowrap" class="ft3050">Plan Year&#160;</p>
<p style="position:absolute;top:963px;left:126px;white-space:nowrap" class="ft3058"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:963px;left:274px;white-space:nowrap" class="ft3050">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3050">305&#160;</p>
</div>
<!-- Page 306 -->
<a name="306"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page306-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2306.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3061"><b>V</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3064"><b>ENTAVIS</b></p>
<p style="position:absolute;top:119px;left:237px;white-space:nowrap" class="ft30613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3062"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3065">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3066">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3060">Ventavis&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3062"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3062"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3068"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3060">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3068"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft3060">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft3069"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft3060">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft3069"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft30610">For&#160;pulmonary&#160;arterial hypertension&#160;(World Health Organization [WHO]&#160;<br/>Group 1), the diagnosis was confirmed by right heart&#160;catheterization. For&#160;<br/>new starts only:&#160;1) pretreatment mean pulmonary arterial pressure is&#160;<br/>greater than&#160;20 mmHg, 2) pretreatment pulmonary&#160;capillary&#160;wedge&#160;<br/>pressure is less than or equal to 15&#160;mmHg, AND 3)&#160;pretreatment&#160;<br/>pulmonary vascular resistance&#160;is greater&#160;than or&#160;equal to 3 Wood units.&#160;</p>
<p style="position:absolute;top:598px;left:126px;white-space:nowrap" class="ft3068"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:598px;left:274px;white-space:nowrap" class="ft3060">N/A&#160;</p>
<p style="position:absolute;top:636px;left:126px;white-space:nowrap" class="ft3069"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:636px;left:274px;white-space:nowrap" class="ft3060">N/A&#160;</p>
<p style="position:absolute;top:696px;left:126px;white-space:nowrap" class="ft3069"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:696px;left:274px;white-space:nowrap" class="ft3060">Plan Year&#160;</p>
<p style="position:absolute;top:755px;left:126px;white-space:nowrap" class="ft3068"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:755px;left:274px;white-space:nowrap" class="ft30610">Coverage&#160;under&#160;Part&#160;D will be denied&#160;if&#160;coverage&#160;is available under Part&#160;<br/>A or Part&#160;B as the&#160;medication&#160;is prescribed&#160;and dispensed or&#160;administered&#160;<br/>for&#160;the individual.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3060">306&#160;</p>
</div>
<!-- Page 307 -->
<a name="307"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page307-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2307.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3071"><b>V</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3074"><b>ERSACLOZ</b></p>
<p style="position:absolute;top:119px;left:262px;white-space:nowrap" class="ft30713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3072"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3075">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3076">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3070">Versacloz&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3072"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3072"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3078"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3070">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3078"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft3070">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft3079"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft3070">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft3079"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft30710">For the&#160;treatment of a severely&#160;ill patient&#160;with schizophrenia who failed&#160;to&#160;<br/>respond adequately&#160;to standard antipsychotic treatment (i.e., treatment-<br/>resistant schizophrenia),&#160;1) the patient experienced an inadequate&#160;<br/>treatment response, intolerance, or contraindication to one of&#160;the&#160;<br/>following generic products:&#160;A) aripiprazole, B) asenapine, C)&#160;olanzapine,&#160;<br/>D) quetiapine, E) risperidone, F) ziprasidone AND 2) The patient&#160;<br/>experienced&#160;an inadequate treatment response, intolerance, or&#160;<br/>contraindication to one of the following brand products: A) Latuda, B)&#160;<br/>Rexulti, C)&#160;Secuado.&#160;</p>
<p style="position:absolute;top:660px;left:126px;white-space:nowrap" class="ft3078"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:660px;left:274px;white-space:nowrap" class="ft3070">N/A&#160;</p>
<p style="position:absolute;top:698px;left:126px;white-space:nowrap" class="ft3079"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:698px;left:274px;white-space:nowrap" class="ft3070">N/A&#160;</p>
<p style="position:absolute;top:758px;left:126px;white-space:nowrap" class="ft3079"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:758px;left:274px;white-space:nowrap" class="ft3070">Plan Year&#160;</p>
<p style="position:absolute;top:817px;left:126px;white-space:nowrap" class="ft3078"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:817px;left:274px;white-space:nowrap" class="ft3070">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3070">307&#160;</p>
</div>
<!-- Page 308 -->
<a name="308"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page308-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2308.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3081"><b>V</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3084"><b>ERZENIO</b></p>
<p style="position:absolute;top:119px;left:240px;white-space:nowrap" class="ft30813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3082"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3085">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3086">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3080">Verzenio&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3082"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3082"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3088"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3080">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3088"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft30810">Recurrent hormone&#160;receptor&#160;(HR)-positive, human epidermal growth&#160;<br/>factor receptor 2 (HER2)-negative breast&#160;cancer&#160;in&#160;combination with&#160;<br/>fulvestrant or an aromatase inhibitor, or as a single agent if progression on&#160;<br/>prior endocrine therapy&#160;and prior&#160;chemotherapy&#160;in the&#160;metastatic setting.&#160;</p>
<p style="position:absolute;top:458px;left:126px;white-space:nowrap" class="ft3089"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:458px;left:274px;white-space:nowrap" class="ft3080">N/A&#160;</p>
<p style="position:absolute;top:518px;left:126px;white-space:nowrap" class="ft3089"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:518px;left:274px;white-space:nowrap" class="ft3080">N/A&#160;</p>
<p style="position:absolute;top:598px;left:126px;white-space:nowrap" class="ft3088"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:598px;left:274px;white-space:nowrap" class="ft3080">N/A&#160;</p>
<p style="position:absolute;top:636px;left:126px;white-space:nowrap" class="ft3089"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:636px;left:274px;white-space:nowrap" class="ft3080">N/A&#160;</p>
<p style="position:absolute;top:696px;left:126px;white-space:nowrap" class="ft3089"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:696px;left:274px;white-space:nowrap" class="ft3080">Plan Year&#160;</p>
<p style="position:absolute;top:755px;left:126px;white-space:nowrap" class="ft3088"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:755px;left:274px;white-space:nowrap" class="ft3080">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3080">308&#160;</p>
</div>
<!-- Page 309 -->
<a name="309"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page309-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2309.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3091"><b>V</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3094"><b>IGABATRIN</b></p>
<p style="position:absolute;top:119px;left:268px;white-space:nowrap" class="ft30913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3092"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3095">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3096">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3090">Vigabatrin&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft3095">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft3096">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft3090">Vigadrone&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft3092"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft3092"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft3098"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft3090">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft3098"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft3090">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft3099"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft3090">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft3099"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft30910">For complex&#160;partial seizures&#160;(CPS): patient had an&#160;inadequate response&#160;to&#160;<br/>at least&#160;2 antiepileptic drugs for&#160;CPS.&#160;</p>
<p style="position:absolute;top:557px;left:126px;white-space:nowrap" class="ft3098"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:557px;left:274px;white-space:nowrap" class="ft3090">N/A&#160;</p>
<p style="position:absolute;top:596px;left:126px;white-space:nowrap" class="ft3099"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:596px;left:274px;white-space:nowrap" class="ft3090">N/A&#160;</p>
<p style="position:absolute;top:656px;left:126px;white-space:nowrap" class="ft3099"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:656px;left:274px;white-space:nowrap" class="ft3090">Plan Year&#160;</p>
<p style="position:absolute;top:715px;left:126px;white-space:nowrap" class="ft3098"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:715px;left:274px;white-space:nowrap" class="ft3090">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3090">309&#160;</p>
</div>
<!-- Page 310 -->
<a name="310"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page310-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2310.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3101"><b>V</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3104"><b>ITRAKVI</b></p>
<p style="position:absolute;top:119px;left:235px;white-space:nowrap" class="ft31013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3102"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3105">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3106">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3100">Vitrakvi&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3102"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3102"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3108"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3100">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3108"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft31010">Advanced,&#160;recurrent, or persistent neurotrophic tyrosine receptor kinase&#160;<br/>(NTRK) gene fusion-positive solid tumors, first-line treatment of NTRK&#160;<br/>gene fusion-positive solid tumors.&#160;</p>
<p style="position:absolute;top:437px;left:126px;white-space:nowrap" class="ft3109"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:437px;left:274px;white-space:nowrap" class="ft3100">N/A&#160;</p>
<p style="position:absolute;top:497px;left:126px;white-space:nowrap" class="ft3109"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:497px;left:274px;white-space:nowrap" class="ft31010">For all&#160;neurotrophic tyrosine receptor kinase (NTRK) gene fusion-<br/>positive solid tumors,&#160;the disease is&#160;without&#160;a known acquired resistance&#160;<br/>mutation.&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft3108"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft3100">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft3109"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft3100">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft3109"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft3100">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft3108"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft3100">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3100">310&#160;</p>
</div>
<!-- Page 311 -->
<a name="311"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page311-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2311.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3111"><b>V</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3114"><b>IZIMPRO</b></p>
<p style="position:absolute;top:119px;left:238px;white-space:nowrap" class="ft31113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3112"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3115">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3116">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3110">Vizimpro&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3112"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3112"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3118"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3110">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3118"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft3110">Recurrent or&#160;advanced non-small cell lung cancer (NSCLC).&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft3119"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft3110">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft3119"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft31110">For non-small&#160;cell&#160;lung cancer (NSCLC): 1)&#160;the disease&#160;is recurrent,&#160;<br/>advanced or metastatic,&#160;and 2) the patient has sensitizing EGFR&#160;mutation-<br/>positive disease.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft3118"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft3110">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft3119"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft3110">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft3119"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft3110">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft3118"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft3110">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3110">311&#160;</p>
</div>
<!-- Page 312 -->
<a name="312"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page312-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2312.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3121"><b>V</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3124"><b>ORICONAZOLE</b></p>
<p style="position:absolute;top:119px;left:312px;white-space:nowrap" class="ft31213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3122"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3125">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3126">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3120">Voriconazole&#160;INJ&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft3125">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft3126">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft3120">Voriconazole&#160;SUSR&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft3122"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft3122"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft3128"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft3120">All&#160;FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft3128"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft3120">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft3129"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft3120">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft3129"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft3120">The patient&#160;will&#160;use&#160;the requested drug orally or&#160;intravenously.&#160;</p>
<p style="position:absolute;top:557px;left:126px;white-space:nowrap" class="ft3128"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:557px;left:274px;white-space:nowrap" class="ft3120">N/A&#160;</p>
<p style="position:absolute;top:596px;left:126px;white-space:nowrap" class="ft3129"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:596px;left:274px;white-space:nowrap" class="ft3120">N/A&#160;</p>
<p style="position:absolute;top:656px;left:126px;white-space:nowrap" class="ft3129"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:656px;left:274px;white-space:nowrap" class="ft3120">6 months&#160;</p>
<p style="position:absolute;top:715px;left:126px;white-space:nowrap" class="ft3128"><b>Other&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:715px;left:274px;white-space:nowrap" class="ft3120">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3120">312&#160;</p>
</div>
<!-- Page 313 -->
<a name="313"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page313-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2313.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3131"><b>V</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3134"><b>OSEVI</b></p>
<p style="position:absolute;top:119px;left:204px;white-space:nowrap" class="ft31313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3132"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3135">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3136">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3130">Vosevi&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3132"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3132"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3138"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3130">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3138"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft3130">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft3139"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft31310">Decompensated cirrhosis/moderate&#160;or severe hepatic&#160;impairment&#160;(Child&#160;<br/>Turcotte Pugh class B or C)&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft3139"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft31310">For hepatitis&#160;C: Infection&#160;confirmed by presence of HCV&#160;RNA in the&#160;<br/>serum prior&#160;to starting treatment. Planned treatment&#160;regimen,&#160;genotype,&#160;<br/>prior treatment history,&#160;presence or&#160;absence of cirrhosis (compensated or&#160;<br/>decompensated [Child Turcotte Pugh&#160;class B or C]), presence&#160;or absence&#160;<br/>of HIV coinfection, presence or&#160;absence of&#160;resistance-associated&#160;<br/>substitutions where applicable, liver&#160;and kidney transplantation status&#160;if&#160;<br/>applicable.&#160;Coverage&#160;conditions and&#160;specific durations of approval will&#160;be&#160;<br/>based on current AASLD&#160;treatment&#160;guidelines.&#160;</p>
<p style="position:absolute;top:639px;left:126px;white-space:nowrap" class="ft3138"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:639px;left:274px;white-space:nowrap" class="ft3130">N/A&#160;</p>
<p style="position:absolute;top:678px;left:126px;white-space:nowrap" class="ft3139"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:678px;left:274px;white-space:nowrap" class="ft3130">N/A&#160;</p>
<p style="position:absolute;top:737px;left:126px;white-space:nowrap" class="ft3139"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:737px;left:274px;white-space:nowrap" class="ft3130">Criteria will&#160;be applied consistent with current AASLD-IDSA guidance.&#160;</p>
<p style="position:absolute;top:796px;left:126px;white-space:nowrap" class="ft3138"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:796px;left:274px;white-space:nowrap" class="ft3130">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3130">313&#160;</p>
</div>
<!-- Page 314 -->
<a name="314"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page314-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2314.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3141"><b>V</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3144"><b>OTRIENT</b></p>
<p style="position:absolute;top:119px;left:240px;white-space:nowrap" class="ft31413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3142"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3145">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3146">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3140">Votrient&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3142"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3142"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3148"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3140">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3148"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft31410">Thyroid carcinoma&#160;(follicular, papillary, Hurthle&#160;cell, or medullary),&#160;<br/>uterine sarcoma.&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft3149"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft3140">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft3149"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft31410">For renal&#160;cell carcinoma: The disease&#160;is advanced, relapsed, or stage&#160;IV.&#160;<br/>For soft&#160;tissue sarcoma (STS): The patient does not have&#160;an adipocytic&#160;<br/>soft tissue&#160;sarcoma. For&#160;uterine sarcoma: The&#160;disease is recurrent or&#160;<br/>metastatic.&#160;</p>
<p style="position:absolute;top:577px;left:126px;white-space:nowrap" class="ft3148"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:577px;left:274px;white-space:nowrap" class="ft3140">N/A&#160;</p>
<p style="position:absolute;top:616px;left:126px;white-space:nowrap" class="ft3149"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:616px;left:274px;white-space:nowrap" class="ft3140">N/A&#160;</p>
<p style="position:absolute;top:675px;left:126px;white-space:nowrap" class="ft3149"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:675px;left:274px;white-space:nowrap" class="ft3140">Plan Year&#160;</p>
<p style="position:absolute;top:734px;left:126px;white-space:nowrap" class="ft3148"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:734px;left:274px;white-space:nowrap" class="ft3140">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3140">314&#160;</p>
</div>
<!-- Page 315 -->
<a name="315"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page315-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2315.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3151"><b>W</b></p>
<p style="position:absolute;top:123px;left:138px;white-space:nowrap" class="ft3154"><b>ELIREG</b></p>
<p style="position:absolute;top:119px;left:231px;white-space:nowrap" class="ft31513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3152"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3155">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3156">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3150">Welireg&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3152"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3152"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3158"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3150">All&#160;FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3158"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft3150">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft3159"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft3150">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft3159"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft3150">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft3158"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft3150">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft3159"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft3150">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft3159"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft3150">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft3158"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft3150">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3150">315&#160;</p>
</div>
<!-- Page 316 -->
<a name="316"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page316-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2316.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3161"><b>X</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3164"><b>ALKORI</b></p>
<p style="position:absolute;top:119px;left:227px;white-space:nowrap" class="ft31613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3162"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3165">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3166">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3160">Xalkori&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3162"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3162"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3168"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3160">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3168"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft31610">Recurrent non-small&#160;cell lung cancer (NSCLC), NSCLC with high-level&#160;<br/>MET amplification or MET exon 14 skipping&#160;mutation, inflammatory&#160;<br/>myofibroblastic&#160;tumors&#160;(IMT).&#160;</p>
<p style="position:absolute;top:437px;left:126px;white-space:nowrap" class="ft3169"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:437px;left:274px;white-space:nowrap" class="ft3160">N/A&#160;</p>
<p style="position:absolute;top:497px;left:126px;white-space:nowrap" class="ft3169"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:497px;left:274px;white-space:nowrap" class="ft31610">For NSCLC,&#160;the requested drug is used in any of the&#160;following&#160;settings:&#160;<br/>1) the patient has&#160;recurrent, advanced&#160;or metastatic ALK-positive&#160;<br/>NSCLC, 2) the patient has recurrent,&#160;advanced or metastatic ROS-1&#160;<br/>positive NSCLC, or 3) the patient has NSCLC with high-level&#160;MET&#160;<br/>amplification or MET exon 14 skipping mutation. For IMT,&#160;the disease&#160;is&#160;<br/>ALK-positive. For anaplastic large cell lymphoma, the disease is relapsed&#160;<br/>or refractory&#160;and ALK-positive.&#160;</p>
<p style="position:absolute;top:660px;left:126px;white-space:nowrap" class="ft3168"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:660px;left:274px;white-space:nowrap" class="ft3160">N/A&#160;</p>
<p style="position:absolute;top:698px;left:126px;white-space:nowrap" class="ft3169"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:698px;left:274px;white-space:nowrap" class="ft3160">N/A&#160;</p>
<p style="position:absolute;top:758px;left:126px;white-space:nowrap" class="ft3169"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:758px;left:274px;white-space:nowrap" class="ft3160">Plan Year&#160;</p>
<p style="position:absolute;top:817px;left:126px;white-space:nowrap" class="ft3168"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:817px;left:274px;white-space:nowrap" class="ft3160">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3160">316&#160;</p>
</div>
<!-- Page 317 -->
<a name="317"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page317-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2317.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3171"><b>X</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3174"><b>ELJANZ</b></p>
<p style="position:absolute;top:119px;left:224px;white-space:nowrap" class="ft31713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3172"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3175">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3176">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3170">Xeljanz&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft3175">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft3176">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft3170">Xeljanz Xr&#160;</p>
<p style="position:absolute;top:299px;left:126px;white-space:nowrap" class="ft3172"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:299px;left:274px;white-space:nowrap" class="ft3172"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:341px;left:126px;white-space:nowrap" class="ft3178"><b>Indications&#160;</b></p>
<p style="position:absolute;top:341px;left:274px;white-space:nowrap" class="ft3170">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:379px;left:126px;white-space:nowrap" class="ft3178"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:379px;left:274px;white-space:nowrap" class="ft3170">N/A&#160;</p>
<p style="position:absolute;top:418px;left:126px;white-space:nowrap" class="ft3179"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:418px;left:274px;white-space:nowrap" class="ft3170">N/A&#160;</p>
<p style="position:absolute;top:477px;left:126px;white-space:nowrap" class="ft3179"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:477px;left:274px;white-space:nowrap" class="ft31710">For moderately&#160;to severely active rheumatoid arthritis (new&#160;starts&#160;only):&#160;<br/>1) Inadequate response,&#160;intolerance or contraindication to methotrexate&#160;<br/>(MTX), OR 2) Inadequate response or intolerance to a prior biologic&#160;<br/>disease-modifying&#160;antirheumatic drug (DMARD) or&#160;a targeted synthetic&#160;<br/>DMARD. For&#160;active psoriatic&#160;arthritis (new starts&#160;only): The&#160;requested&#160;<br/>drug is used&#160;in combination with a&#160;nonbiologic DMARD. For&#160;moderately&#160;<br/>to severely active ulcerative colitis (new starts only):&#160;Inadequate response,&#160;<br/>intolerance&#160;or contraindication to a&#160;tumor&#160;necrosis factor&#160;(TNF) blocker.&#160;</p>
<p style="position:absolute;top:661px;left:126px;white-space:nowrap" class="ft3178"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:661px;left:274px;white-space:nowrap" class="ft3170">N/A&#160;</p>
<p style="position:absolute;top:700px;left:126px;white-space:nowrap" class="ft3179"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:700px;left:274px;white-space:nowrap" class="ft3170">N/A&#160;</p>
<p style="position:absolute;top:759px;left:126px;white-space:nowrap" class="ft3179"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:759px;left:274px;white-space:nowrap" class="ft3170">Plan Year&#160;</p>
<p style="position:absolute;top:819px;left:126px;white-space:nowrap" class="ft3178"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:819px;left:274px;white-space:nowrap" class="ft3170">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3170">317&#160;</p>
</div>
<!-- Page 318 -->
<a name="318"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page318-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2318.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3181"><b>X</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3184"><b>ERMELO</b></p>
<p style="position:absolute;top:119px;left:236px;white-space:nowrap" class="ft31813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3182"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3185">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3186">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3180">Xermelo&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3182"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3182"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3188"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3180">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3188"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft3180">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft3189"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft3180">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft3189"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft3180">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft3188"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft3180">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft3189"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft3180">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft3189"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft3180">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft3188"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft3180">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3180">318&#160;</p>
</div>
<!-- Page 319 -->
<a name="319"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page319-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2319.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3191"><b>X</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3194"><b>GEVA</b></p>
<p style="position:absolute;top:119px;left:199px;white-space:nowrap" class="ft31913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3192"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3195">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3196">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3190">Xgeva&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3192"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3192"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3198"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3190">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3198"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft3190">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft3199"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft3190">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft3199"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft31910">For hypercalcemia&#160;of malignancy: condition&#160;is refractory to&#160;intravenous&#160;<br/>(IV) bisphosphonate&#160;therapy or there is a clinical&#160;reason to&#160;avoid IV&#160;<br/>bisphosphonate&#160;therapy.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft3198"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft3190">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft3199"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft3190">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft3199"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft3190">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft3198"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft31910">Coverage&#160;under&#160;Part&#160;D will be denied&#160;if&#160;coverage&#160;is available under Part&#160;<br/>A or Part&#160;B as the&#160;medication&#160;is prescribed&#160;and dispensed or&#160;administered&#160;<br/>for&#160;the individual.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3190">319&#160;</p>
</div>
<!-- Page 320 -->
<a name="320"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page320-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2320.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3201"><b>X</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3204"><b>IFAXAN</b></p>
<p style="position:absolute;top:119px;left:223px;white-space:nowrap" class="ft32013">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3202"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3205">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3206">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3200">Xifaxan&#160;TABS&#160;550MG&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3202"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3202"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3208"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3200">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3208"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft3200">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft3209"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft3200">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft3209"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft32010">1)&#160;The requested drug&#160;is being prescribed to&#160;reduce the&#160;risk of overt&#160;<br/>hepatic encephalopathy&#160;(HE) recurrence OR 2) The patient has the&#160;<br/>diagnosis of&#160;irritable bowel syndrome with diarrhea (IBS-D) AND 3) If&#160;<br/>the patient has previously received treatment with the requested drug, the&#160;<br/>patient has&#160;experienced a&#160;recurrence&#160;of symptoms AND 4) The patient&#160;<br/>has not&#160;already received an initial 14-day course of treatment&#160;and two&#160;<br/>additional 14-day courses of&#160;treatment with&#160;the requested drug OR 5) The&#160;<br/>patient has&#160;not previously received treatment with the requested&#160;drug.&#160;</p>
<p style="position:absolute;top:639px;left:126px;white-space:nowrap" class="ft3208"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:639px;left:274px;white-space:nowrap" class="ft3200">N/A&#160;</p>
<p style="position:absolute;top:678px;left:126px;white-space:nowrap" class="ft3209"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:678px;left:274px;white-space:nowrap" class="ft3200">N/A&#160;</p>
<p style="position:absolute;top:737px;left:126px;white-space:nowrap" class="ft3209"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:737px;left:274px;white-space:nowrap" class="ft3200">Reduction in&#160;risk of&#160;overt&#160;HE&#160;recurrence:&#160;6&#160;months, IBS-D:&#160;14 days&#160;</p>
<p style="position:absolute;top:796px;left:126px;white-space:nowrap" class="ft3208"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:796px;left:274px;white-space:nowrap" class="ft3200">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3200">320&#160;</p>
</div>
<!-- Page 321 -->
<a name="321"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page321-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2321.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3211"><b>X</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3214"><b>OLAIR</b></p>
<p style="position:absolute;top:119px;left:208px;white-space:nowrap" class="ft32113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3212"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3215">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3216">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3210">Xolair&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3212"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3212"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3218"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3210">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3218"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft3210">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft3219"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft3210">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft3219"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft32110">For allergic&#160;asthma initial therapy: 1) Patient has&#160;positive skin test&#160;(or&#160;<br/>blood test)&#160;to&#160;at least&#160;1 perennial aeroallergen, 2) Patient has&#160;baseline&#160;IgE&#160;<br/>level greater than or&#160;equal to 30&#160;IU/mL, and 3)&#160;Patient has&#160;inadequate&#160;<br/>asthma control&#160;despite&#160;current treatment&#160;with both of&#160;the following&#160;<br/>medications&#160;at optimized&#160;doses: a) Inhaled corticosteroid, and b)&#160;<br/>Additional controller&#160;(long acting beta2-agonist,&#160;leukotriene&#160;modifier, or&#160;<br/>sustained-release theophylline)&#160;unless patient has&#160;an intolerance or&#160;<br/>contraindication to such&#160;therapies. For allergic asthma&#160;continuation&#160;<br/>therapy only: Patient's asthma control&#160;has improved on treatment with&#160;the&#160;<br/>requested drug since&#160;initiation of&#160;therapy. For chronic&#160;idiopathic urticaria&#160;<br/>(CIU) initial&#160;therapy: 1)&#160;Patient has&#160;been evaluated for&#160;other causes&#160;of&#160;<br/>urticaria, including bradykinin-related&#160;angioedema and IL-1-associated&#160;<br/>urticarial&#160;syndromes&#160;(auto-inflammatory disorders, urticarial&#160;vasculitis),&#160;<br/>and 2)&#160;Patient has experienced a spontaneous onset&#160;of wheals,&#160;<br/>angioedema, or both, for&#160;at least&#160;6 weeks. For&#160;CIU continuation therapy:&#160;<br/>Patient has&#160;experienced a&#160;response&#160;(e.g., improved&#160;symptoms)&#160;since&#160;<br/>initiation of&#160;therapy.&#160;</p>
<p style="position:absolute;top:825px;left:126px;white-space:nowrap" class="ft3218"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:825px;left:274px;white-space:nowrap" class="ft32110">For CIU: 12 years&#160;of age&#160;or older. For allergic asthma:&#160;6 years of age or&#160;<br/>older. For nasal&#160;polyps:&#160;18 years&#160;of age or older.&#160;</p>
<p style="position:absolute;top:885px;left:126px;white-space:nowrap" class="ft3219"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:885px;left:274px;white-space:nowrap" class="ft3210">N/A&#160;</p>
<p style="position:absolute;top:944px;left:126px;white-space:nowrap" class="ft3219"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:944px;left:274px;white-space:nowrap" class="ft32110">Allergic asthma&#160;and nasal polyps: Plan Year. CIU initial: 6&#160;months. CIU&#160;<br/>continuation: Plan Year&#160;</p>
<p style="position:absolute;top:1003px;left:126px;white-space:nowrap" class="ft3218"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:1003px;left:274px;white-space:nowrap" class="ft3210">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3210">321&#160;</p>
</div>
<!-- Page 322 -->
<a name="322"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page322-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2322.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3221"><b>X</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3224"><b>OSPATA</b></p>
<p style="position:absolute;top:119px;left:227px;white-space:nowrap" class="ft32213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3222"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3225">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3226">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3220">Xospata&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3222"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3222"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3228"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3220">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3228"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft32210">Myeloid,&#160;lymphoid, or&#160;mixed&#160;lineage neoplasms with eosinophilia and&#160;<br/>FLT3 rearrangement&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft3229"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft3220">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft3229"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft32210">For myeloid, lymphoid,&#160;or mixed lineage neoplasms&#160;with eosinophilia and&#160;<br/>FLT3 rearrangement: the disease is&#160;in&#160;chronic or&#160;blast phase.&#160;</p>
<p style="position:absolute;top:556px;left:126px;white-space:nowrap" class="ft3228"><b>Age&#160;Restrictions&#160;</b></p>
<p style="position:absolute;top:556px;left:274px;white-space:nowrap" class="ft3220">18 years&#160;of age or older&#160;</p>
<p style="position:absolute;top:595px;left:126px;white-space:nowrap" class="ft3229"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:595px;left:274px;white-space:nowrap" class="ft3220">N/A&#160;</p>
<p style="position:absolute;top:654px;left:126px;white-space:nowrap" class="ft3229"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:654px;left:274px;white-space:nowrap" class="ft3220">Plan Year&#160;</p>
<p style="position:absolute;top:714px;left:126px;white-space:nowrap" class="ft3228"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:714px;left:274px;white-space:nowrap" class="ft3220">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3220">322&#160;</p>
</div>
<!-- Page 323 -->
<a name="323"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page323-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2323.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3231"><b>X</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3234"><b>POVIO</b></p>
<p style="position:absolute;top:119px;left:208px;white-space:nowrap" class="ft32313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3232"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3235">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3236">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3230">Xpovio&#160;</p>
<p style="position:absolute;top:220px;left:122px;white-space:nowrap" class="ft3235">•</p>
<p style="position:absolute;top:219px;left:130px;white-space:nowrap" class="ft3236">&#160;</p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft3230">Xpovio 100 Mg Once&#160;Weekly&#160;</p>
<p style="position:absolute;top:242px;left:122px;white-space:nowrap" class="ft3235">•</p>
<p style="position:absolute;top:241px;left:130px;white-space:nowrap" class="ft3236">&#160;</p>
<p style="position:absolute;top:244px;left:149px;white-space:nowrap" class="ft3230">Xpovio 40 Mg Once Weekly&#160;</p>
<p style="position:absolute;top:264px;left:122px;white-space:nowrap" class="ft3235">•</p>
<p style="position:absolute;top:263px;left:130px;white-space:nowrap" class="ft3236">&#160;</p>
<p style="position:absolute;top:266px;left:149px;white-space:nowrap" class="ft3230">Xpovio 40 Mg Twice Weekly&#160;</p>
<p style="position:absolute;top:286px;left:122px;white-space:nowrap" class="ft3235">•</p>
<p style="position:absolute;top:285px;left:130px;white-space:nowrap" class="ft3236">&#160;</p>
<p style="position:absolute;top:288px;left:149px;white-space:nowrap" class="ft3230">Xpovio 60 Mg Once Weekly&#160;</p>
<p style="position:absolute;top:308px;left:122px;white-space:nowrap" class="ft3235">•</p>
<p style="position:absolute;top:307px;left:130px;white-space:nowrap" class="ft3236">&#160;</p>
<p style="position:absolute;top:310px;left:149px;white-space:nowrap" class="ft3230">Xpovio 60 Mg Twice Weekly&#160;</p>
<p style="position:absolute;top:330px;left:122px;white-space:nowrap" class="ft3235">•</p>
<p style="position:absolute;top:329px;left:130px;white-space:nowrap" class="ft3236">&#160;</p>
<p style="position:absolute;top:332px;left:149px;white-space:nowrap" class="ft3230">Xpovio 80 Mg Once Weekly&#160;</p>
<p style="position:absolute;top:352px;left:122px;white-space:nowrap" class="ft3235">•</p>
<p style="position:absolute;top:351px;left:130px;white-space:nowrap" class="ft3236">&#160;</p>
<p style="position:absolute;top:354px;left:149px;white-space:nowrap" class="ft3230">Xpovio 80 Mg Twice Weekly&#160;</p>
<p style="position:absolute;top:431px;left:126px;white-space:nowrap" class="ft3232"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:431px;left:274px;white-space:nowrap" class="ft3232"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:473px;left:126px;white-space:nowrap" class="ft3238"><b>Indications&#160;</b></p>
<p style="position:absolute;top:473px;left:274px;white-space:nowrap" class="ft3230">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:511px;left:126px;white-space:nowrap" class="ft3238"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:511px;left:274px;white-space:nowrap" class="ft3230">N/A&#160;</p>
<p style="position:absolute;top:550px;left:126px;white-space:nowrap" class="ft3239"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:550px;left:274px;white-space:nowrap" class="ft3230">N/A&#160;</p>
<p style="position:absolute;top:609px;left:126px;white-space:nowrap" class="ft3239"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:609px;left:274px;white-space:nowrap" class="ft3230">N/A&#160;</p>
<p style="position:absolute;top:689px;left:126px;white-space:nowrap" class="ft3238"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:689px;left:274px;white-space:nowrap" class="ft3230">N/A&#160;</p>
<p style="position:absolute;top:728px;left:126px;white-space:nowrap" class="ft3239"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:728px;left:274px;white-space:nowrap" class="ft3230">N/A&#160;</p>
<p style="position:absolute;top:788px;left:126px;white-space:nowrap" class="ft3239"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:788px;left:274px;white-space:nowrap" class="ft3230">Plan Year&#160;</p>
<p style="position:absolute;top:847px;left:126px;white-space:nowrap" class="ft3238"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:847px;left:274px;white-space:nowrap" class="ft3230">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3230">323&#160;</p>
</div>
<!-- Page 324 -->
<a name="324"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page324-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2324.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3241"><b>X</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3244"><b>TANDI</b></p>
<p style="position:absolute;top:119px;left:207px;white-space:nowrap" class="ft32413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3242"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3245">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3246">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3240">Xtandi&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3242"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3242"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3248"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3240">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3248"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft3240">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft3249"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft3240">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft3249"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft32410">The requested&#160;drug will&#160;be used in combination with a gonadotropin-<br/>releasing hormone (GnRH) analog or&#160;after bilateral orchiectomy.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft3248"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft3240">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft3249"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft3240">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft3249"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft3240">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft3248"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft3240">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3240">324&#160;</p>
</div>
<!-- Page 325 -->
<a name="325"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page325-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2325.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3251"><b>X</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3254"><b>YREM</b></p>
<p style="position:absolute;top:119px;left:203px;white-space:nowrap" class="ft32513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3252"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3255">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3256">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3250">Xyrem&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3252"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3252"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3258"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3250">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3258"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft3250">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft3259"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft3250">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft3259"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft32510">1)&#160;The&#160;requested drug&#160;is being prescribed for the&#160;treatment of&#160;excessive&#160;<br/>daytime sleepiness in a patient 7 years of&#160;age or&#160;older&#160;with narcolepsy&#160;<br/>AND 2) The&#160;diagnosis has been confirmed by sleep lab evaluation AND&#160;<br/>3)The patient experienced an inadequate&#160;treatment&#160;response or intolerance&#160;<br/>to at&#160;least one central&#160;nervous system&#160;(CNS) stimulant&#160;drug (e.g.,&#160;<br/>amphetamine, dextroamphetamine,&#160;or methylphenidate) OR&#160;has a&#160;<br/>contraindication that would prohibit&#160;a trial of central nervous&#160;system&#160;<br/>(CNS) stimulant&#160;drugs&#160;(e.g., amphetamine, dextroamphetamine, or&#160;<br/>methylphenidate)&#160;[Note:&#160;Coverage&#160;of amphetamines may require prior&#160;<br/>authorization.] AND&#160;4) If the patient is 18 years&#160;of age or&#160;older,&#160;the&#160;<br/>patient experienced an inadequate&#160;treatment response or&#160;intolerance&#160;to at&#160;<br/>least one central nervous system (CNS) wakefulness&#160;promoting drug (e.g.,&#160;<br/>armodafinil) OR has a contraindication that&#160;would&#160;prohibit a trial&#160;of&#160;<br/>central nervous system (CNS) wakefulness promoting drugs&#160;(e.g.,&#160;<br/>armodafinil) [Note:&#160;coverage of&#160;armodafinil&#160;may&#160;require prior&#160;<br/>authorization.] OR 5) The requested drug is being prescribed&#160;for&#160;the&#160;<br/>treatment of&#160;cataplexy in&#160;a patient 7 years of&#160;age or older&#160;with&#160;narcolepsy&#160;<br/>AND 6) The&#160;diagnosis has been confirmed by sleep lab evaluation.&#160;</p>
<p style="position:absolute;top:846px;left:126px;white-space:nowrap" class="ft3258"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:846px;left:274px;white-space:nowrap" class="ft3250">7 years&#160;of age or&#160;older&#160;</p>
<p style="position:absolute;top:885px;left:126px;white-space:nowrap" class="ft3259"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:885px;left:274px;white-space:nowrap" class="ft32510">Prescribed by&#160;or in consultation with a sleep disorder&#160;specialist or&#160;<br/>neurologist.&#160;</p>
<p style="position:absolute;top:944px;left:126px;white-space:nowrap" class="ft3259"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:944px;left:274px;white-space:nowrap" class="ft3250">Plan Year&#160;</p>
<p style="position:absolute;top:1003px;left:126px;white-space:nowrap" class="ft3258"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:1003px;left:274px;white-space:nowrap" class="ft32510">If&#160;the&#160;request is for a&#160;continuation of&#160;therapy,&#160;then the patient experienced&#160;<br/>a decrease in daytime&#160;sleepiness with&#160;narcolepsy&#160;or a&#160;decrease in&#160;<br/>cataplexy episodes with narcolepsy.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3250">325&#160;</p>
</div>
<!-- Page 326 -->
<a name="326"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page326-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2326.png" alt="background image"/>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3260">326</p>
<p style="position:absolute;top:1093px;left:810px;white-space:nowrap" class="ft3266">&#160;</p>
</div>
<!-- Page 327 -->
<a name="327"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page327-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2327.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3271"><b>Y</b></p>
<p style="position:absolute;top:123px;left:130px;white-space:nowrap" class="ft3274"><b>ERVOY</b></p>
<p style="position:absolute;top:119px;left:216px;white-space:nowrap" class="ft32713">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3272"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3275">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3276">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3270">Yervoy&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3272"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3272"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3278"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3270">All Medically-accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3278"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft3270">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft3279"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft3270">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft3279"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft3270">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft3278"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft3270">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft3279"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft3270">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft3279"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft3270">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft3278"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft3270">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3270">327&#160;</p>
</div>
<!-- Page 328 -->
<a name="328"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page328-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2328.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3281"><b>Z</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft3284"><b>ARXIO</b></p>
<p style="position:absolute;top:119px;left:208px;white-space:nowrap" class="ft32813">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3282"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3285">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3286">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3280">Zarxio&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3282"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3282"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3288"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3280">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3288"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft32810">Neutropenia&#160;in&#160;myelodysplastic syndromes&#160;(MDS), agranulocytosis,&#160;<br/>neutropenia in aplastic anemia, human immunodeficiency virus (HIV)-<br/>related neutropenia, neutropenia related to renal transplant.&#160;</p>
<p style="position:absolute;top:437px;left:126px;white-space:nowrap" class="ft3289"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:437px;left:274px;white-space:nowrap" class="ft32810">Use of&#160;the requested product within&#160;24 hours&#160;prior to or&#160;following&#160;<br/>chemotherapy.&#160;</p>
<p style="position:absolute;top:497px;left:126px;white-space:nowrap" class="ft3289"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:497px;left:274px;white-space:nowrap" class="ft32810">For prophylaxis&#160;or treatment of myelosuppressive chemotherapy-induced&#160;<br/>febrile neutropenia (FN)&#160;patient must&#160;meet both of the following: 1)&#160;<br/>Patient has&#160;a&#160;solid tumor&#160;or non-myeloid cancer, and 2) Patient has&#160;<br/>received, is&#160;currently&#160;receiving, or will&#160;be&#160;receiving treatment&#160;with&#160;<br/>myelosuppressive anti-cancer&#160;therapy.&#160;</p>
<p style="position:absolute;top:618px;left:126px;white-space:nowrap" class="ft3288"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:618px;left:274px;white-space:nowrap" class="ft3280">N/A&#160;</p>
<p style="position:absolute;top:657px;left:126px;white-space:nowrap" class="ft3289"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:657px;left:274px;white-space:nowrap" class="ft3280">N/A&#160;</p>
<p style="position:absolute;top:716px;left:126px;white-space:nowrap" class="ft3289"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:716px;left:274px;white-space:nowrap" class="ft3280">6 months&#160;</p>
<p style="position:absolute;top:776px;left:126px;white-space:nowrap" class="ft3288"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:776px;left:274px;white-space:nowrap" class="ft3280">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3280">328&#160;</p>
</div>
<!-- Page 329 -->
<a name="329"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page329-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2329.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3291"><b>Z</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft3294"><b>EJULA</b></p>
<p style="position:absolute;top:119px;left:207px;white-space:nowrap" class="ft32913">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3292"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3295">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3296">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3290">Zejula&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3290">329&#160;</p>
</div>
<!-- Page 330 -->
<a name="330"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page330-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2330.png" alt="background image"/>
<p style="position:absolute;top:132px;left:126px;white-space:nowrap" class="ft3302"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:132px;left:274px;white-space:nowrap" class="ft3302"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:174px;left:126px;white-space:nowrap" class="ft3308"><b>Indications&#160;</b></p>
<p style="position:absolute;top:174px;left:274px;white-space:nowrap" class="ft3300">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:213px;left:126px;white-space:nowrap" class="ft3308"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:213px;left:274px;white-space:nowrap" class="ft33010">In combination&#160;with bevacizumab for persistent&#160;or recurrent&#160;epithelial&#160;<br/>ovarian, fallopian tube,&#160;or primary peritoneal&#160;cancer&#160;for platinum-<br/>sensitive disease.&#160;</p>
<p style="position:absolute;top:293px;left:126px;white-space:nowrap" class="ft3309"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:293px;left:274px;white-space:nowrap" class="ft3300">N/A&#160;</p>
<p style="position:absolute;top:352px;left:126px;white-space:nowrap" class="ft3309"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:352px;left:274px;white-space:nowrap" class="ft33010">For ovarian,&#160;fallopian&#160;tube, or&#160;primary&#160;peritoneal&#160;cancer, the&#160;requested&#160;<br/>drug is used&#160;in any of&#160;the following settings: 1) as&#160;maintenance treatment&#160;<br/>of stage&#160;II-IV&#160;epithelial ovarian,&#160;fallopian tube,&#160;or primary peritoneal&#160;<br/>cancer&#160;in patients who are in a&#160;complete&#160;or partial response&#160;to&#160;first-line&#160;<br/>platinum-based chemotherapy AND if it is known that&#160;the patient has&#160;<br/>breast&#160;cancer susceptibility gene&#160;(BRCA)-mutated disease,&#160;the patient&#160;<br/>experienced&#160;an unacceptable toxicity&#160;with a&#160;trial&#160;of Lynparza&#160;(olaparib),&#160;<br/>2) as maintenance treatment of recurrent epithelial&#160;ovarian,&#160;fallopian tube,&#160;<br/>or primary peritoneal&#160;cancer&#160;in patients who are&#160;in a complete or&#160;partial&#160;<br/>response&#160;to&#160;chemotherapy AND&#160;the&#160;patient experienced an unacceptable&#160;<br/>toxicity with a trial&#160;of Lynparza&#160;(olaparib), 3) as&#160;treatment of&#160;advanced,&#160;<br/>persistent, or recurrent ovarian, fallopian tube, or primary peritoneal&#160;<br/>cancer&#160;in patients treated&#160;with three or&#160;more prior&#160;chemotherapy regimens&#160;<br/>and whose cancer&#160;is associated with&#160;homologous&#160;recombination&#160;<br/>deficiency&#160;(HRD) positive status defined by either&#160;a)&#160;a deleterious or&#160;<br/>suspected deleterious BRCA&#160;mutation AND if prescribed for&#160;advanced,&#160;<br/>persistent, or recurrent ovarian cancer with deleterious or&#160;suspected&#160;<br/>deleterious&#160;germline BRCA mutation, the patient experienced an&#160;<br/>unacceptable toxicity with a trial of&#160;Lynparza (olaparib), or&#160;b) genomic&#160;<br/>instability and progression more&#160;than six months after response to the last&#160;<br/>platinum-based chemotherapy, or 4)&#160;in combination with bevacizumab for&#160;<br/>platinum-sensitive persistent or recurrent epithelial&#160;ovarian,&#160;fallopian&#160;<br/>tube, or&#160;primary peritoneal&#160;cancer.&#160;</p>
<p style="position:absolute;top:846px;left:126px;white-space:nowrap" class="ft3308"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:846px;left:274px;white-space:nowrap" class="ft3300">N/A&#160;</p>
<p style="position:absolute;top:885px;left:126px;white-space:nowrap" class="ft3309"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:885px;left:274px;white-space:nowrap" class="ft3300">N/A&#160;</p>
<p style="position:absolute;top:945px;left:126px;white-space:nowrap" class="ft3309"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:945px;left:274px;white-space:nowrap" class="ft3300">Plan Year&#160;</p>
<p style="position:absolute;top:1004px;left:126px;white-space:nowrap" class="ft3308"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:1004px;left:274px;white-space:nowrap" class="ft3300">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3300">330&#160;</p>
</div>
<!-- Page 331 -->
<a name="331"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page331-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2331.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3311"><b>Z</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft3314"><b>ELBORAF</b></p>
<p style="position:absolute;top:119px;left:244px;white-space:nowrap" class="ft33113">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3312"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3315">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3316">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3310">Zelboraf&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3312"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3312"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3318"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3310">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3318"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft33110">Non-small cell&#160;lung cancer,&#160;hairy cell leukemia, thyroid carcinoma (i.e.,&#160;<br/>papillary carcinoma,&#160;follicular&#160;carcinoma, and Hurthle cell carcinoma),&#160;<br/>central nervous system cancer&#160;(i.e., glioma, meningioma, astrocytoma),&#160;<br/>adjuvant&#160;systemic therapy for cutaneous melanoma.&#160;</p>
<p style="position:absolute;top:458px;left:126px;white-space:nowrap" class="ft3319"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:458px;left:274px;white-space:nowrap" class="ft3310">N/A&#160;</p>
<p style="position:absolute;top:518px;left:126px;white-space:nowrap" class="ft3319"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:518px;left:274px;white-space:nowrap" class="ft33110">For adjuvant&#160;treatment of melanoma, and central&#160;nervous system (CNS)&#160;<br/>cancer&#160;(i.e.,&#160;glioma, meningioma, astrocytoma):&#160;1) The tumor is positive&#160;<br/>for&#160;BRAF&#160;V600 activating mutation&#160;(e.g., V600E&#160;or V600K) and 2)&#160;The&#160;<br/>requested drug will&#160;be used in combination with&#160;cobimetinib.&#160;For&#160;<br/>unresectable&#160;or metastatic melanoma: 1)&#160;The tumor is positive for BRAF&#160;<br/>V600 activating mutation (e.g., V600E&#160;or V600K) and 2)&#160;the requested&#160;<br/>drug will be&#160;used as a single agent, or in combination with cobimetinib&#160;<br/>(with or without atezolizumab). For&#160;Erdheim-Chester Disease: Tumor is&#160;<br/>positive for&#160;BRAF&#160;V600 mutation. For non-small&#160;cell&#160;lung cancer: 1)&#160;<br/>Tumor&#160;is positive for the&#160;BRAF&#160;V600E mutation, and 2)&#160;The&#160;patient has&#160;<br/>recurrent,&#160;advanced, or&#160;metastatic&#160;disease. For thyroid carcinoma:&#160;1)&#160;<br/>Tumor&#160;is positive for BRAF mutation, and 2) Patient has&#160;radioiodine&#160;<br/>refractory follicular, Hurthle cell, or&#160;papillary thyroid carcinoma. For&#160;<br/>hairy cell&#160;leukemia: The&#160;requested drug will be used for subsequent&#160;<br/>therapy.&#160;</p>
<p style="position:absolute;top:846px;left:126px;white-space:nowrap" class="ft3318"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:846px;left:274px;white-space:nowrap" class="ft3310">N/A&#160;</p>
<p style="position:absolute;top:885px;left:126px;white-space:nowrap" class="ft3319"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:885px;left:274px;white-space:nowrap" class="ft3310">N/A&#160;</p>
<p style="position:absolute;top:944px;left:126px;white-space:nowrap" class="ft3319"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:944px;left:274px;white-space:nowrap" class="ft3310">Plan Year&#160;</p>
<p style="position:absolute;top:1003px;left:126px;white-space:nowrap" class="ft3318"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:1003px;left:274px;white-space:nowrap" class="ft3310">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3310">331&#160;</p>
</div>
<!-- Page 332 -->
<a name="332"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page332-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2332.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3321"><b>Z</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft3324"><b>EPZELCA</b></p>
<p style="position:absolute;top:119px;left:241px;white-space:nowrap" class="ft33213">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3322"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3325">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3326">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3320">Zepzelca&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3322"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3322"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3328"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3320">All&#160;FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3328"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft33210">Relapsed small&#160;cell&#160;lung&#160;cancer, primary&#160;progressive small&#160;cell lung&#160;<br/>cancer.&#160;</p>
<p style="position:absolute;top:417px;left:126px;white-space:nowrap" class="ft3329"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:417px;left:274px;white-space:nowrap" class="ft3320">N/A&#160;</p>
<p style="position:absolute;top:476px;left:126px;white-space:nowrap" class="ft3329"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:476px;left:274px;white-space:nowrap" class="ft33210">For small&#160;cell&#160;lung&#160;cancer: the requested medication will be used as a&#160;<br/>single&#160;agent&#160;in one&#160;of the&#160;following settings:&#160;1) the disease has relapsed&#160;<br/>following&#160;complete or&#160;partial response or&#160;stable disease with initial&#160;<br/>treatment, 2) the patient&#160;has primary&#160;progressive&#160;disease, or 3) the patient&#160;<br/>has metastatic disease&#160;following disease progression on or&#160;after&#160;platinum-<br/>based chemotherapy.&#160;</p>
<p style="position:absolute;top:618px;left:126px;white-space:nowrap" class="ft3328"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:618px;left:274px;white-space:nowrap" class="ft3320">N/A&#160;</p>
<p style="position:absolute;top:657px;left:126px;white-space:nowrap" class="ft3329"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:657px;left:274px;white-space:nowrap" class="ft3320">N/A&#160;</p>
<p style="position:absolute;top:716px;left:126px;white-space:nowrap" class="ft3329"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:716px;left:274px;white-space:nowrap" class="ft3320">Plan Year&#160;</p>
<p style="position:absolute;top:776px;left:126px;white-space:nowrap" class="ft3328"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:776px;left:274px;white-space:nowrap" class="ft3320">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3320">332&#160;</p>
</div>
<!-- Page 333 -->
<a name="333"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page333-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2333.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3331"><b>Z</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft3334"><b>OLINZA</b></p>
<p style="position:absolute;top:119px;left:223px;white-space:nowrap" class="ft33313">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3332"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3335">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3336">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3330">Zolinza&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3332"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3332"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3338"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3330">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3338"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft3330">Mycosis&#160;fungoides, Sezary syndrome.&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft3339"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft3330">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft3339"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft3330">N/A&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft3338"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft3330">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft3339"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft3330">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft3339"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft3330">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft3338"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft3330">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3330">333&#160;</p>
</div>
<!-- Page 334 -->
<a name="334"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page334-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2334.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3341"><b>Z</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft3344"><b>YDELIG</b></p>
<p style="position:absolute;top:119px;left:223px;white-space:nowrap" class="ft33413">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3342"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3345">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3346">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3340">Zydelig&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3342"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3342"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3348"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3340">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3348"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft33410">Relapsed or&#160;refractory chronic&#160;lymphocytic&#160;leukemia&#160;(CLL)/small&#160;<br/>lymphocytic&#160;lymphoma (SLL), relapsed or refractory follicular&#160;<br/>lymphoma,&#160;and marginal zone&#160;lymphomas&#160;[nodal marginal&#160;zone&#160;<br/>lymphoma,&#160;gastric mucosa associated lymphoid&#160;tissue (MALT)&#160;<br/>lymphoma,&#160;non-gastric&#160;MALT lymphoma, and&#160;splenic marginal&#160;zone&#160;<br/>lymphoma].&#160;</p>
<p style="position:absolute;top:500px;left:126px;white-space:nowrap" class="ft3349"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:500px;left:274px;white-space:nowrap" class="ft3340">N/A&#160;</p>
<p style="position:absolute;top:559px;left:126px;white-space:nowrap" class="ft3349"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:559px;left:274px;white-space:nowrap" class="ft3340">N/A&#160;</p>
<p style="position:absolute;top:639px;left:126px;white-space:nowrap" class="ft3348"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:639px;left:274px;white-space:nowrap" class="ft3340">N/A&#160;</p>
<p style="position:absolute;top:678px;left:126px;white-space:nowrap" class="ft3349"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:678px;left:274px;white-space:nowrap" class="ft3340">N/A&#160;</p>
<p style="position:absolute;top:737px;left:126px;white-space:nowrap" class="ft3349"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:737px;left:274px;white-space:nowrap" class="ft3340">Plan Year&#160;</p>
<p style="position:absolute;top:796px;left:126px;white-space:nowrap" class="ft3348"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:796px;left:274px;white-space:nowrap" class="ft3340">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3340">334&#160;</p>
</div>
<!-- Page 335 -->
<a name="335"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page335-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2335.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3351"><b>Z</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft3354"><b>YKADIA</b></p>
<p style="position:absolute;top:119px;left:225px;white-space:nowrap" class="ft33513">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3352"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3355">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3356">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3350">Zykadia&#160;TABS&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3352"><b>PA Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3352"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3358"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3350">All FDA-approved Indications, Some Medically&#160;accepted Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3358"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft33510">Recurrent or&#160;advanced ALK-positive&#160;non-small cell&#160;lung cancer&#160;<br/>(NSCLC), recurrent, advanced, or&#160;metastatic&#160;ROS1-positive NSCLC,&#160;<br/>inflammatory myofibroblastic tumor&#160;(IMT), brain&#160;metastases from&#160;<br/>NSCLC.&#160;</p>
<p style="position:absolute;top:458px;left:126px;white-space:nowrap" class="ft3359"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:458px;left:274px;white-space:nowrap" class="ft3350">N/A&#160;</p>
<p style="position:absolute;top:518px;left:126px;white-space:nowrap" class="ft3359"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:518px;left:274px;white-space:nowrap" class="ft33510">For NSCLC:&#160;the patient&#160;has recurrent, advanced,&#160;or metastatic ALK-<br/>positive or&#160;ROS1-positive disease.&#160;For inflammatory&#160;myofibroblastic&#160;<br/>tumor: the disease is ALK-positive.&#160;For brain metastases&#160;from NSCLC:&#160;<br/>the patient has ALK-positive NSCLC.&#160;</p>
<p style="position:absolute;top:618px;left:126px;white-space:nowrap" class="ft3358"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:618px;left:274px;white-space:nowrap" class="ft3350">N/A&#160;</p>
<p style="position:absolute;top:657px;left:126px;white-space:nowrap" class="ft3359"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:657px;left:274px;white-space:nowrap" class="ft3350">N/A&#160;</p>
<p style="position:absolute;top:716px;left:126px;white-space:nowrap" class="ft3359"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:716px;left:274px;white-space:nowrap" class="ft3350">Plan Year&#160;</p>
<p style="position:absolute;top:776px;left:126px;white-space:nowrap" class="ft3358"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:776px;left:274px;white-space:nowrap" class="ft3350">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3350">335&#160;</p>
</div>
<!-- Page 336 -->
<a name="336"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page336-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2336.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3361"><b>Z</b></p>
<p style="position:absolute;top:123px;left:128px;white-space:nowrap" class="ft3364"><b>YPREXA&#160;</b></p>
<p style="position:absolute;top:118px;left:234px;white-space:nowrap" class="ft3361"><b>R</b></p>
<p style="position:absolute;top:123px;left:256px;white-space:nowrap" class="ft3364"><b>ELPREVV</b></p>
<p style="position:absolute;top:119px;left:370px;white-space:nowrap" class="ft33613">&#160;</p>
<p style="position:absolute;top:174px;left:116px;white-space:nowrap" class="ft3362"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3365">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3366">&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft3360">Zyprexa&#160;Relprevv&#160;</p>
<p style="position:absolute;top:277px;left:126px;white-space:nowrap" class="ft3362"><b>PA&#160;Criteria&#160;</b></p>
<p style="position:absolute;top:277px;left:274px;white-space:nowrap" class="ft3362"><b>Criteria&#160;Details&#160;</b></p>
<p style="position:absolute;top:319px;left:126px;white-space:nowrap" class="ft3368"><b>Indications&#160;</b></p>
<p style="position:absolute;top:319px;left:274px;white-space:nowrap" class="ft3360">All FDA-approved Indications.&#160;</p>
<p style="position:absolute;top:357px;left:126px;white-space:nowrap" class="ft3368"><b>Off-Label Uses&#160;</b></p>
<p style="position:absolute;top:357px;left:274px;white-space:nowrap" class="ft3360">N/A&#160;</p>
<p style="position:absolute;top:396px;left:126px;white-space:nowrap" class="ft3369"><b>Exclusion&#160;<br/>Criteria&#160;</b></p>
<p style="position:absolute;top:396px;left:274px;white-space:nowrap" class="ft3360">N/A&#160;</p>
<p style="position:absolute;top:455px;left:126px;white-space:nowrap" class="ft3369"><b>Required&#160;<br/>Medical&#160;<br/>Information&#160;</b></p>
<p style="position:absolute;top:455px;left:274px;white-space:nowrap" class="ft3360">Tolerability&#160;with&#160;oral olanzapine&#160;has&#160;been established.&#160;</p>
<p style="position:absolute;top:536px;left:126px;white-space:nowrap" class="ft3368"><b>Age Restrictions&#160;</b></p>
<p style="position:absolute;top:536px;left:274px;white-space:nowrap" class="ft3360">N/A&#160;</p>
<p style="position:absolute;top:574px;left:126px;white-space:nowrap" class="ft3369"><b>Prescriber&#160;<br/>Restrictions&#160;</b></p>
<p style="position:absolute;top:574px;left:274px;white-space:nowrap" class="ft3360">N/A&#160;</p>
<p style="position:absolute;top:634px;left:126px;white-space:nowrap" class="ft3369"><b>Coverage&#160;<br/>Duration&#160;</b></p>
<p style="position:absolute;top:634px;left:274px;white-space:nowrap" class="ft3360">Plan Year&#160;</p>
<p style="position:absolute;top:693px;left:126px;white-space:nowrap" class="ft3368"><b>Other Criteria&#160;</b></p>
<p style="position:absolute;top:693px;left:274px;white-space:nowrap" class="ft3360">N/A&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3360">336&#160;</p>
</div>
<!-- Page 337 -->
<a name="337"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page337-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2337.png" alt="background image"/>
<p style="position:absolute;top:118px;left:108px;white-space:nowrap" class="ft3371"><b>P</b></p>
<p style="position:absolute;top:123px;left:126px;white-space:nowrap" class="ft3374"><b>ART&#160;</b></p>
<p style="position:absolute;top:118px;left:183px;white-space:nowrap" class="ft3371"><b>B&#160;V</b></p>
<p style="position:absolute;top:123px;left:231px;white-space:nowrap" class="ft3374"><b>ERSUS&#160;</b></p>
<p style="position:absolute;top:118px;left:314px;white-space:nowrap" class="ft3371"><b>P</b></p>
<p style="position:absolute;top:123px;left:332px;white-space:nowrap" class="ft3374"><b>ART&#160;</b></p>
<p style="position:absolute;top:118px;left:389px;white-space:nowrap" class="ft3371"><b>D</b></p>
<p style="position:absolute;top:113px;left:411px;white-space:nowrap" class="ft33714">&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3370">337&#160;</p>
</div>
<!-- Page 338 -->
<a name="338"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page338-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2338.png" alt="background image"/>
<p style="position:absolute;top:109px;left:116px;white-space:nowrap" class="ft3382"><b>Products&#160;Affected&#160;</b></p>
<p style="position:absolute;top:132px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:131px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:134px;left:149px;white-space:nowrap" class="ft3380">Abelcet&#160;</p>
<p style="position:absolute;top:154px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:153px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:156px;left:149px;white-space:nowrap" class="ft3380">Acetylcysteine&#160;INHALATION&#160;SOLN&#160;</p>
<p style="position:absolute;top:176px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:175px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:178px;left:149px;white-space:nowrap" class="ft3380">Acyclovir Sodium&#160;INJ 50MG/ML&#160;</p>
<p style="position:absolute;top:198px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:197px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:200px;left:149px;white-space:nowrap" class="ft33810">Albuterol Sulfate&#160;NEBU&#160;0.083%,&#160;<br/>0.63MG/3ML, 1.25MG/3ML,&#160;<br/>2.5MG/0.5ML&#160;</p>
<p style="position:absolute;top:262px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:261px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:264px;left:149px;white-space:nowrap" class="ft3380">Ambisome&#160;</p>
<p style="position:absolute;top:284px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:283px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:286px;left:149px;white-space:nowrap" class="ft33810">Aminosyn-pf 7%&#160;INJ 32.5MEQ/L;&#160;<br/>490MG/100ML;&#160;861MG/100ML;&#160;<br/>370MG/100ML;&#160;576MG/100ML;&#160;<br/>270MG/100ML;&#160;220MG/100ML;&#160;<br/>534MG/100ML;&#160;831MG/100ML;&#160;<br/>475MG/100ML;&#160;125MG/100ML;&#160;<br/>10.69GM/L; 300MG/100ML;&#160;<br/>570MG/100ML;&#160;70GM/L;&#160;<br/>347MG/100ML;&#160;50MG/100ML;&#160;<br/>360MG/100ML;&#160;125MG/100ML;&#160;<br/>44MG/100ML;&#160;452MG/100ML&#160;</p>
<p style="position:absolute;top:512px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:512px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:515px;left:149px;white-space:nowrap" class="ft3380">Amphotericin B&#160;INJ&#160;</p>
<p style="position:absolute;top:534px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:534px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:537px;left:149px;white-space:nowrap" class="ft3380">Aprepitant&#160;CAPS&#160;</p>
<p style="position:absolute;top:557px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:556px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:559px;left:149px;white-space:nowrap" class="ft3380">Azathioprine&#160;INJ&#160;</p>
<p style="position:absolute;top:578px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:578px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:581px;left:149px;white-space:nowrap" class="ft3380">Azathioprine&#160;TABS&#160;50MG&#160;</p>
<p style="position:absolute;top:600px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:600px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:602px;left:149px;white-space:nowrap" class="ft3380">Bleomycin Sulfate&#160;INJ&#160;</p>
<p style="position:absolute;top:623px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:622px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:625px;left:149px;white-space:nowrap" class="ft3380">Budesonide&#160;SUSP&#160;</p>
<p style="position:absolute;top:644px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:644px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:647px;left:149px;white-space:nowrap" class="ft3380">Cladribine&#160;</p>
<p style="position:absolute;top:666px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:666px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:668px;left:149px;white-space:nowrap" class="ft3380">Clinimix 4.25%/dextrose 10%&#160;</p>
<p style="position:absolute;top:688px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:688px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:691px;left:149px;white-space:nowrap" class="ft3380">Clinimix 4.25%/dextrose 5%&#160;</p>
<p style="position:absolute;top:710px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:710px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:712px;left:149px;white-space:nowrap" class="ft3380">Clinimix 5%/dextrose&#160;15%&#160;</p>
<p style="position:absolute;top:732px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:732px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:734px;left:149px;white-space:nowrap" class="ft3380">Clinimix 5%/dextrose&#160;20%&#160;</p>
<p style="position:absolute;top:754px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:754px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:756px;left:149px;white-space:nowrap" class="ft3380">Clinimix 6/5&#160;</p>
<p style="position:absolute;top:776px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:776px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:778px;left:149px;white-space:nowrap" class="ft3380">Clinimix 8/10&#160;</p>
<p style="position:absolute;top:798px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:798px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:800px;left:149px;white-space:nowrap" class="ft3380">Clinimix 8/14&#160;</p>
<p style="position:absolute;top:820px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:820px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:822px;left:149px;white-space:nowrap" class="ft3380">Clinisol Sf&#160;15%&#160;</p>
<p style="position:absolute;top:842px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:842px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:844px;left:149px;white-space:nowrap" class="ft3380">Clinolipid&#160;</p>
<p style="position:absolute;top:864px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:864px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:866px;left:149px;white-space:nowrap" class="ft3380">Cromolyn Sodium&#160;NEBU&#160;</p>
<p style="position:absolute;top:886px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:886px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:888px;left:149px;white-space:nowrap" class="ft3380">Cyclophosphamide&#160;CAPS&#160;</p>
<p style="position:absolute;top:908px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:908px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:910px;left:149px;white-space:nowrap" class="ft3380">Cyclophosphamide&#160;TABS&#160;</p>
<p style="position:absolute;top:930px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:929px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:932px;left:149px;white-space:nowrap" class="ft3380">Cyclosporine&#160;CAPS&#160;</p>
<p style="position:absolute;top:952px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:952px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:954px;left:149px;white-space:nowrap" class="ft3380">Cyclosporine&#160;INJ&#160;</p>
<p style="position:absolute;top:974px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:974px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:976px;left:149px;white-space:nowrap" class="ft3380">Cyclosporine Modified&#160;</p>
<p style="position:absolute;top:996px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:995px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:998px;left:149px;white-space:nowrap" class="ft3380">Cytarabine&#160;INJ&#160;100MG/ML&#160;</p>
<p style="position:absolute;top:1018px;left:122px;white-space:nowrap" class="ft3385">•</p>
<p style="position:absolute;top:1018px;left:130px;white-space:nowrap" class="ft3386">&#160;&#160;</p>
<p style="position:absolute;top:1020px;left:149px;white-space:nowrap" class="ft3380">Cytarabine&#160;Aqueous&#160;</p>
<p style="position:absolute;top:1057px;left:783px;white-space:nowrap" class="ft3380">338&#160;</p>
</div>
<!-- Page 339 -->
<a name="339"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page339-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2339.png" alt="background image"/>
<p style="position:absolute;top:117px;left:122px;white-space:nowrap" class="ft3395">•</p>
<p style="position:absolute;top:116px;left:130px;white-space:nowrap" class="ft3396">&#160;&#160;</p>
<p style="position:absolute;top:119px;left:149px;white-space:nowrap" class="ft3390">Dextrose 50%&#160;</p>
<p style="position:absolute;top:139px;left:122px;white-space:nowrap" class="ft3395">•</p>
<p style="position:absolute;top:138px;left:130px;white-space:nowrap" class="ft3396">&#160;&#160;</p>
<p style="position:absolute;top:141px;left:149px;white-space:nowrap" class="ft3390">Dextrose 70%&#160;</p>
<p style="position:absolute;top:161px;left:122px;white-space:nowrap" class="ft3395">•</p>
<p style="position:absolute;top:160px;left:130px;white-space:nowrap" class="ft3396">&#160;&#160;</p>
<p style="position:absolute;top:163px;left:149px;white-space:nowrap" class="ft33910">Diphtheria/tetanus Toxoids Adsorbed&#160;<br/>Pediatric&#160;</p>
<p style="position:absolute;top:203px;left:122px;white-space:nowrap" class="ft3395">•</p>
<p style="position:absolute;top:203px;left:130px;white-space:nowrap" class="ft3396">&#160;&#160;</p>
<p style="position:absolute;top:205px;left:149px;white-space:nowrap" class="ft3390">Emend&#160;SUSR&#160;</p>
<p style="position:absolute;top:225px;left:122px;white-space:nowrap" class="ft3395">•</p>
<p style="position:absolute;top:224px;left:130px;white-space:nowrap" class="ft3396">&#160;&#160;</p>
<p style="position:absolute;top:227px;left:149px;white-space:nowrap" class="ft3390">Engerix-b&#160;</p>
<p style="position:absolute;top:247px;left:122px;white-space:nowrap" class="ft3395">•</p>
<p style="position:absolute;top:246px;left:130px;white-space:nowrap" class="ft3396">&#160;&#160;</p>
<p style="position:absolute;top:249px;left:149px;white-space:nowrap" class="ft3390">Epoprostenol Sodium&#160;</p>
<p style="position:absolute;top:269px;left:122px;white-space:nowrap" class="ft3395">•</p>
<p style="position:absolute;top:269px;left:130px;white-space:nowrap" class="ft3396">&#160;&#160;</p>
<p style="position:absolute;top:271px;left:149px;white-space:nowrap" class="ft33910">Everolimus&#160;TABS&#160;0.25MG, 0.5MG,&#160;<br/>0.75MG, 1MG&#160;</p>
<p style="position:absolute;top:312px;left:122px;white-space:nowrap" class="ft3395">•</p>
<p style="position:absolute;top:311px;left:130px;white-space:nowrap" class="ft3396">&#160;&#160;</p>
<p style="position:absolute;top:314px;left:149px;white-space:nowrap" class="ft33910">Fluorouracil&#160;INJ 1GM/20ML,&#160;<br/>2.5GM/50ML, 500MG/10ML,&#160;<br/>5GM/100ML&#160;</p>
<p style="position:absolute;top:375px;left:122px;white-space:nowrap" class="ft3395">•</p>
<p style="position:absolute;top:375px;left:130px;white-space:nowrap" class="ft3396">&#160;&#160;</p>
<p style="position:absolute;top:377px;left:149px;white-space:nowrap" class="ft3390">Freamine&#160;Hbc 6.9%&#160;</p>
<p style="position:absolute;top:397px;left:122px;white-space:nowrap" class="ft3395">•</p>
<p style="position:absolute;top:397px;left:130px;white-space:nowrap" class="ft3396">&#160;&#160;</p>
<p style="position:absolute;top:399px;left:149px;white-space:nowrap" class="ft33910">Freamine&#160;III&#160;INJ 89MEQ/L;&#160;<br/>710MG/100ML;&#160;950MG/100ML;&#160;<br/>3MEQ/L; 24MG/100ML;&#160;<br/>1400MG/100ML;&#160;280MG/100ML;&#160;<br/>690MG/100ML;&#160;910MG/100ML;&#160;<br/>730MG/100ML;&#160;530MG/100ML;&#160;<br/>560MG/100ML;&#160;10MMOLE/L;&#160;<br/>120MG/100ML;&#160;1120MG/100ML;&#160;<br/>590MG/100ML;&#160;10MEQ/L;&#160;<br/>400MG/100ML;&#160;150MG/100ML;&#160;<br/>660MG/100ML&#160;</p>
<p style="position:absolute;top:626px;left:122px;white-space:nowrap" class="ft3395">•</p>
<p style="position:absolute;top:626px;left:130px;white-space:nowrap" class="ft3396">&#160;&#160;</p>
<p style="position:absolute;top:628px;left:149px;white-space:nowrap" class="ft3390">Gamastan&#160;</p>
<p style="position:absolute;top:648px;left:122px;white-space:nowrap" class="ft3395">•</p>
<p style="position:absolute;top:648px;left:130px;white-space:nowrap" class="ft3396">&#160;&#160;</p>
<p style="position:absolute;top:650px;left:149px;white-space:nowrap" class="ft33910">Ganciclovir&#160;INJ 500MG,&#160;<br/>500MG/10ML&#160;</p>
<p style="position:absolute;top:691px;left:122px;white-space:nowrap" class="ft3395">•</p>
<p style="position:absolute;top:690px;left:130px;white-space:nowrap" class="ft3396">&#160;&#160;</p>
<p style="position:absolute;top:693px;left:149px;white-space:nowrap" class="ft3390">Gengraf&#160;CAPS 100MG,&#160;25MG&#160;</p>
<p style="position:absolute;top:713px;left:122px;white-space:nowrap" class="ft3395">•</p>
<p style="position:absolute;top:712px;left:130px;white-space:nowrap" class="ft3396">&#160;&#160;</p>
<p style="position:absolute;top:715px;left:149px;white-space:nowrap" class="ft3390">Gengraf&#160;SOLN&#160;</p>
<p style="position:absolute;top:735px;left:122px;white-space:nowrap" class="ft3395">•</p>
<p style="position:absolute;top:734px;left:130px;white-space:nowrap" class="ft3396">&#160;&#160;</p>
<p style="position:absolute;top:737px;left:149px;white-space:nowrap" class="ft3390">Granisetron&#160;Hcl&#160;TABS&#160;</p>
<p style="position:absolute;top:757px;left:122px;white-space:nowrap" class="ft3395">•</p>
<p style="position:absolute;top:756px;left:130px;white-space:nowrap" class="ft3396">&#160;&#160;</p>
<p style="position:absolute;top:759px;left:149px;white-space:nowrap" class="ft33910">Hepatamine&#160;INJ 62MEQ/L;&#160;<br/>770MG/100ML;&#160;600MG/100ML;&#160;<br/>3MEQ/L; 20MG/100ML;&#160;<br/>900MG/100ML;&#160;240MG/100ML;&#160;<br/>900MG/100ML;&#160;1100MG/100ML;&#160;<br/>610MG/100ML;&#160;100MG/100ML;&#160;<br/>100MG/100ML;&#160;115MG/100ML;&#160;<br/>800MG/100ML;&#160;500MG/100ML;&#160;<br/>450MG/100ML;&#160;66MG/100ML;&#160;<br/>840MG/100ML&#160;</p>
<p style="position:absolute;top:965px;left:122px;white-space:nowrap" class="ft3395">•</p>
<p style="position:absolute;top:965px;left:130px;white-space:nowrap" class="ft3396">&#160;&#160;</p>
<p style="position:absolute;top:967px;left:149px;white-space:nowrap" class="ft3390">Humulin R&#160;U-500 (concentrated)&#160;</p>
<p style="position:absolute;top:987px;left:122px;white-space:nowrap" class="ft3395">•</p>
<p style="position:absolute;top:986px;left:130px;white-space:nowrap" class="ft3396">&#160;&#160;</p>
<p style="position:absolute;top:989px;left:149px;white-space:nowrap" class="ft33910">Hydromorphone Hcl&#160;INJ 10MG/ML,&#160;<br/>1MG/ML, 4MG/ML&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3390">339&#160;</p>
</div>
<!-- Page 340 -->
<a name="340"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page340-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2340.png" alt="background image"/>
</div>
<!-- Page 341 -->
<a name="341"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page341-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2341.png" alt="background image"/>
<p style="position:absolute;top:117px;left:122px;white-space:nowrap" class="ft3415">•</p>
<p style="position:absolute;top:116px;left:130px;white-space:nowrap" class="ft3416">&#160;&#160;</p>
<p style="position:absolute;top:119px;left:149px;white-space:nowrap" class="ft34110">Plenamine&#160;INJ 147.4MEQ/L;&#160;<br/>2.17GM/100ML;&#160;1.47GM/100ML;&#160;<br/>434MG/100ML;&#160;749MG/100ML;&#160;<br/>1.04GM/100ML;&#160;894MG/100ML;&#160;<br/>749MG/100ML;&#160;1.04GM/100ML;&#160;<br/>1.18GM/100ML;&#160;749MG/100ML;&#160;<br/>1.04GM/100ML;&#160;894MG/100ML;&#160;<br/>592MG/100ML;&#160;749MG/100ML;&#160;<br/>250MG/100ML;&#160;39MG/100ML;&#160;<br/>960MG/100ML&#160;</p>
<p style="position:absolute;top:325px;left:122px;white-space:nowrap" class="ft3415">•</p>
<p style="position:absolute;top:324px;left:130px;white-space:nowrap" class="ft3416">&#160;&#160;</p>
<p style="position:absolute;top:327px;left:149px;white-space:nowrap" class="ft3410">Prednisolone&#160;SOLN&#160;</p>
<p style="position:absolute;top:347px;left:122px;white-space:nowrap" class="ft3415">•</p>
<p style="position:absolute;top:346px;left:130px;white-space:nowrap" class="ft3416">&#160;&#160;</p>
<p style="position:absolute;top:349px;left:149px;white-space:nowrap" class="ft34110">Prednisolone Sodium Phosphate&#160;<br/>ORAL&#160;SOLN 10MG/5ML,&#160;<br/>15MG/5ML, 20MG/5ML,&#160;<br/>25MG/5ML, 5MG/5ML&#160;</p>
<p style="position:absolute;top:431px;left:122px;white-space:nowrap" class="ft3415">•</p>
<p style="position:absolute;top:430px;left:130px;white-space:nowrap" class="ft3416">&#160;&#160;</p>
<p style="position:absolute;top:433px;left:149px;white-space:nowrap" class="ft3410">Prednisone&#160;SOLN&#160;</p>
<p style="position:absolute;top:453px;left:122px;white-space:nowrap" class="ft3415">•</p>
<p style="position:absolute;top:452px;left:130px;white-space:nowrap" class="ft3416">&#160;&#160;</p>
<p style="position:absolute;top:455px;left:149px;white-space:nowrap" class="ft34110">Prednisone&#160;TABS&#160;10MG, 1MG,&#160;<br/>2.5MG, 20MG, 50MG, 5MG&#160;</p>
<p style="position:absolute;top:496px;left:122px;white-space:nowrap" class="ft3415">•</p>
<p style="position:absolute;top:495px;left:130px;white-space:nowrap" class="ft3416">&#160;&#160;</p>
<p style="position:absolute;top:498px;left:149px;white-space:nowrap" class="ft3410">Prednisone&#160;Intensol&#160;</p>
<p style="position:absolute;top:518px;left:122px;white-space:nowrap" class="ft3415">•</p>
<p style="position:absolute;top:517px;left:130px;white-space:nowrap" class="ft3416">&#160;&#160;</p>
<p style="position:absolute;top:520px;left:149px;white-space:nowrap" class="ft34110">Premasol&#160;INJ 52MEQ/L;&#160;<br/>1760MG/100ML;&#160;880MG/100ML;&#160;<br/>34MEQ/L; 1760MG/100ML;&#160;<br/>372MG/100ML;&#160;406MG/100ML;&#160;<br/>526MG/100ML; 492MG/100ML;&#160;<br/>492MG/100ML;&#160;526MG/100ML;&#160;<br/>356MG/100ML;&#160;356MG/100ML;&#160;<br/>390MG/100ML;&#160;34MG/100ML;&#160;<br/>152MG/100ML&#160;</p>
<p style="position:absolute;top:705px;left:122px;white-space:nowrap" class="ft3415">•</p>
<p style="position:absolute;top:704px;left:130px;white-space:nowrap" class="ft3416">&#160;&#160;</p>
<p style="position:absolute;top:707px;left:149px;white-space:nowrap" class="ft3410">Procalamine&#160;</p>
<p style="position:absolute;top:727px;left:122px;white-space:nowrap" class="ft3415">•</p>
<p style="position:absolute;top:726px;left:130px;white-space:nowrap" class="ft3416">&#160;&#160;</p>
<p style="position:absolute;top:729px;left:149px;white-space:nowrap" class="ft3410">Prograf&#160;PACK&#160;</p>
<p style="position:absolute;top:749px;left:122px;white-space:nowrap" class="ft3415">•</p>
<p style="position:absolute;top:748px;left:130px;white-space:nowrap" class="ft3416">&#160;&#160;</p>
<p style="position:absolute;top:751px;left:149px;white-space:nowrap" class="ft3410">Prosol&#160;</p>
<p style="position:absolute;top:771px;left:122px;white-space:nowrap" class="ft3415">•</p>
<p style="position:absolute;top:770px;left:130px;white-space:nowrap" class="ft3416">&#160;&#160;</p>
<p style="position:absolute;top:773px;left:149px;white-space:nowrap" class="ft3410">Rabavert&#160;</p>
<p style="position:absolute;top:793px;left:122px;white-space:nowrap" class="ft3415">•</p>
<p style="position:absolute;top:792px;left:130px;white-space:nowrap" class="ft3416">&#160;&#160;</p>
<p style="position:absolute;top:795px;left:149px;white-space:nowrap" class="ft3410">Recombivax&#160;Hb&#160;</p>
<p style="position:absolute;top:815px;left:122px;white-space:nowrap" class="ft3415">•</p>
<p style="position:absolute;top:814px;left:130px;white-space:nowrap" class="ft3416">&#160;&#160;</p>
<p style="position:absolute;top:817px;left:149px;white-space:nowrap" class="ft3410">Sandimmune&#160;SOLN&#160;</p>
<p style="position:absolute;top:837px;left:122px;white-space:nowrap" class="ft3415">•</p>
<p style="position:absolute;top:836px;left:130px;white-space:nowrap" class="ft3416">&#160;&#160;</p>
<p style="position:absolute;top:839px;left:149px;white-space:nowrap" class="ft3410">Sirolimus&#160;SOLN&#160;</p>
<p style="position:absolute;top:859px;left:122px;white-space:nowrap" class="ft3415">•</p>
<p style="position:absolute;top:858px;left:130px;white-space:nowrap" class="ft3416">&#160;&#160;</p>
<p style="position:absolute;top:861px;left:149px;white-space:nowrap" class="ft3410">Sirolimus&#160;TABS&#160;</p>
<p style="position:absolute;top:881px;left:122px;white-space:nowrap" class="ft3415">•</p>
<p style="position:absolute;top:880px;left:130px;white-space:nowrap" class="ft3416">&#160;&#160;</p>
<p style="position:absolute;top:883px;left:149px;white-space:nowrap" class="ft3410">Tacrolimus&#160;CAPS&#160;</p>
<p style="position:absolute;top:903px;left:122px;white-space:nowrap" class="ft3415">•</p>
<p style="position:absolute;top:902px;left:130px;white-space:nowrap" class="ft3416">&#160;&#160;</p>
<p style="position:absolute;top:905px;left:149px;white-space:nowrap" class="ft3410">Tdvax&#160;</p>
<p style="position:absolute;top:925px;left:122px;white-space:nowrap" class="ft3415">•</p>
<p style="position:absolute;top:924px;left:130px;white-space:nowrap" class="ft3416">&#160;&#160;</p>
<p style="position:absolute;top:927px;left:149px;white-space:nowrap" class="ft3410">Tenivac&#160;</p>
<p style="position:absolute;top:947px;left:122px;white-space:nowrap" class="ft3415">•</p>
<p style="position:absolute;top:946px;left:130px;white-space:nowrap" class="ft3416">&#160;&#160;</p>
<p style="position:absolute;top:949px;left:149px;white-space:nowrap" class="ft34110">Tpn Electrolytes&#160;INJ&#160;<br/>29.5MEQ/20ML; 4.5MEQ/20ML;&#160;<br/>35MEQ/20ML;&#160;5MEQ/20ML;&#160;<br/>20MEQ/20ML; 35MEQ/20ML&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3410">341&#160;</p>
</div>
<!-- Page 342 -->
<a name="342"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page342-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2342.png" alt="background image"/>
<p style="position:absolute;top:117px;left:122px;white-space:nowrap" class="ft3425">•</p>
<p style="position:absolute;top:116px;left:130px;white-space:nowrap" class="ft3426">&#160;&#160;</p>
<p style="position:absolute;top:119px;left:149px;white-space:nowrap" class="ft3420">Travasol&#160;INJ 52MEQ/L;&#160;</p>
<p style="position:absolute;top:116px;left:330px;white-space:nowrap" class="ft3426"></p>
<p style="position:absolute;top:139px;left:149px;white-space:nowrap" class="ft3420">1760MG/100ML;&#160;880MG/100ML;&#160;</p>
<p style="position:absolute;top:137px;left:406px;white-space:nowrap" class="ft3426"></p>
<p style="position:absolute;top:160px;left:149px;white-space:nowrap" class="ft3420">34MEQ/L; 1760MG/100ML;&#160;</p>
<p style="position:absolute;top:157px;left:366px;white-space:nowrap" class="ft3426"></p>
<p style="position:absolute;top:181px;left:149px;white-space:nowrap" class="ft3420">372MG/100ML;&#160;406MG/100ML;&#160;</p>
<p style="position:absolute;top:178px;left:397px;white-space:nowrap" class="ft3426"></p>
<p style="position:absolute;top:202px;left:149px;white-space:nowrap" class="ft3420">526MG/100ML;&#160;492MG/100ML;&#160;</p>
<p style="position:absolute;top:199px;left:397px;white-space:nowrap" class="ft3426"></p>
<p style="position:absolute;top:222px;left:149px;white-space:nowrap" class="ft3420">492MG/100ML;&#160;526MG/100ML;&#160;</p>
<p style="position:absolute;top:219px;left:397px;white-space:nowrap" class="ft3426"></p>
<p style="position:absolute;top:243px;left:149px;white-space:nowrap" class="ft3420">356MG/100ML;&#160;500MG/100ML;&#160;</p>
<p style="position:absolute;top:240px;left:397px;white-space:nowrap" class="ft3426"></p>
<p style="position:absolute;top:264px;left:149px;white-space:nowrap" class="ft3420">356MG/100ML;&#160;390MG/100ML;&#160;</p>
<p style="position:absolute;top:261px;left:397px;white-space:nowrap" class="ft3426"></p>
<p style="position:absolute;top:284px;left:149px;white-space:nowrap" class="ft3420">34MG/100ML;&#160;152MG/100ML</p>
<p style="position:absolute;top:281px;left:379px;white-space:nowrap" class="ft3426">&#160;</p>
<p style="position:absolute;top:304px;left:122px;white-space:nowrap" class="ft3425">•</p>
<p style="position:absolute;top:303px;left:130px;white-space:nowrap" class="ft3426">&#160;&#160;</p>
<p style="position:absolute;top:306px;left:149px;white-space:nowrap" class="ft3420">Trophamine&#160;INJ 97MEQ/L;&#160;</p>
<p style="position:absolute;top:303px;left:355px;white-space:nowrap" class="ft3426"></p>
<p style="position:absolute;top:327px;left:149px;white-space:nowrap" class="ft3420">0.54GM/100ML;&#160;1.2GM/100ML;</p>
<p style="position:absolute;top:324px;left:393px;white-space:nowrap" class="ft3426">&#160;</p>
<p style="position:absolute;top:348px;left:149px;white-space:nowrap" class="ft3420">0.32GM/100ML;&#160;0; 0;</p>
<p style="position:absolute;top:345px;left:310px;white-space:nowrap" class="ft3426">&#160;</p>
<p style="position:absolute;top:368px;left:149px;white-space:nowrap" class="ft3420">0.5GM/100ML;&#160;0.36GM/100ML;</p>
<p style="position:absolute;top:366px;left:393px;white-space:nowrap" class="ft3426">&#160;</p>
<p style="position:absolute;top:389px;left:149px;white-space:nowrap" class="ft3420">0.48GM/100ML;&#160;0.82GM/100ML;</p>
<p style="position:absolute;top:386px;left:402px;white-space:nowrap" class="ft3426">&#160;</p>
<p style="position:absolute;top:410px;left:149px;white-space:nowrap" class="ft3420">1.4GM/100ML;&#160;1.2GM/100ML;</p>
<p style="position:absolute;top:407px;left:384px;white-space:nowrap" class="ft3426">&#160;</p>
<p style="position:absolute;top:430px;left:149px;white-space:nowrap" class="ft3420">0.34GM/100ML;&#160;0.48GM/100ML;</p>
<p style="position:absolute;top:428px;left:402px;white-space:nowrap" class="ft3426">&#160;</p>
<p style="position:absolute;top:451px;left:149px;white-space:nowrap" class="ft3420">0.68GM/100ML;&#160;0.38GM/100ML;</p>
<p style="position:absolute;top:448px;left:402px;white-space:nowrap" class="ft3426">&#160;</p>
<p style="position:absolute;top:472px;left:149px;white-space:nowrap" class="ft3420">5MEQ/L; 0.025GM/100ML;</p>
<p style="position:absolute;top:469px;left:357px;white-space:nowrap" class="ft3426">&#160;</p>
<p style="position:absolute;top:493px;left:149px;white-space:nowrap" class="ft3420">0.42GM/100ML;&#160;0.2GM/100ML;</p>
<p style="position:absolute;top:490px;left:393px;white-space:nowrap" class="ft3426">&#160;</p>
<p style="position:absolute;top:513px;left:149px;white-space:nowrap" class="ft3420">0.24GM/100ML;&#160;0.78GM/100ML</p>
<p style="position:absolute;top:510px;left:397px;white-space:nowrap" class="ft3426">&#160;</p>
<p style="position:absolute;top:533px;left:122px;white-space:nowrap" class="ft3425">•</p>
<p style="position:absolute;top:532px;left:130px;white-space:nowrap" class="ft3426">&#160;&#160;</p>
<p style="position:absolute;top:535px;left:149px;white-space:nowrap" class="ft3420">Vinblastine&#160;Sulfate&#160;INJ&#160;1MG/ML&#160;</p>
<p style="position:absolute;top:555px;left:122px;white-space:nowrap" class="ft3425">•</p>
<p style="position:absolute;top:554px;left:130px;white-space:nowrap" class="ft3426">&#160;&#160;</p>
<p style="position:absolute;top:557px;left:149px;white-space:nowrap" class="ft3420">Vincristine Sulfate&#160;INJ&#160;</p>
<p style="position:absolute;top:577px;left:122px;white-space:nowrap" class="ft3425">•</p>
<p style="position:absolute;top:576px;left:130px;white-space:nowrap" class="ft3426">&#160;&#160;</p>
<p style="position:absolute;top:579px;left:149px;white-space:nowrap" class="ft3420">Zortress&#160;TABS&#160;1MG&#160;</p>
<p style="position:absolute;top:662px;left:108px;white-space:nowrap" class="ft3422"><b>Details&#160;</b></p>
<p style="position:absolute;top:710px;left:108px;white-space:nowrap" class="ft34210">This&#160;&#160;drug&#160;&#160;may&#160;&#160;be&#160;&#160;covered&#160;&#160;under&#160;&#160;Medicare&#160;&#160;Part&#160;&#160;B&#160;&#160;or&#160;&#160;D&#160;&#160;depending&#160;&#160;upon&#160;&#160;the&#160;&#160;circumstances.&#160;<br/>Information&#160;&#160;may&#160;&#160;need&#160;&#160;to&#160;&#160;be&#160;&#160;submitted&#160;&#160;describing&#160;&#160;the&#160;&#160;use&#160;&#160;and&#160;&#160;setting&#160;&#160;of&#160;&#160;the&#160;&#160;drug&#160;&#160;to&#160;&#160;make&#160;&#160;the&#160;<br/>determination.&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3420">342&#160;</p>
</div>
<!-- Page 343 -->
<a name="343"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft34315{font-size:18px;font-family:BCDIEE+TimesNewRomanPS;color:#000000;}
	.ft34316{font-size:18px;font-family:BCDJEE+Calibri;color:#000000;}
-->
</style>
<div id="page343-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2343.png" alt="background image"/>
<p style="position:absolute;top:55px;left:108px;white-space:nowrap" class="ft3437">&#160;<br/>&#160;</p>
<p style="position:absolute;top:1096px;left:783px;white-space:nowrap" class="ft3430">343&#160;</p>
<p style="position:absolute;top:118px;left:61px;white-space:nowrap" class="ft3434"><b>INDEX</b></p>
<p style="position:absolute;top:184px;left:62px;white-space:nowrap" class="ft34315"><i><b>A</b></i></p>
<p style="position:absolute;top:186px;left:74px;white-space:nowrap" class="ft34316"><i>&#160;</i></p>
<p style="position:absolute;top:217px;left:62px;white-space:nowrap" class="ft3430">Abelcet</p>
<p style="position:absolute;top:217px;left:404px;white-space:nowrap" class="ft3430">338</p>
<p style="position:absolute;top:240px;left:62px;white-space:nowrap" class="ft3430">Abiraterone</p>
<p style="position:absolute;top:240px;left:422px;white-space:nowrap" class="ft3430">1</p>
<p style="position:absolute;top:264px;left:62px;white-space:nowrap" class="ft3430">Abiraterone&#160;Acetate</p>
<p style="position:absolute;top:264px;left:422px;white-space:nowrap" class="ft3430">1</p>
<p style="position:absolute;top:288px;left:62px;white-space:nowrap" class="ft3430">Accutane</p>
<p style="position:absolute;top:288px;left:404px;white-space:nowrap" class="ft3430">153</p>
<p style="position:absolute;top:312px;left:62px;white-space:nowrap" class="ft3430">Acetylcysteine</p>
<p style="position:absolute;top:312px;left:404px;white-space:nowrap" class="ft3430">338</p>
<p style="position:absolute;top:336px;left:62px;white-space:nowrap" class="ft3430">Acitretin</p>
<p style="position:absolute;top:336px;left:422px;white-space:nowrap" class="ft3430">3</p>
<p style="position:absolute;top:359px;left:62px;white-space:nowrap" class="ft3430">Actimmune</p>
<p style="position:absolute;top:359px;left:422px;white-space:nowrap" class="ft3430">4</p>
<p style="position:absolute;top:383px;left:62px;white-space:nowrap" class="ft3430">Acyclovir Sodium</p>
<p style="position:absolute;top:383px;left:404px;white-space:nowrap" class="ft3430">338</p>
<p style="position:absolute;top:407px;left:62px;white-space:nowrap" class="ft3430">Adempas</p>
<p style="position:absolute;top:407px;left:422px;white-space:nowrap" class="ft3430">5</p>
<p style="position:absolute;top:431px;left:62px;white-space:nowrap" class="ft3430">Afinitor</p>
<p style="position:absolute;top:431px;left:413px;white-space:nowrap" class="ft3430">83</p>
<p style="position:absolute;top:455px;left:62px;white-space:nowrap" class="ft3430">Afinitor Disperz</p>
<p style="position:absolute;top:455px;left:413px;white-space:nowrap" class="ft3430">83</p>
<p style="position:absolute;top:478px;left:62px;white-space:nowrap" class="ft3430">Aimovig</p>
<p style="position:absolute;top:478px;left:422px;white-space:nowrap" class="ft3430">6</p>
<p style="position:absolute;top:502px;left:62px;white-space:nowrap" class="ft3430">Albuterol Sulfate</p>
<p style="position:absolute;top:502px;left:404px;white-space:nowrap" class="ft3430">338</p>
<p style="position:absolute;top:526px;left:62px;white-space:nowrap" class="ft3430">Alecensa</p>
<p style="position:absolute;top:526px;left:422px;white-space:nowrap" class="ft3430">7</p>
<p style="position:absolute;top:550px;left:62px;white-space:nowrap" class="ft3430">Alosetron</p>
<p style="position:absolute;top:550px;left:422px;white-space:nowrap" class="ft3430">8</p>
<p style="position:absolute;top:574px;left:62px;white-space:nowrap" class="ft3430">Alosetron Hydrochloride</p>
<p style="position:absolute;top:574px;left:422px;white-space:nowrap" class="ft3430">8</p>
<p style="position:absolute;top:598px;left:62px;white-space:nowrap" class="ft3430">Alpha1-proteinase&#160;Inhibitor</p>
<p style="position:absolute;top:598px;left:422px;white-space:nowrap" class="ft3430">9</p>
<p style="position:absolute;top:621px;left:62px;white-space:nowrap" class="ft3430">Alunbrig</p>
<p style="position:absolute;top:621px;left:413px;white-space:nowrap" class="ft3430">10</p>
<p style="position:absolute;top:645px;left:62px;white-space:nowrap" class="ft3430">Alyq</p>
<p style="position:absolute;top:645px;left:404px;white-space:nowrap" class="ft3430">266</p>
<p style="position:absolute;top:669px;left:62px;white-space:nowrap" class="ft3430">Ambisome</p>
<p style="position:absolute;top:669px;left:404px;white-space:nowrap" class="ft3430">338</p>
<p style="position:absolute;top:693px;left:62px;white-space:nowrap" class="ft3430">Ambrisentan</p>
<p style="position:absolute;top:693px;left:413px;white-space:nowrap" class="ft3430">11</p>
<p style="position:absolute;top:717px;left:62px;white-space:nowrap" class="ft3430">Aminosyn-pf 7%</p>
<p style="position:absolute;top:717px;left:404px;white-space:nowrap" class="ft3430">338</p>
<p style="position:absolute;top:740px;left:62px;white-space:nowrap" class="ft3430">Amitriptyline Hcl</p>
<p style="position:absolute;top:740px;left:404px;white-space:nowrap" class="ft3430">127</p>
<p style="position:absolute;top:764px;left:62px;white-space:nowrap" class="ft3430">Amitriptyline Hydrochloride</p>
<p style="position:absolute;top:764px;left:404px;white-space:nowrap" class="ft3430">127</p>
<p style="position:absolute;top:788px;left:62px;white-space:nowrap" class="ft3430">Amnesteem</p>
<p style="position:absolute;top:788px;left:404px;white-space:nowrap" class="ft3430">153</p>
<p style="position:absolute;top:812px;left:62px;white-space:nowrap" class="ft3430">Amphotericin B</p>
<p style="position:absolute;top:812px;left:404px;white-space:nowrap" class="ft3430">338</p>
<p style="position:absolute;top:836px;left:62px;white-space:nowrap" class="ft3430">Androderm</p>
<p style="position:absolute;top:836px;left:404px;white-space:nowrap" class="ft3430">288</p>
<p style="position:absolute;top:859px;left:62px;white-space:nowrap" class="ft3430">Apo-varenicline</p>
<p style="position:absolute;top:859px;left:413px;white-space:nowrap" class="ft3430">45</p>
<p style="position:absolute;top:883px;left:62px;white-space:nowrap" class="ft3430">Aprepitant</p>
<p style="position:absolute;top:883px;left:404px;white-space:nowrap" class="ft3430">338</p>
<p style="position:absolute;top:907px;left:62px;white-space:nowrap" class="ft3430">Arcalyst</p>
<p style="position:absolute;top:907px;left:413px;white-space:nowrap" class="ft3430">12</p>
<p style="position:absolute;top:931px;left:62px;white-space:nowrap" class="ft3430">Armodafinil</p>
<p style="position:absolute;top:931px;left:413px;white-space:nowrap" class="ft3430">13</p>
<p style="position:absolute;top:955px;left:62px;white-space:nowrap" class="ft3430">Asparlas</p>
<p style="position:absolute;top:955px;left:413px;white-space:nowrap" class="ft3430">14</p>
<p style="position:absolute;top:978px;left:62px;white-space:nowrap" class="ft3430">Atovaquone</p>
<p style="position:absolute;top:978px;left:404px;white-space:nowrap" class="ft3430">187</p>
<p style="position:absolute;top:1002px;left:62px;white-space:nowrap" class="ft3430">Austedo</p>
<p style="position:absolute;top:1002px;left:413px;white-space:nowrap" class="ft3430">15</p>
<p style="position:absolute;top:1026px;left:62px;white-space:nowrap" class="ft3430">Avonex</p>
<p style="position:absolute;top:1026px;left:413px;white-space:nowrap" class="ft3430">16</p>
<p style="position:absolute;top:1050px;left:62px;white-space:nowrap" class="ft3430">Avonex Pen</p>
<p style="position:absolute;top:1050px;left:413px;white-space:nowrap" class="ft3430">16</p>
<p style="position:absolute;top:217px;left:118px;white-space:nowrap" class="ft3430">&#160;..............................................................&#160;</p>
<p style="position:absolute;top:217px;left:431px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:240px;left:148px;white-space:nowrap" class="ft3430">&#160;............................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:264px;left:207px;white-space:nowrap" class="ft3430">...............................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:288px;left:130px;white-space:nowrap" class="ft3430">&#160;............................................................&#160;</p>
<p style="position:absolute;top:288px;left:431px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:312px;left:169px;white-space:nowrap" class="ft3430">&#160;...................................................&#160;</p>
<p style="position:absolute;top:312px;left:431px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:336px;left:126px;white-space:nowrap" class="ft3430">&#160;.................................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:359px;left:147px;white-space:nowrap" class="ft3430">&#160;............................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:383px;left:194px;white-space:nowrap" class="ft3430">&#160;.............................................&#160;</p>
<p style="position:absolute;top:383px;left:431px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:407px;left:130px;white-space:nowrap" class="ft3430">&#160;................................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:431px;left:120px;white-space:nowrap" class="ft3430">&#160;................................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:455px;left:180px;white-space:nowrap" class="ft3430">...................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:478px;left:126px;white-space:nowrap" class="ft3430">&#160;.................................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:502px;left:186px;white-space:nowrap" class="ft3430">&#160;...............................................&#160;</p>
<p style="position:absolute;top:502px;left:431px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:526px;left:128px;white-space:nowrap" class="ft3430">&#160;................................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:550px;left:133px;white-space:nowrap" class="ft3430">&#160;...............................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:574px;left:242px;white-space:nowrap" class="ft3430">&#160;.......................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:598px;left:262px;white-space:nowrap" class="ft3430">&#160;..................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:621px;left:127px;white-space:nowrap" class="ft3430">&#160;..............................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:645px;left:98px;white-space:nowrap" class="ft3430">&#160;...................................................................&#160;</p>
<p style="position:absolute;top:645px;left:431px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:669px;left:141px;white-space:nowrap" class="ft3430">&#160;.........................................................&#160;</p>
<p style="position:absolute;top:669px;left:431px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:693px;left:155px;white-space:nowrap" class="ft3430">&#160;........................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:717px;left:186px;white-space:nowrap" class="ft3430">&#160;...............................................&#160;</p>
<p style="position:absolute;top:717px;left:431px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:740px;left:190px;white-space:nowrap" class="ft3430">&#160;..............................................&#160;</p>
<p style="position:absolute;top:740px;left:431px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:764px;left:269px;white-space:nowrap" class="ft3430">&#160;.............................&#160;</p>
<p style="position:absolute;top:764px;left:431px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:788px;left:148px;white-space:nowrap" class="ft3430">&#160;........................................................&#160;</p>
<p style="position:absolute;top:788px;left:431px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:812px;left:178px;white-space:nowrap" class="ft3430">&#160;.................................................&#160;</p>
<p style="position:absolute;top:812px;left:431px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:836px;left:145px;white-space:nowrap" class="ft3430">&#160;........................................................&#160;</p>
<p style="position:absolute;top:836px;left:431px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:859px;left:179px;white-space:nowrap" class="ft3430">&#160;...................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:883px;left:139px;white-space:nowrap" class="ft3430">&#160;..........................................................&#160;</p>
<p style="position:absolute;top:883px;left:431px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:907px;left:123px;white-space:nowrap" class="ft3430">&#160;...............................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:931px;left:151px;white-space:nowrap" class="ft3430">&#160;.........................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:955px;left:125px;white-space:nowrap" class="ft3430">&#160;...............................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:978px;left:150px;white-space:nowrap" class="ft3430">&#160;.......................................................&#160;</p>
<p style="position:absolute;top:978px;left:431px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:1002px;left:122px;white-space:nowrap" class="ft3430">&#160;...............................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:1026px;left:119px;white-space:nowrap" class="ft3430">&#160;................................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:1050px;left:150px;white-space:nowrap" class="ft3430">&#160;.........................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:184px;left:486px;white-space:nowrap" class="ft3430">Ayvakit</p>
<p style="position:absolute;top:184px;left:838px;white-space:nowrap" class="ft3430">17</p>
<p style="position:absolute;top:208px;left:486px;white-space:nowrap" class="ft3430">Azathioprine</p>
<p style="position:absolute;top:208px;left:829px;white-space:nowrap" class="ft3430">338</p>
<p style="position:absolute;top:240px;left:486px;white-space:nowrap" class="ft34315"><i><b>B</b></i></p>
<p style="position:absolute;top:243px;left:498px;white-space:nowrap" class="ft34316"><i>&#160;</i></p>
<p style="position:absolute;top:273px;left:486px;white-space:nowrap" class="ft3430">Balversa</p>
<p style="position:absolute;top:273px;left:838px;white-space:nowrap" class="ft3430">18</p>
<p style="position:absolute;top:297px;left:486px;white-space:nowrap" class="ft3430">Banzel</p>
<p style="position:absolute;top:297px;left:838px;white-space:nowrap" class="ft3430">19</p>
<p style="position:absolute;top:321px;left:486px;white-space:nowrap" class="ft3430">Beleodaq</p>
<p style="position:absolute;top:321px;left:838px;white-space:nowrap" class="ft3430">20</p>
<p style="position:absolute;top:345px;left:486px;white-space:nowrap" class="ft3430">Benlysta</p>
<p style="position:absolute;top:345px;left:837px;white-space:nowrap" class="ft3430">&#160;21</p>
<p style="position:absolute;top:368px;left:486px;white-space:nowrap" class="ft3430">Benztropine&#160;Mesylate</p>
<p style="position:absolute;top:368px;left:829px;white-space:nowrap" class="ft3430">116</p>
<p style="position:absolute;top:392px;left:486px;white-space:nowrap" class="ft3430">Besremi</p>
<p style="position:absolute;top:392px;left:838px;white-space:nowrap" class="ft3430">22</p>
<p style="position:absolute;top:416px;left:486px;white-space:nowrap" class="ft3430">Betaseron</p>
<p style="position:absolute;top:416px;left:838px;white-space:nowrap" class="ft3430">23</p>
<p style="position:absolute;top:440px;left:486px;white-space:nowrap" class="ft3430">Bevacizumab</p>
<p style="position:absolute;top:440px;left:838px;white-space:nowrap" class="ft3430">24</p>
<p style="position:absolute;top:464px;left:486px;white-space:nowrap" class="ft3430">Bexarotene</p>
<p style="position:absolute;top:464px;left:838px;white-space:nowrap" class="ft3430">26</p>
<p style="position:absolute;top:487px;left:486px;white-space:nowrap" class="ft3430">Bivigam</p>
<p style="position:absolute;top:487px;left:829px;white-space:nowrap" class="ft3430">156</p>
<p style="position:absolute;top:511px;left:486px;white-space:nowrap" class="ft3430">Blenrep</p>
<p style="position:absolute;top:511px;left:838px;white-space:nowrap" class="ft3430">27</p>
<p style="position:absolute;top:535px;left:486px;white-space:nowrap" class="ft3430">Bleomycin Sulfate</p>
<p style="position:absolute;top:535px;left:829px;white-space:nowrap" class="ft3430">338</p>
<p style="position:absolute;top:559px;left:486px;white-space:nowrap" class="ft3430">Bortezomib</p>
<p style="position:absolute;top:559px;left:829px;white-space:nowrap" class="ft3430">303</p>
<p style="position:absolute;top:583px;left:486px;white-space:nowrap" class="ft3430">Bosentan</p>
<p style="position:absolute;top:583px;left:838px;white-space:nowrap" class="ft3430">28</p>
<p style="position:absolute;top:607px;left:486px;white-space:nowrap" class="ft3430">Bosulif</p>
<p style="position:absolute;top:607px;left:838px;white-space:nowrap" class="ft3430">29</p>
<p style="position:absolute;top:630px;left:486px;white-space:nowrap" class="ft3430">Braftovi</p>
<p style="position:absolute;top:630px;left:838px;white-space:nowrap" class="ft3430">30</p>
<p style="position:absolute;top:654px;left:486px;white-space:nowrap" class="ft3430">Briviact</p>
<p style="position:absolute;top:654px;left:811px;white-space:nowrap" class="ft3430">31, 32</p>
<p style="position:absolute;top:678px;left:486px;white-space:nowrap" class="ft3430">Briviact Inj</p>
<p style="position:absolute;top:678px;left:838px;white-space:nowrap" class="ft3430">32</p>
<p style="position:absolute;top:702px;left:486px;white-space:nowrap" class="ft3430">Brukinsa</p>
<p style="position:absolute;top:702px;left:838px;white-space:nowrap" class="ft3430">33</p>
<p style="position:absolute;top:726px;left:486px;white-space:nowrap" class="ft3430">Budesonide</p>
<p style="position:absolute;top:726px;left:829px;white-space:nowrap" class="ft3430">338</p>
<p style="position:absolute;top:749px;left:486px;white-space:nowrap" class="ft3430">Buprenorphine</p>
<p style="position:absolute;top:749px;left:811px;white-space:nowrap" class="ft3430">34, 35</p>
<p style="position:absolute;top:773px;left:486px;white-space:nowrap" class="ft3430">Buprenorphine Hcl</p>
<p style="position:absolute;top:773px;left:838px;white-space:nowrap" class="ft3430">34</p>
<p style="position:absolute;top:797px;left:486px;white-space:nowrap" class="ft3430">Buprenorphine Patch</p>
<p style="position:absolute;top:797px;left:838px;white-space:nowrap" class="ft3430">35</p>
<p style="position:absolute;top:830px;left:486px;white-space:nowrap" class="ft34315"><i><b>C</b></i></p>
<p style="position:absolute;top:832px;left:498px;white-space:nowrap" class="ft34316"><i>&#160;</i></p>
<p style="position:absolute;top:863px;left:486px;white-space:nowrap" class="ft3430">Cabometyx</p>
<p style="position:absolute;top:863px;left:838px;white-space:nowrap" class="ft3430">36</p>
<p style="position:absolute;top:886px;left:486px;white-space:nowrap" class="ft3430">Calcipotriene</p>
<p style="position:absolute;top:886px;left:838px;white-space:nowrap" class="ft3430">37</p>
<p style="position:absolute;top:910px;left:486px;white-space:nowrap" class="ft3430">Calcipotriene/betamethasone Dipropionate</p>
<p style="position:absolute;top:910px;left:838px;white-space:nowrap" class="ft3430">37</p>
<p style="position:absolute;top:934px;left:486px;white-space:nowrap" class="ft3430">Calcitriol</p>
<p style="position:absolute;top:934px;left:838px;white-space:nowrap" class="ft3430">37</p>
<p style="position:absolute;top:958px;left:486px;white-space:nowrap" class="ft3430">Calquence</p>
<p style="position:absolute;top:958px;left:838px;white-space:nowrap" class="ft3430">38</p>
<p style="position:absolute;top:982px;left:486px;white-space:nowrap" class="ft3430">Caplyta</p>
<p style="position:absolute;top:982px;left:838px;white-space:nowrap" class="ft3430">39</p>
<p style="position:absolute;top:1005px;left:486px;white-space:nowrap" class="ft3430">Caprelsa</p>
<p style="position:absolute;top:1005px;left:838px;white-space:nowrap" class="ft3430">40</p>
<p style="position:absolute;top:1029px;left:486px;white-space:nowrap" class="ft3430">Carac</p>
<p style="position:absolute;top:1029px;left:838px;white-space:nowrap" class="ft3430">41</p>
<p style="position:absolute;top:1053px;left:486px;white-space:nowrap" class="ft3430">Carbaglu</p>
<p style="position:absolute;top:1053px;left:838px;white-space:nowrap" class="ft3430">42</p>
<p style="position:absolute;top:184px;left:544px;white-space:nowrap" class="ft3430">&#160;.................................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:208px;left:580px;white-space:nowrap" class="ft3430">&#160;.......................................................&#160;</p>
<p style="position:absolute;top:208px;left:856px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:273px;left:549px;white-space:nowrap" class="ft3430">................................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:297px;left:536px;white-space:nowrap" class="ft3430">&#160;..................................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:321px;left:554px;white-space:nowrap" class="ft3430">&#160;..............................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:345px;left:549px;white-space:nowrap" class="ft3430">................................................................&#160;&#160;</p>
<p style="position:absolute;top:368px;left:644px;white-space:nowrap" class="ft3430">&#160;........................................&#160;</p>
<p style="position:absolute;top:368px;left:856px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:392px;left:546px;white-space:nowrap" class="ft3430">&#160;................................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:416px;left:558px;white-space:nowrap" class="ft3430">..............................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:440px;left:584px;white-space:nowrap" class="ft3430">&#160;........................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:464px;left:568px;white-space:nowrap" class="ft3430">&#160;...........................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:487px;left:548px;white-space:nowrap" class="ft3430">&#160;..............................................................&#160;</p>
<p style="position:absolute;top:487px;left:856px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:511px;left:543px;white-space:nowrap" class="ft3430">&#160;.................................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:535px;left:621px;white-space:nowrap" class="ft3430">&#160;..............................................&#160;</p>
<p style="position:absolute;top:535px;left:856px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:559px;left:571px;white-space:nowrap" class="ft3430">&#160;.........................................................&#160;</p>
<p style="position:absolute;top:559px;left:856px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:583px;left:553px;white-space:nowrap" class="ft3430">&#160;...............................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:607px;left:539px;white-space:nowrap" class="ft3430">&#160;..................................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:630px;left:546px;white-space:nowrap" class="ft3430">&#160;................................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:654px;left:544px;white-space:nowrap" class="ft3430">&#160;...........................................................&#160;</p>
<p style="position:absolute;top:654px;left:856px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:678px;left:569px;white-space:nowrap" class="ft3430">&#160;...........................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:702px;left:551px;white-space:nowrap" class="ft3430">&#160;...............................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:726px;left:571px;white-space:nowrap" class="ft3430">&#160;.........................................................&#160;</p>
<p style="position:absolute;top:726px;left:856px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:749px;left:594px;white-space:nowrap" class="ft3430">................................................&#160;</p>
<p style="position:absolute;top:749px;left:856px;white-space:nowrap" class="ft3430">&#160;</p>
<p style="position:absolute;top:773px;left:625px;white-space:nowrap" class="ft3430">&#160;...............................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:797px;left:639px;white-space:nowrap" class="ft3430">&#160;............................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:863px;left:569px;white-space:nowrap" class="ft3430">&#160;...........................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:886px;left:583px;white-space:nowrap" class="ft3430">&#160;........................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:910px;left:794px;white-space:nowrap" class="ft3430">&#160;.........&#160;&#160;&#160;</p>
<p style="position:absolute;top:934px;left:554px;white-space:nowrap" class="ft3430">&#160;..............................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:958px;left:562px;white-space:nowrap" class="ft3430">&#160;.............................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:982px;left:542px;white-space:nowrap" class="ft3430">&#160;.................................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:1005px;left:549px;white-space:nowrap" class="ft3430">................................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:1029px;left:528px;white-space:nowrap" class="ft3430">&#160;....................................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:1053px;left:552px;white-space:nowrap" class="ft3430">&#160;...............................................................&#160;&#160;&#160;</p>
</div>
<!-- Page 344 -->
<a name="344"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page344-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2344.png" alt="background image"/>
<p style="position:absolute;top:33px;left:62px;white-space:nowrap" class="ft3447">&#160;<br/>&#160;</p>
<p style="position:absolute;top:1128px;left:830px;white-space:nowrap" class="ft3440">344&#160;</p>
<p style="position:absolute;top:96px;left:62px;white-space:nowrap" class="ft3440">Carbinoxamine Maleate</p>
<p style="position:absolute;top:96px;left:404px;white-space:nowrap" class="ft3440">129</p>
<p style="position:absolute;top:120px;left:62px;white-space:nowrap" class="ft3440">Cayston</p>
<p style="position:absolute;top:120px;left:413px;white-space:nowrap" class="ft3440">43</p>
<p style="position:absolute;top:143px;left:62px;white-space:nowrap" class="ft3440">Cerdelga</p>
<p style="position:absolute;top:143px;left:413px;white-space:nowrap" class="ft3440">44</p>
<p style="position:absolute;top:167px;left:62px;white-space:nowrap" class="ft3440">Chantix</p>
<p style="position:absolute;top:167px;left:413px;white-space:nowrap" class="ft3440">45</p>
<p style="position:absolute;top:191px;left:62px;white-space:nowrap" class="ft3440">Chantix Continuing Month Pak</p>
<p style="position:absolute;top:191px;left:413px;white-space:nowrap" class="ft3440">45</p>
<p style="position:absolute;top:215px;left:62px;white-space:nowrap" class="ft3440">Chantix Starting Month&#160;Pak</p>
<p style="position:absolute;top:215px;left:413px;white-space:nowrap" class="ft3440">45</p>
<p style="position:absolute;top:239px;left:62px;white-space:nowrap" class="ft3440">Chlordiazepoxide&#160;-&#160;65</p>
<p style="position:absolute;top:239px;left:413px;white-space:nowrap" class="ft3440">46</p>
<p style="position:absolute;top:262px;left:62px;white-space:nowrap" class="ft3440">Chlordiazepoxide Hcl</p>
<p style="position:absolute;top:262px;left:413px;white-space:nowrap" class="ft3440">46</p>
<p style="position:absolute;top:286px;left:62px;white-space:nowrap" class="ft3440">Chlordiazepoxide Hydrochloride</p>
<p style="position:absolute;top:286px;left:413px;white-space:nowrap" class="ft3440">46</p>
<p style="position:absolute;top:310px;left:62px;white-space:nowrap" class="ft3440">Chlordiazepoxide/amitriptyline</p>
<p style="position:absolute;top:310px;left:404px;white-space:nowrap" class="ft3440">110</p>
<p style="position:absolute;top:334px;left:62px;white-space:nowrap" class="ft3440">Chlorzoxazone</p>
<p style="position:absolute;top:334px;left:404px;white-space:nowrap" class="ft3440">133</p>
<p style="position:absolute;top:358px;left:62px;white-space:nowrap" class="ft3440">Cladribine</p>
<p style="position:absolute;top:358px;left:404px;white-space:nowrap" class="ft3440">338</p>
<p style="position:absolute;top:381px;left:62px;white-space:nowrap" class="ft3440">Claravis</p>
<p style="position:absolute;top:381px;left:404px;white-space:nowrap" class="ft3440">153</p>
<p style="position:absolute;top:405px;left:62px;white-space:nowrap" class="ft3440">Clemastine&#160;Fumarate</p>
<p style="position:absolute;top:405px;left:404px;white-space:nowrap" class="ft3440">130</p>
<p style="position:absolute;top:429px;left:62px;white-space:nowrap" class="ft3440">Clinimix 4.25%/dextrose 10%</p>
<p style="position:absolute;top:429px;left:404px;white-space:nowrap" class="ft3440">338</p>
<p style="position:absolute;top:453px;left:62px;white-space:nowrap" class="ft3440">Clinimix 4.25%/dextrose 5%</p>
<p style="position:absolute;top:453px;left:404px;white-space:nowrap" class="ft3440">338</p>
<p style="position:absolute;top:477px;left:62px;white-space:nowrap" class="ft3440">Clinimix 5%/dextrose&#160;15%</p>
<p style="position:absolute;top:477px;left:404px;white-space:nowrap" class="ft3440">338</p>
<p style="position:absolute;top:501px;left:62px;white-space:nowrap" class="ft3440">Clinimix 5%/dextrose&#160;20%</p>
<p style="position:absolute;top:501px;left:404px;white-space:nowrap" class="ft3440">338</p>
<p style="position:absolute;top:524px;left:62px;white-space:nowrap" class="ft3440">Clinimix 6/5</p>
<p style="position:absolute;top:524px;left:404px;white-space:nowrap" class="ft3440">338</p>
<p style="position:absolute;top:548px;left:62px;white-space:nowrap" class="ft3440">Clinimix 8/10</p>
<p style="position:absolute;top:548px;left:404px;white-space:nowrap" class="ft3440">338</p>
<p style="position:absolute;top:572px;left:62px;white-space:nowrap" class="ft3440">Clinimix 8/14</p>
<p style="position:absolute;top:572px;left:404px;white-space:nowrap" class="ft3440">338</p>
<p style="position:absolute;top:596px;left:62px;white-space:nowrap" class="ft3440">Clinisol Sf&#160;15%</p>
<p style="position:absolute;top:596px;left:404px;white-space:nowrap" class="ft3440">338</p>
<p style="position:absolute;top:620px;left:62px;white-space:nowrap" class="ft3440">Clinolipid</p>
<p style="position:absolute;top:620px;left:404px;white-space:nowrap" class="ft3440">338</p>
<p style="position:absolute;top:643px;left:62px;white-space:nowrap" class="ft3440">Clobazam</p>
<p style="position:absolute;top:643px;left:413px;white-space:nowrap" class="ft3440">47</p>
<p style="position:absolute;top:667px;left:62px;white-space:nowrap" class="ft3440">Clomipramine</p>
<p style="position:absolute;top:667px;left:413px;white-space:nowrap" class="ft3440">48</p>
<p style="position:absolute;top:691px;left:62px;white-space:nowrap" class="ft3440">Clomipramine Hcl</p>
<p style="position:absolute;top:691px;left:413px;white-space:nowrap" class="ft3440">48</p>
<p style="position:absolute;top:715px;left:62px;white-space:nowrap" class="ft3440">Clorazepate</p>
<p style="position:absolute;top:715px;left:413px;white-space:nowrap" class="ft3440">49</p>
<p style="position:absolute;top:739px;left:62px;white-space:nowrap" class="ft3440">Clorazepate&#160;Dipotassium</p>
<p style="position:absolute;top:739px;left:413px;white-space:nowrap" class="ft3440">49</p>
<p style="position:absolute;top:762px;left:62px;white-space:nowrap" class="ft3440">Clozapine Odt</p>
<p style="position:absolute;top:762px;left:413px;white-space:nowrap" class="ft3440">50</p>
<p style="position:absolute;top:786px;left:62px;white-space:nowrap" class="ft3440">Colistimethate Sodium</p>
<p style="position:absolute;top:786px;left:413px;white-space:nowrap" class="ft3440">51</p>
<p style="position:absolute;top:810px;left:62px;white-space:nowrap" class="ft3440">Coly-mycin</p>
<p style="position:absolute;top:810px;left:413px;white-space:nowrap" class="ft3440">51</p>
<p style="position:absolute;top:834px;left:62px;white-space:nowrap" class="ft3440">Cometriq</p>
<p style="position:absolute;top:834px;left:413px;white-space:nowrap" class="ft3440">52</p>
<p style="position:absolute;top:858px;left:62px;white-space:nowrap" class="ft3440">Copaxone</p>
<p style="position:absolute;top:858px;left:404px;white-space:nowrap" class="ft3440">101</p>
<p style="position:absolute;top:881px;left:62px;white-space:nowrap" class="ft3440">Copiktra</p>
<p style="position:absolute;top:881px;left:413px;white-space:nowrap" class="ft3440">53</p>
<p style="position:absolute;top:905px;left:62px;white-space:nowrap" class="ft3440">Cotellic</p>
<p style="position:absolute;top:905px;left:413px;white-space:nowrap" class="ft3440">54</p>
<p style="position:absolute;top:929px;left:62px;white-space:nowrap" class="ft3440">Cromolyn Sodium</p>
<p style="position:absolute;top:929px;left:404px;white-space:nowrap" class="ft3440">338</p>
<p style="position:absolute;top:953px;left:62px;white-space:nowrap" class="ft3440">Cyclobenzaprine Hydrochloride</p>
<p style="position:absolute;top:953px;left:404px;white-space:nowrap" class="ft3440">133</p>
<p style="position:absolute;top:977px;left:62px;white-space:nowrap" class="ft3440">Cyclophosphamide</p>
<p style="position:absolute;top:977px;left:404px;white-space:nowrap" class="ft3440">338</p>
<p style="position:absolute;top:1000px;left:62px;white-space:nowrap" class="ft3440">Cyclosporine</p>
<p style="position:absolute;top:1000px;left:404px;white-space:nowrap" class="ft3440">338</p>
<p style="position:absolute;top:1024px;left:62px;white-space:nowrap" class="ft3440">Cyclosporine Modified</p>
<p style="position:absolute;top:1024px;left:404px;white-space:nowrap" class="ft3440">338</p>
<p style="position:absolute;top:1048px;left:62px;white-space:nowrap" class="ft3440">Cyproheptadine Hcl</p>
<p style="position:absolute;top:1048px;left:404px;white-space:nowrap" class="ft3440">118</p>
<p style="position:absolute;top:1072px;left:62px;white-space:nowrap" class="ft3440">Cyproheptadine Hydrochloride</p>
<p style="position:absolute;top:1072px;left:404px;white-space:nowrap" class="ft3440">118</p>
<p style="position:absolute;top:1096px;left:62px;white-space:nowrap" class="ft3440">Cystagon</p>
<p style="position:absolute;top:1096px;left:413px;white-space:nowrap" class="ft3440">55</p>
<p style="position:absolute;top:96px;left:235px;white-space:nowrap" class="ft3440">&#160;....................................&#160;</p>
<p style="position:absolute;top:96px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:120px;left:121px;white-space:nowrap" class="ft3440">&#160;................................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:143px;left:127px;white-space:nowrap" class="ft3440">&#160;..............................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:167px;left:119px;white-space:nowrap" class="ft3440">&#160;................................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:191px;left:288px;white-space:nowrap" class="ft3440">&#160;..........................&#160;&#160;&#160;</p>
<p style="position:absolute;top:215px;left:264px;white-space:nowrap" class="ft3440">&#160;................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:239px;left:223px;white-space:nowrap" class="ft3440">&#160;.........................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:262px;left:220px;white-space:nowrap" class="ft3440">&#160;..........................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:286px;left:299px;white-space:nowrap" class="ft3440">&#160;........................&#160;&#160;&#160;</p>
<p style="position:absolute;top:310px;left:287px;white-space:nowrap" class="ft3440">&#160;.........................&#160;</p>
<p style="position:absolute;top:310px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:334px;left:171px;white-space:nowrap" class="ft3440">&#160;...................................................&#160;</p>
<p style="position:absolute;top:334px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:358px;left:138px;white-space:nowrap" class="ft3440">&#160;..........................................................&#160;</p>
<p style="position:absolute;top:358px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:381px;left:122px;white-space:nowrap" class="ft3440">..............................................................&#160;</p>
<p style="position:absolute;top:381px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:405px;left:215px;white-space:nowrap" class="ft3440">&#160;.........................................&#160;</p>
<p style="position:absolute;top:405px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:429px;left:280px;white-space:nowrap" class="ft3440">&#160;..........................&#160;</p>
<p style="position:absolute;top:429px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:453px;left:271px;white-space:nowrap" class="ft3440">&#160;............................&#160;</p>
<p style="position:absolute;top:453px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:477px;left:258px;white-space:nowrap" class="ft3440">&#160;...............................&#160;</p>
<p style="position:absolute;top:477px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:501px;left:258px;white-space:nowrap" class="ft3440">&#160;...............................&#160;</p>
<p style="position:absolute;top:501px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:524px;left:153px;white-space:nowrap" class="ft3440">&#160;......................................................&#160;</p>
<p style="position:absolute;top:524px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:548px;left:162px;white-space:nowrap" class="ft3440">&#160;....................................................&#160;</p>
<p style="position:absolute;top:548px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:572px;left:162px;white-space:nowrap" class="ft3440">&#160;....................................................&#160;</p>
<p style="position:absolute;top:572px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:596px;left:177px;white-space:nowrap" class="ft3440">&#160;.................................................&#160;</p>
<p style="position:absolute;top:596px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:620px;left:135px;white-space:nowrap" class="ft3440">&#160;...........................................................&#160;</p>
<p style="position:absolute;top:620px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:643px;left:135px;white-space:nowrap" class="ft3440">&#160;.............................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:667px;left:166px;white-space:nowrap" class="ft3440">&#160;......................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:691px;left:196px;white-space:nowrap" class="ft3440">&#160;...............................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:715px;left:148px;white-space:nowrap" class="ft3440">&#160;..........................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:739px;left:243px;white-space:nowrap" class="ft3440">.....................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:762px;left:166px;white-space:nowrap" class="ft3440">&#160;......................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:786px;left:227px;white-space:nowrap" class="ft3440">&#160;........................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:810px;left:148px;white-space:nowrap" class="ft3440">&#160;..........................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:834px;left:130px;white-space:nowrap" class="ft3440">&#160;..............................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:858px;left:135px;white-space:nowrap" class="ft3440">&#160;...........................................................&#160;</p>
<p style="position:absolute;top:858px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:881px;left:125px;white-space:nowrap" class="ft3440">&#160;...............................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:905px;left:119px;white-space:nowrap" class="ft3440">&#160;................................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:929px;left:195px;white-space:nowrap" class="ft3440">&#160;.............................................&#160;</p>
<p style="position:absolute;top:929px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:953px;left:293px;white-space:nowrap" class="ft3440">&#160;.......................&#160;</p>
<p style="position:absolute;top:953px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:977px;left:201px;white-space:nowrap" class="ft3440">&#160;............................................&#160;</p>
<p style="position:absolute;top:977px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:1000px;left:158px;white-space:nowrap" class="ft3440">&#160;.....................................................&#160;</p>
<p style="position:absolute;top:1000px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:1024px;left:229px;white-space:nowrap" class="ft3440">&#160;......................................&#160;</p>
<p style="position:absolute;top:1024px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:1048px;left:207px;white-space:nowrap" class="ft3440">...........................................&#160;</p>
<p style="position:absolute;top:1048px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:1072px;left:286px;white-space:nowrap" class="ft3440">&#160;.........................&#160;</p>
<p style="position:absolute;top:1072px;left:431px;white-space:nowrap" class="ft3440">&#160;</p>
<p style="position:absolute;top:1096px;left:130px;white-space:nowrap" class="ft3440">&#160;..............................................................&#160;&#160;&#160;</p>
<p style="position:absolute;top:96px;left:486px;white-space:nowrap" class="ft3440">Cystaran&#160;...............................................................</p>
<p style="position:absolute;top:120px;left:565px;white-space:nowrap" class="ft3440">&#160;..........................................................&#160;</p>
<p style="position:absolute;top:143px;left:633px;white-space:nowrap" class="ft3440">&#160;...........................................&#160;</p>
<p style="position:absolute;top:209px;left:591px;white-space:nowrap" class="ft3440">&#160;......................................................&#160;</p>
<p style="position:absolute;top:233px;left:613px;white-space:nowrap" class="ft3440">&#160;.................................................&#160;</p>
<p style="position:absolute;top:257px;left:558px;white-space:nowrap" class="ft3440">..............................................................</p>
<p style="position:absolute;top:280px;left:572px;white-space:nowrap" class="ft3440">...........................................................</p>
<p style="position:absolute;top:304px;left:545px;white-space:nowrap" class="ft3440">.................................................................</p>
<p style="position:absolute;top:328px;left:689px;white-space:nowrap" class="ft3440">...............................</p>
<p style="position:absolute;top:352px;left:599px;white-space:nowrap" class="ft3440">.....................................................</p>
<p style="position:absolute;top:376px;left:621px;white-space:nowrap" class="ft3440">................................................</p>
<p style="position:absolute;top:399px;left:590px;white-space:nowrap" class="ft3447">.....................................................<br/>.....................................................</p>
<p style="position:absolute;top:447px;left:563px;white-space:nowrap" class="ft3440">.............................................................</p>
<p style="position:absolute;top:471px;left:554px;white-space:nowrap" class="ft3440">...............................................................</p>
<p style="position:absolute;top:495px;left:563px;white-space:nowrap" class="ft3440">.............................................................</p>
<p style="position:absolute;top:519px;left:626px;white-space:nowrap" class="ft3447">...............................................<br/>...............................................</p>
<p style="position:absolute;top:566px;left:603px;white-space:nowrap" class="ft3440">....................................................</p>
<p style="position:absolute;top:590px;left:612px;white-space:nowrap" class="ft3440">................................................</p>
<p style="position:absolute;top:614px;left:689px;white-space:nowrap" class="ft3440">...............................</p>
<p style="position:absolute;top:638px;left:698px;white-space:nowrap" class="ft3440">.......................</p>
<p style="position:absolute;top:661px;left:648px;white-space:nowrap" class="ft3440">........................................</p>
<p style="position:absolute;top:709px;left:590px;white-space:nowrap" class="ft3440">.....................................................</p>
<p style="position:absolute;top:733px;left:671px;white-space:nowrap" class="ft3440">...................................</p>
<p style="position:absolute;top:757px;left:549px;white-space:nowrap" class="ft3440">................................................................</p>
<p style="position:absolute;top:780px;left:581px;white-space:nowrap" class="ft3440">.......................................................</p>
<p style="position:absolute;top:804px;left:662px;white-space:nowrap" class="ft3440">.............................</p>
<p style="position:absolute;top:828px;left:581px;white-space:nowrap" class="ft3440">.......................................................</p>
<p style="position:absolute;top:852px;left:554px;white-space:nowrap" class="ft3440">...............................................................</p>
<p style="position:absolute;top:876px;left:621px;white-space:nowrap" class="ft3440">................................................</p>
<p style="position:absolute;top:899px;left:572px;white-space:nowrap" class="ft3440">...........................................................</p>
<p style="position:absolute;top:923px;left:567px;white-space:nowrap" class="ft3440">..........................................................</p>
<p style="position:absolute;top:947px;left:540px;white-space:nowrap" class="ft3440">..................................................................</p>
<p style="position:absolute;top:1013px;left:540px;white-space:nowrap" class="ft3440">................................................................</p>
<p style="position:absolute;top:1036px;left:684px;white-space:nowrap" class="ft3440">................................</p>
<p style="position:absolute;top:1036px;left:540px;white-space:nowrap" class="ft3440">................................</p>
<p style="position:absolute;top:1060px;left:536px;white-space:nowrap" class="ft3440">................................................................</p>
<p style="position:absolute;top:1084px;left:720px;white-space:nowrap" class="ft3440">..........................</p>
<p style="position:absolute;top:1084px;left:576px;white-space:nowrap" class="ft3440">................................</p>
<p style="position:absolute;top:1036px;left:828px;white-space:nowrap" class="ft3440">..</p>
<p style="position:absolute;top:1060px;left:824px;white-space:nowrap" class="ft3440">...</p>
<p style="position:absolute;top:96px;left:837px;white-space:nowrap" class="ft3440">&#160;56&#160;</p>
<p style="position:absolute;top:120px;left:486px;white-space:nowrap" class="ft3440">Cytarabine</p>
<p style="position:absolute;top:120px;left:829px;white-space:nowrap" class="ft3440">338&#160;</p>
<p style="position:absolute;top:143px;left:486px;white-space:nowrap" class="ft3440">Cytarabine&#160;Aqueous</p>
<p style="position:absolute;top:143px;left:829px;white-space:nowrap" class="ft3440">338&#160;</p>
<p style="position:absolute;top:176px;left:486px;white-space:nowrap" class="ft34415"><i><b>D</b></i></p>
<p style="position:absolute;top:179px;left:499px;white-space:nowrap" class="ft34416"><i>&#160;</i></p>
<p style="position:absolute;top:209px;left:486px;white-space:nowrap" class="ft3440">Dalfampridine</p>
<p style="position:absolute;top:209px;left:838px;white-space:nowrap" class="ft3440">57&#160;</p>
<p style="position:absolute;top:233px;left:486px;white-space:nowrap" class="ft3440">Dalfampridine Er</p>
<p style="position:absolute;top:233px;left:838px;white-space:nowrap" class="ft3440">57&#160;</p>
<p style="position:absolute;top:257px;left:486px;white-space:nowrap" class="ft3440">Daurismo&#160;</p>
<p style="position:absolute;top:257px;left:837px;white-space:nowrap" class="ft3440">&#160;58&#160;</p>
<p style="position:absolute;top:280px;left:486px;white-space:nowrap" class="ft3440">Deferasirox&#160;</p>
<p style="position:absolute;top:280px;left:837px;white-space:nowrap" class="ft3440">&#160;59&#160;</p>
<p style="position:absolute;top:304px;left:486px;white-space:nowrap" class="ft3440">Demser&#160;</p>
<p style="position:absolute;top:304px;left:837px;white-space:nowrap" class="ft3440">&#160;60&#160;</p>
<p style="position:absolute;top:328px;left:486px;white-space:nowrap" class="ft3440">Desipramine&#160;Hydrochloride&#160;</p>
<p style="position:absolute;top:328px;left:828px;white-space:nowrap" class="ft3440">&#160;127&#160;</p>
<p style="position:absolute;top:352px;left:486px;white-space:nowrap" class="ft3440">Desvenlafaxine&#160;</p>
<p style="position:absolute;top:352px;left:837px;white-space:nowrap" class="ft3440">&#160;61&#160;</p>
<p style="position:absolute;top:376px;left:486px;white-space:nowrap" class="ft3440">Desvenlafaxine Er&#160;</p>
<p style="position:absolute;top:376px;left:837px;white-space:nowrap" class="ft3440">&#160;61&#160;</p>
<p style="position:absolute;top:399px;left:486px;white-space:nowrap" class="ft3440">Dextrose 50%&#160;</p>
<p style="position:absolute;top:399px;left:828px;white-space:nowrap" class="ft3440">&#160;339&#160;</p>
<p style="position:absolute;top:423px;left:486px;white-space:nowrap" class="ft3440">Dextrose 70%&#160;</p>
<p style="position:absolute;top:423px;left:828px;white-space:nowrap" class="ft3440">&#160;339&#160;</p>
<p style="position:absolute;top:447px;left:486px;white-space:nowrap" class="ft3440">Dhe Nasal&#160;</p>
<p style="position:absolute;top:447px;left:837px;white-space:nowrap" class="ft3440">&#160;62&#160;</p>
<p style="position:absolute;top:471px;left:486px;white-space:nowrap" class="ft3440">Diacomit&#160;</p>
<p style="position:absolute;top:471px;left:837px;white-space:nowrap" class="ft3440">&#160;63&#160;</p>
<p style="position:absolute;top:495px;left:486px;white-space:nowrap" class="ft3440">Diazepam&#160;</p>
<p style="position:absolute;top:495px;left:837px;white-space:nowrap" class="ft3440">&#160;64&#160;</p>
<p style="position:absolute;top:519px;left:486px;white-space:nowrap" class="ft3440">Diclofenac&#160;Gel 1%&#160;</p>
<p style="position:absolute;top:519px;left:837px;white-space:nowrap" class="ft3440">&#160;65&#160;</p>
<p style="position:absolute;top:542px;left:486px;white-space:nowrap" class="ft3440">Diclofenac&#160;Sodium&#160;</p>
<p style="position:absolute;top:542px;left:837px;white-space:nowrap" class="ft3440">&#160;65&#160;</p>
<p style="position:absolute;top:566px;left:486px;white-space:nowrap" class="ft3440">Diclofenac&#160;Soln&#160;</p>
<p style="position:absolute;top:566px;left:837px;white-space:nowrap" class="ft3440">&#160;66&#160;</p>
<p style="position:absolute;top:590px;left:486px;white-space:nowrap" class="ft3440">Dicyclomine Hcl&#160;</p>
<p style="position:absolute;top:590px;left:828px;white-space:nowrap" class="ft3440">&#160;110&#160;</p>
<p style="position:absolute;top:614px;left:486px;white-space:nowrap" class="ft3440">Dicyclomine Hydrochloride&#160;</p>
<p style="position:absolute;top:614px;left:828px;white-space:nowrap" class="ft3440">&#160;110&#160;</p>
<p style="position:absolute;top:638px;left:486px;white-space:nowrap" class="ft3440">Dihydroergotamine Mesylate</p>
<p style="position:absolute;top:638px;left:801px;white-space:nowrap" class="ft3440">&#160;62, 110&#160;</p>
<p style="position:absolute;top:661px;left:486px;white-space:nowrap" class="ft3440">Diphenhydramine&#160;Hcl&#160;</p>
<p style="position:absolute;top:661px;left:828px;white-space:nowrap" class="ft3440">&#160;110&#160;</p>
<p style="position:absolute;top:685px;left:486px;white-space:nowrap" class="ft3447">Diphtheria/tetanus Toxoids Adsorbed Pediatric&#160;339&#160;<br/>Dipyridamole&#160;</p>
<p style="position:absolute;top:709px;left:828px;white-space:nowrap" class="ft3440">&#160;110&#160;</p>
<p style="position:absolute;top:733px;left:486px;white-space:nowrap" class="ft3440">Disopyramide Phosphate&#160;</p>
<p style="position:absolute;top:733px;left:828px;white-space:nowrap" class="ft3440">&#160;110&#160;</p>
<p style="position:absolute;top:757px;left:486px;white-space:nowrap" class="ft3440">Doptelet&#160;</p>
<p style="position:absolute;top:757px;left:837px;white-space:nowrap" class="ft3440">&#160;67&#160;</p>
<p style="position:absolute;top:780px;left:486px;white-space:nowrap" class="ft3440">Doxepin Hcl&#160;</p>
<p style="position:absolute;top:780px;left:828px;white-space:nowrap" class="ft3440">&#160;119&#160;</p>
<p style="position:absolute;top:804px;left:486px;white-space:nowrap" class="ft3440">Doxepin Hydrochloride&#160;</p>
<p style="position:absolute;top:804px;left:792px;white-space:nowrap" class="ft3440">&#160;119, 286&#160;</p>
<p style="position:absolute;top:828px;left:486px;white-space:nowrap" class="ft3440">Doxycycline&#160;</p>
<p style="position:absolute;top:828px;left:828px;white-space:nowrap" class="ft3440">&#160;208&#160;</p>
<p style="position:absolute;top:852px;left:486px;white-space:nowrap" class="ft3440">Drizalma&#160;</p>
<p style="position:absolute;top:852px;left:837px;white-space:nowrap" class="ft3440">&#160;68&#160;</p>
<p style="position:absolute;top:876px;left:486px;white-space:nowrap" class="ft3440">Drizalma Sprinkle&#160;</p>
<p style="position:absolute;top:876px;left:837px;white-space:nowrap" class="ft3440">&#160;68&#160;</p>
<p style="position:absolute;top:899px;left:486px;white-space:nowrap" class="ft3440">Dronabinol&#160;</p>
<p style="position:absolute;top:899px;left:837px;white-space:nowrap" class="ft3440">&#160;69&#160;</p>
<p style="position:absolute;top:923px;left:486px;white-space:nowrap" class="ft3440">Droxidopa&#160;</p>
<p style="position:absolute;top:923px;left:828px;white-space:nowrap" class="ft3440">&#160;198&#160;</p>
<p style="position:absolute;top:947px;left:486px;white-space:nowrap" class="ft3440">Duexis&#160;</p>
<p style="position:absolute;top:947px;left:837px;white-space:nowrap" class="ft3440">&#160;70&#160;</p>
<p style="position:absolute;top:980px;left:486px;white-space:nowrap" class="ft34415"><i><b>E</b></i></p>
<p style="position:absolute;top:982px;left:498px;white-space:nowrap" class="ft34416"><i>&#160;</i></p>
<p style="position:absolute;top:1013px;left:486px;white-space:nowrap" class="ft3440">Emend&#160;</p>
<p style="position:absolute;top:1013px;left:828px;white-space:nowrap" class="ft3440">&#160;339&#160;</p>
<p style="position:absolute;top:1036px;left:486px;white-space:nowrap" class="ft3440">Emsam</p>
<p style="position:absolute;top:1036px;left:837px;white-space:nowrap" class="ft3440">&#160;71&#160;</p>
<p style="position:absolute;top:1060px;left:486px;white-space:nowrap" class="ft3440">Enbrel&#160;</p>
<p style="position:absolute;top:1060px;left:837px;white-space:nowrap" class="ft3440">&#160;72&#160;</p>
<p style="position:absolute;top:1084px;left:486px;white-space:nowrap" class="ft3440">Enbrel&#160;Mini&#160;</p>
<p style="position:absolute;top:1084px;left:837px;white-space:nowrap" class="ft3440">&#160;72&#160;</p>
</div>
<!-- Page 345 -->
<a name="345"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page345-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2345.png" alt="background image"/>
<p style="position:absolute;top:33px;left:62px;white-space:nowrap" class="ft3457">&#160;<br/>&#160;</p>
<p style="position:absolute;top:1128px;left:830px;white-space:nowrap" class="ft3450">345&#160;</p>
<p style="position:absolute;top:96px;left:62px;white-space:nowrap" class="ft3450">Enbrel&#160;Sureclick&#160;..................................................&#160;</p>
<p style="position:absolute;top:120px;left:135px;white-space:nowrap" class="ft3450">...........................................................&#160;</p>
<p style="position:absolute;top:143px;left:122px;white-space:nowrap" class="ft3450">................................................................&#160;</p>
<p style="position:absolute;top:167px;left:118px;white-space:nowrap" class="ft3450">&#160;................................................................&#160;</p>
<p style="position:absolute;top:191px;left:119px;white-space:nowrap" class="ft3450">&#160;................................................................&#160;</p>
<p style="position:absolute;top:215px;left:132px;white-space:nowrap" class="ft3450">&#160;.............................................................&#160;</p>
<p style="position:absolute;top:239px;left:95px;white-space:nowrap" class="ft3450">............................</p>
<p style="position:absolute;top:239px;left:374px;white-space:nowrap" class="ft3457">........&#160;<br/>......&#160;</p>
<p style="position:absolute;top:286px;left:198px;white-space:nowrap" class="ft3450">.....</p>
<p style="position:absolute;top:286px;left:374px;white-space:nowrap" class="ft3450">........&#160;</p>
<p style="position:absolute;top:310px;left:117px;white-space:nowrap" class="ft3450">.......................</p>
<p style="position:absolute;top:310px;left:374px;white-space:nowrap" class="ft3450">........&#160;</p>
<p style="position:absolute;top:334px;left:157px;white-space:nowrap" class="ft3450">..............</p>
<p style="position:absolute;top:334px;left:374px;white-space:nowrap" class="ft3457">........&#160;<br/>........&#160;</p>
<p style="position:absolute;top:381px;left:112px;white-space:nowrap" class="ft3450">........................</p>
<p style="position:absolute;top:381px;left:374px;white-space:nowrap" class="ft3450">........&#160;</p>
<p style="position:absolute;top:405px;left:149px;white-space:nowrap" class="ft3450">&#160;...............</p>
<p style="position:absolute;top:405px;left:374px;white-space:nowrap" class="ft3450">......&#160;</p>
<p style="position:absolute;top:429px;left:148px;white-space:nowrap" class="ft3450">..................................................&#160;</p>
<p style="position:absolute;top:453px;left:126px;white-space:nowrap" class="ft3450">...............................................................&#160;</p>
<p style="position:absolute;top:519px;left:112px;white-space:nowrap" class="ft3450">..................................................................&#160;</p>
<p style="position:absolute;top:542px;left:221px;white-space:nowrap" class="ft3450">..........................................&#160;</p>
<p style="position:absolute;top:566px;left:121px;white-space:nowrap" class="ft3450">................................................................&#160;</p>
<p style="position:absolute;top:590px;left:266px;white-space:nowrap" class="ft3450">................................&#160;</p>
<p style="position:absolute;top:590px;left:121px;white-space:nowrap" class="ft3450">................................</p>
<p style="position:absolute;top:614px;left:153px;white-space:nowrap" class="ft3450">.........................................................&#160;</p>
<p style="position:absolute;top:638px;left:270px;white-space:nowrap" class="ft3450">...............................&#160;</p>
<p style="position:absolute;top:638px;left:126px;white-space:nowrap" class="ft3450">................................</p>
<p style="position:absolute;top:661px;left:324px;white-space:nowrap" class="ft3450">.................&#160;</p>
<p style="position:absolute;top:685px;left:171px;white-space:nowrap" class="ft3450">.....................................................&#160;</p>
<p style="position:absolute;top:709px;left:122px;white-space:nowrap" class="ft3450">................................................................&#160;</p>
<p style="position:absolute;top:733px;left:230px;white-space:nowrap" class="ft3450">........................................&#160;</p>
<p style="position:absolute;top:757px;left:266px;white-space:nowrap" class="ft3450">................................&#160;</p>
<p style="position:absolute;top:757px;left:122px;white-space:nowrap" class="ft3450">................................</p>
<p style="position:absolute;top:780px;left:185px;white-space:nowrap" class="ft3450">................................................&#160;</p>
<p style="position:absolute;top:804px;left:144px;white-space:nowrap" class="ft3450">...........................................................&#160;</p>
<p style="position:absolute;top:828px;left:297px;white-space:nowrap" class="ft3450">...........&#160;</p>
<p style="position:absolute;top:828px;left:153px;white-space:nowrap" class="ft3450">................................</p>
<p style="position:absolute;top:852px;left:198px;white-space:nowrap" class="ft3450">...............................................&#160;</p>
<p style="position:absolute;top:876px;left:257px;white-space:nowrap" class="ft3450">..................................&#160;</p>
<p style="position:absolute;top:876px;left:113px;white-space:nowrap" class="ft3450">................................</p>
<p style="position:absolute;top:899px;left:117px;white-space:nowrap" class="ft3450">.................................................................&#160;</p>
<p style="position:absolute;top:923px;left:207px;white-space:nowrap" class="ft3450">...........................................&#160;</p>
<p style="position:absolute;top:947px;left:153px;white-space:nowrap" class="ft3450">.......................................................&#160;</p>
<p style="position:absolute;top:971px;left:275px;white-space:nowrap" class="ft3450">..............................&#160;</p>
<p style="position:absolute;top:971px;left:131px;white-space:nowrap" class="ft3450">................................</p>
<p style="position:absolute;top:1036px;left:135px;white-space:nowrap" class="ft3450">...........................................................&#160;</p>
<p style="position:absolute;top:1060px;left:207px;white-space:nowrap" class="ft3450">...........................................&#160;</p>
<p style="position:absolute;top:1084px;left:356px;white-space:nowrap" class="ft3450">..........&#160;</p>
<p style="position:absolute;top:239px;left:221px;white-space:nowrap" class="ft3450">..................................</p>
<p style="position:absolute;top:262px;left:347px;white-space:nowrap" class="ft3450">......</p>
<p style="position:absolute;top:286px;left:221px;white-space:nowrap" class="ft3457">............<br/>.........</p>
<p style="position:absolute;top:262px;left:221px;white-space:nowrap" class="ft3450">............................</p>
<p style="position:absolute;top:286px;left:275px;white-space:nowrap" class="ft3450">.................</p>
<p style="position:absolute;top:310px;left:261px;white-space:nowrap" class="ft3450">....................</p>
<p style="position:absolute;top:286px;left:131px;white-space:nowrap" class="ft3450">...............</p>
<p style="position:absolute;top:286px;left:351px;white-space:nowrap" class="ft3457">.....<br/>.....<br/>.....</p>
<p style="position:absolute;top:334px;left:270px;white-space:nowrap" class="ft3450">..................</p>
<p style="position:absolute;top:334px;left:221px;white-space:nowrap" class="ft3450">...........</p>
<p style="position:absolute;top:334px;left:126px;white-space:nowrap" class="ft3450">.......</p>
<p style="position:absolute;top:358px;left:239px;white-space:nowrap" class="ft3450">..............................</p>
<p style="position:absolute;top:381px;left:221px;white-space:nowrap" class="ft3450">..................................</p>
<p style="position:absolute;top:405px;left:297px;white-space:nowrap" class="ft3450">.................</p>
<p style="position:absolute;top:405px;left:221px;white-space:nowrap" class="ft3450">.................</p>
<p style="position:absolute;top:262px;left:218px;white-space:nowrap" class="ft3450">&#160;</p>
<p style="position:absolute;top:358px;left:235px;white-space:nowrap" class="ft3450">&#160;</p>
<p style="position:absolute;top:96px;left:413px;white-space:nowrap" class="ft3450">72&#160;</p>
<p style="position:absolute;top:120px;left:62px;white-space:nowrap" class="ft3450">Engerix-b&#160;</p>
<p style="position:absolute;top:120px;left:404px;white-space:nowrap" class="ft3450">339&#160;</p>
<p style="position:absolute;top:143px;left:62px;white-space:nowrap" class="ft3450">Enhertu&#160;</p>
<p style="position:absolute;top:143px;left:413px;white-space:nowrap" class="ft3450">74&#160;</p>
<p style="position:absolute;top:167px;left:62px;white-space:nowrap" class="ft3450">Enstilar</p>
<p style="position:absolute;top:167px;left:413px;white-space:nowrap" class="ft3450">37&#160;</p>
<p style="position:absolute;top:191px;left:62px;white-space:nowrap" class="ft3450">Epclusa</p>
<p style="position:absolute;top:191px;left:413px;white-space:nowrap" class="ft3450">75&#160;</p>
<p style="position:absolute;top:215px;left:62px;white-space:nowrap" class="ft3450">Epidiolex</p>
<p style="position:absolute;top:215px;left:413px;white-space:nowrap" class="ft3450">76&#160;</p>
<p style="position:absolute;top:239px;left:62px;white-space:nowrap" class="ft3450">Epo&#160;</p>
<p style="position:absolute;top:239px;left:413px;white-space:nowrap" class="ft3450">77&#160;</p>
<p style="position:absolute;top:262px;left:62px;white-space:nowrap" class="ft3450">Epoprostenol Sodium</p>
<p style="position:absolute;top:262px;left:404px;white-space:nowrap" class="ft3450">339&#160;</p>
<p style="position:absolute;top:286px;left:62px;white-space:nowrap" class="ft3450">Erivedge&#160;</p>
<p style="position:absolute;top:286px;left:413px;white-space:nowrap" class="ft3450">79&#160;</p>
<p style="position:absolute;top:310px;left:62px;white-space:nowrap" class="ft3450">Erleada&#160;</p>
<p style="position:absolute;top:310px;left:413px;white-space:nowrap" class="ft3450">80&#160;</p>
<p style="position:absolute;top:334px;left:62px;white-space:nowrap" class="ft3450">Erlotinib&#160;</p>
<p style="position:absolute;top:334px;left:413px;white-space:nowrap" class="ft3450">81&#160;</p>
<p style="position:absolute;top:358px;left:62px;white-space:nowrap" class="ft3450">Erlotinib Hydrochloride</p>
<p style="position:absolute;top:358px;left:413px;white-space:nowrap" class="ft3450">81&#160;</p>
<p style="position:absolute;top:381px;left:62px;white-space:nowrap" class="ft3450">Esbriet</p>
<p style="position:absolute;top:381px;left:413px;white-space:nowrap" class="ft3450">82&#160;</p>
<p style="position:absolute;top:405px;left:62px;white-space:nowrap" class="ft3450">Eszopiclone</p>
<p style="position:absolute;top:405px;left:404px;white-space:nowrap" class="ft3450">113&#160;</p>
<p style="position:absolute;top:429px;left:62px;white-space:nowrap" class="ft3450">Everolimus&#160;</p>
<p style="position:absolute;top:429px;left:377px;white-space:nowrap" class="ft3450">83, 339&#160;</p>
<p style="position:absolute;top:453px;left:62px;white-space:nowrap" class="ft3450">Exkivity&#160;</p>
<p style="position:absolute;top:453px;left:413px;white-space:nowrap" class="ft3450">84&#160;</p>
<p style="position:absolute;top:486px;left:62px;white-space:nowrap" class="ft34515"><i><b>F</b></i></p>
<p style="position:absolute;top:488px;left:74px;white-space:nowrap" class="ft34516"><i>&#160;</i></p>
<p style="position:absolute;top:519px;left:62px;white-space:nowrap" class="ft3450">Fanapt&#160;</p>
<p style="position:absolute;top:519px;left:413px;white-space:nowrap" class="ft3450">85&#160;</p>
<p style="position:absolute;top:542px;left:62px;white-space:nowrap" class="ft3450">Fanapt Titration Pack&#160;</p>
<p style="position:absolute;top:542px;left:413px;white-space:nowrap" class="ft3450">85&#160;</p>
<p style="position:absolute;top:566px;left:62px;white-space:nowrap" class="ft3450">Farydak&#160;</p>
<p style="position:absolute;top:566px;left:413px;white-space:nowrap" class="ft3450">86&#160;</p>
<p style="position:absolute;top:590px;left:62px;white-space:nowrap" class="ft3450">Fasenra&#160;</p>
<p style="position:absolute;top:590px;left:413px;white-space:nowrap" class="ft3450">87&#160;</p>
<p style="position:absolute;top:614px;left:62px;white-space:nowrap" class="ft3450">Fasenra Pen&#160;</p>
<p style="position:absolute;top:614px;left:413px;white-space:nowrap" class="ft3450">87&#160;</p>
<p style="position:absolute;top:638px;left:62px;white-space:nowrap" class="ft3450">Fentanyl&#160;</p>
<p style="position:absolute;top:638px;left:413px;white-space:nowrap" class="ft3450">88&#160;</p>
<p style="position:absolute;top:661px;left:62px;white-space:nowrap" class="ft3450">Fentanyl&#160;Citrate Oral Transmucosal&#160;</p>
<p style="position:absolute;top:661px;left:404px;white-space:nowrap" class="ft3450">209&#160;</p>
<p style="position:absolute;top:685px;left:62px;white-space:nowrap" class="ft3450">Fentanyl&#160;Patch&#160;</p>
<p style="position:absolute;top:685px;left:413px;white-space:nowrap" class="ft3450">88&#160;</p>
<p style="position:absolute;top:709px;left:62px;white-space:nowrap" class="ft3450">Fetzima&#160;</p>
<p style="position:absolute;top:709px;left:413px;white-space:nowrap" class="ft3450">89&#160;</p>
<p style="position:absolute;top:733px;left:62px;white-space:nowrap" class="ft3450">Fetzima Titration Pack&#160;</p>
<p style="position:absolute;top:733px;left:413px;white-space:nowrap" class="ft3450">89&#160;</p>
<p style="position:absolute;top:757px;left:62px;white-space:nowrap" class="ft3450">Fintepla&#160;</p>
<p style="position:absolute;top:757px;left:413px;white-space:nowrap" class="ft3450">90&#160;</p>
<p style="position:absolute;top:780px;left:62px;white-space:nowrap" class="ft3450">Flebogamma Dif&#160;</p>
<p style="position:absolute;top:780px;left:404px;white-space:nowrap" class="ft3450">156&#160;</p>
<p style="position:absolute;top:804px;left:62px;white-space:nowrap" class="ft3450">Fluoroplex&#160;</p>
<p style="position:absolute;top:804px;left:413px;white-space:nowrap" class="ft3450">91&#160;</p>
<p style="position:absolute;top:828px;left:62px;white-space:nowrap" class="ft3450">Fluorouracil&#160;</p>
<p style="position:absolute;top:828px;left:350px;white-space:nowrap" class="ft3450">41, 91, 339&#160;</p>
<p style="position:absolute;top:852px;left:62px;white-space:nowrap" class="ft3450">Fortamet/glumetza&#160;</p>
<p style="position:absolute;top:852px;left:413px;white-space:nowrap" class="ft3450">92&#160;</p>
<p style="position:absolute;top:876px;left:62px;white-space:nowrap" class="ft3450">Forteo&#160;</p>
<p style="position:absolute;top:876px;left:413px;white-space:nowrap" class="ft3450">93&#160;</p>
<p style="position:absolute;top:899px;left:62px;white-space:nowrap" class="ft3450">Fotivda&#160;</p>
<p style="position:absolute;top:899px;left:413px;white-space:nowrap" class="ft3450">95&#160;</p>
<p style="position:absolute;top:923px;left:62px;white-space:nowrap" class="ft3450">Freamine&#160;Hbc 6.9%&#160;</p>
<p style="position:absolute;top:923px;left:404px;white-space:nowrap" class="ft3450">339&#160;</p>
<p style="position:absolute;top:947px;left:62px;white-space:nowrap" class="ft3450">Freamine&#160;III&#160;</p>
<p style="position:absolute;top:947px;left:404px;white-space:nowrap" class="ft3450">339&#160;</p>
<p style="position:absolute;top:971px;left:62px;white-space:nowrap" class="ft3450">Fycompa&#160;</p>
<p style="position:absolute;top:971px;left:413px;white-space:nowrap" class="ft3450">96&#160;</p>
<p style="position:absolute;top:1004px;left:62px;white-space:nowrap" class="ft34515"><i><b>G</b></i></p>
<p style="position:absolute;top:1006px;left:75px;white-space:nowrap" class="ft34516"><i>&#160;</i></p>
<p style="position:absolute;top:1036px;left:62px;white-space:nowrap" class="ft3450">Gamastan&#160;</p>
<p style="position:absolute;top:1036px;left:404px;white-space:nowrap" class="ft3450">339&#160;</p>
<p style="position:absolute;top:1060px;left:62px;white-space:nowrap" class="ft3450">Gammagard Liquid&#160;</p>
<p style="position:absolute;top:1060px;left:404px;white-space:nowrap" class="ft3450">156&#160;</p>
<p style="position:absolute;top:1084px;left:62px;white-space:nowrap" class="ft3450">Gammagard S/d Iga Less Than 1mcg/ml&#160;</p>
<p style="position:absolute;top:1084px;left:404px;white-space:nowrap" class="ft3450">156&#160;</p>
<p style="position:absolute;top:96px;left:486px;white-space:nowrap" class="ft3450">Gammaked&#160;.........................................................</p>
<p style="position:absolute;top:120px;left:574px;white-space:nowrap" class="ft3450">&#160;........................................................</p>
<p style="position:absolute;top:143px;left:570px;white-space:nowrap" class="ft3450">&#160;.........................................................</p>
<p style="position:absolute;top:167px;left:571px;white-space:nowrap" class="ft3450">&#160;.........................................................</p>
<p style="position:absolute;top:191px;left:534px;white-space:nowrap" class="ft3450">&#160;...................................................................</p>
<p style="position:absolute;top:215px;left:544px;white-space:nowrap" class="ft3450">&#160;.................................................................&#160;</p>
<p style="position:absolute;top:239px;left:545px;white-space:nowrap" class="ft3450">&#160;..............................................................&#160;</p>
<p style="position:absolute;top:262px;left:568px;white-space:nowrap" class="ft3450">&#160;.........................................................&#160;</p>
<p style="position:absolute;top:286px;left:648px;white-space:nowrap" class="ft3450">........................................</p>
<p style="position:absolute;top:310px;left:545px;white-space:nowrap" class="ft3450">................................................................</p>
<p style="position:absolute;top:334px;left:540px;white-space:nowrap" class="ft3450">................................................................</p>
<p style="position:absolute;top:358px;left:567px;white-space:nowrap" class="ft3450">..........................................................</p>
<p style="position:absolute;top:381px;left:603px;white-space:nowrap" class="ft3450">..................................................</p>
<p style="position:absolute;top:405px;left:617px;white-space:nowrap" class="ft3450">...............................................</p>
<p style="position:absolute;top:429px;left:594px;white-space:nowrap" class="ft3450">....................................................</p>
<p style="position:absolute;top:453px;left:603px;white-space:nowrap" class="ft3450">..................................................</p>
<p style="position:absolute;top:477px;left:680px;white-space:nowrap" class="ft3450">.................................</p>
<p style="position:absolute;top:542px;left:558px;white-space:nowrap" class="ft3450">............................................................</p>
<p style="position:absolute;top:566px;left:549px;white-space:nowrap" class="ft3450">..............................................................</p>
<p style="position:absolute;top:590px;left:576px;white-space:nowrap" class="ft3450">........................................................</p>
<p style="position:absolute;top:614px;left:621px;white-space:nowrap" class="ft3450">..............................................</p>
<p style="position:absolute;top:638px;left:540px;white-space:nowrap" class="ft3450">................................................................</p>
<p style="position:absolute;top:661px;left:567px;white-space:nowrap" class="ft3450">..........................................................</p>
<p style="position:absolute;top:685px;left:680px;white-space:nowrap" class="ft3450">.................................</p>
<p style="position:absolute;top:709px;left:684px;white-space:nowrap" class="ft3450">................................</p>
<p style="position:absolute;top:733px;left:644px;white-space:nowrap" class="ft3450">.........................................</p>
<p style="position:absolute;top:757px;left:662px;white-space:nowrap" class="ft3450">.....................................</p>
<p style="position:absolute;top:780px;left:657px;white-space:nowrap" class="ft3450">......................................</p>
<p style="position:absolute;top:804px;left:671px;white-space:nowrap" class="ft3450">...................................&#160;</p>
<p style="position:absolute;top:828px;left:617px;white-space:nowrap" class="ft3450">...............................................</p>
<p style="position:absolute;top:852px;left:648px;white-space:nowrap" class="ft3450">........................................</p>
<p style="position:absolute;top:876px;left:675px;white-space:nowrap" class="ft3450">..................................&#160;</p>
<p style="position:absolute;top:899px;left:801px;white-space:nowrap" class="ft3450">......</p>
<p style="position:absolute;top:899px;left:657px;white-space:nowrap" class="ft3457">................................<br/>................................</p>
<p style="position:absolute;top:923px;left:828px;white-space:nowrap" class="ft3450">&#160;</p>
<p style="position:absolute;top:923px;left:801px;white-space:nowrap" class="ft3450">......</p>
<p style="position:absolute;top:947px;left:797px;white-space:nowrap" class="ft3450">.......</p>
<p style="position:absolute;top:947px;left:653px;white-space:nowrap" class="ft3457">................................<br/>.......................................</p>
<p style="position:absolute;top:995px;left:648px;white-space:nowrap" class="ft3450">........................................</p>
<p style="position:absolute;top:1018px;left:720px;white-space:nowrap" class="ft3450">........................</p>
<p style="position:absolute;top:1018px;left:576px;white-space:nowrap" class="ft3450">................................</p>
<p style="position:absolute;top:1042px;left:747px;white-space:nowrap" class="ft3450">..................</p>
<p style="position:absolute;top:1066px;left:689px;white-space:nowrap" class="ft3450">...............................</p>
<p style="position:absolute;top:1066px;left:545px;white-space:nowrap" class="ft3450">................................</p>
<p style="position:absolute;top:1090px;left:818px;white-space:nowrap" class="ft3450">&#160;..</p>
<p style="position:absolute;top:96px;left:828px;white-space:nowrap" class="ft3450">&#160;156&#160;</p>
<p style="position:absolute;top:120px;left:486px;white-space:nowrap" class="ft3450">Gammaplex</p>
<p style="position:absolute;top:120px;left:828px;white-space:nowrap" class="ft3450">&#160;156&#160;</p>
<p style="position:absolute;top:143px;left:486px;white-space:nowrap" class="ft3450">Gamunex-c</p>
<p style="position:absolute;top:143px;left:828px;white-space:nowrap" class="ft3450">&#160;156&#160;</p>
<p style="position:absolute;top:167px;left:486px;white-space:nowrap" class="ft3450">Ganciclovir</p>
<p style="position:absolute;top:167px;left:828px;white-space:nowrap" class="ft3450">&#160;339&#160;</p>
<p style="position:absolute;top:191px;left:486px;white-space:nowrap" class="ft3450">Gattex</p>
<p style="position:absolute;top:191px;left:837px;white-space:nowrap" class="ft3450">&#160;97&#160;</p>
<p style="position:absolute;top:215px;left:486px;white-space:nowrap" class="ft3450">Gavreto</p>
<p style="position:absolute;top:215px;left:838px;white-space:nowrap" class="ft3450">98&#160;</p>
<p style="position:absolute;top:239px;left:486px;white-space:nowrap" class="ft3450">Gengraf</p>
<p style="position:absolute;top:239px;left:829px;white-space:nowrap" class="ft3450">339&#160;</p>
<p style="position:absolute;top:262px;left:486px;white-space:nowrap" class="ft3450">Genotropin</p>
<p style="position:absolute;top:262px;left:829px;white-space:nowrap" class="ft3450">102&#160;</p>
<p style="position:absolute;top:286px;left:486px;white-space:nowrap" class="ft3450">Genotropin&#160;Miniquick&#160;</p>
<p style="position:absolute;top:286px;left:828px;white-space:nowrap" class="ft3450">&#160;102&#160;</p>
<p style="position:absolute;top:310px;left:486px;white-space:nowrap" class="ft3450">Gilenya&#160;</p>
<p style="position:absolute;top:310px;left:833px;white-space:nowrap" class="ft3450">.&#160;99&#160;</p>
<p style="position:absolute;top:334px;left:486px;white-space:nowrap" class="ft3450">Gilotrif</p>
<p style="position:absolute;top:334px;left:828px;white-space:nowrap" class="ft3450">&#160;100&#160;</p>
<p style="position:absolute;top:358px;left:486px;white-space:nowrap" class="ft3450">Glatiramer&#160;</p>
<p style="position:absolute;top:358px;left:828px;white-space:nowrap" class="ft3450">&#160;101&#160;</p>
<p style="position:absolute;top:381px;left:486px;white-space:nowrap" class="ft3450">Granisetron&#160;Hcl&#160;</p>
<p style="position:absolute;top:381px;left:828px;white-space:nowrap" class="ft3450">&#160;339&#160;</p>
<p style="position:absolute;top:405px;left:486px;white-space:nowrap" class="ft3450">Growth Hormone&#160;</p>
<p style="position:absolute;top:405px;left:828px;white-space:nowrap" class="ft3450">&#160;102&#160;</p>
<p style="position:absolute;top:429px;left:486px;white-space:nowrap" class="ft3450">Guanfacine Er&#160;</p>
<p style="position:absolute;top:429px;left:828px;white-space:nowrap" class="ft3450">&#160;110&#160;</p>
<p style="position:absolute;top:453px;left:486px;white-space:nowrap" class="ft3450">Guanfacine Hcl&#160;</p>
<p style="position:absolute;top:453px;left:828px;white-space:nowrap" class="ft3450">&#160;110&#160;</p>
<p style="position:absolute;top:477px;left:486px;white-space:nowrap" class="ft3450">Guanfacine Hydrochloride&#160;</p>
<p style="position:absolute;top:477px;left:828px;white-space:nowrap" class="ft3450">&#160;110&#160;</p>
<p style="position:absolute;top:510px;left:486px;white-space:nowrap" class="ft34515"><i><b>H</b></i></p>
<p style="position:absolute;top:512px;left:500px;white-space:nowrap" class="ft34516"><i>&#160;</i></p>
<p style="position:absolute;top:542px;left:486px;white-space:nowrap" class="ft3450">Haegarda&#160;</p>
<p style="position:absolute;top:542px;left:828px;white-space:nowrap" class="ft3450">&#160;105&#160;</p>
<p style="position:absolute;top:566px;left:486px;white-space:nowrap" class="ft3450">Harvoni&#160;</p>
<p style="position:absolute;top:566px;left:828px;white-space:nowrap" class="ft3450">&#160;106&#160;</p>
<p style="position:absolute;top:590px;left:486px;white-space:nowrap" class="ft3450">Hepatamine&#160;</p>
<p style="position:absolute;top:590px;left:828px;white-space:nowrap" class="ft3450">&#160;339&#160;</p>
<p style="position:absolute;top:614px;left:486px;white-space:nowrap" class="ft3450">Herceptin Hylecta&#160;</p>
<p style="position:absolute;top:614px;left:828px;white-space:nowrap" class="ft3450">&#160;107&#160;</p>
<p style="position:absolute;top:638px;left:486px;white-space:nowrap" class="ft3450">Hetlioz&#160;</p>
<p style="position:absolute;top:638px;left:828px;white-space:nowrap" class="ft3450">&#160;108&#160;</p>
<p style="position:absolute;top:661px;left:486px;white-space:nowrap" class="ft3450">Hetlioz Lq&#160;</p>
<p style="position:absolute;top:661px;left:828px;white-space:nowrap" class="ft3450">&#160;109&#160;</p>
<p style="position:absolute;top:685px;left:486px;white-space:nowrap" class="ft3450">High Risk Medication&#160;-&#160;65&#160;</p>
<p style="position:absolute;top:685px;left:828px;white-space:nowrap" class="ft3450">&#160;110&#160;</p>
<p style="position:absolute;top:709px;left:486px;white-space:nowrap" class="ft3450">Hrm&#160;-&#160;Anticonvulsants&#160;-&#160;65</p>
<p style="position:absolute;top:709px;left:828px;white-space:nowrap" class="ft3450">&#160;112&#160;</p>
<p style="position:absolute;top:733px;left:486px;white-space:nowrap" class="ft3450">Hrm&#160;-&#160;Hypnotics&#160;-&#160;65&#160;</p>
<p style="position:absolute;top:733px;left:828px;white-space:nowrap" class="ft3450">&#160;113&#160;</p>
<p style="position:absolute;top:757px;left:486px;white-space:nowrap" class="ft3450">Hrm&#160;-&#160;Scopolamine&#160;-&#160;65&#160;</p>
<p style="position:absolute;top:757px;left:828px;white-space:nowrap" class="ft3450">&#160;115&#160;</p>
<p style="position:absolute;top:780px;left:486px;white-space:nowrap" class="ft3450">Hrm-antiparkinson&#160;-&#160;65&#160;</p>
<p style="position:absolute;top:780px;left:828px;white-space:nowrap" class="ft3450">&#160;116&#160;</p>
<p style="position:absolute;top:804px;left:486px;white-space:nowrap" class="ft3450">Hrm-cyproheptadine&#160;-&#160;65&#160;</p>
<p style="position:absolute;top:804px;left:829px;white-space:nowrap" class="ft3450">118&#160;</p>
<p style="position:absolute;top:828px;left:486px;white-space:nowrap" class="ft3450">Hrm-doxepin&#160;-&#160;65&#160;</p>
<p style="position:absolute;top:828px;left:828px;white-space:nowrap" class="ft3450">&#160;119&#160;</p>
<p style="position:absolute;top:852px;left:486px;white-space:nowrap" class="ft3450">Hrm-hydroxyzine&#160;-&#160;65</p>
<p style="position:absolute;top:852px;left:828px;white-space:nowrap" class="ft3450">&#160;121&#160;</p>
<p style="position:absolute;top:876px;left:486px;white-space:nowrap" class="ft3450">Hrm-hydroxyzine&#160;Inj&#160;-&#160;65&#160;</p>
<p style="position:absolute;top:876px;left:829px;white-space:nowrap" class="ft3450">123&#160;</p>
<p style="position:absolute;top:899px;left:486px;white-space:nowrap" class="ft3450">Hrm-promethazine&#160;-&#160;65&#160;</p>
<p style="position:absolute;top:899px;left:828px;white-space:nowrap" class="ft3450">&#160;125&#160;</p>
<p style="position:absolute;top:923px;left:486px;white-space:nowrap" class="ft3450">Hrms&#160;-&#160;Antidepressants&#160;</p>
<p style="position:absolute;top:923px;left:829px;white-space:nowrap" class="ft3450">127&#160;</p>
<p style="position:absolute;top:947px;left:486px;white-space:nowrap" class="ft3450">Hrms&#160;-&#160;Carbinoxamine&#160;</p>
<p style="position:absolute;top:947px;left:828px;white-space:nowrap" class="ft3450">&#160;129&#160;</p>
<p style="position:absolute;top:971px;left:486px;white-space:nowrap" class="ft3450">Hrms&#160;-&#160;Clemastine-&#160;65&#160;</p>
<p style="position:absolute;top:971px;left:828px;white-space:nowrap" class="ft3450">&#160;130&#160;</p>
<p style="position:absolute;top:995px;left:486px;white-space:nowrap" class="ft3450">Hrms&#160;-&#160;Meclizine&#160;-&#160;65&#160;</p>
<p style="position:absolute;top:995px;left:828px;white-space:nowrap" class="ft3450">&#160;131&#160;</p>
<p style="position:absolute;top:1018px;left:486px;white-space:nowrap" class="ft3450">Hrms&#160;-&#160;Tcas&#160;</p>
<p style="position:absolute;top:1018px;left:828px;white-space:nowrap" class="ft3450">&#160;132&#160;</p>
<p style="position:absolute;top:1042px;left:486px;white-space:nowrap" class="ft3450">Hrm-skeletal Muscle Relaxants&#160;-&#160;65&#160;</p>
<p style="position:absolute;top:1042px;left:828px;white-space:nowrap" class="ft3450">&#160;133&#160;</p>
<p style="position:absolute;top:1066px;left:486px;white-space:nowrap" class="ft3450">Humira&#160;</p>
<p style="position:absolute;top:1066px;left:828px;white-space:nowrap" class="ft3450">&#160;134&#160;</p>
<p style="position:absolute;top:1090px;left:486px;white-space:nowrap" class="ft3450">Humira Pediatric Crohns&#160;Disease Starter Pack&#160;&#160;134&#160;</p>
</div>
<!-- Page 346 -->
<a name="346"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page346-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2346.png" alt="background image"/>
<p style="position:absolute;top:33px;left:62px;white-space:nowrap" class="ft3467">&#160;<br/>&#160;</p>
<p style="position:absolute;top:1128px;left:830px;white-space:nowrap" class="ft3460">346&#160;</p>
<p style="position:absolute;top:96px;left:62px;white-space:nowrap" class="ft3460">Humira Pen&#160;........................................................&#160;</p>
<p style="position:absolute;top:120px;left:270px;white-space:nowrap" class="ft3460">.............................&#160;</p>
<p style="position:absolute;top:143px;left:338px;white-space:nowrap" class="ft3460">..............&#160;</p>
<p style="position:absolute;top:167px;left:248px;white-space:nowrap" class="ft3460">..................................&#160;</p>
<p style="position:absolute;top:191px;left:302px;white-space:nowrap" class="ft3460">......................&#160;</p>
<p style="position:absolute;top:215px;left:257px;white-space:nowrap" class="ft3460">................................&#160;</p>
<p style="position:absolute;top:239px;left:212px;white-space:nowrap" class="ft3460">..........................................&#160;</p>
<p style="position:absolute;top:262px;left:293px;white-space:nowrap" class="ft3460">........................&#160;</p>
<p style="position:absolute;top:286px;left:189px;white-space:nowrap" class="ft3460">.......................................&#160;</p>
<p style="position:absolute;top:310px;left:266px;white-space:nowrap" class="ft3460">......................&#160;</p>
<p style="position:absolute;top:334px;left:225px;white-space:nowrap" class="ft3460">.......................................&#160;</p>
<p style="position:absolute;top:358px;left:158px;white-space:nowrap" class="ft3460">......................................................</p>
<p style="position:absolute;top:381px;left:288px;white-space:nowrap" class="ft3460">.........................&#160;</p>
<p style="position:absolute;top:405px;left:148px;white-space:nowrap" class="ft3460">........................................................&#160;</p>
<p style="position:absolute;top:471px;left:117px;white-space:nowrap" class="ft3460">...............................................................&#160;</p>
<p style="position:absolute;top:495px;left:216px;white-space:nowrap" class="ft3460">...........................................&#160;</p>
<p style="position:absolute;top:519px;left:126px;white-space:nowrap" class="ft3460">.............................................................&#160;</p>
<p style="position:absolute;top:542px;left:185px;white-space:nowrap" class="ft3460">................................................&#160;</p>
<p style="position:absolute;top:566px;left:112px;white-space:nowrap" class="ft3460">................................................................&#160;</p>
<p style="position:absolute;top:590px;left:108px;white-space:nowrap" class="ft3460">.................................................................&#160;</p>
<p style="position:absolute;top:614px;left:126px;white-space:nowrap" class="ft3460">.............................................................&#160;</p>
<p style="position:absolute;top:638px;left:194px;white-space:nowrap" class="ft3460">..............................................&#160;</p>
<p style="position:absolute;top:661px;left:139px;white-space:nowrap" class="ft3460">..........................................................&#160;</p>
<p style="position:absolute;top:685px;left:180px;white-space:nowrap" class="ft3460">.................................................&#160;</p>
<p style="position:absolute;top:709px;left:257px;white-space:nowrap" class="ft3460">................................&#160;</p>
<p style="position:absolute;top:733px;left:216px;white-space:nowrap" class="ft3460">.........................................&#160;</p>
<p style="position:absolute;top:757px;left:121px;white-space:nowrap" class="ft3460">..............................................................&#160;</p>
<p style="position:absolute;top:780px;left:243px;white-space:nowrap" class="ft3460">...................................&#160;</p>
<p style="position:absolute;top:804px;left:121px;white-space:nowrap" class="ft3460">..............................................................&#160;</p>
<p style="position:absolute;top:828px;left:103px;white-space:nowrap" class="ft3460">..................................................................&#160;</p>
<p style="position:absolute;top:852px;left:112px;white-space:nowrap" class="ft3467">................................................................&#160;<br/>................................................................&#160;</p>
<p style="position:absolute;top:899px;left:216px;white-space:nowrap" class="ft3460">.........................................&#160;</p>
<p style="position:absolute;top:923px;left:342px;white-space:nowrap" class="ft3460">.............&#160;</p>
<p style="position:absolute;top:947px;left:149px;white-space:nowrap" class="ft3460">........................................................&#160;</p>
<p style="position:absolute;top:971px;left:248px;white-space:nowrap" class="ft3460">..................................&#160;</p>
<p style="position:absolute;top:971px;left:103px;white-space:nowrap" class="ft3460">................................</p>
<p style="position:absolute;top:995px;left:126px;white-space:nowrap" class="ft3460">.............................................................&#160;</p>
<p style="position:absolute;top:1018px;left:176px;white-space:nowrap" class="ft3460">..................................................&#160;</p>
<p style="position:absolute;top:1042px;left:148px;white-space:nowrap" class="ft3460">........................................................&#160;</p>
<p style="position:absolute;top:1066px;left:297px;white-space:nowrap" class="ft3460">.......................&#160;</p>
<p style="position:absolute;top:1066px;left:153px;white-space:nowrap" class="ft3460">................................</p>
<p style="position:absolute;top:1090px;left:139px;white-space:nowrap" class="ft3460">..........................................................&#160;</p>
<p style="position:absolute;top:96px;left:404px;white-space:nowrap" class="ft3460">134&#160;</p>
<p style="position:absolute;top:120px;left:62px;white-space:nowrap" class="ft3460">Humira Pen-cd/uc/hs Starter&#160;</p>
<p style="position:absolute;top:120px;left:404px;white-space:nowrap" class="ft3460">134&#160;</p>
<p style="position:absolute;top:143px;left:62px;white-space:nowrap" class="ft3460">Humira Pen-pediatric Uc Starter&#160;Pack&#160;</p>
<p style="position:absolute;top:143px;left:404px;white-space:nowrap" class="ft3460">134&#160;</p>
<p style="position:absolute;top:167px;left:62px;white-space:nowrap" class="ft3460">Humira Pen-ps/uv&#160;Starter&#160;</p>
<p style="position:absolute;top:167px;left:404px;white-space:nowrap" class="ft3460">134&#160;</p>
<p style="position:absolute;top:191px;left:62px;white-space:nowrap" class="ft3460">Humulin R&#160;U-500 (concentrated)&#160;</p>
<p style="position:absolute;top:191px;left:404px;white-space:nowrap" class="ft3460">339&#160;</p>
<p style="position:absolute;top:215px;left:62px;white-space:nowrap" class="ft3460">Hydrocodone Bitartrate&#160;Er&#160;</p>
<p style="position:absolute;top:215px;left:404px;white-space:nowrap" class="ft3460">150&#160;</p>
<p style="position:absolute;top:239px;left:62px;white-space:nowrap" class="ft3460">Hydromorphone Hcl&#160;</p>
<p style="position:absolute;top:239px;left:404px;white-space:nowrap" class="ft3460">339&#160;</p>
<p style="position:absolute;top:262px;left:62px;white-space:nowrap" class="ft3460">Hydromorphone Hydrochloride&#160;</p>
<p style="position:absolute;top:262px;left:404px;white-space:nowrap" class="ft3460">340&#160;</p>
<p style="position:absolute;top:286px;left:62px;white-space:nowrap" class="ft3460">Hydroxyzine Hcl&#160;</p>
<p style="position:absolute;top:286px;left:368px;white-space:nowrap" class="ft3460">121, 123&#160;</p>
<p style="position:absolute;top:310px;left:62px;white-space:nowrap" class="ft3460">Hydroxyzine Hydrochloride&#160;</p>
<p style="position:absolute;top:310px;left:368px;white-space:nowrap" class="ft3460">121, 123&#160;</p>
<p style="position:absolute;top:334px;left:62px;white-space:nowrap" class="ft3460">Hydroxyzine Pamoate&#160;</p>
<p style="position:absolute;top:334px;left:404px;white-space:nowrap" class="ft3460">121&#160;</p>
<p style="position:absolute;top:358px;left:62px;white-space:nowrap" class="ft3460">Hyperlyte-cr&#160;</p>
<p style="position:absolute;top:358px;left:401px;white-space:nowrap" class="ft3460">&#160;340&#160;</p>
<p style="position:absolute;top:381px;left:62px;white-space:nowrap" class="ft3460">Hypnotic-benzodiazepines&#160;-&#160;65&#160;</p>
<p style="position:absolute;top:381px;left:404px;white-space:nowrap" class="ft3460">136&#160;</p>
<p style="position:absolute;top:405px;left:62px;white-space:nowrap" class="ft3460">Hysingla Er&#160;</p>
<p style="position:absolute;top:405px;left:404px;white-space:nowrap" class="ft3460">150&#160;</p>
<p style="position:absolute;top:438px;left:62px;white-space:nowrap" class="ft34615"><i><b>I</b></i></p>
<p style="position:absolute;top:441px;left:69px;white-space:nowrap" class="ft34616"><i>&#160;</i></p>
<p style="position:absolute;top:471px;left:62px;white-space:nowrap" class="ft3460">Ibrance&#160;</p>
<p style="position:absolute;top:471px;left:404px;white-space:nowrap" class="ft3460">137&#160;</p>
<p style="position:absolute;top:495px;left:62px;white-space:nowrap" class="ft3460">Ibuprofen/famotidine&#160;</p>
<p style="position:absolute;top:495px;left:413px;white-space:nowrap" class="ft3460">70&#160;</p>
<p style="position:absolute;top:519px;left:62px;white-space:nowrap" class="ft3460">Icatibant&#160;</p>
<p style="position:absolute;top:519px;left:404px;white-space:nowrap" class="ft3460">138&#160;</p>
<p style="position:absolute;top:542px;left:62px;white-space:nowrap" class="ft3460">Icatibant Acetate&#160;</p>
<p style="position:absolute;top:542px;left:404px;white-space:nowrap" class="ft3460">138&#160;</p>
<p style="position:absolute;top:566px;left:62px;white-space:nowrap" class="ft3460">Iclusig&#160;</p>
<p style="position:absolute;top:566px;left:404px;white-space:nowrap" class="ft3460">139&#160;</p>
<p style="position:absolute;top:590px;left:62px;white-space:nowrap" class="ft3460">Idhifa&#160;</p>
<p style="position:absolute;top:590px;left:404px;white-space:nowrap" class="ft3460">140&#160;</p>
<p style="position:absolute;top:614px;left:62px;white-space:nowrap" class="ft3460">Imatinib&#160;</p>
<p style="position:absolute;top:614px;left:404px;white-space:nowrap" class="ft3460">141&#160;</p>
<p style="position:absolute;top:638px;left:62px;white-space:nowrap" class="ft3460">Imatinib&#160;Mesylate&#160;</p>
<p style="position:absolute;top:638px;left:404px;white-space:nowrap" class="ft3460">141&#160;</p>
<p style="position:absolute;top:661px;left:62px;white-space:nowrap" class="ft3460">Imbruvica&#160;</p>
<p style="position:absolute;top:661px;left:404px;white-space:nowrap" class="ft3460">142&#160;</p>
<p style="position:absolute;top:685px;left:62px;white-space:nowrap" class="ft3460">Imipramine Hcl&#160;</p>
<p style="position:absolute;top:685px;left:404px;white-space:nowrap" class="ft3460">127&#160;</p>
<p style="position:absolute;top:709px;left:62px;white-space:nowrap" class="ft3460">Imipramine Hydrochloride&#160;</p>
<p style="position:absolute;top:709px;left:404px;white-space:nowrap" class="ft3460">127&#160;</p>
<p style="position:absolute;top:733px;left:62px;white-space:nowrap" class="ft3460">Imipramine Pamoate&#160;</p>
<p style="position:absolute;top:733px;left:404px;white-space:nowrap" class="ft3460">127&#160;</p>
<p style="position:absolute;top:757px;left:62px;white-space:nowrap" class="ft3460">Imlygic&#160;</p>
<p style="position:absolute;top:757px;left:404px;white-space:nowrap" class="ft3460">145&#160;</p>
<p style="position:absolute;top:780px;left:62px;white-space:nowrap" class="ft3460">Imovax Rabies&#160;(h.d.c.v.)&#160;</p>
<p style="position:absolute;top:780px;left:404px;white-space:nowrap" class="ft3460">340&#160;</p>
<p style="position:absolute;top:804px;left:62px;white-space:nowrap" class="ft3460">Increlex&#160;</p>
<p style="position:absolute;top:804px;left:404px;white-space:nowrap" class="ft3460">146&#160;</p>
<p style="position:absolute;top:828px;left:62px;white-space:nowrap" class="ft3460">Inlyta</p>
<p style="position:absolute;top:828px;left:404px;white-space:nowrap" class="ft3460">147&#160;</p>
<p style="position:absolute;top:852px;left:62px;white-space:nowrap" class="ft3460">Inqovi&#160;</p>
<p style="position:absolute;top:852px;left:404px;white-space:nowrap" class="ft3460">148&#160;</p>
<p style="position:absolute;top:876px;left:62px;white-space:nowrap" class="ft3460">Inrebic</p>
<p style="position:absolute;top:876px;left:404px;white-space:nowrap" class="ft3460">149&#160;</p>
<p style="position:absolute;top:899px;left:62px;white-space:nowrap" class="ft3460">Ipratropium&#160;Bromide&#160;</p>
<p style="position:absolute;top:899px;left:404px;white-space:nowrap" class="ft3460">340&#160;</p>
<p style="position:absolute;top:923px;left:62px;white-space:nowrap" class="ft3460">Ipratropium&#160;Bromide/albuterol Sulfate&#160;</p>
<p style="position:absolute;top:923px;left:404px;white-space:nowrap" class="ft3460">340&#160;</p>
<p style="position:absolute;top:947px;left:62px;white-space:nowrap" class="ft3460">Ir&#160;Before Er</p>
<p style="position:absolute;top:947px;left:404px;white-space:nowrap" class="ft3460">150&#160;</p>
<p style="position:absolute;top:971px;left:62px;white-space:nowrap" class="ft3460">Iressa</p>
<p style="position:absolute;top:971px;left:404px;white-space:nowrap" class="ft3460">152&#160;</p>
<p style="position:absolute;top:995px;left:62px;white-space:nowrap" class="ft3460">Isolyte-s&#160;</p>
<p style="position:absolute;top:995px;left:404px;white-space:nowrap" class="ft3460">340&#160;</p>
<p style="position:absolute;top:1018px;left:62px;white-space:nowrap" class="ft3460">Isolyte-s Ph&#160;7.4&#160;</p>
<p style="position:absolute;top:1018px;left:404px;white-space:nowrap" class="ft3460">340&#160;</p>
<p style="position:absolute;top:1042px;left:62px;white-space:nowrap" class="ft3460">Isotretinoin&#160;</p>
<p style="position:absolute;top:1042px;left:404px;white-space:nowrap" class="ft3460">153&#160;</p>
<p style="position:absolute;top:1066px;left:62px;white-space:nowrap" class="ft3460">Itraconazole&#160;</p>
<p style="position:absolute;top:1066px;left:404px;white-space:nowrap" class="ft3460">154&#160;</p>
<p style="position:absolute;top:1090px;left:62px;white-space:nowrap" class="ft3460">Ivermectin</p>
<p style="position:absolute;top:1090px;left:404px;white-space:nowrap" class="ft3460">155&#160;</p>
<p style="position:absolute;top:96px;left:486px;white-space:nowrap" class="ft3460">Ivermectin&#160;Tab&#160;...................................................&#160;</p>
<p style="position:absolute;top:120px;left:518px;white-space:nowrap" class="ft3460">.....................................................................</p>
<p style="position:absolute;top:185px;left:531px;white-space:nowrap" class="ft3460">..................................................................</p>
<p style="position:absolute;top:251px;left:558px;white-space:nowrap" class="ft3467">............................................................<br/>............................................................</p>
<p style="position:absolute;top:298px;left:585px;white-space:nowrap" class="ft3460">......................................................</p>
<p style="position:absolute;top:322px;left:671px;white-space:nowrap" class="ft3460">...................................</p>
<p style="position:absolute;top:346px;left:554px;white-space:nowrap" class="ft3460">.............................................................</p>
<p style="position:absolute;top:370px;left:558px;white-space:nowrap" class="ft3460">............................................................</p>
<p style="position:absolute;top:394px;left:540px;white-space:nowrap" class="ft3460">................................................................</p>
<p style="position:absolute;top:417px;left:671px;white-space:nowrap" class="ft3467">...................................<br/>...................................<br/>...................................</p>
<p style="position:absolute;top:489px;left:545px;white-space:nowrap" class="ft3460">...............................................................</p>
<p style="position:absolute;top:513px;left:563px;white-space:nowrap" class="ft3460">...........................................................</p>
<p style="position:absolute;top:537px;left:536px;white-space:nowrap" class="ft3460">................................................................</p>
<p style="position:absolute;top:560px;left:558px;white-space:nowrap" class="ft3460">............................................................</p>
<p style="position:absolute;top:626px;left:558px;white-space:nowrap" class="ft3460">............................................................</p>
<p style="position:absolute;top:650px;left:635px;white-space:nowrap" class="ft3460">...........................................</p>
<p style="position:absolute;top:674px;left:554px;white-space:nowrap" class="ft3460">.............................................................</p>
<p style="position:absolute;top:697px;left:689px;white-space:nowrap" class="ft3460">...............................</p>
<p style="position:absolute;top:721px;left:684px;white-space:nowrap" class="ft3460">................................</p>
<p style="position:absolute;top:745px;left:689px;white-space:nowrap" class="ft3467">...............................<br/>...............................<br/>...............................<br/>...............................</p>
<p style="position:absolute;top:840px;left:680px;white-space:nowrap" class="ft3467">................................<br/>................................</p>
<p style="position:absolute;top:888px;left:567px;white-space:nowrap" class="ft3460">..........................................................</p>
<p style="position:absolute;top:912px;left:626px;white-space:nowrap" class="ft3460">.............................................</p>
<p style="position:absolute;top:935px;left:581px;white-space:nowrap" class="ft3460">.......................................................</p>
<p style="position:absolute;top:959px;left:612px;white-space:nowrap" class="ft3460">................................................</p>
<p style="position:absolute;top:983px;left:545px;white-space:nowrap" class="ft3460">...............................................................</p>
<p style="position:absolute;top:1007px;left:558px;white-space:nowrap" class="ft3460">....................................................</p>
<p style="position:absolute;top:1031px;left:590px;white-space:nowrap" class="ft3460">.....................................................</p>
<p style="position:absolute;top:1054px;left:765px;white-space:nowrap" class="ft3460">..............</p>
<p style="position:absolute;top:1054px;left:621px;white-space:nowrap" class="ft3460">................................</p>
<p style="position:absolute;top:1078px;left:639px;white-space:nowrap" class="ft3460">..........................................</p>
<p style="position:absolute;top:1102px;left:702px;white-space:nowrap" class="ft3460">............................</p>
<p style="position:absolute;top:1102px;left:558px;white-space:nowrap" class="ft3460">................................</p>
<p style="position:absolute;top:537px;left:824px;white-space:nowrap" class="ft3460">.</p>
<p style="position:absolute;top:840px;left:824px;white-space:nowrap" class="ft3467">.<br/>.</p>
<p style="position:absolute;top:96px;left:829px;white-space:nowrap" class="ft3460">155&#160;</p>
<p style="position:absolute;top:120px;left:486px;white-space:nowrap" class="ft3460">Ivig&#160;</p>
<p style="position:absolute;top:120px;left:828px;white-space:nowrap" class="ft3460">&#160;156&#160;</p>
<p style="position:absolute;top:152px;left:486px;white-space:nowrap" class="ft34615"><i><b>J</b></i></p>
<p style="position:absolute;top:155px;left:495px;white-space:nowrap" class="ft34616"><i>&#160;</i></p>
<p style="position:absolute;top:185px;left:486px;white-space:nowrap" class="ft3460">Jakafi&#160;</p>
<p style="position:absolute;top:185px;left:828px;white-space:nowrap" class="ft3460">&#160;158&#160;</p>
<p style="position:absolute;top:218px;left:486px;white-space:nowrap" class="ft34615"><i><b>K</b></i></p>
<p style="position:absolute;top:221px;left:498px;white-space:nowrap" class="ft34616"><i>&#160;</i></p>
<p style="position:absolute;top:251px;left:486px;white-space:nowrap" class="ft3460">Kalydeco&#160;</p>
<p style="position:absolute;top:251px;left:828px;white-space:nowrap" class="ft3460">&#160;159&#160;</p>
<p style="position:absolute;top:275px;left:486px;white-space:nowrap" class="ft3460">Kesimpta&#160;</p>
<p style="position:absolute;top:275px;left:828px;white-space:nowrap" class="ft3460">&#160;160&#160;</p>
<p style="position:absolute;top:298px;left:486px;white-space:nowrap" class="ft3460">Ketoconazole</p>
<p style="position:absolute;top:298px;left:828px;white-space:nowrap" class="ft3460">&#160;161&#160;</p>
<p style="position:absolute;top:322px;left:486px;white-space:nowrap" class="ft3460">Ketorolac Tromethamine&#160;</p>
<p style="position:absolute;top:322px;left:828px;white-space:nowrap" class="ft3460">&#160;110&#160;</p>
<p style="position:absolute;top:346px;left:486px;white-space:nowrap" class="ft3460">Keytruda&#160;</p>
<p style="position:absolute;top:346px;left:828px;white-space:nowrap" class="ft3460">&#160;162&#160;</p>
<p style="position:absolute;top:370px;left:486px;white-space:nowrap" class="ft3460">Khapzory&#160;</p>
<p style="position:absolute;top:370px;left:828px;white-space:nowrap" class="ft3460">&#160;340&#160;</p>
<p style="position:absolute;top:394px;left:486px;white-space:nowrap" class="ft3460">Kisqali&#160;</p>
<p style="position:absolute;top:394px;left:828px;white-space:nowrap" class="ft3460">&#160;163&#160;</p>
<p style="position:absolute;top:417px;left:486px;white-space:nowrap" class="ft3460">Kisqali Femara&#160;200 Dose&#160;</p>
<p style="position:absolute;top:417px;left:828px;white-space:nowrap" class="ft3460">&#160;163&#160;</p>
<p style="position:absolute;top:441px;left:486px;white-space:nowrap" class="ft3460">Kisqali Femara&#160;400 Dose&#160;</p>
<p style="position:absolute;top:441px;left:828px;white-space:nowrap" class="ft3460">&#160;163&#160;</p>
<p style="position:absolute;top:465px;left:486px;white-space:nowrap" class="ft3460">Kisqali Femara&#160;600 Dose&#160;</p>
<p style="position:absolute;top:465px;left:828px;white-space:nowrap" class="ft3460">&#160;163&#160;</p>
<p style="position:absolute;top:489px;left:486px;white-space:nowrap" class="ft3460">Korlym&#160;</p>
<p style="position:absolute;top:489px;left:828px;white-space:nowrap" class="ft3460">&#160;165&#160;</p>
<p style="position:absolute;top:513px;left:486px;white-space:nowrap" class="ft3460">Kristalose&#160;</p>
<p style="position:absolute;top:513px;left:828px;white-space:nowrap" class="ft3460">&#160;166&#160;</p>
<p style="position:absolute;top:537px;left:486px;white-space:nowrap" class="ft3460">Kuvan&#160;</p>
<p style="position:absolute;top:537px;left:828px;white-space:nowrap" class="ft3460">&#160;167&#160;</p>
<p style="position:absolute;top:560px;left:486px;white-space:nowrap" class="ft3460">Kynmobi&#160;</p>
<p style="position:absolute;top:560px;left:828px;white-space:nowrap" class="ft3460">&#160;168&#160;</p>
<p style="position:absolute;top:593px;left:486px;white-space:nowrap" class="ft34615"><i><b>L</b></i></p>
<p style="position:absolute;top:596px;left:497px;white-space:nowrap" class="ft34616"><i>&#160;</i></p>
<p style="position:absolute;top:626px;left:486px;white-space:nowrap" class="ft3460">Lapatinib&#160;</p>
<p style="position:absolute;top:626px;left:828px;white-space:nowrap" class="ft3460">&#160;169&#160;</p>
<p style="position:absolute;top:650px;left:486px;white-space:nowrap" class="ft3460">Lapatinib Ditosylate&#160;</p>
<p style="position:absolute;top:650px;left:828px;white-space:nowrap" class="ft3460">&#160;169&#160;</p>
<p style="position:absolute;top:674px;left:486px;white-space:nowrap" class="ft3460">Lenvima&#160;</p>
<p style="position:absolute;top:674px;left:828px;white-space:nowrap" class="ft3460">&#160;170&#160;</p>
<p style="position:absolute;top:697px;left:486px;white-space:nowrap" class="ft3460">Lenvima 10&#160;Mg Daily Dose&#160;</p>
<p style="position:absolute;top:697px;left:828px;white-space:nowrap" class="ft3460">&#160;170&#160;</p>
<p style="position:absolute;top:721px;left:486px;white-space:nowrap" class="ft3460">Lenvima 12mg Daily Dose&#160;</p>
<p style="position:absolute;top:721px;left:828px;white-space:nowrap" class="ft3460">&#160;170&#160;</p>
<p style="position:absolute;top:745px;left:486px;white-space:nowrap" class="ft3460">Lenvima 14&#160;Mg Daily Dose&#160;</p>
<p style="position:absolute;top:745px;left:828px;white-space:nowrap" class="ft3460">&#160;170&#160;</p>
<p style="position:absolute;top:769px;left:486px;white-space:nowrap" class="ft3460">Lenvima 18&#160;Mg Daily Dose&#160;</p>
<p style="position:absolute;top:769px;left:828px;white-space:nowrap" class="ft3460">&#160;170&#160;</p>
<p style="position:absolute;top:793px;left:486px;white-space:nowrap" class="ft3460">Lenvima 20&#160;Mg Daily Dose&#160;</p>
<p style="position:absolute;top:793px;left:828px;white-space:nowrap" class="ft3460">&#160;170&#160;</p>
<p style="position:absolute;top:816px;left:486px;white-space:nowrap" class="ft3460">Lenvima 24&#160;Mg Daily Dose&#160;</p>
<p style="position:absolute;top:816px;left:828px;white-space:nowrap" class="ft3460">&#160;170&#160;</p>
<p style="position:absolute;top:840px;left:486px;white-space:nowrap" class="ft3460">Lenvima 4&#160;Mg Daily Dose&#160;</p>
<p style="position:absolute;top:840px;left:828px;white-space:nowrap" class="ft3460">&#160;170&#160;</p>
<p style="position:absolute;top:864px;left:486px;white-space:nowrap" class="ft3460">Lenvima 8&#160;Mg Daily Dose&#160;</p>
<p style="position:absolute;top:864px;left:828px;white-space:nowrap" class="ft3460">&#160;170&#160;</p>
<p style="position:absolute;top:888px;left:486px;white-space:nowrap" class="ft3460">Leuprolide&#160;</p>
<p style="position:absolute;top:888px;left:828px;white-space:nowrap" class="ft3460">&#160;171&#160;</p>
<p style="position:absolute;top:912px;left:486px;white-space:nowrap" class="ft3460">Leuprolide&#160;Acetate&#160;</p>
<p style="position:absolute;top:912px;left:828px;white-space:nowrap" class="ft3460">&#160;171&#160;</p>
<p style="position:absolute;top:935px;left:486px;white-space:nowrap" class="ft3460">Levalbuterol&#160;</p>
<p style="position:absolute;top:935px;left:828px;white-space:nowrap" class="ft3460">&#160;340&#160;</p>
<p style="position:absolute;top:959px;left:486px;white-space:nowrap" class="ft3460">Levalbuterol&#160;Hcl&#160;</p>
<p style="position:absolute;top:959px;left:828px;white-space:nowrap" class="ft3460">&#160;340&#160;</p>
<p style="position:absolute;top:983px;left:486px;white-space:nowrap" class="ft3460">Libtayo&#160;</p>
<p style="position:absolute;top:983px;left:828px;white-space:nowrap" class="ft3460">&#160;172&#160;</p>
<p style="position:absolute;top:1007px;left:486px;white-space:nowrap" class="ft3460">Lidocaine</p>
<p style="position:absolute;top:1007px;left:792px;white-space:nowrap" class="ft3460">&#160;173, 287&#160;</p>
<p style="position:absolute;top:1031px;left:486px;white-space:nowrap" class="ft3460">Lidocaine Hcl&#160;</p>
<p style="position:absolute;top:1031px;left:828px;white-space:nowrap" class="ft3460">&#160;287&#160;</p>
<p style="position:absolute;top:1054px;left:486px;white-space:nowrap" class="ft3460">Lidocaine Patches&#160;</p>
<p style="position:absolute;top:1054px;left:828px;white-space:nowrap" class="ft3460">&#160;173&#160;</p>
<p style="position:absolute;top:1078px;left:486px;white-space:nowrap" class="ft3460">Lidocaine/prilocaine&#160;</p>
<p style="position:absolute;top:1078px;left:828px;white-space:nowrap" class="ft3460">&#160;287&#160;</p>
<p style="position:absolute;top:1102px;left:486px;white-space:nowrap" class="ft3460">Linezolid&#160;</p>
<p style="position:absolute;top:1102px;left:828px;white-space:nowrap" class="ft3460">&#160;174&#160;</p>
</div>
<!-- Page 347 -->
<a name="347"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page347-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2347.png" alt="background image"/>
<p style="position:absolute;top:33px;left:62px;white-space:nowrap" class="ft3477">&#160;<br/>&#160;</p>
<p style="position:absolute;top:1128px;left:830px;white-space:nowrap" class="ft3470">347&#160;</p>
<p style="position:absolute;top:96px;left:62px;white-space:nowrap" class="ft3470">Lonsurf&#160;..............................................................&#160;</p>
<p style="position:absolute;top:120px;left:275px;white-space:nowrap" class="ft3470">............................&#160;</p>
<p style="position:absolute;top:120px;left:130px;white-space:nowrap" class="ft3470">................................</p>
<p style="position:absolute;top:143px;left:135px;white-space:nowrap" class="ft3470">...........................................................&#160;</p>
<p style="position:absolute;top:167px;left:275px;white-space:nowrap" class="ft3470">............................&#160;</p>
<p style="position:absolute;top:167px;left:130px;white-space:nowrap" class="ft3470">................................</p>
<p style="position:absolute;top:191px;left:243px;white-space:nowrap" class="ft3477">...................................&#160;<br/>...................................&#160;</p>
<p style="position:absolute;top:239px;left:275px;white-space:nowrap" class="ft3477">............................&#160;<br/>............................&#160;</p>
<p style="position:absolute;top:286px;left:148px;white-space:nowrap" class="ft3470">........................................................&#160;</p>
<p style="position:absolute;top:310px;left:225px;white-space:nowrap" class="ft3470">.......................................&#160;</p>
<p style="position:absolute;top:334px;left:275px;white-space:nowrap" class="ft3470">............................&#160;</p>
<p style="position:absolute;top:334px;left:130px;white-space:nowrap" class="ft3470">................................</p>
<p style="position:absolute;top:358px;left:135px;white-space:nowrap" class="ft3470">...........................................................&#160;</p>
<p style="position:absolute;top:423px;left:126px;white-space:nowrap" class="ft3470">.............................................................&#160;</p>
<p style="position:absolute;top:447px;left:167px;white-space:nowrap" class="ft3470">....................................................&#160;</p>
<p style="position:absolute;top:471px;left:243px;white-space:nowrap" class="ft3470">...................................&#160;</p>
<p style="position:absolute;top:495px;left:270px;white-space:nowrap" class="ft3470">.............................&#160;</p>
<p style="position:absolute;top:495px;left:126px;white-space:nowrap" class="ft3477">................................<br/>.............................................................&#160;</p>
<p style="position:absolute;top:542px;left:284px;white-space:nowrap" class="ft3470">..........................&#160;</p>
<p style="position:absolute;top:542px;left:139px;white-space:nowrap" class="ft3470">................................</p>
<p style="position:absolute;top:566px;left:144px;white-space:nowrap" class="ft3470">.........................................................&#160;</p>
<p style="position:absolute;top:590px;left:275px;white-space:nowrap" class="ft3470">............................&#160;</p>
<p style="position:absolute;top:614px;left:257px;white-space:nowrap" class="ft3470">................................&#160;</p>
<p style="position:absolute;top:638px;left:279px;white-space:nowrap" class="ft3470">...........................&#160;</p>
<p style="position:absolute;top:661px;left:162px;white-space:nowrap" class="ft3470">.....................................................&#160;</p>
<p style="position:absolute;top:685px;left:266px;white-space:nowrap" class="ft3470">..............................&#160;</p>
<p style="position:absolute;top:685px;left:121px;white-space:nowrap" class="ft3470">................................</p>
<p style="position:absolute;top:709px;left:275px;white-space:nowrap" class="ft3470">..............................&#160;</p>
<p style="position:absolute;top:733px;left:176px;white-space:nowrap" class="ft3470">..................................................&#160;</p>
<p style="position:absolute;top:757px;left:257px;white-space:nowrap" class="ft3470">................................&#160;</p>
<p style="position:absolute;top:780px;left:261px;white-space:nowrap" class="ft3470">...............................&#160;</p>
<p style="position:absolute;top:804px;left:148px;white-space:nowrap" class="ft3470">........................................................&#160;</p>
<p style="position:absolute;top:828px;left:207px;white-space:nowrap" class="ft3470">...........................................&#160;</p>
<p style="position:absolute;top:852px;left:270px;white-space:nowrap" class="ft3470">.............................&#160;</p>
<p style="position:absolute;top:876px;left:342px;white-space:nowrap" class="ft3470">.............&#160;</p>
<p style="position:absolute;top:899px;left:338px;white-space:nowrap" class="ft3470">..............&#160;</p>
<p style="position:absolute;top:923px;left:288px;white-space:nowrap" class="ft3470">...........................&#160;</p>
<p style="position:absolute;top:923px;left:144px;white-space:nowrap" class="ft3470">................................</p>
<p style="position:absolute;top:947px;left:135px;white-space:nowrap" class="ft3470">...........................................................&#160;</p>
<p style="position:absolute;top:971px;left:270px;white-space:nowrap" class="ft3470">.............................&#160;</p>
<p style="position:absolute;top:971px;left:126px;white-space:nowrap" class="ft3470">................................</p>
<p style="position:absolute;top:995px;left:189px;white-space:nowrap" class="ft3470">...............................................&#160;</p>
<p style="position:absolute;top:1018px;left:212px;white-space:nowrap" class="ft3470">..........................................&#160;</p>
<p style="position:absolute;top:1042px;left:234px;white-space:nowrap" class="ft3470">.....................................&#160;</p>
<p style="position:absolute;top:1066px;left:230px;white-space:nowrap" class="ft3470">......................................&#160;</p>
<p style="position:absolute;top:1090px;left:275px;white-space:nowrap" class="ft3470">............................&#160;</p>
<p style="position:absolute;top:1090px;left:131px;white-space:nowrap" class="ft3470">................................</p>
<p style="position:absolute;top:96px;left:404px;white-space:nowrap" class="ft3470">175&#160;</p>
<p style="position:absolute;top:120px;left:62px;white-space:nowrap" class="ft3470">Lorbrena&#160;</p>
<p style="position:absolute;top:120px;left:404px;white-space:nowrap" class="ft3470">176&#160;</p>
<p style="position:absolute;top:143px;left:62px;white-space:nowrap" class="ft3470">Lumakras&#160;</p>
<p style="position:absolute;top:143px;left:404px;white-space:nowrap" class="ft3470">177&#160;</p>
<p style="position:absolute;top:167px;left:62px;white-space:nowrap" class="ft3470">Lumoxiti&#160;</p>
<p style="position:absolute;top:167px;left:404px;white-space:nowrap" class="ft3470">178&#160;</p>
<p style="position:absolute;top:191px;left:62px;white-space:nowrap" class="ft3470">Lupron Depot (1-month)&#160;</p>
<p style="position:absolute;top:191px;left:404px;white-space:nowrap" class="ft3470">180&#160;</p>
<p style="position:absolute;top:215px;left:62px;white-space:nowrap" class="ft3470">Lupron Depot (3-month)&#160;</p>
<p style="position:absolute;top:215px;left:404px;white-space:nowrap" class="ft3470">180&#160;</p>
<p style="position:absolute;top:239px;left:62px;white-space:nowrap" class="ft3470">Lupron Depot-ped (1-month)&#160;</p>
<p style="position:absolute;top:239px;left:404px;white-space:nowrap" class="ft3470">179&#160;</p>
<p style="position:absolute;top:262px;left:62px;white-space:nowrap" class="ft3470">Lupron Depot-ped (3-month)&#160;</p>
<p style="position:absolute;top:262px;left:404px;white-space:nowrap" class="ft3470">179&#160;</p>
<p style="position:absolute;top:286px;left:62px;white-space:nowrap" class="ft3470">Lupron Ped&#160;</p>
<p style="position:absolute;top:286px;left:404px;white-space:nowrap" class="ft3470">179&#160;</p>
<p style="position:absolute;top:310px;left:62px;white-space:nowrap" class="ft3470">Lupron-endometriosis&#160;</p>
<p style="position:absolute;top:310px;left:404px;white-space:nowrap" class="ft3470">180&#160;</p>
<p style="position:absolute;top:334px;left:62px;white-space:nowrap" class="ft3470">Lynparza&#160;</p>
<p style="position:absolute;top:334px;left:404px;white-space:nowrap" class="ft3470">181&#160;</p>
<p style="position:absolute;top:358px;left:62px;white-space:nowrap" class="ft3470">Lyrica Cr&#160;</p>
<p style="position:absolute;top:358px;left:404px;white-space:nowrap" class="ft3470">182&#160;</p>
<p style="position:absolute;top:390px;left:62px;white-space:nowrap" class="ft34715"><i><b>M</b></i></p>
<p style="position:absolute;top:393px;left:78px;white-space:nowrap" class="ft34716"><i>&#160;</i></p>
<p style="position:absolute;top:423px;left:62px;white-space:nowrap" class="ft3470">Mavyret&#160;</p>
<p style="position:absolute;top:423px;left:404px;white-space:nowrap" class="ft3470">183&#160;</p>
<p style="position:absolute;top:447px;left:62px;white-space:nowrap" class="ft3470">Meclizine Hcl&#160;</p>
<p style="position:absolute;top:447px;left:404px;white-space:nowrap" class="ft3470">131&#160;</p>
<p style="position:absolute;top:471px;left:62px;white-space:nowrap" class="ft3470">Meclizine Hydrochloride</p>
<p style="position:absolute;top:471px;left:404px;white-space:nowrap" class="ft3470">131&#160;</p>
<p style="position:absolute;top:495px;left:62px;white-space:nowrap" class="ft3470">Mekinist&#160;</p>
<p style="position:absolute;top:495px;left:404px;white-space:nowrap" class="ft3470">184&#160;</p>
<p style="position:absolute;top:519px;left:62px;white-space:nowrap" class="ft3470">Mektovi&#160;</p>
<p style="position:absolute;top:519px;left:404px;white-space:nowrap" class="ft3470">185&#160;</p>
<p style="position:absolute;top:542px;left:62px;white-space:nowrap" class="ft3470">Melphalan&#160;</p>
<p style="position:absolute;top:542px;left:404px;white-space:nowrap" class="ft3470">340&#160;</p>
<p style="position:absolute;top:566px;left:62px;white-space:nowrap" class="ft3470">Memantine&#160;</p>
<p style="position:absolute;top:566px;left:404px;white-space:nowrap" class="ft3470">186&#160;</p>
<p style="position:absolute;top:590px;left:62px;white-space:nowrap" class="ft3470">Memantine&#160;Hcl Titration Pak&#160;</p>
<p style="position:absolute;top:590px;left:404px;white-space:nowrap" class="ft3470">186&#160;</p>
<p style="position:absolute;top:614px;left:62px;white-space:nowrap" class="ft3470">Memantine&#160;Hydrochloride&#160;</p>
<p style="position:absolute;top:614px;left:404px;white-space:nowrap" class="ft3470">186&#160;</p>
<p style="position:absolute;top:638px;left:62px;white-space:nowrap" class="ft3470">Memantine&#160;Hydrochloride Er&#160;</p>
<p style="position:absolute;top:638px;left:404px;white-space:nowrap" class="ft3470">186&#160;</p>
<p style="position:absolute;top:661px;left:62px;white-space:nowrap" class="ft3470">Meprobamate&#160;</p>
<p style="position:absolute;top:661px;left:404px;white-space:nowrap" class="ft3470">110&#160;</p>
<p style="position:absolute;top:685px;left:62px;white-space:nowrap" class="ft3470">Mepron&#160;</p>
<p style="position:absolute;top:685px;left:404px;white-space:nowrap" class="ft3470">187&#160;</p>
<p style="position:absolute;top:709px;left:62px;white-space:nowrap" class="ft3470">Metformin&#160;Hydrochloride Er&#160;</p>
<p style="position:absolute;top:709px;left:413px;white-space:nowrap" class="ft3470">92&#160;</p>
<p style="position:absolute;top:733px;left:62px;white-space:nowrap" class="ft3470">Methadone&#160;Hcl&#160;</p>
<p style="position:absolute;top:733px;left:404px;white-space:nowrap" class="ft3470">150&#160;</p>
<p style="position:absolute;top:757px;left:62px;white-space:nowrap" class="ft3470">Methadone&#160;Hydrochloride&#160;</p>
<p style="position:absolute;top:757px;left:404px;white-space:nowrap" class="ft3470">150&#160;</p>
<p style="position:absolute;top:780px;left:62px;white-space:nowrap" class="ft3470">Methscopolamine&#160;Bromide&#160;</p>
<p style="position:absolute;top:780px;left:404px;white-space:nowrap" class="ft3470">110&#160;</p>
<p style="position:absolute;top:804px;left:62px;white-space:nowrap" class="ft3470">Methyldopa</p>
<p style="position:absolute;top:804px;left:404px;white-space:nowrap" class="ft3470">110&#160;</p>
<p style="position:absolute;top:828px;left:62px;white-space:nowrap" class="ft3470">Methylprednisolone&#160;</p>
<p style="position:absolute;top:828px;left:404px;white-space:nowrap" class="ft3470">340&#160;</p>
<p style="position:absolute;top:852px;left:62px;white-space:nowrap" class="ft3470">Methylprednisolone Acetate&#160;</p>
<p style="position:absolute;top:852px;left:404px;white-space:nowrap" class="ft3470">340&#160;</p>
<p style="position:absolute;top:876px;left:62px;white-space:nowrap" class="ft3470">Methylprednisolone Sodium&#160;Succinate&#160;</p>
<p style="position:absolute;top:876px;left:404px;white-space:nowrap" class="ft3470">340&#160;</p>
<p style="position:absolute;top:899px;left:62px;white-space:nowrap" class="ft3470">Methylprednisolone Sodiumsuccinate&#160;</p>
<p style="position:absolute;top:899px;left:404px;white-space:nowrap" class="ft3470">340&#160;</p>
<p style="position:absolute;top:923px;left:62px;white-space:nowrap" class="ft3470">Metyrosine&#160;</p>
<p style="position:absolute;top:923px;left:413px;white-space:nowrap" class="ft3470">60&#160;</p>
<p style="position:absolute;top:947px;left:62px;white-space:nowrap" class="ft3470">Modafinil&#160;</p>
<p style="position:absolute;top:947px;left:404px;white-space:nowrap" class="ft3470">188&#160;</p>
<p style="position:absolute;top:971px;left:62px;white-space:nowrap" class="ft3470">Monjuvi&#160;</p>
<p style="position:absolute;top:971px;left:404px;white-space:nowrap" class="ft3470">189&#160;</p>
<p style="position:absolute;top:995px;left:62px;white-space:nowrap" class="ft3470">Morphine Sulfate&#160;</p>
<p style="position:absolute;top:995px;left:404px;white-space:nowrap" class="ft3470">340&#160;</p>
<p style="position:absolute;top:1018px;left:62px;white-space:nowrap" class="ft3470">Morphine Sulfate Er&#160;</p>
<p style="position:absolute;top:1018px;left:404px;white-space:nowrap" class="ft3470">150&#160;</p>
<p style="position:absolute;top:1042px;left:62px;white-space:nowrap" class="ft3470">Mycophenolate Mofetil&#160;</p>
<p style="position:absolute;top:1042px;left:404px;white-space:nowrap" class="ft3470">340&#160;</p>
<p style="position:absolute;top:1066px;left:62px;white-space:nowrap" class="ft3470">Mycophenolic&#160;Acid Dr&#160;</p>
<p style="position:absolute;top:1066px;left:404px;white-space:nowrap" class="ft3470">340&#160;</p>
<p style="position:absolute;top:1090px;left:62px;white-space:nowrap" class="ft3470">Mylotarg&#160;</p>
<p style="position:absolute;top:1090px;left:404px;white-space:nowrap" class="ft3470">190&#160;</p>
<p style="position:absolute;top:96px;left:486px;white-space:nowrap" class="ft3470">Myorisan&#160;............................................................&#160;</p>
<p style="position:absolute;top:161px;left:752px;white-space:nowrap" class="ft3470">.................</p>
<p style="position:absolute;top:185px;left:666px;white-space:nowrap" class="ft3470">....................................&#160;</p>
<p style="position:absolute;top:209px;left:545px;white-space:nowrap" class="ft3470">...............................................................</p>
<p style="position:absolute;top:233px;left:558px;white-space:nowrap" class="ft3470">............................................................</p>
<p style="position:absolute;top:257px;left:576px;white-space:nowrap" class="ft3470">........................................................</p>
<p style="position:absolute;top:280px;left:549px;white-space:nowrap" class="ft3477">..............................................................<br/>..............................................................</p>
<p style="position:absolute;top:328px;left:545px;white-space:nowrap" class="ft3470">...............................................................</p>
<p style="position:absolute;top:352px;left:563px;white-space:nowrap" class="ft3470">...........................................................</p>
<p style="position:absolute;top:376px;left:554px;white-space:nowrap" class="ft3470">.............................................................</p>
<p style="position:absolute;top:399px;left:545px;white-space:nowrap" class="ft3470">...............................................................</p>
<p style="position:absolute;top:423px;left:558px;white-space:nowrap" class="ft3470">............................................................</p>
<p style="position:absolute;top:447px;left:545px;white-space:nowrap" class="ft3470">...............................................................</p>
<p style="position:absolute;top:471px;left:554px;white-space:nowrap" class="ft3470">.............................................................</p>
<p style="position:absolute;top:495px;left:558px;white-space:nowrap" class="ft3470">............................................................</p>
<p style="position:absolute;top:560px;left:554px;white-space:nowrap" class="ft3470">.............................................................</p>
<p style="position:absolute;top:584px;left:563px;white-space:nowrap" class="ft3470">...........................................................</p>
<p style="position:absolute;top:608px;left:626px;white-space:nowrap" class="ft3470">.............................................</p>
<p style="position:absolute;top:632px;left:549px;white-space:nowrap" class="ft3470">..............................................................</p>
<p style="position:absolute;top:656px;left:522px;white-space:nowrap" class="ft3470">....................................................................</p>
<p style="position:absolute;top:679px;left:558px;white-space:nowrap" class="ft3470">............................................................</p>
<p style="position:absolute;top:703px;left:612px;white-space:nowrap" class="ft3470">................................................</p>
<p style="position:absolute;top:727px;left:689px;white-space:nowrap" class="ft3470">...............................</p>
<p style="position:absolute;top:751px;left:612px;white-space:nowrap" class="ft3470">................................................</p>
<p style="position:absolute;top:775px;left:540px;white-space:nowrap" class="ft3470">................................................................</p>
<p style="position:absolute;top:798px;left:549px;white-space:nowrap" class="ft3470">..............................................................</p>
<p style="position:absolute;top:822px;left:540px;white-space:nowrap" class="ft3470">................................................................</p>
<p style="position:absolute;top:846px;left:662px;white-space:nowrap" class="ft3470">.....................................</p>
<p style="position:absolute;top:870px;left:554px;white-space:nowrap" class="ft3477">.............................................................<br/>.............................................................</p>
<p style="position:absolute;top:917px;left:581px;white-space:nowrap" class="ft3470">.......................................................</p>
<p style="position:absolute;top:941px;left:711px;white-space:nowrap" class="ft3470">..........................</p>
<p style="position:absolute;top:941px;left:567px;white-space:nowrap" class="ft3470">................................</p>
<p style="position:absolute;top:965px;left:599px;white-space:nowrap" class="ft3470">...................................................</p>
<p style="position:absolute;top:96px;left:829px;white-space:nowrap" class="ft3470">153&#160;</p>
<p style="position:absolute;top:129px;left:486px;white-space:nowrap" class="ft34715"><i><b>N</b></i></p>
<p style="position:absolute;top:131px;left:499px;white-space:nowrap" class="ft34716"><i>&#160;</i></p>
<p style="position:absolute;top:161px;left:486px;white-space:nowrap" class="ft3470">Naproxen/esomeprazole&#160;Magnesium&#160;</p>
<p style="position:absolute;top:161px;left:828px;white-space:nowrap" class="ft3470">&#160;191&#160;</p>
<p style="position:absolute;top:185px;left:486px;white-space:nowrap" class="ft3470">Naproxen-esomeprazole&#160;</p>
<p style="position:absolute;top:185px;left:829px;white-space:nowrap" class="ft3470">191&#160;</p>
<p style="position:absolute;top:209px;left:486px;white-space:nowrap" class="ft3470">Natpara&#160;</p>
<p style="position:absolute;top:209px;left:828px;white-space:nowrap" class="ft3470">&#160;192&#160;</p>
<p style="position:absolute;top:233px;left:486px;white-space:nowrap" class="ft3470">Nayzilam&#160;</p>
<p style="position:absolute;top:233px;left:828px;white-space:nowrap" class="ft3470">&#160;193&#160;</p>
<p style="position:absolute;top:257px;left:486px;white-space:nowrap" class="ft3470">Nephramine&#160;</p>
<p style="position:absolute;top:257px;left:828px;white-space:nowrap" class="ft3470">&#160;340&#160;</p>
<p style="position:absolute;top:280px;left:486px;white-space:nowrap" class="ft3470">Nerlynx&#160;</p>
<p style="position:absolute;top:280px;left:828px;white-space:nowrap" class="ft3470">&#160;194&#160;</p>
<p style="position:absolute;top:304px;left:486px;white-space:nowrap" class="ft3470">Nexavar&#160;</p>
<p style="position:absolute;top:304px;left:828px;white-space:nowrap" class="ft3470">&#160;195&#160;</p>
<p style="position:absolute;top:328px;left:486px;white-space:nowrap" class="ft3470">Ninlaro&#160;</p>
<p style="position:absolute;top:328px;left:828px;white-space:nowrap" class="ft3470">&#160;196&#160;</p>
<p style="position:absolute;top:352px;left:486px;white-space:nowrap" class="ft3470">Nitisinone&#160;</p>
<p style="position:absolute;top:352px;left:828px;white-space:nowrap" class="ft3470">&#160;197&#160;</p>
<p style="position:absolute;top:376px;left:486px;white-space:nowrap" class="ft3470">Northera&#160;</p>
<p style="position:absolute;top:376px;left:828px;white-space:nowrap" class="ft3470">&#160;198&#160;</p>
<p style="position:absolute;top:399px;left:486px;white-space:nowrap" class="ft3470">Nubeqa&#160;</p>
<p style="position:absolute;top:399px;left:828px;white-space:nowrap" class="ft3470">&#160;199&#160;</p>
<p style="position:absolute;top:423px;left:486px;white-space:nowrap" class="ft3470">Nuedexta&#160;</p>
<p style="position:absolute;top:423px;left:828px;white-space:nowrap" class="ft3470">&#160;200&#160;</p>
<p style="position:absolute;top:447px;left:486px;white-space:nowrap" class="ft3470">Nulojix&#160;</p>
<p style="position:absolute;top:447px;left:828px;white-space:nowrap" class="ft3470">&#160;340&#160;</p>
<p style="position:absolute;top:471px;left:486px;white-space:nowrap" class="ft3470">Nuplazid&#160;</p>
<p style="position:absolute;top:471px;left:828px;white-space:nowrap" class="ft3470">&#160;201&#160;</p>
<p style="position:absolute;top:495px;left:486px;white-space:nowrap" class="ft3470">Nutrilipid&#160;</p>
<p style="position:absolute;top:495px;left:828px;white-space:nowrap" class="ft3470">&#160;340&#160;</p>
<p style="position:absolute;top:528px;left:486px;white-space:nowrap" class="ft34715"><i><b>O</b></i></p>
<p style="position:absolute;top:530px;left:499px;white-space:nowrap" class="ft34716"><i>&#160;</i></p>
<p style="position:absolute;top:560px;left:486px;white-space:nowrap" class="ft3470">Octagam&#160;</p>
<p style="position:absolute;top:560px;left:828px;white-space:nowrap" class="ft3470">&#160;156&#160;</p>
<p style="position:absolute;top:584px;left:486px;white-space:nowrap" class="ft3470">Octreotide&#160;</p>
<p style="position:absolute;top:584px;left:828px;white-space:nowrap" class="ft3470">&#160;202&#160;</p>
<p style="position:absolute;top:608px;left:486px;white-space:nowrap" class="ft3470">Octreotide&#160;Acetate&#160;</p>
<p style="position:absolute;top:608px;left:828px;white-space:nowrap" class="ft3470">&#160;202&#160;</p>
<p style="position:absolute;top:632px;left:486px;white-space:nowrap" class="ft3470">Odomzo&#160;</p>
<p style="position:absolute;top:632px;left:828px;white-space:nowrap" class="ft3470">&#160;203&#160;</p>
<p style="position:absolute;top:656px;left:486px;white-space:nowrap" class="ft3470">Ofev</p>
<p style="position:absolute;top:656px;left:828px;white-space:nowrap" class="ft3470">&#160;204&#160;</p>
<p style="position:absolute;top:679px;left:486px;white-space:nowrap" class="ft3470">Oncaspar&#160;</p>
<p style="position:absolute;top:679px;left:828px;white-space:nowrap" class="ft3470">&#160;205&#160;</p>
<p style="position:absolute;top:703px;left:486px;white-space:nowrap" class="ft3470">Ondansetron&#160;Hcl&#160;</p>
<p style="position:absolute;top:703px;left:828px;white-space:nowrap" class="ft3470">&#160;340&#160;</p>
<p style="position:absolute;top:727px;left:486px;white-space:nowrap" class="ft3470">Ondansetron&#160;Hydrochloride&#160;</p>
<p style="position:absolute;top:727px;left:828px;white-space:nowrap" class="ft3470">&#160;340&#160;</p>
<p style="position:absolute;top:751px;left:486px;white-space:nowrap" class="ft3470">Ondansetron&#160;Odt&#160;</p>
<p style="position:absolute;top:751px;left:828px;white-space:nowrap" class="ft3470">&#160;340&#160;</p>
<p style="position:absolute;top:775px;left:486px;white-space:nowrap" class="ft3470">Onureg</p>
<p style="position:absolute;top:775px;left:828px;white-space:nowrap" class="ft3470">&#160;206&#160;</p>
<p style="position:absolute;top:798px;left:486px;white-space:nowrap" class="ft3470">Opsumit&#160;</p>
<p style="position:absolute;top:798px;left:828px;white-space:nowrap" class="ft3470">&#160;207&#160;</p>
<p style="position:absolute;top:822px;left:486px;white-space:nowrap" class="ft3470">Oracea&#160;</p>
<p style="position:absolute;top:822px;left:828px;white-space:nowrap" class="ft3470">&#160;208&#160;</p>
<p style="position:absolute;top:846px;left:486px;white-space:nowrap" class="ft3470">Oral-intranasal&#160;Fentanyl&#160;</p>
<p style="position:absolute;top:846px;left:828px;white-space:nowrap" class="ft3470">&#160;209&#160;</p>
<p style="position:absolute;top:870px;left:486px;white-space:nowrap" class="ft3470">Orgovyx&#160;</p>
<p style="position:absolute;top:870px;left:828px;white-space:nowrap" class="ft3470">&#160;210&#160;</p>
<p style="position:absolute;top:894px;left:486px;white-space:nowrap" class="ft3470">Orkambi&#160;</p>
<p style="position:absolute;top:894px;left:828px;white-space:nowrap" class="ft3470">&#160;211&#160;</p>
<p style="position:absolute;top:917px;left:486px;white-space:nowrap" class="ft3470">Oxandrolone&#160;</p>
<p style="position:absolute;top:917px;left:828px;white-space:nowrap" class="ft3470">&#160;212&#160;</p>
<p style="position:absolute;top:941px;left:486px;white-space:nowrap" class="ft3470">Oxazepam&#160;</p>
<p style="position:absolute;top:941px;left:828px;white-space:nowrap" class="ft3470">&#160;213&#160;</p>
<p style="position:absolute;top:965px;left:486px;white-space:nowrap" class="ft3470">Oxazepam&#160;-&#160;65&#160;</p>
<p style="position:absolute;top:965px;left:828px;white-space:nowrap" class="ft3470">&#160;213&#160;</p>
<p style="position:absolute;top:998px;left:486px;white-space:nowrap" class="ft34715"><i><b>P</b></i></p>
<p style="position:absolute;top:1000px;left:497px;white-space:nowrap" class="ft34716"><i>&#160;</i></p>
<p style="position:absolute;top:1031px;left:486px;white-space:nowrap" class="ft3470">Padcev&#160;................................................................&#160;</p>
<p style="position:absolute;top:1054px;left:549px;white-space:nowrap" class="ft3470">..............................................................</p>
<p style="position:absolute;top:1078px;left:639px;white-space:nowrap" class="ft3470">..........................................</p>
<p style="position:absolute;top:1102px;left:689px;white-space:nowrap" class="ft3470">...............................</p>
<p style="position:absolute;top:1102px;left:545px;white-space:nowrap" class="ft3470">................................</p>
<p style="position:absolute;top:1031px;left:829px;white-space:nowrap" class="ft3470">214&#160;</p>
<p style="position:absolute;top:1054px;left:486px;white-space:nowrap" class="ft3470">Panzyga&#160;</p>
<p style="position:absolute;top:1054px;left:828px;white-space:nowrap" class="ft3470">&#160;156&#160;</p>
<p style="position:absolute;top:1078px;left:486px;white-space:nowrap" class="ft3470">Part&#160;B Versus Part&#160;D&#160;</p>
<p style="position:absolute;top:1078px;left:828px;white-space:nowrap" class="ft3470">&#160;337&#160;</p>
<p style="position:absolute;top:1102px;left:486px;white-space:nowrap" class="ft3470">Pegasys&#160;</p>
<p style="position:absolute;top:1102px;left:828px;white-space:nowrap" class="ft3470">&#160;215&#160;</p>
</div>
<!-- Page 348 -->
<a name="348"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page348-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2348.png" alt="background image"/>
<p style="position:absolute;top:33px;left:62px;white-space:nowrap" class="ft3487">&#160;<br/>&#160;</p>
<p style="position:absolute;top:1128px;left:830px;white-space:nowrap" class="ft3480">348&#160;</p>
<p style="position:absolute;top:96px;left:62px;white-space:nowrap" class="ft3480">Pemazyre&#160;...........................................................&#160;</p>
<p style="position:absolute;top:120px;left:131px;white-space:nowrap" class="ft3480">..............................................................&#160;</p>
<p style="position:absolute;top:143px;left:239px;white-space:nowrap" class="ft3480">....................................&#160;</p>
<p style="position:absolute;top:167px;left:121px;white-space:nowrap" class="ft3480">..............................................................&#160;</p>
<p style="position:absolute;top:191px;left:257px;white-space:nowrap" class="ft3480">................................&#160;</p>
<p style="position:absolute;top:215px;left:162px;white-space:nowrap" class="ft3480">.....................................................&#160;</p>
<p style="position:absolute;top:239px;left:225px;white-space:nowrap" class="ft3480">.......................................&#160;</p>
<p style="position:absolute;top:262px;left:171px;white-space:nowrap" class="ft3480">...................................................&#160;</p>
<p style="position:absolute;top:286px;left:117px;white-space:nowrap" class="ft3480">...............................................................&#160;</p>
<p style="position:absolute;top:310px;left:112px;white-space:nowrap" class="ft3480">................................................................&#160;</p>
<p style="position:absolute;top:334px;left:252px;white-space:nowrap" class="ft3487">.................................&#160;<br/>.................................&#160;<br/>.................................&#160;</p>
<p style="position:absolute;top:405px;left:139px;white-space:nowrap" class="ft3480">..........................................................&#160;</p>
<p style="position:absolute;top:429px;left:112px;white-space:nowrap" class="ft3480">................................................................&#160;</p>
<p style="position:absolute;top:453px;left:130px;white-space:nowrap" class="ft3487">............................................................&#160;<br/>............................................................&#160;</p>
<p style="position:absolute;top:501px;left:121px;white-space:nowrap" class="ft3480">..............................................................&#160;</p>
<p style="position:absolute;top:524px;left:157px;white-space:nowrap" class="ft3480">......................................................&#160;</p>
<p style="position:absolute;top:548px;left:297px;white-space:nowrap" class="ft3480">.......................&#160;</p>
<p style="position:absolute;top:572px;left:144px;white-space:nowrap" class="ft3480">.........................................................&#160;</p>
<p style="position:absolute;top:596px;left:207px;white-space:nowrap" class="ft3480">...........................................&#160;</p>
<p style="position:absolute;top:620px;left:139px;white-space:nowrap" class="ft3480">..........................................................&#160;</p>
<p style="position:absolute;top:643px;left:162px;white-space:nowrap" class="ft3480">.....................................................&#160;</p>
<p style="position:absolute;top:667px;left:130px;white-space:nowrap" class="ft3480">............................................................&#160;</p>
<p style="position:absolute;top:691px;left:148px;white-space:nowrap" class="ft3480">........................................................&#160;</p>
<p style="position:absolute;top:715px;left:126px;white-space:nowrap" class="ft3480">.............................................................&#160;</p>
<p style="position:absolute;top:739px;left:153px;white-space:nowrap" class="ft3480">.......................................................&#160;</p>
<p style="position:absolute;top:762px;left:112px;white-space:nowrap" class="ft3480">..................................................................&#160;</p>
<p style="position:absolute;top:786px;left:117px;white-space:nowrap" class="ft3480">...............................................................&#160;</p>
<p style="position:absolute;top:810px;left:284px;white-space:nowrap" class="ft3480">..............................&#160;</p>
<p style="position:absolute;top:810px;left:139px;white-space:nowrap" class="ft3480">................................</p>
<p style="position:absolute;top:834px;left:130px;white-space:nowrap" class="ft3480">............................................................&#160;</p>
<p style="position:absolute;top:858px;left:194px;white-space:nowrap" class="ft3480">..............................................&#160;</p>
<p style="position:absolute;top:881px;left:234px;white-space:nowrap" class="ft3480">.....................................&#160;</p>
<p style="position:absolute;top:905px;left:270px;white-space:nowrap" class="ft3480">.............................&#160;</p>
<p style="position:absolute;top:929px;left:157px;white-space:nowrap" class="ft3480">......................................................&#160;</p>
<p style="position:absolute;top:953px;left:252px;white-space:nowrap" class="ft3480">.................................&#160;</p>
<p style="position:absolute;top:953px;left:108px;white-space:nowrap" class="ft3480">................................</p>
<p style="position:absolute;top:977px;left:185px;white-space:nowrap" class="ft3480">................................................&#160;</p>
<p style="position:absolute;top:1000px;left:148px;white-space:nowrap" class="ft3480">........................................................&#160;</p>
<p style="position:absolute;top:1066px;left:121px;white-space:nowrap" class="ft3480">..............................................................&#160;</p>
<p style="position:absolute;top:1090px;left:239px;white-space:nowrap" class="ft3480">....................................&#160;</p>
<p style="position:absolute;top:96px;left:404px;white-space:nowrap" class="ft3480">216&#160;</p>
<p style="position:absolute;top:120px;left:62px;white-space:nowrap" class="ft3480">Pennsaid&#160;</p>
<p style="position:absolute;top:120px;left:413px;white-space:nowrap" class="ft3480">66&#160;</p>
<p style="position:absolute;top:143px;left:62px;white-space:nowrap" class="ft3480">Pentamidine&#160;Isethionate&#160;</p>
<p style="position:absolute;top:143px;left:404px;white-space:nowrap" class="ft3480">340&#160;</p>
<p style="position:absolute;top:167px;left:62px;white-space:nowrap" class="ft3480">Pepaxto&#160;</p>
<p style="position:absolute;top:167px;left:404px;white-space:nowrap" class="ft3480">217&#160;</p>
<p style="position:absolute;top:191px;left:62px;white-space:nowrap" class="ft3480">Perphenazine/amitriptyline</p>
<p style="position:absolute;top:191px;left:404px;white-space:nowrap" class="ft3480">110&#160;</p>
<p style="position:absolute;top:215px;left:62px;white-space:nowrap" class="ft3480">Phenobarbital&#160;</p>
<p style="position:absolute;top:215px;left:404px;white-space:nowrap" class="ft3480">112&#160;</p>
<p style="position:absolute;top:239px;left:62px;white-space:nowrap" class="ft3480">Phenobarbital Sodium&#160;</p>
<p style="position:absolute;top:239px;left:404px;white-space:nowrap" class="ft3480">112&#160;</p>
<p style="position:absolute;top:262px;left:62px;white-space:nowrap" class="ft3480">Phenylbutyrate&#160;</p>
<p style="position:absolute;top:262px;left:404px;white-space:nowrap" class="ft3480">218&#160;</p>
<p style="position:absolute;top:286px;left:62px;white-space:nowrap" class="ft3480">Phesgo&#160;</p>
<p style="position:absolute;top:286px;left:404px;white-space:nowrap" class="ft3480">219&#160;</p>
<p style="position:absolute;top:310px;left:62px;white-space:nowrap" class="ft3480">Piqray&#160;</p>
<p style="position:absolute;top:310px;left:404px;white-space:nowrap" class="ft3480">220&#160;</p>
<p style="position:absolute;top:334px;left:62px;white-space:nowrap" class="ft3480">Piqray 200mg Daily Dose&#160;</p>
<p style="position:absolute;top:334px;left:404px;white-space:nowrap" class="ft3480">220&#160;</p>
<p style="position:absolute;top:358px;left:62px;white-space:nowrap" class="ft3480">Piqray 250mg Daily Dose&#160;</p>
<p style="position:absolute;top:358px;left:404px;white-space:nowrap" class="ft3480">220&#160;</p>
<p style="position:absolute;top:381px;left:62px;white-space:nowrap" class="ft3480">Piqray 300mg Daily Dose&#160;</p>
<p style="position:absolute;top:381px;left:404px;white-space:nowrap" class="ft3480">220&#160;</p>
<p style="position:absolute;top:405px;left:62px;white-space:nowrap" class="ft3480">Plenamine&#160;</p>
<p style="position:absolute;top:405px;left:404px;white-space:nowrap" class="ft3480">341&#160;</p>
<p style="position:absolute;top:429px;left:62px;white-space:nowrap" class="ft3480">Polivy&#160;</p>
<p style="position:absolute;top:429px;left:404px;white-space:nowrap" class="ft3480">221&#160;</p>
<p style="position:absolute;top:453px;left:62px;white-space:nowrap" class="ft3480">Pomalyst&#160;</p>
<p style="position:absolute;top:453px;left:404px;white-space:nowrap" class="ft3480">222&#160;</p>
<p style="position:absolute;top:477px;left:62px;white-space:nowrap" class="ft3480">Poteligeo&#160;</p>
<p style="position:absolute;top:477px;left:404px;white-space:nowrap" class="ft3480">223&#160;</p>
<p style="position:absolute;top:501px;left:62px;white-space:nowrap" class="ft3480">Praluent</p>
<p style="position:absolute;top:501px;left:404px;white-space:nowrap" class="ft3480">224&#160;</p>
<p style="position:absolute;top:524px;left:62px;white-space:nowrap" class="ft3480">Prednisolone&#160;</p>
<p style="position:absolute;top:524px;left:404px;white-space:nowrap" class="ft3480">341&#160;</p>
<p style="position:absolute;top:548px;left:62px;white-space:nowrap" class="ft3480">Prednisolone Sodium Phosphate&#160;</p>
<p style="position:absolute;top:548px;left:404px;white-space:nowrap" class="ft3480">341&#160;</p>
<p style="position:absolute;top:572px;left:62px;white-space:nowrap" class="ft3480">Prednisone&#160;</p>
<p style="position:absolute;top:572px;left:404px;white-space:nowrap" class="ft3480">341&#160;</p>
<p style="position:absolute;top:596px;left:62px;white-space:nowrap" class="ft3480">Prednisone&#160;Intensol&#160;</p>
<p style="position:absolute;top:596px;left:404px;white-space:nowrap" class="ft3480">341&#160;</p>
<p style="position:absolute;top:620px;left:62px;white-space:nowrap" class="ft3480">Pregabalin&#160;</p>
<p style="position:absolute;top:620px;left:404px;white-space:nowrap" class="ft3480">225&#160;</p>
<p style="position:absolute;top:643px;left:62px;white-space:nowrap" class="ft3480">Pregabalin&#160;Er&#160;</p>
<p style="position:absolute;top:643px;left:404px;white-space:nowrap" class="ft3480">182&#160;</p>
<p style="position:absolute;top:667px;left:62px;white-space:nowrap" class="ft3480">Premasol&#160;</p>
<p style="position:absolute;top:667px;left:404px;white-space:nowrap" class="ft3480">341&#160;</p>
<p style="position:absolute;top:691px;left:62px;white-space:nowrap" class="ft3480">Pretomanid&#160;</p>
<p style="position:absolute;top:691px;left:404px;white-space:nowrap" class="ft3480">226&#160;</p>
<p style="position:absolute;top:715px;left:62px;white-space:nowrap" class="ft3480">Privigen&#160;</p>
<p style="position:absolute;top:715px;left:404px;white-space:nowrap" class="ft3480">156&#160;</p>
<p style="position:absolute;top:739px;left:62px;white-space:nowrap" class="ft3480">Procalamine&#160;</p>
<p style="position:absolute;top:739px;left:404px;white-space:nowrap" class="ft3480">341&#160;</p>
<p style="position:absolute;top:762px;left:62px;white-space:nowrap" class="ft3480">Procrit&#160;</p>
<p style="position:absolute;top:762px;left:413px;white-space:nowrap" class="ft3480">77&#160;</p>
<p style="position:absolute;top:786px;left:62px;white-space:nowrap" class="ft3480">Prograf&#160;</p>
<p style="position:absolute;top:786px;left:404px;white-space:nowrap" class="ft3480">341&#160;</p>
<p style="position:absolute;top:810px;left:62px;white-space:nowrap" class="ft3480">Prolastin-c</p>
<p style="position:absolute;top:810px;left:422px;white-space:nowrap" class="ft3480">9&#160;</p>
<p style="position:absolute;top:834px;left:62px;white-space:nowrap" class="ft3480">Promacta&#160;</p>
<p style="position:absolute;top:834px;left:404px;white-space:nowrap" class="ft3480">227&#160;</p>
<p style="position:absolute;top:858px;left:62px;white-space:nowrap" class="ft3480">Promethazine Hcl&#160;</p>
<p style="position:absolute;top:858px;left:404px;white-space:nowrap" class="ft3480">125&#160;</p>
<p style="position:absolute;top:881px;left:62px;white-space:nowrap" class="ft3480">Promethazine Hcl Plain&#160;</p>
<p style="position:absolute;top:881px;left:404px;white-space:nowrap" class="ft3480">125&#160;</p>
<p style="position:absolute;top:905px;left:62px;white-space:nowrap" class="ft3480">Promethazine Hydrochloride</p>
<p style="position:absolute;top:905px;left:404px;white-space:nowrap" class="ft3480">125&#160;</p>
<p style="position:absolute;top:929px;left:62px;white-space:nowrap" class="ft3480">Promethegan&#160;</p>
<p style="position:absolute;top:929px;left:404px;white-space:nowrap" class="ft3480">125&#160;</p>
<p style="position:absolute;top:953px;left:62px;white-space:nowrap" class="ft3480">Prosol&#160;</p>
<p style="position:absolute;top:953px;left:404px;white-space:nowrap" class="ft3480">341&#160;</p>
<p style="position:absolute;top:977px;left:62px;white-space:nowrap" class="ft3480">Protriptyline&#160;Hcl&#160;</p>
<p style="position:absolute;top:977px;left:404px;white-space:nowrap" class="ft3480">132&#160;</p>
<p style="position:absolute;top:1000px;left:62px;white-space:nowrap" class="ft3480">Pulmozyme&#160;</p>
<p style="position:absolute;top:1000px;left:404px;white-space:nowrap" class="ft3480">230&#160;</p>
<p style="position:absolute;top:1033px;left:62px;white-space:nowrap" class="ft34815"><i><b>Q</b></i></p>
<p style="position:absolute;top:1036px;left:75px;white-space:nowrap" class="ft34816"><i>&#160;</i></p>
<p style="position:absolute;top:1066px;left:62px;white-space:nowrap" class="ft3480">Qinlock&#160;</p>
<p style="position:absolute;top:1066px;left:404px;white-space:nowrap" class="ft3480">231&#160;</p>
<p style="position:absolute;top:1090px;left:62px;white-space:nowrap" class="ft3480">Quetiapine&#160;Fumarate Er&#160;</p>
<p style="position:absolute;top:1090px;left:404px;white-space:nowrap" class="ft3480">232&#160;</p>
<p style="position:absolute;top:96px;left:486px;white-space:nowrap" class="ft3480">Quetiapine&#160;Xr&#160;.....................................................&#160;</p>
<p style="position:absolute;top:120px;left:603px;white-space:nowrap" class="ft3480">..................................................</p>
<p style="position:absolute;top:185px;left:554px;white-space:nowrap" class="ft3480">.............................................................</p>
<p style="position:absolute;top:209px;left:608px;white-space:nowrap" class="ft3480">.................................................</p>
<p style="position:absolute;top:233px;left:558px;white-space:nowrap" class="ft3480">............................................................</p>
<p style="position:absolute;top:257px;left:554px;white-space:nowrap" class="ft3487">.............................................................<br/>.............................................................</p>
<p style="position:absolute;top:304px;left:558px;white-space:nowrap" class="ft3480">............................................................</p>
<p style="position:absolute;top:328px;left:540px;white-space:nowrap" class="ft3480">................................................................</p>
<p style="position:absolute;top:352px;left:545px;white-space:nowrap" class="ft3480">...............................................................</p>
<p style="position:absolute;top:376px;left:599px;white-space:nowrap" class="ft3480">...................................................</p>
<p style="position:absolute;top:399px;left:563px;white-space:nowrap" class="ft3480">...........................................................</p>
<p style="position:absolute;top:423px;left:558px;white-space:nowrap" class="ft3480">............................................................</p>
<p style="position:absolute;top:447px;left:549px;white-space:nowrap" class="ft3480">..............................................................</p>
<p style="position:absolute;top:471px;left:572px;white-space:nowrap" class="ft3480">...........................................................</p>
<p style="position:absolute;top:495px;left:558px;white-space:nowrap" class="ft3480">............................................................</p>
<p style="position:absolute;top:519px;left:540px;white-space:nowrap" class="ft3480">................................................................</p>
<p style="position:absolute;top:584px;left:540px;white-space:nowrap" class="ft3480">................................................................</p>
<p style="position:absolute;top:608px;left:585px;white-space:nowrap" class="ft3480">......................................................</p>
<p style="position:absolute;top:632px;left:603px;white-space:nowrap" class="ft3480">..................................................</p>
<p style="position:absolute;top:656px;left:648px;white-space:nowrap" class="ft3480">........................................</p>
<p style="position:absolute;top:679px;left:698px;white-space:nowrap" class="ft3480">.............................</p>
<p style="position:absolute;top:703px;left:545px;white-space:nowrap" class="ft3480">...............................................................</p>
<p style="position:absolute;top:727px;left:558px;white-space:nowrap" class="ft3480">............................................................</p>
<p style="position:absolute;top:751px;left:581px;white-space:nowrap" class="ft3480">.......................................................</p>
<p style="position:absolute;top:775px;left:549px;white-space:nowrap" class="ft3480">..............................................................</p>
<p style="position:absolute;top:798px;left:558px;white-space:nowrap" class="ft3480">............................................................</p>
<p style="position:absolute;top:822px;left:612px;white-space:nowrap" class="ft3480">................................................</p>
<p style="position:absolute;top:846px;left:558px;white-space:nowrap" class="ft3480">............................................................</p>
<p style="position:absolute;top:870px;left:540px;white-space:nowrap" class="ft3487">................................................................<br/>................................................................</p>
<p style="position:absolute;top:917px;left:572px;white-space:nowrap" class="ft3480">.........................................................</p>
<p style="position:absolute;top:941px;left:657px;white-space:nowrap" class="ft3480">......................................</p>
<p style="position:absolute;top:965px;left:617px;white-space:nowrap" class="ft3480">...............................................</p>
<p style="position:absolute;top:989px;left:558px;white-space:nowrap" class="ft3480">............................................................</p>
<p style="position:absolute;top:1013px;left:545px;white-space:nowrap" class="ft3487">...............................................................<br/>...............................................................</p>
<p style="position:absolute;top:1060px;left:540px;white-space:nowrap" class="ft3480">................................................................</p>
<p style="position:absolute;top:1084px;left:693px;white-space:nowrap" class="ft3480">..............................</p>
<p style="position:absolute;top:1084px;left:549px;white-space:nowrap" class="ft3480">................................</p>
<p style="position:absolute;top:96px;left:829px;white-space:nowrap" class="ft3480">232&#160;</p>
<p style="position:absolute;top:120px;left:486px;white-space:nowrap" class="ft3480">Quinine&#160;Sulfate&#160;</p>
<p style="position:absolute;top:120px;left:828px;white-space:nowrap" class="ft3480">&#160;233&#160;</p>
<p style="position:absolute;top:152px;left:486px;white-space:nowrap" class="ft34815"><i><b>R</b></i></p>
<p style="position:absolute;top:155px;left:498px;white-space:nowrap" class="ft34816"><i>&#160;</i></p>
<p style="position:absolute;top:185px;left:486px;white-space:nowrap" class="ft3480">Rabavert&#160;</p>
<p style="position:absolute;top:185px;left:828px;white-space:nowrap" class="ft3480">&#160;341&#160;</p>
<p style="position:absolute;top:209px;left:486px;white-space:nowrap" class="ft3480">Recombivax&#160;Hb&#160;</p>
<p style="position:absolute;top:209px;left:828px;white-space:nowrap" class="ft3480">&#160;341&#160;</p>
<p style="position:absolute;top:233px;left:486px;white-space:nowrap" class="ft3480">Regranex&#160;</p>
<p style="position:absolute;top:233px;left:828px;white-space:nowrap" class="ft3480">&#160;234&#160;</p>
<p style="position:absolute;top:257px;left:486px;white-space:nowrap" class="ft3480">Retevmo&#160;</p>
<p style="position:absolute;top:257px;left:828px;white-space:nowrap" class="ft3480">&#160;235&#160;</p>
<p style="position:absolute;top:280px;left:486px;white-space:nowrap" class="ft3480">Revlimid&#160;</p>
<p style="position:absolute;top:280px;left:828px;white-space:nowrap" class="ft3480">&#160;236&#160;</p>
<p style="position:absolute;top:304px;left:486px;white-space:nowrap" class="ft3480">Rezurock&#160;</p>
<p style="position:absolute;top:304px;left:828px;white-space:nowrap" class="ft3480">&#160;238&#160;</p>
<p style="position:absolute;top:328px;left:486px;white-space:nowrap" class="ft3480">Rinvoq&#160;</p>
<p style="position:absolute;top:328px;left:828px;white-space:nowrap" class="ft3480">&#160;239&#160;</p>
<p style="position:absolute;top:352px;left:486px;white-space:nowrap" class="ft3480">Rituxan&#160;</p>
<p style="position:absolute;top:352px;left:828px;white-space:nowrap" class="ft3480">&#160;241&#160;</p>
<p style="position:absolute;top:376px;left:486px;white-space:nowrap" class="ft3480">Rituxan Hycela&#160;</p>
<p style="position:absolute;top:376px;left:828px;white-space:nowrap" class="ft3480">&#160;240&#160;</p>
<p style="position:absolute;top:399px;left:486px;white-space:nowrap" class="ft3480">Rituximab&#160;</p>
<p style="position:absolute;top:399px;left:828px;white-space:nowrap" class="ft3480">&#160;241&#160;</p>
<p style="position:absolute;top:423px;left:486px;white-space:nowrap" class="ft3480">Rozlytrek&#160;</p>
<p style="position:absolute;top:423px;left:828px;white-space:nowrap" class="ft3480">&#160;244&#160;</p>
<p style="position:absolute;top:447px;left:486px;white-space:nowrap" class="ft3480">Rubraca&#160;</p>
<p style="position:absolute;top:447px;left:828px;white-space:nowrap" class="ft3480">&#160;245&#160;</p>
<p style="position:absolute;top:471px;left:486px;white-space:nowrap" class="ft3480">Rufinamide&#160;</p>
<p style="position:absolute;top:471px;left:837px;white-space:nowrap" class="ft3480">&#160;19&#160;</p>
<p style="position:absolute;top:495px;left:486px;white-space:nowrap" class="ft3480">Ruxience&#160;</p>
<p style="position:absolute;top:495px;left:828px;white-space:nowrap" class="ft3480">&#160;241&#160;</p>
<p style="position:absolute;top:519px;left:486px;white-space:nowrap" class="ft3480">Rydapt&#160;</p>
<p style="position:absolute;top:519px;left:828px;white-space:nowrap" class="ft3480">&#160;246&#160;</p>
<p style="position:absolute;top:551px;left:486px;white-space:nowrap" class="ft34815"><i><b>S</b></i></p>
<p style="position:absolute;top:554px;left:496px;white-space:nowrap" class="ft34816"><i>&#160;</i></p>
<p style="position:absolute;top:584px;left:486px;white-space:nowrap" class="ft3480">Sajazir&#160;</p>
<p style="position:absolute;top:584px;left:828px;white-space:nowrap" class="ft3480">&#160;138&#160;</p>
<p style="position:absolute;top:608px;left:486px;white-space:nowrap" class="ft3480">Sandimmune&#160;</p>
<p style="position:absolute;top:608px;left:828px;white-space:nowrap" class="ft3480">&#160;341&#160;</p>
<p style="position:absolute;top:632px;left:486px;white-space:nowrap" class="ft3480">Sandostatin&#160;Lar&#160;</p>
<p style="position:absolute;top:632px;left:828px;white-space:nowrap" class="ft3480">&#160;247&#160;</p>
<p style="position:absolute;top:656px;left:486px;white-space:nowrap" class="ft3480">Sandostatin&#160;Lar Depot&#160;</p>
<p style="position:absolute;top:656px;left:828px;white-space:nowrap" class="ft3480">&#160;247&#160;</p>
<p style="position:absolute;top:679px;left:486px;white-space:nowrap" class="ft3480">Sapropterin&#160;Dihydrochloride&#160;</p>
<p style="position:absolute;top:679px;left:828px;white-space:nowrap" class="ft3480">&#160;167&#160;</p>
<p style="position:absolute;top:703px;left:486px;white-space:nowrap" class="ft3480">Sarclisa&#160;</p>
<p style="position:absolute;top:703px;left:828px;white-space:nowrap" class="ft3480">&#160;249&#160;</p>
<p style="position:absolute;top:727px;left:486px;white-space:nowrap" class="ft3480">Scemblix&#160;</p>
<p style="position:absolute;top:727px;left:828px;white-space:nowrap" class="ft3480">&#160;250&#160;</p>
<p style="position:absolute;top:751px;left:486px;white-space:nowrap" class="ft3480">Scopolamine&#160;</p>
<p style="position:absolute;top:751px;left:828px;white-space:nowrap" class="ft3480">&#160;115&#160;</p>
<p style="position:absolute;top:775px;left:486px;white-space:nowrap" class="ft3480">Signifor&#160;</p>
<p style="position:absolute;top:775px;left:828px;white-space:nowrap" class="ft3480">&#160;251&#160;</p>
<p style="position:absolute;top:798px;left:486px;white-space:nowrap" class="ft3480">Sildenafil&#160;</p>
<p style="position:absolute;top:798px;left:828px;white-space:nowrap" class="ft3480">&#160;252&#160;</p>
<p style="position:absolute;top:822px;left:486px;white-space:nowrap" class="ft3480">Sildenafil Citrate&#160;</p>
<p style="position:absolute;top:822px;left:828px;white-space:nowrap" class="ft3480">&#160;252&#160;</p>
<p style="position:absolute;top:846px;left:486px;white-space:nowrap" class="ft3480">Sirolimus&#160;</p>
<p style="position:absolute;top:846px;left:828px;white-space:nowrap" class="ft3480">&#160;341&#160;</p>
<p style="position:absolute;top:870px;left:486px;white-space:nowrap" class="ft3480">Sirturo&#160;</p>
<p style="position:absolute;top:870px;left:828px;white-space:nowrap" class="ft3480">&#160;253&#160;</p>
<p style="position:absolute;top:894px;left:486px;white-space:nowrap" class="ft3480">Skyrizi&#160;</p>
<p style="position:absolute;top:894px;left:828px;white-space:nowrap" class="ft3480">&#160;254&#160;</p>
<p style="position:absolute;top:917px;left:486px;white-space:nowrap" class="ft3480">Skyrizi Pen&#160;</p>
<p style="position:absolute;top:917px;left:828px;white-space:nowrap" class="ft3480">&#160;254&#160;</p>
<p style="position:absolute;top:941px;left:486px;white-space:nowrap" class="ft3480">Sodium&#160;Phenylbutyrate&#160;</p>
<p style="position:absolute;top:941px;left:828px;white-space:nowrap" class="ft3480">&#160;218&#160;</p>
<p style="position:absolute;top:965px;left:486px;white-space:nowrap" class="ft3480">Somatuline Depot</p>
<p style="position:absolute;top:965px;left:828px;white-space:nowrap" class="ft3480">&#160;255&#160;</p>
<p style="position:absolute;top:989px;left:486px;white-space:nowrap" class="ft3480">Somavert&#160;</p>
<p style="position:absolute;top:989px;left:828px;white-space:nowrap" class="ft3480">&#160;256&#160;</p>
<p style="position:absolute;top:1013px;left:486px;white-space:nowrap" class="ft3480">Spritam&#160;</p>
<p style="position:absolute;top:1013px;left:828px;white-space:nowrap" class="ft3480">&#160;257&#160;</p>
<p style="position:absolute;top:1036px;left:486px;white-space:nowrap" class="ft3480">Sprycel&#160;</p>
<p style="position:absolute;top:1036px;left:828px;white-space:nowrap" class="ft3480">&#160;258&#160;</p>
<p style="position:absolute;top:1060px;left:486px;white-space:nowrap" class="ft3480">Stelara&#160;</p>
<p style="position:absolute;top:1060px;left:828px;white-space:nowrap" class="ft3480">&#160;259&#160;</p>
<p style="position:absolute;top:1084px;left:486px;white-space:nowrap" class="ft3480">Stivarga&#160;</p>
<p style="position:absolute;top:1084px;left:828px;white-space:nowrap" class="ft3480">&#160;260&#160;</p>
</div>
<!-- Page 349 -->
<a name="349"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page349-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2349.png" alt="background image"/>
<p style="position:absolute;top:33px;left:62px;white-space:nowrap" class="ft3497">&#160;<br/>&#160;</p>
<p style="position:absolute;top:1128px;left:830px;white-space:nowrap" class="ft3490">349&#160;</p>
<p style="position:absolute;top:96px;left:62px;white-space:nowrap" class="ft3490">Sunitinib Malate&#160;................................................&#160;</p>
<p style="position:absolute;top:120px;left:108px;white-space:nowrap" class="ft3490">.................................................................&#160;</p>
<p style="position:absolute;top:143px;left:117px;white-space:nowrap" class="ft3490">...............................................................&#160;</p>
<p style="position:absolute;top:167px;left:176px;white-space:nowrap" class="ft3490">..................................................&#160;</p>
<p style="position:absolute;top:191px;left:167px;white-space:nowrap" class="ft3490">....................................................&#160;</p>
<p style="position:absolute;top:215px;left:140px;white-space:nowrap" class="ft3490">..........................................................&#160;</p>
<p style="position:absolute;top:239px;left:122px;white-space:nowrap" class="ft3490">..............................................................&#160;</p>
<p style="position:absolute;top:304px;left:126px;white-space:nowrap" class="ft3490">.............................................................&#160;</p>
<p style="position:absolute;top:328px;left:144px;white-space:nowrap" class="ft3490">.........................................................&#160;</p>
<p style="position:absolute;top:352px;left:131px;white-space:nowrap" class="ft3490">............................................................&#160;</p>
<p style="position:absolute;top:376px;left:171px;white-space:nowrap" class="ft3490">...................................................&#160;</p>
<p style="position:absolute;top:399px;left:122px;white-space:nowrap" class="ft3490">..............................................................&#160;</p>
<p style="position:absolute;top:423px;left:126px;white-space:nowrap" class="ft3490">.............................................................&#160;</p>
<p style="position:absolute;top:447px;left:99px;white-space:nowrap" class="ft3490">...................................................................&#160;</p>
<p style="position:absolute;top:471px;left:131px;white-space:nowrap" class="ft3497">............................................................&#160;<br/>............................................................&#160;</p>
<p style="position:absolute;top:519px;left:189px;white-space:nowrap" class="ft3490">...............................................&#160;</p>
<p style="position:absolute;top:542px;left:122px;white-space:nowrap" class="ft3490">..............................................................&#160;</p>
<p style="position:absolute;top:566px;left:144px;white-space:nowrap" class="ft3490">.........................................................&#160;</p>
<p style="position:absolute;top:590px;left:122px;white-space:nowrap" class="ft3490">..............................................................&#160;</p>
<p style="position:absolute;top:614px;left:126px;white-space:nowrap" class="ft3490">.............................................................&#160;</p>
<p style="position:absolute;top:638px;left:108px;white-space:nowrap" class="ft3490">.................................................................&#160;</p>
<p style="position:absolute;top:661px;left:275px;white-space:nowrap" class="ft3490">............................&#160;</p>
<p style="position:absolute;top:661px;left:130px;white-space:nowrap" class="ft3497">................................<br/>............................................................&#160;</p>
<p style="position:absolute;top:709px;left:225px;white-space:nowrap" class="ft3490">.......................................&#160;</p>
<p style="position:absolute;top:733px;left:153px;white-space:nowrap" class="ft3490">...............................................&#160;</p>
<p style="position:absolute;top:757px;left:230px;white-space:nowrap" class="ft3490">......................................&#160;</p>
<p style="position:absolute;top:780px;left:121px;white-space:nowrap" class="ft3490">..............................................................&#160;</p>
<p style="position:absolute;top:804px;left:279px;white-space:nowrap" class="ft3490">...........................&#160;</p>
<p style="position:absolute;top:804px;left:135px;white-space:nowrap" class="ft3490">................................</p>
<p style="position:absolute;top:828px;left:157px;white-space:nowrap" class="ft3490">......................................................&#160;</p>
<p style="position:absolute;top:852px;left:234px;white-space:nowrap" class="ft3490">.....................................&#160;</p>
<p style="position:absolute;top:876px;left:261px;white-space:nowrap" class="ft3490">...............................&#160;</p>
<p style="position:absolute;top:899px;left:234px;white-space:nowrap" class="ft3490">.....................................&#160;</p>
<p style="position:absolute;top:923px;left:257px;white-space:nowrap" class="ft3490">................................&#160;</p>
<p style="position:absolute;top:947px;left:203px;white-space:nowrap" class="ft3490">............................................&#160;</p>
<p style="position:absolute;top:971px;left:279px;white-space:nowrap" class="ft3490">...........................&#160;</p>
<p style="position:absolute;top:995px;left:167px;white-space:nowrap" class="ft3490">....................................................&#160;</p>
<p style="position:absolute;top:1018px;left:279px;white-space:nowrap" class="ft3490">...........................&#160;</p>
<p style="position:absolute;top:1018px;left:135px;white-space:nowrap" class="ft3490">................................</p>
<p style="position:absolute;top:1042px;left:185px;white-space:nowrap" class="ft3490">................................................&#160;</p>
<p style="position:absolute;top:1066px;left:266px;white-space:nowrap" class="ft3490">..............................&#160;</p>
<p style="position:absolute;top:1066px;left:121px;white-space:nowrap" class="ft3490">................................</p>
<p style="position:absolute;top:1090px;left:153px;white-space:nowrap" class="ft3490">.......................................................&#160;</p>
<p style="position:absolute;top:96px;left:404px;white-space:nowrap" class="ft3490">261&#160;</p>
<p style="position:absolute;top:120px;left:62px;white-space:nowrap" class="ft3490">Sutent&#160;</p>
<p style="position:absolute;top:120px;left:404px;white-space:nowrap" class="ft3490">261&#160;</p>
<p style="position:absolute;top:143px;left:62px;white-space:nowrap" class="ft3490">Symlin&#160;</p>
<p style="position:absolute;top:143px;left:404px;white-space:nowrap" class="ft3490">262&#160;</p>
<p style="position:absolute;top:167px;left:62px;white-space:nowrap" class="ft3490">Symlinpen 120&#160;</p>
<p style="position:absolute;top:167px;left:404px;white-space:nowrap" class="ft3490">262&#160;</p>
<p style="position:absolute;top:191px;left:62px;white-space:nowrap" class="ft3490">Symlinpen 60&#160;</p>
<p style="position:absolute;top:191px;left:404px;white-space:nowrap" class="ft3490">262&#160;</p>
<p style="position:absolute;top:215px;left:62px;white-space:nowrap" class="ft3490">Sympazan&#160;</p>
<p style="position:absolute;top:215px;left:404px;white-space:nowrap" class="ft3490">263&#160;</p>
<p style="position:absolute;top:239px;left:62px;white-space:nowrap" class="ft3490">Synribo&#160;</p>
<p style="position:absolute;top:239px;left:404px;white-space:nowrap" class="ft3490">264&#160;</p>
<p style="position:absolute;top:271px;left:62px;white-space:nowrap" class="ft34915"><i><b>T</b></i></p>
<p style="position:absolute;top:274px;left:73px;white-space:nowrap" class="ft34916"><i>&#160;</i></p>
<p style="position:absolute;top:304px;left:62px;white-space:nowrap" class="ft3490">Tabrecta&#160;</p>
<p style="position:absolute;top:304px;left:404px;white-space:nowrap" class="ft3490">265&#160;</p>
<p style="position:absolute;top:328px;left:62px;white-space:nowrap" class="ft3490">Tacrolimus&#160;</p>
<p style="position:absolute;top:328px;left:404px;white-space:nowrap" class="ft3490">341&#160;</p>
<p style="position:absolute;top:352px;left:62px;white-space:nowrap" class="ft3490">Tadalafil&#160;</p>
<p style="position:absolute;top:352px;left:404px;white-space:nowrap" class="ft3490">266&#160;</p>
<p style="position:absolute;top:376px;left:62px;white-space:nowrap" class="ft3490">Tadalafil&#160;(pah)&#160;</p>
<p style="position:absolute;top:376px;left:404px;white-space:nowrap" class="ft3490">266&#160;</p>
<p style="position:absolute;top:399px;left:62px;white-space:nowrap" class="ft3490">Tafinlar&#160;</p>
<p style="position:absolute;top:399px;left:404px;white-space:nowrap" class="ft3490">267&#160;</p>
<p style="position:absolute;top:423px;left:62px;white-space:nowrap" class="ft3490">Tagrisso&#160;</p>
<p style="position:absolute;top:423px;left:404px;white-space:nowrap" class="ft3490">268&#160;</p>
<p style="position:absolute;top:447px;left:62px;white-space:nowrap" class="ft3490">Taltz&#160;</p>
<p style="position:absolute;top:447px;left:404px;white-space:nowrap" class="ft3490">269&#160;</p>
<p style="position:absolute;top:471px;left:62px;white-space:nowrap" class="ft3490">Talzenna&#160;</p>
<p style="position:absolute;top:471px;left:404px;white-space:nowrap" class="ft3490">270&#160;</p>
<p style="position:absolute;top:495px;left:62px;white-space:nowrap" class="ft3490">Targretin&#160;</p>
<p style="position:absolute;top:495px;left:404px;white-space:nowrap" class="ft3490">271&#160;</p>
<p style="position:absolute;top:519px;left:62px;white-space:nowrap" class="ft3490">Targretin Topical&#160;</p>
<p style="position:absolute;top:519px;left:404px;white-space:nowrap" class="ft3490">271&#160;</p>
<p style="position:absolute;top:542px;left:62px;white-space:nowrap" class="ft3490">Tasigna&#160;</p>
<p style="position:absolute;top:542px;left:404px;white-space:nowrap" class="ft3490">272&#160;</p>
<p style="position:absolute;top:566px;left:62px;white-space:nowrap" class="ft3490">Tazarotene&#160;</p>
<p style="position:absolute;top:566px;left:404px;white-space:nowrap" class="ft3490">273&#160;</p>
<p style="position:absolute;top:590px;left:62px;white-space:nowrap" class="ft3490">Tazorac&#160;</p>
<p style="position:absolute;top:590px;left:404px;white-space:nowrap" class="ft3490">273&#160;</p>
<p style="position:absolute;top:614px;left:62px;white-space:nowrap" class="ft3490">Tazverik&#160;</p>
<p style="position:absolute;top:614px;left:404px;white-space:nowrap" class="ft3490">274&#160;</p>
<p style="position:absolute;top:638px;left:62px;white-space:nowrap" class="ft3490">Tdvax&#160;</p>
<p style="position:absolute;top:638px;left:404px;white-space:nowrap" class="ft3490">341&#160;</p>
<p style="position:absolute;top:661px;left:62px;white-space:nowrap" class="ft3490">Tecentriq</p>
<p style="position:absolute;top:661px;left:404px;white-space:nowrap" class="ft3490">275&#160;</p>
<p style="position:absolute;top:685px;left:62px;white-space:nowrap" class="ft3490">Tecfidera</p>
<p style="position:absolute;top:685px;left:404px;white-space:nowrap" class="ft3490">277&#160;</p>
<p style="position:absolute;top:709px;left:62px;white-space:nowrap" class="ft3490">Tecfidera&#160;Starter Pack&#160;</p>
<p style="position:absolute;top:709px;left:404px;white-space:nowrap" class="ft3490">277&#160;</p>
<p style="position:absolute;top:733px;left:62px;white-space:nowrap" class="ft3490">Temazepam&#160;</p>
<p style="position:absolute;top:733px;left:368px;white-space:nowrap" class="ft3490">136, 278&#160;</p>
<p style="position:absolute;top:757px;left:62px;white-space:nowrap" class="ft3490">Temazepam&#160;30mg&#160;-&#160;65&#160;</p>
<p style="position:absolute;top:757px;left:404px;white-space:nowrap" class="ft3490">278&#160;</p>
<p style="position:absolute;top:780px;left:62px;white-space:nowrap" class="ft3490">Tenivac&#160;</p>
<p style="position:absolute;top:780px;left:404px;white-space:nowrap" class="ft3490">341&#160;</p>
<p style="position:absolute;top:804px;left:62px;white-space:nowrap" class="ft3490">Tepmetko&#160;</p>
<p style="position:absolute;top:804px;left:404px;white-space:nowrap" class="ft3490">279&#160;</p>
<p style="position:absolute;top:828px;left:62px;white-space:nowrap" class="ft3490">Testosterone&#160;</p>
<p style="position:absolute;top:828px;left:404px;white-space:nowrap" class="ft3490">288&#160;</p>
<p style="position:absolute;top:852px;left:62px;white-space:nowrap" class="ft3490">Testosterone&#160;Cypionate&#160;</p>
<p style="position:absolute;top:852px;left:404px;white-space:nowrap" class="ft3490">280&#160;</p>
<p style="position:absolute;top:876px;left:62px;white-space:nowrap" class="ft3490">Testosterone&#160;Cypionate&#160;Inj&#160;</p>
<p style="position:absolute;top:876px;left:404px;white-space:nowrap" class="ft3490">280&#160;</p>
<p style="position:absolute;top:899px;left:62px;white-space:nowrap" class="ft3490">Testosterone&#160;Enanthate&#160;</p>
<p style="position:absolute;top:899px;left:404px;white-space:nowrap" class="ft3490">281&#160;</p>
<p style="position:absolute;top:923px;left:62px;white-space:nowrap" class="ft3490">Testosterone&#160;Enanthate&#160;Inj&#160;</p>
<p style="position:absolute;top:923px;left:404px;white-space:nowrap" class="ft3490">281&#160;</p>
<p style="position:absolute;top:947px;left:62px;white-space:nowrap" class="ft3490">Testosterone&#160;Pump&#160;</p>
<p style="position:absolute;top:947px;left:404px;white-space:nowrap" class="ft3490">288&#160;</p>
<p style="position:absolute;top:971px;left:62px;white-space:nowrap" class="ft3490">Testosterone&#160;Topical Solution&#160;</p>
<p style="position:absolute;top:971px;left:404px;white-space:nowrap" class="ft3490">288&#160;</p>
<p style="position:absolute;top:995px;left:62px;white-space:nowrap" class="ft3490">Tetrabenazine&#160;</p>
<p style="position:absolute;top:995px;left:404px;white-space:nowrap" class="ft3490">282&#160;</p>
<p style="position:absolute;top:1018px;left:62px;white-space:nowrap" class="ft3490">Thalomid&#160;</p>
<p style="position:absolute;top:1018px;left:404px;white-space:nowrap" class="ft3490">283&#160;</p>
<p style="position:absolute;top:1042px;left:62px;white-space:nowrap" class="ft3490">Thioridazine Hcl&#160;</p>
<p style="position:absolute;top:1042px;left:404px;white-space:nowrap" class="ft3490">110&#160;</p>
<p style="position:absolute;top:1066px;left:62px;white-space:nowrap" class="ft3490">Tibsovo&#160;</p>
<p style="position:absolute;top:1066px;left:404px;white-space:nowrap" class="ft3490">284&#160;</p>
<p style="position:absolute;top:1090px;left:62px;white-space:nowrap" class="ft3490">Tobramycin&#160;</p>
<p style="position:absolute;top:1090px;left:404px;white-space:nowrap" class="ft3490">285&#160;</p>
<p style="position:absolute;top:96px;left:486px;white-space:nowrap" class="ft3490">Topical&#160;Doxepin&#160;.................................................&#160;</p>
<p style="position:absolute;top:120px;left:621px;white-space:nowrap" class="ft3490">..............................................</p>
<p style="position:absolute;top:143px;left:648px;white-space:nowrap" class="ft3490">........................................</p>
<p style="position:absolute;top:167px;left:617px;white-space:nowrap" class="ft3490">...............................................</p>
<p style="position:absolute;top:191px;left:572px;white-space:nowrap" class="ft3490">.........................................................</p>
<p style="position:absolute;top:215px;left:626px;white-space:nowrap" class="ft3490">.............................................</p>
<p style="position:absolute;top:239px;left:608px;white-space:nowrap" class="ft3490">.................................................</p>
<p style="position:absolute;top:262px;left:549px;white-space:nowrap" class="ft3490">................................................................</p>
<p style="position:absolute;top:286px;left:612px;white-space:nowrap" class="ft3490">................................................</p>
<p style="position:absolute;top:310px;left:549px;white-space:nowrap" class="ft3490">..............................................................</p>
<p style="position:absolute;top:334px;left:545px;white-space:nowrap" class="ft3490">...............................................................</p>
<p style="position:absolute;top:358px;left:603px;white-space:nowrap" class="ft3490">..................................................</p>
<p style="position:absolute;top:381px;left:572px;white-space:nowrap" class="ft3490">.........................................................</p>
<p style="position:absolute;top:405px;left:599px;white-space:nowrap" class="ft3490">...................................................</p>
<p style="position:absolute;top:429px;left:554px;white-space:nowrap" class="ft3490">.............................................................</p>
<p style="position:absolute;top:453px;left:653px;white-space:nowrap" class="ft3490">.......................................</p>
<p style="position:absolute;top:477px;left:698px;white-space:nowrap" class="ft3490">.............................</p>
<p style="position:absolute;top:501px;left:563px;white-space:nowrap" class="ft3490">...........................................................</p>
<p style="position:absolute;top:524px;left:554px;white-space:nowrap" class="ft3490">.............................................................</p>
<p style="position:absolute;top:548px;left:662px;white-space:nowrap" class="ft3490">.....................................</p>
<p style="position:absolute;top:572px;left:639px;white-space:nowrap" class="ft3490">..........................................</p>
<p style="position:absolute;top:596px;left:716px;white-space:nowrap" class="ft3490">.........................</p>
<p style="position:absolute;top:620px;left:545px;white-space:nowrap" class="ft3490">...............................................................</p>
<p style="position:absolute;top:643px;left:743px;white-space:nowrap" class="ft3490">...................</p>
<p style="position:absolute;top:667px;left:653px;white-space:nowrap" class="ft3490">.......................................</p>
<p style="position:absolute;top:691px;left:554px;white-space:nowrap" class="ft3490">.............................................................</p>
<p style="position:absolute;top:715px;left:576px;white-space:nowrap" class="ft3490">........................................................</p>
<p style="position:absolute;top:739px;left:554px;white-space:nowrap" class="ft3490">.............................................................</p>
<p style="position:absolute;top:762px;left:540px;white-space:nowrap" class="ft3497">................................................................<br/>................................................................</p>
<p style="position:absolute;top:852px;left:549px;white-space:nowrap" class="ft3490">..............................................................</p>
<p style="position:absolute;top:876px;left:540px;white-space:nowrap" class="ft3490">................................................................</p>
<p style="position:absolute;top:941px;left:549px;white-space:nowrap" class="ft3490">..............................................................</p>
<p style="position:absolute;top:965px;left:545px;white-space:nowrap" class="ft3490">...............................................................</p>
<p style="position:absolute;top:989px;left:635px;white-space:nowrap" class="ft3490">.............................................</p>
<p style="position:absolute;top:1013px;left:549px;white-space:nowrap" class="ft3497">..............................................................<br/>..............................................................</p>
<p style="position:absolute;top:1060px;left:707px;white-space:nowrap" class="ft3490">...........................</p>
<p style="position:absolute;top:1084px;left:662px;white-space:nowrap" class="ft3490">.....................................</p>
<p style="position:absolute;top:1060px;left:563px;white-space:nowrap" class="ft3490">................................</p>
<p style="position:absolute;top:96px;left:829px;white-space:nowrap" class="ft3490">286&#160;</p>
<p style="position:absolute;top:120px;left:486px;white-space:nowrap" class="ft3490">Topical&#160;Lidocaine&#160;</p>
<p style="position:absolute;top:120px;left:828px;white-space:nowrap" class="ft3490">&#160;287&#160;</p>
<p style="position:absolute;top:143px;left:486px;white-space:nowrap" class="ft3490">Topical&#160;Testosterones&#160;</p>
<p style="position:absolute;top:143px;left:828px;white-space:nowrap" class="ft3490">&#160;288&#160;</p>
<p style="position:absolute;top:167px;left:486px;white-space:nowrap" class="ft3490">Topical&#160;Tretinoin&#160;</p>
<p style="position:absolute;top:167px;left:828px;white-space:nowrap" class="ft3490">&#160;289&#160;</p>
<p style="position:absolute;top:191px;left:486px;white-space:nowrap" class="ft3490">Toremifene&#160;</p>
<p style="position:absolute;top:191px;left:828px;white-space:nowrap" class="ft3490">&#160;290&#160;</p>
<p style="position:absolute;top:215px;left:486px;white-space:nowrap" class="ft3490">Toremifene&#160;Citrate&#160;</p>
<p style="position:absolute;top:215px;left:828px;white-space:nowrap" class="ft3490">&#160;290&#160;</p>
<p style="position:absolute;top:239px;left:486px;white-space:nowrap" class="ft3490">Tpn Electrolytes&#160;</p>
<p style="position:absolute;top:239px;left:828px;white-space:nowrap" class="ft3490">&#160;341&#160;</p>
<p style="position:absolute;top:262px;left:486px;white-space:nowrap" class="ft3490">Tracleer&#160;</p>
<p style="position:absolute;top:262px;left:837px;white-space:nowrap" class="ft3490">&#160;28&#160;</p>
<p style="position:absolute;top:286px;left:486px;white-space:nowrap" class="ft3490">Tramadol Hcl Er&#160;</p>
<p style="position:absolute;top:286px;left:828px;white-space:nowrap" class="ft3490">&#160;150&#160;</p>
<p style="position:absolute;top:310px;left:486px;white-space:nowrap" class="ft3490">Travasol</p>
<p style="position:absolute;top:310px;left:828px;white-space:nowrap" class="ft3490">&#160;342&#160;</p>
<p style="position:absolute;top:334px;left:486px;white-space:nowrap" class="ft3490">Trelstar&#160;</p>
<p style="position:absolute;top:334px;left:828px;white-space:nowrap" class="ft3490">&#160;291&#160;</p>
<p style="position:absolute;top:358px;left:486px;white-space:nowrap" class="ft3490">Trelstar&#160;Mixject&#160;</p>
<p style="position:absolute;top:358px;left:828px;white-space:nowrap" class="ft3490">&#160;291&#160;</p>
<p style="position:absolute;top:381px;left:486px;white-space:nowrap" class="ft3490">Treprostinil&#160;</p>
<p style="position:absolute;top:381px;left:828px;white-space:nowrap" class="ft3490">&#160;292&#160;</p>
<p style="position:absolute;top:405px;left:486px;white-space:nowrap" class="ft3490">Treprostinil&#160;Inj&#160;</p>
<p style="position:absolute;top:405px;left:828px;white-space:nowrap" class="ft3490">&#160;292&#160;</p>
<p style="position:absolute;top:429px;left:486px;white-space:nowrap" class="ft3490">Tretinoin&#160;</p>
<p style="position:absolute;top:429px;left:828px;white-space:nowrap" class="ft3490">&#160;289&#160;</p>
<p style="position:absolute;top:453px;left:486px;white-space:nowrap" class="ft3490">Tretinoin Microsphere&#160;</p>
<p style="position:absolute;top:453px;left:828px;white-space:nowrap" class="ft3490">&#160;289&#160;</p>
<p style="position:absolute;top:477px;left:486px;white-space:nowrap" class="ft3490">Tretinoin Microsphere&#160;Pump&#160;</p>
<p style="position:absolute;top:477px;left:828px;white-space:nowrap" class="ft3490">&#160;289&#160;</p>
<p style="position:absolute;top:501px;left:486px;white-space:nowrap" class="ft3490">Triazolam&#160;</p>
<p style="position:absolute;top:501px;left:828px;white-space:nowrap" class="ft3490">&#160;136&#160;</p>
<p style="position:absolute;top:524px;left:486px;white-space:nowrap" class="ft3490">Trientine&#160;</p>
<p style="position:absolute;top:524px;left:828px;white-space:nowrap" class="ft3490">&#160;293&#160;</p>
<p style="position:absolute;top:548px;left:486px;white-space:nowrap" class="ft3490">Trientine Hydrochloride&#160;</p>
<p style="position:absolute;top:548px;left:828px;white-space:nowrap" class="ft3490">&#160;293&#160;</p>
<p style="position:absolute;top:572px;left:486px;white-space:nowrap" class="ft3490">Trihexyphenidyl&#160;Hcl&#160;</p>
<p style="position:absolute;top:572px;left:828px;white-space:nowrap" class="ft3490">&#160;116&#160;</p>
<p style="position:absolute;top:596px;left:486px;white-space:nowrap" class="ft3490">Trihexyphenidyl&#160;Hydrochloride&#160;</p>
<p style="position:absolute;top:596px;left:828px;white-space:nowrap" class="ft3490">&#160;116&#160;</p>
<p style="position:absolute;top:620px;left:486px;white-space:nowrap" class="ft3490">Trikafta&#160;</p>
<p style="position:absolute;top:620px;left:828px;white-space:nowrap" class="ft3490">&#160;294&#160;</p>
<p style="position:absolute;top:643px;left:486px;white-space:nowrap" class="ft3490">Trimethobenzamide Hydrochloride&#160;</p>
<p style="position:absolute;top:643px;left:828px;white-space:nowrap" class="ft3490">&#160;110&#160;</p>
<p style="position:absolute;top:667px;left:486px;white-space:nowrap" class="ft3490">Trimipramine Maleate&#160;</p>
<p style="position:absolute;top:667px;left:828px;white-space:nowrap" class="ft3490">&#160;132&#160;</p>
<p style="position:absolute;top:691px;left:486px;white-space:nowrap" class="ft3490">Trodelvy&#160;</p>
<p style="position:absolute;top:691px;left:828px;white-space:nowrap" class="ft3490">&#160;295&#160;</p>
<p style="position:absolute;top:715px;left:486px;white-space:nowrap" class="ft3490">Trophamine&#160;</p>
<p style="position:absolute;top:715px;left:828px;white-space:nowrap" class="ft3490">&#160;342&#160;</p>
<p style="position:absolute;top:739px;left:486px;white-space:nowrap" class="ft3490">Truseltiq&#160;</p>
<p style="position:absolute;top:739px;left:828px;white-space:nowrap" class="ft3490">&#160;296&#160;</p>
<p style="position:absolute;top:762px;left:486px;white-space:nowrap" class="ft3490">Tukysa&#160;</p>
<p style="position:absolute;top:762px;left:828px;white-space:nowrap" class="ft3490">&#160;297&#160;</p>
<p style="position:absolute;top:786px;left:486px;white-space:nowrap" class="ft3490">Turalio&#160;</p>
<p style="position:absolute;top:786px;left:828px;white-space:nowrap" class="ft3490">&#160;298&#160;</p>
<p style="position:absolute;top:819px;left:486px;white-space:nowrap" class="ft34915"><i><b>U</b></i></p>
<p style="position:absolute;top:821px;left:499px;white-space:nowrap" class="ft34916"><i>&#160;</i></p>
<p style="position:absolute;top:852px;left:486px;white-space:nowrap" class="ft3490">Ubrelvy&#160;</p>
<p style="position:absolute;top:852px;left:828px;white-space:nowrap" class="ft3490">&#160;299&#160;</p>
<p style="position:absolute;top:876px;left:486px;white-space:nowrap" class="ft3490">Ukoniq</p>
<p style="position:absolute;top:876px;left:828px;white-space:nowrap" class="ft3490">&#160;300&#160;</p>
<p style="position:absolute;top:908px;left:486px;white-space:nowrap" class="ft34915"><i><b>V</b></i></p>
<p style="position:absolute;top:911px;left:498px;white-space:nowrap" class="ft34916"><i>&#160;</i></p>
<p style="position:absolute;top:941px;left:486px;white-space:nowrap" class="ft3490">Valchlor</p>
<p style="position:absolute;top:941px;left:828px;white-space:nowrap" class="ft3490">&#160;301&#160;</p>
<p style="position:absolute;top:965px;left:486px;white-space:nowrap" class="ft3490">Valtoco&#160;</p>
<p style="position:absolute;top:965px;left:828px;white-space:nowrap" class="ft3490">&#160;302&#160;</p>
<p style="position:absolute;top:989px;left:486px;white-space:nowrap" class="ft3490">Varenicline&#160;Tartrate&#160;</p>
<p style="position:absolute;top:989px;left:837px;white-space:nowrap" class="ft3490">&#160;45&#160;</p>
<p style="position:absolute;top:1013px;left:486px;white-space:nowrap" class="ft3490">Velcade&#160;</p>
<p style="position:absolute;top:1013px;left:828px;white-space:nowrap" class="ft3490">&#160;303&#160;</p>
<p style="position:absolute;top:1036px;left:486px;white-space:nowrap" class="ft3490">Veltassa&#160;</p>
<p style="position:absolute;top:1036px;left:828px;white-space:nowrap" class="ft3490">&#160;304&#160;</p>
<p style="position:absolute;top:1060px;left:486px;white-space:nowrap" class="ft3490">Venclexta&#160;</p>
<p style="position:absolute;top:1060px;left:828px;white-space:nowrap" class="ft3490">&#160;305&#160;</p>
<p style="position:absolute;top:1084px;left:486px;white-space:nowrap" class="ft3490">Venclexta Starting Pack&#160;</p>
<p style="position:absolute;top:1084px;left:828px;white-space:nowrap" class="ft3490">&#160;305&#160;</p>
</div>
<!-- Page 350 -->
<a name="350"></a>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
<div id="page350-div" style="position:relative;width:918px;height:1188px;">
<img width="918" height="1188" src="out2350.png" alt="background image"/>
<p style="position:absolute;top:33px;left:62px;white-space:nowrap" class="ft3507">&#160;<br/>&#160;</p>
<p style="position:absolute;top:1128px;left:830px;white-space:nowrap" class="ft3500">350&#160;</p>
<p style="position:absolute;top:96px;left:62px;white-space:nowrap" class="ft3500">Ventavis&#160;.............................................................&#160;</p>
<p style="position:absolute;top:120px;left:135px;white-space:nowrap" class="ft3500">...........................................................&#160;</p>
<p style="position:absolute;top:143px;left:131px;white-space:nowrap" class="ft3500">............................................................&#160;</p>
<p style="position:absolute;top:167px;left:140px;white-space:nowrap" class="ft3507">..........................................................&#160;<br/>..........................................................&#160;</p>
<p style="position:absolute;top:215px;left:203px;white-space:nowrap" class="ft3500">............................................&#160;</p>
<p style="position:absolute;top:239px;left:198px;white-space:nowrap" class="ft3500">.............................................&#160;</p>
<p style="position:absolute;top:262px;left:122px;white-space:nowrap" class="ft3500">..............................................................&#160;</p>
<p style="position:absolute;top:286px;left:131px;white-space:nowrap" class="ft3500">............................................................&#160;</p>
<p style="position:absolute;top:310px;left:162px;white-space:nowrap" class="ft3500">.....................................................&#160;</p>
<p style="position:absolute;top:334px;left:117px;white-space:nowrap" class="ft3500">...............................................................&#160;</p>
<p style="position:absolute;top:358px;left:122px;white-space:nowrap" class="ft3500">..............................................................&#160;</p>
<p style="position:absolute;top:423px;left:122px;white-space:nowrap" class="ft3500">..............................................................&#160;</p>
<p style="position:absolute;top:489px;left:117px;white-space:nowrap" class="ft3500">...............................................................&#160;</p>
<p style="position:absolute;top:513px;left:122px;white-space:nowrap" class="ft3500">..............................................................&#160;</p>
<p style="position:absolute;top:537px;left:144px;white-space:nowrap" class="ft3500">.........................................................&#160;</p>
<p style="position:absolute;top:560px;left:126px;white-space:nowrap" class="ft3500">.............................................................&#160;</p>
<p style="position:absolute;top:584px;left:113px;white-space:nowrap" class="ft3500">................................................................&#160;</p>
<p style="position:absolute;top:608px;left:266px;white-space:nowrap" class="ft3500">..............................&#160;</p>
<p style="position:absolute;top:608px;left:121px;white-space:nowrap" class="ft3500">................................</p>
<p style="position:absolute;top:632px;left:108px;white-space:nowrap" class="ft3500">.................................................................&#160;</p>
<p style="position:absolute;top:656px;left:266px;white-space:nowrap" class="ft3500">..............................&#160;</p>
<p style="position:absolute;top:656px;left:121px;white-space:nowrap" class="ft3500">................................</p>
<p style="position:absolute;top:679px;left:117px;white-space:nowrap" class="ft3500">...............................................................&#160;</p>
<p style="position:absolute;top:703px;left:284px;white-space:nowrap" class="ft3500">..........................&#160;</p>
<p style="position:absolute;top:96px;left:404px;white-space:nowrap" class="ft3500">306&#160;</p>
<p style="position:absolute;top:120px;left:62px;white-space:nowrap" class="ft3500">Versacloz&#160;</p>
<p style="position:absolute;top:120px;left:404px;white-space:nowrap" class="ft3500">307&#160;</p>
<p style="position:absolute;top:143px;left:62px;white-space:nowrap" class="ft3500">Verzenio&#160;</p>
<p style="position:absolute;top:143px;left:404px;white-space:nowrap" class="ft3500">308&#160;</p>
<p style="position:absolute;top:167px;left:62px;white-space:nowrap" class="ft3500">Vigabatrin&#160;</p>
<p style="position:absolute;top:167px;left:404px;white-space:nowrap" class="ft3500">309&#160;</p>
<p style="position:absolute;top:191px;left:62px;white-space:nowrap" class="ft3500">Vigadrone&#160;</p>
<p style="position:absolute;top:191px;left:404px;white-space:nowrap" class="ft3500">309&#160;</p>
<p style="position:absolute;top:215px;left:62px;white-space:nowrap" class="ft3500">Vinblastine&#160;Sulfate&#160;</p>
<p style="position:absolute;top:215px;left:404px;white-space:nowrap" class="ft3500">342&#160;</p>
<p style="position:absolute;top:239px;left:62px;white-space:nowrap" class="ft3500">Vincristine Sulfate&#160;</p>
<p style="position:absolute;top:239px;left:404px;white-space:nowrap" class="ft3500">342&#160;</p>
<p style="position:absolute;top:262px;left:62px;white-space:nowrap" class="ft3500">Vitrakvi</p>
<p style="position:absolute;top:262px;left:404px;white-space:nowrap" class="ft3500">310&#160;</p>
<p style="position:absolute;top:286px;left:62px;white-space:nowrap" class="ft3500">Vizimpro</p>
<p style="position:absolute;top:286px;left:404px;white-space:nowrap" class="ft3500">311&#160;</p>
<p style="position:absolute;top:310px;left:62px;white-space:nowrap" class="ft3500">Voriconazole&#160;</p>
<p style="position:absolute;top:310px;left:404px;white-space:nowrap" class="ft3500">312&#160;</p>
<p style="position:absolute;top:334px;left:62px;white-space:nowrap" class="ft3500">Vosevi&#160;</p>
<p style="position:absolute;top:334px;left:404px;white-space:nowrap" class="ft3500">313&#160;</p>
<p style="position:absolute;top:358px;left:62px;white-space:nowrap" class="ft3500">Votrient</p>
<p style="position:absolute;top:358px;left:404px;white-space:nowrap" class="ft3500">314&#160;</p>
<p style="position:absolute;top:390px;left:62px;white-space:nowrap" class="ft35015"><i><b>W</b></i></p>
<p style="position:absolute;top:393px;left:78px;white-space:nowrap" class="ft35016"><i>&#160;</i></p>
<p style="position:absolute;top:423px;left:62px;white-space:nowrap" class="ft3500">Welireg&#160;</p>
<p style="position:absolute;top:423px;left:404px;white-space:nowrap" class="ft3500">315&#160;</p>
<p style="position:absolute;top:456px;left:62px;white-space:nowrap" class="ft35015"><i><b>X</b></i></p>
<p style="position:absolute;top:459px;left:74px;white-space:nowrap" class="ft35016"><i>&#160;</i></p>
<p style="position:absolute;top:489px;left:62px;white-space:nowrap" class="ft3500">Xalkori&#160;</p>
<p style="position:absolute;top:489px;left:404px;white-space:nowrap" class="ft3500">316&#160;</p>
<p style="position:absolute;top:513px;left:62px;white-space:nowrap" class="ft3500">Xeljanz&#160;</p>
<p style="position:absolute;top:513px;left:404px;white-space:nowrap" class="ft3500">317&#160;</p>
<p style="position:absolute;top:537px;left:62px;white-space:nowrap" class="ft3500">Xeljanz Xr&#160;</p>
<p style="position:absolute;top:537px;left:404px;white-space:nowrap" class="ft3500">317&#160;</p>
<p style="position:absolute;top:560px;left:62px;white-space:nowrap" class="ft3500">Xermelo&#160;</p>
<p style="position:absolute;top:560px;left:404px;white-space:nowrap" class="ft3500">318&#160;</p>
<p style="position:absolute;top:584px;left:62px;white-space:nowrap" class="ft3500">Xgeva&#160;</p>
<p style="position:absolute;top:584px;left:404px;white-space:nowrap" class="ft3500">319&#160;</p>
<p style="position:absolute;top:608px;left:62px;white-space:nowrap" class="ft3500">Xifaxan&#160;</p>
<p style="position:absolute;top:608px;left:404px;white-space:nowrap" class="ft3500">320&#160;</p>
<p style="position:absolute;top:632px;left:62px;white-space:nowrap" class="ft3500">Xolair&#160;</p>
<p style="position:absolute;top:632px;left:404px;white-space:nowrap" class="ft3500">321&#160;</p>
<p style="position:absolute;top:656px;left:62px;white-space:nowrap" class="ft3500">Xospata&#160;</p>
<p style="position:absolute;top:656px;left:404px;white-space:nowrap" class="ft3500">322&#160;</p>
<p style="position:absolute;top:679px;left:62px;white-space:nowrap" class="ft3500">Xpovio&#160;</p>
<p style="position:absolute;top:679px;left:404px;white-space:nowrap" class="ft3500">323&#160;</p>
<p style="position:absolute;top:703px;left:62px;white-space:nowrap" class="ft3500">Xpovio 100 Mg Once Weekly&#160;</p>
<p style="position:absolute;top:703px;left:404px;white-space:nowrap" class="ft3500">323&#160;</p>
<p style="position:absolute;top:96px;left:486px;white-space:nowrap" class="ft3500">Xpovio 40 Mg Once Weekly&#160;.............................</p>
<p style="position:absolute;top:120px;left:702px;white-space:nowrap" class="ft3500">............................</p>
<p style="position:absolute;top:143px;left:698px;white-space:nowrap" class="ft3500">.............................</p>
<p style="position:absolute;top:167px;left:702px;white-space:nowrap" class="ft3500">............................</p>
<p style="position:absolute;top:191px;left:698px;white-space:nowrap" class="ft3500">.............................</p>
<p style="position:absolute;top:215px;left:702px;white-space:nowrap" class="ft3500">............................</p>
<p style="position:absolute;top:239px;left:536px;white-space:nowrap" class="ft3500">................................................................</p>
<p style="position:absolute;top:262px;left:540px;white-space:nowrap" class="ft3500">................................................................</p>
<p style="position:absolute;top:328px;left:540px;white-space:nowrap" class="ft3500">................................................................</p>
<p style="position:absolute;top:394px;left:554px;white-space:nowrap" class="ft3500">.............................................................</p>
<p style="position:absolute;top:417px;left:536px;white-space:nowrap" class="ft3507">................................................................<br/>................................................................</p>
<p style="position:absolute;top:465px;left:549px;white-space:nowrap" class="ft3500">..............................................................</p>
<p style="position:absolute;top:489px;left:554px;white-space:nowrap" class="ft3507">.............................................................<br/>.............................................................</p>
<p style="position:absolute;top:537px;left:545px;white-space:nowrap" class="ft3507">................................................................<br/>...............................................................</p>
<p style="position:absolute;top:584px;left:621px;white-space:nowrap" class="ft3500">..............................................</p>
<p style="position:absolute;top:608px;left:549px;white-space:nowrap" class="ft3500">..............................................................</p>
<p style="position:absolute;top:632px;left:545px;white-space:nowrap" class="ft3500">...............................................................</p>
<p style="position:absolute;top:656px;left:693px;white-space:nowrap" class="ft3500">..............................</p>
<p style="position:absolute;top:656px;left:549px;white-space:nowrap" class="ft3500">................................</p>
<p style="position:absolute;top:679px;left:617px;white-space:nowrap" class="ft3500">...............................................</p>
<p style="position:absolute;top:703px;left:680px;white-space:nowrap" class="ft3500">................................</p>
<p style="position:absolute;top:703px;left:536px;white-space:nowrap" class="ft3500">................................</p>
<p style="position:absolute;top:703px;left:824px;white-space:nowrap" class="ft3500">.....</p>
<p style="position:absolute;top:537px;left:833px;white-space:nowrap" class="ft3500">.</p>
<p style="position:absolute;top:441px;left:824px;white-space:nowrap" class="ft3500">.</p>
<p style="position:absolute;top:417px;left:824px;white-space:nowrap" class="ft3500">.</p>
<p style="position:absolute;top:239px;left:824px;white-space:nowrap" class="ft3500">.</p>
<p style="position:absolute;top:96px;left:828px;white-space:nowrap" class="ft3500">&#160;323&#160;</p>
<p style="position:absolute;top:120px;left:486px;white-space:nowrap" class="ft3500">Xpovio 40 Mg Twice Weekly</p>
<p style="position:absolute;top:120px;left:828px;white-space:nowrap" class="ft3500">&#160;323&#160;</p>
<p style="position:absolute;top:143px;left:486px;white-space:nowrap" class="ft3500">Xpovio 60 Mg Once Weekly&#160;</p>
<p style="position:absolute;top:143px;left:828px;white-space:nowrap" class="ft3500">&#160;323&#160;</p>
<p style="position:absolute;top:167px;left:486px;white-space:nowrap" class="ft3500">Xpovio 60 Mg Twice Weekly</p>
<p style="position:absolute;top:167px;left:828px;white-space:nowrap" class="ft3500">&#160;323&#160;</p>
<p style="position:absolute;top:191px;left:486px;white-space:nowrap" class="ft3500">Xpovio 80 Mg Once Weekly&#160;</p>
<p style="position:absolute;top:191px;left:828px;white-space:nowrap" class="ft3500">&#160;323&#160;</p>
<p style="position:absolute;top:215px;left:486px;white-space:nowrap" class="ft3500">Xpovio 80 Mg Twice Weekly</p>
<p style="position:absolute;top:215px;left:828px;white-space:nowrap" class="ft3500">&#160;323&#160;</p>
<p style="position:absolute;top:239px;left:486px;white-space:nowrap" class="ft3500">Xtandi&#160;</p>
<p style="position:absolute;top:239px;left:828px;white-space:nowrap" class="ft3500">&#160;324&#160;</p>
<p style="position:absolute;top:262px;left:486px;white-space:nowrap" class="ft3500">Xyrem&#160;</p>
<p style="position:absolute;top:262px;left:828px;white-space:nowrap" class="ft3500">&#160;325&#160;</p>
<p style="position:absolute;top:295px;left:486px;white-space:nowrap" class="ft35015"><i><b>Y</b></i></p>
<p style="position:absolute;top:298px;left:497px;white-space:nowrap" class="ft35016"><i>&#160;</i></p>
<p style="position:absolute;top:328px;left:486px;white-space:nowrap" class="ft3500">Yervoy</p>
<p style="position:absolute;top:328px;left:828px;white-space:nowrap" class="ft3500">&#160;327&#160;</p>
<p style="position:absolute;top:361px;left:486px;white-space:nowrap" class="ft35015"><i><b>Z</b></i></p>
<p style="position:absolute;top:363px;left:497px;white-space:nowrap" class="ft35016"><i>&#160;</i></p>
<p style="position:absolute;top:394px;left:486px;white-space:nowrap" class="ft3500">Zaleplon&#160;</p>
<p style="position:absolute;top:394px;left:828px;white-space:nowrap" class="ft3500">&#160;113&#160;</p>
<p style="position:absolute;top:417px;left:486px;white-space:nowrap" class="ft3500">Zarxio&#160;</p>
<p style="position:absolute;top:417px;left:828px;white-space:nowrap" class="ft3500">&#160;328&#160;</p>
<p style="position:absolute;top:441px;left:486px;white-space:nowrap" class="ft3500">Zejula&#160;</p>
<p style="position:absolute;top:441px;left:828px;white-space:nowrap" class="ft3500">&#160;329&#160;</p>
<p style="position:absolute;top:465px;left:486px;white-space:nowrap" class="ft3500">Zelboraf&#160;</p>
<p style="position:absolute;top:465px;left:828px;white-space:nowrap" class="ft3500">&#160;331&#160;</p>
<p style="position:absolute;top:489px;left:486px;white-space:nowrap" class="ft3500">Zenatane&#160;</p>
<p style="position:absolute;top:489px;left:828px;white-space:nowrap" class="ft3500">&#160;153&#160;</p>
<p style="position:absolute;top:513px;left:486px;white-space:nowrap" class="ft3500">Zepzelca&#160;</p>
<p style="position:absolute;top:513px;left:828px;white-space:nowrap" class="ft3500">&#160;332&#160;</p>
<p style="position:absolute;top:537px;left:486px;white-space:nowrap" class="ft3500">Zirabev&#160;</p>
<p style="position:absolute;top:537px;left:837px;white-space:nowrap" class="ft3500">&#160;24&#160;</p>
<p style="position:absolute;top:560px;left:486px;white-space:nowrap" class="ft3500">Zolinza&#160;</p>
<p style="position:absolute;top:560px;left:828px;white-space:nowrap" class="ft3500">&#160;333&#160;</p>
<p style="position:absolute;top:584px;left:486px;white-space:nowrap" class="ft3500">Zolpidem Tartrate&#160;</p>
<p style="position:absolute;top:584px;left:828px;white-space:nowrap" class="ft3500">&#160;113&#160;</p>
<p style="position:absolute;top:608px;left:486px;white-space:nowrap" class="ft3500">Zortress&#160;</p>
<p style="position:absolute;top:608px;left:828px;white-space:nowrap" class="ft3500">&#160;342&#160;</p>
<p style="position:absolute;top:632px;left:486px;white-space:nowrap" class="ft3500">Zydelig&#160;</p>
<p style="position:absolute;top:632px;left:828px;white-space:nowrap" class="ft3500">&#160;334&#160;</p>
<p style="position:absolute;top:656px;left:486px;white-space:nowrap" class="ft3500">Zykadia&#160;</p>
<p style="position:absolute;top:656px;left:828px;white-space:nowrap" class="ft3500">&#160;335&#160;</p>
<p style="position:absolute;top:679px;left:486px;white-space:nowrap" class="ft3500">Zyprexa&#160;Relprevv&#160;</p>
<p style="position:absolute;top:679px;left:828px;white-space:nowrap" class="ft3500">&#160;336&#160;</p>
<p style="position:absolute;top:703px;left:486px;white-space:nowrap" class="ft3500">Zytiga&#160;</p>
<p style="position:absolute;top:703px;left:846px;white-space:nowrap" class="ft3500">&#160;1&#160;</p>
<p style="position:absolute;top:727px;left:62px;white-space:nowrap" class="ft3500">&#160;</p>
<p style="position:absolute;top:766px;left:62px;white-space:nowrap" class="ft3504"><b>&#160;</b></p>
</div>
<hr/>
<a name="outline"></a><h1>Document Outline</h1>
<ul>
<li><a href="out2.html#1">ABIRATERONE&#160;</a></li>
<li><a href="out2.html#3">ACITRETIN &#160;</a></li>
<li><a href="out2.html#4">ACTIMMUNE</a></li>
<li><a href="out2.html#5">ADEMPAS</a></li>
<li><a href="out2.html#6">AIMOVIG</a></li>
<li><a href="out2.html#7">ALECENSA &#160;</a></li>
<li><a href="out2.html#8">ALOSETRON</a></li>
<li><a href="out2.html#9">ALPHA1-PROTEINASE &#160;INHIBITOR&#160;</a></li>
<li><a href="out2.html#10">ALUNBRIG &#160;</a></li>
<li><a href="out2.html#11">AMBRISENTAN &#160;</a></li>
<li><a href="out2.html#12">ARCALYST</a></li>
<li><a href="out2.html#13">ARMODAFINIL &#160;</a></li>
<li><a href="out2.html#14">ASPARLAS</a></li>
<li><a href="out2.html#15">AUSTEDO</a></li>
<li><a href="out2.html#16">AVONEX. &#160;</a></li>
<li><a href="out2.html#17">AYVAKIT&#160;</a></li>
<li><a href="out2.html#18">BALVERSA</a></li>
<li><a href="out2.html#19">BANZEL</a></li>
<li><a href="out2.html#20">BELEODAQ</a></li>
<li><a href="out2.html#21">BENLYSTA</a></li>
<li><a href="out2.html#22">BESREMI&#160;</a></li>
<li><a href="out2.html#23">BETASERON</a></li>
<li><a href="out2.html#24">BEVACIZUMAB&#160;</a></li>
<li><a href="out2.html#26">BEXAROTENE&#160;</a></li>
<li><a href="out2.html#27">BLENREP</a></li>
<li><a href="out2.html#28">BOSENTAN&#160;</a></li>
<li><a href="out2.html#29">BOSULIF&#160;</a></li>
<li><a href="out2.html#30">BRAFTOVI &#160;</a></li>
<li><a href="out2.html#31">BRIVIACT &#160;</a></li>
<li><a href="out2.html#32">BRIVIACT INJ &#160;</a></li>
<li><a href="out2.html#33">BRUKINSA&#160;</a></li>
<li><a href="out2.html#34">BUPRENORPHINE&#160;</a></li>
<li><a href="out2.html#35">BUPRENORPHINE PATCH&#160;</a></li>
<li><a href="out2.html#36">CABOMETYX &#160;</a></li>
<li><a href="out2.html#37">CALCIPOTRIENE&#160;</a></li>
<li><a href="out2.html#38">CALQUENCE &#160;</a></li>
<li><a href="out2.html#39">CAPLYTA &#160;</a></li>
<li><a href="out2.html#40">CAPRELSA&#160;</a></li>
<li><a href="out2.html#41">CARAC &#160;</a></li>
<li><a href="out2.html#42">CARBAGLU &#160;</a></li>
<li><a href="out2.html#43">CAYSTON &#160;</a></li>
<li><a href="out2.html#44">CERDELGA&#160;</a></li>
<li><a href="out2.html#45">CHANTIX &#160;</a></li>
<li><a href="out2.html#46">CHLORDIAZEPOXIDE - 65 &#160;</a></li>
<li><a href="out2.html#47">CLOBAZAM &#160;</a></li>
<li><a href="out2.html#48">CLOMIPRAMINE &#160;</a></li>
<li><a href="out2.html#49">CLORAZEPATE&#160;</a></li>
<li><a href="out2.html#50">CLOZAPINE ODT &#160;</a></li>
<li><a href="out2.html#51">COLY-MYCIN&#160;</a></li>
<li><a href="out2.html#52">COMETRIQ</a></li>
<li><a href="out2.html#53">COPIKTRA</a></li>
<li><a href="out2.html#54">COTELLIC&#160;</a></li>
<li><a href="out2.html#55">CYSTAGON &#160;</a></li>
<li><a href="out2.html#56">CYSTARAN &#160;</a></li>
<li><a href="out2.html#58">DAURISMO &#160;</a></li>
<li><a href="out2.html#59">DEFERASIROX &#160;</a></li>
<li><a href="out2.html#60">DEMSER&#160;</a></li>
<li><a href="out2.html#57">DALFAMPRIDINE &#160;</a></li>
<li><a href="out2.html#61">DESVENLAFAXINE</a></li>
<li><a href="out2.html#62">DHE NASAL &#160;</a></li>
<li><a href="out2.html#63">DIACOMIT &#160;</a></li>
<li><a href="out2.html#64">DIAZEPAM &#160;</a></li>
<li><a href="out2.html#65">DICLOFENAC GEL &#160;1%&#160;</a></li>
<li><a href="out2.html#66">DICLOFENAC SOLN &#160;</a></li>
<li><a href="out2.html#67">DOPTELET</a></li>
<li><a href="out2.html#68">DRIZALMA</a></li>
<li><a href="out2.html#69">DRONABINOL&#160;</a></li>
<li><a href="out2.html#70">DUEXIS &#160;</a></li>
<li><a href="out2.html#71">EMSAM&#160;</a></li>
<li><a href="out2.html#72">ENBREL &#160;</a></li>
<li><a href="out2.html#74">ENHERTU</a></li>
<li><a href="out2.html#75">EPCLUSA&#160;</a></li>
<li><a href="out2.html#76">EPIDIOLEX &#160;</a></li>
<li><a href="out2.html#77">EPO&#160;</a></li>
<li><a href="out2.html#79">ERIVEDGE</a></li>
<li><a href="out2.html#80">ERLEADA</a></li>
<li><a href="out2.html#81">ERLOTINIB &#160;</a></li>
<li><a href="out2.html#82">ESBRIET &#160;</a></li>
<li><a href="out2.html#83">EVEROLIMUS &#160;</a></li>
<li><a href="out2.html#84">EXKIVITY &#160;</a></li>
<li><a href="out2.html#85">FANAPT &#160;</a></li>
<li><a href="out2.html#86">FARYDAK &#160;</a></li>
<li><a href="out2.html#87">FASENRA &#160;</a></li>
<li><a href="out2.html#88">FENTANYL PATCH &#160;</a></li>
<li><a href="out2.html#89">FETZIMA</a></li>
<li><a href="out2.html#90">FINTEPLA &#160;</a></li>
<li><a href="out2.html#91">FLUOROURACIL &#160;</a></li>
<li><a href="out2.html#92">FORTAMET/GLUMETZA &#160;</a></li>
<li><a href="out2.html#93">FORTEO &#160;</a></li>
<li><a href="out2.html#95">FOTIVDA &#160;</a></li>
<li><a href="out2.html#96">FYCOMPA&#160;</a></li>
<li><a href="out2.html#97">GATTEX</a></li>
<li><a href="out2.html#98">GAVRETO&#160;</a></li>
<li><a href="out2.html#99">GILENYA&#160;</a></li>
<li><a href="out2.html#100">GILOTRIF &#160;</a></li>
<li><a href="out2.html#101">GLATIRAMER &#160;</a></li>
<li><a href="out2.html#102">GROWTH HORMONE</a></li>
<li><a href="out2.html#105">HAEGARDA&#160;</a></li>
<li><a href="out2.html#106">HARVONI &#160;</a></li>
<li><a href="out2.html#107">HERCEPTIN HYLECTA&#160;</a></li>
<li><a href="out2.html#108">HETLIOZ &#160;</a></li>
<li><a href="out2.html#109">HETLIOZ LQ &#160;</a></li>
<li><a href="out2.html#110">HIGH RISK &#160;MEDICATION - 65 &#160;</a></li>
<li><a href="out2.html#112">HRM - ANTICONVULSANTS - 65 &#160;</a></li>
<li><a href="out2.html#113">HRM - HYPNOTICS - 65&#160;</a></li>
<li><a href="out2.html#115">HRM - SCOPOLAMINE &#160;- 65&#160;</a></li>
<li><a href="out2.html#116">HRM-ANTIPARKINSON - 65 &#160;</a></li>
<li><a href="out2.html#118">HRM-CYPROHEPTADINE - 65&#160;</a></li>
<li><a href="out2.html#119">HRM-DOXEPIN - 65 &#160;</a></li>
<li><a href="out2.html#121">HRM-HYDROXYZINE &#160;- 65 &#160;</a></li>
<li><a href="out2.html#123">HRM-HYDROXYZINE &#160;INJ &#160;- 65&#160;</a></li>
<li><a href="out2.html#125">HRM-PROMETHAZINE - 65 &#160;</a></li>
<li><a href="out2.html#127">HRMS - ANTIDEPRESSANTS &#160;</a></li>
<li><a href="out2.html#129">HRMS - CARBINOXAMINE &#160;</a></li>
<li><a href="out2.html#130">HRMS - CLEMASTINE- 65 &#160;</a></li>
<li><a href="out2.html#131">HRMS - MECLIZINE - 65 &#160;</a></li>
<li><a href="out2.html#132">HRMS - TCAS &#160;</a></li>
<li><a href="out2.html#133">HRM-SKELETAL MUSCLE &#160;RELAXANTS - 65 &#160;</a></li>
<li><a href="out2.html#134">HUMIRA &#160;</a></li>
<li><a href="out2.html#136">HYPNOTIC-BENZODIAZEPINES - 65 &#160;</a></li>
<li><a href="out2.html#137">IBRANCE &#160;</a></li>
<li><a href="out2.html#138">ICATIBANT &#160;</a></li>
<li><a href="out2.html#139">ICLUSIG &#160;</a></li>
<li><a href="out2.html#140">IDHIFA &#160;</a></li>
<li><a href="out2.html#141">IMATINIB &#160;</a></li>
<li><a href="out2.html#142">IMBRUVICA &#160;</a></li>
<li><a href="out2.html#145">IMLYGIC &#160;</a></li>
<li><a href="out2.html#146">INCRELEX &#160;</a></li>
<li><a href="out2.html#147">INLYTA &#160;</a></li>
<li><a href="out2.html#148">INQOVI &#160;</a></li>
<li><a href="out2.html#149">INREBIC&#160;</a></li>
<li><a href="out2.html#150">IR BEFORE &#160;ER&#160;</a></li>
<li><a href="out2.html#152">IRESSA &#160;</a></li>
<li><a href="out2.html#153">ISOTRETINOIN</a></li>
<li><a href="out2.html#154">ITRACONAZOLE</a></li>
<li><a href="out2.html#155">IVERMECTIN TAB &#160;</a></li>
<li><a href="out2.html#156">IVIG &#160;</a></li>
<li><a href="out2.html#158">JAKAFI &#160;</a></li>
<li><a href="out2.html#159">KALYDECO</a></li>
<li><a href="out2.html#160">KESIMPTA&#160;</a></li>
<li><a href="out2.html#161">KETOCONAZOLE&#160;</a></li>
<li><a href="out2.html#162">KEYTRUDA &#160;</a></li>
<li><a href="out2.html#163">KISQALI&#160;</a></li>
<li><a href="out2.html#165">KORLYM &#160;</a></li>
<li><a href="out2.html#166">KRISTALOSE</a></li>
<li><a href="out2.html#167">KUVAN &#160;</a></li>
<li><a href="out2.html#168">KYNMOBI</a></li>
<li><a href="out2.html#169">LAPATINIB &#160;</a></li>
<li><a href="out2.html#170">LENVIMA&#160;</a></li>
<li><a href="out2.html#171">LEUPROLIDE</a></li>
<li><a href="out2.html#172">LIBTAYO &#160;</a></li>
<li><a href="out2.html#173">LIDOCAINE PATCHES</a></li>
<li><a href="out2.html#174">LINEZOLID &#160;</a></li>
<li><a href="out2.html#175">LONSURF &#160;</a></li>
<li><a href="out2.html#176">LORBRENA &#160;</a></li>
<li><a href="out2.html#177">LUMAKRAS &#160;</a></li>
<li><a href="out2.html#178">LUMOXITI</a></li>
<li><a href="out2.html#179">LUPRON PED</a></li>
<li><a href="out2.html#180">LUPRON-ENDOMETRIOSIS &#160;</a></li>
<li><a href="out2.html#181">LYNPARZA&#160;</a></li>
<li><a href="out2.html#182">LYRICA CR</a></li>
<li><a href="out2.html#183">MAVYRET&#160;</a></li>
<li><a href="out2.html#184">MEKINIST &#160;</a></li>
<li><a href="out2.html#185">MEKTOVI &#160;</a></li>
<li><a href="out2.html#186">MEMANTINE&#160;</a></li>
<li><a href="out2.html#187">MEPRON&#160;</a></li>
<li><a href="out2.html#188">MODAFINIL&#160;</a></li>
<li><a href="out2.html#189">MONJUVI&#160;</a></li>
<li><a href="out2.html#190">MYLOTARG&#160;</a></li>
<li><a href="out2.html#191">NAPROXEN-ESOMEPRAZOLE&#160;</a></li>
<li><a href="out2.html#192">NATPARA&#160;</a></li>
<li><a href="out2.html#193">NAYZILAM&#160;</a></li>
<li><a href="out2.html#194">NERLYNX</a></li>
<li><a href="out2.html#195">NEXAVAR</a></li>
<li><a href="out2.html#196">NINLARO &#160;</a></li>
<li><a href="out2.html#197">NITISINONE &#160;</a></li>
<li><a href="out2.html#198">NORTHERA &#160;</a></li>
<li><a href="out2.html#199">NUBEQA&#160;</a></li>
<li><a href="out2.html#200">NUEDEXTA &#160;</a></li>
<li><a href="out2.html#201">NUPLAZID &#160;</a></li>
<li><a href="out2.html#202">OCTREOTIDE</a></li>
<li><a href="out2.html#203">ODOMZO</a></li>
<li><a href="out2.html#204">OFEV &#160;</a></li>
<li><a href="out2.html#205">ONCASPAR &#160;</a></li>
<li><a href="out2.html#206">ONUREG &#160;</a></li>
<li><a href="out2.html#207">OPSUMIT</a></li>
<li><a href="out2.html#208">ORACEA &#160;</a></li>
<li><a href="out2.html#209">ORAL-INTRANASAL FENTANYL &#160;</a></li>
<li><a href="out2.html#210">ORGOVYX &#160;</a></li>
<li><a href="out2.html#211">ORKAMBI &#160;</a></li>
<li><a href="out2.html#212">OXANDROLONE &#160;</a></li>
<li><a href="out2.html#213">OXAZEPAM - 65&#160;</a></li>
<li><a href="out2.html#214">PADCEV &#160;</a></li>
<li><a href="out2.html#215">PEGASYS &#160;</a></li>
<li><a href="out2.html#216">PEMAZYRE &#160;</a></li>
<li><a href="out2.html#217">PEPAXTO&#160;</a></li>
<li><a href="out2.html#218">PHENYLBUTYRATE &#160;</a></li>
<li><a href="out2.html#219">PHESGO &#160;</a></li>
<li><a href="out2.html#220">&#160;PIQRAY</a></li>
<li><a href="out2.html#221">&#160;POLIVY &#160;</a></li>
<li><a href="out2.html#222">POMALYST&#160;</a></li>
<li><a href="out2.html#223">POTELIGEO&#160;</a></li>
<li><a href="out2.html#224">PRALUENT &#160;</a></li>
<li><a href="out2.html#225">&#160;PREGABALIN &#160;</a></li>
<li><a href="out2.html#226">PRETOMANID&#160;</a></li>
<li><a href="out2.html#227">PROMACTA &#160;</a></li>
<li><a href="out2.html#230">PULMOZYME</a></li>
<li><a href="out2.html#231">QINLOCK&#160;</a></li>
<li><a href="out2.html#232">QUETIAPINE XR &#160;</a></li>
<li><a href="out2.html#233">QUININE SULFATE &#160;</a></li>
<li><a href="out2.html#234">REGRANEX &#160;</a></li>
<li><a href="out2.html#235">RETEVMO &#160;</a></li>
<li><a href="out2.html#236">REVLIMID &#160;</a></li>
<li><a href="out2.html#238">REZUROCK &#160;</a></li>
<li><a href="out2.html#239">RINVOQ &#160;</a></li>
<li><a href="out2.html#240">RITUXAN HYCELA &#160;</a></li>
<li><a href="out2.html#241">RITUXIMAB &#160;</a></li>
<li><a href="out2.html#244">ROZLYTREK &#160;</a></li>
<li><a href="out2.html#245">RUBRACA &#160;</a></li>
<li><a href="out2.html#246">RYDAPT &#160;</a></li>
<li><a href="out2.html#247">SANDOSTATIN &#160;LAR &#160;</a></li>
<li><a href="out2.html#249">SARCLISA &#160;</a></li>
<li><a href="out2.html#250">SCEMBLIX &#160;</a></li>
<li><a href="out2.html#253">SIRTURO&#160;</a></li>
<li><a href="out2.html#254">SKYRIZI &#160;</a></li>
<li><a href="out2.html#256">SOMAVERT&#160;</a></li>
<li><a href="out2.html#257">SPRITAM &#160;</a></li>
<li><a href="out2.html#258">SPRYCEL&#160;</a></li>
<li><a href="out2.html#259">STELARA &#160;</a></li>
<li><a href="out2.html#260">STIVARGA &#160;</a></li>
<li><a href="out2.html#261">SUTENT</a></li>
<li><a href="out2.html#263">SYMPAZAN &#160;</a></li>
<li><a href="out2.html#264">SYNRIBO&#160;</a></li>
<li><a href="out2.html#265">TABRECTA&#160;</a></li>
<li><a href="out2.html#267">TAFINLAR&#160;</a></li>
<li><a href="out2.html#268">TAGRISSO &#160;</a></li>
<li><a href="out2.html#269">TALTZ</a></li>
<li><a href="out2.html#270">TALZENNA &#160;</a></li>
<li><a href="out2.html#271">TARGRETIN TOPICAL&#160;</a></li>
<li><a href="out2.html#272">TASIGNA&#160;</a></li>
<li><a href="out2.html#273">TAZAROTENE</a></li>
<li><a href="out2.html#274">TAZVERIK&#160;</a></li>
<li><a href="out2.html#275">TECENTRIQ&#160;</a></li>
<li><a href="out2.html#277">TECFIDERA &#160;</a></li>
<li><a href="out2.html#278">TEMAZEPAM 30MG &#160;- 65 &#160;</a></li>
<li><a href="out2.html#279">TEPMETKO&#160;</a></li>
<li><a href="out2.html#280">TESTOSTERONE CYPIONATE &#160;INJ &#160;</a></li>
<li><a href="out2.html#281">TESTOSTERONE ENANTHATE &#160;INJ</a></li>
<li><a href="out2.html#282">TETRABENAZINE &#160;</a></li>
<li><a href="out2.html#283">THALOMID &#160;</a></li>
<li><a href="out2.html#284">TIBSOVO &#160;</a></li>
<li><a href="out2.html#285">TOBRAMYCIN &#160;</a></li>
<li><a href="out2.html#286">TOPICAL DOXEPIN &#160;</a></li>
<li><a href="out2.html#287">TOPICAL LIDOCAINE &#160;</a></li>
<li><a href="out2.html#288">TOPICAL TESTOSTERONES &#160;</a></li>
<li><a href="out2.html#289">TOPICAL TRETINOIN &#160;</a></li>
<li><a href="out2.html#290">TOREMIFENE&#160;</a></li>
<li><a href="out2.html#291">TRELSTAR &#160;</a></li>
<li><a href="out2.html#292">TREPROSTINIL INJ&#160;</a></li>
<li><a href="out2.html#293">TRIENTINE &#160;</a></li>
<li><a href="out2.html#294">TRIKAFTA &#160;</a></li>
<li><a href="out2.html#295">TRODELVY &#160;</a></li>
<li><a href="out2.html#296">TRUSELTIQ &#160;</a></li>
<li><a href="out2.html#297">TUKYSA &#160;</a></li>
<li><a href="out2.html#298">TURALIO &#160;</a></li>
<li><a href="out2.html#299">UBRELVY &#160;</a></li>
<li><a href="out2.html#300">UKONIQ &#160;</a></li>
<li><a href="out2.html#301">VALCHLOR &#160;</a></li>
<li><a href="out2.html#302">VALTOCO &#160;</a></li>
<li><a href="out2.html#303">VELCADE &#160;</a></li>
<li><a href="out2.html#304">VELTASSA &#160;</a></li>
<li><a href="out2.html#305">VENCLEXTA &#160;</a></li>
<li><a href="out2.html#306">VENTAVIS&#160;</a></li>
<li><a href="out2.html#307">VERSACLOZ</a></li>
<li><a href="out2.html#308">VERZENIO &#160;</a></li>
<li><a href="out2.html#309">VIGABATRIN &#160;</a></li>
<li><a href="out2.html#310">VITRAKVI &#160;</a></li>
<li><a href="out2.html#311">VIZIMPRO &#160;</a></li>
<li><a href="out2.html#312">VORICONAZOLE &#160;</a></li>
<li><a href="out2.html#313">VOSEVI &#160;</a></li>
<li><a href="out2.html#314">VOTRIENT &#160;</a></li>
<li><a href="out2.html#315">WELIREG &#160;</a></li>
<li><a href="out2.html#316">XALKORI &#160;</a></li>
<li><a href="out2.html#317">XELJANZ &#160;</a></li>
<li><a href="out2.html#318">XERMELO&#160;</a></li>
<li><a href="out2.html#319">XGEVA&#160;</a></li>
<li><a href="out2.html#320">XIFAXAN &#160;</a></li>
<li><a href="out2.html#321">XOLAIR &#160;</a></li>
<li><a href="out2.html#322">XOSPATA&#160;</a></li>
<li><a href="out2.html#323">XPOVIO &#160;</a></li>
<li><a href="out2.html#324">XTANDI &#160;</a></li>
<li><a href="out2.html#325">XYREM &#160;</a></li>
<li><a href="out2.html#327">YERVOY &#160;</a></li>
<li><a href="out2.html#328">ZARXIO &#160;</a></li>
<li><a href="out2.html#329">ZEJULA. &#160;</a></li>
<li><a href="out2.html#331">ZELBORAF &#160;</a></li>
<li><a href="out2.html#332">ZEPZELCA&#160;</a></li>
<li><a href="out2.html#333">ZOLINZA &#160;</a></li>
<li><a href="out2.html#334">ZYDELIG &#160;</a></li>
<li><a href="out2.html#335">ZYKADIA &#160;</a></li>
<li><a href="out2.html#336">ZYPREXA RELPREVV &#160;</a></li>
<li><a href="out2.html#337">PART B &#160;VERSUS PART D &#160;</a></li>
<li><a href="out2.html#343">INDEX</a></li>
</ul>
</body>
</html>
